kw1	kw2	pg	crit_p	edge_weight	inv_edge_weight	R1C1	iteration
spleen/pathology	piperazines/pharmacology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
spleen/pathology	liver/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
spleen/pathology	ferroptosis/drug effects	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
spleen/pathology	iron/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
spleen/pathology	kidney	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
spleen/pathology	malondialdehyde/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
spleen/pathology	glutathione	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
spleen/pathology	phospholipid hydroperoxide glutathione peroxidase	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperazines/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	liver/pathology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	oxidative stress	5.133631229115032e-06	1.249986762446474e-05	0.055287464515536164	0.9605811478101344	1	2
piperazines/pharmacology	ferroptosis/drug effects	0.005144779462977533	0.008962713147892593	0.0839634159066658	0.8657199677887635	2	2
piperazines/pharmacology	iron/blood	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	kidney	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	tetrahydrofolate dehydrogenase/genetics	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	folic acid antagonists/pharmacology	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	cystine/antagonists & inhibitors	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	methotrexate/pharmacology	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	vitamin e/pharmacology	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	malondialdehyde/blood	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	gene expression regulation neoplastic	1.6095687582762253e-07	4.395859281862284e-07	0.00535588186581037	0.8657199677887635	2	2
piperazines/pharmacology	glutathione	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	antioxidants/pharmacology	0.00013201752082625529	0.0002773965785930884	0.055287464515536164	0.9605811478101344	1	2
piperazines/pharmacology	carbolines/pharmacology	0.0003482778718123525	0.000698647121983327	0.07319670689438858	0.9605811478101344	1	2
piperazines/pharmacology	biopterin/analogs & derivatives	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	phospholipid hydroperoxide glutathione peroxidase	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	spiro compounds/pharmacology	1.1364735889030086e-06	2.9166534382648742e-06	0.03711991575621956	0.9605811478101344	1	2
piperazines/pharmacology	sulfonamides/pharmacology	3.7268444940119494e-05	8.314223151267373e-05	0.055287464515536164	0.9605811478101344	1	2
piperazines/pharmacology	rna small interfering/genetics	3.7268444940119494e-05	8.314223151267373e-05	0.055287464515536164	0.9605811478101344	1	2
piperazines/pharmacology	curcumin/pharmacology	6.659905439576619e-06	1.6079456321921296e-05	0.055287464515536164	0.9605811478101344	1	2
piperazines/pharmacology	cyclophilin d	2.464627871789915e-07	6.621997967002687e-07	0.03711991575621956	0.9605811478101344	1	2
piperazines/pharmacology	adenine nucleotide translocator 1/antagonists & inhibitors	8.205436330399607e-12	2.8445512612051973e-11	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	pyridines/pharmacology	1.08218036753982e-08	3.1758169497561496e-08	0.03711991575621956	0.9605811478101344	1	2
piperazines/pharmacology	lactones/pharmacology	8.205436330399607e-12	2.8445512612051973e-11	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	cyclosporine/pharmacology	2.464627871789915e-07	6.621997967002687e-07	0.03711991575621956	0.9605811478101344	1	2
piperazines/pharmacology	cyclin-dependent kinase 4/antagonists & inhibitors	1.585062934572612e-06	4.019722519146187e-06	0.03711991575621956	0.9605811478101344	1	2
piperazines/pharmacology	mesothelioma malignant/drug therapy	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	phosphoinositide-3 kinase inhibitors/pharmacology	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	proto-oncogene proteins c-bcl-2/antagonists & inhibitors	8.205436330399607e-12	2.8445512612051973e-11	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	biphenyl compounds/pharmacology	1.360526913485316e-05	3.167571001956098e-05	0.03711991575621956	0.9605811478101344	1	2
piperazines/pharmacology	nitrophenols/pharmacology	8.205436330399607e-12	2.8445512612051973e-11	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	cyclin-dependent kinase 6/antagonists & inhibitors	1.585062934572612e-06	4.019722519146187e-06	0.03711991575621956	0.9605811478101344	1	2
piperazines/pharmacology	CDK4	1.585062934572612e-06	4.019722519146187e-06	0.03711991575621956	0.9605811478101344	1	2
piperazines/pharmacology	CDKN2A	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
piperazines/pharmacology	MYC	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
liver/pathology	ferroptosis/drug effects	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
liver/pathology	iron/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver/pathology	kidney	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver/pathology	malondialdehyde/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver/pathology	glutathione	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver/pathology	phospholipid hydroperoxide glutathione peroxidase	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ferroptosis/drug effects	b-lymphocytes/metabolism	1.5502799377564713e-08	4.5009971118849983e-08	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	acetaminophen/pharmacology	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	proto-oncogene proteins p21(ras)/metabolism	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	pancreas/metabolism	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	exosomes/metabolism	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	oleic acid/metabolism	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	neoplasms/diagnostic imaging	8.80326043284363e-06	2.0910825902104758e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	lymphoma t-cell	7.517679932211863e-05	0.00016242019318511234	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	t-lymphocytes cytotoxic/metabolism	8.80326043284363e-06	2.0910825902104758e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	iron/blood	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	urinary bladder neoplasms/pathology	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	fusion regulatory protein 1 heavy chain/metabolism	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	hepatic stellate cells/drug effects	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	glioblastoma/genetics	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	hyaluronic acid/chemistry	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	t-lymphocytes cytotoxic/immunology	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	gels/chemistry	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	dichloroacetic acid/chemistry	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	hyaluronan receptors/genetics	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	exosomes/drug effects	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	ventricular function left/drug effects	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	iron/metabolism	3.779275124182746e-06	9.324693144357787e-06	0.011499102826099802	0.5304112294886878	4	2
ferroptosis/drug effects	antineoplastic agents immunological/administration & dosage	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	macrophages/drug effects	0.002920509564070417	0.005281013275537157	0.02849245358548201	0.5304112294886878	4	2
ferroptosis/drug effects	kidney	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	cd36 antigens/antagonists & inhibitors	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	neutrophil infiltration	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	carcinoma pancreatic ductal/metabolism	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	killer cells natural/metabolism	7.517679932211863e-05	0.00016242019318511234	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	cell transformation neoplastic/genetics	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	small molecule libraries/pharmacology	8.80326043284363e-06	2.0910825902104758e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	toll-like receptor 4/genetics	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	necroptosis/drug effects	8.80326043284363e-06	2.0910825902104758e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	glutathione/metabolism	1.3523596326114884e-06	3.445836724814295e-06	0.007413269527753435	0.7135314763244264	3	2
ferroptosis/drug effects	dextrans/chemistry	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	b7-h1 antigen/antagonists & inhibitors	0.0035668888613312744	0.0063601104419435455	0.0839634159066658	0.8657199677887635	2	2
ferroptosis/drug effects	diet	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	tumor suppressor protein p53/genetics	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	actins/metabolism	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	pancreatitis/genetics	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	tetrahydrofolate dehydrogenase/genetics	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	immunologic memory	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	macrophages/cytology	0.0003608428861638924	0.0007222754384150249	0.045688342717209625	0.8657199677887635	2	2
ferroptosis/drug effects	lipopolysaccharides/toxicity	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	folic acid antagonists/pharmacology	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	myocardium/immunology	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	ileum/drug effects	8.80326043284363e-06	2.0910825902104758e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	aniline compounds/chemistry	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	radiation-protective agents/pharmacology	8.80326043284363e-06	2.0910825902104758e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	cystine/antagonists & inhibitors	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	adjuvants immunologic/chemistry	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	asparaginase	7.517679932211863e-05	0.00016242019318511234	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	amino acid transport system y+/genetics	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	dna	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	tumor suppressor protein p53/metabolism	0.0002981360982104997	0.0006042195692016818	0.045688342717209625	0.8657199677887635	2	2
ferroptosis/drug effects	phenol/chemistry	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	methotrexate/pharmacology	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	programmed cell death 1 receptor/metabolism	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	cd8-positive t-lymphocytes/cytology	2.0193897036779873e-06	5.071591774312822e-06	0.01658549427405555	0.8657199677887635	2	2
ferroptosis/drug effects	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	flavonolignans/pharmacology	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	vitamin e/pharmacology	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	hypoxia-inducible factor 1 alpha subunit/metabolism	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	basic-leucine zipper transcription factors/analysis	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	malondialdehyde/blood	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	immunogenic cell death/drug effects	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	quinoxalines/pharmacology	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	lipid metabolism/drug effects	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	glutathione	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	gold/chemistry	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	listeriosis/etiology	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	cell line tumor/transplantation	0.00019791111159173091	0.00040822754124562476	0.045688342717209625	0.8657199677887635	2	2
ferroptosis/drug effects	microglia/drug effects	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	ascorbic acid/pharmacology	8.80326043284363e-06	2.0910825902104758e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	biopterin/analogs & derivatives	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	phenylenediamines/pharmacology	5.818418120706603e-05	0.00012729160818152332	0.01658549427405555	0.8657199677887635	2	2
ferroptosis/drug effects	hemeproteins/toxicity	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	membrane proteins/metabolism	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	inflammation mediators/antagonists & inhibitors	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	calreticulin/metabolism	8.80326043284363e-06	2.0910825902104758e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	drug interactions	8.80326043284363e-06	2.0910825902104758e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	aniline compounds/pharmacology	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	transferrin/metabolism	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	tuberculosis/metabolism	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	cyclohexylamines/pharmacology	5.818418120706603e-05	0.00012729160818152332	0.01658549427405555	0.8657199677887635	2	2
ferroptosis/drug effects	ferric compounds/chemistry	5.799061231215319e-11	1.941355937227989e-10	0.0020340700524785105	0.7135314763244264	3	2
ferroptosis/drug effects	melanoma/blood	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	membrane proteins/genetics	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	fatty acids/metabolism	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	metal-organic frameworks/chemistry	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	benzylidene compounds/chemistry	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	biomarkers tumor	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	saponins/chemistry	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	phospholipid hydroperoxide glutathione peroxidase	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	neutral ceramidase/antagonists & inhibitors	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	cysteine/metabolism	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	heme oxygenase-1/metabolism	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	liver x receptors/agonists	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	glutathione peroxidase/therapeutic use	1.5502799377564713e-08	4.5009971118849983e-08	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	adaptor proteins vesicular transport/genetics	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	ACSL3	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	ACSL4	1.9101272974442196e-07	5.190988124497739e-07	0.01658549427405555	0.8657199677887635	2	2
ferroptosis/drug effects	AIFM2	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	ASAH2	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	ATL1	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	ATM	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	BDKRB2	0.0027667287480445113	0.005018579632816569	0.24509674871659862	0.9605811478101344	1	2
ferroptosis/drug effects	CALR	8.80326043284363e-06	2.0910825902104758e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	CD36	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	CD44	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	CD8A	0.002626264775381082	0.0047799146250290655	0.0491501627719923	0.7135314763244264	3	2
ferroptosis/drug effects	FN1	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	nivolumab/therapeutic use	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	GGT1	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	GPX4	0.0	0.0	2.1625342150498376e-12	0.0014672161981045017	12	2
ferroptosis/drug effects	coenzyme a ligases/metabolism	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	HLF	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	HSPB1	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	JAK2	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	KDM8	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	MMRN1	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	PDCD1	0.00015070617393864172	0.0003148052792988321	0.016890906698475917	0.7135314763244264	3	2
ferroptosis/drug effects	S100A4	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	SLC3A2	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	SLC40A1	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	SLC7A11	1.1213252548714081e-14	4.506558370288882e-14	2.7543264082308877e-05	0.35414021462530776	5	2
ferroptosis/drug effects	SLC9A1	7.633005034501927e-05	0.00016481490059807902	0.045688342717209625	0.8657199677887635	2	2
ferroptosis/drug effects	STING1	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	TF	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	TICAM1	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	TLR4	0.0014555451462482383	0.002738914345351298	0.045688342717209625	0.8657199677887635	2	2
ferroptosis/drug effects	TRIM69	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	biological products/chemistry	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	nf-e2-related factor 2/biosynthesis	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	anti-inflammatory agents non-steroidal/pharmacology	7.517679932211863e-05	0.00016242019318511234	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	IREB2	7.517679932211863e-05	0.00016242019318511234	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	ferritins/blood	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	MKI67	7.517679932211863e-05	0.00016242019318511234	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	cisplatin	7.517679932211863e-05	0.00016242019318511234	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	antibodies monoclonal humanized/pharmacology	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	glutathione peroxidase/metabolism	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	amino acid transport system y+/metabolism	7.77221507397563e-06	1.866279655314906e-05	0.01658549427405555	0.8657199677887635	2	2
ferroptosis/drug effects	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	genetic variation	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	malaria/genetics	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	autophagy-related proteins/genetics	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	brain neoplasms/genetics	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	liver cirrhosis/drug therapy	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	collagen type i/metabolism	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	cd8-positive t-lymphocytes/immunology	6.818350085013858e-05	0.00014843106504184987	0.016890906698475917	0.7135314763244264	3	2
ferroptosis/drug effects	t-lymphocytes/immunology	0.0013775428040453397	0.0025967906757516797	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	sulfasalazine/administration & dosage	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	pyruvate dehydrogenase acetyl-transferring kinase/antagonists & inhibitors	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	benzylidene compounds/pharmacology	0.0009047857165859208	0.001741333404267317	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	iron chelating agents/pharmacology	2.8899005380833565e-05	6.53100933411868e-05	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	precursor cell lymphoblastic leukemia-lymphoma/metabolism	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	cation transport proteins/genetics	0.00016503859793592923	0.0003433774660084333	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	neoplasm metastasis/drug therapy	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	phospholipid hydroperoxide glutathione peroxidase/metabolism	9.226478037138719e-08	2.5565588508587967e-07	0.01658549427405555	0.8657199677887635	2	2
ferroptosis/drug effects	neutrophils/immunology	0.0005584039257549023	0.0011012244861399003	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	lymph/metabolism	0.00031889726529688023	0.0006431619927978059	0.1308411214953271	0.9605811478101344	1	2
ferroptosis/drug effects	oxidative stress	0.0002981360982104997	0.0006042195692016818	0.045688342717209625	0.8657199677887635	2	2
ferroptosis/drug effects	macrophages	0.0037076139699631083	0.006579642048434209	0.1308411214953271	0.9605811478101344	1	2
iron/blood	kidney	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
iron/blood	malondialdehyde/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
iron/blood	glutathione	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
iron/blood	phospholipid hydroperoxide glutathione peroxidase	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney	malondialdehyde/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney	glutathione	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney	phospholipid hydroperoxide glutathione peroxidase	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drug synergism	biological products/chemistry	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	dichloroacetic acid/chemistry	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	saponins/chemistry	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	mitochondrial proteins/metabolism	1.4472717261515555e-05	3.3567690951177674e-05	6.262485511168005e-05	0.11552077256850565	7	2
drug synergism	drug combinations	0.0030185814456211713	0.005444954897574702	0.027642490456759247	0.8657199677887635	2	2
drug synergism	cisplatin/administration & dosage	1.1119667516878984e-05	2.6128789237146734e-05	0.027642490456759247	0.8657199677887635	2	2
drug synergism	carcinoma non-small-cell lung/drug therapy	2.66241961810465e-09	8.165395429123844e-09	6.4770888354991655e-06	0.025750963099745193	9	2
drug synergism	drugs chinese herbal/pharmacology	6.166319566069944e-09	1.854269146108976e-08	9.613579891350966e-05	0.2127419111522651	6	2
drug synergism	adenosine triphosphate/metabolism	0.0019955200378475313	0.00369383139908172	0.06111070279085976	0.7135314763244264	3	2
drug synergism	DIABLO	0.00014628395412996653	0.0003064097112538003	0.000555563619810825	0.35414021462530776	5	2
drug synergism	cyclophilin d	0.001017817647835706	0.001950868773318408	0.027642490456759247	0.8657199677887635	2	2
drug synergism	sp1 transcription factor/physiology	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	monoterpenes/pharmacology	0.0013546484695101668	0.0025577879126282574	0.16822429906542055	0.9605811478101344	1	2
drug synergism	hydroxymethylglutaryl-coa reductase inhibitors/pharmacology	0.00011081017083902633	0.0002340847606265069	0.16822429906542055	0.9605811478101344	1	2
drug synergism	necrosis	0.0025774897923146467	0.004696181715639479	0.027642490456759247	0.8657199677887635	2	2
drug synergism	spleen/drug effects	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	artesunate	2.812667174656447e-05	6.368869864108589e-05	0.16822429906542055	0.9605811478101344	1	2
drug synergism	thallium/metabolism	0.0023238349829961535	0.004262200624332351	0.16822429906542055	0.9605811478101344	1	2
drug synergism	thiosemicarbazones/pharmacology	0.0007038336660539768	0.0013726779893107545	0.16822429906542055	0.9605811478101344	1	2
drug synergism	mitochondrial proteins/genetics	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	drug antagonism	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	gefitinib/pharmacology	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	succinate dehydrogenase/metabolism	0.0007038336660539768	0.0013726779893107545	0.16822429906542055	0.9605811478101344	1	2
drug synergism	glycine/analogs & derivatives	0.0007038336660539768	0.0013726779893107545	0.16822429906542055	0.9605811478101344	1	2
drug synergism	deoxycytidine/administration & dosage	2.812667174656447e-05	6.368869864108589e-05	0.16822429906542055	0.9605811478101344	1	2
drug synergism	nucleotidyltransferases/metabolism	0.0023238349829961535	0.004262200624332351	0.16822429906542055	0.9605811478101344	1	2
drug synergism	palmitates/metabolism	0.0023238349829961535	0.004262200624332351	0.16822429906542055	0.9605811478101344	1	2
drug synergism	amyloid beta-peptides/pharmacology	0.0013546484695101668	0.0025577879126282574	0.16822429906542055	0.9605811478101344	1	2
drug synergism	enzyme inhibitors/pharmacology	0.0021826706433161203	0.004015647725620312	0.027642490456759247	0.8657199677887635	2	2
drug synergism	adenosine diphosphate/pharmacology	1.1119667516878984e-05	2.6128789237146734e-05	0.027642490456759247	0.8657199677887635	2	2
drug synergism	peroxiredoxin iii/metabolism	0.0007038336660539768	0.0013726779893107545	0.16822429906542055	0.9605811478101344	1	2
drug synergism	phagosomes/metabolism	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	head and neck neoplasms/drug therapy	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	homeostasis/drug effects	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	carcinoma non-small-cell lung/blood	2.2819819367470018e-09	7.0161954736296045e-09	0.16822429906542055	0.9605811478101344	1	2
drug synergism	dexamethasone/administration & dosage	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	mitochondrial swelling/drug effects	1.1119667516878984e-05	2.6128789237146734e-05	0.027642490456759247	0.8657199677887635	2	2
drug synergism	cyclosporine/pharmacology	0.001017817647835706	0.001950868773318408	0.027642490456759247	0.8657199677887635	2	2
drug synergism	acetaldehyde/pharmacology	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	electron transport complex iv/metabolism	0.0007038336660539768	0.0013726779893107545	0.16822429906542055	0.9605811478101344	1	2
drug synergism	antimycin a/pharmacology	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	ferrous compounds/administration & dosage	2.812667174656447e-05	6.368869864108589e-05	0.16822429906542055	0.9605811478101344	1	2
drug synergism	malaria/drug therapy	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	carbonyl cyanide p-trifluoromethoxyphenylhydrazone/pharmacology	0.0023238349829961535	0.004262200624332351	0.16822429906542055	0.9605811478101344	1	2
drug synergism	monoamine oxidase/metabolism	0.0023238349829961535	0.004262200624332351	0.16822429906542055	0.9605811478101344	1	2
drug synergism	deoxycytidine/analogs & derivatives	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	oxygen consumption/drug effects	0.0021826706433161203	0.004015647725620312	0.07406101216716628	0.8657199677887635	2	2
drug synergism	dna fragmentation/drug effects	0.0021826706433161203	0.004015647725620312	0.07406101216716628	0.8657199677887635	2	2
drug synergism	rna long noncoding/physiology	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	antimalarials/pharmacology	0.0012520215346564223	0.0023754040784876346	0.027642490456759247	0.8657199677887635	2	2
drug synergism	receptors prostaglandin e ep4 subtype/physiology	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	phosphates/pharmacology	0.0023238349829961535	0.004262200624332351	0.16822429906542055	0.9605811478101344	1	2
drug synergism	biological transport/drug effects	0.0023238349829961535	0.004262200624332351	0.16822429906542055	0.9605811478101344	1	2
drug synergism	herbicides/toxicity	0.0007038336660539768	0.0013726779893107545	0.16822429906542055	0.9605811478101344	1	2
drug synergism	thioredoxin-disulfide reductase/antagonists & inhibitors	0.0007038336660539768	0.0013726779893107545	0.16822429906542055	0.9605811478101344	1	2
drug synergism	mitochondrial adp atp translocases/antagonists & inhibitors	0.0023238349829961535	0.004262200624332351	0.16822429906542055	0.9605811478101344	1	2
drug synergism	cytochromes c/metabolism	5.472421561236729e-06	1.328663699836443e-05	6.262485511168005e-05	0.11552077256850565	7	2
drug synergism	neoplasm proteins/genetics	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	diet high-fat/adverse effects	0.00011081017083902633	0.0002340847606265069	0.16822429906542055	0.9605811478101344	1	2
drug synergism	organometallic compounds/metabolism	0.0023238349829961535	0.004262200624332351	0.16822429906542055	0.9605811478101344	1	2
drug synergism	gefitinib	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	chloroquine/pharmacology	0.0021826706433161203	0.004015647725620312	0.027642490456759247	0.8657199677887635	2	2
drug synergism	glutathione disulfide/metabolism	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	isocoumarins	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	mitochondrial proton-translocating atpases/metabolism	0.0007038336660539768	0.0013726779893107545	0.16822429906542055	0.9605811478101344	1	2
drug synergism	antimetabolites antineoplastic/pharmacology	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	mitochondria liver/drug effects	6.049333201030294e-08	1.696891837357709e-07	0.0017041331720541138	0.35414021462530776	5	2
drug synergism	thrombocytopenia/chemically induced	2.2819819367470018e-09	7.0161954736296045e-09	0.16822429906542055	0.9605811478101344	1	2
drug synergism	thymus gland/drug effects	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	liver diseases alcoholic/etiology	0.003655448235923564	0.00650591884934152	0.16822429906542055	0.9605811478101344	1	2
drug synergism	CA2	1.1119667516878984e-05	2.6128789237146734e-05	0.027642490456759247	0.8657199677887635	2	2
drug synergism	DCR	2.812667174656447e-05	6.368869864108589e-05	0.16822429906542055	0.9605811478101344	1	2
drug synergism	EEF1A2	0.00011081017083902633	0.0002340847606265069	0.16822429906542055	0.9605811478101344	1	2
drug synergism	MET	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	PRRX1	0.0007038336660539768	0.0013726779893107545	0.16822429906542055	0.9605811478101344	1	2
drug synergism	PTGER4	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
drug synergism	PTPN2	0.0023238349829961535	0.004262200624332351	0.16822429906542055	0.9605811478101344	1	2
drug synergism	SP1	0.00038688806602804604	0.0007730748667560594	0.027642490456759247	0.8657199677887635	2	2
drug synergism	VIP	2.812667174656447e-05	6.368869864108589e-05	0.16822429906542055	0.9605811478101344	1	2
drug synergism	pyruvate dehydrogenase acetyl-transferring kinase/antagonists & inhibitors	0.0053777070181031394	0.00932355778368625	0.16822429906542055	0.9605811478101344	1	2
multiple myeloma/drug therapy	CCL27	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	CCR10	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	DIABLO	0.001435126087253158	0.0027030292133741352	0.08215010393874443	0.9605811478101344	1	2
multiple myeloma/drug therapy	dexamethasone/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	isocoumarins	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	drug resistance neoplasm	1.538490446151286e-10	5.020073606148225e-10	0.0036161245377395743	0.8657199677887635	2	2
multiple myeloma/drug therapy	antibodies monoclonal humanized/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	cd36 antigens/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	tumor microenvironment	0.00038608464751910265	0.000771539409816113	0.031103389868393932	0.8657199677887635	2	2
multiple myeloma/drug therapy	cd8-positive t-lymphocytes/cytology	9.889866703360894e-13	3.668435078662534e-12	0.027905752270633143	0.9605811478101344	1	2
multiple myeloma/drug therapy	fatty acids/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	CD36	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	CD8A	0.000767608035860512	0.001493225866830119	0.09538832359347407	0.9605811478101344	1	2
multiple myeloma/drug therapy	PDCD1	5.364471128077586e-05	0.00011778117848222926	0.06878335787959994	0.9605811478101344	1	2
multiple myeloma/drug therapy	receptor cross-talk/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	proteasome endopeptidase complex/metabolism	1.496225365826831e-11	5.132842207211758e-11	0.027905752270633143	0.9605811478101344	1	2
multiple myeloma/drug therapy	proteasome inhibitors/pharmacology	2.6147717324676023e-10	8.445720357082581e-10	0.027905752270633143	0.9605811478101344	1	2
multiple myeloma/drug therapy	receptors interleukin-10/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	interleukin-10/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	receptors ccr10/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	bortezomib/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
multiple myeloma/drug therapy	chemokine ccl27/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	biological products/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	cell cycle/drug effects	0.004085590664280603	0.007203446858541282	0.09148348032117941	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	dichloroacetic acid/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	macrophages/cytology	1.4788753555095013e-09	4.584679954762864e-09	0.027905752270633143	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	energy metabolism/drug effects	5.6621374255882984e-14	2.2173855410190196e-13	0.018647711816067742	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	neoplasms/drug therapy	1.7848166501521767e-05	4.115419107148629e-05	0.05541661182045544	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	antineoplastic agents/chemistry	0.0	0.0	0.00026326181387389757	0.8657199677887635	2	2
protein kinase inhibitors/chemistry	saponins/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	NFE2L2	3.3932426944938143e-06	8.378789890043635e-06	0.03711991575621956	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	proto-oncogene proteins c-akt/antagonists & inhibitors	0.005290705352827385	0.009188615330377172	0.09148348032117941	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	azepines/chemistry	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	pyrimidines/chemistry	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	tor serine-threonine kinases/antagonists & inhibitors	0.003158697231605445	0.005679112497956198	0.08253257864946689	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	mitogen-activated protein kinases/antagonists & inhibitors	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	CDH1	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	CDH2	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protein kinase inhibitors/chemistry	pyruvate dehydrogenase acetyl-transferring kinase/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drug resistance neoplasm	triple negative breast neoplasms/drug therapy	0.0034764491894474503	0.0062088903790147735	0.14229963726109734	0.9605811478101344	1	2
drug resistance neoplasm	tumor-associated macrophages/drug effects	6.061463760187458e-05	0.0001323068537616207	0.0735378000087754	0.9605811478101344	1	2
drug resistance neoplasm	tumor microenvironment	0.005122364469361318	0.008924369167955616	0.042639369027172	0.7135314763244264	3	2
drug resistance neoplasm	basic-leucine zipper transcription factors/analysis	5.833880045713613e-10	1.8448850724023771e-09	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	cytoskeletal proteins/metabolism	5.5302820489711024e-06	1.3424161468205975e-05	0.0735378000087754	0.9605811478101344	1	2
drug resistance neoplasm	GGT1	5.833880045713613e-10	1.8448850724023771e-09	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	HLF	5.833880045713613e-10	1.8448850724023771e-09	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	JAK2	5.833880045713613e-10	1.8448850724023771e-09	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	STAT3	0.0013683540353344181	0.0025830025488915455	0.10849863774429329	0.9605811478101344	1	2
drug resistance neoplasm	nerve tissue proteins/metabolism	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	receptor cross-talk/drug effects	4.7240131872960944e-07	1.2431969772440236e-06	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	antineoplastic agents/metabolism	1.0194388222473094e-08	3.0048913306027646e-08	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	proteasome endopeptidase complex/metabolism	8.22170342770212e-05	0.0001764720766880611	0.0735378000087754	0.9605811478101344	1	2
drug resistance neoplasm	proteasome inhibitors/pharmacology	0.0002324067354035897	0.0004766608095049624	0.0735378000087754	0.9605811478101344	1	2
drug resistance neoplasm	tnf-related apoptosis-inducing ligand/metabolism	0.0006312673934151247	0.0012386031405194151	0.0735378000087754	0.9605811478101344	1	2
drug resistance neoplasm	phenotype	0.004604796457234106	0.00806214184778032	0.10849863774429329	0.9605811478101344	1	2
drug resistance neoplasm	oncogene proteins/metabolism	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	interleukin-1beta/metabolism	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	receptors tnf-related apoptosis-inducing ligand/agonists	1.0194388222473094e-08	3.0048913306027646e-08	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	antineoplastic agents immunological/pharmacology	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	paclitaxel/pharmacology	0.00502421532032693	0.008757522284968625	0.10849863774429329	0.9605811478101344	1	2
drug resistance neoplasm	receptors interleukin-10/genetics	4.7240131872960944e-07	1.2431969772440236e-06	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	lymphocytes tumor-infiltrating/drug effects	0.0001428090835920992	0.0002992733271588825	0.0735378000087754	0.9605811478101344	1	2
drug resistance neoplasm	interleukin-10/genetics	4.7240131872960944e-07	1.2431969772440236e-06	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	receptors ccr10/genetics	4.7240131872960944e-07	1.2431969772440236e-06	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	recombinant fusion proteins/metabolism	1.0194388222473094e-08	3.0048913306027646e-08	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	breast neoplasms/immunology	0.0005278539197618448	0.0010437778675254847	0.0735378000087754	0.9605811478101344	1	2
drug resistance neoplasm	mesenchymal stem cells/drug effects	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	leukemia t-cell/drug therapy	1.0194388222473094e-08	3.0048913306027646e-08	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	bortezomib/pharmacology	4.7240131872960944e-07	1.2431969772440236e-06	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	chemokine ccl27/metabolism	4.7240131872960944e-07	1.2431969772440236e-06	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	th1 cells/drug effects	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	cancer vaccines/pharmacology	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	BIRC2	1.0194388222473094e-08	3.0048913306027646e-08	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	CCL27	4.7240131872960944e-07	1.2431969772440236e-06	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	CCL4	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	CCR10	4.7240131872960944e-07	1.2431969772440236e-06	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	CD4	0.00314291285775814	0.0056608890358509495	0.10849863774429329	0.9605811478101344	1	2
drug resistance neoplasm	CFLAR	1.0194388222473094e-08	3.0048913306027646e-08	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	ESR1	0.0004371614176102989	0.0008701394723726524	0.0735378000087754	0.9605811478101344	1	2
drug resistance neoplasm	SOCS1	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	TBX21	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	TNFRSF12A	1.0194388222473094e-08	3.0048913306027646e-08	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	WDTC1	0.00502421532032693	0.008757522284968625	0.14229963726109734	0.9605811478101344	1	2
drug resistance neoplasm	amphiregulin/physiology	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	phenylurea compounds/pharmacology	3.212438159927444e-08	9.193644412004191e-08	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	receptors estrogen/physiology	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	dexamethasone/administration & dosage	2.718516745048305e-09	8.331645426025164e-09	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	letrozole/pharmacology	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	mitophagy/drug effects	0.0034764491894474503	0.0062088903790147735	0.14229963726109734	0.9605811478101344	1	2
drug resistance neoplasm	aromatase inhibitors/pharmacology	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	mitochondrial dynamics/drug effects	3.076678719204917e-05	6.944575389130836e-05	0.0735378000087754	0.9605811478101344	1	2
drug resistance neoplasm	isocoumarins	2.718516745048305e-09	8.331645426025164e-09	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	AREG	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
drug resistance neoplasm	CYP19A1	2.1390163584822375e-07	5.767522645446542e-07	0.037383177570093455	0.9605811478101344	1	2
biological products/chemistry	dichloroacetic acid/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
biological products/chemistry	macrophages/cytology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
biological products/chemistry	energy metabolism/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biological products/chemistry	neoplasms/drug therapy	5.295763827461997e-13	1.979671089655512e-12	0.02803738317757009	0.9605811478101344	1	2
biological products/chemistry	antineoplastic agents/chemistry	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
biological products/chemistry	saponins/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
biological products/chemistry	pyruvate dehydrogenase acetyl-transferring kinase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidative stress	calreticulin/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	ferric compounds/chemistry	4.0513481458503975e-11	1.370842908528385e-10	0.04166180294604871	0.9605811478101344	1	2
oxidative stress	CALR	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	GPX4	0.004048622789790457	0.007142837102448587	0.15967325731855422	0.9605811478101344	1	2
oxidative stress	mcf-7 cells	4.3356877292732854e-05	9.612191357970578e-05	0.06878335787959994	0.9605811478101344	1	2
oxidative stress	breast neoplasms/metabolism	1.3036816781664129e-06	3.327572776130247e-06	0.04166180294604871	0.9605811478101344	1	2
oxidative stress	pentacyclic triterpenes	8.21016588048451e-11	2.705391381451539e-10	0.027905752270633143	0.9605811478101344	1	2
oxidative stress	EIF4EBP1	1.5919403573150248e-09	4.9268811058508795e-09	0.027905752270633143	0.9605811478101344	1	2
oxidative stress	RPS6KB1	1.5919403573150248e-09	4.9268811058508795e-09	0.027905752270633143	0.9605811478101344	1	2
oxidative stress	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	neoplasms/diagnostic imaging	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	t-lymphocytes cytotoxic/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	tetrahydrofolate dehydrogenase/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	folic acid antagonists/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	cystine/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	methotrexate/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	vitamin e/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	gene expression regulation neoplastic	0.0010225856949998002	0.0019572853028349334	0.09538832359347407	0.9605811478101344	1	2
oxidative stress	antioxidants/pharmacology	1.992378137138928e-06	5.004893832475685e-06	0.04166180294604871	0.9605811478101344	1	2
oxidative stress	ascorbic acid/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxidative stress	carbolines/pharmacology	8.475718828671042e-06	2.0230881101498228e-05	0.055287464515536164	0.9605811478101344	1	2
oxidative stress	jurkat cells	0.002208690688217718	0.004061824363485215	0.10849863774429329	0.9605811478101344	1	2
oxidative stress	biopterin/analogs & derivatives	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
calreticulin/metabolism	neoplasms/diagnostic imaging	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/metabolism	ascorbic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/metabolism	ferric compounds/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
calreticulin/metabolism	CALR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/metabolism	t-lymphocytes cytotoxic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell line tumor	neoplasms/drug therapy	0.0023455342625150477	0.004294140946602323	0.004062848110499298	0.2127419111522651	6	2
cell line tumor	ferric compounds/chemistry	0.004243430723455233	0.007459668361564422	0.0658123489659523	0.7135314763244264	3	2
CASP3	gene expression regulation leukemic/drug effects	0.005794797953176722	0.009992468737028028	0.11214953271028036	0.9605811478101344	1	2
CASP3	proto-oncogene proteins c-akt/metabolism	0.0021771620065051955	0.004008188704026933	0.0003665755521601686	0.004109180810744809	11	2
CASP3	receptors antigen b-cell/antagonists & inhibitors	0.005794797953176722	0.009992468737028028	0.11214953271028036	0.9605811478101344	1	2
CASP3	plicamycin/analogs & derivatives	0.005794797953176722	0.009992468737028028	0.11214953271028036	0.9605811478101344	1	2
CASP3	a549 cells	0.0002173048687693635	0.0004473100314281511	0.0016010640457281271	0.5304112294886878	4	2
CASP3	granulosa cells/drug effects	0.004273508997439612	0.007506558825330511	0.11214953271028036	0.9605811478101344	1	2
CASP3	disulfides/administration & dosage	0.0012831143472923356	0.0024320929443862977	0.11214953271028036	0.9605811478101344	1	2
CASP3	potassium channels/metabolism	0.004273508997439612	0.007506558825330511	0.11214953271028036	0.9605811478101344	1	2
CASP3	drugs chinese herbal/chemistry	0.004273508997439612	0.007506558825330511	0.11214953271028036	0.9605811478101344	1	2
CASP3	dexamethasone/administration & dosage	0.00203306953699367	0.003759234917111409	0.11214953271028036	0.9605811478101344	1	2
CASP3	epithelial cells/drug effects	0.005794797953176722	0.009992468737028028	0.11214953271028036	0.9605811478101344	1	2
CASP3	membrane potential mitochondrial/drug effects	0.0008450261230207312	0.0016341668239944814	0.0006057540942494296	0.057030282506445124	8	2
CASP3	quinuclidines/pharmacology	0.004273508997439612	0.007506558825330511	0.11214953271028036	0.9605811478101344	1	2
CASP3	phosphatidylinositol 3-kinase/metabolism	0.0028987061315425278	0.005242017125020477	0.010762377422028404	0.7135314763244264	3	2
CASP3	zearalenone/toxicity	0.004273508997439612	0.007506558825330511	0.11214953271028036	0.9605811478101344	1	2
CASP3	indole alkaloids/administration & dosage	0.0012831143472923356	0.0024320929443862977	0.11214953271028036	0.9605811478101344	1	2
CASP3	isocoumarins	0.00203306953699367	0.003759234917111409	0.11214953271028036	0.9605811478101344	1	2
CASP3	phenylpropionates/pharmacology	0.005794797953176722	0.009992468737028028	0.11214953271028036	0.9605811478101344	1	2
CASP3	carcinoma non-small-cell lung/metabolism	0.004273508997439612	0.007506558825330511	0.11214953271028036	0.9605811478101344	1	2
CASP3	tor serine-threonine kinases/drug effects	0.0014323125161704864	0.002698190905376528	0.012110043438199289	0.8657199677887635	2	2
CASP3	flavones/pharmacology	0.0007079448315316927	0.0013804517242071957	0.012110043438199289	0.8657199677887635	2	2
CASP3	ABCC9	0.004273508997439612	0.007506558825330511	0.11214953271028036	0.9605811478101344	1	2
CASP3	CASP9	5.776257028244913e-09	1.7391084932233216e-08	3.0008170189527243e-07	0.057030282506445124	8	2
CASP3	PARP1	0.0007161677062798022	0.00139586859866134	0.0006282686452363848	0.2127419111522651	6	2
CASP3	SQSTM1	0.004273508997439612	0.007506558825330511	0.11214953271028036	0.9605811478101344	1	2
CASP3	BCL2	5.24635727705558e-06	1.2772933441311995e-05	1.2034139190040994e-07	0.00015281522825958766	14	2
CASP3	leukemia lymphocytic chronic b-cell/drug therapy	0.005794797953176722	0.009992468737028028	0.11214953271028036	0.9605811478101344	1	2
mitochondria/drug effects	reactive oxygen species/metabolism	0.003916376041068648	0.0069228139945066575	5.316423023019171e-05	1.0857363909332076e-14	29	2
mitochondria/drug effects	tor serine-threonine kinases/metabolism	0.00011028293710613202	0.0002333734712847681	1.3997273785215708e-09	1.678973800412177e-15	30	2
mitochondria/drug effects	MTOR	6.321164702782767e-10	1.9955240014267763e-09	1.6312369181127336e-28	0.0	73	2
mitochondria/drug effects	phosphatidylinositol 3-kinases/metabolism	0.00010158762250156439	0.00021538646994081082	1.8508128724162617e-10	0.0	34	2
mitochondria/drug effects	proto-oncogene proteins c-akt/metabolism	0.0009675350520907955	0.001856104831505948	1.4175569787265085e-07	1.678973800412177e-15	30	2
mitochondria/drug effects	AKT1	3.7457892907433177e-06	9.243107138478866e-06	1.981234996234478e-17	0.0	65	2
mitochondria/drug effects	BCL2	0.002203530584333424	0.004053010955483719	4.700778714617632e-08	6.794247312334609e-14	28	2
mitochondria/drug effects	PIK3CA	1.9799729633618313e-09	6.113211580479156e-09	8.965719427035132e-28	0.0	72	2
mitochondria/drug effects	membrane potential mitochondrial/drug effects	0.002116116737029161	0.003904933195348087	4.444245483425025e-06	1.9357992478465205e-07	19	2
cell survival/drug effects	nf-e2-related factor 2/biosynthesis	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	sulfasalazine/administration & dosage	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	antineoplastic agents immunological/administration & dosage	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	raw 264.7 cells	0.0013269711360900383	0.0025102582246686544	0.01696541475900627	0.7135314763244264	3	2
cell survival/drug effects	lipopolysaccharides/toxicity	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	amino acid transport system y+/genetics	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	lipid metabolism/drug effects	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	bone marrow/drug effects	0.00559306547345606	0.00968627032902044	0.07801739018132778	0.8657199677887635	2	2
cell survival/drug effects	microglia/drug effects	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	inflammation mediators/antagonists & inhibitors	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	gene expression	0.0013269711360900383	0.0025102582246686544	0.01696541475900627	0.7135314763244264	3	2
cell survival/drug effects	ATM	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	NFE2L2	0.005767967224963977	0.0099532082160136	0.01696541475900627	0.7135314763244264	3	2
cell survival/drug effects	receptor erbb-2/antagonists & inhibitors	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	antibiotics antineoplastic/pharmacology	0.004104037709358299	0.00723539288468989	0.029222061340002634	0.8657199677887635	2	2
cell survival/drug effects	inflammation mediators/metabolism	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	poly i-c/administration & dosage	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	ERBB2	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	monoterpenes/pharmacology	0.003275966969898514	0.00588611521084854	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	thiosemicarbazones/pharmacology	0.0018630738100782196	0.0034614520404992483	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	gtp phosphohydrolases/genetics	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	amyloid beta-peptides/pharmacology	0.003275966969898514	0.00588611521084854	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	peroxiredoxin iii/metabolism	0.0018630738100782196	0.0034614520404992483	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	leucine/pharmacology	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	thioredoxin-disulfide reductase/antagonists & inhibitors	0.0018630738100782196	0.0034614520404992483	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	myocardial reperfusion injury/enzymology	0.005218843234083725	0.00907667867989887	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	EIF4EBP1	0.00559306547345606	0.00968627032902044	0.029222061340002634	0.8657199677887635	2	2
cell survival/drug effects	PRRX1	0.0018630738100782196	0.0034614520404992483	0.17289719626168223	0.9605811478101344	1	2
cell survival/drug effects	RPS6KB1	0.00559306547345606	0.00968627032902044	0.029222061340002634	0.8657199677887635	2	2
ferric compounds/chemistry	aniline compounds/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	cd8-positive t-lymphocytes/cytology	0.0	0.0	0.027905752270633143	0.9605811478101344	1	2
ferric compounds/chemistry	dextrans/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	urinary bladder neoplasms/pathology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	phenol/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	immunogenic cell death/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	neoplasms/diagnostic imaging	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	interferon-gamma/metabolism	0.00039919911966201926	0.0007968080925500815	0.1214816672917065	0.9605811478101344	1	2
ferric compounds/chemistry	metal-organic frameworks/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	benzylidene compounds/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	CALR	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	CD274	0.000583397120166862	0.001147639160014184	0.1214816672917065	0.9605811478101344	1	2
ferric compounds/chemistry	PDCD1	1.7265535463550918e-06	4.36849352651332e-06	0.06878335787959994	0.9605811478101344	1	2
ferric compounds/chemistry	ascorbic acid/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	programmed cell death 1 receptor/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	gels/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	b7-h1 antigen/metabolism	7.824615122498102e-08	2.181000179783036e-07	0.055287464515536164	0.9605811478101344	1	2
ferric compounds/chemistry	adjuvants immunologic/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	gold/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	t-lymphocytes cytotoxic/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	exosomes/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ferric compounds/chemistry	macrophages/cytology	6.852673983814839e-11	2.2840174753612935e-10	0.04166180294604871	0.9605811478101344	1	2
dose-response relationship drug	nf-e2-related factor 2/biosynthesis	0.00014736939476089894	0.00030827328422090134	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	0.0034513312262458573	0.006172530084058133	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	tetrahydrofolate dehydrogenase/genetics	0.0034513312262458573	0.006172530084058133	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	lipopolysaccharides/toxicity	0.00014736939476089894	0.00030827328422090134	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	folic acid antagonists/pharmacology	0.0034513312262458573	0.006172530084058133	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	cystine/antagonists & inhibitors	0.0034513312262458573	0.006172530084058133	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	methotrexate/pharmacology	0.0034513312262458573	0.006172530084058133	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	vitamin e/pharmacology	0.0034513312262458573	0.006172530084058133	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	microglia/drug effects	0.00014736939476089894	0.00030827328422090134	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	antioxidants/pharmacology	0.002966057235208819	0.0053567848887519694	0.023594219167943648	0.8657199677887635	2	2
dose-response relationship drug	biopterin/analogs & derivatives	0.0034513312262458573	0.006172530084058133	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	inflammation mediators/antagonists & inhibitors	0.00014736939476089894	0.00030827328422090134	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	antineoplastic agents/metabolism	0.0008266389137319141	0.0015995905537968442	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	serum albumin bovine/chemistry	0.00028730260487308534	0.0005834436614388677	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	cell communication/drug effects	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	k562 cells	5.0568487837576725e-05	0.00011132641236574055	0.008336624106006756	0.8657199677887635	2	2
dose-response relationship drug	antigens cd/metabolism	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	galectin 3/genetics	0.00028730260487308534	0.0005834436614388677	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	myeloid cell leukemia sequence 1 protein/metabolism	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	tubulin modulators/pharmacology	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	g2 phase cell cycle checkpoints/drug effects	0.004351001888616146	0.007637809684729999	0.023594219167943648	0.8657199677887635	2	2
dose-response relationship drug	receptors tnf-related apoptosis-inducing ligand/agonists	0.0008266389137319141	0.0015995905537968442	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	endometrial neoplasms/genetics	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	estrogen receptor alpha/genetics	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	receptors cell surface/metabolism	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	alpha 1-antitrypsin/chemistry	0.00028730260487308534	0.0005834436614388677	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	estradiol/pharmacology	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	tumor necrosis factor alpha-induced protein 3/metabolism	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	recombinant fusion proteins/metabolism	0.0008266389137319141	0.0015995905537968442	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	bone marrow cells/drug effects	0.00028730260487308534	0.0005834436614388677	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	leukemia t-cell/drug therapy	0.0008266389137319141	0.0015995905537968442	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	leukemia myelogenous chronic bcr-abl positive/genetics	0.00028730260487308534	0.0005834436614388677	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	stilbenes/pharmacology	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	antigens differentiation myelomonocytic/metabolism	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	BIRC2	0.0008266389137319141	0.0015995905537968442	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	CFLAR	0.0008266389137319141	0.0015995905537968442	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	CTNNB1	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	IL17A	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	IL4	0.0037877784926676483	0.006717038543097909	0.0193118796039811	0.7135314763244264	3	2
dose-response relationship drug	LGALS3	0.00028730260487308534	0.0005834436614388677	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	SERPINA1	0.00028730260487308534	0.0005834436614388677	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	TNFRSF12A	0.0008266389137319141	0.0015995905537968442	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	hypoxia/complications	0.0018406431306735582	0.0034220844712952703	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	glutamates/pharmacology	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	sleep apnea obstructive/complications	0.0018406431306735582	0.0034220844712952703	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	artesunate	2.0956738788768803e-07	5.666595251591545e-07	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	disulfides/administration & dosage	0.00028730260487308534	0.0005834436614388677	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	jurkat cells/drug effects	0.00014736939476089894	0.00030827328422090134	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	depsides/pharmacology	0.0018406431306735582	0.0034220844712952703	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	raf kinases/metabolism	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	antineoplastic agents/administration & dosage	2.1776349612423473e-09	6.720674079713224e-09	0.0007078265750383096	0.7135314763244264	3	2
dose-response relationship drug	rna messenger/metabolism	0.00014736939476089894	0.00030827328422090134	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	urinary bladder neoplasms/metabolism	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	phytohemagglutinins/pharmacology	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	buthionine sulfoximine/pharmacology	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	antibodies monoclonal/immunology	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	naphthoquinones/chemistry	0.0025655755545276326	0.004675246700241776	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	cell division/drug effects	0.005179957216564057	0.009021857706833425	0.044528218079937634	0.8657199677887635	2	2
dose-response relationship drug	sirtuin 1/metabolism	0.0025655755545276326	0.004675246700241776	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	erbb receptors/drug effects	0.0025655755545276326	0.004675246700241776	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	ferrous compounds/administration & dosage	2.0956738788768803e-07	5.666595251591545e-07	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	oleic acid/toxicity	0.00014736939476089894	0.00030827328422090134	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	heart injuries/etiology	0.0018406431306735582	0.0034220844712952703	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	cinnamates/pharmacology	0.0018406431306735582	0.0034220844712952703	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	mercaptoethanol/pharmacology	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	indole alkaloids/administration & dosage	0.00028730260487308534	0.0005834436614388677	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	endoplasmic reticulum stress/drug effects	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	sulindac/administration & dosage	0.004505808465516292	0.00789447433627648	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	interleukins/metabolism	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	arachidonic acid/toxicity	0.00014736939476089894	0.00030827328422090134	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	cd3 complex/immunology	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	ABCB8	0.0018406431306735582	0.0034220844712952703	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	CD28	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	CD3E	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	CYBB	0.0018406431306735582	0.0034220844712952703	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	IL2	0.005630187381056473	0.009742141844100856	0.044528218079937634	0.8657199677887635	2	2
dose-response relationship drug	IL5	0.00573409467492203	0.009895532200429	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	MDM2	0.0025655755545276326	0.004675246700241776	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	METTL7B	0.0025655755545276326	0.004675246700241776	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	NAMPT	0.0025655755545276326	0.004675246700241776	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	PINK1	0.0018406431306735582	0.0034220844712952703	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	SLC25A28	0.0018406431306735582	0.0034220844712952703	0.09345794392523364	0.9605811478101344	1	2
dose-response relationship drug	TP73	0.0025655755545276326	0.004675246700241776	0.09345794392523364	0.9605811478101344	1	2
CCL27	cell movement/drug effects	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
CCL27	tumor microenvironment	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
CCL27	proteasome inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL27	receptor cross-talk/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCL27	receptors interleukin-10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCL27	proteasome endopeptidase complex/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL27	receptors ccr10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCL27	chemokine ccl27/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCL27	rna interference	1.3988681101473333e-05	3.252029111401139e-05	0.04205607476635514	0.9605811478101344	1	2
CCL27	interleukin-10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCL27	bortezomib/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCL27	CCR10	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCL27	IL10	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
CCR10	cell movement/drug effects	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
CCR10	tumor microenvironment	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
CCR10	proteasome inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCR10	receptor cross-talk/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCR10	receptors interleukin-10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCR10	proteasome endopeptidase complex/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCR10	receptors ccr10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCR10	chemokine ccl27/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCR10	rna interference	1.3988681101473333e-05	3.252029111401139e-05	0.04205607476635514	0.9605811478101344	1	2
CCR10	interleukin-10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCR10	IL10	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
CCR10	bortezomib/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
b-lymphocytes/metabolism	cytoskeletal proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b-lymphocytes/metabolism	glutathione peroxidase/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
b-lymphocytes/metabolism	BDKRB2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b-lymphocytes/metabolism	GPX4	0.0	0.0	0.05607476635514018	0.9605811478101344	1	2
cell cycle/drug effects	glutathione peroxidase/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	autophagy-related proteins/genetics	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	flavonolignans/pharmacology	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	jurkat cells	2.4245298213543265e-08	6.964048137209508e-08	0.00015767637213404988	0.5304112294886878	4	2
cell cycle/drug effects	cyclin b1/metabolism	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	interleukin-10/metabolism	0.005290705352827385	0.009188615330377172	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	proto-oncogene proteins c-bcl-2/genetics	0.0030647335234157413	0.00552323399740643	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	aspirin/administration & dosage	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	rna messenger/genetics	1.7845042948883005e-06	4.512012694231336e-06	0.0013814543574779913	0.7135314763244264	3	2
cell cycle/drug effects	lymphoma t-cell/drug therapy	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	interleukin-4/metabolism	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	BIRC5	4.5824936888538836e-05	0.00010138968474847007	0.005774374691101998	0.8657199677887635	2	2
cell cycle/drug effects	IL1B	0.002621392365332098	0.0047714405077885	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	IL4	9.145287300782456e-06	2.1697545938626018e-05	0.0023570206333426743	0.7135314763244264	3	2
cell cycle/drug effects	PCNA	0.002621392365332098	0.0047714405077885	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	SOCS5	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	flavonoids/metabolism	0.0008137316370441239	0.0015782156169553874	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	drug hypersensitivity/drug therapy	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	spleen/drug effects	9.770295995581435e-07	2.5162420991774264e-06	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	multiple myeloma/metabolism	0.0008137316370441239	0.0015782156169553874	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	azepines/chemistry	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	dinitrofluorobenzene/pharmacology	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	berberine/pharmacology	0.0030647335234157413	0.00552323399740643	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	cytostatic agents/pharmacology	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	anti-inflammatory agents/pharmacology	0.0012656389571008564	0.002399381575766095	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	hypersensitivity delayed/chemically induced	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	ear/pathology	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	enzyme inhibitors/pharmacology	0.004664810984252532	0.008163326659322156	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	cyclins/metabolism	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	lactones/metabolism	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	oxazolone/pharmacology	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	lymphoma non-hodgkin/drug therapy	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	cell nucleus/drug effects	3.4789498117304696e-05	7.808600778686083e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	antioxidants/metabolism	0.0015451254639605727	0.002900794127163037	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	everolimus/pharmacology	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	immunosuppressive agents/metabolism	0.0035524822154440194	0.006335959220685143	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	cytokines/biosynthesis	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	triterpenes/pharmacology	0.0004887564791243859	0.0009688997349158837	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	dihydroorotase/antagonists & inhibitors	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	piperidines/metabolism	0.0008137316370441239	0.0015782156169553874	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	foot/pathology	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	pyrimidines/chemistry	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	clone cells	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	poly (adp-ribose) polymerase-1	0.0008137316370441239	0.0015782156169553874	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	cyclophilin a/antagonists & inhibitors	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	neoplasm proteins/genetics	9.770295995581435e-07	2.5162420991774264e-06	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	pentacyclic triterpenes	0.002221297818076118	0.004084327770239533	0.09148348032117941	0.9605811478101344	1	2
cell cycle/drug effects	tacrolimus binding protein 1a/metabolism	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	farnesyltranstransferase/antagonists & inhibitors	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	spiro compounds/metabolism	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	leukemia/metabolism	0.0008137316370441239	0.0015782156169553874	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	mitogen-activated protein kinases/antagonists & inhibitors	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	enzyme inhibitors/metabolism	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	thymus gland/drug effects	9.770295995581435e-07	2.5162420991774264e-06	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	membrane glycoproteins/metabolism	0.0008137316370441239	0.0015782156169553874	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	imp dehydrogenase/antagonists & inhibitors	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	nfatc transcription factors/antagonists & inhibitors	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	AIFM1	0.0002339284582073553	0.0004797372008702232	0.01125813263425861	0.8657199677887635	2	2
cell cycle/drug effects	BCR	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	CD40LG	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	CDH1	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	CDH2	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	PPIA	2.0075977058109373e-05	4.6011969041288514e-05	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	TNFRSF10D	0.0008137316370441239	0.0015782156169553874	0.04672897196261682	0.9605811478101344	1	2
cell cycle/drug effects	precursor cell lymphoblastic leukemia-lymphoma/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
malondialdehyde/blood	glutathione	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
malondialdehyde/blood	phospholipid hydroperoxide glutathione peroxidase	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetaminophen/pharmacology	glioblastoma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetaminophen/pharmacology	t-lymphocytes cytotoxic/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetaminophen/pharmacology	hyaluronan receptors/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetaminophen/pharmacology	heat-shock proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
acetaminophen/pharmacology	gene expression regulation neoplastic	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
acetaminophen/pharmacology	CD44	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetaminophen/pharmacology	HSPB1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetaminophen/pharmacology	SLC40A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetaminophen/pharmacology	brain neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetaminophen/pharmacology	cation transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidative stress/drug effects	coenzyme a ligases/metabolism	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	oleic acid/metabolism	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	melanoma/blood	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	ACSL3	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	PRKAA2	0.0040846038655451	0.007203435132581856	0.044528218079937634	0.8657199677887635	2	2
oxidative stress/drug effects	macrophages peritoneal/cytology	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	cd11b antigen/metabolism	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	caffeic acids/adverse effects	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	hydrogen peroxide/antagonists & inhibitors	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	autocrine communication	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	lymph nodes/drug effects	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	propionates/adverse effects	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	copper/chemistry	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	coumaric acids/adverse effects	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	killer cells natural/cytology	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	pyruvic acid/metabolism	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	antioxidants/adverse effects	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	immunologic factors/adverse effects	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	peroxidase/chemistry	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	granulocyte colony-stimulating factor/pharmacology	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	spleen/cytology	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	mitogens/toxicity	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	radiation tolerance/drug effects	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	tellurium/chemistry	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	immunosuppressive agents/chemistry	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	adenosine triphosphate/metabolism	0.003484775110867977	0.006223256248535328	0.09919986745994218	0.8657199677887635	2	2
oxidative stress/drug effects	peptides/chemistry	0.002438310245593489	0.004454006983831421	0.17857926374446048	0.9605811478101344	1	2
oxidative stress/drug effects	hydrogen peroxide/chemistry	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	cell survival/physiology	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	antioxidants/chemistry	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	neutrophils/metabolism	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	biological factors/chemistry	1.295478623841717e-05	3.0221894718508284e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	CSF3	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	ITGAM	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	hypoxia/complications	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	sleep apnea obstructive/complications	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	hydrogen peroxide	0.0013455630392092965	0.0025423750011557603	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	depsides/pharmacology	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	raf kinases/metabolism	0.0018387819751666257	0.003421798192815139	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	drug antagonism	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	polysaccharides/chemistry	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	glucose/pharmacology	0.00014161126190215256	0.0002967913595455	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	hydrogen peroxide/toxicity	0.003981380161898085	0.00702926567981494	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	ascorbic acid/analogs & derivatives	0.003981380161898085	0.00702926567981494	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	phagosomes/metabolism	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	homeostasis/drug effects	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	drugs chinese herbal/administration & dosage	0.003981380161898085	0.00702926567981494	0.17857926374446048	0.9605811478101344	1	2
oxidative stress/drug effects	chromones/pharmacology	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	epithelial cells/drug effects	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	rna small interfering/administration & dosage	0.0013455630392092965	0.0025423750011557603	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	tert-butylhydroperoxide/toxicity	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	acetaldehyde/pharmacology	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	complex mixtures/chemistry	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	dynamins	0.003981380161898085	0.00702926567981494	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	arsenic/toxicity	3.31139604149433e-05	7.456813392183331e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	antimycin a/pharmacology	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	pc12 cells	5.6274146131851666e-06	1.3658436524824587e-05	0.008336624106006756	0.8657199677887635	2	2
oxidative stress/drug effects	rac1 gtp-binding protein/antagonists & inhibitors	0.0013455630392092965	0.0025423750011557603	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	malaria/drug therapy	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	acetylcysteine/pharmacology	0.003981380161898085	0.00702926567981494	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	spermatogenesis/drug effects	3.31139604149433e-05	7.456813392183331e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	mitophagy/drug effects	0.0003179188867512561	0.000643130160114845	0.044528218079937634	0.8657199677887635	2	2
oxidative stress/drug effects	keratinocytes/drug effects	0.00014161126190215256	0.0002967913595455	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	heart injuries/etiology	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	neoplasm metastasis/drug therapy	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	liver/drug effects	0.003150798848182812	0.005673702466900902	0.17857926374446048	0.9605811478101344	1	2
oxidative stress/drug effects	cinnamates/pharmacology	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	kidney/cytology	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	glutathione disulfide/metabolism	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	sulindac/administration & dosage	0.0018387819751666257	0.003421798192815139	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	t-2 toxin/toxicity	0.00041487935599437975	0.0008272074553232126	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	phenylpropionates/pharmacology	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	astrocytes/drug effects	0.0013455630392092965	0.0025423750011557603	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	histones/metabolism	0.003981380161898085	0.00702926567981494	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	cisplatin/adverse effects	0.00025158591732088453	0.000514131643812296	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	microtubule-associated proteins/metabolism	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.003150798848182812	0.005673702466900902	0.17857926374446048	0.9605811478101344	1	2
oxidative stress/drug effects	liver diseases alcoholic/etiology	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	ABCB8	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	ATG12	3.31139604149433e-05	7.456813392183331e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	BAX	0.005106013484335259	0.0088965848982633	0.044528218079937634	0.8657199677887635	2	2
oxidative stress/drug effects	BECN1	0.004748942238879117	0.00830593990820298	0.07004775961074933	0.8657199677887635	2	2
oxidative stress/drug effects	CAMK2A	0.0013455630392092965	0.0025423750011557603	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	CAMK2B	0.0013455630392092965	0.0025423750011557603	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	CASP12	0.0013455630392092965	0.0025423750011557603	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	CYBB	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	DNM1L	0.003981380161898085	0.00702926567981494	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	H2AX	0.003981380161898085	0.00702926567981494	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	IRF3	0.00014161126190215256	0.0002967913595455	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	OGG1	0.0013455630392092965	0.0025423750011557603	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	PINK1	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	POLG	0.0013455630392092965	0.0025423750011557603	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	RAC1	0.0013455630392092965	0.0025423750011557603	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	SLC25A28	0.0006438834005176863	0.0012603285879451305	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	TESC	3.31139604149433e-05	7.456813392183331e-05	0.09345794392523364	0.9605811478101344	1	2
oxidative stress/drug effects	lymph/metabolism	7.26382735185549e-05	0.00015738292595686892	0.09345794392523364	0.9605811478101344	1	2
cells cultured	dendritic cells/drug effects	7.426242172114961e-05	0.00016058629600901398	0.07476635514018691	0.9605811478101344	1	2
cells cultured	disease progression	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	caffeic acids/adverse effects	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	immunologic memory/drug effects	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	t-lymphocytes cytotoxic/cytology	0.003681474124667794	0.006551181719182851	0.14426747400289588	0.9605811478101344	1	2
cells cultured	propionates/adverse effects	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	receptors interleukin-8a/physiology	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	coumaric acids/adverse effects	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	killer cells natural/cytology	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	amidines/pharmacology	7.426242172114961e-05	0.00016058629600901398	0.07476635514018691	0.9605811478101344	1	2
cells cultured	proteasome endopeptidase complex/chemistry	7.426242172114961e-05	0.00016058629600901398	0.07476635514018691	0.9605811478101344	1	2
cells cultured	antioxidants/adverse effects	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	proto-oncogene proteins c-akt/physiology	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	th1 cells/immunology	7.426242172114961e-05	0.00016058629600901398	0.07476635514018691	0.9605811478101344	1	2
cells cultured	immunologic factors/adverse effects	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	cisplatin/administration & dosage	0.0006548382098359173	0.0012800667479796353	0.14426747400289588	0.9605811478101344	1	2
cells cultured	spleen/cytology	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	mesenchymal stem cells/metabolism	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	mitogens/toxicity	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	anoikis/drug effects	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	lung neoplasms/genetics	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	antigens neoplasm/immunology	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	osteosarcoma/genetics	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	bone neoplasms/genetics	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	burkitt lymphoma/drug therapy	7.426242172114961e-05	0.00016058629600901398	0.07476635514018691	0.9605811478101344	1	2
cells cultured	cell differentiation/drug effects	0.003312161364982469	0.0059492084541860266	0.04601471862595931	0.8657199677887635	2	2
cells cultured	C2	0.0019779234593825246	0.0036661838110521984	0.14426747400289588	0.9605811478101344	1	2
cells cultured	granulosa cells/drug effects	7.426242172114961e-05	0.00016058629600901398	0.07476635514018691	0.9605811478101344	1	2
cells cultured	organophosphorus compounds/chemistry	0.0006548382098359173	0.0012800667479796353	0.07476635514018691	0.9605811478101344	1	2
cells cultured	endothelial cells/microbiology	4.559572053253191e-09	1.3778706774962495e-08	0.07476635514018691	0.9605811478101344	1	2
cells cultured	antimycin a/metabolism	0.0008967493997191767	0.0017302468508802317	0.07476635514018691	0.9605811478101344	1	2
cells cultured	bacterial adhesion	4.559572053253191e-09	1.3778706774962495e-08	0.07476635514018691	0.9605811478101344	1	2
cells cultured	apoferritins/metabolism	0.001553429122150729	0.002915142164029217	0.14426747400289588	0.9605811478101344	1	2
cells cultured	gtp phosphohydrolases/genetics	3.2884563376800457e-06	8.124594949929365e-06	0.07476635514018691	0.9605811478101344	1	2
cells cultured	alpha-crystallins/administration & dosage	0.0008967493997191767	0.0017302468508802317	0.07476635514018691	0.9605811478101344	1	2
cells cultured	glucose/pharmacology	1.9753868325644852e-05	4.534443402850783e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	astrocytes/physiology	0.0008967493997191767	0.0017302468508802317	0.07476635514018691	0.9605811478101344	1	2
cells cultured	hydrogen peroxide/toxicity	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	ascorbic acid/analogs & derivatives	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	antimycin a/analogs & derivatives	0.0006548382098359173	0.0012800667479796353	0.07476635514018691	0.9605811478101344	1	2
cells cultured	cardiotonic agents/pharmacology	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	leucine/pharmacology	3.2884563376800457e-06	8.124594949929365e-06	0.07476635514018691	0.9605811478101344	1	2
cells cultured	intercellular adhesion molecule-1/metabolism	4.559572053253191e-09	1.3778706774962495e-08	0.07476635514018691	0.9605811478101344	1	2
cells cultured	brain/drug effects	0.004401646658032887	0.007721793882583474	0.14426747400289588	0.9605811478101344	1	2
cells cultured	host-parasite interactions	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	hepatocytes/metabolism	0.001553429122150729	0.002915142164029217	0.14426747400289588	0.9605811478101344	1	2
cells cultured	neurons/cytology	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	oxygen consumption	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	sulfides/pharmacology	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	blood-brain barrier/drug effects	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	staurosporine/toxicity	0.0008967493997191767	0.0017302468508802317	0.07476635514018691	0.9605811478101344	1	2
cells cultured	dynamins	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	cyclic n-oxides/chemistry	0.0006548382098359173	0.0012800667479796353	0.07476635514018691	0.9605811478101344	1	2
cells cultured	adipose tissue/cytology	0.0006548382098359173	0.0012800667479796353	0.07476635514018691	0.9605811478101344	1	2
cells cultured	acetylcysteine/pharmacology	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	myocytes cardiac/drug effects	0.001441784719121486	0.002714874838772784	0.04601471862595931	0.8657199677887635	2	2
cells cultured	mitochondria heart/drug effects	0.0002946869893654114	0.0005978889060024469	0.02887405102126009	0.8657199677887635	2	2
cells cultured	keratinocytes/drug effects	1.9753868325644852e-05	4.534443402850783e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	iron overload/metabolism	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	free radical scavengers/pharmacology	0.0006548382098359173	0.0012800667479796353	0.07476635514018691	0.9605811478101344	1	2
cells cultured	organelle biogenesis	0.002471992423600855	0.00451441141021715	0.14426747400289588	0.9605811478101344	1	2
cells cultured	electron transport complex i/antagonists & inhibitors	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	cell hypoxia/drug effects	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	zearalenone/toxicity	7.426242172114961e-05	0.00016058629600901398	0.07476635514018691	0.9605811478101344	1	2
cells cultured	myocardial reperfusion injury/enzymology	3.2884563376800457e-06	8.124594949929365e-06	0.07476635514018691	0.9605811478101344	1	2
cells cultured	stem cells/cytology	0.0006548382098359173	0.0012800667479796353	0.07476635514018691	0.9605811478101344	1	2
cells cultured	extracellular space/drug effects	0.0008967493997191767	0.0017302468508802317	0.07476635514018691	0.9605811478101344	1	2
cells cultured	mitochondrial dynamics/drug effects	0.003038948212182868	0.005479451274305518	0.14426747400289588	0.9605811478101344	1	2
cells cultured	malaria/metabolism	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	histones/metabolism	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	rotenone/pharmacology	2.933030842644513e-07	7.848945748103681e-07	0.005265236277477952	0.8657199677887635	2	2
cells cultured	cell death	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	brain injuries traumatic/drug therapy	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	sphingosine/analogs & derivatives	0.0008967493997191767	0.0017302468508802317	0.07476635514018691	0.9605811478101344	1	2
cells cultured	ceruloplasmin/metabolism	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	fimbriae proteins/metabolism	4.559572053253191e-09	1.3778706774962495e-08	0.07476635514018691	0.9605811478101344	1	2
cells cultured	CP	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	CRYAA	0.0008967493997191767	0.0017302468508802317	0.07476635514018691	0.9605811478101344	1	2
cells cultured	CRYAB	0.0008967493997191767	0.0017302468508802317	0.07476635514018691	0.9605811478101344	1	2
cells cultured	DNM1L	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	H2AX	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	ICAM1	4.559572053253191e-09	1.3778706774962495e-08	0.07476635514018691	0.9605811478101344	1	2
cells cultured	IRF3	1.9753868325644852e-05	4.534443402850783e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	MAPK8	0.004540185975782762	0.007952810073413707	0.04601471862595931	0.8657199677887635	2	2
cells cultured	PPID	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	PPIF	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	inflammasomes/metabolism	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	iron chelating agents/pharmacology	2.5144574011815024e-07	6.750944566640253e-07	0.07476635514018691	0.9605811478101344	1	2
cells cultured	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0008967493997191767	0.0017302468508802317	0.14426747400289588	0.9605811478101344	1	2
cells cultured	hypertension pulmonary/chemically induced	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	monocrotaline/toxicity	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	iron/metabolism	0.004817090626846654	0.008421123861458534	0.11271713304732588	0.8657199677887635	2	2
cells cultured	heart ventricles/diagnostic imaging	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	bacterial toxins/metabolism	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	skin neoplasms/drug therapy	0.004401646658032887	0.007721793882583474	0.14426747400289588	0.9605811478101344	1	2
cells cultured	nlr family pyrin domain-containing 3 protein/metabolism	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	lung/blood supply	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	tuberculosis/metabolism	2.5144574011815024e-07	6.750944566640253e-07	0.07476635514018691	0.9605811478101344	1	2
cells cultured	host-pathogen interactions	6.670638631023351e-06	1.610360675975067e-05	0.04601471862595931	0.8657199677887635	2	2
cells cultured	hemodynamics/drug effects	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
cells cultured	NOX4	5.03129881213038e-06	1.2302326295868983e-05	0.005265236277477952	0.8657199677887635	2	2
cells cultured	macrophages peritoneal/cytology	8.671025409245914e-06	2.0621159338049175e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	adjuvants immunologic/administration & dosage	4.0109319430214896e-05	8.906539176124263e-05	0.07476635514018691	0.9605811478101344	1	2
cells cultured	piperidines/chemistry	7.426242172114961e-05	0.00016058629600901398	0.07476635514018691	0.9605811478101344	1	2
cells cultured	hmgb1 protein/metabolism	0.00119456136496221	0.0022722533840640845	0.07476635514018691	0.9605811478101344	1	2
dichloroacetic acid/chemistry	macrophages/cytology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
dichloroacetic acid/chemistry	energy metabolism/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dichloroacetic acid/chemistry	neoplasms/drug therapy	5.295763827461997e-13	1.979671089655512e-12	0.02803738317757009	0.9605811478101344	1	2
dichloroacetic acid/chemistry	antineoplastic agents/chemistry	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
dichloroacetic acid/chemistry	saponins/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dichloroacetic acid/chemistry	pyruvate dehydrogenase acetyl-transferring kinase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor microenvironment/drug effects	interferon-gamma/metabolism	0.003459167160976939	0.006184537590432984	0.012746294179346489	0.35414021462530776	5	2
tumor microenvironment/drug effects	cytokines/metabolism	0.002469278640295558	0.004509828981215744	0.009702666574409742	0.11552077256850565	7	2
tumor microenvironment/drug effects	raw 264.7 cells	0.0018795950560960284	0.003490970583506464	0.02131083549301754	0.7135314763244264	3	2
tumor microenvironment/drug effects	lymphocytes tumor-infiltrating/immunology	0.0007008037545572776	0.0013682211264038657	0.006134496983665349	0.7135314763244264	3	2
tumor microenvironment/drug effects	cell line tumor/transplantation	7.480626203593133e-05	0.00016173868018064513	0.006134496983665349	0.7135314763244264	3	2
tumor microenvironment/drug effects	myeloid-derived suppressor cells/immunology	0.0038395482559265837	0.006804465874661949	0.03422403580360668	0.8657199677887635	2	2
tumor microenvironment/drug effects	IL6	0.00199608755954106	0.0036945717354567907	0.003543498936736284	0.2127419111522651	6	2
tumor microenvironment/drug effects	TGFB1	0.0004890479742237774	0.000969390428453281	0.002867438375780095	0.35414021462530776	5	2
tumor microenvironment/drug effects	lung neoplasms/immunology	0.00534531941228833	0.00927908057650052	0.03422403580360668	0.8657199677887635	2	2
tumor microenvironment/drug effects	immunity innate/drug effects	0.0013743647363552158	0.002593460604857908	0.03422403580360668	0.8657199677887635	2	2
tumor microenvironment/drug effects	glioblastoma/drug therapy	0.0026461206605666865	0.0048140662038265785	0.03422403580360668	0.8657199677887635	2	2
tumor microenvironment/drug effects	interleukin-8/metabolism	0.0016566190911262435	0.003098764547480395	0.02131083549301754	0.7135314763244264	3	2
tumor microenvironment/drug effects	brain neoplasms/drug therapy	0.0026461206605666865	0.0048140662038265785	0.03422403580360668	0.8657199677887635	2	2
tumor microenvironment/drug effects	copper/chemistry	0.004147659465054465	0.007297709351649576	0.18691588785046728	0.9605811478101344	1	2
tumor microenvironment/drug effects	peroxidase/chemistry	0.004147659465054465	0.007297709351649576	0.18691588785046728	0.9605811478101344	1	2
tumor microenvironment/drug effects	doxorubicin/administration & dosage	0.004147659465054465	0.007297709351649576	0.18691588785046728	0.9605811478101344	1	2
tumor microenvironment/drug effects	tellurium/chemistry	0.004147659465054465	0.007297709351649576	0.18691588785046728	0.9605811478101344	1	2
tumor microenvironment/drug effects	immunosuppressive agents/chemistry	0.004147659465054465	0.007297709351649576	0.18691588785046728	0.9605811478101344	1	2
tumor microenvironment/drug effects	hydrogen peroxide/chemistry	0.004147659465054465	0.007297709351649576	0.18691588785046728	0.9605811478101344	1	2
tumor microenvironment/drug effects	tumor cells cultured	0.000893281468342555	0.0017253674826120588	0.00047173655289842035	0.0106962723396333	10	2
tumor microenvironment/drug effects	ARG1	0.00455175154730425	0.007969902963386604	0.03422403580360668	0.8657199677887635	2	2
tumor microenvironment/drug effects	CCL2	0.00030597752685890267	0.0006194850791721842	0.0010757174805479522	0.5304112294886878	4	2
tumor microenvironment/drug effects	CXCL1	0.0010705630023071233	0.0020453876148065387	0.03422403580360668	0.8657199677887635	2	2
tumor microenvironment/drug effects	CXCL8	0.0006315272783026238	0.001239002796940403	0.002867438375780095	0.35414021462530776	5	2
tumor microenvironment/drug effects	CXCR1	0.0021573789682626243	0.0039730948456610715	0.03422403580360668	0.8657199677887635	2	2
tumor microenvironment/drug effects	IFNG	0.0028263555020455744	0.005123786063895808	0.006701320833710374	0.2127419111522651	6	2
tumor microenvironment/drug effects	MSC	0.004147659465054465	0.007297709351649576	0.18691588785046728	0.9605811478101344	1	2
tumor microenvironment/drug effects	NFKB1	0.000939802161638359	0.001807147920792128	0.002867438375780095	0.35414021462530776	5	2
tumor microenvironment/drug effects	PRF1	0.003205528154449855	0.005760962239102576	0.03422403580360668	0.8657199677887635	2	2
tumor microenvironment/drug effects	tumor-associated macrophages/drug effects	0.0013743647363552158	0.002593460604857908	0.03422403580360668	0.8657199677887635	2	2
tumor microenvironment/drug effects	apoptosis/drug effects	0.005522610022403063	0.00956650736753164	6.2452023328499335e-06	0.0	35	2
tumor microenvironment/drug effects	cell movement/drug effects	0.0002213466771565642	0.00045495795645470214	0.00012958695858116188	0.004109180810744809	11	2
glutathione	phospholipid hydroperoxide glutathione peroxidase	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-gamma/metabolism	b7-h1 antigen/antagonists & inhibitors	6.70669706548388e-07	1.7497249662736786e-06	0.009064629456995965	0.8657199677887635	2	2
interferon-gamma/metabolism	aniline compounds/chemistry	9.200277617527064e-08	2.549619418190507e-07	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	phenol/chemistry	9.200277617527064e-08	2.549619418190507e-07	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	programmed cell death 1 receptor/metabolism	9.200277617527064e-08	2.549619418190507e-07	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	cd8-positive t-lymphocytes/cytology	0.0001035686114601031	0.00021945994670565625	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	tumor escape/drug effects	0.003681474124667794	0.006551181719182851	0.1214816672917065	0.9605811478101344	1	2
interferon-gamma/metabolism	immunogenic cell death/drug effects	9.200277617527064e-08	2.549619418190507e-07	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	metal-organic frameworks/chemistry	9.200277617527064e-08	2.549619418190507e-07	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	benzylidene compounds/chemistry	9.200277617527064e-08	2.549619418190507e-07	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	BDKRB2	1.3242446169625666e-06	3.3796672432909676e-06	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	CD274	8.889231573050438e-10	2.78830242883221e-09	0.0001696339720008152	0.5304112294886878	4	2
interferon-gamma/metabolism	PDCD1	2.007875562037853e-05	4.601355409189334e-05	0.014774701220028882	0.8657199677887635	2	2
interferon-gamma/metabolism	cyclin b1/metabolism	3.509202309437409e-05	7.872496186251119e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	interleukin-10/metabolism	0.001476542903556255	0.002778188934767734	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	chalcones/pharmacology	2.5144574011815024e-07	6.750944566640253e-07	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	zoledronic acid	2.891389927484056e-08	8.282365222965891e-08	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	gene expression regulation	0.003286760598651739	0.005905027516221769	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	neuroblastoma/immunology	2.891389927484056e-08	8.282365222965891e-08	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	receptors antigen b-cell/antagonists & inhibitors	6.072353285757615e-07	1.5893072797291533e-06	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	histone deacetylase inhibitors/pharmacology	0.0008967493997191767	0.0017302468508802317	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	aspirin/administration & dosage	3.509202309437409e-05	7.872496186251119e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	receptors antigen t-cell gamma-delta/metabolism	2.891389927484056e-08	8.282365222965891e-08	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	nitrobenzenes/chemistry	7.515323696694054e-09	2.2394628580174417e-08	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	cell cycle proteins/metabolism	0.0012612954470129223	0.002392175657268035	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	immune checkpoint inhibitors/chemical synthesis	7.515323696694054e-09	2.2394628580174417e-08	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	t-lymphocytes regulatory/immunology	1.247890679678676e-12	4.590172456715957e-12	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	chemokine cxcl10/metabolism	2.891389927484056e-08	8.282365222965891e-08	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	plicamycin/analogs & derivatives	6.072353285757615e-07	1.5893072797291533e-06	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	neoplasms/pathology	1.247890679678676e-12	4.590172456715957e-12	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	gene expression regulation leukemic/drug effects	6.072353285757615e-07	1.5893072797291533e-06	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	programmed cell death 1 receptor/antagonists & inhibitors	7.515323696694054e-09	2.2394628580174417e-08	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	liver neoplasms/drug therapy	0.0008967493997191767	0.0017302468508802317	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	lactic acid/metabolism	0.002265789658880024	0.0041623171470577215	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	antibiotics antineoplastic/pharmacology	0.0008967493997191767	0.0017302468508802317	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	lymphoma t-cell/drug therapy	3.509202309437409e-05	7.872496186251119e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	antigen presentation/drug effects	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	drug combinations	0.0017151163804780545	0.003201666747674214	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	neovascularization pathologic	2.891389927484056e-08	8.282365222965891e-08	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	antibodies monoclonal/pharmacology	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	b7-h1 antigen/genetics	0.0004977624257582747	0.0009862208809416281	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	interleukin-4/metabolism	3.509202309437409e-05	7.872496186251119e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	nitric oxide/metabolism	0.002579457815108821	0.004698990821079012	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	t-lymphocyte subsets/cytology	2.891389927484056e-08	8.282365222965891e-08	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	t-lymphocytes/cytology	3.3584246494910985e-12	1.1971955807919117e-11	0.0015795708832433853	0.8657199677887635	2	2
interferon-gamma/metabolism	leukemia lymphocytic chronic b-cell/drug therapy	6.072353285757615e-07	1.5893072797291533e-06	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	killer cells natural/drug effects	0.0007452469808189033	0.0014499828303119644	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	indoleamine-pyrrole 23-dioxygenase/antagonists & inhibitors	1.247890679678676e-12	4.590172456715957e-12	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	enzyme inhibitors/chemistry	1.247890679678676e-12	4.590172456715957e-12	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	histone deacetylases/chemistry	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	adaptor proteins signal transducing/metabolism	2.5144574011815024e-07	6.750944566640253e-07	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	CIITA	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	EIF2S1	2.5144574011815024e-07	6.750944566640253e-07	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	FOXP3	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	HDAC9	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	IFNG	3.869682352330983e-12	1.3677261382525411e-11	1.4800638431890534e-05	0.35414021462530776	5	2
interferon-gamma/metabolism	IL4	0.0008255023012271323	0.0015995905537968442	0.029672876357553783	0.8657199677887635	2	2
interferon-gamma/metabolism	PRF1	0.0004977624257582747	0.0009862208809416281	0.08253257864946689	0.9605811478101344	1	2
interferon-gamma/metabolism	SOCS5	3.509202309437409e-05	7.872496186251119e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	glutamates/pharmacology	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	phytohemagglutinins/pharmacology	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	buthionine sulfoximine/pharmacology	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	antibodies monoclonal/immunology	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	mercaptoethanol/pharmacology	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	interleukins/metabolism	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	cd3 complex/immunology	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	CD28	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	CD3E	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	IL5	8.671025409245914e-06	2.0621159338049175e-05	0.04205607476635514	0.9605811478101344	1	2
interferon-gamma/metabolism	exosomes/metabolism	9.200277617527064e-08	2.549619418190507e-07	0.04205607476635514	0.9605811478101344	1	2
DIABLO	myeloid-derived suppressor cells/immunology	0.00024702462484893495	0.0005061238666173513	0.05541661182045544	0.9605811478101344	1	2
DIABLO	lung neoplasms/immunology	0.0003795874729707327	0.0007588307737835447	0.05541661182045544	0.9605811478101344	1	2
DIABLO	benzhydryl compounds/immunology	5.266702487460861e-07	1.3828778902410037e-06	0.02803738317757009	0.9605811478101344	1	2
DIABLO	t-lymphocytes regulatory/drug effects	0.0001954257727562192	0.00040321424646538656	0.05541661182045544	0.9605811478101344	1	2
DIABLO	azocines/immunology	5.266702487460861e-07	1.3828778902410037e-06	0.02803738317757009	0.9605811478101344	1	2
DIABLO	cytokines/blood	5.266702487460861e-07	1.3828778902410037e-06	0.02803738317757009	0.9605811478101344	1	2
DIABLO	mitochondrial proteins/metabolism	5.384581669432009e-14	2.1169624937167785e-13	2.0849213518322384e-07	0.35414021462530776	5	2
DIABLO	cyclin d1/metabolism	0.0012483255684894168	0.002368595708610556	0.05541661182045544	0.9605811478101344	1	2
DIABLO	carcinoma lewis lung/immunology	5.266702487460861e-07	1.3828778902410037e-06	0.02803738317757009	0.9605811478101344	1	2
DIABLO	ARG1	0.00030809594669733986	0.0006236595145779425	0.05541661182045544	0.9605811478101344	1	2
DIABLO	CASP8	0.0022224198254118255	0.004086050059262836	0.012970382291718041	0.8657199677887635	2	2
DIABLO	caspase 3/metabolism	0.00019984588901655886	0.00041217980926446115	0.009383502472863752	0.8657199677887635	2	2
DIABLO	p38 mitogen-activated protein kinases/metabolism	0.0010787516535835096	0.0020606754858957907	0.05541661182045544	0.9605811478101344	1	2
DIABLO	caspase 8/metabolism	0.004786241163180716	0.008369848125460693	0.05541661182045544	0.9605811478101344	1	2
DIABLO	MCL1	8.399409860970763e-07	2.173338676384032e-06	0.0002404754836273229	0.7135314763244264	3	2
DIABLO	TCIM	5.266702487460861e-07	1.3828778902410037e-06	0.02803738317757009	0.9605811478101344	1	2
DIABLO	TNF	0.0005566472176623538	0.001099136472776247	0.004009904624670713	0.7135314763244264	3	2
DIABLO	flavonoids/metabolism	4.706236735907421e-05	0.00010405446004140275	0.02803738317757009	0.9605811478101344	1	2
DIABLO	multiple myeloma/metabolism	4.706236735907421e-05	0.00010405446004140275	0.02803738317757009	0.9605811478101344	1	2
DIABLO	multiple myeloma/pathology	6.049025237375716e-06	1.4639836271532358e-05	0.02803738317757009	0.9605811478101344	1	2
DIABLO	mitochondrial proteins/genetics	6.854378176157638e-10	2.1549312708958165e-09	0.02803738317757009	0.9605811478101344	1	2
DIABLO	nitrophenols/toxicity	0.0001954257727562192	0.00040321424646538656	0.02803738317757009	0.9605811478101344	1	2
DIABLO	piperazines/toxicity	0.0001954257727562192	0.00040321424646538656	0.02803738317757009	0.9605811478101344	1	2
DIABLO	enzyme inhibitors/pharmacology	0.000557584202056427	0.0011007894418821726	0.05541661182045544	0.9605811478101344	1	2
DIABLO	jnk mitogen-activated protein kinases/metabolism	0.00030809594669733986	0.0006236595145779425	0.05541661182045544	0.9605811478101344	1	2
DIABLO	head and neck neoplasms/drug therapy	6.854378176157638e-10	2.1549312708958165e-09	0.02803738317757009	0.9605811478101344	1	2
DIABLO	dexamethasone/administration & dosage	3.1556298685231354e-09	9.644486739838937e-09	0.02803738317757009	0.9605811478101344	1	2
DIABLO	poly(adp-ribose) polymerases/metabolism	0.0001954257727562192	0.00040321424646538656	0.02803738317757009	0.9605811478101344	1	2
DIABLO	glioblastoma/enzymology	0.0001954257727562192	0.00040321424646538656	0.02803738317757009	0.9605811478101344	1	2
DIABLO	flavonoids/pharmacology	0.0009256794632915843	0.0017806125289349898	0.05541661182045544	0.9605811478101344	1	2
DIABLO	free radicals/metabolism	6.049025237375716e-06	1.4639836271532358e-05	0.02803738317757009	0.9605811478101344	1	2
DIABLO	piperidines/metabolism	4.706236735907421e-05	0.00010405446004140275	0.02803738317757009	0.9605811478101344	1	2
DIABLO	deoxycytidine/analogs & derivatives	6.854378176157638e-10	2.1549312708958165e-09	0.02803738317757009	0.9605811478101344	1	2
DIABLO	carrier proteins/metabolism	6.049025237375716e-06	1.4639836271532358e-05	0.02803738317757009	0.9605811478101344	1	2
DIABLO	cyclin-dependent kinases/antagonists & inhibitors	6.049025237375716e-06	1.4639836271532358e-05	0.02803738317757009	0.9605811478101344	1	2
DIABLO	aminopyridines/pharmacology	0.0001954257727562192	0.00040321424646538656	0.02803738317757009	0.9605811478101344	1	2
DIABLO	apoptosis inducing factor/metabolism	0.004786241163180716	0.008369848125460693	0.05541661182045544	0.9605811478101344	1	2
DIABLO	chromosome segregation/drug effects	0.0001954257727562192	0.00040321424646538656	0.02803738317757009	0.9605811478101344	1	2
DIABLO	bcl-2 homologous antagonist-killer protein/metabolism	0.0001954257727562192	0.00040321424646538656	0.02803738317757009	0.9605811478101344	1	2
DIABLO	biphenyl compounds/toxicity	0.0001954257727562192	0.00040321424646538656	0.02803738317757009	0.9605811478101344	1	2
DIABLO	protein transport	6.049025237375716e-06	1.4639836271532358e-05	0.02803738317757009	0.9605811478101344	1	2
DIABLO	poly (adp-ribose) polymerase-1	4.706236735907421e-05	0.00010405446004140275	0.02803738317757009	0.9605811478101344	1	2
DIABLO	cytochromes c/metabolism	6.328271240363392e-15	2.5728512688093688e-14	2.0849213518322384e-07	0.35414021462530776	5	2
DIABLO	sulfonamides/toxicity	0.0001954257727562192	0.00040321424646538656	0.02803738317757009	0.9605811478101344	1	2
DIABLO	isocoumarins	3.1556298685231354e-09	9.644486739838937e-09	0.02803738317757009	0.9605811478101344	1	2
DIABLO	nitriles/metabolism	6.049025237375716e-06	1.4639836271532358e-05	0.02803738317757009	0.9605811478101344	1	2
DIABLO	piperidines/pharmacology	0.001435126087253158	0.0027030292133741352	0.05541661182045544	0.9605811478101344	1	2
DIABLO	leukemia/metabolism	4.706236735907421e-05	0.00010405446004140275	0.02803738317757009	0.9605811478101344	1	2
DIABLO	antimetabolites antineoplastic/pharmacology	6.854378176157638e-10	2.1549312708958165e-09	0.02803738317757009	0.9605811478101344	1	2
DIABLO	membrane glycoproteins/metabolism	4.706236735907421e-05	0.00010405446004140275	0.02803738317757009	0.9605811478101344	1	2
DIABLO	dna damage/drug effects	0.0001954257727562192	0.00040321424646538656	0.02803738317757009	0.9605811478101344	1	2
DIABLO	TNFRSF10D	4.706236735907421e-05	0.00010405446004140275	0.02803738317757009	0.9605811478101344	1	2
glioblastoma/genetics	brain neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glioblastoma/genetics	t-lymphocytes cytotoxic/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glioblastoma/genetics	hyaluronan receptors/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glioblastoma/genetics	heat-shock proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/genetics	gene expression regulation neoplastic	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
glioblastoma/genetics	CD44	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glioblastoma/genetics	HSPB1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glioblastoma/genetics	SLC40A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glioblastoma/genetics	cation transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	mucin-1/immunology	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	apigenin/pharmacology	6.947266550938469e-05	0.00015113303691671571	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	adenosine triphosphate/biosynthesis	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	calreticulin/analysis	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	ovalbumin/immunology	2.9132252166164108e-12	1.0422000580230182e-11	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	prostatic neoplasms/therapy	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	affinity labels	2.9132252166164108e-12	1.0422000580230182e-11	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	carcinoembryonic antigen/immunology	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	eif-2 kinase/genetics	0.0008309728644826375	0.0016078358680222194	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	adenosine/analogs & derivatives	2.9132252166164108e-12	1.0422000580230182e-11	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	rna small interfering	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	thyroid hormones/immunology	5.465211916355628e-08	1.5393075157359337e-07	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	cytotoxicity immunologic	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	breast neoplasms/therapy	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	membrane proteins/immunology	5.465211916355628e-08	1.5393075157359337e-07	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	carrier proteins/immunology	5.465211916355628e-08	1.5393075157359337e-07	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	hmgb1 protein/biosynthesis	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	colorectal neoplasms/therapy	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	cytokines/immunology	5.465211916355628e-08	1.5393075157359337e-07	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	KLK3	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	MUC1	0.0003833273953670613	0.0007661682905496299	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	NPEPPS	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	PKM	5.465211916355628e-08	1.5393075157359337e-07	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	PROM1	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	PSAT1	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	hyaluronic acid/chemistry	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	benzylidene compounds/pharmacology	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	cell line	0.004136562938341637	0.007290402850883806	0.06029390964862403	0.8657199677887635	2	2
t-lymphocytes cytotoxic/drug effects	exosomes/drug effects	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	b7-h1 antigen/antagonists & inhibitors	0.0037251038918170165	0.006609084300859546	0.12539913750269532	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	immunologic memory	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	immune checkpoint inhibitors/pharmacology	2.1000354819999956e-05	4.811053855687438e-05	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	tumor escape/drug effects	0.0007213786303140735	0.0014054039092661211	0.09538832359347407	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	skin neoplasms/drug therapy	0.0	0.0	0.0009214163485586416	0.8657199677887635	2	2
t-lymphocytes cytotoxic/drug effects	cell line tumor/transplantation	0.0003210904092953992	0.000647525962146251	0.09538832359347407	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	interferon-gamma/immunology	0.0007213786303140735	0.0014054039092661211	0.09538832359347407	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	aniline compounds/pharmacology	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	HMGB1	0.0009516668167697251	0.0018291648484124224	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	cd11b antigen/metabolism	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	adjuvants immunologic/administration & dosage	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	hydrogen peroxide/antagonists & inhibitors	2.355893258254582e-13	8.918738763392347e-13	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	immunologic memory/drug effects	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	autocrine communication	2.355893258254582e-13	8.918738763392347e-13	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	lymph nodes/drug effects	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	t-lymphocytes regulatory/drug effects	5.294182759463251e-05	0.00011624951845498033	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	docetaxel	0.0004539004348392828	0.0009027238667992519	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	pyruvic acid/metabolism	2.355893258254582e-13	8.918738763392347e-13	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	lactic acid/metabolism	0.0003833273953670613	0.0007661682905496299	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	lymphocytes tumor-infiltrating/drug effects	3.966149089940085e-05	8.832894458080707e-05	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	cytotoxicity immunologic/drug effects	8.353172598063452e-10	2.6253848815695364e-09	0.00535588186581037	0.8657199677887635	2	2
t-lymphocytes cytotoxic/drug effects	chemokines/metabolism	8.97557839122376e-05	0.00019155314332562333	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	cisplatin/administration & dosage	2.599433609473678e-07	6.975695255802782e-07	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	granulocyte colony-stimulating factor/pharmacology	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	radiation tolerance/drug effects	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	killer cells natural/drug effects	8.97557839122376e-05	0.00019155314332562333	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	adenosine triphosphate/metabolism	1.6653345369377348e-15	6.987116245557217e-15	0.00041630292572802344	0.7135314763244264	3	2
t-lymphocytes cytotoxic/drug effects	peptides/chemistry	2.599433609473678e-07	6.975695255802782e-07	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	cell survival/physiology	2.355893258254582e-13	8.918738763392347e-13	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	antioxidants/chemistry	2.355893258254582e-13	8.918738763392347e-13	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	neutrophils/metabolism	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	antigens neoplasm/immunology	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	biological factors/chemistry	2.355893258254582e-13	8.918738763392347e-13	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	CSF3	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	ITGAM	6.497637983216009e-10	2.0454015170466386e-09	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	WDTC1	0.0023718342594257757	0.00433868760904501	0.12539913750269532	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	dendritic cells/immunology	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	prostate-specific antigen/immunology	4.372966338817008e-06	1.0734264288380917e-05	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	adenosine triphosphatases/antagonists & inhibitors	2.9132252166164108e-12	1.0422000580230182e-11	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/drug effects	isoantigens/immunology	2.9132252166164108e-12	1.0422000580230182e-11	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/immunology	hyaluronan receptors/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocytes cytotoxic/immunology	heat-shock proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/immunology	gene expression regulation neoplastic	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
t-lymphocytes cytotoxic/immunology	CD44	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocytes cytotoxic/immunology	HSPB1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocytes cytotoxic/immunology	SLC40A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocytes cytotoxic/immunology	brain neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocytes cytotoxic/immunology	cation transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALR	neoplasms/diagnostic imaging	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALR	ascorbic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALR	t-lymphocytes cytotoxic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
reactive oxygen species/metabolism	urinary bladder neoplasms/pathology	0.0024765058166680287	0.004520781606714414	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	cisplatin	0.004241832357080422	0.007457453138418718	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	killer cells natural/metabolism	0.004241832357080422	0.007457453138418718	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	dextrans/chemistry	0.0024765058166680287	0.004520781606714414	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	adjuvants immunologic/chemistry	0.0024765058166680287	0.004520781606714414	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	asparaginase	0.004241832357080422	0.007457453138418718	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	gold/chemistry	0.0024765058166680287	0.004520781606714414	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	HMOX1	0.0017878521239360623	0.003332930043843942	0.03422403580360668	0.8657199677887635	2	2
reactive oxygen species/metabolism	MTOR	0.005716023981120144	0.009879038703122752	0.0004192967836177035	1.364602746023001e-11	25	2
reactive oxygen species/metabolism	chemokines/metabolism	0.004670822726552504	0.008173198371034095	0.03422403580360668	0.8657199677887635	2	2
reactive oxygen species/metabolism	monoterpenes/pharmacology	0.004241832357080422	0.007457453138418718	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	amyloid beta-peptides/pharmacology	0.004241832357080422	0.007457453138418718	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	lysosomes/drug effects	0.001597792096644124	0.0029925348408774755	0.00464095255893545	0.5304112294886878	4	2
reactive oxygen species/metabolism	lymphoma t-cell	0.004241832357080422	0.007457453138418718	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	enterocytes/cytology	0.00017708514020320365	0.00036757420176993357	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	arginine/pharmacology	0.00017708514020320365	0.00036757420176993357	0.18691588785046728	0.9605811478101344	1	2
reactive oxygen species/metabolism	gels/chemistry	0.0024765058166680287	0.004520781606714414	0.18691588785046728	0.9605811478101344	1	2
hyaluronan receptors/genetics	heat-shock proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hyaluronan receptors/genetics	gene expression regulation neoplastic	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
hyaluronan receptors/genetics	CD44	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hyaluronan receptors/genetics	HSPB1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hyaluronan receptors/genetics	SLC40A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hyaluronan receptors/genetics	brain neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hyaluronan receptors/genetics	cation transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
IL10	cd8-positive t-lymphocytes/drug effects	1.1409781187188273e-05	2.6799068457987328e-05	0.01125813263425861	0.8657199677887635	2	2
IL10	tumor-associated macrophages/drug effects	0.0006585189002574765	0.0012870334822158355	0.09148348032117941	0.9605811478101344	1	2
IL10	immune checkpoint inhibitors/pharmacology	0.0008266389137319141	0.0015995905537968442	0.09148348032117941	0.9605811478101344	1	2
IL10	myeloid-derived suppressor cells/immunology	0.0017963169899918308	0.0033461639908195237	0.09148348032117941	0.9605811478101344	1	2
IL10	interleukin-10/metabolism	7.0365052673437845e-09	2.0987671554977784e-08	0.0019744636040542316	0.8657199677887635	2	2
IL10	neovascularization pathologic/immunology	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	CD8A	1.46657991384469e-06	3.7278249873700397e-06	0.0023570206333426743	0.7135314763244264	3	2
IL10	ht29 cells	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	sarcoma/drug therapy	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	proteasome inhibitors/pharmacology	0.0017963169899918308	0.0033461639908195237	0.09148348032117941	0.9605811478101344	1	2
IL10	lung neoplasms/immunology	0.0024832858160589444	0.004532407754343345	0.09148348032117941	0.9605811478101344	1	2
IL10	benzhydryl compounds/immunology	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	aspirin/administration & dosage	0.00015876343480980548	0.0003311338767085982	0.04672897196261682	0.9605811478101344	1	2
IL10	cyclin b1/metabolism	0.00015876343480980548	0.0003311338767085982	0.04672897196261682	0.9605811478101344	1	2
IL10	t-lymphocytes regulatory/drug effects	0.0015056804766054865	0.0028289086619682803	0.09148348032117941	0.9605811478101344	1	2
IL10	receptor cross-talk/drug effects	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	azocines/immunology	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	cytokines/blood	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	t-lymphocytes cytotoxic/cytology	0.0005161304311359638	0.0010208705253149483	0.09148348032117941	0.9605811478101344	1	2
IL10	receptors interleukin-10/genetics	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	proteasome endopeptidase complex/metabolism	0.0008266389137319141	0.0015995905537968442	0.09148348032117941	0.9605811478101344	1	2
IL10	fas receptor/genetics	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	receptors ccr10/genetics	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	epoxy compounds/pharmacology	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	chemokine ccl27/metabolism	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	lactic acid/metabolism	0.005465546182889414	0.009469146804993384	0.09148348032117941	0.9605811478101344	1	2
IL10	lymphoma t-cell/drug therapy	0.00015876343480980548	0.0003311338767085982	0.04672897196261682	0.9605811478101344	1	2
IL10	interleukin-10/genetics	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	t-lymphocytes/cytology	0.0015056804766054865	0.0028289086619682803	0.09148348032117941	0.9605811478101344	1	2
IL10	bortezomib/pharmacology	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	carcinoma lewis lung/immunology	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	ARG1	7.999587658957807e-10	2.514612328267775e-09	0.0019744636040542316	0.8657199677887635	2	2
IL10	phenanthrenes/pharmacology	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	hypoxia	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	interleukin-4/metabolism	0.00015876343480980548	0.0003311338767085982	0.04672897196261682	0.9605811478101344	1	2
IL10	IL1B	0.0017963169899918308	0.0033461639908195237	0.09148348032117941	0.9605811478101344	1	2
IL10	IL4	1.9984014443252818e-15	8.286769803363515e-15	1.4244514869894097e-06	0.35414021462530776	5	2
IL10	MRC1	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	PRF1	0.0015056804766054865	0.0028289086619682803	0.09148348032117941	0.9605811478101344	1	2
IL10	SOCS5	0.00015876343480980548	0.0003311338767085982	0.04672897196261682	0.9605811478101344	1	2
IL10	TCIM	1.7848166501521767e-05	4.115419107148629e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	glutamates/pharmacology	4.86123297633867e-05	0.00010706269569704824	0.04672897196261682	0.9605811478101344	1	2
IL10	drug hypersensitivity/drug therapy	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	jurkat cells/drug effects	3.2974283636910684e-08	9.399056310621935e-08	0.04672897196261682	0.9605811478101344	1	2
IL10	recombinant fusion proteins/pharmacology	2.4375466437520643e-06	6.0891715841202705e-06	0.04672897196261682	0.9605811478101344	1	2
IL10	dinitrofluorobenzene/pharmacology	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	rna messenger/metabolism	3.2974283636910684e-08	9.399056310621935e-08	0.04672897196261682	0.9605811478101344	1	2
IL10	anti-inflammatory agents/pharmacology	0.0008266389137319141	0.0015995905537968442	0.09148348032117941	0.9605811478101344	1	2
IL10	hypersensitivity delayed/chemically induced	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	ear/pathology	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	phytohemagglutinins/pharmacology	4.86123297633867e-05	0.00010706269569704824	0.04672897196261682	0.9605811478101344	1	2
IL10	mitochondrial membrane transport proteins/genetics	2.4375466437520643e-06	6.0891715841202705e-06	0.04672897196261682	0.9605811478101344	1	2
IL10	cyclins/metabolism	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	oxazolone/pharmacology	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	buthionine sulfoximine/pharmacology	4.86123297633867e-05	0.00010706269569704824	0.04672897196261682	0.9605811478101344	1	2
IL10	antibodies monoclonal/immunology	4.86123297633867e-05	0.00010706269569704824	0.04672897196261682	0.9605811478101344	1	2
IL10	interleukin-10/pharmacology	2.4375466437520643e-06	6.0891715841202705e-06	0.04672897196261682	0.9605811478101344	1	2
IL10	neoplasms/immunology	2.4375466437520643e-06	6.0891715841202705e-06	0.04672897196261682	0.9605811478101344	1	2
IL10	cell division/drug effects	1.6173528189167286e-05	3.739057874748457e-05	0.01125813263425861	0.8657199677887635	2	2
IL10	triterpenes/pharmacology	0.00029965026733114186	0.000606786287115817	0.09148348032117941	0.9605811478101344	1	2
IL10	dna fragmentation/drug effects	0.0033192745475103536	0.0059585869747197755	0.13433803313621812	0.9605811478101344	1	2
IL10	foot/pathology	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	oleic acid/toxicity	3.2974283636910684e-08	9.399056310621935e-08	0.04672897196261682	0.9605811478101344	1	2
IL10	immunoglobulin fc fragments/pharmacology	2.4375466437520643e-06	6.0891715841202705e-06	0.04672897196261682	0.9605811478101344	1	2
IL10	mercaptoethanol/pharmacology	4.86123297633867e-05	0.00010706269569704824	0.04672897196261682	0.9605811478101344	1	2
IL10	receptors chimeric antigen/immunology	2.4375466437520643e-06	6.0891715841202705e-06	0.04672897196261682	0.9605811478101344	1	2
IL10	interleukins/metabolism	4.86123297633867e-05	0.00010706269569704824	0.04672897196261682	0.9605811478101344	1	2
IL10	arachidonic acid/toxicity	3.2974283636910684e-08	9.399056310621935e-08	0.04672897196261682	0.9605811478101344	1	2
IL10	cd3 complex/immunology	4.86123297633867e-05	0.00010706269569704824	0.04672897196261682	0.9605811478101344	1	2
IL10	receptors interleukin-10/metabolism	2.4375466437520643e-06	6.0891715841202705e-06	0.04672897196261682	0.9605811478101344	1	2
IL10	monocarboxylic acid transporters/genetics	2.4375466437520643e-06	6.0891715841202705e-06	0.04672897196261682	0.9605811478101344	1	2
IL10	nfatc transcription factors/antagonists & inhibitors	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	CD28	4.86123297633867e-05	0.00010706269569704824	0.04672897196261682	0.9605811478101344	1	2
IL10	CD3E	4.86123297633867e-05	0.00010706269569704824	0.04672897196261682	0.9605811478101344	1	2
IL10	IL2	1.9106776632082934e-05	4.390934033606051e-05	0.01125813263425861	0.8657199677887635	2	2
IL10	IL5	4.86123297633867e-05	0.00010706269569704824	0.04672897196261682	0.9605811478101344	1	2
IL10	plant leaves/chemistry	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
IL10	DDX53	0.005465546182889414	0.009469146804993384	0.09148348032117941	0.9605811478101344	1	2
IL10	fas ligand protein/genetics	5.133631229115032e-06	1.249986762446474e-05	0.04672897196261682	0.9605811478101344	1	2
tumor microenvironment	proto-oncogene proteins p21(ras)/metabolism	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	cell transformation neoplastic/genetics	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	antibodies monoclonal humanized/pharmacology	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	diet	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	pancreatitis/genetics	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	dna	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	phospholipid hydroperoxide glutathione peroxidase/genetics	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	quinoxalines/pharmacology	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	interferon-gamma/immunology	0.0005501030330672396	0.0010863118381609046	0.031103389868393932	0.8657199677887635	2	2
tumor microenvironment	membrane proteins/genetics	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	fatty acids/metabolism	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	biomarkers tumor	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	BDKRB2	0.002892087846564362	0.005230477634406616	0.20385239787635467	0.9605811478101344	1	2
tumor microenvironment	CD36	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	KDM8	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	PDCD1	0.00016348845716440685	0.0003407954527333688	0.009489295975454759	0.7135314763244264	3	2
tumor microenvironment	STING1	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	neoplasm metastasis/pathology	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	adjuvants immunologic/administration & dosage	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	receptor cross-talk/drug effects	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	lymphatic metastasis/genetics	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	antineoplastic agents/metabolism	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	antigens polyomavirus transforming/genetics	0.0020892101499980775	0.0038562499277653923	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	cell communication/drug effects	0.005020717221043802	0.0087535009718151	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	tumor escape	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	neoplasms/metabolism	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	epithelial-mesenchymal transition	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	receptors ccr7/genetics	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	protein kinases/genetics	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	immunologic memory/drug effects	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	lysosomal-associated membrane protein 2/genetics	0.0014477855814681861	0.002724545621390455	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	oxaliplatin	0.0014477855814681861	0.002724545621390455	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	acetates/therapeutic use	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	antigens cd/metabolism	0.005020717221043802	0.0087535009718151	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	nitrobenzenes/chemistry	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	neovascularization pathologic/metabolism	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	immune checkpoint inhibitors/chemical synthesis	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	t-lymphocytes regulatory/immunology	9.631694485534581e-06	2.2831910549087886e-05	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	tnf-related apoptosis-inducing ligand/metabolism	0.00013591847190141948	0.00028526706030295064	0.011100873151682681	0.8657199677887635	2	2
tumor microenvironment	interleukin-17/biosynthesis	0.0014477855814681861	0.002724545621390455	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	phenotype	0.0019701854058000734	0.0036521479592298654	0.031103389868393932	0.8657199677887635	2	2
tumor microenvironment	interferons/metabolism	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	oncogene proteins/metabolism	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	cyclin d1/genetics	0.0014477855814681861	0.002724545621390455	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	pancreas/metabolism	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	neoplasms/pathology	9.631694485534581e-06	2.2831910549087886e-05	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	receptors tnf-related apoptosis-inducing ligand/agonists	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	janus kinases/metabolism	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	antineoplastic agents immunological/pharmacology	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	rank ligand/antagonists & inhibitors	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	programmed cell death 1 receptor/antagonists & inhibitors	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	cyclophosphamide/administration & dosage	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	paclitaxel/pharmacology	0.0022138603617906094	0.004070991931339396	0.031103389868393932	0.8657199677887635	2	2
tumor microenvironment	endometrial neoplasms/genetics	0.005020717221043802	0.0087535009718151	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	receptors interleukin-10/genetics	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	carcinoma non-small-cell lung/genetics	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	lymphocytes tumor-infiltrating/drug effects	1.8155756370208387e-05	4.1841550794434464e-05	0.011100873151682681	0.8657199677887635	2	2
tumor microenvironment	estrogen receptor alpha/genetics	0.005020717221043802	0.0087535009718151	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	melanoma/drug therapy	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	carcinoma hepatocellular/drug therapy	0.002955901666865657	0.005343696289853558	0.02867483719954821	0.7135314763244264	3	2
tumor microenvironment	bone neoplasms/metabolism	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	cell movement/genetics	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	carbazoles/pharmacology	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	osteoclasts/drug effects	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	receptors cell surface/metabolism	0.005020717221043802	0.0087535009718151	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	macrophages/immunology	0.0014477855814681861	0.002724545621390455	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	prostatic neoplasms/metabolism	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	cell line transformed	0.0020892101499980775	0.0038562499277653923	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	interleukin-10/genetics	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	hypoxia-inducible factor 1 alpha subunit/genetics	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	neoplasm recurrence local/genetics	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	biomarkers	3.514572077023548e-05	7.883740477588278e-05	0.011100873151682681	0.8657199677887635	2	2
tumor microenvironment	receptors ccr10/genetics	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	carcinoma squamous cell/immunology	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	matrix metalloproteinase 9/metabolism	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	src-family kinases/metabolism	0.0005910476991810576	0.0011616526717368476	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	hek293 cells	0.004121363407138978	0.0072653570321100334	0.05812100723456789	0.8657199677887635	2	2
tumor microenvironment	estradiol/pharmacology	0.005020717221043802	0.0087535009718151	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	chemokine ccl21/genetics	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	tumor necrosis factor alpha-induced protein 3/metabolism	0.005020717221043802	0.0087535009718151	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	recombinant fusion proteins/metabolism	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	receptors cxcr4/genetics	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	rna small interfering/genetics	0.0013520627913258254	0.002554437054254653	0.031103389868393932	0.8657199677887635	2	2
tumor microenvironment	ras proteins/metabolism	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	leukemia t-cell/drug therapy	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	integrins/metabolism	0.0005910476991810576	0.0011616526717368476	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	bortezomib/pharmacology	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	chemokine ccl27/metabolism	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	osteoprotegerin/pharmacology	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	receptors interleukin-17/genetics	0.0014477855814681861	0.002724545621390455	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	cd79 antigens/antagonists & inhibitors	0.0005910476991810576	0.0011616526717368476	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	mouth neoplasms/immunology	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	indoleamine-pyrrole 23-dioxygenase/antagonists & inhibitors	9.631694485534581e-06	2.2831910549087886e-05	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	heterocyclic compounds/pharmacology	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	antigens neoplasm/immunology	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	enzyme inhibitors/chemistry	9.631694485534581e-06	2.2831910549087886e-05	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	maleimides	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	bone density conservation agents/pharmacology	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	organoplatinum compounds/pharmacology	0.0014477855814681861	0.002724545621390455	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	antigens differentiation myelomonocytic/metabolism	0.005020717221043802	0.0087535009718151	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	transforming growth factor beta/metabolism	0.00020713467787691897	0.0004266939528945445	0.004085772502219969	0.7135314763244264	3	2
tumor microenvironment	human umbilical vein endothelial cells	0.00010671844529808183	0.00022606920464374598	0.031103389868393932	0.8657199677887635	2	2
tumor microenvironment	tyramine/analogs & derivatives	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	lymphoma large b-cell diffuse/metabolism	0.0005910476991810576	0.0011616526717368476	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	antineoplastic agents phytogenic/therapeutic use	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	th1 cells/drug effects	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	receptors androgen/metabolism	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	hypoxia/metabolism	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	paclitaxel/therapeutic use	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	cancer vaccines/pharmacology	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	BIRC2	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	CD79A	0.0005910476991810576	0.0011616526717368476	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	CD79B	0.0005910476991810576	0.0011616526717368476	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	CFLAR	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	CSF1	0.0020892101499980775	0.0038562499277653923	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	CSF2	0.0020892101499980775	0.0038562499277653923	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	CXCR4	0.0030681684056869107	0.005528972375037598	0.05812100723456789	0.8657199677887635	2	2
tumor microenvironment	EPHB2	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	IL17A	0.005020717221043802	0.0087535009718151	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	PRKD1	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	SOCS1	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	SYK	0.0005910476991810576	0.0011616526717368476	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	TBX21	0.002892087846564362	0.005230477634406616	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	TNFRSF12A	0.0009540540178402113	0.001830561568648593	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	TNFSF11	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	cytokines/metabolism	0.0010664280530024994	0.00203766407076862	0.0133677485878358	0.35414021462530776	5	2
tumor microenvironment	cd36 antigens/antagonists & inhibitors	0.000339035455949932	0.0006804782642498043	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	carcinoma pancreatic ductal/metabolism	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
tumor microenvironment	macrophages	0.003866851608534061	0.006836367914758959	0.10747663551401869	0.9605811478101344	1	2
GPX4	heart ventricles/diagnostic imaging	5.238472634128133e-05	0.00011504915294078801	0.05607476635514018	0.9605811478101344	1	2
GPX4	proto-oncogene proteins p21(ras)/metabolism	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	cell transformation neoplastic/genetics	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	tumor suppressor protein p53/metabolism	0.004048622789790457	0.007142837102448587	0.15967325731855422	0.9605811478101344	1	2
GPX4	tuberculosis/metabolism	1.594815390859594e-10	5.191567951819331e-10	0.05607476635514018	0.9605811478101344	1	2
GPX4	biopterin/analogs & derivatives	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	inflammation mediators/antagonists & inhibitors	7.672186663754132e-09	2.2812727115637374e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	nlr family pyrin domain-containing 3 protein/metabolism	5.238472634128133e-05	0.00011504915294078801	0.05607476635514018	0.9605811478101344	1	2
GPX4	vitamin e/pharmacology	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	coenzyme a ligases/metabolism	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	oleic acid/metabolism	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	nf-e2-related factor 2/biosynthesis	7.672186663754132e-09	2.2812727115637374e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	pancreatitis/genetics	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	cisplatin	1.3393322007004826e-09	4.157341455869948e-09	0.05607476635514018	0.9605811478101344	1	2
GPX4	lipopolysaccharides/toxicity	7.672186663754132e-09	2.2812727115637374e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	cyclohexylamines/pharmacology	0.0015286071798684686	0.002871249880877492	0.10925365275766749	0.9605811478101344	1	2
GPX4	dna	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	phenylenediamines/pharmacology	0.0015286071798684686	0.002871249880877492	0.10925365275766749	0.9605811478101344	1	2
GPX4	hypoxia-inducible factor 1 alpha subunit/metabolism	8.276241856286504e-07	2.141720427786442e-06	0.05607476635514018	0.9605811478101344	1	2
GPX4	phospholipid hydroperoxide glutathione peroxidase/genetics	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	glutathione peroxidase/metabolism	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	amino acid transport system y+/metabolism	0.00046387553203119936	0.0009219803236476953	0.10925365275766749	0.9605811478101344	1	2
GPX4	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	cell survival	0.0007253188547196032	0.0014127058400051071	0.10925365275766749	0.9605811478101344	1	2
GPX4	methotrexate/pharmacology	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	inflammation/metabolism	0.002778863378754659	0.0050385180735841055	0.10925365275766749	0.9605811478101344	1	2
GPX4	folic acid antagonists/pharmacology	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	cystine/antagonists & inhibitors	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	inflammasomes/metabolism	5.238472634128133e-05	0.00011504915294078801	0.05607476635514018	0.9605811478101344	1	2
GPX4	pancreas/metabolism	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	flavonolignans/pharmacology	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	tetrahydrofolate dehydrogenase/genetics	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	lymphoma t-cell	1.3393322007004826e-09	4.157341455869948e-09	0.05607476635514018	0.9605811478101344	1	2
GPX4	hepatic stellate cells/drug effects	8.276241856286504e-07	2.141720427786442e-06	0.05607476635514018	0.9605811478101344	1	2
GPX4	melanoma/blood	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	endothelial cells/metabolism	0.0017963169899918308	0.0033461639908195237	0.10925365275766749	0.9605811478101344	1	2
GPX4	autophagy-related proteins/genetics	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	quinoxalines/pharmacology	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	liver cirrhosis/drug therapy	8.276241856286504e-07	2.141720427786442e-06	0.05607476635514018	0.9605811478101344	1	2
GPX4	cytoskeletal proteins/metabolism	5.238472634128133e-05	0.00011504915294078801	0.10925365275766749	0.9605811478101344	1	2
GPX4	carbolines/pharmacology	8.520210603935041e-06	2.0334878046715718e-05	0.01629997420702796	0.8657199677887635	2	2
GPX4	collagen type i/metabolism	8.276241856286504e-07	2.141720427786442e-06	0.05607476635514018	0.9605811478101344	1	2
GPX4	monocrotaline/toxicity	5.238472634128133e-05	0.00011504915294078801	0.05607476635514018	0.9605811478101344	1	2
GPX4	toll-like receptor 4/metabolism	0.002778863378754659	0.0050385180735841055	0.10925365275766749	0.9605811478101344	1	2
GPX4	diet	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	hypertension pulmonary/chemically induced	5.238472634128133e-05	0.00011504915294078801	0.05607476635514018	0.9605811478101344	1	2
GPX4	lung/blood supply	5.238472634128133e-05	0.00011504915294078801	0.05607476635514018	0.9605811478101344	1	2
GPX4	asparaginase	1.3393322007004826e-09	4.157341455869948e-09	0.05607476635514018	0.9605811478101344	1	2
GPX4	carcinoma pancreatic ductal/metabolism	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	microglia/drug effects	7.672186663754132e-09	2.2812727115637374e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	jurkat cells	0.0034867153574872356	0.006226216911142672	0.0669605181744775	0.8657199677887635	2	2
GPX4	membrane proteins/genetics	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	iron chelating agents/pharmacology	1.594815390859594e-10	5.191567951819331e-10	0.05607476635514018	0.9605811478101344	1	2
GPX4	precursor cell lymphoblastic leukemia-lymphoma/metabolism	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	iron/metabolism	2.567868395697559e-08	7.372882196684437e-08	0.006498460442043069	0.7135314763244264	3	2
GPX4	ACSL4	6.661338147750939e-16	2.8276700708820313e-15	0.0028958799526128736	0.8657199677887635	2	2
GPX4	glutathione peroxidase/therapeutic use	0.0	0.0	0.05607476635514018	0.9605811478101344	1	2
GPX4	neoplasm metastasis/drug therapy	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.1102230246251565e-16	4.854858636837654e-16	0.0028958799526128736	0.8657199677887635	2	2
GPX4	bacterial toxins/metabolism	5.238472634128133e-05	0.00011504915294078801	0.05607476635514018	0.9605811478101344	1	2
GPX4	macrophages/metabolism	0.003592308509438924	0.006403882439853605	0.10925365275766749	0.9605811478101344	1	2
GPX4	killer cells natural/metabolism	1.3393322007004826e-09	4.157341455869948e-09	0.05607476635514018	0.9605811478101344	1	2
GPX4	lymph/metabolism	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	BDKRB2	3.807053167936836e-06	9.389027768084044e-06	0.10925365275766749	0.9605811478101344	1	2
GPX4	hmgb1 protein/metabolism	5.238472634128133e-05	0.00011504915294078801	0.05607476635514018	0.9605811478101344	1	2
GPX4	AIFM2	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	spiro compounds/pharmacology	0.0020932584079262906	0.0038630753643558095	0.10925365275766749	0.9605811478101344	1	2
GPX4	actins/metabolism	8.276241856286504e-07	2.141720427786442e-06	0.05607476635514018	0.9605811478101344	1	2
GPX4	biomarkers tumor	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	macrophages	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	host-pathogen interactions	0.004538660651014603	0.007950769905734147	0.25275210302111656	0.9605811478101344	1	2
GPX4	glutathione/metabolism	1.5987211554602254e-14	6.390247287089747e-14	0.000528913064760064	0.7135314763244264	3	2
GPX4	KDM8	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	MMRN1	8.276241856286504e-07	2.141720427786442e-06	0.05607476635514018	0.9605811478101344	1	2
GPX4	NLRP3	0.0017963169899918308	0.0033461639908195237	0.10925365275766749	0.9605811478101344	1	2
GPX4	NOX4	0.004048622789790457	0.007142837102448587	0.10925365275766749	0.9605811478101344	1	2
GPX4	S100A4	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	SLC7A11	6.84674539286334e-13	2.5551293571741866e-12	0.0012799159762966297	0.7135314763244264	3	2
GPX4	STING1	7.206855936026102e-06	1.733734420922024e-05	0.05607476635514018	0.9605811478101344	1	2
GPX4	cell proliferation	5.238472634128133e-05	0.00011504915294078801	0.10925365275766749	0.9605811478101344	1	2
GPX4	anti-inflammatory agents non-steroidal/pharmacology	1.3393322007004826e-09	4.157341455869948e-09	0.05607476635514018	0.9605811478101344	1	2
GPX4	curcumin/pharmacology	0.004538660651014603	0.007950769905734147	0.15967325731855422	0.9605811478101344	1	2
GPX4	IREB2	1.3393322007004826e-09	4.157341455869948e-09	0.05607476635514018	0.9605811478101344	1	2
GPX4	MKI67	1.3393322007004826e-09	4.157341455869948e-09	0.05607476635514018	0.9605811478101344	1	2
GPX4	hemodynamics/drug effects	5.238472634128133e-05	0.00011504915294078801	0.05607476635514018	0.9605811478101344	1	2
GPX4	sorafenib/pharmacology	0.0007253188547196032	0.0014127058400051071	0.10925365275766749	0.9605811478101344	1	2
GPX4	FN1	8.276241856286504e-07	2.141720427786442e-06	0.05607476635514018	0.9605811478101344	1	2
GPX4	ATL1	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
GPX4	ACSL3	3.2974283636910684e-08	9.399056310621935e-08	0.05607476635514018	0.9605811478101344	1	2
cell proliferation/drug effects	carcinoma non-small-cell lung/drug therapy	0.0020104361245398827	0.003719568320370507	0.0033056211011306983	0.057030282506445124	8	2
b7-h1 antigen/antagonists & inhibitors	nivolumab/therapeutic use	2.220446049250313e-16	9.623824354997229e-16	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	hyaluronic acid/chemistry	2.220446049250313e-16	9.623824354997229e-16	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	amino acid transport system y+/metabolism	1.2180001784933836e-08	3.5601840031051466e-08	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	fusion regulatory protein 1 heavy chain/metabolism	2.220446049250313e-16	9.623824354997229e-16	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	exosomes/drug effects	2.220446049250313e-16	9.623824354997229e-16	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	melanoma/genetics	8.671025409245914e-06	2.0621159338049175e-05	0.055287464515536164	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	immunologic memory	2.220446049250313e-16	9.623824354997229e-16	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	immune checkpoint inhibitors/pharmacology	1.2180001784933836e-08	3.5601840031051466e-08	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	tumor escape/drug effects	5.3953543135421e-06	1.3103852379926881e-05	0.055287464515536164	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	skin neoplasms/drug therapy	6.632486448943098e-09	1.9812093378444308e-08	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	cell line tumor/transplantation	1.345080247738828e-06	3.4276848476821173e-06	0.055287464515536164	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	interferon-gamma/immunology	5.3953543135421e-06	1.3103852379926881e-05	0.055287464515536164	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	aniline compounds/pharmacology	2.220446049250313e-16	9.623824354997229e-16	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	cysteine/metabolism	2.220446049250313e-16	9.623824354997229e-16	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	BDKRB2	7.971401316808624e-14	3.1145393626262015e-13	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	CD274	2.632338791386246e-13	9.939682423785572e-13	0.00020417327297937168	0.7135314763244264	3	2
b7-h1 antigen/antagonists & inhibitors	CD8A	0.0048682339326305835	0.008502441519854175	0.12539913750269532	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	PDCD1	0.0006923052442320277	0.0013518683929525947	0.09085010295354308	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	SLC3A2	2.220446049250313e-16	9.623824354997229e-16	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	SLC7A11	8.891606009264752e-05	0.00018981615926827	0.09085010295354308	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	SLC9A1	3.37278289741505e-07	8.941098631983529e-07	0.055287464515536164	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	histone deacetylase inhibitors/pharmacology	2.2737118288151947e-07	6.120229325078429e-07	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	nitrobenzenes/chemistry	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	immune checkpoint inhibitors/chemical synthesis	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	programmed cell death 1 receptor/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	liver neoplasms/drug therapy	2.2737118288151947e-07	6.120229325078429e-07	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	antigen presentation/drug effects	5.946021452984951e-12	2.0759759460872875e-11	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	drug combinations	9.770295995581435e-07	2.5162420991774264e-06	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	antibodies monoclonal/pharmacology	5.946021452984951e-12	2.0759759460872875e-11	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	benzamides/pharmacology	0.0033849021607051943	0.006064547605983108	0.09085010295354308	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	t-lymphocytes/cytology	6.023819898448579e-08	1.6899501351443477e-07	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	histone deacetylases/chemistry	5.946021452984951e-12	2.0759759460872875e-11	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	pyrimidines/pharmacology	0.00029965026733114186	0.000606786287115817	0.07319670689438858	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	CIITA	5.946021452984951e-12	2.0759759460872875e-11	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	FOXP3	5.946021452984951e-12	2.0759759460872875e-11	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	HDAC9	5.946021452984951e-12	2.0759759460872875e-11	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	cd8-positive t-lymphocytes/immunology	0.0004050279357447062	0.0008080767285584365	0.09085010295354308	0.9605811478101344	1	2
b7-h1 antigen/antagonists & inhibitors	benzylidene compounds/pharmacology	2.220446049250313e-16	9.623824354997229e-16	0.018691588785046728	0.9605811478101344	1	2
macrophages/cytology	golgi apparatus/drug effects	1.887379141862766e-15	7.82786593675513e-15	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	tor serine-threonine kinases/genetics	4.2526251766927814e-05	9.434683024323047e-05	0.055287464515536164	0.9605811478101344	1	2
macrophages/cytology	curcumin/analogs & derivatives	1.887379141862766e-15	7.82786593675513e-15	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	lysosomes/drug effects	0.0001607252703398343	0.0003351622775421041	0.06878335787959994	0.9605811478101344	1	2
macrophages/cytology	dextrans/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	microtubule-associated proteins/genetics	1.887379141862766e-15	7.82786593675513e-15	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	proto-oncogene proteins c-akt/genetics	0.00157515788312379	0.002952902049750304	0.09538832359347407	0.9605811478101344	1	2
macrophages/cytology	urinary bladder neoplasms/pathology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	bcl-2-associated x protein/genetics	1.887379141862766e-15	7.82786593675513e-15	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	cytochromes c/genetics	1.887379141862766e-15	7.82786593675513e-15	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	lipoproteins ldl/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	BAX	4.2526251766927814e-05	9.434683024323047e-05	0.055287464515536164	0.9605811478101344	1	2
macrophages/cytology	endoplasmic reticulum/drug effects	8.848760142399215e-07	2.288801778737892e-06	0.04166180294604871	0.9605811478101344	1	2
macrophages/cytology	gels/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	pyruvate dehydrogenase acetyl-transferring kinase/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	adjuvants immunologic/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	energy metabolism/drug effects	6.4497296392573844e-12	2.251126153021162e-11	0.027905752270633143	0.9605811478101344	1	2
macrophages/cytology	gold/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	neoplasms/drug therapy	9.145353792450184e-05	0.00019506313283925865	0.08215010393874443	0.9605811478101344	1	2
macrophages/cytology	antineoplastic agents/chemistry	4.681002348405627e-06	1.146104828180425e-05	0.055287464515536164	0.9605811478101344	1	2
macrophages/cytology	saponins/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
macrophages/cytology	gene expression	2.1531639805560943e-06	5.403865616767304e-06	0.055287464515536164	0.9605811478101344	1	2
MTOR	tor serine-threonine kinases/metabolism	4.5977148344089613e-07	1.2119848956127305e-06	3.048786049149064e-13	2.2386317338829024e-16	31	2
MTOR	autophagy/drug effects	0.002457846485966808	0.004489321458255007	0.00023222234110962934	3.2730107299542374e-06	17	2
MTOR	phosphatidylinositol 3-kinases/metabolism	4.219709702990571e-06	1.0396263217290881e-05	8.764767436613768e-12	0.0	33	2
MTOR	proto-oncogene proteins c-akt/metabolism	2.879521356347059e-05	6.51690483111681e-05	1.1236527189370639e-09	1.678973800412177e-15	30	2
MTOR	AKT1	9.722711524773331e-11	3.2004530262496627e-10	5.46574434499527e-29	0.0	68	2
MTOR	PIK3CA	1.1102230246251565e-16	4.854858636837654e-16	4.220552831665807e-49	0.0	77	2
MTOR	mitophagy/drug effects	0.004818409414268698	0.008422761497327857	0.019583260762521617	0.5304112294886878	4	2
MTOR	tor serine-threonine kinases/antagonists & inhibitors	0.005775832756368837	0.009964441362474187	0.00011927205057755189	0.025750963099745193	9	2
MTOR	energy metabolism	0.0052966354072802035	0.009198189781010863	0.1421613794919047	0.8657199677887635	2	2
dendritic cells/drug effects	cytokines/metabolism	4.86123297633867e-05	0.00010706269569704824	0.07009345794392523	0.9605811478101344	1	2
dendritic cells/drug effects	proteasome inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dendritic cells/drug effects	amidines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dendritic cells/drug effects	proteasome endopeptidase complex/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dendritic cells/drug effects	th1 cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dendritic cells/drug effects	burkitt lymphoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dendritic cells/drug effects	cell differentiation/drug effects	7.083156283727021e-11	2.3562074493604914e-10	0.02336448598130841	0.9605811478101344	1	2
dendritic cells/drug effects	CD4	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
dendritic cells/drug effects	IFNG	5.737876428324462e-06	1.3900527358718574e-05	0.0514018691588785	0.9605811478101344	1	2
dendritic cells/drug effects	piperidines/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
disease progression	gene expression regulation neoplastic	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
disease progression	interleukin-8/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
disease progression	receptors interleukin-8a/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
disease progression	proto-oncogene proteins c-akt/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
disease progression	mesenchymal stem cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
disease progression	anoikis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
disease progression	lung neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
disease progression	osteosarcoma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
disease progression	bone neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
disease progression	CXCL8	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
disease progression	CXCR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	lymphocytes tumor-infiltrating/immunology	3.0033297815368343e-07	8.027326345414489e-07	0.04166180294604871	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	diterpenes/pharmacology	1.992378137138928e-06	5.004893832475685e-06	0.055287464515536164	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	cell line tumor/transplantation	6.632486448943098e-09	1.9812093378444308e-08	0.04166180294604871	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	membrane proteins/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	myeloid-derived suppressor cells/immunology	1.594815390859594e-10	5.191567951819331e-10	0.027905752270633143	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	neutral ceramidase/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	heme oxygenase-1/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	colonic neoplasms/drug therapy	1.0428744410262425e-06	2.682372337347946e-06	0.04166180294604871	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	ASAH2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	HMOX1	8.537504037064991e-12	2.955949890219989e-11	0.027905752270633143	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	SLC7A11	2.4375466437520643e-06	6.0891715841202705e-06	0.06878335787959994	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	TP53	0.0	0.0	3.4770428247495904e-05	0.7135314763244264	3	2
tumor suppressor protein p53/metabolism	a549 cells	0.0005161304311359638	0.0010208705253149483	0.08215010393874443	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	drugs chinese herbal/pharmacology	0.00013315331632623995	0.0002794901293184442	0.09538832359347407	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	antineoplastic agents phytogenic/isolation & purification	3.0223626583447682e-05	6.825468799670742e-05	0.055287464515536164	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	BIRC5	8.475718828671042e-06	2.0230881101498228e-05	0.04166180294604871	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	erbb receptors/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	cisplatin	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	EGFR	2.962904754433282e-06	7.34083874881953e-06	0.055287464515536164	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	MAPK14	5.376860068295741e-10	1.7064777714953865e-09	0.027905752270633143	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	MDM2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	METTL7B	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	TP73	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	lymphoma t-cell	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	t-lymphocytes/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	asparaginase	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor suppressor protein p53/metabolism	killer cells natural/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
caffeic acids/adverse effects	t-lymphocytes cytotoxic/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
caffeic acids/adverse effects	propionates/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caffeic acids/adverse effects	coumaric acids/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caffeic acids/adverse effects	killer cells natural/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caffeic acids/adverse effects	antioxidants/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caffeic acids/adverse effects	immunologic factors/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caffeic acids/adverse effects	spleen/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caffeic acids/adverse effects	mitogens/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caffeic acids/adverse effects	macrophages peritoneal/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
energy metabolism/drug effects	neoplasms/drug therapy	1.0428744410262425e-06	2.682372337347946e-06	0.05541661182045544	0.9605811478101344	1	2
energy metabolism/drug effects	antineoplastic agents/chemistry	1.1711411285197926e-08	3.4277604674902945e-08	0.03711991575621956	0.9605811478101344	1	2
energy metabolism/drug effects	saponins/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
energy metabolism/drug effects	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0014162765613265904	0.002668666406642908	0.09148348032117941	0.9605811478101344	1	2
energy metabolism/drug effects	cell differentiation/drug effects	2.1324907325537268e-06	5.352590581892596e-06	0.046290202272826986	0.9605811478101344	1	2
energy metabolism/drug effects	pyruvate dehydrogenase acetyl-transferring kinase/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
energy metabolism/drug effects	palmitic acid/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
energy metabolism/drug effects	neuroblastoma/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
energy metabolism/drug effects	insulin antagonists/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
energy metabolism/drug effects	insulin/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	hyaluronic acid/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	exosomes/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	tumor escape/drug effects	4.267353137521468e-11	1.443488830562647e-10	0.027905752270633143	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	skin neoplasms/drug therapy	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	drug resistance neoplasm/drug effects	0.0024338416995206558	0.004446212759220434	0.10925365275766749	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	cell line tumor/transplantation	2.557620781828973e-12	9.178128743125846e-12	0.027905752270633143	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	aniline compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	CD274	0.0003679193957988325	0.0007357053182090203	0.08253257864946689	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	CD8A	3.560085416054459e-05	7.97285558691404e-05	0.0644991443991049	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	t-lymphocytes cytotoxic/cytology	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	hek293 cells	1.6102793432004603e-08	4.672734793219762e-08	0.03711991575621956	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	recombinant fusion proteins/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	mitochondrial membrane transport proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	interleukin-10/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	immunoglobulin fc fragments/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	receptors chimeric antigen/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	immunologic memory	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	receptors interleukin-10/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	monocarboxylic acid transporters/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immune checkpoint inhibitors/pharmacology	benzylidene compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	endoplasmic reticulum/drug effects	1.08218036753982e-08	3.1758169497561496e-08	0.027905752270633143	0.9605811478101344	1	2
heat-shock proteins/genetics	gene expression regulation neoplastic	0.000151096303033893	0.00031553052560061306	0.0644991443991049	0.9605811478101344	1	2
heat-shock proteins/genetics	antioxidants/pharmacology	4.6343591852959776e-08	1.313177629063176e-07	0.027905752270633143	0.9605811478101344	1	2
heat-shock proteins/genetics	CD44	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	HSPB1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	SLC40A1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	gene expression regulation	2.2231305685238567e-10	7.185981934439817e-10	0.018647711816067742	0.9605811478101344	1	2
heat-shock proteins/genetics	SPP1	1.5247580975596975e-11	5.2282840645406236e-11	0.018647711816067742	0.9605811478101344	1	2
heat-shock proteins/genetics	activating transcription factor 4/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	phenylbutyrates/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	organophosphorus compounds/pharmacology	8.21016588048451e-11	2.705391381451539e-10	0.018647711816067742	0.9605811478101344	1	2
heat-shock proteins/genetics	transcription factor chop/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	tor serine-threonine kinases/genetics	1.8600621730646694e-06	4.686395930948444e-06	0.03711991575621956	0.9605811478101344	1	2
heat-shock proteins/genetics	cerebral arteries/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	eukaryotic initiation factor-2/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	taurochenodeoxycholic acid/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	myocytes smooth muscle/cytology	8.915090887740007e-14	3.450841360479137e-13	0.018647711816067742	0.9605811478101344	1	2
heat-shock proteins/genetics	phosphatidylinositol 3-kinases/genetics	0.0015584255859585339	0.002923025718350808	0.08253257864946689	0.9605811478101344	1	2
heat-shock proteins/genetics	eif-2 kinase/genetics	5.525480073487188e-10	1.7516288232961253e-09	0.018647711816067742	0.9605811478101344	1	2
heat-shock proteins/genetics	proto-oncogene proteins c-akt/genetics	0.00022093315072990727	0.0004542273505495147	0.0644991443991049	0.9605811478101344	1	2
heat-shock proteins/genetics	muscle smooth vascular/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	piperidines/pharmacology	1.3665724107880806e-10	4.4657163944057507e-10	0.018647711816067742	0.9605811478101344	1	2
heat-shock proteins/genetics	CALD1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	HSPA5	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	brain neoplasms/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heat-shock proteins/genetics	cation transport proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/metabolism	tor serine-threonine kinases/metabolism	3.4849900742983664e-13	1.3125565623185922e-12	1.5767660634367578e-16	1.364602746023001e-11	25	2
phosphatidylinositol 3-kinases/metabolism	proto-oncogene proteins c-akt/metabolism	1.5265566588595902e-13	5.834203712001429e-13	4.791973210154523e-18	4.121321022078424e-13	27	2
phosphatidylinositol 3-kinases/metabolism	breast neoplasms/metabolism	0.0019966447663803955	0.003695292857311757	0.00523791665528349	0.7135314763244264	3	2
phosphatidylinositol 3-kinases/metabolism	AKT1	3.0506507602834354e-05	6.887941419634324e-05	1.2789508835452946e-10	0.0	32	2
phosphatidylinositol 3-kinases/metabolism	PI3	0.0030940623627607744	0.005574267606974143	0.030845509192224996	0.8657199677887635	2	2
phosphatidylinositol 3-kinases/metabolism	PIK3CA	1.4197790654257858e-05	3.300294025778358e-05	8.083125786843929e-11	0.0	32	2
phosphatidylinositol 3-kinases/metabolism	stomach neoplasms/drug therapy	0.0037309086618408926	0.006618317980229141	0.030845509192224996	0.8657199677887635	2	2
phosphatidylinositol 3-kinases/metabolism	proto-oncogene proteins c-bcl-2/metabolism	0.0006236720734801304	0.0012251177722817103	0.00523791665528349	0.7135314763244264	3	2
phosphatidylinositol 3-kinases/metabolism	sirolimus/pharmacology	0.0037309086618408926	0.006618317980229141	0.030845509192224996	0.8657199677887635	2	2
phosphatidylinositol 3-kinases/metabolism	mitogen-activated protein kinases/metabolism	0.005253319494323616	0.009135199007086292	0.030845509192224996	0.8657199677887635	2	2
skin neoplasms/drug therapy	hyaluronic acid/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
skin neoplasms/drug therapy	exosomes/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
skin neoplasms/drug therapy	drug resistance neoplasm/drug effects	0.002009314075263613	0.0037178043581245503	0.10925365275766749	0.9605811478101344	1	2
skin neoplasms/drug therapy	cell line tumor/transplantation	1.0363931934875836e-12	3.832030375652229e-12	0.027905752270633143	0.9605811478101344	1	2
skin neoplasms/drug therapy	interferon-gamma/immunology	1.9081847213442416e-11	6.5166754548014e-11	0.027905752270633143	0.9605811478101344	1	2
skin neoplasms/drug therapy	aniline compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
skin neoplasms/drug therapy	CD274	0.00028528168608210613	0.0005801411745746427	0.08253257864946689	0.9605811478101344	1	2
skin neoplasms/drug therapy	adjuvants immunologic/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
skin neoplasms/drug therapy	immunologic memory/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
skin neoplasms/drug therapy	t-lymphocytes regulatory/drug effects	1.5543122344752192e-15	6.525033538787059e-15	0.018647711816067742	0.9605811478101344	1	2
skin neoplasms/drug therapy	lymphocytes tumor-infiltrating/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.018647711816067742	0.9605811478101344	1	2
skin neoplasms/drug therapy	cytotoxicity immunologic/drug effects	9.390636046546774e-10	2.9393064104807394e-09	0.03711991575621956	0.9605811478101344	1	2
skin neoplasms/drug therapy	cisplatin/administration & dosage	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
skin neoplasms/drug therapy	antigens neoplasm/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
skin neoplasms/drug therapy	immunologic memory	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
skin neoplasms/drug therapy	tumor escape/drug effects	1.9081847213442416e-11	6.5166754548014e-11	0.027905752270633143	0.9605811478101344	1	2
skin neoplasms/drug therapy	benzylidene compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunologic memory/drug effects	interferon-gamma/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
immunologic memory/drug effects	adjuvants immunologic/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunologic memory/drug effects	t-lymphocytes regulatory/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunologic memory/drug effects	lymphocytes tumor-infiltrating/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunologic memory/drug effects	cytotoxicity immunologic/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
immunologic memory/drug effects	cisplatin/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunologic memory/drug effects	antigens neoplasm/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene expression regulation neoplastic	adenine nucleotide translocator 1/antagonists & inhibitors	6.980661447775205e-07	1.8149719764215532e-06	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	diterpenes kaurane/pharmacology	1.0834047752372733e-05	2.5471218260216894e-05	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	bcl-2-associated x protein/agonists	1.0834047752372733e-05	2.5471218260216894e-05	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	cyclin b1/antagonists & inhibitors	1.0834047752372733e-05	2.5471218260216894e-05	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	esophageal neoplasms/drug therapy	1.0834047752372733e-05	2.5471218260216894e-05	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	lactones/pharmacology	6.980661447775205e-07	1.8149719764215532e-06	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	cyclin-dependent kinase inhibitor p21/agonists	1.0834047752372733e-05	2.5471218260216894e-05	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	cyclosporine/pharmacology	0.00019239971282947188	0.0003974542179765948	0.0644991443991049	0.9605811478101344	1	2
gene expression regulation neoplastic	proto-oncogene proteins c-bcl-2/antagonists & inhibitors	6.980661447775205e-07	1.8149719764215532e-06	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	biphenyl compounds/pharmacology	0.0017527010409279509	0.0032709964914829403	0.0644991443991049	0.9605811478101344	1	2
gene expression regulation neoplastic	nitrophenols/pharmacology	6.980661447775205e-07	1.8149719764215532e-06	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	cyclin-dependent kinase 2/antagonists & inhibitors	1.0834047752372733e-05	2.5471218260216894e-05	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	tumor suppressor protein p53/agonists	1.0834047752372733e-05	2.5471218260216894e-05	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	vitamin e/pharmacology	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	methotrexate/pharmacology	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	folic acid antagonists/pharmacology	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	cystine/antagonists & inhibitors	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	tetrahydrofolate dehydrogenase/genetics	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	brain neoplasms/genetics	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	biopterin/analogs & derivatives	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	spiro compounds/pharmacology	0.0004454742043631388	0.0008864454203789245	0.0644991443991049	0.9605811478101344	1	2
gene expression regulation neoplastic	CD44	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	HSPB1	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	SLC40A1	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	neoplasms/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	epithelial-mesenchymal transition	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	neovascularization pathologic/immunology	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	interleukin-8/metabolism	0.005290705352827385	0.009188615330377172	0.12539913750269532	0.9605811478101344	1	2
gene expression regulation neoplastic	fas receptor/genetics	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	receptors interleukin-8a/physiology	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	interferons/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	sarcoma/drug therapy	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	janus kinases/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	sulfonamides/pharmacology	0.0030647335234157413	0.00552323399740643	0.09538832359347407	0.9605811478101344	1	2
gene expression regulation neoplastic	cytotoxicity immunologic/drug effects	0.004085590664280603	0.007203446858541282	0.12539913750269532	0.9605811478101344	1	2
gene expression regulation neoplastic	proto-oncogene proteins c-akt/physiology	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	hypoxia-inducible factor 1 alpha subunit/genetics	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	biomarkers	0.00019239971282947188	0.0003974542179765948	0.0644991443991049	0.9605811478101344	1	2
gene expression regulation neoplastic	mesenchymal stem cells/metabolism	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	rna small interfering/genetics	0.0030647335234157413	0.00552323399740643	0.09538832359347407	0.9605811478101344	1	2
gene expression regulation neoplastic	ras proteins/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	hypoxia	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	anoikis/drug effects	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	lung neoplasms/genetics	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	osteosarcoma/genetics	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	bone neoplasms/genetics	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	plant leaves/chemistry	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	curcumin/pharmacology	0.0011806792803203958	0.002249146083679289	0.09538832359347407	0.9605811478101344	1	2
gene expression regulation neoplastic	hypoxia/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	cation transport proteins/genetics	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	fas ligand protein/genetics	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
gene expression regulation neoplastic	CXCR1	8.891606009264752e-05	0.00018981615926827	0.0644991443991049	0.9605811478101344	1	2
gene expression regulation neoplastic	PRF1	0.000151096303033893	0.00031553052560061306	0.0644991443991049	0.9605811478101344	1	2
gene expression regulation neoplastic	cyclophilin d	0.00019239971282947188	0.0003974542179765948	0.0644991443991049	0.9605811478101344	1	2
hepatocytes/drug effects	cyclophilins/genetics	1.3227471340471197e-09	4.116291998796174e-09	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	polycyclic compounds/pharmacology	4.5583425922757215e-10	1.4496226377397246e-09	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	cyclooctanes/pharmacology	4.5583425922757215e-10	1.4496226377397246e-09	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	phosphatidylinositol 3-kinases/physiology	1.431965657161527e-12	5.228014374747035e-12	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	cell division/drug effects	0.0013320121226125803	0.0025191459323522193	0.09085010295354308	0.9605811478101344	1	2
hepatocytes/drug effects	chemical and drug induced liver injury/pathology	4.5583425922757215e-10	1.4496226377397246e-09	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	mitochondrial adp atp translocases/genetics	1.3227471340471197e-09	4.116291998796174e-09	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	autophagy-related proteins/metabolism	1.5690773335075292e-06	3.981014620158113e-06	0.046290202272826986	0.9605811478101344	1	2
hepatocytes/drug effects	lignans/pharmacology	9.871939865790935e-05	0.0002098703405273923	0.046290202272826986	0.9605811478101344	1	2
hepatocytes/drug effects	g1 phase/drug effects	4.5583425922757215e-10	1.4496226377397246e-09	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	liver/drug effects	8.244331328732812e-09	2.4454596681810985e-08	0.046290202272826986	0.9605811478101344	1	2
hepatocytes/drug effects	t-2 toxin/toxicity	8.043898880316647e-12	2.7938229759486676e-11	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	voltage-dependent anion channels/genetics	1.3227471340471197e-09	4.116291998796174e-09	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	mitochondria liver/drug effects	0.0025586523829360663	0.004666101549956525	0.15455249958593884	0.9605811478101344	1	2
hepatocytes/drug effects	adenosine triphosphate/antagonists & inhibitors	1.3227471340471197e-09	4.116291998796174e-09	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	ATG7	0.0003059683409074587	0.0006194850791721842	0.06878335787959994	0.9605811478101344	1	2
hepatocytes/drug effects	BECN1	0.003158697231605445	0.005679112497956198	0.11249652907369678	0.9605811478101344	1	2
hepatocytes/drug effects	CCL22	1.3447498348195808e-07	3.6890686024763117e-07	0.046290202272826986	0.9605811478101344	1	2
hepatocytes/drug effects	CDK2	0.0012141822542055536	0.0023087788133440315	0.06878335787959994	0.9605811478101344	1	2
hepatocytes/drug effects	PARP1	0.0017488656311686057	0.00326411491035346	0.026313346360848835	0.8657199677887635	2	2
hepatocytes/drug effects	macrophages/drug effects	0.00025961094000592766	0.0005295986311297828	0.018291269805799152	0.8657199677887635	2	2
hepatocytes/drug effects	hypoxia-inducible factor 1 alpha subunit/metabolism	8.043898880316647e-12	2.7938229759486676e-11	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	amino acid transport system y+/metabolism	1.026071400289652e-06	2.641310243267513e-06	0.046290202272826986	0.9605811478101344	1	2
hepatocytes/drug effects	hepatic stellate cells/drug effects	8.043898880316647e-12	2.7938229759486676e-11	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	liver cirrhosis/drug therapy	8.043898880316647e-12	2.7938229759486676e-11	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	collagen type i/metabolism	8.043898880316647e-12	2.7938229759486676e-11	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	autophagy/drug effects	0.00033275424154077804	0.0006695168386102459	0.009489295975454759	0.7135314763244264	3	2
hepatocytes/drug effects	sorafenib/pharmacology	2.33575571040312e-06	5.852794852025002e-06	0.046290202272826986	0.9605811478101344	1	2
hepatocytes/drug effects	FN1	8.043898880316647e-12	2.7938229759486676e-11	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	HIF1A	0.0025586523829360663	0.004666101549956525	0.09085010295354308	0.9605811478101344	1	2
hepatocytes/drug effects	MMRN1	8.043898880316647e-12	2.7938229759486676e-11	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	SLC7A11	0.0008137316370441239	0.0015782156169553874	0.11249652907369678	0.9605811478101344	1	2
hepatocytes/drug effects	antibiotics antineoplastic/pharmacology	9.175420383256139e-06	2.1764353804199175e-05	0.046290202272826986	0.9605811478101344	1	2
hepatocytes/drug effects	drug combinations	2.7370855089858814e-05	6.21368011759892e-05	0.046290202272826986	0.9605811478101344	1	2
hepatocytes/drug effects	doxorubicin/pharmacology	3.3932426944938143e-06	8.378789890043635e-06	0.046290202272826986	0.9605811478101344	1	2
hepatocytes/drug effects	antineoplastic agents phytogenic/isolation & purification	0.003158697231605445	0.005679112497956198	0.09085010295354308	0.9605811478101344	1	2
hepatocytes/drug effects	WDTC1	0.00045602481600359734	0.0009067035028629555	0.09085010295354308	0.9605811478101344	1	2
hepatocytes/drug effects	plant extracts/chemistry	1.3227471340471197e-09	4.116291998796174e-09	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	anthraquinones/isolation & purification	1.3227471340471197e-09	4.116291998796174e-09	0.02336448598130841	0.9605811478101344	1	2
hepatocytes/drug effects	cell line	0.0007196845368018234	0.001402351274185294	0.030797282136299682	0.8657199677887635	2	2
hepatocytes/drug effects	actins/metabolism	8.043898880316647e-12	2.7938229759486676e-11	0.02336448598130841	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	glutathione peroxidase/therapeutic use	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	BDKRB2	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	nerve tissue proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	interleukin-1beta/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	leukemia myeloid acute/drug therapy	2.5567992167907505e-11	8.710183734827328e-11	0.03711991575621956	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	mesenchymal stem cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	cell adhesion/drug effects	2.2819819367470018e-09	7.0161954736296045e-09	0.03711991575621956	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	nf-kappa b/metabolism	9.630031228002878e-08	2.6630243134956406e-07	0.046290202272826986	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	CCL2	4.814946774622797e-09	1.4524551441631335e-08	0.03711991575621956	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	CCL4	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	CXCL12	1.3311593866083271e-06	3.3969215458264345e-06	0.0644991443991049	0.9605811478101344	1	2
cytoskeletal proteins/metabolism	NFKB1	4.602362399630522e-06	1.1279778366724517e-05	0.0644991443991049	0.9605811478101344	1	2
autophagy/drug effects	glutathione peroxidase/metabolism	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	endoplasmic reticulum/drug effects	0.0027274807715393923	0.004958810592141546	0.031103389868393932	0.8657199677887635	2	2
autophagy/drug effects	tor serine-threonine kinases/metabolism	0.002933150705465515	0.00530300178385434	0.0029311966211418945	0.025750963099745193	9	2
autophagy/drug effects	ACSL4	4.6881459869752007e-07	1.2353799775406863e-06	0.011100873151682681	0.8657199677887635	2	2
autophagy/drug effects	AIFM2	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	ATG5	8.002673642648617e-07	2.0757993938013727e-06	0.00017060452375223216	0.35414021462530776	5	2
autophagy/drug effects	ATL1	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	PRKAA2	0.00014368825294008847	0.0003010520341455549	0.004085772502219969	0.7135314763244264	3	2
autophagy/drug effects	S100A4	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	flavonolignans/pharmacology	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	apoptosis regulatory proteins/metabolism	0.0009949570769065552	0.0019082127376161908	0.005400617486841887	0.5304112294886878	4	2
autophagy/drug effects	anti-inflammatory agents non-steroidal/pharmacology	0.00012481328540059344	0.00026273470656027154	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	curcumin/pharmacology	0.000578093264185453	0.0011386278621369366	0.031103389868393932	0.8657199677887635	2	2
autophagy/drug effects	IREB2	0.00012481328540059344	0.00026273470656027154	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	MKI67	0.00012481328540059344	0.00026273470656027154	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	PIK3CA	0.0008408028978067472	0.0016261423062143125	2.9896049554977014e-05	8.15982166930275e-07	18	2
autophagy/drug effects	granulosa cells/drug effects	0.0019487879143551545	0.0036133946628292366	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	kidney tubules/cytology	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	carcinoma hepatocellular/pathology	0.002764305867319128	0.005018579632816569	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	drugs chinese herbal/chemistry	0.0019487879143551545	0.0036133946628292366	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	drug antagonism	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	polycyclic compounds/pharmacology	0.004971895893240763	0.00867524221701269	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	cyclooctanes/pharmacology	0.004971895893240763	0.00867524221701269	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	polysaccharides/chemistry	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	phosphatidylinositol 3-kinases/physiology	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	phagosomes/metabolism	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	homeostasis/drug effects	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	naphthoquinones/chemistry	0.0037690506626346654	0.006684365267838569	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	epithelial cells/drug effects	0.002764305867319128	0.005018579632816569	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	neurons/cytology	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	complex mixtures/chemistry	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	chemical and drug induced liver injury/pathology	0.004971895893240763	0.00867524221701269	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	kidney failure chronic/etiology	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	sirtuin 1/metabolism	0.0037690506626346654	0.006684365267838569	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	sulfides/pharmacology	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	blood-brain barrier/drug effects	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	arsenic/toxicity	0.0002623133846895165	0.000534864099291081	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	fibrosis	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	malaria/drug therapy	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	autophagy-related proteins/metabolism	2.233447186950066e-05	5.089720266447034e-05	0.011100873151682681	0.8657199677887635	2	2
autophagy/drug effects	spermatogenesis/drug effects	0.0002623133846895165	0.000534864099291081	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	berberine/analogs & derivatives	0.002764305867319128	0.005018579632816569	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	g1 phase/drug effects	0.004971895893240763	0.00867524221701269	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	ureteral obstruction/complications	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	inflammasomes/antagonists & inhibitors	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	zearalenone/toxicity	0.0019487879143551545	0.0036133946628292366	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	ovarian neoplasms/metabolism	0.004971895893240763	0.00867524221701269	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	autophagy-related proteins/genetics	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	kidney/cytology	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	t-2 toxin/toxicity	0.0019487879143551545	0.0036133946628292366	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	nlr family pyrin domain-containing 3 protein/antagonists & inhibitors	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	phenylpropionates/pharmacology	0.002764305867319128	0.005018579632816569	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	pyrazoles/pharmacology	0.0003997090255795088	0.0007977536522111896	0.011100873151682681	0.8657199677887635	2	2
autophagy/drug effects	cisplatin/adverse effects	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	brain injuries traumatic/drug therapy	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	ATG12	0.0002623133846895165	0.000534864099291081	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	ATG7	0.0021573789682626243	0.0039730948456610715	0.031103389868393932	0.8657199677887635	2	2
autophagy/drug effects	BECN1	7.656475453643452e-11	2.546537498897735e-10	9.430232937582532e-06	0.35414021462530776	5	2
autophagy/drug effects	CASP9	0.004341605690644235	0.007621922308091733	0.013936518858151278	0.5304112294886878	4	2
autophagy/drug effects	CCL22	2.654262455381584e-06	6.597652606116479e-06	0.011100873151682681	0.8657199677887635	2	2
autophagy/drug effects	MAP1LC3A	0.0013096325633298322	0.002478521781656321	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	NAMPT	0.0037690506626346654	0.006684365267838569	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	SQSTM1	0.0019487879143551545	0.0036133946628292366	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	TESC	0.0002623133846895165	0.000534864099291081	0.10747663551401869	0.9605811478101344	1	2
autophagy/drug effects	precursor cell lymphoblastic leukemia-lymphoma/metabolism	0.0004887564791243859	0.0009688997349158837	0.10747663551401869	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	hemodynamics/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	FTH1	3.737010700888277e-13	1.4050752376054693e-12	0.018691588785046728	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	HMGB1	1.1757261830780408e-13	4.5192487595022044e-13	0.009345794392523364	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	NLRP3	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	NOX4	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	TLR4	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	inflammasomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	monocrotaline/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	hypertension pulmonary/chemically induced	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	endothelial cells/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	toll-like receptor 4/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	bacterial toxins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	inflammation/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	nlr family pyrin domain-containing 3 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	lung/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	macrophages/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
heart ventricles/diagnostic imaging	hmgb1 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemodynamics/drug effects	nlr family pyrin domain-containing 3 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemodynamics/drug effects	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hemodynamics/drug effects	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hemodynamics/drug effects	inflammation/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
hemodynamics/drug effects	inflammasomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemodynamics/drug effects	endothelial cells/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hemodynamics/drug effects	monocrotaline/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemodynamics/drug effects	toll-like receptor 4/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
hemodynamics/drug effects	hypertension pulmonary/chemically induced	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemodynamics/drug effects	lung/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemodynamics/drug effects	bacterial toxins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemodynamics/drug effects	macrophages/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
hemodynamics/drug effects	hmgb1 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemodynamics/drug effects	FTH1	3.737010700888277e-13	1.4050752376054693e-12	0.018691588785046728	0.9605811478101344	1	2
hemodynamics/drug effects	HMGB1	1.1757261830780408e-13	4.5192487595022044e-13	0.009345794392523364	0.9605811478101344	1	2
hemodynamics/drug effects	NLRP3	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hemodynamics/drug effects	NOX4	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
hemodynamics/drug effects	TLR4	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	hyaluronic acid/chemistry	8.937137668696415e-06	2.120598486003213e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	cell line tumor/transplantation	3.461658931724898e-07	9.172293729920749e-07	0.00841444363589401	0.8657199677887635	2	2
drug resistance neoplasm/drug effects	aniline compounds/pharmacology	8.937137668696415e-06	2.120598486003213e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	sorafenib/pharmacology	0.0034457648070689295	0.006167577729035213	0.10925365275766749	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	mutant proteins/metabolism	1.5219314860592803e-06	3.862731139016348e-06	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	receptors tumor necrosis factor type i/metabolism	4.958998789383884e-07	1.3041031167501894e-06	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	mechanistic target of rapamycin complex 1/antagonists & inhibitors	0.00022428773847948946	0.00046069462064428764	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	immunity innate/drug effects	0.002009314075263613	0.0037178043581245503	0.10925365275766749	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	acetates/therapeutic use	5.907567133878189e-05	0.0001291394409753582	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	osteoprotegerin/genetics	1.5219314860592803e-06	3.862731139016348e-06	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	sirtuin 1/antagonists & inhibitors	0.0008009656450789215	0.0015548239604419845	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	interleukin-8/metabolism	2.853874548125468e-05	6.460850809843959e-05	0.01629997420702796	0.8657199677887635	2	2
drug resistance neoplasm/drug effects	mutation	1.5219314860592803e-06	3.862731139016348e-06	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	janus kinases/antagonists & inhibitors	0.0008009656450789215	0.0015548239604419845	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	fibroblast growth factor 2/pharmacology	0.00022428773847948946	0.00046069462064428764	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	receptors fibroblast growth factor/metabolism	0.00022428773847948946	0.00046069462064428764	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	nucleotides cyclic/pharmacology	4.958998789383884e-07	1.3041031167501894e-06	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	carcinoma hepatocellular/genetics	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	melanoma/drug therapy	5.907567133878189e-05	0.0001291394409753582	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	neoplasms/blood supply	4.958998789383884e-07	1.3041031167501894e-06	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	cisplatin/pharmacology	0.004011736026002466	0.007081725852786419	0.03823117565875766	0.8657199677887635	2	2
drug resistance neoplasm/drug effects	potassium channels voltage-gated/metabolism	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	neoplasm recurrence local/pathology	0.00022428773847948946	0.00046069462064428764	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	oligopeptides/pharmacology	0.004684919556339651	0.008195914177432088	0.10925365275766749	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	receptor igf type 1/biosynthesis	0.0008009656450789215	0.0015548239604419845	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	naphthols/pharmacology	0.0008009656450789215	0.0015548239604419845	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	doxorubicin/administration & dosage	1.2967100559979627e-07	3.567489807167842e-07	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	receptors estrogen/metabolism	0.004036345689392595	0.007123457116763624	0.10925365275766749	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	doxorubicin/pharmacology	0.004036345689392595	0.007123457116763624	0.10925365275766749	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	breast neoplasms/metabolism	2.853874548125468e-05	6.460850809843959e-05	0.00841444363589401	0.8657199677887635	2	2
drug resistance neoplasm/drug effects	recombinant proteins/metabolism	1.5219314860592803e-06	3.862731139016348e-06	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	micrornas/genetics	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	receptors tnf-related apoptosis-inducing ligand/biosynthesis	0.0008009656450789215	0.0015548239604419845	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	tnf-related apoptosis-inducing ligand/genetics	1.5219314860592803e-06	3.862731139016348e-06	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	insulin-like growth factor i/metabolism	0.0008009656450789215	0.0015548239604419845	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	immune evasion/drug effects	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	multiple myeloma/genetics	1.5219314860592803e-06	3.862731139016348e-06	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	tyramine/analogs & derivatives	5.907567133878189e-05	0.0001291394409753582	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	antineoplastic agents phytogenic/therapeutic use	5.907567133878189e-05	0.0001291394409753582	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	bcl-2-like protein 11/metabolism	0.00022428773847948946	0.00046069462064428764	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	paclitaxel/therapeutic use	5.907567133878189e-05	0.0001291394409753582	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	mesenchymal stem cells/cytology	0.004036345689392595	0.007123457116763624	0.10925365275766749	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	FGF2	0.00022428773847948946	0.00046069462064428764	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	IGF1R	0.0008009656450789215	0.0015548239604419845	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	KCNQ1	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	KCNQ1OT1	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	MSC	1.2967100559979627e-07	3.567489807167842e-07	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	NOS2	0.0008009656450789215	0.0015548239604419845	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	PCNA	0.004684919556339651	0.008195914177432088	0.10925365275766749	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	TNFRSF11B	1.5219314860592803e-06	3.862731139016348e-06	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	glucose/deficiency	0.00032219111712628035	0.0006493299589031288	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	paracrine communication/drug effects	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	plant extracts/chemistry	0.00015047025582948237	0.0003143422589092692	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	anthraquinones/isolation & purification	0.00015047025582948237	0.0003143422589092692	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	0.00032219111712628035	0.0006493299589031288	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	cyclophilins/genetics	0.00015047025582948237	0.0003143422589092692	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	hydrazones/pharmacology	0.00044827030169536375	0.0008918483677837375	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	exosomes/drug effects	8.937137668696415e-06	2.120598486003213e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	autocrine communication/drug effects	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	decitabine	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	mitochondrial adp atp translocases/genetics	0.00015047025582948237	0.0003143422589092692	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	cytoprotection/drug effects	0.00032219111712628035	0.0006493299589031288	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	quinolines/pharmacology	0.00032219111712628035	0.0006493299589031288	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	glutamine/pharmacology	0.00032219111712628035	0.0006493299589031288	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	lactates/metabolism	0.00032219111712628035	0.0006493299589031288	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	leukemia myeloid acute/enzymology	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	isoflavones/pharmacology	0.00044827030169536375	0.0008918483677837375	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	voltage-dependent anion channels/genetics	0.00015047025582948237	0.0003143422589092692	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	adenosine triphosphate/antagonists & inhibitors	0.00015047025582948237	0.0003143422589092692	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	BIRC3	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	ESRRA	0.00032219111712628035	0.0006493299589031288	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	MLKL	3.399284815031045e-05	7.636787405930761e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	immunologic memory	8.937137668696415e-06	2.120598486003213e-05	0.05607476635514018	0.9605811478101344	1	2
drug resistance neoplasm/drug effects	benzylidene compounds/pharmacology	8.937137668696415e-06	2.120598486003213e-05	0.05607476635514018	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	pancreas/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	iron/metabolism	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	carcinoma pancreatic ductal/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	cell transformation neoplastic/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	diet	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	pancreatitis/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	dna	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	quinoxalines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	membrane proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	biomarkers tumor	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	spiro compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins p21(ras)/metabolism	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	CD8A	1.7848166501521767e-05	4.115419107148629e-05	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	macrophages peritoneal/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	propionates/adverse effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	coumaric acids/adverse effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	killer cells natural/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	antioxidants/adverse effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	immunologic factors/adverse effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	spleen/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	hek293 cells	4.660237640230491e-09	1.4080981155516223e-08	0.03711991575621956	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	mitogens/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	recombinant fusion proteins/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	mitochondrial membrane transport proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	interleukin-10/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	immunoglobulin fc fragments/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	receptors chimeric antigen/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	receptors interleukin-10/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes cytotoxic/cytology	monocarboxylic acid transporters/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pancreas/metabolism	iron/metabolism	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
pancreas/metabolism	carcinoma pancreatic ductal/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	cell transformation neoplastic/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	diet	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	pancreatitis/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	dna	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	quinoxalines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	membrane proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	biomarkers tumor	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	spiro compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pancreas/metabolism	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreas/metabolism	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents/pharmacology	cisplatin/pharmacology	0.0008817854758214061	0.0017036107755792466	0.001373379482988985	0.35414021462530776	5	2
antineoplastic agents/pharmacology	carcinoma non-small-cell lung/drug therapy	0.0006656815808472327	0.0013008018695843118	0.003020454915489516	0.11552077256850565	7	2
antineoplastic agents/pharmacology	drugs chinese herbal/pharmacology	0.00015204186635930927	0.0003174449876411033	0.004079342664187234	0.35414021462530776	5	2
antineoplastic agents/pharmacology	thiosemicarbazones/pharmacology	0.004369397380413309	0.007667659459037937	0.20093457943925233	0.9605811478101344	1	2
antineoplastic agents/pharmacology	peroxiredoxin iii/metabolism	0.004369397380413309	0.007667659459037937	0.20093457943925233	0.9605811478101344	1	2
antineoplastic agents/pharmacology	thioredoxin-disulfide reductase/antagonists & inhibitors	0.004369397380413309	0.007667659459037937	0.20093457943925233	0.9605811478101344	1	2
antineoplastic agents/pharmacology	PRRX1	0.004369397380413309	0.007667659459037937	0.20093457943925233	0.9605811478101344	1	2
antineoplastic agents/pharmacology	SP1	0.003557046326495117	0.006343586298355119	0.03962090298802159	0.8657199677887635	2	2
jurkat cells	cyclins/metabolism	4.126230470635761e-07	1.0899140938849558e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	lactones/metabolism	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	oxazolone/pharmacology	4.126230470635761e-07	1.0899140938849558e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	interphase/drug effects	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	immunosuppressive agents/metabolism	1.558897455566921e-11	5.3445142435607955e-11	0.0012285551314115217	0.8657199677887635	2	2
jurkat cells	cytokines/biosynthesis	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	transcription factors/metabolism	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	triterpenes/pharmacology	5.77168171780329e-05	0.00012630673797928233	0.0735378000087754	0.9605811478101344	1	2
jurkat cells	dihydroorotase/antagonists & inhibitors	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	piperidines/metabolism	0.00011155506601645548	0.00023547784543138443	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	receptors calcitriol/physiology	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	foot/pathology	4.126230470635761e-07	1.0899140938849558e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	growth inhibitors/pharmacology	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	th2 cells/metabolism	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	clone cells	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	poly (adp-ribose) polymerase-1	0.00011155506601645548	0.00023547784543138443	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	cyclophilin a/antagonists & inhibitors	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	l-selectin/biosynthesis	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	interferon-gamma/antagonists & inhibitors	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	tacrolimus binding protein 1a/metabolism	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	spiro compounds/metabolism	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	leukemia/metabolism	0.00011155506601645548	0.00023547784543138443	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	enzyme inhibitors/metabolism	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	membrane glycoproteins/metabolism	0.00011155506601645548	0.00023547784543138443	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	imp dehydrogenase/antagonists & inhibitors	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	th1 cells/metabolism	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	nfatc transcription factors/antagonists & inhibitors	4.126230470635761e-07	1.0899140938849558e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	CD40LG	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	PPIA	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	SELP	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	TNFRSF10D	0.00011155506601645548	0.00023547784543138443	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	vitamin e/pharmacology	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	glutathione peroxidase/metabolism	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	methotrexate/pharmacology	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	folic acid antagonists/pharmacology	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	cystine/antagonists & inhibitors	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	flavonolignans/pharmacology	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	tetrahydrofolate dehydrogenase/genetics	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	autophagy-related proteins/genetics	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	tumor escape/drug effects	0.003182466786760485	0.0057199826945867095	0.10849863774429329	0.9605811478101344	1	2
jurkat cells	biopterin/analogs & derivatives	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	antineoplastic agents/metabolism	5.9273965846706744e-08	1.666291468810647e-07	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	chalcones/pharmacology	1.666650076836973e-07	4.542749523315809e-07	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	cell cycle proteins/metabolism	0.0010593723784503295	0.0020245334315743143	0.0735378000087754	0.9605811478101344	1	2
jurkat cells	tnf-related apoptosis-inducing ligand/metabolism	0.0012454557093865004	0.002363760650818074	0.0735378000087754	0.9605811478101344	1	2
jurkat cells	receptors tnf-related apoptosis-inducing ligand/agonists	5.9273965846706744e-08	1.666291468810647e-07	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	precursor cell lymphoblastic leukemia-lymphoma/metabolism	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	b7-h1 antigen/genetics	0.00040763822352196666	0.0008132109620170396	0.0735378000087754	0.9605811478101344	1	2
jurkat cells	recombinant fusion proteins/metabolism	5.9273965846706744e-08	1.666291468810647e-07	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	leukemia t-cell/drug therapy	5.9273965846706744e-08	1.666291468810647e-07	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	adaptor proteins signal transducing/metabolism	1.666650076836973e-07	4.542749523315809e-07	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	ligands	0.0012454557093865004	0.002363760650818074	0.0735378000087754	0.9605811478101344	1	2
jurkat cells	BIRC2	5.9273965846706744e-08	1.666291468810647e-07	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	CD4	0.005326854309534834	0.009248482858226948	0.10849863774429329	0.9605811478101344	1	2
jurkat cells	CFLAR	5.9273965846706744e-08	1.666291468810647e-07	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	EIF2S1	1.666650076836973e-07	4.542749523315809e-07	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	IL1B	0.0005045945599098101	0.0009994879936116696	0.0735378000087754	0.9605811478101344	1	2
jurkat cells	IL4	1.895699021092767e-07	5.153047961663584e-07	0.0011324126182882125	0.7135314763244264	3	2
jurkat cells	TNFRSF12A	5.9273965846706744e-08	1.666291468810647e-07	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	dose-response relationship immunologic	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	flavonoids/metabolism	0.00011155506601645548	0.00023547784543138443	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	drug hypersensitivity/drug therapy	4.126230470635761e-07	1.0899140938849558e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	multiple myeloma/metabolism	0.00011155506601645548	0.00023547784543138443	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	dinitrofluorobenzene/pharmacology	4.126230470635761e-07	1.0899140938849558e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	calcitriol/metabolism	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	interleukin-4/antagonists & inhibitors	1.8785003579324666e-06	4.721520279490997e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	anti-inflammatory agents/pharmacology	0.00019733506627150899	0.0004070774271289512	0.0735378000087754	0.9605811478101344	1	2
jurkat cells	hypersensitivity delayed/chemically induced	4.126230470635761e-07	1.0899140938849558e-06	0.037383177570093455	0.9605811478101344	1	2
jurkat cells	ear/pathology	4.126230470635761e-07	1.0899140938849558e-06	0.037383177570093455	0.9605811478101344	1	2
neoplasms/drug therapy	cd8-positive t-lymphocytes/drug effects	0.0013729432408663422	0.0025912217578001294	0.10825010098314035	0.9605811478101344	1	2
neoplasms/drug therapy	endoplasmic reticulum/drug effects	0.0005161304311359638	0.0010208705253149483	0.08215010393874443	0.9605811478101344	1	2
neoplasms/drug therapy	antineoplastic agents/chemistry	1.0886014312205816e-10	3.5759064892061063e-10	0.0038501128055567616	0.8657199677887635	2	2
neoplasms/drug therapy	saponins/chemistry	5.295763827461997e-13	1.979671089655512e-12	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	gene expression	0.0008266389137319141	0.0015995905537968442	0.10825010098314035	0.9605811478101344	1	2
neoplasms/drug therapy	ACSL4	3.2974283636910684e-08	9.399056310621935e-08	0.05541661182045544	0.9605811478101344	1	2
neoplasms/drug therapy	AIFM2	5.6621374255882984e-14	2.2173855410190196e-13	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	ATL1	5.6621374255882984e-14	2.2173855410190196e-13	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	S100A4	5.6621374255882984e-14	2.2173855410190196e-13	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	cd11b antigen/metabolism	3.608668919241609e-12	1.2766998127637835e-11	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	lymph nodes/drug effects	3.608668919241609e-12	1.2766998127637835e-11	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	receptor erbb-2/antagonists & inhibitors	3.9968028886505635e-15	1.6294657930652298e-14	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	chemokines/metabolism	9.921553742686662e-06	2.3488716516563464e-05	0.05541661182045544	0.9605811478101344	1	2
neoplasms/drug therapy	granulocyte colony-stimulating factor/pharmacology	3.608668919241609e-12	1.2766998127637835e-11	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	radiation tolerance/drug effects	3.608668919241609e-12	1.2766998127637835e-11	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	inflammation mediators/metabolism	3.9968028886505635e-15	1.6294657930652298e-14	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	poly i-c/administration & dosage	3.9968028886505635e-15	1.6294657930652298e-14	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	neutrophils/metabolism	3.608668919241609e-12	1.2766998127637835e-11	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	CSF3	3.608668919241609e-12	1.2766998127637835e-11	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	ERBB2	3.9968028886505635e-15	1.6294657930652298e-14	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	ITGAM	3.608668919241609e-12	1.2766998127637835e-11	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	sulfonamides/administration & dosage	9.390636046546774e-10	2.9393064104807394e-09	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	epothilones/administration & dosage	9.390636046546774e-10	2.9393064104807394e-09	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	nih 3t3 cells	8.21016588048451e-11	2.705391381451539e-10	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	biphenyl compounds/administration & dosage	9.390636046546774e-10	2.9393064104807394e-09	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	coordination complexes/chemistry	8.21016588048451e-11	2.705391381451539e-10	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	pyruvate dehydrogenase acetyl-transferring kinase/antagonists & inhibitors	5.295763827461997e-13	1.979671089655512e-12	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	hemolysis/drug effects	8.21016588048451e-11	2.705391381451539e-10	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	iridium/chemistry	8.21016588048451e-11	2.705391381451539e-10	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	piperazines/administration & dosage	9.390636046546774e-10	2.9393064104807394e-09	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	calcium/metabolism	0.0007392287055421054	0.0014384003618208754	0.10825010098314035	0.9605811478101344	1	2
neoplasms/drug therapy	nitrophenols/administration & dosage	9.390636046546774e-10	2.9393064104807394e-09	0.02803738317757009	0.9605811478101344	1	2
neoplasms/drug therapy	SPAG17	8.21016588048451e-11	2.705391381451539e-10	0.02803738317757009	0.9605811478101344	1	2
FTH1	nlr family pyrin domain-containing 3 protein/metabolism	3.737010700888277e-13	1.4050752376054693e-12	0.018691588785046728	0.9605811478101344	1	2
FTH1	cyclohexylamines/pharmacology	9.503276943156891e-09	2.807560633025903e-08	0.03711991575621956	0.9605811478101344	1	2
FTH1	phenylenediamines/pharmacology	9.503276943156891e-09	2.807560633025903e-08	0.03711991575621956	0.9605811478101344	1	2
FTH1	inflammation/metabolism	5.600441377318077e-08	1.576992739298965e-07	0.03711991575621956	0.9605811478101344	1	2
FTH1	inflammasomes/metabolism	3.737010700888277e-13	1.4050752376054693e-12	0.018691588785046728	0.9605811478101344	1	2
FTH1	endothelial cells/metabolism	1.5355919646964367e-08	4.459527349529378e-08	0.03711991575621956	0.9605811478101344	1	2
FTH1	monocrotaline/toxicity	3.737010700888277e-13	1.4050752376054693e-12	0.018691588785046728	0.9605811478101344	1	2
FTH1	toll-like receptor 4/metabolism	5.600441377318077e-08	1.576992739298965e-07	0.03711991575621956	0.9605811478101344	1	2
FTH1	hypertension pulmonary/chemically induced	3.737010700888277e-13	1.4050752376054693e-12	0.018691588785046728	0.9605811478101344	1	2
FTH1	lung/blood supply	3.737010700888277e-13	1.4050752376054693e-12	0.018691588785046728	0.9605811478101344	1	2
FTH1	viral structural proteins/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	oxidoreductases/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	homeostasis	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	protein kinases/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	hepatocytes/metabolism	1.219468970248272e-12	4.493123639043098e-12	0.03711991575621956	0.9605811478101344	1	2
FTH1	iron/metabolism	7.465361662184478e-12	2.600668256088535e-11	0.007095639193881167	0.8657199677887635	2	2
FTH1	apoptosis	1.702227759858843e-07	4.633994030049114e-07	0.055287464515536164	0.9605811478101344	1	2
FTH1	ferritins/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	apolipoprotein b-100/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	cell line	6.214832351081334e-06	1.5029573727831661e-05	0.019139049120127486	0.8657199677887635	2	2
FTH1	nuclear receptor coactivators/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	gene expression regulation viral	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	viral proteins/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	fatty liver/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	NCOA4	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	bacterial toxins/metabolism	3.737010700888277e-13	1.4050752376054693e-12	0.018691588785046728	0.9605811478101344	1	2
FTH1	macrophages/metabolism	1.1962268298137957e-07	3.299688370290825e-07	0.03711991575621956	0.9605811478101344	1	2
FTH1	hmgb1 protein/metabolism	3.737010700888277e-13	1.4050752376054693e-12	0.018691588785046728	0.9605811478101344	1	2
FTH1	host-pathogen interactions	0.0	0.0	2.4659460791639788e-05	0.7135314763244264	3	2
FTH1	HMGB1	7.957021090909677e-07	2.064443410359809e-06	0.03711991575621956	0.9605811478101344	1	2
FTH1	NLRP3	1.5355919646964367e-08	4.459527349529378e-08	0.03711991575621956	0.9605811478101344	1	2
FTH1	NOX4	1.702227759858843e-07	4.633994030049114e-07	0.03711991575621956	0.9605811478101344	1	2
FTH1	TLR4	2.7782234328643796e-06	6.900334600404849e-06	0.055287464515536164	0.9605811478101344	1	2
FTH1	proteasome endopeptidase complex/metabolism	2.692343015198162e-10	8.695002021252246e-10	0.03711991575621956	0.9605811478101344	1	2
FTH1	hepatitis c/pathology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	ferritins/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	apoferritins/metabolism	1.219468970248272e-12	4.493123639043098e-12	0.03711991575621956	0.9605811478101344	1	2
FTH1	viral nonstructural proteins/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
FTH1	protein interaction maps	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
mucin-1/immunology	HMGB1	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
mucin-1/immunology	CD8A	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
mucin-1/immunology	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
mucin-1/immunology	rna interference	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
mucin-1/immunology	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	adenosine triphosphate/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	calreticulin/analysis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	prostatic neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	carcinoembryonic antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	eif-2 kinase/genetics	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
mucin-1/immunology	rna small interfering	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	cytotoxicity immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	hmgb1 protein/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	colorectal neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	KLK3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
mucin-1/immunology	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mucin-1/immunology	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tor serine-threonine kinases/metabolism	cell cycle checkpoints/drug effects	0.001796543000020412	0.003346302277980066	0.0057175808912086614	0.5304112294886878	4	2
tor serine-threonine kinases/metabolism	proto-oncogene proteins c-akt/metabolism	9.992007221626409e-16	4.201063600732629e-15	3.7644500721652264e-19	2.414252393406016e-12	26	2
tor serine-threonine kinases/metabolism	AKT1	1.4986705781039333e-05	3.472329645442993e-05	1.5639007456248754e-10	1.0857363909332076e-14	29	2
tor serine-threonine kinases/metabolism	PIK3CA	1.9251518897922537e-06	4.838225107276828e-06	5.280871724987545e-12	1.678973800412177e-15	30	2
tor serine-threonine kinases/metabolism	gtp phosphohydrolases/genetics	0.003406956025203245	0.006100590144049472	0.1542056074766355	0.9605811478101344	1	2
tor serine-threonine kinases/metabolism	leucine/pharmacology	0.003406956025203245	0.006100590144049472	0.1542056074766355	0.9605811478101344	1	2
tor serine-threonine kinases/metabolism	monocrotaline	0.003406956025203245	0.006100590144049472	0.1542056074766355	0.9605811478101344	1	2
tor serine-threonine kinases/metabolism	pulmonary arterial hypertension/drug therapy	0.003406956025203245	0.006100590144049472	0.1542056074766355	0.9605811478101344	1	2
tor serine-threonine kinases/metabolism	pulmonary artery/cytology	0.003406956025203245	0.006100590144049472	0.1542056074766355	0.9605811478101344	1	2
tor serine-threonine kinases/metabolism	pyruvates/pharmacology	0.003406956025203245	0.006100590144049472	0.1542056074766355	0.9605811478101344	1	2
tor serine-threonine kinases/metabolism	phosphatidylinositol 3-kinase/metabolism	8.736338384829345e-06	2.0774243821043723e-05	6.651412417825457e-05	0.35414021462530776	5	2
tor serine-threonine kinases/metabolism	organelle biogenesis	0.00020773147462149755	0.00042788336626072286	0.02316703962090299	0.8657199677887635	2	2
tor serine-threonine kinases/metabolism	myocardial reperfusion injury/enzymology	0.003406956025203245	0.006100590144049472	0.1542056074766355	0.9605811478101344	1	2
tor serine-threonine kinases/metabolism	stomach neoplasms/drug therapy	0.0013621678429177608	0.0025715452179682157	0.02316703962090299	0.8657199677887635	2	2
tor serine-threonine kinases/metabolism	proto-oncogene proteins c-bcl-2/metabolism	0.00014785672427508612	0.00030926335801319596	0.0033876331521131725	0.7135314763244264	3	2
tor serine-threonine kinases/metabolism	sirolimus/pharmacology	0.0013621678429177608	0.0025715452179682157	0.02316703962090299	0.8657199677887635	2	2
iron/metabolism	coenzyme a ligases/metabolism	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	oleic acid/metabolism	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	ferritins/blood	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	cell survival	1.3652725137647259e-05	3.177948520215865e-05	0.0735378000087754	0.9605811478101344	1	2
iron/metabolism	genetic variation	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	malaria/genetics	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	iron chelating agents/pharmacology	3.3306690738754696e-16	1.4334294698576293e-15	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	macrophages/drug effects	0.0008908422524538384	0.0017208069022342936	0.04744357798811946	0.8657199677887635	2	2
iron/metabolism	carcinoma pancreatic ductal/metabolism	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	cell transformation neoplastic/genetics	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	glutathione/metabolism	5.0118464933746054e-11	1.6880719750370195e-10	0.007095639193881167	0.8657199677887635	2	2
iron/metabolism	diet	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	tumor suppressor protein p53/genetics	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	pancreatitis/genetics	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	dna	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	phospholipid hydroperoxide glutathione peroxidase/genetics	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	quinoxalines/pharmacology	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	listeriosis/etiology	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	hemeproteins/toxicity	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	transferrin/metabolism	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	tuberculosis/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	melanoma/blood	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	membrane proteins/genetics	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	host-pathogen interactions	0.0	0.0	0.0003354392905203583	0.7135314763244264	3	2
iron/metabolism	biomarkers tumor	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	cell line	0.0021399351694465496	0.0039462437785176925	0.07762709181584306	0.8657199677887635	2	2
iron/metabolism	liver x receptors/agonists	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	spiro compounds/pharmacology	7.245952637824349e-05	0.0001573512890364929	0.0735378000087754	0.9605811478101344	1	2
iron/metabolism	ACSL3	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	KDM8	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	STING1	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	TF	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	neoplasm metastasis/drug therapy	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0	0.0	0.0012285551314115217	0.8657199677887635	2	2
iron/metabolism	hypoxia/complications	1.0406933093065618e-09	3.2514108096345575e-09	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	sleep apnea obstructive/complications	1.0406933093065618e-09	3.2514108096345575e-09	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	ferritins/genetics	9.658940314238862e-15	3.8840108708433053e-14	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	depsides/pharmacology	1.0406933093065618e-09	3.2514108096345575e-09	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	lymph/metabolism	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	apoferritins/metabolism	3.950154128240513e-07	1.044405782701125e-06	0.0735378000087754	0.9605811478101344	1	2
iron/metabolism	viral structural proteins/metabolism	9.658940314238862e-15	3.8840108708433053e-14	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	jnk mitogen-activated protein kinases/metabolism	3.379596134700513e-05	7.601850191580994e-05	0.0735378000087754	0.9605811478101344	1	2
iron/metabolism	oxidoreductases/genetics	9.658940314238862e-15	3.8840108708433053e-14	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	drugs chinese herbal/administration & dosage	2.1244838133149813e-07	5.739568571984893e-07	0.0735378000087754	0.9605811478101344	1	2
iron/metabolism	homeostasis	9.658940314238862e-15	3.8840108708433053e-14	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	protein kinases/metabolism	0.0	0.0	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	host-parasite interactions	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	hepatocytes/metabolism	3.950154128240513e-07	1.044405782701125e-06	0.0735378000087754	0.9605811478101344	1	2
iron/metabolism	antioxidants/metabolism	9.703503700775329e-06	2.298236648347776e-05	0.0735378000087754	0.9605811478101344	1	2
iron/metabolism	apoptosis	0.0002039311921900877	0.0004202126098511265	0.10849863774429329	0.9605811478101344	1	2
iron/metabolism	ferritins/metabolism	0.0	0.0	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	cytoprotection	1.3652725137647259e-05	3.177948520215865e-05	0.0735378000087754	0.9605811478101344	1	2
iron/metabolism	heart injuries/etiology	1.0406933093065618e-09	3.2514108096345575e-09	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	iron overload/metabolism	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	nuclear receptor coactivators/genetics	9.658940314238862e-15	3.8840108708433053e-14	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	cinnamates/pharmacology	1.0406933093065618e-09	3.2514108096345575e-09	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	viral proteins/metabolism	0.0	0.0	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	malaria/metabolism	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	ceruloplasmin/metabolism	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	ABCB8	1.0406933093065618e-09	3.2514108096345575e-09	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	CP	1.6409096303959814e-12	5.956334463445933e-12	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	CYBB	1.0406933093065618e-09	3.2514108096345575e-09	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	NCOA4	9.658940314238862e-15	3.8840108708433053e-14	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	PINK1	1.0406933093065618e-09	3.2514108096345575e-09	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	SLC25A28	1.0406933093065618e-09	3.2514108096345575e-09	0.037383177570093455	0.9605811478101344	1	2
iron/metabolism	macrophages	9.035364678666724e-09	2.6700404829814224e-08	0.037383177570093455	0.9605811478101344	1	2
HMGB1	nlr family pyrin domain-containing 3 protein/metabolism	1.1757261830780408e-13	4.5192487595022044e-13	0.009345794392523364	0.9605811478101344	1	2
HMGB1	cyclohexylamines/pharmacology	4.559572053253191e-09	1.3778706774962495e-08	0.018647711816067742	0.9605811478101344	1	2
HMGB1	phenylenediamines/pharmacology	4.559572053253191e-09	1.3778706774962495e-08	0.018647711816067742	0.9605811478101344	1	2
HMGB1	inflammation/metabolism	2.891389927484056e-08	8.282365222965891e-08	0.018647711816067742	0.9605811478101344	1	2
HMGB1	inflammasomes/metabolism	1.1757261830780408e-13	4.5192487595022044e-13	0.009345794392523364	0.9605811478101344	1	2
HMGB1	endothelial cells/metabolism	7.515323696694054e-09	2.2394628580174417e-08	0.018647711816067742	0.9605811478101344	1	2
HMGB1	monocrotaline/toxicity	1.1757261830780408e-13	4.5192487595022044e-13	0.009345794392523364	0.9605811478101344	1	2
HMGB1	toll-like receptor 4/metabolism	2.891389927484056e-08	8.282365222965891e-08	0.018647711816067742	0.9605811478101344	1	2
HMGB1	hypertension pulmonary/chemically induced	1.1757261830780408e-13	4.5192487595022044e-13	0.009345794392523364	0.9605811478101344	1	2
HMGB1	lung/blood supply	1.1757261830780408e-13	4.5192487595022044e-13	0.009345794392523364	0.9605811478101344	1	2
HMGB1	bacterial toxins/metabolism	1.1757261830780408e-13	4.5192487595022044e-13	0.009345794392523364	0.9605811478101344	1	2
HMGB1	macrophages/metabolism	6.372166871937424e-08	1.7838183747140214e-07	0.018647711816067742	0.9605811478101344	1	2
HMGB1	hmgb1 protein/metabolism	1.1757261830780408e-13	4.5192487595022044e-13	0.009345794392523364	0.9605811478101344	1	2
HMGB1	NLRP3	7.515323696694054e-09	2.2394628580174417e-08	0.018647711816067742	0.9605811478101344	1	2
HMGB1	NOX4	9.200277617527064e-08	2.549619418190507e-07	0.018647711816067742	0.9605811478101344	1	2
HMGB1	TLR4	1.6838795831031206e-06	4.2624772730490935e-06	0.027905752270633143	0.9605811478101344	1	2
HMGB1	docetaxel	9.200277617527064e-08	2.549619418190507e-07	0.018647711816067742	0.9605811478101344	1	2
HMGB1	dendritic cells/immunology	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	prostate-specific antigen/immunology	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	CD8A	0.0013305121763778072	0.0025165250463050435	0.0644991443991049	0.9605811478101344	1	2
HMGB1	adenosine triphosphate/biosynthesis	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	calreticulin/analysis	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	prostatic neoplasms/therapy	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	carcinoembryonic antigen/immunology	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	eif-2 kinase/genetics	3.4161414586009187e-07	9.052774865292433e-07	0.018647711816067742	0.9605811478101344	1	2
HMGB1	rna small interfering	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	cytotoxicity immunologic	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	breast neoplasms/therapy	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	hmgb1 protein/biosynthesis	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	colorectal neoplasms/therapy	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	KLK3	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	MUC1	6.372166871937424e-08	1.7838183747140214e-07	0.018647711816067742	0.9605811478101344	1	2
HMGB1	NPEPPS	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	PROM1	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
HMGB1	PSAT1	3.5328406866597106e-12	1.2536950178572878e-11	0.009345794392523364	0.9605811478101344	1	2
antineoplastic agents/chemistry	saponins/chemistry	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	NFE2L2	0.00046244094466096897	0.0009193776328119968	0.07319670689438858	0.9605811478101344	1	2
antineoplastic agents/chemistry	copper/chemistry	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	peroxidase/chemistry	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	tellurium/chemistry	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	immunosuppressive agents/chemistry	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	hydrogen peroxide/chemistry	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	azepines/chemistry	2.895462758445433e-10	9.322307666209828e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	nih 3t3 cells	3.5416114485542494e-14	1.392890638917661e-13	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	coordination complexes/chemistry	3.5416114485542494e-14	1.392890638917661e-13	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	hemolysis/drug effects	3.5416114485542494e-14	1.392890638917661e-13	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	pyrimidines/chemistry	2.895462758445433e-10	9.322307666209828e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	iridium/chemistry	3.5416114485542494e-14	1.392890638917661e-13	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	mitogen-activated protein kinases/antagonists & inhibitors	2.895462758445433e-10	9.322307666209828e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	calcium/metabolism	7.591455780109335e-05	0.00016393380709094088	0.07319670689438858	0.9605811478101344	1	2
antineoplastic agents/chemistry	CDH1	2.895462758445433e-10	9.322307666209828e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	CDH2	2.895462758445433e-10	9.322307666209828e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	SPAG17	3.5416114485542494e-14	1.392890638917661e-13	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents/chemistry	pyruvate dehydrogenase acetyl-transferring kinase/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	triple negative breast neoplasms/drug therapy	1.1940993098313868e-05	2.7966328429108155e-05	0.07319670689438858	0.9605811478101344	1	2
interleukin-8/metabolism	toll-like receptor 4/metabolism	4.989061767046721e-07	1.310758267872332e-06	0.03711991575621956	0.9605811478101344	1	2
interleukin-8/metabolism	breast neoplasms/drug therapy	0.003795571073938131	0.006728692694233973	0.12539913750269532	0.9605811478101344	1	2
interleukin-8/metabolism	nf-kappa b	2.6645352591003757e-15	1.0984980065939618e-14	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	TLR4	1.4580143245956911e-05	3.3795521266490534e-05	0.055287464515536164	0.9605811478101344	1	2
interleukin-8/metabolism	neovascularization pathologic/drug therapy	1.7438755116616633e-06	4.409790948631305e-06	0.03711991575621956	0.9605811478101344	1	2
interleukin-8/metabolism	interleukin-6/metabolism	0.0007977961353913265	0.0015497629245029047	0.09085010295354308	0.9605811478101344	1	2
interleukin-8/metabolism	receptors interleukin-8a/physiology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	rna messenger/genetics	0.0028672299848212512	0.005196176779988406	0.10825010098314035	0.9605811478101344	1	2
interleukin-8/metabolism	sulfonamides/pharmacology	1.1940993098313868e-05	2.7966328429108155e-05	0.055287464515536164	0.9605811478101344	1	2
interleukin-8/metabolism	melanoma/drug therapy	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	proto-oncogene proteins c-akt/physiology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	receptors interleukin-8a/antagonists & inhibitors	2.6645352591003757e-15	1.0984980065939618e-14	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	mesenchymal stem cells/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	doxorubicin/administration & dosage	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	receptors interleukin-8b/antagonists & inhibitors	2.6645352591003757e-15	1.0984980065939618e-14	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	anoikis/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	lung neoplasms/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	osteosarcoma/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	bone neoplasms/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	cell adhesion/drug effects	0.00025250561210343747	0.0005151993092408466	0.07319670689438858	0.9605811478101344	1	2
interleukin-8/metabolism	tyramine/analogs & derivatives	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	antineoplastic agents phytogenic/therapeutic use	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	paclitaxel/therapeutic use	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	mesenchymal stem cells/cytology	2.66944835125571e-08	7.655566759688592e-08	0.03711991575621956	0.9605811478101344	1	2
interleukin-8/metabolism	CXCL1	1.3227471340471197e-09	4.116291998796174e-09	0.03711991575621956	0.9605811478101344	1	2
interleukin-8/metabolism	CXCL8	0.0	0.0	8.569015492273871e-05	0.7135314763244264	3	2
interleukin-8/metabolism	CXCR1	0.0	0.0	0.00026326181387389757	0.8657199677887635	2	2
interleukin-8/metabolism	CXCR2	2.6645352591003757e-15	1.0984980065939618e-14	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	MSC	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/metabolism	XIAP	7.591455780109335e-05	0.00016393380709094088	0.055287464515536164	0.9605811478101344	1	2
interleukin-8/metabolism	acetates/therapeutic use	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
interferon-gamma/immunology	nivolumab/therapeutic use	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	cysteine/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	CD274	0.0048168909402244164	0.008421123861458534	0.1214816672917065	0.9605811478101344	1	2
interferon-gamma/immunology	CD8A	0.0010225856949998002	0.0019572853028349334	0.09538832359347407	0.9605811478101344	1	2
interferon-gamma/immunology	PDCD1	7.988018617155479e-05	0.00017170696545875403	0.06878335787959994	0.9605811478101344	1	2
interferon-gamma/immunology	SLC3A2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	SLC7A11	5.3953543135421e-06	1.3103852379926881e-05	0.06878335787959994	0.9605811478101344	1	2
interferon-gamma/immunology	SLC9A1	3.454814989645172e-09	1.0513700606169323e-08	0.04166180294604871	0.9605811478101344	1	2
interferon-gamma/immunology	cd8-positive t-lymphocytes/drug effects	9.175420383256139e-06	2.1764353804199175e-05	0.055287464515536164	0.9605811478101344	1	2
interferon-gamma/immunology	adjuvants immunologic/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	tumor escape	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	protein kinases/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	t-lymphocytes regulatory/drug effects	3.540051585204651e-10	1.1305193706632698e-09	0.027905752270633143	0.9605811478101344	1	2
interferon-gamma/immunology	lymphocytes tumor-infiltrating/drug effects	1.8292256598329004e-10	5.94585984785431e-10	0.027905752270633143	0.9605811478101344	1	2
interferon-gamma/immunology	carbazoles/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	cytotoxicity immunologic/drug effects	1.5690773335075292e-06	3.981014620158113e-06	0.055287464515536164	0.9605811478101344	1	2
interferon-gamma/immunology	cisplatin/administration & dosage	1.7763568394002505e-15	7.423259210594527e-15	0.027905752270633143	0.9605811478101344	1	2
interferon-gamma/immunology	amino acid transport system y+/metabolism	4.267353137521468e-11	1.443488830562647e-10	0.027905752270633143	0.9605811478101344	1	2
interferon-gamma/immunology	carcinoma squamous cell/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	b7-h1 antigen/genetics	3.540051585204651e-10	1.1305193706632698e-09	0.027905752270633143	0.9605811478101344	1	2
interferon-gamma/immunology	rna small interfering/genetics	7.605051600689805e-07	1.9759153628565735e-06	0.04166180294604871	0.9605811478101344	1	2
interferon-gamma/immunology	mouth neoplasms/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	antigens neoplasm/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	maleimides	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	PRKD1	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	fusion regulatory protein 1 heavy chain/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/immunology	melanoma/genetics	2.5144574011815024e-07	6.750944566640253e-07	0.04166180294604871	0.9605811478101344	1	2
interferon-gamma/immunology	cd8-positive t-lymphocytes/immunology	3.955015241885462e-05	8.810768521076152e-05	0.06878335787959994	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	cell transformation neoplastic/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	diet	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	pancreatitis/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	dna	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	quinoxalines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	membrane proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	biomarkers tumor	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	spiro compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma pancreatic ductal/metabolism	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
apigenin/pharmacology	a549 cells	8.162793669252988e-05	0.00017522468583359933	0.05541661182045544	0.9605811478101344	1	2
apigenin/pharmacology	lactic acid/metabolism	9.498024589049692e-11	3.12695902851079e-10	0.018647711816067742	0.9605811478101344	1	2
apigenin/pharmacology	carcinoma non-small-cell lung/drug therapy	0.0022530193887317918	0.00413989261461443	0.10925365275766749	0.9605811478101344	1	2
apigenin/pharmacology	cisplatin/pharmacology	7.536071625635632e-05	0.00016278564436368611	0.05541661182045544	0.9605811478101344	1	2
apigenin/pharmacology	glucose/metabolism	1.6670598709245255e-06	4.220385352410602e-06	0.03711991575621956	0.9605811478101344	1	2
apigenin/pharmacology	adenosine triphosphate/metabolism	1.1858723574231789e-06	3.035304589791763e-06	0.05541661182045544	0.9605811478101344	1	2
apigenin/pharmacology	killer cells natural/drug effects	1.0859091403858656e-12	4.002361204819051e-12	0.018647711816067742	0.9605811478101344	1	2
apigenin/pharmacology	proto-oncogene proteins c-akt/drug effects	1.329542209660417e-08	3.8815872137967255e-08	0.027905752270633143	0.9605811478101344	1	2
apigenin/pharmacology	phosphatidylinositol 3-kinases/drug effects	1.329542209660417e-08	3.8815872137967255e-08	0.027905752270633143	0.9605811478101344	1	2
apigenin/pharmacology	thyroid hormones/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apigenin/pharmacology	membrane proteins/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apigenin/pharmacology	carrier proteins/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apigenin/pharmacology	carcinoma non-small-cell lung/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apigenin/pharmacology	tor serine-threonine kinases/drug effects	1.594815390859594e-10	5.191567951819331e-10	0.018647711816067742	0.9605811478101344	1	2
apigenin/pharmacology	cytokines/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apigenin/pharmacology	IL2	3.7805497232756835e-07	1.0004027880314723e-06	0.03711991575621956	0.9605811478101344	1	2
apigenin/pharmacology	PKM	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	amidines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	proteasome endopeptidase complex/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	receptors interleukin-10/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	th1 cells/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	interleukin-10/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	rna interference	0.0015651042031368245	0.0029345537435802966	0.08253257864946689	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	receptors ccr10/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	bortezomib/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	chemokine ccl27/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	burkitt lymphoma/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	cell differentiation/drug effects	1.3276802133588284e-05	3.0966564417788475e-05	0.046290202272826986	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	CD4	4.814946774622797e-09	1.4524551441631335e-08	0.027905752270633143	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	IFNG	0.0026993969535505924	0.0049085611572687385	0.10039050502391293	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	receptor cross-talk/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	piperidines/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome inhibitors/pharmacology	proteasome endopeptidase complex/metabolism	1.2101430968414206e-14	4.8608553469046536e-14	0.018647711816067742	0.9605811478101344	1	2
cell transformation neoplastic/genetics	diet	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell transformation neoplastic/genetics	pancreatitis/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell transformation neoplastic/genetics	dna	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell transformation neoplastic/genetics	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell transformation neoplastic/genetics	quinoxalines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell transformation neoplastic/genetics	membrane proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell transformation neoplastic/genetics	biomarkers tumor	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell transformation neoplastic/genetics	spiro compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell transformation neoplastic/genetics	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell transformation neoplastic/genetics	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell transformation neoplastic/genetics	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	CD8A	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	rna interference	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	calreticulin/analysis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	prostatic neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	carcinoembryonic antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	eif-2 kinase/genetics	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	rna small interfering	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	cytotoxicity immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	hmgb1 protein/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	colorectal neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	KLK3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/biosynthesis	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
NLRP3	nlr family pyrin domain-containing 3 protein/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	cyclohexylamines/pharmacology	1.9081847213442416e-11	6.5166754548014e-11	0.018647711816067742	0.9605811478101344	1	2
NLRP3	phenylenediamines/pharmacology	1.9081847213442416e-11	6.5166754548014e-11	0.018647711816067742	0.9605811478101344	1	2
NLRP3	inflammation/metabolism	2.094446838185604e-10	6.793933189394763e-10	0.018647711816067742	0.9605811478101344	1	2
NLRP3	inflammasomes/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	endothelial cells/metabolism	3.6489922194959945e-11	1.2373574354882757e-10	0.018647711816067742	0.9605811478101344	1	2
NLRP3	monocrotaline/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	toll-like receptor 4/metabolism	2.094446838185604e-10	6.793933189394763e-10	0.018647711816067742	0.9605811478101344	1	2
NLRP3	hypertension pulmonary/chemically induced	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	lung/blood supply	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	kidney failure chronic/etiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	fibrosis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	ureteral obstruction/complications	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	inflammasomes/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	nlr family pyrin domain-containing 3 protein/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	BECN1	6.247304675577325e-06	1.5103133057799219e-05	0.046290202272826986	0.9605811478101344	1	2
NLRP3	MAP1LC3A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	bacterial toxins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	macrophages/metabolism	5.833880045713613e-10	1.8448850724023771e-09	0.018647711816067742	0.9605811478101344	1	2
NLRP3	hmgb1 protein/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NLRP3	NOX4	9.390636046546774e-10	2.9393064104807394e-09	0.018647711816067742	0.9605811478101344	1	2
NLRP3	TLR4	4.051452284770107e-08	1.1493363352368931e-07	0.027905752270633143	0.9605811478101344	1	2
NLRP3	curcumin/pharmacology	1.4788753555095013e-09	4.584679954762864e-09	0.027905752270633143	0.9605811478101344	1	2
NLRP3	kidney tubules/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NOX4	nlr family pyrin domain-containing 3 protein/metabolism	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
NOX4	cyclohexylamines/pharmacology	5.376860068295741e-10	1.7064777714953865e-09	0.018647711816067742	0.9605811478101344	1	2
NOX4	phenylenediamines/pharmacology	5.376860068295741e-10	1.7064777714953865e-09	0.018647711816067742	0.9605811478101344	1	2
NOX4	inflammation/metabolism	4.2223107232786106e-09	1.2798117518125765e-08	0.018647711816067742	0.9605811478101344	1	2
NOX4	inflammasomes/metabolism	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
NOX4	endothelial cells/metabolism	9.390636046546774e-10	2.9393064104807394e-09	0.018647711816067742	0.9605811478101344	1	2
NOX4	monocrotaline/toxicity	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
NOX4	toll-like receptor 4/metabolism	4.2223107232786106e-09	1.2798117518125765e-08	0.018647711816067742	0.9605811478101344	1	2
NOX4	hypertension pulmonary/chemically induced	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
NOX4	lung/blood supply	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
NOX4	TLR4	3.925533308413165e-07	1.0381451167553493e-06	0.027905752270633143	0.9605811478101344	1	2
NOX4	bacterial toxins/metabolism	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
NOX4	macrophages/metabolism	1.0194388222473094e-08	3.0048913306027646e-08	0.018647711816067742	0.9605811478101344	1	2
NOX4	rna interference	0.005465546182889414	0.009469146804993384	0.08253257864946689	0.9605811478101344	1	2
NOX4	cell differentiation/drug effects	0.00012159104929931885	0.0002561474732420583	0.046290202272826986	0.9605811478101344	1	2
NOX4	organophosphorus compounds/chemistry	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
NOX4	hmgb1 protein/metabolism	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
NOX4	antimycin a/analogs & derivatives	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
NOX4	cyclic n-oxides/chemistry	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
NOX4	cell hypoxia	2.980518054584991e-10	9.580764261188203e-10	0.018647711816067742	0.9605811478101344	1	2
NOX4	adipose tissue/cytology	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
NOX4	free radical scavengers/pharmacology	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
NOX4	stem cells/cytology	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
NOX4	rotenone/pharmacology	2.980518054584991e-10	9.580764261188203e-10	0.018647711816067742	0.9605811478101344	1	2
propionates/adverse effects	coumaric acids/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
propionates/adverse effects	killer cells natural/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
propionates/adverse effects	antioxidants/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
propionates/adverse effects	immunologic factors/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
propionates/adverse effects	spleen/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
propionates/adverse effects	mitogens/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
propionates/adverse effects	macrophages peritoneal/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	amino acid transport system y+/genetics	8.276241856286504e-07	2.141720427786442e-06	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	lipid metabolism/drug effects	8.276241856286504e-07	2.141720427786442e-06	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	b7-h1 antigen/metabolism	0.0001111039990979723	0.0002346829825744485	0.019139049120127486	0.8657199677887635	2	2
gene expression regulation neoplastic/drug effects	sorafenib/pharmacology	0.004178907695906786	0.00735151654666503	0.11807292352244307	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	ATM	8.276241856286504e-07	2.141720427786442e-06	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	CD274	0.0004315600857037749	0.0008593885776893424	0.011996596231227244	0.7135314763244264	3	2
gene expression regulation neoplastic/drug effects	tumor escape	8.28094089788678e-05	0.0001775361580285956	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	chemokine ccl19/immunology	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	protein kinases/genetics	8.28094089788678e-05	0.0001775361580285956	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	histone deacetylase inhibitors/pharmacology	8.044286381458932e-08	2.240530901192604e-07	0.0034224035803606685	0.8657199677887635	2	2
gene expression regulation neoplastic/drug effects	sulfasalazine/administration & dosage	8.276241856286504e-07	2.141720427786442e-06	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	receptors ccr7/immunology	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	tamoxifen/pharmacology	0.0020370465275560967	0.0037650097945810057	0.11807292352244307	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	osteopontin/genetics	0.00013315331632623995	0.0002794901293184442	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	diterpenes/isolation & purification	0.00013315331632623995	0.0002794901293184442	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	rna messenger/genetics	0.004739428154637237	0.008289957314830768	0.044603084392293074	0.8657199677887635	2	2
gene expression regulation neoplastic/drug effects	carcinoma hepatocellular/genetics	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	carbazoles/pharmacology	8.28094089788678e-05	0.0001775361580285956	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	antigen presentation/drug effects	0.00029965026733114186	0.000606786287115817	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	drug combinations	4.2182076864794027e-07	1.1132755933863763e-06	0.0034224035803606685	0.8657199677887635	2	2
gene expression regulation neoplastic/drug effects	potassium channels voltage-gated/metabolism	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	antibodies monoclonal/pharmacology	0.00029965026733114186	0.000606786287115817	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	carcinoma non-small-cell lung/drug therapy	1.2933646878710015e-05	3.0207737964173562e-05	0.003143705104805374	0.5304112294886878	4	2
gene expression regulation neoplastic/drug effects	carcinoma squamous cell/immunology	8.28094089788678e-05	0.0001775361580285956	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	b7-h1 antigen/genetics	0.0048682339326305835	0.008502441519854175	0.11807292352244307	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	human umbilical vein endothelial cells/drug effects	0.00013315331632623995	0.0002794901293184442	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	myeloid-derived suppressor cells/drug effects	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	drugs chinese herbal/pharmacology	1.5619741142725019e-06	3.963904842481597e-06	0.0053760212514656945	0.7135314763244264	3	2
gene expression regulation neoplastic/drug effects	leukemia lymphocytic chronic b-cell/blood	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	doxorubicin/pharmacology	0.0048682339326305835	0.008502441519854175	0.11807292352244307	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	micrornas/genetics	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	antineoplastic agents phytogenic/isolation & purification	0.0005345684599782352	0.0010567291843353013	0.019139049120127486	0.8657199677887635	2	2
gene expression regulation neoplastic/drug effects	selective estrogen receptor modulators/pharmacology	0.0020370465275560967	0.0037650097945810057	0.11807292352244307	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	mouth neoplasms/immunology	8.28094089788678e-05	0.0001775361580285956	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	chemokine ccl21/immunology	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	immune evasion/drug effects	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	maleimides	8.28094089788678e-05	0.0001775361580285956	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	histone deacetylases/chemistry	0.00029965026733114186	0.000606786287115817	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	CCL19	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	CCL21	0.0035524822154440194	0.006335959220685143	0.11807292352244307	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	CCR7	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	CIITA	0.00029965026733114186	0.000606786287115817	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	FOXP3	0.00029965026733114186	0.000606786287115817	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	HDAC9	0.00029965026733114186	0.000606786287115817	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	KCNQ1	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	KCNQ1OT1	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	PCNA	0.005621281807727696	0.009727495588790538	0.11807292352244307	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	PI3	0.004178907695906786	0.00735151654666503	0.11807292352244307	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	PRKD1	8.28094089788678e-05	0.0001775361580285956	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	spleen/drug effects	6.09810297691471e-06	1.4748900223235578e-05	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	plant extracts/chemistry	0.0002039311921900877	0.0004202126098511265	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	anthraquinones/isolation & purification	0.0002039311921900877	0.0004202126098511265	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	hydroxamic acids/pharmacology	2.6631302138979684e-05	6.04952554667447e-05	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	carcinoma hepatocellular/pathology	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	cyclophilins/genetics	0.0002039311921900877	0.0004202126098511265	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	breast neoplasms/genetics	2.6631302138979684e-05	6.04952554667447e-05	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	sp1 transcription factor/metabolism	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	histone deacetylases/metabolism	2.6631302138979684e-05	6.04952554667447e-05	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	dna (cytosine-5-)-methyltransferase 1/metabolism	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	endoplasmic reticulum/metabolism	2.6631302138979684e-05	6.04952554667447e-05	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	erlotinib hydrochloride/pharmacology	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	mitochondrial adp atp translocases/genetics	0.0002039311921900877	0.0004202126098511265	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	neoplasm invasiveness/pathology	0.00013315331632623995	0.0002794901293184442	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	benzofurans/pharmacology	2.6631302138979684e-05	6.04952554667447e-05	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	berberine/analogs & derivatives	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	neoplasm proteins/genetics	6.09810297691471e-06	1.4748900223235578e-05	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	kidney neoplasms/drug therapy	0.00013315331632623995	0.0002794901293184442	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	voltage-dependent anion channels/genetics	0.0002039311921900877	0.0004202126098511265	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	adenosine triphosphate/antagonists & inhibitors	0.0002039311921900877	0.0004202126098511265	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	thymus gland/drug effects	6.09810297691471e-06	1.4748900223235578e-05	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	proto-oncogene proteins c-met/antagonists & inhibitors	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	DNMT1	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	HGF	4.86123297633867e-05	0.00010706269569704824	0.06074766355140186	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	SP1	0.0029877882020005186	0.005392056501408483	0.11807292352244307	0.9605811478101344	1	2
gene expression regulation neoplastic/drug effects	antineoplastic agents immunological/administration & dosage	8.276241856286504e-07	2.141720427786442e-06	0.06074766355140186	0.9605811478101344	1	2
diet	pancreatitis/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diet	dna	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diet	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diet	quinoxalines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diet	membrane proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diet	biomarkers tumor	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diet	spiro compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
diet	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diet	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diet	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreatitis/genetics	dna	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreatitis/genetics	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreatitis/genetics	quinoxalines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreatitis/genetics	membrane proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreatitis/genetics	biomarkers tumor	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreatitis/genetics	spiro compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pancreatitis/genetics	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreatitis/genetics	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreatitis/genetics	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
saponins/chemistry	pyruvate dehydrogenase acetyl-transferring kinase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TLR4	ventricular function left/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
TLR4	nlr family pyrin domain-containing 3 protein/metabolism	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
TLR4	cyclohexylamines/pharmacology	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
TLR4	phenylenediamines/pharmacology	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
TLR4	toll-like receptor 4/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
TLR4	inflammation/metabolism	1.3743073712380038e-07	3.769216186224096e-07	0.027905752270633143	0.9605811478101344	1	2
TLR4	inflammasomes/metabolism	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
TLR4	endothelial cells/metabolism	4.051452284770107e-08	1.1493363352368931e-07	0.027905752270633143	0.9605811478101344	1	2
TLR4	myocardium/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
TLR4	monocrotaline/toxicity	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
TLR4	toll-like receptor 4/metabolism	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
TLR4	neutrophil infiltration	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
TLR4	myocardial reperfusion injury/drug therapy	4.433428069106071e-10	1.4109154455492301e-09	0.027905752270633143	0.9605811478101344	1	2
TLR4	hypertension pulmonary/chemically induced	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
TLR4	lung/blood supply	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
TLR4	inflammation/drug therapy	5.59903934327366e-09	1.6864428885313885e-08	0.027905752270633143	0.9605811478101344	1	2
TLR4	neutrophils/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
TLR4	bacterial toxins/metabolism	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
TLR4	macrophages/metabolism	2.8135184382271916e-07	7.532781363209851e-07	0.027905752270633143	0.9605811478101344	1	2
TLR4	hmgb1 protein/metabolism	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
TLR4	TICAM1	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
TLR4	adaptor proteins vesicular transport/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
TLR4	TRIM69	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
TLR4	acetates/therapeutic use	9.992007221626409e-16	4.201063600732629e-15	0.014018691588785045	0.9605811478101344	1	2
TLR4	breast neoplasms/drug therapy	0.0023586807672586474	0.004317133783539653	0.09538832359347407	0.9605811478101344	1	2
TLR4	interleukin-6/metabolism	0.00043168217062361514	0.0008593885776893424	0.06878335787959994	0.9605811478101344	1	2
TLR4	melanoma/drug therapy	9.992007221626409e-16	4.201063600732629e-15	0.014018691588785045	0.9605811478101344	1	2
TLR4	tyramine/analogs & derivatives	9.992007221626409e-16	4.201063600732629e-15	0.014018691588785045	0.9605811478101344	1	2
TLR4	antineoplastic agents phytogenic/therapeutic use	9.992007221626409e-16	4.201063600732629e-15	0.014018691588785045	0.9605811478101344	1	2
TLR4	paclitaxel/therapeutic use	9.992007221626409e-16	4.201063600732629e-15	0.014018691588785045	0.9605811478101344	1	2
TLR4	CXCL8	0.0028425077655068742	0.005151797058273371	0.09538832359347407	0.9605811478101344	1	2
TLR4	XIAP	3.3210715583043005e-05	7.476310569480622e-05	0.04166180294604871	0.9605811478101344	1	2
dna	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna	quinoxalines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna	membrane proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna	biomarkers tumor	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna	spiro compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dna	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD44	brain neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD44	cation transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD44	HSPB1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD44	SLC40A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
spiro compounds/pharmacology	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	quinoxalines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	membrane proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	KDM8	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	STING1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	biomarkers tumor	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	macrophages	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	sulfonamides/pharmacology	4.595889480096815e-08	1.302779265327521e-07	0.027905752270633143	0.9605811478101344	1	2
spiro compounds/pharmacology	rna small interfering/genetics	4.595889480096815e-08	1.302779265327521e-07	0.027905752270633143	0.9605811478101344	1	2
spiro compounds/pharmacology	curcumin/pharmacology	2.477217875274107e-09	7.60692196574422e-09	0.027905752270633143	0.9605811478101344	1	2
spiro compounds/pharmacology	cyclophilin d	9.058753747126502e-12	3.13445390170504e-11	0.018647711816067742	0.9605811478101344	1	2
spiro compounds/pharmacology	adenine nucleotide translocator 1/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	lactones/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	cyclosporine/pharmacology	9.058753747126502e-12	3.13445390170504e-11	0.018647711816067742	0.9605811478101344	1	2
spiro compounds/pharmacology	proto-oncogene proteins c-bcl-2/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	biphenyl compounds/pharmacology	8.329080758429086e-09	2.4662848853323194e-08	0.018647711816067742	0.9605811478101344	1	2
spiro compounds/pharmacology	nitrophenols/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
spiro compounds/pharmacology	cell death/drug effects	0.00025388982061913534	0.0005179756421773569	0.05541661182045544	0.9605811478101344	1	2
receptors interleukin-8a/physiology	proto-oncogene proteins c-akt/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-8a/physiology	mesenchymal stem cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-8a/physiology	anoikis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-8a/physiology	lung neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-8a/physiology	osteosarcoma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-8a/physiology	bone neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-8a/physiology	CXCL8	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
receptors interleukin-8a/physiology	CXCR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
calreticulin/analysis	CD8A	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
calreticulin/analysis	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
calreticulin/analysis	rna interference	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
calreticulin/analysis	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	prostatic neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	carcinoembryonic antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	eif-2 kinase/genetics	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
calreticulin/analysis	rna small interfering	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	cytotoxicity immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	hmgb1 protein/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	colorectal neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	KLK3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
calreticulin/analysis	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calreticulin/analysis	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	quinoxalines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	membrane proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	biomarkers tumor	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ATG5	glutathione peroxidase/metabolism	2.980518054584991e-10	9.580764261188203e-10	0.03271028037383177	0.9605811478101344	1	2
ATG5	cell survival	0.00010908687140964712	0.0002310198195024397	0.0644991443991049	0.9605811478101344	1	2
ATG5	flavonolignans/pharmacology	2.980518054584991e-10	9.580764261188203e-10	0.03271028037383177	0.9605811478101344	1	2
ATG5	autophagy-related proteins/genetics	2.980518054584991e-10	9.580764261188203e-10	0.03271028037383177	0.9605811478101344	1	2
ATG5	precursor cell lymphoblastic leukemia-lymphoma/metabolism	2.980518054584991e-10	9.580764261188203e-10	0.03271028037383177	0.9605811478101344	1	2
ATG5	glutathione/metabolism	0.0035723610251464644	0.006368837703762371	0.12539913750269532	0.9605811478101344	1	2
ATG5	a549 cells	8.491123885945306e-05	0.00018188312390685137	0.012970382291718041	0.8657199677887635	2	2
ATG5	colonic neoplasms/drug therapy	0.00467821093383991	0.008185476920030342	0.09538832359347407	0.9605811478101344	1	2
ATG5	hela cells	0.003920846835742564	0.006929605694144452	0.09538832359347407	0.9605811478101344	1	2
ATG5	adenocarcinoma/drug therapy	0.0021217393206759416	0.00391399837200997	0.0644991443991049	0.9605811478101344	1	2
ATG5	DDX53	0.0008342337002943401	0.001614003564767428	0.0644991443991049	0.9605811478101344	1	2
ATG5	autophagy	2.376576713203349e-11	8.113775684841659e-11	0.0009214163485586416	0.8657199677887635	2	2
ATG5	neoplasms/enzymology	6.252785638150016e-07	1.6343973651444166e-06	0.03271028037383177	0.9605811478101344	1	2
ATG5	lipid droplets/metabolism	6.252785638150016e-07	1.6343973651444166e-06	0.03271028037383177	0.9605811478101344	1	2
ATG5	drugs chinese herbal/chemistry	1.8712719040969716e-08	5.408731376708184e-08	0.03271028037383177	0.9605811478101344	1	2
ATG5	imidazoles/pharmacology	0.0011222380855465675	0.0021420747389949545	0.0644991443991049	0.9605811478101344	1	2
ATG5	crotonates/pharmacology	1.5139915970241447e-05	3.505249052944276e-05	0.03271028037383177	0.9605811478101344	1	2
ATG5	phospholipids/metabolism	6.252785638150016e-07	1.6343973651444166e-06	0.03271028037383177	0.9605811478101344	1	2
ATG5	cell respiration/drug effects	0.0032437189987082338	0.005829123521356194	0.09538832359347407	0.9605811478101344	1	2
ATG5	heterocyclic compounds 3-ring/pharmacology	0.00034595022541650255	0.0006940409981786213	0.0644991443991049	0.9605811478101344	1	2
ATG5	neuroblastoma/drug therapy	3.807053167936836e-06	9.389027768084044e-06	0.03271028037383177	0.9605811478101344	1	2
ATG5	cell membrane permeability/drug effects	3.807053167936836e-06	9.389027768084044e-06	0.03271028037383177	0.9605811478101344	1	2
ATG5	apoptosis	0.0009708803418468914	0.0018623603425300386	0.09538832359347407	0.9605811478101344	1	2
ATG5	arsenic/toxicity	4.571698575261962e-11	1.5428870379209513e-10	0.03271028037383177	0.9605811478101344	1	2
ATG5	autophagy-related proteins/metabolism	8.28094089788678e-05	0.0001775361580285956	0.0644991443991049	0.9605811478101344	1	2
ATG5	sesquiterpenes/pharmacology	1.5139915970241447e-05	3.505249052944276e-05	0.03271028037383177	0.9605811478101344	1	2
ATG5	spermatogenesis/drug effects	4.571698575261962e-11	1.5428870379209513e-10	0.03271028037383177	0.9605811478101344	1	2
ATG5	phospholipase a2 inhibitors/pharmacology	6.252785638150016e-07	1.6343973651444166e-06	0.03271028037383177	0.9605811478101344	1	2
ATG5	antimalarials/pharmacology	0.0002268284533887277	0.00046582654064033797	0.0644991443991049	0.9605811478101344	1	2
ATG5	liver/drug effects	2.2055820314559327e-06	5.529127075558886e-06	0.0644991443991049	0.9605811478101344	1	2
ATG5	chloroquine/pharmacology	1.7648105199441488e-12	6.405027546292772e-12	0.0009214163485586416	0.8657199677887635	2	2
ATG5	t-2 toxin/toxicity	1.8712719040969716e-08	5.408731376708184e-08	0.03271028037383177	0.9605811478101344	1	2
ATG5	ATG12	4.571698575261962e-11	1.5428870379209513e-10	0.03271028037383177	0.9605811478101344	1	2
ATG5	ATG7	0.0	0.0	2.173151765468494e-05	0.7135314763244264	3	2
ATG5	CCL22	1.5139915970241447e-05	3.505249052944276e-05	0.0644991443991049	0.9605811478101344	1	2
ATG5	PLA2G1B	6.252785638150016e-07	1.6343973651444166e-06	0.03271028037383177	0.9605811478101344	1	2
ATG5	SQSTM1	1.8712719040969716e-08	5.408731376708184e-08	0.03271028037383177	0.9605811478101344	1	2
ATG5	TESC	4.571698575261962e-11	1.5428870379209513e-10	0.03271028037383177	0.9605811478101344	1	2
coumaric acids/adverse effects	macrophages peritoneal/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
coumaric acids/adverse effects	killer cells natural/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
coumaric acids/adverse effects	antioxidants/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
coumaric acids/adverse effects	immunologic factors/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
coumaric acids/adverse effects	spleen/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
coumaric acids/adverse effects	mitogens/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPB1	brain neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPB1	cation transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPB1	SLC40A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
quinoxalines/pharmacology	membrane proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
quinoxalines/pharmacology	biomarkers tumor	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
quinoxalines/pharmacology	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
quinoxalines/pharmacology	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
quinoxalines/pharmacology	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutathione/metabolism	IL4	0.0037251038918170165	0.006609084300859546	0.12539913750269532	0.9605811478101344	1	2
glutathione/metabolism	glutamates/pharmacology	2.355893258254582e-13	8.918738763392347e-13	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	phytohemagglutinins/pharmacology	2.355893258254582e-13	8.918738763392347e-13	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	buthionine sulfoximine/pharmacology	2.355893258254582e-13	8.918738763392347e-13	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	antibodies monoclonal/immunology	2.355893258254582e-13	8.918738763392347e-13	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	cell division/drug effects	6.077023600126186e-05	0.0001326333561033282	0.07319670689438858	0.9605811478101344	1	2
glutathione/metabolism	mercaptoethanol/pharmacology	2.355893258254582e-13	8.918738763392347e-13	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	coenzyme a ligases/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	interleukins/metabolism	2.355893258254582e-13	8.918738763392347e-13	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	cd3 complex/immunology	2.355893258254582e-13	8.918738763392347e-13	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	CD28	2.355893258254582e-13	8.918738763392347e-13	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	CD3E	2.355893258254582e-13	8.918738763392347e-13	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	IL2	6.947266550938469e-05	0.00015113303691671571	0.07319670689438858	0.9605811478101344	1	2
glutathione/metabolism	IL5	2.355893258254582e-13	8.918738763392347e-13	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	oleic acid/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	glutathione peroxidase/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	cell survival	4.460846914078331e-09	1.3517420665420429e-08	0.03711991575621956	0.9605811478101344	1	2
glutathione/metabolism	autophagy-related proteins/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	iron chelating agents/pharmacology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	precursor cell lymphoblastic leukemia-lymphoma/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	neoplasm metastasis/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0	0.0	0.00026326181387389757	0.8657199677887635	2	2
glutathione/metabolism	lymph/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	flavonolignans/pharmacology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	tuberculosis/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	melanoma/blood	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	host-pathogen interactions	6.940633325847045e-07	1.805416276171256e-06	0.09085010295354308	0.9605811478101344	1	2
glutathione/metabolism	ACSL3	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
glutathione/metabolism	t-lymphocytes/cytology	7.831947423930785e-09	2.323762303900228e-08	0.03711991575621956	0.9605811478101344	1	2
IFNG	receptors antigen b-cell/antagonists & inhibitors	1.1479437476147325e-05	2.6951191297422662e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	zoledronic acid	1.0485269077431525e-06	2.6950246283423906e-06	0.0514018691588785	0.9605811478101344	1	2
IFNG	protein kinases/genetics	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	chalcones/pharmacology	5.737876428324462e-06	1.3900527358718574e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	cell cycle proteins/metabolism	0.0047896409177445864	0.008374464944840019	0.10039050502391293	0.9605811478101344	1	2
IFNG	oncogene proteins/metabolism	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	recombinant proteins	5.984129732228283e-05	0.00013068353044390767	0.0514018691588785	0.9605811478101344	1	2
IFNG	histone deacetylase inhibitors/pharmacology	0.0036525635005038026	0.00650591884934152	0.10039050502391293	0.9605811478101344	1	2
IFNG	gene expression regulation leukemic/drug effects	1.1479437476147325e-05	2.6951191297422662e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	tumor escape	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	neuroblastoma/immunology	1.0485269077431525e-06	2.6950246283423906e-06	0.0514018691588785	0.9605811478101344	1	2
IFNG	CD274	0.00010849115641320406	0.0002297803089911934	0.0072322232786017375	0.7135314763244264	3	2
IFNG	piperidines/chemistry	5.737876428324462e-06	1.3900527358718574e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	proteasome endopeptidase complex/chemistry	5.737876428324462e-06	1.3900527358718574e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	receptors antigen t-cell gamma-delta/metabolism	1.0485269077431525e-06	2.6950246283423906e-06	0.0514018691588785	0.9605811478101344	1	2
IFNG	nf-kappa b/genetics	0.004197725122568663	0.007383441843031024	0.10039050502391293	0.9605811478101344	1	2
IFNG	muscle skeletal/immunology	5.984129732228283e-05	0.00013068353044390767	0.0514018691588785	0.9605811478101344	1	2
IFNG	antibodies monoclonal/pharmacology	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	chemokine cxcl10/metabolism	1.0485269077431525e-06	2.6950246283423906e-06	0.0514018691588785	0.9605811478101344	1	2
IFNG	carbazoles/pharmacology	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	t-lymphocyte subsets/cytology	1.0485269077431525e-06	2.6950246283423906e-06	0.0514018691588785	0.9605811478101344	1	2
IFNG	antineoplastic agents immunological/pharmacology	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	lymphocytes tumor-infiltrating/drug effects	0.0019218498437348908	0.0035676471629760773	0.10039050502391293	0.9605811478101344	1	2
IFNG	plicamycin/analogs & derivatives	1.1479437476147325e-05	2.6951191297422662e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	antibiotics antineoplastic/pharmacology	0.0036525635005038026	0.00650591884934152	0.10039050502391293	0.9605811478101344	1	2
IFNG	th1 cells/immunology	5.737876428324462e-06	1.3900527358718574e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	breast neoplasms/immunology	0.0047896409177445864	0.008374464944840019	0.10039050502391293	0.9605811478101344	1	2
IFNG	amidines/pharmacology	5.737876428324462e-06	1.3900527358718574e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	cytotoxicity immunologic/drug effects	4.466609636044616e-06	1.0960468475849939e-05	0.013671464016649978	0.8657199677887635	2	2
IFNG	th1 cells/drug effects	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	adaptor proteins signal transducing/metabolism	5.737876428324462e-06	1.3900527358718574e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	interferon-gamma/genetics	5.984129732228283e-05	0.00013068353044390767	0.0514018691588785	0.9605811478101344	1	2
IFNG	interferon regulatory factor-2/genetics	5.984129732228283e-05	0.00013068353044390767	0.0514018691588785	0.9605811478101344	1	2
IFNG	rna small interfering/pharmacology	5.984129732228283e-05	0.00013068353044390767	0.0514018691588785	0.9605811478101344	1	2
IFNG	proto-oncogene proteins/genetics	5.984129732228283e-05	0.00013068353044390767	0.0514018691588785	0.9605811478101344	1	2
IFNG	gene silencing/drug effects	5.984129732228283e-05	0.00013068353044390767	0.0514018691588785	0.9605811478101344	1	2
IFNG	plasmids/genetics	0.005428844710119951	0.00941073733538208	0.10039050502391293	0.9605811478101344	1	2
IFNG	carcinoma squamous cell/immunology	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	CIITA	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	neovascularization pathologic	1.0485269077431525e-06	2.6950246283423906e-06	0.0514018691588785	0.9605811478101344	1	2
IFNG	mouth neoplasms/immunology	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	t-lymphocytes/cytology	0.0022893232381460127	0.004204848280126898	0.10039050502391293	0.9605811478101344	1	2
IFNG	cancer vaccines/pharmacology	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	cell differentiation/drug effects	0.0005737612483897037	0.0011301963731346544	0.022141107963423473	0.8657199677887635	2	2
IFNG	b7-h1 antigen/genetics	1.0637484226805327e-09	3.322499677469951e-09	0.002413233293844061	0.8657199677887635	2	2
IFNG	antigen presentation/drug effects	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	CD28	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	CD3E	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	IL5	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	burkitt lymphoma/drug therapy	5.737876428324462e-06	1.3900527358718574e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	SELP	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	maleimides	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	interferon regulatory factor-1/genetics	5.984129732228283e-05	0.00013068353044390767	0.0514018691588785	0.9605811478101344	1	2
IFNG	CD4	3.764766276503906e-13	1.4152696822567456e-12	0.00010244858322922901	0.7135314763244264	3	2
IFNG	leukemia lymphocytic chronic b-cell/drug therapy	1.1479437476147325e-05	2.6951191297422662e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	histone deacetylases/chemistry	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	killer cells natural/drug effects	0.003153430265424917	0.005677977173710786	0.10039050502391293	0.9605811478101344	1	2
IFNG	ligands	0.005428844710119951	0.00941073733538208	0.10039050502391293	0.9605811478101344	1	2
IFNG	EIF2S1	5.737876428324462e-06	1.3900527358718574e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	FOXP3	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	HDAC9	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	IL4	0.0041257023625257405	0.007272424503435204	0.04390360402651234	0.8657199677887635	2	2
IFNG	IRF1	5.984129732228283e-05	0.00013068353044390767	0.0514018691588785	0.9605811478101344	1	2
IFNG	IRF2	5.984129732228283e-05	0.00013068353044390767	0.0514018691588785	0.9605811478101344	1	2
IFNG	PRF1	0.0022893232381460127	0.004204848280126898	0.10039050502391293	0.9605811478101344	1	2
IFNG	PRKD1	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	SOCS1	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	TBX21	2.1202803945685744e-05	4.845350553425366e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	dose-response relationship immunologic	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	glutamates/pharmacology	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	adenosine triphosphatases/antagonists & inhibitors	1.0463361843626728e-07	2.89092984872534e-07	0.0514018691588785	0.9605811478101344	1	2
IFNG	calcitriol/metabolism	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	isoantigens/immunology	1.0463361843626728e-07	2.89092984872534e-07	0.0514018691588785	0.9605811478101344	1	2
IFNG	interleukin-4/antagonists & inhibitors	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	phytohemagglutinins/pharmacology	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	buthionine sulfoximine/pharmacology	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	antibodies monoclonal/immunology	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	ovalbumin/immunology	1.0463361843626728e-07	2.89092984872534e-07	0.0514018691588785	0.9605811478101344	1	2
IFNG	interphase/drug effects	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	affinity labels	1.0463361843626728e-07	2.89092984872534e-07	0.0514018691588785	0.9605811478101344	1	2
IFNG	immunosuppressive agents/metabolism	0.0036525635005038026	0.00650591884934152	0.10039050502391293	0.9605811478101344	1	2
IFNG	transcription factors/metabolism	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	receptors calcitriol/physiology	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	adenosine/analogs & derivatives	1.0463361843626728e-07	2.89092984872534e-07	0.0514018691588785	0.9605811478101344	1	2
IFNG	growth inhibitors/pharmacology	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	th2 cells/metabolism	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	mercaptoethanol/pharmacology	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	l-selectin/biosynthesis	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	interferon-gamma/antagonists & inhibitors	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
IFNG	interleukins/metabolism	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	cd3 complex/immunology	9.317589423873951e-05	0.00019833385944928835	0.0514018691588785	0.9605811478101344	1	2
IFNG	th1 cells/metabolism	3.663601893721946e-05	8.175616857568974e-05	0.0514018691588785	0.9605811478101344	1	2
glutathione peroxidase/therapeutic use	BDKRB2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	cd8-positive t-lymphocytes/drug effects	1.2593558440521235e-07	3.465586326717576e-07	0.03711991575621956	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	myeloid-derived suppressor cells/immunology	2.1216362000586741e-13	8.055421894075021e-13	0.018647711816067742	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	CD8A	8.561751006697094e-05	0.00018302257726939843	0.0644991443991049	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	lung neoplasms/immunology	1.0363931934875836e-12	3.832030375652229e-12	0.018647711816067742	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	benzhydryl compounds/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	adjuvants immunologic/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	azocines/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	mitochondrial proteins/metabolism	0.0021545962730634693	0.0039686331352133146	0.08253257864946689	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	apoptosis regulatory proteins/metabolism	0.000688492180403788	0.0013445416823332787	0.0735378000087754	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	lymphocytes tumor-infiltrating/drug effects	3.5416114485542494e-14	1.392890638917661e-13	0.018647711816067742	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	cytotoxicity immunologic/drug effects	1.08218036753982e-08	3.1758169497561496e-08	0.03711991575621956	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	cisplatin/administration & dosage	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	carcinoma lewis lung/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	antigens neoplasm/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	ARG1	4.798383912429927e-13	1.8004555565223794e-12	0.018647711816067742	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	cytokines/blood	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes regulatory/drug effects	TCIM	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CD274	aniline compounds/chemistry	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	cd8-positive t-lymphocytes/cytology	0.0001620432826867635	0.00033784683656527294	0.08253257864946689	0.9605811478101344	1	2
CD274	hyaluronic acid/chemistry	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	iron/chemistry	8.400403802788503e-05	0.00017999232560143917	0.04205607476635514	0.9605811478101344	1	2
CD274	phenol/chemistry	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	nf-e2-related factor 2/genetics	0.0020211690018200335	0.0037378572514786194	0.08253257864946689	0.9605811478101344	1	2
CD274	immunogenic cell death/drug effects	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	exosomes/drug effects	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	aniline compounds/pharmacology	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	programmed cell death 1 receptor/metabolism	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	glycogen synthase kinase 3/metabolism	8.400403802788503e-05	0.00017999232560143917	0.04205607476635514	0.9605811478101344	1	2
CD274	b7-h1 antigen/metabolism	1.0695888619238758e-12	3.954107181035817e-12	0.00020417327297937168	0.7135314763244264	3	2
CD274	cell line tumor/transplantation	0.002668493786680215	0.004853567976301384	0.1214816672917065	0.9605811478101344	1	2
CD274	immunologic memory	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	lung neoplasms/drug therapy	0.0002859574723710345	0.000581461804928209	0.014774701220028882	0.8657199677887635	2	2
CD274	tumor escape/drug effects	1.7074954561380196e-08	4.954186053024221e-08	0.004634401364987668	0.8657199677887635	2	2
CD274	allografts	8.400403802788503e-05	0.00017999232560143917	0.04205607476635514	0.9605811478101344	1	2
CD274	benzylidene compounds/pharmacology	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	exosomes/metabolism	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	BDKRB2	2.591099653725948e-06	6.450103326786688e-06	0.08253257864946689	0.9605811478101344	1	2
CD274	BTRC	8.400403802788503e-05	0.00017999232560143917	0.04205607476635514	0.9605811478101344	1	2
CD274	metal-organic frameworks/chemistry	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	CTLA4	8.400403802788503e-05	0.00017999232560143917	0.04205607476635514	0.9605811478101344	1	2
CD274	GABPA	8.400403802788503e-05	0.00017999232560143917	0.04205607476635514	0.9605811478101344	1	2
CD274	PDCD1	0.0	0.0	7.274246667891831e-06	0.5304112294886878	4	2
CD274	interleukin-10/metabolism	0.0020211690018200335	0.0037378572514786194	0.08253257864946689	0.9605811478101344	1	2
CD274	chalcones/pharmacology	5.362130687247557e-07	1.4072641041832417e-06	0.04205607476635514	0.9605811478101344	1	2
CD274	tumor escape	2.591099653725948e-06	6.450103326786688e-06	0.04205607476635514	0.9605811478101344	1	2
CD274	protein kinases/genetics	2.591099653725948e-06	6.450103326786688e-06	0.04205607476635514	0.9605811478101344	1	2
CD274	histone deacetylase inhibitors/pharmacology	0.0012584053938039519	0.002386899700842183	0.08253257864946689	0.9605811478101344	1	2
CD274	nitrobenzenes/chemistry	1.9241567561500972e-08	5.5594035066960214e-08	0.04205607476635514	0.9605811478101344	1	2
CD274	cell cycle proteins/metabolism	0.0017401129002054816	0.0032480536085108752	0.08253257864946689	0.9605811478101344	1	2
CD274	immune checkpoint inhibitors/chemical synthesis	1.9241567561500972e-08	5.5594035066960214e-08	0.04205607476635514	0.9605811478101344	1	2
CD274	programmed cell death 1 receptor/antagonists & inhibitors	1.9241567561500972e-08	5.5594035066960214e-08	0.04205607476635514	0.9605811478101344	1	2
CD274	liver neoplasms/drug therapy	0.0012584053938039519	0.002386899700842183	0.08253257864946689	0.9605811478101344	1	2
CD274	antineoplastic agents phytogenic/pharmacology	0.000796583568725473	0.001547543794454069	0.021673232895463388	0.8657199677887635	2	2
CD274	carbazoles/pharmacology	2.591099653725948e-06	6.450103326786688e-06	0.04205607476635514	0.9605811478101344	1	2
CD274	antigen presentation/drug effects	1.5400029707679508e-05	3.56285262324153e-05	0.04205607476635514	0.9605811478101344	1	2
CD274	drug combinations	0.002330343092947551	0.004273781776185959	0.08253257864946689	0.9605811478101344	1	2
CD274	antibodies monoclonal/pharmacology	1.5400029707679508e-05	3.56285262324153e-05	0.04205607476635514	0.9605811478101344	1	2
CD274	carcinoma squamous cell/immunology	2.591099653725948e-06	6.450103326786688e-06	0.04205607476635514	0.9605811478101344	1	2
CD274	b7-h1 antigen/genetics	1.3570589096900676e-11	4.6663185965138196e-11	0.0015795708832433853	0.8657199677887635	2	2
CD274	t-lymphocytes/cytology	0.0007194141701180046	0.0014019483491923075	0.08253257864946689	0.9605811478101344	1	2
CD274	mouth neoplasms/immunology	2.591099653725948e-06	6.450103326786688e-06	0.04205607476635514	0.9605811478101344	1	2
CD274	maleimides	2.591099653725948e-06	6.450103326786688e-06	0.04205607476635514	0.9605811478101344	1	2
CD274	histone deacetylases/chemistry	1.5400029707679508e-05	3.56285262324153e-05	0.04205607476635514	0.9605811478101344	1	2
CD274	adaptor proteins signal transducing/metabolism	5.362130687247557e-07	1.4072641041832417e-06	0.04205607476635514	0.9605811478101344	1	2
CD274	CIITA	1.5400029707679508e-05	3.56285262324153e-05	0.04205607476635514	0.9605811478101344	1	2
CD274	EIF2S1	5.362130687247557e-07	1.4072641041832417e-06	0.04205607476635514	0.9605811478101344	1	2
CD274	FOXP3	1.5400029707679508e-05	3.56285262324153e-05	0.04205607476635514	0.9605811478101344	1	2
CD274	HDAC9	1.5400029707679508e-05	3.56285262324153e-05	0.04205607476635514	0.9605811478101344	1	2
CD274	PRKD1	2.591099653725948e-06	6.450103326786688e-06	0.04205607476635514	0.9605811478101344	1	2
CD274	benzylidene compounds/chemistry	2.0672014011680062e-07	5.594409781877034e-07	0.04205607476635514	0.9605811478101344	1	2
CD274	naphthalenes/pharmacology	5.0067516861318495e-06	1.224366250841116e-05	0.04205607476635514	0.9605811478101344	1	2
CD274	g1 phase cell cycle checkpoints/drug effects	0.0007194141701180046	0.0014019483491923075	0.08253257864946689	0.9605811478101344	1	2
CD274	uterine cervical neoplasms/drug therapy	0.0008763121684151054	0.0016937784421159152	0.08253257864946689	0.9605811478101344	1	2
killer cells natural/cytology	macrophages peritoneal/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
killer cells natural/cytology	antioxidants/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
killer cells natural/cytology	immunologic factors/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
killer cells natural/cytology	spleen/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
killer cells natural/cytology	mitogens/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD8A	cd8-positive t-lymphocytes/cytology	1.2155711399119973e-05	2.8435981424699963e-05	0.0644991443991049	0.9605811478101344	1	2
CD8A	nivolumab/therapeutic use	1.8864353412695323e-09	5.825227787718578e-09	0.03271028037383177	0.9605811478101344	1	2
CD8A	antibodies monoclonal humanized/pharmacology	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
CD8A	cd8-positive t-lymphocytes/drug effects	1.1102230246251565e-16	4.854858636837654e-16	8.569015492273871e-05	0.7135314763244264	3	2
CD8A	amino acid transport system y+/metabolism	3.560085416054459e-05	7.97285558691404e-05	0.0644991443991049	0.9605811478101344	1	2
CD8A	fusion regulatory protein 1 heavy chain/metabolism	1.8864353412695323e-09	5.825227787718578e-09	0.03271028037383177	0.9605811478101344	1	2
CD8A	melanoma/genetics	0.0013305121763778072	0.0025165250463050435	0.09538832359347407	0.9605811478101344	1	2
CD8A	endoplasmic reticulum/drug effects	0.0028821284122195756	0.005221459920510863	0.09538832359347407	0.9605811478101344	1	2
CD8A	cd36 antigens/antagonists & inhibitors	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
CD8A	ACSL4	1.8600621730646694e-06	4.686395930948444e-06	0.0644991443991049	0.9605811478101344	1	2
CD8A	myeloid-derived suppressor cells/immunology	0.00011081017083902633	0.0002340847606265069	0.0644991443991049	0.9605811478101344	1	2
CD8A	fatty acids/metabolism	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
CD8A	AIFM2	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
CD8A	cysteine/metabolism	1.8864353412695323e-09	5.825227787718578e-09	0.03271028037383177	0.9605811478101344	1	2
CD8A	S100A4	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
CD8A	SLC3A2	1.8864353412695323e-09	5.825227787718578e-09	0.03271028037383177	0.9605811478101344	1	2
CD8A	SLC7A11	0.0048682339326305835	0.008502441519854175	0.15455249958593884	0.9605811478101344	1	2
CD8A	SLC9A1	0.00022093315072990727	0.0004542273505495147	0.09538832359347407	0.9605811478101344	1	2
CD8A	benzhydryl compounds/immunology	1.2593558440521235e-07	3.465586326717576e-07	0.03271028037383177	0.9605811478101344	1	2
CD8A	lung neoplasms/immunology	0.00017779292097908073	0.0003690085966061161	0.0644991443991049	0.9605811478101344	1	2
CD8A	neovascularization pathologic/immunology	1.996716358920736e-08	5.760743559471916e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	fas receptor/genetics	1.996716358920736e-08	5.760743559471916e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	cytokines/blood	1.2593558440521235e-07	3.465586326717576e-07	0.03271028037383177	0.9605811478101344	1	2
CD8A	sarcoma/drug therapy	1.996716358920736e-08	5.760743559471916e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	azocines/immunology	1.2593558440521235e-07	3.465586326717576e-07	0.03271028037383177	0.9605811478101344	1	2
CD8A	docetaxel	0.0006585189002574765	0.0012870334822158355	0.0644991443991049	0.9605811478101344	1	2
CD8A	cytotoxicity immunologic/drug effects	0.0028821284122195756	0.005221459920510863	0.12539913750269532	0.9605811478101344	1	2
CD8A	hek293 cells	0.0052618907930607195	0.009148660847362412	0.12539913750269532	0.9605811478101344	1	2
CD8A	hypoxia	1.996716358920736e-08	5.760743559471916e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	carcinoma lewis lung/immunology	1.2593558440521235e-07	3.465586326717576e-07	0.03271028037383177	0.9605811478101344	1	2
CD8A	plant leaves/chemistry	1.996716358920736e-08	5.760743559471916e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	fas ligand protein/genetics	1.996716358920736e-08	5.760743559471916e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	ARG1	0.00014131299984299073	0.00029625073885502135	0.0644991443991049	0.9605811478101344	1	2
CD8A	PRF1	8.561751006697094e-05	0.00018302257726939843	0.0644991443991049	0.9605811478101344	1	2
CD8A	TCIM	1.2593558440521235e-07	3.465586326717576e-07	0.03271028037383177	0.9605811478101344	1	2
CD8A	dendritic cells/immunology	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	prostate-specific antigen/immunology	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	recombinant fusion proteins/pharmacology	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	mitochondrial membrane transport proteins/genetics	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	interleukin-10/pharmacology	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	neoplasms/immunology	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	prostatic neoplasms/therapy	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	carcinoembryonic antigen/immunology	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	eif-2 kinase/genetics	0.001169653025281825	0.0022283340448815067	0.0644991443991049	0.9605811478101344	1	2
CD8A	rna small interfering	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	immunoglobulin fc fragments/pharmacology	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	cytotoxicity immunologic	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	breast neoplasms/therapy	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	receptors chimeric antigen/immunology	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	hmgb1 protein/biosynthesis	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	receptors interleukin-10/metabolism	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	colorectal neoplasms/therapy	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	monocarboxylic acid transporters/genetics	6.632486448943098e-09	1.9812093378444308e-08	0.03271028037383177	0.9605811478101344	1	2
CD8A	KLK3	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	MUC1	0.0005608682519995245	0.0011057876437526172	0.0644991443991049	0.9605811478101344	1	2
CD8A	NPEPPS	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	PROM1	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	PSAT1	8.033954999486781e-06	1.919720817477886e-05	0.03271028037383177	0.9605811478101344	1	2
CD8A	ATL1	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
CD8A	CD36	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
IL4	interleukin-10/metabolism	4.4155790135391726e-12	1.558423020498026e-11	0.0009214163485586416	0.8657199677887635	2	2
IL4	gene expression regulation	0.0013546484695101668	0.0025577879126282574	0.0644991443991049	0.9605811478101344	1	2
IL4	aspirin/administration & dosage	6.874443155169274e-06	1.6584716345899132e-05	0.03271028037383177	0.9605811478101344	1	2
IL4	cyclin b1/metabolism	6.874443155169274e-06	1.6584716345899132e-05	0.03271028037383177	0.9605811478101344	1	2
IL4	b-lymphocytes/drug effects	0.0030647335234157413	0.00552323399740643	0.09538832359347407	0.9605811478101344	1	2
IL4	nitric oxide/metabolism	0.0010225856949998002	0.0019572853028349334	0.0644991443991049	0.9605811478101344	1	2
IL4	lactic acid/metabolism	0.000879695684553039	0.0017001692192343447	0.0644991443991049	0.9605811478101344	1	2
IL4	lymphoma t-cell/drug therapy	6.874443155169274e-06	1.6584716345899132e-05	0.03271028037383177	0.9605811478101344	1	2
IL4	monocytes/drug effects	0.0030647335234157413	0.00552323399740643	0.09538832359347407	0.9605811478101344	1	2
IL4	t-lymphocytes/cytology	0.000151096303033893	0.00031553052560061306	0.0644991443991049	0.9605811478101344	1	2
IL4	interleukin-4/metabolism	6.874443155169274e-06	1.6584716345899132e-05	0.03271028037383177	0.9605811478101344	1	2
IL4	CD4	0.002764305867319128	0.005018579632816569	0.09538832359347407	0.9605811478101344	1	2
IL4	ligands	0.0005349787352844082	0.0010567291843353013	0.0644991443991049	0.9605811478101344	1	2
IL4	IL1B	0.00019239971282947188	0.0003974542179765948	0.0644991443991049	0.9605811478101344	1	2
IL4	SOCS5	6.874443155169274e-06	1.6584716345899132e-05	0.03271028037383177	0.9605811478101344	1	2
IL4	dose-response relationship immunologic	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	glutamates/pharmacology	1.345080247738828e-06	3.4276848476821173e-06	0.03271028037383177	0.9605811478101344	1	2
IL4	drug hypersensitivity/drug therapy	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	jurkat cells/drug effects	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
IL4	dinitrofluorobenzene/pharmacology	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	calcitriol/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	interleukin-4/antagonists & inhibitors	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	rna messenger/metabolism	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
IL4	anti-inflammatory agents/pharmacology	6.641519666106266e-05	0.0001446101378612591	0.0644991443991049	0.9605811478101344	1	2
IL4	hypersensitivity delayed/chemically induced	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	ear/pathology	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	phytohemagglutinins/pharmacology	1.345080247738828e-06	3.4276848476821173e-06	0.03271028037383177	0.9605811478101344	1	2
IL4	cyclins/metabolism	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	lactones/metabolism	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	oxazolone/pharmacology	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	buthionine sulfoximine/pharmacology	1.345080247738828e-06	3.4276848476821173e-06	0.03271028037383177	0.9605811478101344	1	2
IL4	antibodies monoclonal/immunology	1.345080247738828e-06	3.4276848476821173e-06	0.03271028037383177	0.9605811478101344	1	2
IL4	interphase/drug effects	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	cell division/drug effects	2.041793161211558e-07	5.53379909261124e-07	0.00535588186581037	0.8657199677887635	2	2
IL4	immunosuppressive agents/metabolism	4.874989301129062e-13	1.8288882782251757e-12	0.0009214163485586416	0.8657199677887635	2	2
IL4	cytokines/biosynthesis	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	transcription factors/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	triterpenes/pharmacology	1.6476800976938932e-05	3.80837098164954e-05	0.0644991443991049	0.9605811478101344	1	2
IL4	dihydroorotase/antagonists & inhibitors	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	receptors calcitriol/physiology	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	dna fragmentation/drug effects	0.0004454742043631388	0.0008864454203789245	0.09538832359347407	0.9605811478101344	1	2
IL4	foot/pathology	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	growth inhibitors/pharmacology	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	oleic acid/toxicity	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
IL4	th2 cells/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	clone cells	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	mercaptoethanol/pharmacology	1.345080247738828e-06	3.4276848476821173e-06	0.03271028037383177	0.9605811478101344	1	2
IL4	cyclophilin a/antagonists & inhibitors	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	l-selectin/biosynthesis	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	interferon-gamma/antagonists & inhibitors	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	tacrolimus binding protein 1a/metabolism	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	spiro compounds/metabolism	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	interleukins/metabolism	1.345080247738828e-06	3.4276848476821173e-06	0.03271028037383177	0.9605811478101344	1	2
IL4	arachidonic acid/toxicity	5.513522971511975e-11	1.8460463853590893e-10	0.03271028037383177	0.9605811478101344	1	2
IL4	cd3 complex/immunology	1.345080247738828e-06	3.4276848476821173e-06	0.03271028037383177	0.9605811478101344	1	2
IL4	enzyme inhibitors/metabolism	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	imp dehydrogenase/antagonists & inhibitors	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	th1 cells/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	nfatc transcription factors/antagonists & inhibitors	6.023819898448579e-08	1.6899501351443477e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	CD28	1.345080247738828e-06	3.4276848476821173e-06	0.03271028037383177	0.9605811478101344	1	2
IL4	CD3E	1.345080247738828e-06	3.4276848476821173e-06	0.03271028037383177	0.9605811478101344	1	2
IL4	CD40LG	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	IL2	5.995204332975845e-15	2.4378875900673447e-14	8.569015492273871e-05	0.7135314763244264	3	2
IL4	IL5	1.345080247738828e-06	3.4276848476821173e-06	0.03271028037383177	0.9605811478101344	1	2
IL4	PPIA	1.4982355600601238e-07	4.1009432188957925e-07	0.03271028037383177	0.9605811478101344	1	2
IL4	SELP	3.37278289741505e-07	8.941098631983529e-07	0.03271028037383177	0.9605811478101344	1	2
SLC40A1	brain neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SLC40A1	cation transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondrial proteins/metabolism	myeloid-derived suppressor cells/immunology	0.0025448419271099088	0.004642067908407319	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	glioblastoma/drug therapy	0.0018054928989259533	0.0033618366215285383	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	MCL1	7.888045931536691e-05	0.0001698289734030108	0.0009776378691598736	0.7135314763244264	3	2
mitochondrial proteins/metabolism	lung neoplasms/immunology	0.0034541165284649455	0.006176008532932862	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	TCIM	3.301742878480951e-05	7.438114538137121e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	flavonoids/metabolism	0.000785205698855207	0.0015257085792156168	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	paracrine communication/drug effects	1.0218480160695265e-05	2.4106254074792336e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	necrosis	2.196025039591376e-08	6.328317876475057e-08	0.0015795708832433853	0.8657199677887635	2	2
mitochondrial proteins/metabolism	multiple myeloma/metabolism	0.000785205698855207	0.0015257085792156168	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	multiple myeloma/pathology	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	nitrophenols/toxicity	0.0021545962730634693	0.0039686331352133146	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	superoxide dismutase/metabolism	0.0025448419271099088	0.004642067908407319	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	piperazines/toxicity	0.0021545962730634693	0.0039686331352133146	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	tumor necrosis factor-alpha/pharmacology	0.004541953776193042	0.007953379148399983	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	hydrogen peroxide/toxicity	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	ascorbic acid/analogs & derivatives	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	enzyme inhibitors/pharmacology	0.004541953776193042	0.007953379148399983	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	jnk mitogen-activated protein kinases/metabolism	0.0029776217975442387	0.005374589061993891	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	autocrine communication/drug effects	1.0218480160695265e-05	2.4106254074792336e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	dexamethasone/administration & dosage	9.097026248960915e-07	2.3510870324357085e-06	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	decitabine	1.0218480160695265e-05	2.4106254074792336e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	poly(adp-ribose) polymerases/metabolism	0.0021545962730634693	0.0039686331352133146	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	acetaldehyde/pharmacology	3.122413273493052e-07	8.325428450111841e-07	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	glioblastoma/enzymology	0.0021545962730634693	0.0039686331352133146	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	dynamins	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	free radicals/metabolism	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	benzhydryl compounds/immunology	3.301742878480951e-05	7.438114538137121e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	antimycin a/pharmacology	3.122413273493052e-07	8.325428450111841e-07	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	piperidines/metabolism	0.000785205698855207	0.0015257085792156168	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	acetylcysteine/pharmacology	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	dna fragmentation/drug effects	0.004541953776193042	0.007953379148399983	0.1214816672917065	0.9605811478101344	1	2
mitochondrial proteins/metabolism	carrier proteins/metabolism	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	cyclin-dependent kinases/antagonists & inhibitors	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	aminopyridines/pharmacology	0.0021545962730634693	0.0039686331352133146	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	apoptosis inducing factor/metabolism	3.8958911260378315e-06	9.605972662366598e-06	0.0015795708832433853	0.8657199677887635	2	2
mitochondrial proteins/metabolism	chromosome segregation/drug effects	0.0021545962730634693	0.0039686331352133146	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	bcl-2 homologous antagonist-killer protein/metabolism	0.0021545962730634693	0.0039686331352133146	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	biphenyl compounds/toxicity	0.0021545962730634693	0.0039686331352133146	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	protein transport	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	bcl-2-associated x protein/metabolism	0.0006769211516448603	0.001322413392828804	0.009064629456995965	0.8657199677887635	2	2
mitochondrial proteins/metabolism	poly (adp-ribose) polymerase-1	0.000785205698855207	0.0015257085792156168	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	cytochromes c/metabolism	2.9168401027845903e-10	9.389763554707934e-10	4.17068384444988e-06	0.35414021462530776	5	2
mitochondrial proteins/metabolism	sulfonamides/toxicity	0.0021545962730634693	0.0039686331352133146	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	leukemia myeloid acute/enzymology	1.0218480160695265e-05	2.4106254074792336e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	glutathione disulfide/metabolism	3.122413273493052e-07	8.325428450111841e-07	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	isocoumarins	9.097026248960915e-07	2.3510870324357085e-06	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	nitriles/metabolism	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	leukemia/metabolism	0.000785205698855207	0.0015257085792156168	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	histones/metabolism	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	membrane glycoproteins/metabolism	0.000785205698855207	0.0015257085792156168	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	liver diseases alcoholic/etiology	3.122413273493052e-07	8.325428450111841e-07	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	protective agents/pharmacology	0.004541953776193042	0.007953379148399983	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	dna damage/drug effects	0.0021545962730634693	0.0039686331352133146	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	AIFM1	0.00022316174065717398	0.0004586381485840205	0.009064629456995965	0.8657199677887635	2	2
mitochondrial proteins/metabolism	BIRC3	1.0218480160695265e-05	2.4106254074792336e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	DNM1L	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	H2AX	0.00018425897927920598	0.0003816743682025492	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	MLKL	1.0218480160695265e-05	2.4106254074792336e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	TNFRSF10D	0.000785205698855207	0.0015257085792156168	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	azocines/immunology	3.301742878480951e-05	7.438114538137121e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	cytokines/blood	3.301742878480951e-05	7.438114538137121e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	nf-kappa b/genetics	0.003975301289094624	0.007023032277400502	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	brain neoplasms/drug therapy	0.0018054928989259533	0.0033618366215285383	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	biomarkers tumor/genetics	1.899771066815603e-05	4.366324661852436e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	chemokine ccl2/genetics	1.899771066815603e-05	4.366324661852436e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	rna messenger/genetics	0.0018106668643547152	0.0033709012095999966	0.021673232895463388	0.8657199677887635	2	2
mitochondrial proteins/metabolism	paracrine communication	1.899771066815603e-05	4.366324661852436e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	oligopeptides/pharmacology	1.5810688314132904e-09	4.8987360307757485e-09	0.0015795708832433853	0.8657199677887635	2	2
mitochondrial proteins/metabolism	apoptosis regulatory proteins	1.899771066815603e-05	4.366324661852436e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	carcinoma lewis lung/immunology	3.301742878480951e-05	7.438114538137121e-05	0.04205607476635514	0.9605811478101344	1	2
mitochondrial proteins/metabolism	mesenchymal stem cells/cytology	0.0021545962730634693	0.0039686331352133146	0.08253257864946689	0.9605811478101344	1	2
mitochondrial proteins/metabolism	ARG1	0.0029776217975442387	0.005374589061993891	0.08253257864946689	0.9605811478101344	1	2
BDKRB2	PDCD1	8.077349900048603e-11	2.680858205573861e-10	0.046290202272826986	0.9605811478101344	1	2
BDKRB2	nitrobenzenes/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
BDKRB2	immune checkpoint inhibitors/chemical synthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
BDKRB2	programmed cell death 1 receptor/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
BDKRB2	liver neoplasms/drug therapy	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
BDKRB2	t-lymphocytes/cytology	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
ovalbumin/immunology	cell line	6.03680407773588e-07	1.5807536378375377e-06	0.06074766355140186	0.9605811478101344	1	2
ovalbumin/immunology	cytotoxicity immunologic/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
ovalbumin/immunology	adenosine triphosphate/metabolism	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
ovalbumin/immunology	TNF	1.0069125590095318e-05	2.3815069835917354e-05	0.06542056074766354	0.9605811478101344	1	2
ovalbumin/immunology	isoantigens/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ovalbumin/immunology	adenosine triphosphatases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ovalbumin/immunology	affinity labels	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ovalbumin/immunology	adenosine/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ovalbumin/immunology	WDTC1	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
IL6	tumor-associated macrophages/drug effects	0.0008266389137319141	0.0015995905537968442	0.09148348032117941	0.9605811478101344	1	2
IL6	inflammation/metabolism	0.0050980101162090286	0.008883342056601332	0.09148348032117941	0.9605811478101344	1	2
IL6	basic-leucine zipper transcription factors/analysis	2.0956738788768803e-07	5.666595251591545e-07	0.04672897196261682	0.9605811478101344	1	2
IL6	toll-like receptor 4/metabolism	0.0050980101162090286	0.008883342056601332	0.09148348032117941	0.9605811478101344	1	2
IL6	HLF	2.0956738788768803e-07	5.666595251591545e-07	0.04672897196261682	0.9605811478101344	1	2
IL6	GGT1	2.0956738788768803e-07	5.666595251591545e-07	0.04672897196261682	0.9605811478101344	1	2
IL6	JAK2	2.0956738788768803e-07	5.666595251591545e-07	0.04672897196261682	0.9605811478101344	1	2
IL6	STAT3	8.881784197001252e-16	3.739270154200565e-15	7.450806053034836e-05	0.7135314763244264	3	2
IL6	TGFB1	1.9294632558342073e-10	6.270755581461174e-10	8.069932299174802e-05	0.5304112294886878	4	2
IL6	cyclin b1/metabolism	0.00020868551760833132	0.0004296478001894191	0.04672897196261682	0.9605811478101344	1	2
IL6	interleukin-10/metabolism	0.004505808465516292	0.00789447433627648	0.09148348032117941	0.9605811478101344	1	2
IL6	neoplasm metastasis/pathology	1.617445133716977e-06	4.096660575323597e-06	0.04672897196261682	0.9605811478101344	1	2
IL6	liver neoplasms/metabolism	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	antineoplastic agents phytogenic	1.617445133716977e-06	4.096660575323597e-06	0.04672897196261682	0.9605811478101344	1	2
IL6	receptor igf type 1/metabolism	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	neovascularization pathologic/pathology	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	gene silencing	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	glioblastoma/drug therapy	0.001535200262871128	0.0028831427083290144	0.09148348032117941	0.9605811478101344	1	2
IL6	neovascularization pathologic/immunology	7.55233245641751e-06	1.8148645885459756e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	thiazoles/pharmacology	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	aspirin/administration & dosage	0.00020868551760833132	0.0004296478001894191	0.04672897196261682	0.9605811478101344	1	2
IL6	acetates/therapeutic use	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	neoplasm metastasis/immunology	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	stat3 transcription factor/metabolism	2.3723811803932904e-10	7.667291155865035e-10	0.0019744636040542316	0.8657199677887635	2	2
IL6	neoplasm proteins/metabolism	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	neovascularization pathologic/metabolism	1.617445133716977e-06	4.096660575323597e-06	0.04672897196261682	0.9605811478101344	1	2
IL6	breast neoplasms/blood supply	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	fas receptor/genetics	7.55233245641751e-06	1.8148645885459756e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	receptor protein-tyrosine kinases/metabolism	1.617445133716977e-06	4.096660575323597e-06	0.04672897196261682	0.9605811478101344	1	2
IL6	mutation/genetics	5.738583852554768e-08	1.6146541192078551e-07	0.04672897196261682	0.9605811478101344	1	2
IL6	brain neoplasms/drug therapy	0.001535200262871128	0.0028831427083290144	0.09148348032117941	0.9605811478101344	1	2
IL6	interleukin-6/metabolism	0.0	0.0	7.062375405720226e-08	0.35414021462530776	5	2
IL6	head and neck neoplasms/genetics	5.738583852554768e-08	1.6146541192078551e-07	0.04672897196261682	0.9605811478101344	1	2
IL6	sarcoma/drug therapy	7.55233245641751e-06	1.8148645885459756e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	tumor escape/immunology	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	melanoma/drug therapy	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	proto-oncogene proteins/metabolism	1.617445133716977e-06	4.096660575323597e-06	0.04672897196261682	0.9605811478101344	1	2
IL6	lipopolysaccharides/pharmacology	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	lymphoma t-cell/drug therapy	0.00020868551760833132	0.0004296478001894191	0.04672897196261682	0.9605811478101344	1	2
IL6	prostatic neoplasms/metabolism	1.617445133716977e-06	4.096660575323597e-06	0.04672897196261682	0.9605811478101344	1	2
IL6	caspase 8/genetics	5.738583852554768e-08	1.6146541192078551e-07	0.04672897196261682	0.9605811478101344	1	2
IL6	myeloid differentiation factor 88/antagonists & inhibitors	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	interleukin-4/metabolism	0.00020868551760833132	0.0004296478001894191	0.04672897196261682	0.9605811478101344	1	2
IL6	matrix metalloproteinase 9/metabolism	1.617445133716977e-06	4.096660575323597e-06	0.04672897196261682	0.9605811478101344	1	2
IL6	quercetin/pharmacology	1.617445133716977e-06	4.096660575323597e-06	0.04672897196261682	0.9605811478101344	1	2
IL6	piperazines	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	tumor microenvironment/immunology	0.0010301235463895386	0.001971199787432438	0.09148348032117941	0.9605811478101344	1	2
IL6	hypoxia	7.55233245641751e-06	1.8148645885459756e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	tnf-related apoptosis-inducing ligand/pharmacology	5.738583852554768e-08	1.6146541192078551e-07	0.04672897196261682	0.9605811478101344	1	2
IL6	plant leaves/chemistry	7.55233245641751e-06	1.8148645885459756e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	transforming growth factor beta/metabolism	0.00019479799703037148	0.00040233313709841975	0.01125813263425861	0.8657199677887635	2	2
IL6	human umbilical vein endothelial cells	0.003957098735767217	0.0069919949451992	0.13433803313621812	0.9605811478101344	1	2
IL6	tyramine/analogs & derivatives	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	antineoplastic agents phytogenic/therapeutic use	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	receptors androgen/metabolism	1.617445133716977e-06	4.096660575323597e-06	0.04672897196261682	0.9605811478101344	1	2
IL6	paclitaxel/therapeutic use	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	fas ligand protein/genetics	7.55233245641751e-06	1.8148645885459756e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	AXL	1.617445133716977e-06	4.096660575323597e-06	0.04672897196261682	0.9605811478101344	1	2
IL6	CXCL1	0.000653003327605095	0.0012777260709120638	0.09148348032117941	0.9605811478101344	1	2
IL6	CXCL8	3.836864868600465e-06	9.461491625422553e-06	0.0023570206333426743	0.7135314763244264	3	2
IL6	IL6R	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	IL6ST	1.4281936911886284e-05	3.31531001298451e-05	0.04672897196261682	0.9605811478101344	1	2
IL6	ITK	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	MMP2	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	MMP9	7.332059781539613e-08	2.0452587811663132e-07	0.0019744636040542316	0.8657199677887635	2	2
IL6	MYD88	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	NFKB1	0.0034441966771970867	0.006165271441003602	0.03650184028860656	0.8657199677887635	2	2
IL6	PRF1	0.0018406431306735582	0.0034220844712952703	0.09148348032117941	0.9605811478101344	1	2
IL6	SOCS5	0.00020868551760833132	0.0004296478001894191	0.04672897196261682	0.9605811478101344	1	2
IL6	TRAF6	0.0008266389137319141	0.0015995905537968442	0.04672897196261682	0.9605811478101344	1	2
IL6	multiple myeloma/pathology	0.00014736939476089894	0.00030827328422090134	0.04672897196261682	0.9605811478101344	1	2
IL6	enzyme inhibitors/pharmacology	0.003957098735767217	0.0069919949451992	0.09148348032117941	0.9605811478101344	1	2
IL6	jnk mitogen-activated protein kinases/metabolism	0.0025655755545276326	0.004675246700241776	0.09148348032117941	0.9605811478101344	1	2
IL6	flavonoids/pharmacology	0.00573409467492203	0.009895532200429	0.09148348032117941	0.9605811478101344	1	2
IL6	free radicals/metabolism	0.00014736939476089894	0.00030827328422090134	0.04672897196261682	0.9605811478101344	1	2
IL6	carrier proteins/metabolism	0.00014736939476089894	0.00030827328422090134	0.04672897196261682	0.9605811478101344	1	2
IL6	cyclin-dependent kinases/antagonists & inhibitors	0.00014736939476089894	0.00030827328422090134	0.04672897196261682	0.9605811478101344	1	2
IL6	protein transport	0.00014736939476089894	0.00030827328422090134	0.04672897196261682	0.9605811478101344	1	2
IL6	nitriles/metabolism	0.00014736939476089894	0.00030827328422090134	0.04672897196261682	0.9605811478101344	1	2
amidines/pharmacology	cytokines/metabolism	4.86123297633867e-05	0.00010706269569704824	0.07009345794392523	0.9605811478101344	1	2
amidines/pharmacology	piperidines/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amidines/pharmacology	proteasome endopeptidase complex/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amidines/pharmacology	th1 cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amidines/pharmacology	burkitt lymphoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amidines/pharmacology	cell differentiation/drug effects	7.083156283727021e-11	2.3562074493604914e-10	0.02336448598130841	0.9605811478101344	1	2
amidines/pharmacology	CD4	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
membrane proteins/genetics	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane proteins/genetics	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane proteins/genetics	biomarkers tumor	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane proteins/genetics	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
biomarkers tumor	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
biomarkers tumor	KDM8	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
biomarkers tumor	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proteasome endopeptidase complex/chemistry	cytokines/metabolism	4.86123297633867e-05	0.00010706269569704824	0.07009345794392523	0.9605811478101344	1	2
proteasome endopeptidase complex/chemistry	piperidines/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proteasome endopeptidase complex/chemistry	th1 cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proteasome endopeptidase complex/chemistry	burkitt lymphoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proteasome endopeptidase complex/chemistry	cell differentiation/drug effects	7.083156283727021e-11	2.3562074493604914e-10	0.02336448598130841	0.9605811478101344	1	2
proteasome endopeptidase complex/chemistry	CD4	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	amino acid transport system y+/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	lipid metabolism/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	nivolumab/therapeutic use	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	amino acid transport system y+/metabolism	1.5420997812043424e-13	5.891564022871832e-13	0.027905752270633143	0.9605811478101344	1	2
SLC9A1	fusion regulatory protein 1 heavy chain/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	melanoma/genetics	7.515323696694054e-09	2.2394628580174417e-08	0.04166180294604871	0.9605811478101344	1	2
SLC9A1	cd8-positive t-lymphocytes/immunology	0.0	0.0	0.0013038910592810965	0.8657199677887635	2	2
SLC9A1	sulfasalazine/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	ATM	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	SLC7A11	0.0	0.0	0.0013038910592810965	0.8657199677887635	2	2
SLC9A1	antineoplastic agents immunological/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	cysteine/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	WDTC1	9.630031228002878e-08	2.6630243134956406e-07	0.055287464515536164	0.9605811478101344	1	2
SLC9A1	nucleotidyltransferases/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	palmitates/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	adenosine diphosphate/pharmacology	0.0	0.0	0.027905752270633143	0.9605811478101344	1	2
SLC9A1	carbonyl cyanide p-trifluoromethoxyphenylhydrazone/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	oxygen consumption/drug effects	6.740019653506124e-11	2.2474887072066398e-10	0.04166180294604871	0.9605811478101344	1	2
SLC9A1	uncoupling agents/pharmacology	0.0	0.0	0.027905752270633143	0.9605811478101344	1	2
SLC9A1	biological transport/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	mitochondrial adp atp translocases/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC9A1	SLC3A2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
TP53	ferritins/blood	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
TP53	cisplatin	1.244289116186792e-10	4.069131775984335e-10	0.037383177570093455	0.9605811478101344	1	2
TP53	hemeproteins/toxicity	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
TP53	listeriosis/etiology	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
TP53	lymphoma t-cell	1.244289116186792e-10	4.069131775984335e-10	0.037383177570093455	0.9605811478101344	1	2
TP53	genetic variation	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
TP53	malaria/genetics	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
TP53	transferrin/metabolism	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
TP53	cell line tumor/transplantation	0.001681574612566461	0.0031403826069680953	0.10849863774429329	0.9605811478101344	1	2
TP53	t-lymphocytes/immunology	1.666650076836973e-07	4.542749523315809e-07	0.037383177570093455	0.9605811478101344	1	2
TP53	asparaginase	1.244289116186792e-10	4.069131775984335e-10	0.037383177570093455	0.9605811478101344	1	2
TP53	membrane proteins/metabolism	1.666650076836973e-07	4.542749523315809e-07	0.037383177570093455	0.9605811478101344	1	2
TP53	tumor suppressor protein p53/genetics	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
TP53	neutral ceramidase/antagonists & inhibitors	1.666650076836973e-07	4.542749523315809e-07	0.037383177570093455	0.9605811478101344	1	2
TP53	myeloid-derived suppressor cells/immunology	0.0005045945599098101	0.0009994879936116696	0.0735378000087754	0.9605811478101344	1	2
TP53	killer cells natural/metabolism	1.244289116186792e-10	4.069131775984335e-10	0.037383177570093455	0.9605811478101344	1	2
TP53	ASAH2	1.666650076836973e-07	4.542749523315809e-07	0.037383177570093455	0.9605811478101344	1	2
TP53	HMOX1	0.00019733506627150899	0.0004070774271289512	0.0735378000087754	0.9605811478101344	1	2
TP53	heme oxygenase-1/metabolism	1.666650076836973e-07	4.542749523315809e-07	0.037383177570093455	0.9605811478101344	1	2
TP53	cyclin b1/metabolism	2.6712679373930293e-05	6.0648867761962214e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	interleukin-10/metabolism	0.0012454557093865004	0.002363760650818074	0.0735378000087754	0.9605811478101344	1	2
TP53	gene expression regulation	0.002832656813488321	0.005134787258389419	0.0735378000087754	0.9605811478101344	1	2
TP53	aspirin/administration & dosage	2.6712679373930293e-05	6.0648867761962214e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	antineoplastic agents phytogenic/pharmacology	0.000422000030373737	0.0008411768076738228	0.01707421177850705	0.8657199677887635	2	2
TP53	lactic acid/metabolism	0.0019333646230976775	0.003587512473494159	0.0735378000087754	0.9605811478101344	1	2
TP53	lymphoma t-cell/drug therapy	2.6712679373930293e-05	6.0648867761962214e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	interleukin-4/metabolism	2.6712679373930293e-05	6.0648867761962214e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	nitric oxide/metabolism	0.002208690688217718	0.004061824363485215	0.0735378000087754	0.9605811478101344	1	2
TP53	BIRC5	2.0222528315239074e-06	5.078203921348418e-06	0.0036161245377395743	0.8657199677887635	2	2
TP53	SOCS5	2.6712679373930293e-05	6.0648867761962214e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	1-phosphatidylinositol 4-kinase/metabolism	5.77168171780329e-05	0.00012630673797928233	0.037383177570093455	0.9605811478101344	1	2
TP53	diterpenes kaurane/pharmacology	3.988490947781642e-05	8.876375130381513e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	plant roots	5.77168171780329e-05	0.00012630673797928233	0.037383177570093455	0.9605811478101344	1	2
TP53	bcl-2-associated x protein/agonists	3.988490947781642e-05	8.876375130381513e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	cellular senescence/drug effects	8.801668283098252e-10	2.761229116473396e-09	0.037383177570093455	0.9605811478101344	1	2
TP53	cyclin b1/antagonists & inhibitors	3.988490947781642e-05	8.876375130381513e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	esophageal neoplasms/drug therapy	3.988490947781642e-05	8.876375130381513e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	plant extracts/pharmacology	5.77168171780329e-05	0.00012630673797928233	0.037383177570093455	0.9605811478101344	1	2
TP53	cyclin-dependent kinase inhibitor p21/agonists	3.988490947781642e-05	8.876375130381513e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	hair cells auditory/drug effects	8.801668283098252e-10	2.761229116473396e-09	0.037383177570093455	0.9605811478101344	1	2
TP53	liver x receptors/agonists	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
TP53	dna/metabolism	5.77168171780329e-05	0.00012630673797928233	0.037383177570093455	0.9605811478101344	1	2
TP53	erbb receptors/drug effects	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
TP53	cyclin-dependent kinase 2/antagonists & inhibitors	3.988490947781642e-05	8.876375130381513e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	hydrogen peroxide/metabolism	8.801668283098252e-10	2.761229116473396e-09	0.037383177570093455	0.9605811478101344	1	2
TP53	abietanes/pharmacology	0.0012454557093865004	0.002363760650818074	0.0735378000087754	0.9605811478101344	1	2
TP53	tumor suppressor protein p53/agonists	3.988490947781642e-05	8.876375130381513e-05	0.037383177570093455	0.9605811478101344	1	2
TP53	nima-interacting peptidylprolyl isomerase/metabolism	8.801668283098252e-10	2.761229116473396e-09	0.037383177570093455	0.9605811478101344	1	2
TP53	MAPK14	0.0007462533573256991	0.001451812761168006	0.0735378000087754	0.9605811478101344	1	2
TP53	MDM2	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
TP53	METTL7B	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
TP53	PIN1	8.801668283098252e-10	2.761229116473396e-09	0.037383177570093455	0.9605811478101344	1	2
TP53	TNS1	5.77168171780329e-05	0.00012630673797928233	0.037383177570093455	0.9605811478101344	1	2
TP53	TP73	9.197971770902313e-07	2.373003529193239e-06	0.037383177570093455	0.9605811478101344	1	2
TP53	TF	4.509968953847476e-09	1.3641898133410503e-08	0.037383177570093455	0.9605811478101344	1	2
hl-60 cells	carbolines/pharmacology	0.0030056319935469755	0.005423371322835233	0.07319670689438858	0.9605811478101344	1	2
hl-60 cells	inflammation/drug therapy	1.2155711399119973e-05	2.8435981424699963e-05	0.03711991575621956	0.9605811478101344	1	2
hl-60 cells	gene expression/drug effects	6.756060821899723e-09	2.017575904120887e-08	0.001559737378978988	0.8657199677887635	2	2
hl-60 cells	chemokine ccl5/metabolism	1.0929630311906635e-08	3.2014944747830144e-08	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	butyrates/pharmacology	1.0929630311906635e-08	3.2014944747830144e-08	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	antineoplastic agents alkylating/pharmacology	1.1358602913791316e-07	3.133956664288211e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	valproic acid/pharmacology	1.0929630311906635e-08	3.2014944747830144e-08	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	k562 cells	2.959959655557398e-05	6.687282558226202e-05	0.03711991575621956	0.9605811478101344	1	2
hl-60 cells	interleukin-8/biosynthesis	1.1358602913791316e-07	3.133956664288211e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	g2 phase cell cycle checkpoints/drug effects	0.002164931462201647	0.003986670749070568	0.055287464515536164	0.9605811478101344	1	2
hl-60 cells	heterocyclic compounds 4 or more rings/pharmacology	6.282147886715883e-05	0.00013706956616161482	0.03711991575621956	0.9605811478101344	1	2
hl-60 cells	u937 cells	1.7763568394002505e-15	7.423259210594527e-15	9.899096193684516e-06	0.7135314763244264	3	2
hl-60 cells	leukocytes mononuclear/drug effects	1.0929630311906635e-08	3.2014944747830144e-08	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	ovarian neoplasms/drug therapy	0.0002094858808664446	0.00043125534092841925	0.03711991575621956	0.9605811478101344	1	2
hl-60 cells	fibrosarcoma/drug therapy	1.1358602913791316e-07	3.133956664288211e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	rho gtp-binding proteins/genetics	1.1358602913791316e-07	3.133956664288211e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	neovascularization pathologic/prevention & control	1.1358602913791316e-07	3.133956664288211e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	leukemia/drug therapy	3.097522238704187e-14	1.2239098623467724e-13	0.00026326181387389757	0.8657199677887635	2	2
hl-60 cells	vascular endothelial growth factor a/biosynthesis	1.1358602913791316e-07	3.133956664288211e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	caspase 8/metabolism	0.0008729377013856343	0.0016874040364852241	0.03711991575621956	0.9605811478101344	1	2
hl-60 cells	p38 mitogen-activated protein kinases/metabolism	0.00011974091999267245	0.00025229814640657895	0.03711991575621956	0.9605811478101344	1	2
hl-60 cells	cell adhesion/drug effects	0.004311709748259229	0.00757245312487012	0.07319670689438858	0.9605811478101344	1	2
hl-60 cells	chemokine ccl2/biosynthesis	1.1358602913791316e-07	3.133956664288211e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	trabectedin	1.1358602913791316e-07	3.133956664288211e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	BIRC5	0.0030056319935469755	0.005423371322835233	0.055287464515536164	0.9605811478101344	1	2
hl-60 cells	BRCA1	1.1358602913791316e-07	3.133956664288211e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	CASP8	0.00023092865779394955	0.00047407030233156424	0.00535588186581037	0.8657199677887635	2	2
hl-60 cells	CCL2	2.328620218872146e-08	6.695542329902593e-08	0.001559737378978988	0.8657199677887635	2	2
hl-60 cells	CCL5	0.0019818296117002365	0.003672806529273499	0.055287464515536164	0.9605811478101344	1	2
hl-60 cells	XIAP	0.0019818296117002365	0.003672806529273499	0.055287464515536164	0.9605811478101344	1	2
hl-60 cells	flavonoids/metabolism	1.7967192348367078e-06	4.538733465820318e-06	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	multiple myeloma/metabolism	1.7967192348367078e-06	4.538733465820318e-06	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	piperidines/metabolism	1.7967192348367078e-06	4.538733465820318e-06	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	aurora kinase b/antagonists & inhibitors	2.1683386797199944e-07	5.843727076209074e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	ribosomal proteins/genetics	2.1683386797199944e-07	5.843727076209074e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	poly (adp-ribose) polymerase-1	1.7967192348367078e-06	4.538733465820318e-06	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	ribosomal protein s6 kinases 70-kda/metabolism	6.282147886715883e-05	0.00013706956616161482	0.03711991575621956	0.9605811478101344	1	2
hl-60 cells	leukemia/metabolism	1.7967192348367078e-06	4.538733465820318e-06	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	pyrazoles/pharmacology	0.00011974091999267245	0.00025229814640657895	0.03711991575621956	0.9605811478101344	1	2
hl-60 cells	membrane glycoproteins/metabolism	1.7967192348367078e-06	4.538733465820318e-06	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	AURKB	2.1683386797199944e-07	5.843727076209074e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	RPL15	2.1683386797199944e-07	5.843727076209074e-07	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	TNFRSF10D	1.7967192348367078e-06	4.538733465820318e-06	0.018691588785046728	0.9605811478101344	1	2
hl-60 cells	PRKAA2	0.004916447499568766	0.008583247641974198	0.07319670689438858	0.9605811478101344	1	2
prostatic neoplasms/therapy	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
prostatic neoplasms/therapy	rna interference	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
prostatic neoplasms/therapy	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	carcinoembryonic antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	eif-2 kinase/genetics	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
prostatic neoplasms/therapy	rna small interfering	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	cytotoxicity immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	hmgb1 protein/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	colorectal neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	KLK3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
prostatic neoplasms/therapy	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/therapy	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TNF	liver neoplasms/metabolism	0.00043168217062361514	0.0008593885776893424	0.06542056074766354	0.9605811478101344	1	2
TNF	neoplasm metastasis/immunology	0.00043168217062361514	0.0008593885776893424	0.06542056074766354	0.9605811478101344	1	2
TNF	cell communication/drug effects	0.0009024845525811287	0.0017399422363858627	0.06542056074766354	0.9605811478101344	1	2
TNF	tubulin modulators/pharmacology	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	antigens cd/metabolism	0.0009024845525811287	0.0017399422363858627	0.06542056074766354	0.9605811478101344	1	2
TNF	benzhydryl compounds/immunology	0.0006366526207366441	0.0012478368727888284	0.06542056074766354	0.9605811478101344	1	2
TNF	GSK3B	0.0006786434614470815	0.0013256605863369588	0.004009904624670713	0.7135314763244264	3	2
TNF	azocines/immunology	0.0006366526207366441	0.0012478368727888284	0.06542056074766354	0.9605811478101344	1	2
TNF	cytokines/blood	0.0006366526207366441	0.0012478368727888284	0.06542056074766354	0.9605811478101344	1	2
TNF	receptors tumor necrosis factor type i/metabolism	1.0069125590095318e-05	2.3815069835917354e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	gene silencing	0.00043168217062361514	0.0008593885776893424	0.06542056074766354	0.9605811478101344	1	2
TNF	lymphatic metastasis/genetics	9.759095198280665e-05	0.00020749135094666547	0.06542056074766354	0.9605811478101344	1	2
TNF	janus kinases/antagonists & inhibitors	0.0033849021607051943	0.006064547605983108	0.06542056074766354	0.9605811478101344	1	2
TNF	tumor escape/immunology	0.00043168217062361514	0.0008593885776893424	0.06542056074766354	0.9605811478101344	1	2
TNF	receptor igf type 1/metabolism	0.00043168217062361514	0.0008593885776893424	0.06542056074766354	0.9605811478101344	1	2
TNF	receptors ccr7/genetics	9.759095198280665e-05	0.00020749135094666547	0.06542056074766354	0.9605811478101344	1	2
TNF	tumor necrosis factor alpha-induced protein 3/metabolism	0.0009024845525811287	0.0017399422363858627	0.06542056074766354	0.9605811478101344	1	2
TNF	sirtuin 1/antagonists & inhibitors	0.0033849021607051943	0.006064547605983108	0.06542056074766354	0.9605811478101344	1	2
TNF	receptors cell surface/metabolism	0.0009024845525811287	0.0017399422363858627	0.06542056074766354	0.9605811478101344	1	2
TNF	tumor necrosis factor-alpha/metabolism	1.27675647831893e-14	5.127491226589393e-14	7.214109634498094e-09	0.11552077256850565	7	2
TNF	neoplasm recurrence local/genetics	9.759095198280665e-05	0.00020749135094666547	0.06542056074766354	0.9605811478101344	1	2
TNF	myeloid cell leukemia sequence 1 protein/metabolism	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	estrogen receptor alpha/genetics	0.0009024845525811287	0.0017399422363858627	0.06542056074766354	0.9605811478101344	1	2
TNF	insulin-like growth factor i/metabolism	0.0033849021607051943	0.006064547605983108	0.06542056074766354	0.9605811478101344	1	2
TNF	transforming growth factor beta/metabolism	0.00344997412451431	0.006172530084058133	0.022184109982560516	0.8657199677887635	2	2
TNF	antigens differentiation myelomonocytic/metabolism	0.0009024845525811287	0.0017399422363858627	0.06542056074766354	0.9605811478101344	1	2
TNF	nucleotides cyclic/pharmacology	1.0069125590095318e-05	2.3815069835917354e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	endometrial neoplasms/genetics	0.0009024845525811287	0.0017399422363858627	0.06542056074766354	0.9605811478101344	1	2
TNF	estradiol/pharmacology	0.0009024845525811287	0.0017399422363858627	0.06542056074766354	0.9605811478101344	1	2
TNF	carcinoma lewis lung/immunology	0.0006366526207366441	0.0012478368727888284	0.06542056074766354	0.9605811478101344	1	2
TNF	carcinoma non-small-cell lung/genetics	9.759095198280665e-05	0.00020749135094666547	0.06542056074766354	0.9605811478101344	1	2
TNF	stilbenes/pharmacology	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	naphthols/pharmacology	0.0033849021607051943	0.006064547605983108	0.06542056074766354	0.9605811478101344	1	2
TNF	adenosine triphosphate/metabolism	0.0016580883596909457	0.0031012497586075647	0.05136861435356347	0.8657199677887635	2	2
TNF	glycogen synthase kinase 3 beta/metabolism	6.416493885608165e-05	0.000139959296784615	0.003992804177087446	0.8657199677887635	2	2
TNF	IGF1R	0.0033849021607051943	0.006064547605983108	0.06542056074766354	0.9605811478101344	1	2
TNF	receptor igf type 1/biosynthesis	0.0033849021607051943	0.006064547605983108	0.06542056074766354	0.9605811478101344	1	2
TNF	neoplasms/blood supply	1.0069125590095318e-05	2.3815069835917354e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	chemokine ccl21/genetics	9.759095198280665e-05	0.00020749135094666547	0.06542056074766354	0.9605811478101344	1	2
TNF	CTNNB1	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	receptors tnf-related apoptosis-inducing ligand/biosynthesis	0.0033849021607051943	0.006064547605983108	0.06542056074766354	0.9605811478101344	1	2
TNF	IL17A	0.0009024845525811287	0.0017399422363858627	0.06542056074766354	0.9605811478101344	1	2
TNF	TCIM	0.0006366526207366441	0.0012478368727888284	0.06542056074766354	0.9605811478101344	1	2
TNF	glutamates/pharmacology	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	muscle proteins/biosynthesis	0.0016467406573135168	0.003080547939288004	0.06542056074766354	0.9605811478101344	1	2
TNF	adenosine triphosphatases/antagonists & inhibitors	1.0069125590095318e-05	2.3815069835917354e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	mitochondrial proteins/genetics	2.4280373925877896e-05	5.526310357363021e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	receptors tumor necrosis factor type i/genetics	0.0016467406573135168	0.003080547939288004	0.06542056074766354	0.9605811478101344	1	2
TNF	isoantigens/immunology	1.0069125590095318e-05	2.3815069835917354e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	mitochondria muscle/drug effects	0.0016467406573135168	0.003080547939288004	0.06542056074766354	0.9605811478101344	1	2
TNF	phytohemagglutinins/pharmacology	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	head and neck neoplasms/drug therapy	2.4280373925877896e-05	5.526310357363021e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	buthionine sulfoximine/pharmacology	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	oxidoreductases/metabolism	0.0016467406573135168	0.003080547939288004	0.06542056074766354	0.9605811478101344	1	2
TNF	antibodies monoclonal/immunology	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	affinity labels	1.0069125590095318e-05	2.3815069835917354e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	deoxycytidine/analogs & derivatives	2.4280373925877896e-05	5.526310357363021e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	mitogen-activated protein kinases/genetics	0.0016467406573135168	0.003080547939288004	0.06542056074766354	0.9605811478101344	1	2
TNF	adenosine/analogs & derivatives	1.0069125590095318e-05	2.3815069835917354e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	muscle fibers skeletal/drug effects	0.0016467406573135168	0.003080547939288004	0.06542056074766354	0.9605811478101344	1	2
TNF	thyroid hormones/immunology	0.0006366526207366441	0.0012478368727888284	0.06542056074766354	0.9605811478101344	1	2
TNF	mercaptoethanol/pharmacology	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	IL6R	0.00043168217062361514	0.0008593885776893424	0.06542056074766354	0.9605811478101344	1	2
TNF	membrane proteins/immunology	0.0006366526207366441	0.0012478368727888284	0.06542056074766354	0.9605811478101344	1	2
TNF	carrier proteins/immunology	0.0006366526207366441	0.0012478368727888284	0.06542056074766354	0.9605811478101344	1	2
TNF	interleukins/metabolism	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	antimetabolites antineoplastic/pharmacology	2.4280373925877896e-05	5.526310357363021e-05	0.06542056074766354	0.9605811478101344	1	2
TNF	cd3 complex/immunology	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	cytokines/immunology	0.0006366526207366441	0.0012478368727888284	0.06542056074766354	0.9605811478101344	1	2
TNF	oncogene protein v-akt/metabolism	0.0016467406573135168	0.003080547939288004	0.06542056074766354	0.9605811478101344	1	2
TNF	CD28	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	CD3E	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	EIF4E	0.0016467406573135168	0.003080547939288004	0.06542056074766354	0.9605811478101344	1	2
TNF	IL2	0.000913435676277885	0.001757827510742324	0.022184109982560516	0.8657199677887635	2	2
TNF	IL5	0.001236872997159244	0.0023482800173397927	0.06542056074766354	0.9605811478101344	1	2
TNF	PKM	0.0006366526207366441	0.0012478368727888284	0.06542056074766354	0.9605811478101344	1	2
TNF	RPS6KB2	0.0016467406573135168	0.003080547939288004	0.06542056074766354	0.9605811478101344	1	2
TNF	TNFRSF1A	0.0016467406573135168	0.003080547939288004	0.06542056074766354	0.9605811478101344	1	2
TNF	IL6ST	0.00043168217062361514	0.0008593885776893424	0.06542056074766354	0.9605811478101344	1	2
TNF	NOS2	0.0033849021607051943	0.006064547605983108	0.06542056074766354	0.9605811478101344	1	2
affinity labels	cell line	6.03680407773588e-07	1.5807536378375377e-06	0.06074766355140186	0.9605811478101344	1	2
affinity labels	cytotoxicity immunologic/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
affinity labels	adenosine triphosphate/metabolism	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
affinity labels	isoantigens/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
affinity labels	adenosine triphosphatases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
affinity labels	WDTC1	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
affinity labels	adenosine/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	myeloid-derived suppressor cells/immunology	0.0008396882185267573	0.0016241289448265589	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	antineoplastic agents/metabolism	1.8770705223492e-07	5.103039565567838e-07	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	cell cycle proteins/metabolism	0.0016745690743001918	0.0031275645023439752	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	lung neoplasms/immunology	0.001208554096470027	0.0022984732786139185	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	benzhydryl compounds/immunology	4.641544744110604e-06	1.136696418062319e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	k562 cells	0.001208554096470027	0.0022984732786139185	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	azocines/immunology	4.641544744110604e-06	1.136696418062319e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	cytokines/blood	4.641544744110604e-06	1.136696418062319e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	tnf-related apoptosis-inducing ligand/metabolism	0.0019468556078824362	0.003611330341796395	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	receptors tnf-related apoptosis-inducing ligand/agonists	1.8770705223492e-07	5.103039565567838e-07	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	g2 phase cell cycle checkpoints/drug effects	2.4756067268372206e-06	6.183547877343043e-06	0.0036161245377395743	0.8657199677887635	2	2
apoptosis regulatory proteins/metabolism	plant extracts/isolation & purification	0.0025748250717483323	0.004691714312554316	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	ovarian neoplasms/drug therapy	0.004185174462404517	0.007361953609948523	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	nitric oxide/metabolism	0.0033192745475103536	0.0059585869747197755	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	recombinant fusion proteins/metabolism	1.8770705223492e-07	5.103039565567838e-07	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	leukemia t-cell/drug therapy	1.8770705223492e-07	5.103039565567838e-07	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	leukemia/drug therapy	0.0033192745475103536	0.0059585869747197755	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	carcinoma lewis lung/immunology	4.641544744110604e-06	1.136696418062319e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	ARG1	0.001012594348746676	0.0019411946962148256	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	BIRC2	1.8770705223492e-07	5.103039565567838e-07	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	CFLAR	1.8770705223492e-07	5.103039565567838e-07	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	TCIM	4.641544744110604e-06	1.136696418062319e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	TNFRSF12A	1.8770705223492e-07	5.103039565567838e-07	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	granulosa cells/drug effects	4.899336563113366e-07	1.2888745083346078e-06	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	creatine kinase mb form/metabolism	8.41142134544448e-06	2.0083930888494683e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	hydrazones/pharmacology	3.642710610984867e-05	8.138881592115359e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	nitric oxide synthase type iii/metabolism	8.41142134544448e-06	2.0083930888494683e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	myocardial reperfusion injury/metabolism	0.0008396882185267573	0.0016241289448265589	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	autophagy-related proteins/metabolism	2.2033486146710857e-12	7.931335552043772e-12	0.0012285551314115217	0.8657199677887635	2	2
apoptosis regulatory proteins/metabolism	cytoprotection	0.000557584202056427	0.0011007894418821726	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	aurora kinase b/antagonists & inhibitors	5.464098694807351e-05	0.0001197896470350129	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	ribosomal proteins/genetics	5.464098694807351e-05	0.0001197896470350129	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	phosphatidylinositol 3-kinase/metabolism	6.6592196201753495e-09	1.988925415681741e-08	0.0003354392905203583	0.7135314763244264	3	2
apoptosis regulatory proteins/metabolism	liver/drug effects	2.338776675170351e-05	5.325898381961981e-05	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	zearalenone/toxicity	4.899336563113366e-07	1.2888745083346078e-06	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	rhizome/chemistry	3.642710610984867e-05	8.138881592115359e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	saponins/isolation & purification	3.642710610984867e-05	8.138881592115359e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	isoflavones/pharmacology	3.642710610984867e-05	8.138881592115359e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	ribosomal protein s6 kinases 70-kda/metabolism	0.0019468556078824362	0.003611330341796395	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	t-2 toxin/toxicity	4.899336563113366e-07	1.2888745083346078e-06	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	pyrazoles/pharmacology	0.002932143048774316	0.005301614723583412	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	chalcones/administration & dosage	8.41142134544448e-06	2.0083930888494683e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	mitogen-activated protein kinases/metabolism	0.001012594348746676	0.0019411946962148256	0.0735378000087754	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	AURKB	5.464098694807351e-05	0.0001197896470350129	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	BECN1	2.2292073921459377e-05	5.0805834796396146e-05	0.01160243912945504	0.8657199677887635	2	2
apoptosis regulatory proteins/metabolism	COL4A5	3.642710610984867e-05	8.138881592115359e-05	0.037383177570093455	0.9605811478101344	1	2
apoptosis regulatory proteins/metabolism	RPL15	5.464098694807351e-05	0.0001197896470350129	0.037383177570093455	0.9605811478101344	1	2
hep g2 cells	adenocarcinoma/drug therapy	0.0013546484695101668	0.0025577879126282574	0.05541661182045544	0.9605811478101344	1	2
hep g2 cells	stilbenes/pharmacology	4.3356429157981324e-07	1.1434480264057085e-06	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	glycogen synthase kinase 3 beta/metabolism	0.0013546484695101668	0.0025577879126282574	0.05541661182045544	0.9605811478101344	1	2
hep g2 cells	CASP8	0.0009998493932872332	0.001917262082379276	0.012970382291718041	0.8657199677887635	2	2
hep g2 cells	CTNNB1	4.3356429157981324e-07	1.1434480264057085e-06	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	DDX53	0.0004962532326744373	0.0009834074486793091	0.05541661182045544	0.9605811478101344	1	2
hep g2 cells	phenylurea compounds/pharmacology	4.814946774622797e-09	1.4524551441631335e-08	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	crotonates/pharmacology	6.607139012682062e-06	1.595380582100691e-05	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	superoxide dismutase/metabolism	9.536379190955291e-05	0.00020293223472848398	0.05541661182045544	0.9605811478101344	1	2
hep g2 cells	g2 phase/drug effects	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	cell respiration/drug effects	0.00213812675650904	0.0039432387057725905	0.08215010393874443	0.9605811478101344	1	2
hep g2 cells	receptors death domain/drug effects	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	genes cdc/drug effects	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	acetaldehyde/pharmacology	5.513522971511975e-11	1.8460463853590893e-10	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	antimycin a/pharmacology	5.513522971511975e-11	1.8460463853590893e-10	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	diosgenin/analogs & derivatives	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	cell cycle proteins/drug effects	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	anticarcinogenic agents/isolation & purification	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	sesquiterpenes/pharmacology	6.607139012682062e-06	1.595380582100691e-05	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	mitophagy/drug effects	0.0019199350996133013	0.0035643928154491466	0.10825010098314035	0.9605811478101344	1	2
hep g2 cells	rhizome/chemistry	1.491167605727206e-06	3.787703153349475e-06	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	mitochondrial dynamics/drug effects	1.0069125590095318e-05	2.3815069835917354e-05	0.05541661182045544	0.9605811478101344	1	2
hep g2 cells	saponins/isolation & purification	1.491167605727206e-06	3.787703153349475e-06	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	glutathione disulfide/metabolism	5.513522971511975e-11	1.8460463853590893e-10	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	liver diseases alcoholic/etiology	5.513522971511975e-11	1.8460463853590893e-10	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	CASP9	0.002293179610604379	0.004211229723022268	0.026746177529959735	0.8657199677887635	2	2
hep g2 cells	COL4A5	1.491167605727206e-06	3.787703153349475e-06	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	colonic neoplasms/drug therapy	0.0031692476956168836	0.0056966878520268265	0.08215010393874443	0.9605811478101344	1	2
hep g2 cells	myeloid cell leukemia sequence 1 protein/metabolism	4.3356429157981324e-07	1.1434480264057085e-06	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	tubulin modulators/pharmacology	4.3356429157981324e-07	1.1434480264057085e-06	0.02803738317757009	0.9605811478101344	1	2
hep g2 cells	plant extracts/isolation & purification	0.00041820137838455285	0.0008336802884830579	0.05541661182045544	0.9605811478101344	1	2
hep g2 cells	carcinoma hepatocellular/drug therapy	6.17164724505681e-05	0.0001346852206859473	0.012970382291718041	0.8657199677887635	2	2
hep g2 cells	a549 cells	3.9386491975768045e-05	8.776969628883504e-05	0.009383502472863752	0.8657199677887635	2	2
hep g2 cells	hela cells	0.002621392365332098	0.0047714405077885	0.08215010393874443	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	cytokines/metabolism	0.005673764595456876	0.009815234350775456	0.13557983414505725	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	oncogene proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	adjuvants immunologic/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	phenotype	6.226627435879095e-09	1.8701087277790802e-08	0.027905752270633143	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	paclitaxel/pharmacology	8.587982325281018e-09	2.5426055365623188e-08	0.027905752270633143	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	antineoplastic agents immunological/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	cytotoxicity immunologic/drug effects	6.226627435879095e-09	1.8701087277790802e-08	0.03711991575621956	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	cisplatin/administration & dosage	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	breast neoplasms/immunology	1.9200196987867457e-12	6.954590819590958e-12	0.018647711816067742	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	antigens neoplasm/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	th1 cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	cancer vaccines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	CD4	1.5157368693508033e-09	4.69829417903086e-09	0.027905752270633143	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	SOCS1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/drug effects	TBX21	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
KDM8	STING1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
KDM8	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mcf-7 cells	breast neoplasms/drug therapy	0.0	0.0	2.0363182419826644e-06	0.5304112294886878	4	2
mcf-7 cells	antibiotics antineoplastic/therapeutic use	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	rank ligand/antagonists & inhibitors	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	paracrine communication/genetics	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	plant extracts/isolation & purification	2.745402695703003e-05	6.231919966525256e-05	0.046290202272826986	0.9605811478101344	1	2
mcf-7 cells	osteoclasts/drug effects	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	doxorubicin/therapeutic use	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	receptors estrogen/metabolism	2.531112663128887e-06	6.315035871524918e-06	0.046290202272826986	0.9605811478101344	1	2
mcf-7 cells	extracellular vesicles/metabolism	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	breast neoplasms/metabolism	0.000490996908170338	0.0009730786365249089	0.06878335787959994	0.9605811478101344	1	2
mcf-7 cells	osteoprotegerin/pharmacology	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	antineoplastic agents phytogenic/isolation & purification	0.002774005480236208	0.005030537327541365	0.09085010295354308	0.9605811478101344	1	2
mcf-7 cells	selective estrogen receptor modulators/pharmacology	2.832023504595327e-07	7.580484913113726e-07	0.046290202272826986	0.9605811478101344	1	2
mcf-7 cells	embryo nonmammalian	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	bone neoplasms/drug therapy	7.434083939550362e-07	1.932406068134949e-06	0.046290202272826986	0.9605811478101344	1	2
mcf-7 cells	bone density conservation agents/pharmacology	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	drug resistance neoplasm/genetics	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	ESR1	9.489375423665791e-06	2.2506642571104064e-05	0.046290202272826986	0.9605811478101344	1	2
mcf-7 cells	SMAD2	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	TNFSF11	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	amphiregulin/physiology	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	receptors estrogen/physiology	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	letrozole/pharmacology	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	aromatase inhibitors/pharmacology	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	rhizome/chemistry	1.194367449386391e-08	3.492032028122417e-08	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	pentacyclic triterpenes	2.531112663128887e-06	6.315035871524918e-06	0.046290202272826986	0.9605811478101344	1	2
mcf-7 cells	saponins/isolation & purification	1.194367449386391e-08	3.492032028122417e-08	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	calcium/metabolism	0.000490996908170338	0.0009730786365249089	0.09085010295354308	0.9605811478101344	1	2
mcf-7 cells	AREG	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	COL4A5	1.194367449386391e-08	3.492032028122417e-08	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	CYP19A1	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
mcf-7 cells	EGFR	0.0007706932421335244	0.0014990952450427831	0.09085010295354308	0.9605811478101344	1	2
mcf-7 cells	EIF4EBP1	1.2639127327740418e-05	2.953237381539007e-05	0.046290202272826986	0.9605811478101344	1	2
mcf-7 cells	RPS6KB1	1.2639127327740418e-05	2.953237381539007e-05	0.046290202272826986	0.9605811478101344	1	2
mcf-7 cells	transforming growth factor beta1/genetics	1.654934543848796e-07	4.5152823688625494e-07	0.046290202272826986	0.9605811478101344	1	2
mcf-7 cells	tamoxifen/pharmacology	2.832023504595327e-07	7.580484913113726e-07	0.046290202272826986	0.9605811478101344	1	2
mcf-7 cells	tumor microenvironment/genetics	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
adjuvants immunologic/administration & dosage	cytotoxicity immunologic/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
adjuvants immunologic/administration & dosage	cisplatin/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adjuvants immunologic/administration & dosage	antigens neoplasm/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antioxidants/adverse effects	macrophages peritoneal/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antioxidants/adverse effects	immunologic factors/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antioxidants/adverse effects	spleen/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antioxidants/adverse effects	mitogens/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	rna interference	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	eif-2 kinase/genetics	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	rna small interfering	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	cytotoxicity immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	hmgb1 protein/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	colorectal neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	KLK3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoembryonic antigen/immunology	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/metabolism	antibodies monoclonal humanized/pharmacology	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	cd36 antigens/antagonists & inhibitors	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	small molecule libraries/pharmacology	1.996716358920736e-08	5.760743559471916e-08	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	necroptosis/drug effects	1.996716358920736e-08	5.760743559471916e-08	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	ileum/drug effects	1.996716358920736e-08	5.760743559471916e-08	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	radiation-protective agents/pharmacology	1.996716358920736e-08	5.760743559471916e-08	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	cd8-positive t-lymphocytes/cytology	0.0023586807672586474	0.004317133783539653	0.13557983414505725	0.9605811478101344	1	2
cytokines/metabolism	drug interactions	1.996716358920736e-08	5.760743559471916e-08	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	fatty acids/metabolism	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	sorafenib/pharmacology	0.005673764595456876	0.009815234350775456	0.13557983414505725	0.9605811478101344	1	2
cytokines/metabolism	CD36	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	piperidines/chemistry	4.86123297633867e-05	0.00010706269569704824	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	neovascularization pathologic/pathology	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	antigens polyomavirus transforming/genetics	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	serum albumin bovine/chemistry	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	cell communication/drug effects	0.0003299736443082013	0.0006641039625474416	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	mechanistic target of rapamycin complex 1/antagonists & inhibitors	0.0004740074998741406	0.000940845999029983	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	thiazoles/pharmacology	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	antigens cd/metabolism	0.0003299736443082013	0.0006641039625474416	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	neoplasm proteins/metabolism	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	breast neoplasms/blood supply	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	galectin 3/genetics	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	receptor erbb-2/antagonists & inhibitors	1.8600621730646694e-06	4.686395930948444e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	fibroblast growth factor 2/pharmacology	0.0004740074998741406	0.000940845999029983	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	phenotype	4.72087634818541e-05	0.00010436767444579556	0.013256225769357815	0.8657199677887635	2	2
cytokines/metabolism	oncogene proteins/metabolism	0.00014131299984299073	0.00029625073885502135	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	copper/chemistry	5.524455328753675e-07	1.4481416132250745e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	receptors fibroblast growth factor/metabolism	0.0004740074998741406	0.000940845999029983	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	antineoplastic agents immunological/pharmacology	0.00014131299984299073	0.00029625073885502135	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	endometrial neoplasms/genetics	0.0003299736443082013	0.0006641039625474416	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	carcinoma hepatocellular/genetics	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	estrogen receptor alpha/genetics	0.0003299736443082013	0.0006641039625474416	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	lipopolysaccharides/pharmacology	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	receptors cell surface/metabolism	0.0003299736443082013	0.0006641039625474416	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	th1 cells/immunology	4.86123297633867e-05	0.00010706269569704824	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	cell line transformed	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	potassium channels voltage-gated/metabolism	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	cell proliferation	0.0008887627208469251	0.0017169403723151673	0.13557983414505725	0.9605811478101344	1	2
cytokines/metabolism	myeloid differentiation factor 88/antagonists & inhibitors	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	peroxidase/chemistry	5.524455328753675e-07	1.4481416132250745e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	neoplasm recurrence local/pathology	0.0004740074998741406	0.000940845999029983	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	src-family kinases/metabolism	1.2155711399119973e-05	2.8435981424699963e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	alpha 1-antitrypsin/chemistry	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	estradiol/pharmacology	0.0003299736443082013	0.0006641039625474416	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	tumor necrosis factor alpha-induced protein 3/metabolism	0.0003299736443082013	0.0006641039625474416	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	bone marrow cells/drug effects	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	piperazines	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	tellurium/chemistry	5.524455328753675e-07	1.4481416132250745e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	inflammation mediators/metabolism	1.8600621730646694e-06	4.686395930948444e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	integrins/metabolism	1.2155711399119973e-05	2.8435981424699963e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	leukemia myelogenous chronic bcr-abl positive/genetics	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	poly i-c/administration & dosage	1.8600621730646694e-06	4.686395930948444e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	immunosuppressive agents/chemistry	5.524455328753675e-07	1.4481416132250745e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	hydrogen peroxide/chemistry	5.524455328753675e-07	1.4481416132250745e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	cd79 antigens/antagonists & inhibitors	1.2155711399119973e-05	2.8435981424699963e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	micrornas/genetics	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	immune evasion/drug effects	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	antigens differentiation myelomonocytic/metabolism	0.0003299736443082013	0.0006641039625474416	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	burkitt lymphoma/drug therapy	4.86123297633867e-05	0.00010706269569704824	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	lymphoma large b-cell diffuse/metabolism	1.2155711399119973e-05	2.8435981424699963e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	th1 cells/drug effects	0.00014131299984299073	0.00029625073885502135	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	bcl-2-like protein 11/metabolism	0.0004740074998741406	0.000940845999029983	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	cancer vaccines/pharmacology	0.00014131299984299073	0.00029625073885502135	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	CD4	2.129406817186208e-05	4.8601616465136145e-05	0.013256225769357815	0.8657199677887635	2	2
cytokines/metabolism	CD79A	1.2155711399119973e-05	2.8435981424699963e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	CD79B	1.2155711399119973e-05	2.8435981424699963e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	CSF1	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	CSF2	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	ERBB2	1.8600621730646694e-06	4.686395930948444e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	FGF2	0.0004740074998741406	0.000940845999029983	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	IL17A	0.0003299736443082013	0.0006641039625474416	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	ITK	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	KCNQ1	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	KCNQ1OT1	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	LGALS3	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	MMP2	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	MYD88	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	SERPINA1	5.133631229115032e-06	1.249986762446474e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	SOCS1	0.00014131299984299073	0.00029625073885502135	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	SYK	1.2155711399119973e-05	2.8435981424699963e-05	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	TBX21	0.00014131299984299073	0.00029625073885502135	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	TRAF6	0.0034736527206499224	0.006204901173530705	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	drug hypersensitivity/drug therapy	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	jurkat cells/drug effects	1.8600621730646694e-06	4.686395930948444e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	dinitrofluorobenzene/pharmacology	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	rna messenger/metabolism	1.8600621730646694e-06	4.686395930948444e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	anti-inflammatory agents/pharmacology	0.004135200104046333	0.007288583571349712	0.13557983414505725	0.9605811478101344	1	2
cytokines/metabolism	hypersensitivity delayed/chemically induced	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	ear/pathology	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	cyclins/metabolism	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	oxazolone/pharmacology	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	triterpenes/pharmacology	0.0019008564884910317	0.0035298647231744515	0.13557983414505725	0.9605811478101344	1	2
cytokines/metabolism	foot/pathology	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	oleic acid/toxicity	1.8600621730646694e-06	4.686395930948444e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	arachidonic acid/toxicity	1.8600621730646694e-06	4.686395930948444e-06	0.07009345794392523	0.9605811478101344	1	2
cytokines/metabolism	nfatc transcription factors/antagonists & inhibitors	8.561751006697094e-05	0.00018302257726939843	0.07009345794392523	0.9605811478101344	1	2
aniline compounds/chemistry	b7-h1 antigen/metabolism	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
aniline compounds/chemistry	phenol/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
aniline compounds/chemistry	programmed cell death 1 receptor/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
aniline compounds/chemistry	cd8-positive t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
aniline compounds/chemistry	immunogenic cell death/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
aniline compounds/chemistry	metal-organic frameworks/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
aniline compounds/chemistry	benzylidene compounds/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
aniline compounds/chemistry	PDCD1	7.439604488013174e-13	2.765611191227693e-12	0.02336448598130841	0.9605811478101344	1	2
aniline compounds/chemistry	exosomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
b7-h1 antigen/metabolism	cell movement/drug effects	0.004714512854465336	0.008247031054843838	0.044528218079937634	0.8657199677887635	2	2
b7-h1 antigen/metabolism	phenol/chemistry	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	programmed cell death 1 receptor/metabolism	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	cd8-positive t-lymphocytes/cytology	4.2223107232786106e-09	1.2798117518125765e-08	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/metabolism	immunogenic cell death/drug effects	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	metal-organic frameworks/chemistry	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	sorafenib/pharmacology	7.824615122498102e-08	2.181000179783036e-07	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/metabolism	benzylidene compounds/chemistry	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	PDCD1	0.0009457168758258971	0.001818204192379611	0.09085010295354308	0.9605811478101344	1	2
b7-h1 antigen/metabolism	interleukin-10/metabolism	1.3036816781664129e-06	3.327572776130247e-06	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/metabolism	neoplasm invasiveness	3.028416872830064e-08	8.668120889543978e-08	0.0038501128055567616	0.8657199677887635	2	2
b7-h1 antigen/metabolism	t-lymphocytes/drug effects	3.855916164230422e-05	8.598689146247835e-05	0.055287464515536164	0.9605811478101344	1	2
b7-h1 antigen/metabolism	carcinoma hepatocellular/genetics	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	potassium channels voltage-gated/metabolism	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	hela cells	5.435487294180863e-05	0.00011924539687771112	0.055287464515536164	0.9605811478101344	1	2
b7-h1 antigen/metabolism	drugs chinese herbal/pharmacology	0.0020370465275560967	0.0037650097945810057	0.12539913750269532	0.9605811478101344	1	2
b7-h1 antigen/metabolism	micrornas/genetics	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	immune evasion/drug effects	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	KCNQ1	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	KCNQ1OT1	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	naphthalenes/pharmacology	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/metabolism	phosphatidylinositol 3-kinase/metabolism	0.0022979199130953587	0.00421852941248347	0.09085010295354308	0.9605811478101344	1	2
b7-h1 antigen/metabolism	g1 phase cell cycle checkpoints/drug effects	1.2593558440521235e-07	3.465586326717576e-07	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/metabolism	uterine cervical neoplasms/drug therapy	1.9701580900033377e-07	5.351490152567894e-07	0.03711991575621956	0.9605811478101344	1	2
b7-h1 antigen/metabolism	exosomes/metabolism	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
glutamates/pharmacology	tumor necrosis factor-alpha/metabolism	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
glutamates/pharmacology	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glutamates/pharmacology	phytohemagglutinins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamates/pharmacology	buthionine sulfoximine/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamates/pharmacology	antibodies monoclonal/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamates/pharmacology	cell division/drug effects	3.9129477436006255e-11	1.324622629370591e-10	0.018691588785046728	0.9605811478101344	1	2
glutamates/pharmacology	mercaptoethanol/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamates/pharmacology	interleukins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamates/pharmacology	cd3 complex/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamates/pharmacology	CD28	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamates/pharmacology	CD3E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamates/pharmacology	IL2	5.513522971511975e-11	1.8460463853590893e-10	0.018691588785046728	0.9605811478101344	1	2
glutamates/pharmacology	IL5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
exosomes/drug effects	hyaluronic acid/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
exosomes/drug effects	immunologic memory	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
exosomes/drug effects	tumor escape/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
exosomes/drug effects	cell line tumor/transplantation	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
exosomes/drug effects	aniline compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
exosomes/drug effects	benzylidene compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenol/chemistry	programmed cell death 1 receptor/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenol/chemistry	cd8-positive t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phenol/chemistry	immunogenic cell death/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenol/chemistry	metal-organic frameworks/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenol/chemistry	benzylidene compounds/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenol/chemistry	PDCD1	7.439604488013174e-13	2.765611191227693e-12	0.02336448598130841	0.9605811478101344	1	2
phenol/chemistry	exosomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
STING1	macrophages	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	cd8-positive t-lymphocytes/drug effects	5.435487294180863e-05	0.00011924539687771112	0.07319670689438858	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	lymphocytes tumor-infiltrating/immunology	6.713017350223893e-06	1.620413909981787e-05	0.055287464515536164	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	TGFB1	0.0030184185630593996	0.005444954897574702	0.12539913750269532	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	zoledronic acid	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	neovascularization pathologic/immunology	4.440892098500626e-16	1.9067729111536865e-15	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	neuroblastoma/immunology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	receptors antigen t-cell gamma-delta/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	chemokine cxcl10/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	fas receptor/genetics	4.440892098500626e-16	1.9067729111536865e-15	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	sarcoma/drug therapy	4.440892098500626e-16	1.9067729111536865e-15	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	neovascularization pathologic	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	cisplatin/administration & dosage	3.930189507173054e-13	1.4767010609091941e-12	0.03711991575621956	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	t-lymphocyte subsets/cytology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	hypoxia	4.440892098500626e-16	1.9067729111536865e-15	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	adenosine triphosphate/metabolism	0.0001667205860131915	0.0003464519774193069	0.10825010098314035	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	antigens neoplasm/immunology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	plant leaves/chemistry	4.440892098500626e-16	1.9067729111536865e-15	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	fas ligand protein/genetics	4.440892098500626e-16	1.9067729111536865e-15	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	CXCL10	1.7848166501521767e-05	4.115419107148629e-05	0.055287464515536164	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	PRF1	1.08218036753982e-08	3.1758169497561496e-08	0.03711991575621956	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	WDTC1	1.4883361335149559e-05	3.44874777422362e-05	0.07319670689438858	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	adenosine triphosphatases/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	isoantigens/immunology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cytotoxicity immunologic/drug effects	adenosine/analogs & derivatives	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
programmed cell death 1 receptor/metabolism	cd8-positive t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
programmed cell death 1 receptor/metabolism	immunogenic cell death/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
programmed cell death 1 receptor/metabolism	metal-organic frameworks/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
programmed cell death 1 receptor/metabolism	benzylidene compounds/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
programmed cell death 1 receptor/metabolism	PDCD1	7.439604488013174e-13	2.765611191227693e-12	0.02336448598130841	0.9605811478101344	1	2
programmed cell death 1 receptor/metabolism	exosomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
macrophages/drug effects	ferritins/blood	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	glycogen synthase kinase 3/metabolism	0.00036731261271538695	0.0007345585927572655	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	tumor suppressor protein p53/genetics	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	actins/metabolism	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	hypoxia-inducible factor 1 alpha subunit/metabolism	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	listeriosis/etiology	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	hemeproteins/toxicity	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	transferrin/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	tuberculosis/metabolism	3.454814989645172e-09	1.0513700606169323e-08	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	sorafenib/pharmacology	0.0018630738100782196	0.0034614520404992483	0.09148348032117941	0.9605811478101344	1	2
macrophages/drug effects	liver x receptors/agonists	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	BTRC	0.00036731261271538695	0.0007345585927572655	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	CTLA4	0.00036731261271538695	0.0007345585927572655	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	FN1	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	GABPA	0.00036731261271538695	0.0007345585927572655	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	GSK3B	1.8114109771372178e-05	4.174993646657054e-05	0.0013814543574779913	0.7135314763244264	3	2
macrophages/drug effects	MMRN1	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	TF	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	interleukin-10/metabolism	0.005290705352827385	0.009188615330377172	0.09148348032117941	0.9605811478101344	1	2
macrophages/drug effects	pyridines/therapeutic use	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	iron/chemistry	0.00036731261271538695	0.0007345585927572655	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	neovascularization pathologic/pathology	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	antigens polyomavirus transforming/genetics	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	thiazoles/pharmacology	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	ceramides/pharmacology	0.002621392365332098	0.0047714405077885	0.09148348032117941	0.9605811478101344	1	2
macrophages/drug effects	phenylurea compounds/therapeutic use	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	neoplasm invasiveness	2.968209591558413e-06	7.353155626368527e-06	0.0013814543574779913	0.7135314763244264	3	2
macrophages/drug effects	neoplasm proteins/metabolism	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	breast neoplasms/blood supply	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	interferon-alpha/metabolism	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	myeloid cell leukemia sequence 1 protein/metabolism	8.891606009264752e-05	0.00018981615926827	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	tubulin modulators/pharmacology	8.891606009264752e-05	0.00018981615926827	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	stat3 transcription factor/physiology	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	clodronic acid/pharmacology	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	ng-nitroarginine methyl ester/pharmacology	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	liver neoplasms/drug therapy	0.0035524822154440194	0.006335959220685143	0.09148348032117941	0.9605811478101344	1	2
macrophages/drug effects	carcinoma hepatocellular/drug therapy	0.002802147851638348	0.00508031871005035	0.03650184028860656	0.8657199677887635	2	2
macrophages/drug effects	lipopolysaccharides/pharmacology	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	cell line transformed	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	myeloid differentiation factor 88/antagonists & inhibitors	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	colorectal neoplasms/immunology	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	receptors ccr5/drug effects	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	piperazines	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	nf-e2-related factor 2/genetics	0.005290705352827385	0.009188615330377172	0.09148348032117941	0.9605811478101344	1	2
macrophages/drug effects	maraviroc	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	neoplasm proteins/antagonists & inhibitors	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	stilbenes/pharmacology	8.891606009264752e-05	0.00018981615926827	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	glycogen synthase kinase 3 beta/metabolism	8.992366710147692e-07	2.3256739146667014e-06	0.0019744636040542316	0.8657199677887635	2	2
macrophages/drug effects	chemokine ccl5/antagonists & inhibitors	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	CCR5	0.0002694894333351572	0.0005482793232604546	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	CSF1	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	CSF2	1.0834047752372733e-05	2.5471218260216894e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	CTNNB1	8.891606009264752e-05	0.00018981615926827	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	ITK	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	MMP2	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	MYD88	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	TRAF6	0.0010225856949998002	0.0019572853028349334	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	polycyclic compounds/pharmacology	3.4789498117304696e-05	7.808600778686083e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	amino acid transport system y+/metabolism	0.0012656389571008564	0.002399381575766095	0.09148348032117941	0.9605811478101344	1	2
macrophages/drug effects	cyclooctanes/pharmacology	3.4789498117304696e-05	7.808600778686083e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	chemical and drug induced liver injury/pathology	3.4789498117304696e-05	7.808600778686083e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	g1 phase/drug effects	3.4789498117304696e-05	7.808600778686083e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	hepatic stellate cells/drug effects	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	genetic variation	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	malaria/genetics	3.37278289741505e-07	8.941098631983529e-07	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	liver cirrhosis/drug therapy	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	collagen type i/metabolism	5.3953543135421e-06	1.3103852379926881e-05	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	cd8-positive t-lymphocytes/immunology	0.00010435783206808047	0.00022111103992283665	0.018291269805799152	0.8657199677887635	2	2
macrophages/drug effects	lung neoplasms/drug therapy	0.0011901813079731038	0.00226705118602082	0.018291269805799152	0.8657199677887635	2	2
macrophages/drug effects	allografts	0.00036731261271538695	0.0007345585927572655	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	iron chelating agents/pharmacology	3.454814989645172e-09	1.0513700606169323e-08	0.04672897196261682	0.9605811478101344	1	2
macrophages/drug effects	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.00013315331632623995	0.0002794901293184442	0.09148348032117941	0.9605811478101344	1	2
proto-oncogene proteins c-akt/physiology	mesenchymal stem cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/physiology	anoikis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/physiology	lung neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/physiology	osteosarcoma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/physiology	bone neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/physiology	CXCL8	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/physiology	CXCR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd8-positive t-lymphocytes/cytology	immunogenic cell death/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd8-positive t-lymphocytes/cytology	fatty acids/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd8-positive t-lymphocytes/cytology	metal-organic frameworks/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd8-positive t-lymphocytes/cytology	benzylidene compounds/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd8-positive t-lymphocytes/cytology	CD36	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd8-positive t-lymphocytes/cytology	PDCD1	0.0	0.0	0.00043876968978982925	0.8657199677887635	2	2
cd8-positive t-lymphocytes/cytology	antibodies monoclonal humanized/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd8-positive t-lymphocytes/cytology	cd36 antigens/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd8-positive t-lymphocytes/cytology	exosomes/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
th1 cells/immunology	piperidines/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th1 cells/immunology	burkitt lymphoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th1 cells/immunology	cell differentiation/drug effects	7.083156283727021e-11	2.3562074493604914e-10	0.02336448598130841	0.9605811478101344	1	2
th1 cells/immunology	CD4	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
immunologic factors/adverse effects	macrophages peritoneal/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunologic factors/adverse effects	spleen/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunologic factors/adverse effects	mitogens/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	iron/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	nf-e2-related factor 2/genetics	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	BTRC	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	CTLA4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	GABPA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	GSK3B	1.930989817899853e-05	4.4348399484433295e-05	0.02803738317757009	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	NFE2L2	1.08218036753982e-08	3.1758169497561496e-08	0.018691588785046728	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	PDCD1	4.952394028201468e-08	1.398979929965227e-07	0.02336448598130841	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	PRKAA2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	cd8-positive t-lymphocytes/immunology	1.36867830402565e-08	3.990032956122905e-08	0.02336448598130841	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	lung neoplasms/drug therapy	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
glycogen synthase kinase 3/metabolism	allografts	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
raw 264.7 cells	nf-e2-related factor 2/biosynthesis	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	tumor-associated macrophages/drug effects	3.6136885706028465e-09	1.0972952155991126e-08	0.03711991575621956	0.9605811478101344	1	2
raw 264.7 cells	melanoma/genetics	6.000272821826691e-06	1.4531416429661125e-05	0.055287464515536164	0.9605811478101344	1	2
raw 264.7 cells	lipopolysaccharides/toxicity	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	diterpenes/pharmacology	5.726932958083353e-05	0.00012540214307262066	0.07319670689438858	0.9605811478101344	1	2
raw 264.7 cells	microglia/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	carbolines/pharmacology	0.0001660462485749692	0.0003451808116708392	0.07319670689438858	0.9605811478101344	1	2
raw 264.7 cells	inflammation mediators/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	gene expression	4.9137784643216165e-05	0.0001082091366174221	0.07319670689438858	0.9605811478101344	1	2
raw 264.7 cells	colonic neoplasms/drug therapy	3.560085416054459e-05	7.97285558691404e-05	0.055287464515536164	0.9605811478101344	1	2
raw 264.7 cells	HIF1A	0.0003178048211939233	0.0006429584049994147	0.07319670689438858	0.9605811478101344	1	2
raw 264.7 cells	NFE2L2	0.00028730260487308534	0.0005834436614388677	0.07319670689438858	0.9605811478101344	1	2
raw 264.7 cells	TGFB1	0.004318096573720398	0.007581254439989436	0.12539913750269532	0.9605811478101344	1	2
raw 264.7 cells	cell cycle checkpoints/drug effects	0.0029877882020005186	0.005392056501408483	0.10825010098314035	0.9605811478101344	1	2
raw 264.7 cells	epithelial-mesenchymal transition/drug effects	6.641519666106266e-05	0.0001446101378612591	0.055287464515536164	0.9605811478101344	1	2
raw 264.7 cells	ceramides/pharmacology	5.738583852554768e-08	1.6146541192078551e-07	0.03711991575621956	0.9605811478101344	1	2
raw 264.7 cells	chemokine cxcl12/metabolism	1.1645568596674316e-05	2.7329589826447614e-05	0.055287464515536164	0.9605811478101344	1	2
raw 264.7 cells	transforming growth factor beta1/genetics	8.916732907593428e-10	2.796530969368704e-09	0.03711991575621956	0.9605811478101344	1	2
raw 264.7 cells	ht29 cells	4.6629367034256575e-15	1.8989366168660674e-14	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	epoxy compounds/pharmacology	4.6629367034256575e-15	1.8989366168660674e-14	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	cytokines/genetics	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	isoflavones/adverse effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	phenanthrenes/pharmacology	4.6629367034256575e-15	1.8989366168660674e-14	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	pancreatic neoplasms/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	protein kinase c/genetics	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	receptors vascular endothelial growth factor/genetics	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	nf-kappa b/metabolism	0.0012656389571008564	0.002399381575766095	0.09085010295354308	0.9605811478101344	1	2
raw 264.7 cells	vascular endothelial growth factor a/genetics	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	ARG1	9.060780714609251e-08	2.5163382440572464e-07	0.03711991575621956	0.9605811478101344	1	2
raw 264.7 cells	C2	1.7478318792285563e-10	5.686320978785777e-10	0.03711991575621956	0.9605811478101344	1	2
raw 264.7 cells	CDKN1A	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	CXCL12	0.0036151897888914153	0.00644415106035071	0.12539913750269532	0.9605811478101344	1	2
raw 264.7 cells	DDX53	1.1985013493864827e-06	3.067273099393287e-06	0.03711991575621956	0.9605811478101344	1	2
raw 264.7 cells	FLT1	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	KDR	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	MRC1	4.6629367034256575e-15	1.8989366168660674e-14	0.018691588785046728	0.9605811478101344	1	2
raw 264.7 cells	ZHX2	0.00035061693254145876	0.0007032753028269726	0.07319670689438858	0.9605811478101344	1	2
immunogenic cell death/drug effects	metal-organic frameworks/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunogenic cell death/drug effects	benzylidene compounds/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunogenic cell death/drug effects	PDCD1	7.439604488013174e-13	2.765611191227693e-12	0.02336448598130841	0.9605811478101344	1	2
immunogenic cell death/drug effects	exosomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	sulfonamides/pharmacology	1.765254609153999e-14	7.017730548616547e-14	0.014018691588785045	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	rna small interfering/genetics	1.765254609153999e-14	7.017730548616547e-14	0.014018691588785045	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	curcumin/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	cyclophilin d	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	lactones/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	cyclosporine/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	proto-oncogene proteins c-bcl-2/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	membrane potential mitochondrial/drug effects	0.005711427168056726	0.009871867842686947	0.09813084112149532	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	biphenyl compounds/pharmacology	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	nitrophenols/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenine nucleotide translocator 1/antagonists & inhibitors	cell death/drug effects	2.415650552922699e-07	6.492778665224878e-07	0.02803738317757009	0.9605811478101344	1	2
cyclins/metabolism	dinitrofluorobenzene/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclins/metabolism	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclins/metabolism	drug hypersensitivity/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclins/metabolism	oxazolone/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclins/metabolism	triterpenes/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclins/metabolism	foot/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclins/metabolism	nfatc transcription factors/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclins/metabolism	ear/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclins/metabolism	anti-inflammatory agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclins/metabolism	hypersensitivity delayed/chemically induced	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/metabolism	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
lactones/metabolism	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
lactones/metabolism	immunosuppressive agents/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lactones/metabolism	cytokines/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/metabolism	dihydroorotase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/metabolism	clone cells	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/metabolism	cyclophilin a/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/metabolism	tacrolimus binding protein 1a/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/metabolism	spiro compounds/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/metabolism	enzyme inhibitors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/metabolism	imp dehydrogenase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/metabolism	CD40LG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/metabolism	IL2	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
lactones/metabolism	PPIA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxazolone/pharmacology	dinitrofluorobenzene/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxazolone/pharmacology	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oxazolone/pharmacology	drug hypersensitivity/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxazolone/pharmacology	ear/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxazolone/pharmacology	anti-inflammatory agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oxazolone/pharmacology	triterpenes/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oxazolone/pharmacology	foot/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxazolone/pharmacology	nfatc transcription factors/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxazolone/pharmacology	hypersensitivity delayed/chemically induced	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilins/genetics	drug combinations	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclophilins/genetics	antibiotics antineoplastic/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclophilins/genetics	antineoplastic agents phytogenic/isolation & purification	3.7466474367420233e-10	1.1952840787916093e-09	0.018691588785046728	0.9605811478101344	1	2
cyclophilins/genetics	doxorubicin/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclophilins/genetics	plant extracts/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilins/genetics	anthraquinones/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilins/genetics	mitochondrial adp atp translocases/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilins/genetics	membrane potential mitochondrial/drug effects	0.005711427168056726	0.009871867842686947	0.09813084112149532	0.9605811478101344	1	2
cyclophilins/genetics	WDTC1	1.5842882561400984e-13	6.04645793169065e-13	0.018691588785046728	0.9605811478101344	1	2
cyclophilins/genetics	voltage-dependent anion channels/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilins/genetics	adenosine triphosphate/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunologic memory	hyaluronic acid/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunologic memory	tumor escape/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
immunologic memory	cell line tumor/transplantation	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
immunologic memory	aniline compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunologic memory	benzylidene compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	antineoplastic agents phytogenic/pharmacology	5.667977414525183e-06	1.3746294800951627e-05	0.02803738317757009	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0005349787352844082	0.0010567291843353013	0.04672897196261682	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	ZHX2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	bcl-2-associated x protein/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	cyclin b1/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	esophageal neoplasms/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	cyclin-dependent kinase inhibitor p21/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	phosphatidylinositol 3-kinases/genetics	0.00023111048486224028	0.000474090432661209	0.04205607476635514	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	cyclin-dependent kinase 2/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	tor serine-threonine kinases/antagonists & inhibitors	0.00025250561210343747	0.0005151993092408466	0.04205607476635514	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	tumor suppressor protein p53/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diterpenes kaurane/pharmacology	CDK2	1.2740916099929223e-09	3.968800765346701e-09	0.014018691588785045	0.9605811478101344	1	2
rna interference	lysosomal-associated membrane protein 2/genetics	1.8236408904082069e-06	4.6025222472207125e-06	0.04205607476635514	0.9605811478101344	1	2
rna interference	rna small interfering/metabolism	4.837227285392487e-10	1.5367606223102818e-09	0.0015795708832433853	0.8657199677887635	2	2
rna interference	interleukin-17/biosynthesis	1.8236408904082069e-06	4.6025222472207125e-06	0.04205607476635514	0.9605811478101344	1	2
rna interference	cyclin d1/genetics	1.8236408904082069e-06	4.6025222472207125e-06	0.04205607476635514	0.9605811478101344	1	2
rna interference	k562 cells	0.002179454742623821	0.004011069963720367	0.08253257864946689	0.9605811478101344	1	2
rna interference	ceramides/pharmacology	0.0015651042031368245	0.0029345537435802966	0.08253257864946689	0.9605811478101344	1	2
rna interference	receptor cross-talk/drug effects	1.3988681101473333e-05	3.252029111401139e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	proteasome endopeptidase complex/metabolism	0.0007077063124778515	0.0013801086836645736	0.08253257864946689	0.9605811478101344	1	2
rna interference	oxaliplatin	1.8236408904082069e-06	4.6025222472207125e-06	0.04205607476635514	0.9605811478101344	1	2
rna interference	cytokines/genetics	7.670460632658305e-06	1.842046792602661e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	docetaxel	0.005465546182889414	0.009469146804993384	0.08253257864946689	0.9605811478101344	1	2
rna interference	macrophages/immunology	1.8236408904082069e-06	4.6025222472207125e-06	0.04205607476635514	0.9605811478101344	1	2
rna interference	biomarkers	0.0015651042031368245	0.0029345537435802966	0.08253257864946689	0.9605811478101344	1	2
rna interference	receptors ccr10/genetics	1.3988681101473333e-05	3.252029111401139e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	src-family kinases/metabolism	2.8135184382271916e-07	7.532781363209851e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	interleukin-10/genetics	1.3988681101473333e-05	3.252029111401139e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	integrins/metabolism	2.8135184382271916e-07	7.532781363209851e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	leukemia/drug therapy	0.005465546182889414	0.009469146804993384	0.08253257864946689	0.9605811478101344	1	2
rna interference	doxorubicin/pharmacology	0.001306667958922647	0.0024763121160672613	0.08253257864946689	0.9605811478101344	1	2
rna interference	bortezomib/pharmacology	1.3988681101473333e-05	3.252029111401139e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	chemokine ccl27/metabolism	1.3988681101473333e-05	3.252029111401139e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	protein kinase c/genetics	7.670460632658305e-06	1.842046792602661e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	receptors interleukin-17/genetics	1.8236408904082069e-06	4.6025222472207125e-06	0.04205607476635514	0.9605811478101344	1	2
rna interference	cd79 antigens/antagonists & inhibitors	2.8135184382271916e-07	7.532781363209851e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	receptors vascular endothelial growth factor/genetics	7.670460632658305e-06	1.842046792602661e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	organoplatinum compounds/pharmacology	1.8236408904082069e-06	4.6025222472207125e-06	0.04205607476635514	0.9605811478101344	1	2
rna interference	cell differentiation/drug effects	0.0002619941215403765	0.0005344108050441504	0.014774701220028882	0.8657199677887635	2	2
rna interference	lymphoma large b-cell diffuse/metabolism	2.8135184382271916e-07	7.532781363209851e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	vascular endothelial growth factor a/genetics	7.670460632658305e-06	1.842046792602661e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	C2	0.00018353194505138504	0.0003806332729275644	0.08253257864946689	0.9605811478101344	1	2
rna interference	CD79A	2.8135184382271916e-07	7.532781363209851e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	CD79B	2.8135184382271916e-07	7.532781363209851e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	FLT1	7.670460632658305e-06	1.842046792602661e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	KDR	7.670460632658305e-06	1.842046792602661e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	SYK	2.8135184382271916e-07	7.532781363209851e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	dendritic cells/immunology	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	organophosphorus compounds/chemistry	3.8997152822406456e-05	8.691086883942359e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	prostate-specific antigen/immunology	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	pten phosphohydrolase/antagonists & inhibitors	6.061463760187458e-05	0.0001323068537616207	0.04205607476635514	0.9605811478101344	1	2
rna interference	mitochondrial proteins/genetics	8.78729425890512e-08	2.4425398867919834e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	organophosphorus compounds/pharmacology	0.005465546182889414	0.009469146804993384	0.08253257864946689	0.9605811478101344	1	2
rna interference	superoxide dismutase/metabolism	0.0015651042031368245	0.0029345537435802966	0.08253257864946689	0.9605811478101344	1	2
rna interference	head and neck neoplasms/drug therapy	8.78729425890512e-08	2.4425398867919834e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	antimycin a/analogs & derivatives	3.8997152822406456e-05	8.691086883942359e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	ubiquinone/analogs & derivatives	0.0005608682519995245	0.0011057876437526172	0.08253257864946689	0.9605811478101344	1	2
rna interference	cyclic n-oxides/chemistry	3.8997152822406456e-05	8.691086883942359e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	cell hypoxia	0.0018555770436964325	0.0034489767880137366	0.08253257864946689	0.9605811478101344	1	2
rna interference	autophagy-related protein-1 homolog/metabolism	6.061463760187458e-05	0.0001323068537616207	0.04205607476635514	0.9605811478101344	1	2
rna interference	adipose tissue/cytology	3.8997152822406456e-05	8.691086883942359e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	deoxycytidine/analogs & derivatives	8.78729425890512e-08	2.4425398867919834e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	aurora kinase b/antagonists & inhibitors	0.0001308891017559599	0.00027515664716966094	0.04205607476635514	0.9605811478101344	1	2
rna interference	ribosomal proteins/genetics	0.0001308891017559599	0.00027515664716966094	0.04205607476635514	0.9605811478101344	1	2
rna interference	rna small interfering	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	free radical scavengers/pharmacology	3.8997152822406456e-05	8.691086883942359e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	cytotoxicity immunologic	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	stem cells/cytology	3.8997152822406456e-05	8.691086883942359e-05	0.04205607476635514	0.9605811478101344	1	2
rna interference	breast neoplasms/therapy	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	hmgb1 protein/biosynthesis	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	ribosomal protein s6 kinases 70-kda/metabolism	0.003362937346997108	0.006032547606101395	0.08253257864946689	0.9605811478101344	1	2
rna interference	pyrazoles/pharmacology	0.004881980318146573	0.008525099164778682	0.08253257864946689	0.9605811478101344	1	2
rna interference	antimetabolites antineoplastic/pharmacology	8.78729425890512e-08	2.4425398867919834e-07	0.04205607476635514	0.9605811478101344	1	2
rna interference	rotenone/pharmacology	0.0018555770436964325	0.0034489767880137366	0.08253257864946689	0.9605811478101344	1	2
rna interference	colorectal neoplasms/therapy	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	sirolimus/pharmacology	0.001306667958922647	0.0024763121160672613	0.08253257864946689	0.9605811478101344	1	2
rna interference	AURKB	0.0001308891017559599	0.00027515664716966094	0.04205607476635514	0.9605811478101344	1	2
rna interference	KLK3	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	MUC1	0.004881980318146573	0.008525099164778682	0.08253257864946689	0.9605811478101344	1	2
rna interference	NPEPPS	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	PROM1	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	PSAT1	0.0002506687066090585	0.0005127800745329859	0.04205607476635514	0.9605811478101344	1	2
rna interference	RPL15	0.0001308891017559599	0.00027515664716966094	0.04205607476635514	0.9605811478101344	1	2
rna interference	ULK1	6.061463760187458e-05	0.0001323068537616207	0.04205607476635514	0.9605811478101344	1	2
rna interference	receptors interleukin-10/genetics	1.3988681101473333e-05	3.252029111401139e-05	0.04205607476635514	0.9605811478101344	1	2
cisplatin/administration & dosage	carcinoma non-small-cell lung/drug therapy	6.981901330971318e-05	0.00015178166095962888	0.10925365275766749	0.9605811478101344	1	2
cisplatin/administration & dosage	antigens neoplasm/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cisplatin/administration & dosage	deoxycytidine/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cisplatin/administration & dosage	drugs chinese herbal/administration & dosage	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
cisplatin/administration & dosage	DCR	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cisplatin/administration & dosage	VIP	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
microtubule-associated proteins/metabolism	morpholines/pharmacology	1.3844481117075702e-13	5.292009703004249e-13	0.014018691588785045	0.9605811478101344	1	2
microtubule-associated proteins/metabolism	cell death/drug effects	1.720221642909081e-08	4.9806233464030755e-08	0.02803738317757009	0.9605811478101344	1	2
microtubule-associated proteins/metabolism	berberine/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
microtubule-associated proteins/metabolism	membrane potential mitochondrial/drug effects	0.002429378420712003	0.004438426866080398	0.09813084112149532	0.9605811478101344	1	2
microtubule-associated proteins/metabolism	tert-butylhydroperoxide/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
microtubule-associated proteins/metabolism	lysosomes/drug effects	3.540051585204651e-10	1.1305193706632698e-09	0.02336448598130841	0.9605811478101344	1	2
microtubule-associated proteins/metabolism	chromones/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
microtubule-associated proteins/metabolism	mitophagy/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.018691588785046728	0.9605811478101344	1	2
microtubule-associated proteins/metabolism	pc12 cells	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
microtubule-associated proteins/metabolism	cytochromes c/metabolism	5.133631229115032e-06	1.249986762446474e-05	0.04205607476635514	0.9605811478101344	1	2
i-kappa b proteins/metabolism	nf-kappa b/metabolism	9.049661020554822e-11	2.9797928043786246e-10	0.02336448598130841	0.9605811478101344	1	2
i-kappa b proteins/metabolism	stomach neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
i-kappa b proteins/metabolism	ribosomal protein s6 kinases 70-kda/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
i-kappa b proteins/metabolism	NFKB1	2.4626201189370533e-08	7.071613490795019e-08	0.03271028037383177	0.9605811478101344	1	2
i-kappa b proteins/metabolism	biological products/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimetabolites antineoplastic/pharmacology	caspase 3/metabolism	1.20579102258489e-10	3.9473319177359547e-10	0.02803738317757009	0.9605811478101344	1	2
antimetabolites antineoplastic/pharmacology	head and neck neoplasms/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimetabolites antineoplastic/pharmacology	mitochondrial proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimetabolites antineoplastic/pharmacology	deoxycytidine/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimetabolites antineoplastic/pharmacology	cytochromes c/metabolism	1.2593558440521235e-07	3.465586326717576e-07	0.04205607476635514	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	antineoplastic agents phytogenic/pharmacology	5.667977414525183e-06	1.3746294800951627e-05	0.02803738317757009	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0005349787352844082	0.0010567291843353013	0.04672897196261682	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	ZHX2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	cyclin b1/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	esophageal neoplasms/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	cyclin-dependent kinase inhibitor p21/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	phosphatidylinositol 3-kinases/genetics	0.00023111048486224028	0.000474090432661209	0.04205607476635514	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	cyclin-dependent kinase 2/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	tor serine-threonine kinases/antagonists & inhibitors	0.00025250561210343747	0.0005151993092408466	0.04205607476635514	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	tumor suppressor protein p53/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bcl-2-associated x protein/agonists	CDK2	1.2740916099929223e-09	3.968800765346701e-09	0.014018691588785045	0.9605811478101344	1	2
tor serine-threonine kinases/biosynthesis	24-dinitrophenol/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tor serine-threonine kinases/biosynthesis	uncoupling agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/biosynthesis	brain/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/biosynthesis	cyclic amp response element-binding protein/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	tamoxifen/pharmacology	8.215650382226158e-15	3.329142797782069e-14	0.018647711816067742	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	rna messenger/genetics	0.00011431913718906728	0.0002411277467468244	0.05541661182045544	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	antigen presentation/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	drug combinations	1.1500711494250027e-10	3.773890266784113e-10	0.018647711816067742	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	antibodies monoclonal/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	carcinoma non-small-cell lung/drug therapy	0.003077677585448413	0.005545201879869789	0.10925365275766749	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	benzamides/pharmacology	9.759095198280665e-05	0.00020749135094666547	0.046290202272826986	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	selective estrogen receptor modulators/pharmacology	8.215650382226158e-15	3.329142797782069e-14	0.018647711816067742	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	histone deacetylases/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	pyrimidines/pharmacology	1.7351963819134397e-06	4.389354041811326e-06	0.03711991575621956	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	CIITA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	FOXP3	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	HDAC9	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	hydroxamic acids/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	breast neoplasms/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	histone deacetylases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	endoplasmic reticulum/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	benzofurans/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	proto-oncogene proteins c-akt/genetics	0.0004249031122725011	0.0008465808620444699	0.0644991443991049	0.9605811478101344	1	2
histone deacetylase inhibitors/pharmacology	receptors estrogen/antagonists & inhibitors	1.9081847213442416e-11	6.5166754548014e-11	0.018647711816067742	0.9605811478101344	1	2
eif-2 kinase/genetics	antioxidants/pharmacology	5.714498345521513e-06	1.38575956359501e-05	0.027905752270633143	0.9605811478101344	1	2
eif-2 kinase/genetics	endoplasmic reticulum/drug effects	2.051451114204461e-06	5.150938864136198e-06	0.027905752270633143	0.9605811478101344	1	2
eif-2 kinase/genetics	gene expression regulation	1.3350204552953215e-07	3.665570485473381e-07	0.018647711816067742	0.9605811478101344	1	2
eif-2 kinase/genetics	docetaxel	6.631623683528431e-08	1.8543315025292944e-07	0.018647711816067742	0.9605811478101344	1	2
eif-2 kinase/genetics	SPP1	2.0338917883222507e-08	5.867230949748657e-08	0.018647711816067742	0.9605811478101344	1	2
eif-2 kinase/genetics	tor serine-threonine kinases/genetics	7.740687822466175e-05	0.00016710729962766496	0.03711991575621956	0.9605811478101344	1	2
eif-2 kinase/genetics	dendritic cells/immunology	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	rna small interfering	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	phenylbutyrates/pharmacology	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	proto-oncogene proteins c-akt/genetics	0.0022979199130953587	0.00421852941248347	0.0644991443991049	0.9605811478101344	1	2
eif-2 kinase/genetics	cytotoxicity immunologic	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	muscle smooth vascular/cytology	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	breast neoplasms/therapy	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	hmgb1 protein/biosynthesis	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	piperidines/pharmacology	9.484881946519863e-08	2.624531590824171e-07	0.018647711816067742	0.9605811478101344	1	2
eif-2 kinase/genetics	colorectal neoplasms/therapy	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	CALD1	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	HSPA5	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	KLK3	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	MUC1	4.557699428975326e-08	1.2924521801935432e-07	0.018647711816067742	0.9605811478101344	1	2
eif-2 kinase/genetics	NPEPPS	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	PROM1	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	PSAT1	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	eukaryotic initiation factor-2/genetics	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	myocytes smooth muscle/cytology	5.525480073487188e-10	1.7516288232961253e-09	0.018647711816067742	0.9605811478101344	1	2
eif-2 kinase/genetics	cerebral arteries/cytology	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	organophosphorus compounds/pharmacology	6.631623683528431e-08	1.8543315025292944e-07	0.018647711816067742	0.9605811478101344	1	2
eif-2 kinase/genetics	transcription factor chop/genetics	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	taurochenodeoxycholic acid/pharmacology	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	prostate-specific antigen/immunology	2.052469305624527e-12	7.41363749187575e-12	0.009345794392523364	0.9605811478101344	1	2
eif-2 kinase/genetics	activating transcription factor 4/genetics	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
arginine/pharmacology	enterocytes/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
arginine/pharmacology	dna/biosynthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
arginine/pharmacology	energy metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
flavonoids/chemistry	phosphoinositide-3 kinase inhibitors	0.0005733062746914319	0.0011294010672262948	0.07009345794392523	0.9605811478101344	1	2
flavonoids/chemistry	proto-oncogene proteins c-akt/antagonists & inhibitors	3.379596134700513e-05	7.601850191580994e-05	0.04672897196261682	0.9605811478101344	1	2
flavonoids/chemistry	morpholines/pharmacology	7.263079027097774e-13	2.703636103147927e-12	0.014018691588785045	0.9605811478101344	1	2
flavonoids/chemistry	membrane potential mitochondrial/drug effects	0.003335606434196392	0.0059844943169633045	0.09813084112149532	0.9605811478101344	1	2
flavonoids/chemistry	tor serine-threonine kinases/antagonists & inhibitors	1.1940993098313868e-05	2.7966328429108155e-05	0.04205607476635514	0.9605811478101344	1	2
flavonoids/chemistry	antineoplastic agents phytogenic/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
flavonoids/chemistry	chondrosarcoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
flavonoids/chemistry	CASP9	1.899771066815603e-05	4.366324661852436e-05	0.04672897196261682	0.9605811478101344	1	2
inflammation/drug therapy	ventricular function left/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	toll-like receptor 4/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	myocardium/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	myocardial reperfusion injury/drug therapy	1.5543122344752192e-15	6.525033538787059e-15	0.018647711816067742	0.9605811478101344	1	2
inflammation/drug therapy	neutrophil infiltration	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	phenylenediamines/pharmacology	1.0363931934875836e-12	3.832030375652229e-12	0.018647711816067742	0.9605811478101344	1	2
inflammation/drug therapy	cyclohexylamines/pharmacology	1.0363931934875836e-12	3.832030375652229e-12	0.018647711816067742	0.9605811478101344	1	2
inflammation/drug therapy	adaptor proteins vesicular transport/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	TICAM1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	TRIM69	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	gene expression/drug effects	5.524455328753675e-07	1.4481416132250745e-06	0.03711991575621956	0.9605811478101344	1	2
inflammation/drug therapy	chemokine ccl5/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	butyrates/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	valproic acid/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	u937 cells	5.133631229115032e-06	1.249986762446474e-05	0.03711991575621956	0.9605811478101344	1	2
inflammation/drug therapy	leukocytes mononuclear/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/drug therapy	leukemia/drug therapy	8.21016588048451e-11	2.705391381451539e-10	0.018647711816067742	0.9605811478101344	1	2
inflammation/drug therapy	p38 mitogen-activated protein kinases/metabolism	4.8128057095198074e-11	1.6240088809839716e-10	0.018647711816067742	0.9605811478101344	1	2
inflammation/drug therapy	caspase 3/metabolism	9.940125707075254e-05	0.00021089289029021862	0.05541661182045544	0.9605811478101344	1	2
inflammation/drug therapy	CCL2	1.345080247738828e-06	3.4276848476821173e-06	0.03711991575621956	0.9605811478101344	1	2
inflammation/drug therapy	CCL5	9.926129962423147e-08	2.744561241679277e-07	0.027905752270633143	0.9605811478101344	1	2
inflammation/drug therapy	neutrophils/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	cell differentiation/drug effects	1.796646799778756e-05	4.14139766246963e-05	0.046290202272826986	0.9605811478101344	1	2
rotenone/pharmacology	cyclic n-oxides/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	myocardial reperfusion injury/metabolism	1.0859091403858656e-12	4.002361204819051e-12	0.018647711816067742	0.9605811478101344	1	2
rotenone/pharmacology	cyclophilin d	1.0859091403858656e-12	4.002361204819051e-12	0.018647711816067742	0.9605811478101344	1	2
rotenone/pharmacology	cell hypoxia/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	organophosphorus compounds/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	myocytes cardiac/drug effects	4.4105279979334e-06	1.0824056244260419e-05	0.046290202272826986	0.9605811478101344	1	2
rotenone/pharmacology	cell death	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	PPID	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	PPIF	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	cardiotonic agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	cell hypoxia	2.3432367157738554e-12	8.428007032525606e-12	0.018647711816067742	0.9605811478101344	1	2
rotenone/pharmacology	adipose tissue/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	oxygen consumption	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	antimycin a/analogs & derivatives	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	mitochondria heart/drug effects	3.0033297815368343e-07	8.027326345414489e-07	0.03711991575621956	0.9605811478101344	1	2
rotenone/pharmacology	free radical scavengers/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	stem cells/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rotenone/pharmacology	cyclosporine/pharmacology	1.0859091403858656e-12	4.002361204819051e-12	0.018647711816067742	0.9605811478101344	1	2
rotenone/pharmacology	electron transport complex i/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dexamethasone/administration & dosage	cytochromes c/metabolism	3.925533308413165e-07	1.0381451167553493e-06	0.04205607476635514	0.9605811478101344	1	2
dexamethasone/administration & dosage	isocoumarins	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dexamethasone/administration & dosage	CASP9	9.097026248960915e-07	2.3510870324357085e-06	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/metabolism	cell cycle checkpoints/drug effects	0.003914573999354909	0.006920183413869229	0.008021265709392201	0.5304112294886878	4	2
proto-oncogene proteins c-akt/metabolism	AKT1	5.636595011848655e-07	1.4771858649856075e-06	7.311284576865112e-15	0.0	34	2
proto-oncogene proteins c-akt/metabolism	PI3	0.002178441189371716	0.004010208845559622	0.027642490456759247	0.8657199677887635	2	2
proto-oncogene proteins c-akt/metabolism	PIK3CA	3.0438326259041304e-05	6.873250894708549e-05	7.390272956073215e-10	1.678973800412177e-15	30	2
proto-oncogene proteins c-akt/metabolism	biological transport	0.005621281807727696	0.009727495588790538	0.16822429906542055	0.9605811478101344	1	2
proto-oncogene proteins c-akt/metabolism	monocrotaline	0.005621281807727696	0.009727495588790538	0.16822429906542055	0.9605811478101344	1	2
proto-oncogene proteins c-akt/metabolism	pulmonary arterial hypertension/drug therapy	0.005621281807727696	0.009727495588790538	0.16822429906542055	0.9605811478101344	1	2
proto-oncogene proteins c-akt/metabolism	pulmonary artery/cytology	0.005621281807727696	0.009727495588790538	0.16822429906542055	0.9605811478101344	1	2
proto-oncogene proteins c-akt/metabolism	pyruvates/pharmacology	0.005621281807727696	0.009727495588790538	0.16822429906542055	0.9605811478101344	1	2
proto-oncogene proteins c-akt/metabolism	phosphatidylinositol 3-kinase/metabolism	0.001428018912642215	0.0026905623812968345	0.0030441309830046173	0.5304112294886878	4	2
proto-oncogene proteins c-akt/metabolism	cytoskeleton/metabolism	0.005621281807727696	0.009727495588790538	0.16822429906542055	0.9605811478101344	1	2
proto-oncogene proteins c-akt/metabolism	stomach neoplasms/drug therapy	0.0026541811273850247	0.004827933792309631	0.027642490456759247	0.8657199677887635	2	2
proto-oncogene proteins c-akt/metabolism	sirolimus/pharmacology	0.0026541811273850247	0.004827933792309631	0.027642490456759247	0.8657199677887635	2	2
proto-oncogene proteins c-akt/metabolism	mitogen-activated protein kinases/metabolism	0.003808590796336775	0.006751230895452099	0.027642490456759247	0.8657199677887635	2	2
proto-oncogene proteins c-akt/metabolism	ATF4	0.004494116128639591	0.007881504327413753	0.027642490456759247	0.8657199677887635	2	2
spleen/cytology	macrophages peritoneal/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
spleen/cytology	mitogens/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minocycline/analogs & derivatives	paclitaxel/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
minocycline/analogs & derivatives	antineoplastic agents phytogenic/pharmacology	2.228787709945834e-09	6.864130664741689e-09	0.02803738317757009	0.9605811478101344	1	2
minocycline/analogs & derivatives	peptide elongation factor tu/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minocycline/analogs & derivatives	carcinoma renal cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minocycline/analogs & derivatives	dna mitochondrial/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minocycline/analogs & derivatives	tigecycline	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minocycline/analogs & derivatives	anti-bacterial agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
minocycline/analogs & derivatives	EEF1A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minocycline/analogs & derivatives	kidney/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	cell line tumor/transplantation	1.4982355600601238e-07	4.1009432188957925e-07	0.04166180294604871	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	membrane proteins/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	t-lymphocytes/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	myeloid-derived suppressor cells/immunology	6.844090960633764e-09	2.0416522459755544e-08	0.027905752270633143	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	neutral ceramidase/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	heme oxygenase-1/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	colonic neoplasms/drug therapy	9.921553742686662e-06	2.3488716516563464e-05	0.04166180294604871	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	ASAH2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	HMOX1	6.075266956173664e-10	1.9206694271539568e-09	0.027905752270633143	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	pyridines/therapeutic use	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	zoledronic acid	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	neuroblastoma/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	lung neoplasms/drug therapy	0.0010339067553616355	0.001978267477411554	0.06878335787959994	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	phenylurea compounds/therapeutic use	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	receptors antigen t-cell gamma-delta/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	neoplasm invasiveness	0.0019199350996133013	0.0035643928154491466	0.08215010393874443	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	interferon-alpha/metabolism	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	chemokine cxcl10/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	stat3 transcription factor/physiology	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	clodronic acid/pharmacology	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	ng-nitroarginine methyl ester/pharmacology	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	liver neoplasms/drug therapy	1.8712719040969716e-08	5.408731376708184e-08	0.027905752270633143	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	neovascularization pathologic	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	colorectal neoplasms/immunology	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	t-lymphocyte subsets/cytology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	receptors ccr5/drug effects	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	adenocarcinoma/drug therapy	1.7179468846384438e-06	4.347215989040331e-06	0.027905752270633143	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	maraviroc	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	neoplasm proteins/antagonists & inhibitors	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	chemokine ccl5/antagonists & inhibitors	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	CCL5	2.7620974430098144e-05	6.267235198464587e-05	0.04166180294604871	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	CCR5	3.3855140912919524e-12	1.2045153249121345e-11	0.014018691588785045	0.9605811478101344	1	2
lymphocytes tumor-infiltrating/immunology	CXCL10	0.0	0.0	0.00039365091980200724	0.8657199677887635	2	2
lymphocytes tumor-infiltrating/immunology	CXCL9	4.1519241933407613e-07	1.0959131403660614e-06	0.027905752270633143	0.9605811478101344	1	2
abietanes/pharmacology	cell cycle checkpoints/drug effects	0.0002039311921900877	0.0004202126098511265	0.05541661182045544	0.9605811478101344	1	2
abietanes/pharmacology	antineoplastic agents phytogenic/pharmacology	0.00035179075315983077	0.000705501412194647	0.05541661182045544	0.9605811478101344	1	2
abietanes/pharmacology	CASP8	0.002774005480236208	0.005030537327541365	0.0644991443991049	0.9605811478101344	1	2
abietanes/pharmacology	prostatic neoplasms/drug therapy	0.0	0.0	0.00043876968978982925	0.8657199677887635	2	2
abietanes/pharmacology	MCL1	0.001803655249378977	0.003358982256804433	0.05541661182045544	0.9605811478101344	1	2
abietanes/pharmacology	PI3	3.764988321108831e-12	1.3309357464134602e-11	0.018647711816067742	0.9605811478101344	1	2
abietanes/pharmacology	plant roots	9.658940314238862e-15	3.8840108708433053e-14	0.009345794392523364	0.9605811478101344	1	2
abietanes/pharmacology	1-phosphatidylinositol 4-kinase/metabolism	9.658940314238862e-15	3.8840108708433053e-14	0.009345794392523364	0.9605811478101344	1	2
abietanes/pharmacology	dna/metabolism	9.658940314238862e-15	3.8840108708433053e-14	0.009345794392523364	0.9605811478101344	1	2
abietanes/pharmacology	CASP9	0.005154663843904728	0.008979223230655878	0.09148348032117941	0.9605811478101344	1	2
abietanes/pharmacology	PTEN	0.0002893340491763041	0.0005872985745018554	0.046290202272826986	0.9605811478101344	1	2
abietanes/pharmacology	TNS1	9.658940314238862e-15	3.8840108708433053e-14	0.009345794392523364	0.9605811478101344	1	2
abietanes/pharmacology	caspases/metabolism	0.0015385039170436876	0.0028888549108311385	0.0644991443991049	0.9605811478101344	1	2
abietanes/pharmacology	plant extracts/pharmacology	9.658940314238862e-15	3.8840108708433053e-14	0.009345794392523364	0.9605811478101344	1	2
adenosine/analogs & derivatives	cell line	6.03680407773588e-07	1.5807536378375377e-06	0.06074766355140186	0.9605811478101344	1	2
adenosine/analogs & derivatives	adenosine triphosphate/metabolism	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine/analogs & derivatives	isoantigens/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine/analogs & derivatives	adenosine triphosphatases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine/analogs & derivatives	WDTC1	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
rna small interfering	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
rna small interfering	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering	cytotoxicity immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering	breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering	hmgb1 protein/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering	colorectal neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering	KLK3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
rna small interfering	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diterpenes/pharmacology	heterocyclic compounds 3-ring/pharmacology	2.669181906611584e-07	7.161996188021444e-07	0.03711991575621956	0.9605811478101344	1	2
diterpenes/pharmacology	epithelial cells/drug effects	7.882583474838611e-15	3.195352095113839e-14	0.018691588785046728	0.9605811478101344	1	2
diterpenes/pharmacology	membrane potential mitochondrial/drug effects	0.003990469136231689	0.00704474845989561	0.04888994113051045	0.8657199677887635	2	2
diterpenes/pharmacology	caspase 9/metabolism	4.8960835385969403e-14	1.9252514688600918e-13	0.018691588785046728	0.9605811478101344	1	2
diterpenes/pharmacology	stomach neoplasms/drug therapy	4.6343591852959776e-08	1.313177629063176e-07	0.03711991575621956	0.9605811478101344	1	2
diterpenes/pharmacology	phenylpropionates/pharmacology	7.882583474838611e-15	3.195352095113839e-14	0.018691588785046728	0.9605811478101344	1	2
diterpenes/pharmacology	BECN1	0.0004769313456710611	0.0009465642550504596	0.09085010295354308	0.9605811478101344	1	2
diterpenes/pharmacology	cisplatin	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
diterpenes/pharmacology	tumor-associated macrophages/drug effects	4.920609031344725e-09	1.4841256897823322e-08	0.03711991575621956	0.9605811478101344	1	2
diterpenes/pharmacology	lymphoma t-cell	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
diterpenes/pharmacology	asparaginase	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
diterpenes/pharmacology	colonic neoplasms/drug therapy	4.170820558080379e-05	9.256920844026192e-05	0.055287464515536164	0.9605811478101344	1	2
diterpenes/pharmacology	SLC7A11	7.703168886663558e-05	0.0001663136188926343	0.09085010295354308	0.9605811478101344	1	2
diterpenes/pharmacology	chemokine cxcl12/metabolism	1.3892018759120717e-05	3.232625114523415e-05	0.055287464515536164	0.9605811478101344	1	2
diterpenes/pharmacology	ht29 cells	7.882583474838611e-15	3.195352095113839e-14	0.018691588785046728	0.9605811478101344	1	2
diterpenes/pharmacology	epoxy compounds/pharmacology	7.882583474838611e-15	3.195352095113839e-14	0.018691588785046728	0.9605811478101344	1	2
diterpenes/pharmacology	phenanthrenes/pharmacology	7.882583474838611e-15	3.195352095113839e-14	0.018691588785046728	0.9605811478101344	1	2
diterpenes/pharmacology	nf-kappa b/metabolism	0.0014006963161076191	0.002640211368516781	0.09085010295354308	0.9605811478101344	1	2
diterpenes/pharmacology	caspase 3/metabolism	0.004888862185590037	0.008536440442534977	0.10825010098314035	0.9605811478101344	1	2
diterpenes/pharmacology	ARG1	1.1700231949962614e-07	3.227811737146843e-07	0.03711991575621956	0.9605811478101344	1	2
diterpenes/pharmacology	CXCL12	0.003935926978073323	0.006955700385745481	0.12539913750269532	0.9605811478101344	1	2
diterpenes/pharmacology	DDX53	1.4835589351447354e-06	3.7696793133653477e-06	0.03711991575621956	0.9605811478101344	1	2
diterpenes/pharmacology	MRC1	7.882583474838611e-15	3.195352095113839e-14	0.018691588785046728	0.9605811478101344	1	2
diterpenes/pharmacology	killer cells natural/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	triple negative breast neoplasms/drug therapy	1.1940993098313868e-05	2.7966328429108155e-05	0.07319670689438858	0.9605811478101344	1	2
calcium/metabolism	breast neoplasms/drug therapy	0.003795571073938131	0.006728692694233973	0.12539913750269532	0.9605811478101344	1	2
calcium/metabolism	ESR1	1.631716847194653e-07	4.4524867632361027e-07	0.03711991575621956	0.9605811478101344	1	2
calcium/metabolism	letrozole/pharmacology	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	receptors estrogen/physiology	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	phagosomes/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	aromatase inhibitors/pharmacology	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	drug antagonism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	antineoplastic agents/administration & dosage	2.415650552922699e-07	6.492778665224878e-07	0.055287464515536164	0.9605811478101344	1	2
calcium/metabolism	coordination complexes/chemistry	2.6645352591003757e-15	1.0984980065939618e-14	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	antimalarials/pharmacology	6.955092368698956e-08	1.9428085207788495e-07	0.03711991575621956	0.9605811478101344	1	2
calcium/metabolism	homeostasis/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	disulfides/administration & dosage	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	malaria/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	AREG	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	amphiregulin/physiology	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	CYP19A1	1.765254609153999e-14	7.017730548616547e-14	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	EGFR	6.591595510940795e-05	0.00014357982397275503	0.07319670689438858	0.9605811478101344	1	2
calcium/metabolism	SPAG17	2.6645352591003757e-15	1.0984980065939618e-14	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	hemolysis/drug effects	2.6645352591003757e-15	1.0984980065939618e-14	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	indole alkaloids/administration & dosage	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	iridium/chemistry	2.6645352591003757e-15	1.0984980065939618e-14	0.018691588785046728	0.9605811478101344	1	2
calcium/metabolism	nih 3t3 cells	2.6645352591003757e-15	1.0984980065939618e-14	0.018691588785046728	0.9605811478101344	1	2
interphase/drug effects	cell differentiation/drug effects	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
interphase/drug effects	CD4	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
interphase/drug effects	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interphase/drug effects	dose-response relationship immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interphase/drug effects	immunosuppressive agents/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interphase/drug effects	transcription factors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interphase/drug effects	receptors calcitriol/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interphase/drug effects	growth inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interphase/drug effects	th2 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interphase/drug effects	l-selectin/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interphase/drug effects	interferon-gamma/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interphase/drug effects	calcitriol/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interphase/drug effects	th1 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interphase/drug effects	SELP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interphase/drug effects	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/drug therapy	toll-like receptor 4/metabolism	0.0003972697744608622	0.0007934599136980786	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	tamoxifen/pharmacology	1.7848166501521767e-05	4.115419107148629e-05	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	osteopontin/genetics	1.2593558440521235e-07	3.465586326717576e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	transforming growth factor beta1/genetics	1.2155711399119973e-05	2.8435981424699963e-05	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	rank ligand/antagonists & inhibitors	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	paracrine communication/genetics	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	diterpenes/isolation & purification	1.2593558440521235e-07	3.465586326717576e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	plant extracts/isolation & purification	2.7893243270682433e-12	9.98685007521933e-12	0.0009214163485586416	0.8657199677887635	2	2
breast neoplasms/drug therapy	melanoma/drug therapy	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	osteoclasts/drug effects	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	human umbilical vein endothelial cells/drug effects	1.2593558440521235e-07	3.465586326717576e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	doxorubicin/therapeutic use	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	receptors estrogen/metabolism	8.561751006697094e-05	0.00018302257726939843	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	extracellular vesicles/metabolism	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	osteoprotegerin/pharmacology	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	antineoplastic agents phytogenic/isolation & purification	7.308830283214718e-07	1.9000718085640621e-06	0.00535588186581037	0.8657199677887635	2	2
breast neoplasms/drug therapy	selective estrogen receptor modulators/pharmacology	1.7848166501521767e-05	4.115419107148629e-05	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	embryo nonmammalian	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	bone neoplasms/drug therapy	3.560085416054459e-05	7.97285558691404e-05	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	bone density conservation agents/pharmacology	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	tyramine/analogs & derivatives	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	antineoplastic agents phytogenic/therapeutic use	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	drug resistance neoplasm/genetics	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	paclitaxel/therapeutic use	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	ESR1	0.00022093315072990727	0.0004542273505495147	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	MAPK1	0.0019232779664449806	0.0035696971634126555	0.03650184028860656	0.8657199677887635	2	2
breast neoplasms/drug therapy	PI3	6.509037427737674e-05	0.0001419498093044117	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	SMAD2	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	SPP1	0.0003972697744608622	0.0007934599136980786	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	TNFSF11	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	XIAP	0.005673764595456876	0.009815234350775456	0.09538832359347407	0.9605811478101344	1	2
breast neoplasms/drug therapy	amphiregulin/physiology	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	metabolic networks and pathways/drug effects	1.8864353412695323e-09	5.825227787718578e-09	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	levofloxacin/pharmacology	1.8864353412695323e-09	5.825227787718578e-09	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	receptors estrogen/physiology	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	letrozole/pharmacology	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	antibiotics antineoplastic/therapeutic use	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	aromatase inhibitors/pharmacology	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	organelle biogenesis	8.033954999486781e-06	1.919720817477886e-05	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	rhizome/chemistry	1.8600621730646694e-06	4.686395930948444e-06	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	saponins/isolation & purification	1.8600621730646694e-06	4.686395930948444e-06	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	anti-bacterial agents/pharmacology	2.5512621698586813e-05	5.803779232464321e-05	0.0644991443991049	0.9605811478101344	1	2
breast neoplasms/drug therapy	fluorouracil/therapeutic use	1.8864353412695323e-09	5.825227787718578e-09	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	AREG	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	COL4A5	1.8600621730646694e-06	4.686395930948444e-06	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	CYP19A1	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	EGFR	0.0052618907930607195	0.009148660847362412	0.12539913750269532	0.9605811478101344	1	2
breast neoplasms/drug therapy	tumor microenvironment/genetics	8.21016588048451e-11	2.705391381451539e-10	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/drug therapy	acetates/therapeutic use	5.289347437820169e-08	1.4914890946292245e-07	0.03271028037383177	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	g2 phase cell cycle checkpoints/drug effects	0.0022979199130953587	0.00421852941248347	0.06878335787959994	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	cell cycle proteins/metabolism	5.464098694807351e-05	0.0001197896470350129	0.046290202272826986	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	plant extracts/isolation & purification	0.00010690141144531484	0.00022643503886504962	0.046290202272826986	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	nitric oxide/metabolism	0.00015876343480980548	0.0003311338767085982	0.046290202272826986	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	hela cells	0.0009350718661649271	0.0017982088534848942	0.06878335787959994	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	ovarian neoplasms/drug therapy	0.00022768009842311088	0.0004675319744838175	0.046290202272826986	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	monocrotaline	6.350475700855895e-14	2.482980816677971e-13	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	myocardial reperfusion injury/metabolism	1.856747308770501e-05	4.277697457029468e-05	0.046290202272826986	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	pulmonary artery/cytology	6.350475700855895e-14	2.482980816677971e-13	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	myocytes smooth muscle/cytology	1.360526913485316e-05	3.167571001956098e-05	0.046290202272826986	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	nitric oxide synthase type iii/metabolism	1.31671838987657e-08	3.845166498013062e-08	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	creatine kinase mb form/metabolism	1.31671838987657e-08	3.845166498013062e-08	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	naphthalenes/pharmacology	5.138143244209914e-09	1.5484661324267384e-08	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	pyruvates/pharmacology	6.350475700855895e-14	2.482980816677971e-13	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	hydrazones/pharmacology	1.3350204552953215e-07	3.665570485473381e-07	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	mitochondria heart/drug effects	0.0022979199130953587	0.00421852941248347	0.09085010295354308	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	cytoprotection	9.775748664120343e-06	2.3148502475193353e-05	0.046290202272826986	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	g1 phase cell cycle checkpoints/drug effects	1.360526913485316e-05	3.167571001956098e-05	0.046290202272826986	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	rhizome/chemistry	1.3350204552953215e-07	3.665570485473381e-07	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	saponins/isolation & purification	1.3350204552953215e-07	3.665570485473381e-07	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	isoflavones/pharmacology	1.3350204552953215e-07	3.665570485473381e-07	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	uterine cervical neoplasms/drug therapy	1.856747308770501e-05	4.277697457029468e-05	0.046290202272826986	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	chalcones/administration & dosage	1.31671838987657e-08	3.845166498013062e-08	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	CDK2	0.002501423995658114	0.004564757180621594	0.06878335787959994	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	pulmonary arterial hypertension/drug therapy	6.350475700855895e-14	2.482980816677971e-13	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	COL4A5	1.3350204552953215e-07	3.665570485473381e-07	0.02336448598130841	0.9605811478101344	1	2
phosphatidylinositol 3-kinase/metabolism	PARP1	0.0038250807275843624	0.006779371373133443	0.026313346360848835	0.8657199677887635	2	2
heterocyclic compounds 3-ring/pharmacology	cell survival	9.435785486289205e-13	3.5005922665607337e-12	0.018647711816067742	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	protein kinase inhibitors/pharmacology	0.004664810984252532	0.008163326659322156	0.09148348032117941	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	benzamides/pharmacology	0.0001231941431495409	0.0002594006750225459	0.046290202272826986	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	pyrimidines/pharmacology	2.4375466437520643e-06	6.0891715841202705e-06	0.03711991575621956	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	proto-oncogene proteins c-akt/antagonists & inhibitors	0.005290705352827385	0.009188615330377172	0.09148348032117941	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	caspase 3/metabolism	0.00025250561210343747	0.0005151993092408466	0.05541661182045544	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	phospholipids/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	autophagy	5.833880045713613e-10	1.8448850724023771e-09	0.018647711816067742	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	cell respiration/drug effects	4.051452284770107e-08	1.1493363352368931e-07	0.027905752270633143	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	neoplasms/enzymology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	apoptosis	9.390636046546774e-10	2.9393064104807394e-09	0.027905752270633143	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	phospholipase a2 inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	caspase 9/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	stomach neoplasms/drug therapy	2.145505995088115e-12	7.72438213254454e-12	0.018647711816067742	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	lipid droplets/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 3-ring/pharmacology	PLA2G1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
basic-leucine zipper transcription factors/analysis	tumor-associated macrophages/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
basic-leucine zipper transcription factors/analysis	GGT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
basic-leucine zipper transcription factors/analysis	HLF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
basic-leucine zipper transcription factors/analysis	JAK2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
basic-leucine zipper transcription factors/analysis	STAT3	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
basic-leucine zipper transcription factors/analysis	TGFB1	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
basic-leucine zipper transcription factors/analysis	triple negative breast neoplasms/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
plant extracts/administration & dosage	endometrial neoplasms/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
plant extracts/administration & dosage	antineoplastic agents phytogenic/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
plant extracts/administration & dosage	proto-oncogene proteins c-akt/genetics	1.5355919646964367e-08	4.459527349529378e-08	0.03271028037383177	0.9605811478101344	1	2
plant extracts/administration & dosage	phosphatidylinositol 3-kinases/genetics	1.1243992147358384e-06	2.886337627953867e-06	0.04205607476635514	0.9605811478101344	1	2
plant extracts/administration & dosage	g1 phase cell cycle checkpoints/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plant extracts/administration & dosage	resting phase cell cycle/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
plant extracts/administration & dosage	saponins/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
plant extracts/administration & dosage	cytochromes c/metabolism	1.0428744410262425e-06	2.682372337347946e-06	0.04205607476635514	0.9605811478101344	1	2
cyclin b1/antagonists & inhibitors	antineoplastic agents phytogenic/pharmacology	5.667977414525183e-06	1.3746294800951627e-05	0.02803738317757009	0.9605811478101344	1	2
cyclin b1/antagonists & inhibitors	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0005349787352844082	0.0010567291843353013	0.04672897196261682	0.9605811478101344	1	2
cyclin b1/antagonists & inhibitors	ZHX2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
cyclin b1/antagonists & inhibitors	esophageal neoplasms/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin b1/antagonists & inhibitors	cyclin-dependent kinase inhibitor p21/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin b1/antagonists & inhibitors	phosphatidylinositol 3-kinases/genetics	0.00023111048486224028	0.000474090432661209	0.04205607476635514	0.9605811478101344	1	2
cyclin b1/antagonists & inhibitors	cyclin-dependent kinase 2/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin b1/antagonists & inhibitors	tor serine-threonine kinases/antagonists & inhibitors	0.00025250561210343747	0.0005151993092408466	0.04205607476635514	0.9605811478101344	1	2
cyclin b1/antagonists & inhibitors	tumor suppressor protein p53/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin b1/antagonists & inhibitors	CDK2	1.2740916099929223e-09	3.968800765346701e-09	0.014018691588785045	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	mesenchymal stem cells/cytology	1.08218036753982e-08	3.1758169497561496e-08	0.018647711816067742	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	caspase 3/metabolism	0.003158697231605445	0.005679112497956198	0.05541661182045544	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	caspase 8/metabolism	1.2329732074656263e-05	2.8836950544396022e-05	0.018647711816067742	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	morpholines/pharmacology	7.157089921661086e-05	0.00015555946233515735	0.027905752270633143	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	cell death/drug effects	0.002749796883666389	0.004997322922113134	0.05541661182045544	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	aminopyridines/pharmacology	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	hydrogen peroxide/toxicity	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	poly(adp-ribose) polymerases/metabolism	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	necrosis	1.631716847194653e-07	4.4524867632361027e-07	0.018647711816067742	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	piperazines/toxicity	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	nitrophenols/toxicity	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	glioblastoma/enzymology	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	dynamins	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	ascorbic acid/analogs & derivatives	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	acetylcysteine/pharmacology	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	chromosome segregation/drug effects	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	bcl-2 homologous antagonist-killer protein/metabolism	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	biphenyl compounds/toxicity	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	bcl-2-associated x protein/metabolism	3.658418012975062e-11	1.2403629148096903e-10	0.00026326181387389757	0.8657199677887635	2	2
apoptosis inducing factor/metabolism	cytochromes c/metabolism	1.7347628525898884e-06	4.388760914962921e-06	0.0015795708832433853	0.8657199677887635	2	2
apoptosis inducing factor/metabolism	sulfonamides/toxicity	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	histones/metabolism	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	protective agents/pharmacology	1.102566139499217e-07	3.0455247110597264e-07	0.018647711816067742	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	dna damage/drug effects	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	AIFM1	0.00036731261271538695	0.0007345585927572655	0.03711991575621956	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	BAX	0.00027829089907138727	0.0005660293120595892	0.03711991575621956	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	DNM1L	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	H2AX	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
apoptosis inducing factor/metabolism	PTEN	0.002621392365332098	0.0047714405077885	0.046290202272826986	0.9605811478101344	1	2
receptors interleukin-10/metabolism	hek293 cells	2.9976021664879227e-15	1.2339643869814361e-14	0.018691588785046728	0.9605811478101344	1	2
receptors interleukin-10/metabolism	interleukin-10/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-10/metabolism	neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-10/metabolism	immunoglobulin fc fragments/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-10/metabolism	monocarboxylic acid transporters/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-10/metabolism	recombinant fusion proteins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-10/metabolism	mitochondrial membrane transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-10/metabolism	receptors chimeric antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor escape/drug effects	hyaluronic acid/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor escape/drug effects	cd8-positive t-lymphocytes/immunology	3.955015241885462e-05	8.810768521076152e-05	0.06878335787959994	0.9605811478101344	1	2
tumor escape/drug effects	lung neoplasms/drug therapy	0.00045602481600359734	0.0009067035028629555	0.06878335787959994	0.9605811478101344	1	2
tumor escape/drug effects	cell line tumor/transplantation	2.1491015744778963e-08	6.197958340626377e-08	0.04166180294604871	0.9605811478101344	1	2
tumor escape/drug effects	aniline compounds/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor escape/drug effects	benzylidene compounds/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor escape/drug effects	chalcones/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor escape/drug effects	antigens polyomavirus transforming/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor escape/drug effects	ceramides/pharmacology	6.585219036736589e-10	2.0717880896399588e-09	0.027905752270633143	0.9605811478101344	1	2
tumor escape/drug effects	cell cycle proteins/metabolism	5.659161250726186e-09	1.7043189080181796e-08	0.027905752270633143	0.9605811478101344	1	2
tumor escape/drug effects	antineoplastic agents phytogenic/pharmacology	0.0010800521782097228	0.0020628023583825336	0.08215010393874443	0.9605811478101344	1	2
tumor escape/drug effects	carcinoma hepatocellular/drug therapy	0.0010800521782097228	0.0020628023583825336	0.09538832359347407	0.9605811478101344	1	2
tumor escape/drug effects	cell line transformed	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor escape/drug effects	b7-h1 antigen/genetics	3.540051585204651e-10	1.1305193706632698e-09	0.027905752270633143	0.9605811478101344	1	2
tumor escape/drug effects	adaptor proteins signal transducing/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor escape/drug effects	CSF1	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor escape/drug effects	CSF2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tumor escape/drug effects	EIF2S1	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
polycyclic compounds/pharmacology	cell line	0.00010933179359395861	0.0002313829319600307	0.06074766355140186	0.9605811478101344	1	2
polycyclic compounds/pharmacology	cyclooctanes/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
polycyclic compounds/pharmacology	cell division/drug effects	3.175126828125485e-12	1.1320374564442222e-11	0.018691588785046728	0.9605811478101344	1	2
polycyclic compounds/pharmacology	chemical and drug induced liver injury/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
polycyclic compounds/pharmacology	lignans/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
polycyclic compounds/pharmacology	g1 phase/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
polycyclic compounds/pharmacology	mitochondria liver/drug effects	4.979927581416632e-11	1.6775774379690435e-10	0.03271028037383177	0.9605811478101344	1	2
polycyclic compounds/pharmacology	CDK2	2.145505995088115e-12	7.72438213254454e-12	0.014018691588785045	0.9605811478101344	1	2
polycyclic compounds/pharmacology	PARP1	0.00029652745217612075	0.0006010698966239874	0.05607476635514018	0.9605811478101344	1	2
tumor suppressor protein p53/agonists	antineoplastic agents phytogenic/pharmacology	5.667977414525183e-06	1.3746294800951627e-05	0.02803738317757009	0.9605811478101344	1	2
tumor suppressor protein p53/agonists	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0005349787352844082	0.0010567291843353013	0.04672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/agonists	ZHX2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
tumor suppressor protein p53/agonists	tor serine-threonine kinases/antagonists & inhibitors	0.00025250561210343747	0.0005151993092408466	0.04205607476635514	0.9605811478101344	1	2
tumor suppressor protein p53/agonists	cyclin-dependent kinase inhibitor p21/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/agonists	cyclin-dependent kinase 2/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/agonists	esophageal neoplasms/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/agonists	phosphatidylinositol 3-kinases/genetics	0.00023111048486224028	0.000474090432661209	0.04205607476635514	0.9605811478101344	1	2
tumor suppressor protein p53/agonists	CDK2	1.2740916099929223e-09	3.968800765346701e-09	0.014018691588785045	0.9605811478101344	1	2
adenosine triphosphate/antagonists & inhibitors	drug combinations	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenosine triphosphate/antagonists & inhibitors	antibiotics antineoplastic/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenosine triphosphate/antagonists & inhibitors	antineoplastic agents phytogenic/isolation & purification	3.7466474367420233e-10	1.1952840787916093e-09	0.018691588785046728	0.9605811478101344	1	2
adenosine triphosphate/antagonists & inhibitors	doxorubicin/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenosine triphosphate/antagonists & inhibitors	WDTC1	1.5842882561400984e-13	6.04645793169065e-13	0.018691588785046728	0.9605811478101344	1	2
adenosine triphosphate/antagonists & inhibitors	plant extracts/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/antagonists & inhibitors	anthraquinones/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/antagonists & inhibitors	membrane potential mitochondrial/drug effects	0.005711427168056726	0.009871867842686947	0.09813084112149532	0.9605811478101344	1	2
adenosine triphosphate/antagonists & inhibitors	mitochondrial adp atp translocases/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphate/antagonists & inhibitors	voltage-dependent anion channels/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
esophageal neoplasms/drug therapy	antineoplastic agents phytogenic/pharmacology	5.667977414525183e-06	1.3746294800951627e-05	0.02803738317757009	0.9605811478101344	1	2
esophageal neoplasms/drug therapy	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0005349787352844082	0.0010567291843353013	0.04672897196261682	0.9605811478101344	1	2
esophageal neoplasms/drug therapy	ZHX2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
esophageal neoplasms/drug therapy	cyclin-dependent kinase inhibitor p21/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
esophageal neoplasms/drug therapy	phosphatidylinositol 3-kinases/genetics	0.00023111048486224028	0.000474090432661209	0.04205607476635514	0.9605811478101344	1	2
esophageal neoplasms/drug therapy	cyclin-dependent kinase 2/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
esophageal neoplasms/drug therapy	tor serine-threonine kinases/antagonists & inhibitors	0.00025250561210343747	0.0005151993092408466	0.04205607476635514	0.9605811478101344	1	2
esophageal neoplasms/drug therapy	CDK2	1.2740916099929223e-09	3.968800765346701e-09	0.014018691588785045	0.9605811478101344	1	2
metal-organic frameworks/chemistry	exosomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
metal-organic frameworks/chemistry	benzylidene compounds/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
metal-organic frameworks/chemistry	PDCD1	7.439604488013174e-13	2.765611191227693e-12	0.02336448598130841	0.9605811478101344	1	2
chromosome segregation/drug effects	CASP8	0.0010427713481141465	0.0019929804683790483	0.03271028037383177	0.9605811478101344	1	2
chromosome segregation/drug effects	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0029624131333876313	0.00535064182558618	0.04672897196261682	0.9605811478101344	1	2
chromosome segregation/drug effects	caspase 3/metabolism	9.940125707075254e-05	0.00021089289029021862	0.02803738317757009	0.9605811478101344	1	2
chromosome segregation/drug effects	MCL1	0.0006294795090561189	0.0012353150169710113	0.02803738317757009	0.9605811478101344	1	2
chromosome segregation/drug effects	caspase 8/metabolism	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
chromosome segregation/drug effects	morpholines/pharmacology	1.983776046765584e-07	5.377218377070026e-07	0.014018691588785045	0.9605811478101344	1	2
chromosome segregation/drug effects	cell death/drug effects	7.930407666079109e-05	0.00017048520692444636	0.02803738317757009	0.9605811478101344	1	2
chromosome segregation/drug effects	aminopyridines/pharmacology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
chromosome segregation/drug effects	poly(adp-ribose) polymerases/metabolism	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
chromosome segregation/drug effects	piperazines/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
chromosome segregation/drug effects	nitrophenols/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
chromosome segregation/drug effects	bcl-2 homologous antagonist-killer protein/metabolism	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
chromosome segregation/drug effects	biphenyl compounds/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
chromosome segregation/drug effects	bcl-2-associated x protein/metabolism	1.360526913485316e-05	3.167571001956098e-05	0.018691588785046728	0.9605811478101344	1	2
chromosome segregation/drug effects	cytochromes c/metabolism	0.0015056804766054865	0.0028289086619682803	0.04205607476635514	0.9605811478101344	1	2
chromosome segregation/drug effects	sulfonamides/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
chromosome segregation/drug effects	dna damage/drug effects	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
chromosome segregation/drug effects	PTEN	7.335668233077186e-05	0.00015875227051716313	0.02336448598130841	0.9605811478101344	1	2
chromosome segregation/drug effects	glioblastoma/enzymology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
brain injuries traumatic/drug therapy	blood-brain barrier/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
brain injuries traumatic/drug therapy	neurons/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
brain injuries traumatic/drug therapy	membrane potential mitochondrial/drug effects	0.0011316140902800642	0.002159223493076145	0.09813084112149532	0.9605811478101344	1	2
brain injuries traumatic/drug therapy	sulfides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mesenchymal stem cells/metabolism	anoikis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mesenchymal stem cells/metabolism	lung neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mesenchymal stem cells/metabolism	osteosarcoma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mesenchymal stem cells/metabolism	bone neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mesenchymal stem cells/metabolism	CXCL8	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
mesenchymal stem cells/metabolism	CXCR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	myeloid-derived suppressor cells/immunology	1.9701580900033377e-07	5.351490152567894e-07	0.03711991575621956	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	ACSL4	1.594815390859594e-10	5.191567951819331e-10	0.03711991575621956	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	AIFM2	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	ATL1	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	PDCD1	0.0009457168758258971	0.001818204192379611	0.09085010295354308	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	S100A4	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	benzhydryl compounds/immunology	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	tumor escape	3.128608483393691e-13	1.179944574783854e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	lung neoplasms/immunology	4.4710874202991135e-07	1.1787460892353803e-06	0.03711991575621956	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	protein kinases/genetics	3.128608483393691e-13	1.179944574783854e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	neovascularization pathologic/immunology	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	fas receptor/genetics	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	cytokines/blood	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	sarcoma/drug therapy	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	azocines/immunology	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	carbazoles/pharmacology	3.128608483393691e-13	1.179944574783854e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	carcinoma squamous cell/immunology	3.128608483393691e-13	1.179944574783854e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	b7-h1 antigen/genetics	1.2593558440521235e-07	3.465586326717576e-07	0.03711991575621956	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	rna small interfering/genetics	3.215864324634943e-05	7.25280039172987e-05	0.055287464515536164	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	hypoxia	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	mouth neoplasms/immunology	3.128608483393691e-13	1.179944574783854e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	carcinoma lewis lung/immunology	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	maleimides	3.128608483393691e-13	1.179944574783854e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	plant leaves/chemistry	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	fas ligand protein/genetics	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	ARG1	3.0033297815368343e-07	8.027326345414489e-07	0.03711991575621956	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	PRF1	1.2593558440521235e-07	3.465586326717576e-07	0.03711991575621956	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	PRKD1	3.128608483393691e-13	1.179944574783854e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	TCIM	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
cd8-positive t-lymphocytes/drug effects	endoplasmic reticulum/drug effects	5.435487294180863e-05	0.00011924539687771112	0.055287464515536164	0.9605811478101344	1	2
mammary neoplasms animal/immunology	t-lymphocytes/drug effects	1.3844481117075702e-13	5.292009703004249e-13	0.014018691588785045	0.9605811478101344	1	2
mammary neoplasms animal/immunology	protein kinase inhibitors/pharmacology	0.00011180421294365583	0.00023589084085949512	0.04672897196261682	0.9605811478101344	1	2
mammary neoplasms animal/immunology	breast neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mammary neoplasms animal/immunology	CCL5	1.3098300222225134e-11	4.508841893827007e-11	0.014018691588785045	0.9605811478101344	1	2
mammary neoplasms animal/immunology	chemokines/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mammary neoplasms animal/immunology	CXCL9	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
mammary neoplasms animal/immunology	CXCL10	1.0363931934875836e-12	3.832030375652229e-12	0.014018691588785045	0.9605811478101344	1	2
mammary neoplasms animal/immunology	cyclin-dependent kinase 6/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mammary neoplasms animal/immunology	hypertrophy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mammary neoplasms animal/immunology	CDK4	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mammary neoplasms animal/immunology	TNFRSF4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mammary neoplasms animal/immunology	TNFRSF9	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mammary neoplasms animal/immunology	cyclin-dependent kinase 4/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mammary neoplasms animal/immunology	receptors chemokine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzylidene compounds/chemistry	exosomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzylidene compounds/chemistry	PDCD1	7.439604488013174e-13	2.765611191227693e-12	0.02336448598130841	0.9605811478101344	1	2
lactones/pharmacology	sulfonamides/pharmacology	1.765254609153999e-14	7.017730548616547e-14	0.014018691588785045	0.9605811478101344	1	2
lactones/pharmacology	rna small interfering/genetics	1.765254609153999e-14	7.017730548616547e-14	0.014018691588785045	0.9605811478101344	1	2
lactones/pharmacology	curcumin/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
lactones/pharmacology	cyclosporine/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lactones/pharmacology	proto-oncogene proteins c-bcl-2/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/pharmacology	membrane potential mitochondrial/drug effects	0.005711427168056726	0.009871867842686947	0.09813084112149532	0.9605811478101344	1	2
lactones/pharmacology	biphenyl compounds/pharmacology	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
lactones/pharmacology	nitrophenols/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactones/pharmacology	cell death/drug effects	2.415650552922699e-07	6.492778665224878e-07	0.02803738317757009	0.9605811478101344	1	2
lactones/pharmacology	cyclophilin d	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
epithelial cells/drug effects	membrane potential mitochondrial/drug effects	0.002429378420712003	0.004438426866080398	0.09813084112149532	0.9605811478101344	1	2
epithelial cells/drug effects	phenylpropionates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
epithelial cells/drug effects	BECN1	8.205436330399607e-12	2.8445512612051973e-11	0.02336448598130841	0.9605811478101344	1	2
epithelial cells/drug effects	CASP9	1.0218480160695265e-05	2.4106254074792336e-05	0.04672897196261682	0.9605811478101344	1	2
leukemia myeloid acute/metabolism	sulfonamides/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
leukemia myeloid acute/metabolism	pyrimidines/pharmacology	1.0363931934875836e-12	3.832030375652229e-12	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/metabolism	u937 cells	8.21016588048451e-11	2.705391381451539e-10	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/metabolism	heterografts	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia myeloid acute/metabolism	bcl-2-associated x protein/metabolism	5.525480073487188e-10	1.7516288232961253e-09	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/metabolism	bridged bicyclo compounds heterocyclic/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia myeloid acute/metabolism	BAK1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia myeloid acute/metabolism	BAX	1.1230016916385921e-11	3.875401674322692e-11	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/metabolism	CD34	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia myeloid acute/metabolism	PIK3CB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thyroid hormones/immunology	lactic acid/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
thyroid hormones/immunology	carcinoma non-small-cell lung/drug therapy	2.6631302138979684e-05	6.04952554667447e-05	0.05607476635514018	0.9605811478101344	1	2
thyroid hormones/immunology	cisplatin/pharmacology	6.321351797566876e-08	1.770042728381439e-07	0.02803738317757009	0.9605811478101344	1	2
thyroid hormones/immunology	glucose/metabolism	6.740019653506124e-11	2.2474887072066398e-10	0.018691588785046728	0.9605811478101344	1	2
thyroid hormones/immunology	adenosine triphosphate/metabolism	3.6489922194959945e-11	1.2373574354882757e-10	0.02803738317757009	0.9605811478101344	1	2
thyroid hormones/immunology	killer cells natural/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
thyroid hormones/immunology	membrane proteins/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thyroid hormones/immunology	carrier proteins/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thyroid hormones/immunology	cytokines/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thyroid hormones/immunology	IL2	4.643840867402105e-12	1.6329729416982715e-11	0.018691588785046728	0.9605811478101344	1	2
thyroid hormones/immunology	PKM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin-dependent kinase 2/antagonists & inhibitors	antineoplastic agents phytogenic/pharmacology	5.667977414525183e-06	1.3746294800951627e-05	0.02803738317757009	0.9605811478101344	1	2
cyclin-dependent kinase 2/antagonists & inhibitors	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0005349787352844082	0.0010567291843353013	0.04672897196261682	0.9605811478101344	1	2
cyclin-dependent kinase 2/antagonists & inhibitors	ZHX2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
cyclin-dependent kinase 2/antagonists & inhibitors	cyclin-dependent kinase inhibitor p21/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin-dependent kinase 2/antagonists & inhibitors	tor serine-threonine kinases/antagonists & inhibitors	0.00025250561210343747	0.0005151993092408466	0.04205607476635514	0.9605811478101344	1	2
cyclin-dependent kinase 2/antagonists & inhibitors	CDK2	1.2740916099929223e-09	3.968800765346701e-09	0.014018691588785045	0.9605811478101344	1	2
cyclin-dependent kinase 2/antagonists & inhibitors	phosphatidylinositol 3-kinases/genetics	0.00023111048486224028	0.000474090432661209	0.04205607476635514	0.9605811478101344	1	2
sphingosine/analogs & derivatives	astrocytes/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sphingosine/analogs & derivatives	antimycin a/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sphingosine/analogs & derivatives	cell death/drug effects	9.299864525136314e-07	2.396766955583933e-06	0.02803738317757009	0.9605811478101344	1	2
sphingosine/analogs & derivatives	extracellular space/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sphingosine/analogs & derivatives	brain/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sphingosine/analogs & derivatives	alpha-crystallins/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sphingosine/analogs & derivatives	staurosporine/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sphingosine/analogs & derivatives	MAPK3	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
sphingosine/analogs & derivatives	CRYAA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sphingosine/analogs & derivatives	CRYAB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sphingosine/analogs & derivatives	MAPK8	9.200277617527064e-08	2.549619418190507e-07	0.02336448598130841	0.9605811478101344	1	2
immunosuppressive agents/metabolism	b-lymphocytes/drug effects	1.8712719040969716e-08	5.408731376708184e-08	0.027905752270633143	0.9605811478101344	1	2
immunosuppressive agents/metabolism	monocytes/drug effects	1.8712719040969716e-08	5.408731376708184e-08	0.027905752270633143	0.9605811478101344	1	2
immunosuppressive agents/metabolism	cell differentiation/drug effects	2.3905205762009274e-05	5.443168198293715e-05	0.046290202272826986	0.9605811478101344	1	2
immunosuppressive agents/metabolism	CD4	1.3424762523861489e-08	3.917273215009239e-08	0.027905752270633143	0.9605811478101344	1	2
immunosuppressive agents/metabolism	ligands	6.519751405420493e-11	2.177662157047584e-10	0.018647711816067742	0.9605811478101344	1	2
immunosuppressive agents/metabolism	dose-response relationship immunologic	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	calcitriol/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	cytokines/biosynthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	transcription factors/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	dihydroorotase/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	receptors calcitriol/physiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	growth inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	th2 cells/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	clone cells	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	interleukin-4/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	cyclophilin a/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	l-selectin/biosynthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	interferon-gamma/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	tacrolimus binding protein 1a/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	spiro compounds/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	enzyme inhibitors/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	imp dehydrogenase/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	th1 cells/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	CD40LG	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	IL2	8.276241856286504e-07	2.141720427786442e-06	0.03711991575621956	0.9605811478101344	1	2
immunosuppressive agents/metabolism	PPIA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/metabolism	SELP	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunoglobulin fc fragments/pharmacology	hek293 cells	2.9976021664879227e-15	1.2339643869814361e-14	0.018691588785046728	0.9605811478101344	1	2
immunoglobulin fc fragments/pharmacology	interleukin-10/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunoglobulin fc fragments/pharmacology	neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunoglobulin fc fragments/pharmacology	receptors chimeric antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunoglobulin fc fragments/pharmacology	monocarboxylic acid transporters/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunoglobulin fc fragments/pharmacology	recombinant fusion proteins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunoglobulin fc fragments/pharmacology	mitochondrial membrane transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	paclitaxel/pharmacology	1.3393322007004826e-09	4.157341455869948e-09	0.027905752270633143	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	antineoplastic agents phytogenic/pharmacology	2.778872919972919e-05	6.296874628937608e-05	0.05541661182045544	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	levofloxacin/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	peptide elongation factor tu/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	carcinoma renal cell/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	dna mitochondrial/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	tigecycline	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	MAPK1	0.0007392287055421054	0.0014384003618208754	0.09148348032117941	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	metabolic networks and pathways/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	kidney/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	fluorouracil/therapeutic use	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	EEF1A1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-bacterial agents/pharmacology	organelle biogenesis	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
sirolimus/pharmacology	cell line	1.1562645840790253e-08	3.384668288605198e-08	0.0034224035803606685	0.8657199677887635	2	2
sirolimus/pharmacology	rna small interfering/metabolism	4.798383912429927e-13	1.8004555565223794e-12	0.018647711816067742	0.9605811478101344	1	2
sirolimus/pharmacology	cell differentiation/drug effects	9.631694485534581e-06	2.2831910549087886e-05	0.046290202272826986	0.9605811478101344	1	2
sirolimus/pharmacology	superoxide dismutase/metabolism	2.1216362000586741e-13	8.055421894075021e-13	0.018647711816067742	0.9605811478101344	1	2
sirolimus/pharmacology	ubiquinone/analogs & derivatives	1.5543122344752192e-15	6.525033538787059e-15	0.018647711816067742	0.9605811478101344	1	2
sirolimus/pharmacology	organophosphorus compounds/pharmacology	8.21016588048451e-11	2.705391381451539e-10	0.018647711816067742	0.9605811478101344	1	2
sirolimus/pharmacology	neurons/drug effects	1.3665724107880806e-10	4.4657163944057507e-10	0.027905752270633143	0.9605811478101344	1	2
sirolimus/pharmacology	pten phosphohydrolase/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sirolimus/pharmacology	autophagy-related protein-1 homolog/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sirolimus/pharmacology	mitophagy/drug effects	3.951110216782183e-09	1.1990926092169797e-08	0.03711991575621956	0.9605811478101344	1	2
sirolimus/pharmacology	PTEN	7.335668233077186e-05	0.00015875227051716313	0.046290202272826986	0.9605811478101344	1	2
sirolimus/pharmacology	ULK1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bone marrow/drug effects	necroptosis/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	drug interactions	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	TGFB1	0.00028984355859373867	0.0005881703432926599	0.09538832359347407	0.9605811478101344	1	2
bone marrow/drug effects	mutant proteins/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	cyclams	8.329080758429086e-09	2.4662848853323194e-08	0.04166180294604871	0.9605811478101344	1	2
bone marrow/drug effects	chemokine cxcl12/metabolism	3.355178501696088e-08	9.559960662366936e-08	0.04166180294604871	0.9605811478101344	1	2
bone marrow/drug effects	osteoprotegerin/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	mutation	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	receptors cxcr4/antagonists & inhibitors	8.329080758429086e-09	2.4662848853323194e-08	0.04166180294604871	0.9605811478101344	1	2
bone marrow/drug effects	benzylamines	8.329080758429086e-09	2.4662848853323194e-08	0.04166180294604871	0.9605811478101344	1	2
bone marrow/drug effects	cytarabine/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	transforming growth factor beta/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	leukemia myeloid acute/drug therapy	3.082276387456062e-07	8.232347642717294e-07	0.055287464515536164	0.9605811478101344	1	2
bone marrow/drug effects	antibodies neutralizing/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	recombinant proteins/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	tnf-related apoptosis-inducing ligand/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	multiple myeloma/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	CXCL12	0.00022135041722104454	0.00045495795645470214	0.09538832359347407	0.9605811478101344	1	2
bone marrow/drug effects	CXCR4	3.082276387456062e-07	8.232347642717294e-07	0.055287464515536164	0.9605811478101344	1	2
bone marrow/drug effects	TNFRSF11B	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	small molecule libraries/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	radiation-protective agents/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bone marrow/drug effects	ileum/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
glutamine/pharmacology	protein kinase inhibitors/pharmacology	0.00016570985144803707	0.00034454647347475684	0.04672897196261682	0.9605811478101344	1	2
glutamine/pharmacology	phosphoinositide-3 kinase inhibitors	0.002079111832937297	0.003839860754950706	0.07009345794392523	0.9605811478101344	1	2
glutamine/pharmacology	glucose/deficiency	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamine/pharmacology	imidazoles/pharmacology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
glutamine/pharmacology	breast neoplasms/metabolism	5.592304397339376e-12	1.956197482984905e-11	0.014018691588785045	0.9605811478101344	1	2
glutamine/pharmacology	cytoprotection/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamine/pharmacology	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamine/pharmacology	quinolines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamine/pharmacology	cell respiration/drug effects	5.295763827461997e-13	1.979671089655512e-12	0.014018691588785045	0.9605811478101344	1	2
glutamine/pharmacology	lactates/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutamine/pharmacology	tor serine-threonine kinases/antagonists & inhibitors	8.70488068962505e-05	0.0001859560211654424	0.04205607476635514	0.9605811478101344	1	2
glutamine/pharmacology	receptors estrogen/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glutamine/pharmacology	ESRRA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocarboxylic acid transporters/genetics	hek293 cells	2.9976021664879227e-15	1.2339643869814361e-14	0.018691588785046728	0.9605811478101344	1	2
monocarboxylic acid transporters/genetics	interleukin-10/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocarboxylic acid transporters/genetics	neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocarboxylic acid transporters/genetics	recombinant fusion proteins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocarboxylic acid transporters/genetics	mitochondrial membrane transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocarboxylic acid transporters/genetics	receptors chimeric antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclooctanes/pharmacology	cell line	0.00010933179359395861	0.0002313829319600307	0.06074766355140186	0.9605811478101344	1	2
cyclooctanes/pharmacology	lignans/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclooctanes/pharmacology	g1 phase/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclooctanes/pharmacology	mitochondria liver/drug effects	4.979927581416632e-11	1.6775774379690435e-10	0.03271028037383177	0.9605811478101344	1	2
cyclooctanes/pharmacology	CDK2	2.145505995088115e-12	7.72438213254454e-12	0.014018691588785045	0.9605811478101344	1	2
cyclooctanes/pharmacology	PARP1	0.00029652745217612075	0.0006010698966239874	0.05607476635514018	0.9605811478101344	1	2
cyclooctanes/pharmacology	cell division/drug effects	3.175126828125485e-12	1.1320374564442222e-11	0.018691588785046728	0.9605811478101344	1	2
cyclooctanes/pharmacology	chemical and drug induced liver injury/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	melanoma/genetics	0.002579457815108821	0.004698990821079012	0.09538832359347407	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	endoplasmic reticulum/drug effects	2.2072832450703572e-08	6.359929559240883e-08	0.002720786010366554	0.8657199677887635	2	2
proto-oncogene proteins c-akt/genetics	triple negative breast neoplasms/drug therapy	0.003920846835742564	0.006929605694144452	0.12539913750269532	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	gene expression regulation	0.0017963169899918308	0.0033461639908195237	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	proto-oncogene proteins c-bcl-2/genetics	0.00034595022541650255	0.0006940409981786213	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	cell cycle proteins/metabolism	0.0006205938576925307	0.0012191796644751775	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	tamoxifen/pharmacology	5.435487294180863e-05	0.00011924539687771112	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	bone neoplasms/drug therapy	0.00010077581033063332	0.00021368581132619766	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	selective estrogen receptor modulators/pharmacology	5.435487294180863e-05	0.00011924539687771112	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	ovarian neoplasms/drug therapy	0.0017963169899918308	0.0033461639908195237	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	SPP1	0.0008729377013856343	0.0016874040364852241	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	tor serine-threonine kinases/genetics	2.6597613000944875e-12	9.524511473848182e-12	8.569015492273871e-05	0.7135314763244264	3	2
proto-oncogene proteins c-akt/genetics	histone deacetylases/metabolism	4.712144485718994e-08	1.3323077920124696e-07	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	carboxy-lyases/genetics	3.0033297815368343e-07	8.027326345414489e-07	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	phenylbutyrates/pharmacology	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	benzofurans/pharmacology	4.712144485718994e-08	1.3323077920124696e-07	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	breast neoplasms/genetics	4.712144485718994e-08	1.3323077920124696e-07	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	endometrial neoplasms/drug therapy	1.5355919646964367e-08	4.459527349529378e-08	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	eukaryotic initiation factor-2/genetics	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	myocytes smooth muscle/cytology	0.00022093315072990727	0.0004542273505495147	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	microtubule-associated proteins/genetics	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	cerebral arteries/cytology	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	organophosphorus compounds/pharmacology	0.0013729432408663422	0.0025912217578001294	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	antineoplastic agents phytogenic/administration & dosage	1.5355919646964367e-08	4.459527349529378e-08	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	endoplasmic reticulum/metabolism	4.712144485718994e-08	1.3323077920124696e-07	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	transcription factor chop/genetics	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	taurochenodeoxycholic acid/pharmacology	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	activating transcription factor 4/genetics	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	hydroxamic acids/pharmacology	4.712144485718994e-08	1.3323077920124696e-07	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	mitochondrial dynamics/physiology	3.0033297815368343e-07	8.027326345414489e-07	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	muscle smooth vascular/cytology	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	g1 phase cell cycle checkpoints/drug effects	0.00022093315072990727	0.0004542273505495147	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	pentacyclic triterpenes	0.00022093315072990727	0.0004542273505495147	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	bcl-2-associated x protein/genetics	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	isoflavones/pharmacology	7.206855936026102e-06	1.733734420922024e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	immunosuppressive agents/pharmacology	3.0033297815368343e-07	8.027326345414489e-07	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	piperidines/pharmacology	0.00157515788312379	0.002952902049750304	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	cytochromes c/genetics	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	receptors estrogen/antagonists & inhibitors	0.0005161304311359638	0.0010208705253149483	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	resting phase cell cycle/drug effects	1.5355919646964367e-08	4.459527349529378e-08	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	lipoproteins ldl/metabolism	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	phosphatidylinositol 3-kinases/genetics	1.3433698597964394e-14	5.3901034884061686e-14	7.180417409074023e-07	0.35414021462530776	5	2
proto-oncogene proteins c-akt/genetics	leflunomide/pharmacology	3.0033297815368343e-07	8.027326345414489e-07	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	CALD1	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	HSPA5	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	hydrazones/pharmacology	7.206855936026102e-06	1.733734420922024e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	golgi apparatus/drug effects	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	curcumin/analogs & derivatives	4.298636627986241e-06	1.0570638007343368e-05	0.03271028037383177	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	cell transformation neoplastic/drug effects	0.0005161304311359638	0.0010208705253149483	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-akt/genetics	saponins/administration & dosage	1.5355919646964367e-08	4.459527349529378e-08	0.03271028037383177	0.9605811478101344	1	2
cytokines/biosynthesis	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
cytokines/biosynthesis	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
cytokines/biosynthesis	dihydroorotase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/biosynthesis	clone cells	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/biosynthesis	cyclophilin a/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/biosynthesis	tacrolimus binding protein 1a/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/biosynthesis	spiro compounds/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/biosynthesis	enzyme inhibitors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/biosynthesis	imp dehydrogenase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/biosynthesis	CD40LG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/biosynthesis	IL2	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
cytokines/biosynthesis	PPIA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell line tumor/transplantation	hyaluronic acid/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell line tumor/transplantation	membrane proteins/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell line tumor/transplantation	aniline compounds/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell line tumor/transplantation	myeloid-derived suppressor cells/immunology	5.513522971511975e-11	1.8460463853590893e-10	0.027905752270633143	0.9605811478101344	1	2
cell line tumor/transplantation	neutral ceramidase/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell line tumor/transplantation	heme oxygenase-1/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell line tumor/transplantation	colonic neoplasms/drug therapy	5.524455328753675e-07	1.4481416132250745e-06	0.04166180294604871	0.9605811478101344	1	2
cell line tumor/transplantation	ASAH2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell line tumor/transplantation	HMOX1	2.557620781828973e-12	9.178128743125846e-12	0.027905752270633143	0.9605811478101344	1	2
cell line tumor/transplantation	receptors tumor necrosis factor type i/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell line tumor/transplantation	immunity innate/drug effects	1.0363931934875836e-12	3.832030375652229e-12	0.027905752270633143	0.9605811478101344	1	2
cell line tumor/transplantation	nucleotides cyclic/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell line tumor/transplantation	neoplasms/blood supply	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell line tumor/transplantation	tumor necrosis factor-alpha/metabolism	0.0029624131333876313	0.00535064182558618	0.10849863774429329	0.9605811478101344	1	2
cell line tumor/transplantation	human umbilical vein endothelial cells	6.157706566867205e-10	1.9461742314548185e-09	0.04166180294604871	0.9605811478101344	1	2
cell line tumor/transplantation	t-lymphocytes/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell line tumor/transplantation	benzylidene compounds/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
mitogens/toxicity	macrophages peritoneal/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane glycoproteins/metabolism	rna messenger/genetics	1.0143579034505024e-05	2.3965455481436644e-05	0.02803738317757009	0.9605811478101344	1	2
membrane glycoproteins/metabolism	tumor necrosis factor-alpha/metabolism	0.00025250561210343747	0.0005151993092408466	0.037383177570093455	0.9605811478101344	1	2
membrane glycoproteins/metabolism	BIRC5	2.332691073636539e-08	6.70113000541217e-08	0.014018691588785045	0.9605811478101344	1	2
membrane glycoproteins/metabolism	CASP8	0.000335616220874857	0.0006746595949898656	0.03271028037383177	0.9605811478101344	1	2
membrane glycoproteins/metabolism	u937 cells	6.51304561172239e-07	1.7006114358983332e-06	0.018691588785046728	0.9605811478101344	1	2
membrane glycoproteins/metabolism	MCL1	0.00018571952850299223	0.00038444692183212586	0.02803738317757009	0.9605811478101344	1	2
membrane glycoproteins/metabolism	XIAP	6.226627435879095e-09	1.8701087277790802e-08	0.014018691588785045	0.9605811478101344	1	2
membrane glycoproteins/metabolism	piperidines/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane glycoproteins/metabolism	flavonoids/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane glycoproteins/metabolism	multiple myeloma/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane glycoproteins/metabolism	leukemia/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane glycoproteins/metabolism	caspases/metabolism	0.00014922404803296985	0.00031191617472799767	0.03271028037383177	0.9605811478101344	1	2
membrane glycoproteins/metabolism	poly (adp-ribose) polymerase-1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane glycoproteins/metabolism	AIFM1	3.37278289741505e-07	8.941098631983529e-07	0.018691588785046728	0.9605811478101344	1	2
membrane glycoproteins/metabolism	PARP1	0.0035270245753111773	0.006293100091968992	0.05607476635514018	0.9605811478101344	1	2
membrane glycoproteins/metabolism	TNFRSF10D	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane glycoproteins/metabolism	cytochromes c/metabolism	0.0005161304311359638	0.0010208705253149483	0.04205607476635514	0.9605811478101344	1	2
transcription factors/metabolism	cell differentiation/drug effects	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
transcription factors/metabolism	CD4	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
transcription factors/metabolism	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transcription factors/metabolism	dose-response relationship immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factors/metabolism	receptors calcitriol/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factors/metabolism	growth inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factors/metabolism	calcitriol/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factors/metabolism	th2 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factors/metabolism	l-selectin/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factors/metabolism	interferon-gamma/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factors/metabolism	th1 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factors/metabolism	SELP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factors/metabolism	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caspase 9/metabolism	caspase 3/metabolism	6.955092368698956e-08	1.9428085207788495e-07	0.02803738317757009	0.9605811478101344	1	2
caspase 9/metabolism	membrane potential mitochondrial/drug effects	0.003335606434196392	0.0059844943169633045	0.09813084112149532	0.9605811478101344	1	2
caspase 9/metabolism	stomach neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chlorogenic acid/pharmacology	hek293 cells	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
chlorogenic acid/pharmacology	caspases/metabolism	3.240552104433192e-08	9.272899779174954e-08	0.03271028037383177	0.9605811478101344	1	2
chlorogenic acid/pharmacology	proto-oncogene proteins c-bcl-2/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	CASP8	0.0010427713481141465	0.0019929804683790483	0.03271028037383177	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0029624131333876313	0.00535064182558618	0.04672897196261682	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	caspase 3/metabolism	9.940125707075254e-05	0.00021089289029021862	0.02803738317757009	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	MCL1	0.0006294795090561189	0.0012353150169710113	0.02803738317757009	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	caspase 8/metabolism	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	morpholines/pharmacology	1.983776046765584e-07	5.377218377070026e-07	0.014018691588785045	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	cell death/drug effects	7.930407666079109e-05	0.00017048520692444636	0.02803738317757009	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	aminopyridines/pharmacology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	poly(adp-ribose) polymerases/metabolism	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	piperazines/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	nitrophenols/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	glioblastoma/enzymology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	biphenyl compounds/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	bcl-2-associated x protein/metabolism	1.360526913485316e-05	3.167571001956098e-05	0.018691588785046728	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	cytochromes c/metabolism	0.0015056804766054865	0.0028289086619682803	0.04205607476635514	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	sulfonamides/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	dna damage/drug effects	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
bcl-2 homologous antagonist-killer protein/metabolism	PTEN	7.335668233077186e-05	0.00015875227051716313	0.02336448598130841	0.9605811478101344	1	2
nima-interacting peptidylprolyl isomerase/metabolism	proto-oncogene proteins c-akt/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
nima-interacting peptidylprolyl isomerase/metabolism	hydrogen peroxide/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nima-interacting peptidylprolyl isomerase/metabolism	phosphatidylinositol 3-kinases/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
nima-interacting peptidylprolyl isomerase/metabolism	cellular senescence/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nima-interacting peptidylprolyl isomerase/metabolism	hair cells auditory/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nima-interacting peptidylprolyl isomerase/metabolism	PIN1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carbolines/pharmacology	vitamin e/pharmacology	6.7160721428649595e-12	2.341492071566835e-11	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	nf-e2-related factor 2/biosynthesis	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	lipopolysaccharides/toxicity	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	antioxidants/pharmacology	0.00018978082435372468	0.0003923750577035748	0.055287464515536164	0.9605811478101344	1	2
carbolines/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	6.7160721428649595e-12	2.341492071566835e-11	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	methotrexate/pharmacology	6.7160721428649595e-12	2.341492071566835e-11	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	folic acid antagonists/pharmacology	6.7160721428649595e-12	2.341492071566835e-11	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	cystine/antagonists & inhibitors	6.7160721428649595e-12	2.341492071566835e-11	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	tetrahydrofolate dehydrogenase/genetics	6.7160721428649595e-12	2.341492071566835e-11	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	biopterin/analogs & derivatives	6.7160721428649595e-12	2.341492071566835e-11	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	inflammation mediators/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	gene expression	0.0001660462485749692	0.0003451808116708392	0.07319670689438858	0.9605811478101344	1	2
carbolines/pharmacology	NFE2L2	0.0007758545250967641	0.0015088683575313975	0.07319670689438858	0.9605811478101344	1	2
carbolines/pharmacology	gene expression/drug effects	0.0006457001335501422	0.0012637724407024886	0.07319670689438858	0.9605811478101344	1	2
carbolines/pharmacology	chemokine ccl19/immunology	3.2096547641913276e-13	1.2090631853902338e-12	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	antineoplastic agents alkylating/pharmacology	5.677793790681562e-10	1.7975875573944153e-09	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	interleukin-8/biosynthesis	5.677793790681562e-10	1.7975875573944153e-09	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	receptors ccr7/immunology	3.2096547641913276e-13	1.2090631853902338e-12	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	b-lymphocytes/drug effects	5.65295405280386e-05	0.00012386834720355745	0.055287464515536164	0.9605811478101344	1	2
carbolines/pharmacology	heterocyclic compounds 4 or more rings/pharmacology	0.0	0.0	0.00026326181387389757	0.8657199677887635	2	2
carbolines/pharmacology	u937 cells	0.0019545923744020977	0.003623547689465858	0.07319670689438858	0.9605811478101344	1	2
carbolines/pharmacology	ovarian neoplasms/drug therapy	1.3795897473856122e-05	3.210596870419884e-05	0.03711991575621956	0.9605811478101344	1	2
carbolines/pharmacology	fibrosarcoma/drug therapy	5.677793790681562e-10	1.7975875573944153e-09	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	rho gtp-binding proteins/genetics	5.677793790681562e-10	1.7975875573944153e-09	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	neovascularization pathologic/prevention & control	5.677793790681562e-10	1.7975875573944153e-09	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	myeloid-derived suppressor cells/drug effects	3.2096547641913276e-13	1.2090631853902338e-12	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	monocytes/drug effects	5.65295405280386e-05	0.00012386834720355745	0.055287464515536164	0.9605811478101344	1	2
carbolines/pharmacology	leukemia lymphocytic chronic b-cell/blood	3.2096547641913276e-13	1.2090631853902338e-12	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	vascular endothelial growth factor a/biosynthesis	5.677793790681562e-10	1.7975875573944153e-09	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	chemokine ccl21/immunology	3.2096547641913276e-13	1.2090631853902338e-12	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	caspase 8/metabolism	9.274298595451924e-05	0.00019773690690699547	0.03711991575621956	0.9605811478101344	1	2
carbolines/pharmacology	cell adhesion/drug effects	0.0007758545250967641	0.0015088683575313975	0.07319670689438858	0.9605811478101344	1	2
carbolines/pharmacology	chemokine ccl2/biosynthesis	5.677793790681562e-10	1.7975875573944153e-09	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	trabectedin	5.677793790681562e-10	1.7975875573944153e-09	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	BRCA1	5.677793790681562e-10	1.7975875573944153e-09	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	CCL19	3.2096547641913276e-13	1.2090631853902338e-12	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	CCL2	0.001003907200557208	0.0019248757246617379	0.07319670689438858	0.9605811478101344	1	2
carbolines/pharmacology	CCL21	1.20507371859091e-07	3.3236759253805836e-07	0.03711991575621956	0.9605811478101344	1	2
carbolines/pharmacology	CCR7	3.2096547641913276e-13	1.2090631853902338e-12	0.018691588785046728	0.9605811478101344	1	2
carbolines/pharmacology	microglia/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
triterpenes/pharmacology	prostatic neoplasms/drug therapy	1.3447498348195808e-07	3.6890686024763117e-07	0.046290202272826986	0.9605811478101344	1	2
triterpenes/pharmacology	dinitrofluorobenzene/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
triterpenes/pharmacology	IL1B	1.1102230246251565e-16	4.854858636837654e-16	0.018647711816067742	0.9605811478101344	1	2
triterpenes/pharmacology	drug hypersensitivity/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
triterpenes/pharmacology	foot/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
triterpenes/pharmacology	cell death/drug effects	7.291985433366399e-06	1.7536397778671726e-05	0.05541661182045544	0.9605811478101344	1	2
triterpenes/pharmacology	mitophagy/drug effects	2.5110025170249628e-11	8.560782974387874e-11	0.03711991575621956	0.9605811478101344	1	2
triterpenes/pharmacology	nfatc transcription factors/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
triterpenes/pharmacology	ear/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
triterpenes/pharmacology	anti-inflammatory agents/pharmacology	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
triterpenes/pharmacology	hypersensitivity delayed/chemically induced	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	clone cells	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	cyclophilin a/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	tacrolimus binding protein 1a/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	spiro compounds/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	enzyme inhibitors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	imp dehydrogenase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	CD40LG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	IL2	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
dihydroorotase/antagonists & inhibitors	PPIA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactates/metabolism	protein kinase inhibitors/pharmacology	0.00016570985144803707	0.00034454647347475684	0.04672897196261682	0.9605811478101344	1	2
lactates/metabolism	phosphoinositide-3 kinase inhibitors	0.002079111832937297	0.003839860754950706	0.07009345794392523	0.9605811478101344	1	2
lactates/metabolism	glucose/deficiency	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactates/metabolism	imidazoles/pharmacology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
lactates/metabolism	breast neoplasms/metabolism	5.592304397339376e-12	1.956197482984905e-11	0.014018691588785045	0.9605811478101344	1	2
lactates/metabolism	cytoprotection/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactates/metabolism	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactates/metabolism	quinolines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lactates/metabolism	cell respiration/drug effects	5.295763827461997e-13	1.979671089655512e-12	0.014018691588785045	0.9605811478101344	1	2
lactates/metabolism	tor serine-threonine kinases/antagonists & inhibitors	8.70488068962505e-05	0.0001859560211654424	0.04205607476635514	0.9605811478101344	1	2
lactates/metabolism	receptors estrogen/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lactates/metabolism	ESRRA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytotoxicity immunologic	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
cytotoxicity immunologic	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytotoxicity immunologic	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytotoxicity immunologic	breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytotoxicity immunologic	hmgb1 protein/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytotoxicity immunologic	colorectal neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytotoxicity immunologic	KLK3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytotoxicity immunologic	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
cytotoxicity immunologic	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytotoxicity immunologic	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytotoxicity immunologic	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
flavones/pharmacology	antioxidants/pharmacology	5.590548282086161e-07	1.4652925406970478e-06	0.027905752270633143	0.9605811478101344	1	2
flavones/pharmacology	MCL1	0.001803655249378977	0.003358982256804433	0.05541661182045544	0.9605811478101344	1	2
flavones/pharmacology	BCL2	0.005608955554539441	0.009713026395419856	0.02176297661357553	0.8657199677887635	2	2
flavones/pharmacology	urinary bladder neoplasms/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
flavones/pharmacology	hydrogen peroxide	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
flavones/pharmacology	MAPK3	0.0010402333012837772	0.0019898545745882976	0.0735378000087754	0.9605811478101344	1	2
flavones/pharmacology	endoplasmic reticulum stress/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
flavones/pharmacology	astrocytes/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
flavones/pharmacology	ATF4	6.519751405420493e-11	2.177662157047584e-10	0.018647711816067742	0.9605811478101344	1	2
flavones/pharmacology	BAX	1.2773637315999231e-05	2.9837181432688954e-05	0.03711991575621956	0.9605811478101344	1	2
flavones/pharmacology	CAMK2A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
flavones/pharmacology	CAMK2B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
flavones/pharmacology	CASP12	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
flavones/pharmacology	CASP9	2.196025039591376e-08	6.328317876475057e-08	0.0019744636040542316	0.8657199677887635	2	2
flavones/pharmacology	MAPK14	6.519751405420493e-11	2.177662157047584e-10	0.018647711816067742	0.9605811478101344	1	2
cyclin-dependent kinase inhibitor p21/agonists	antineoplastic agents phytogenic/pharmacology	5.667977414525183e-06	1.3746294800951627e-05	0.02803738317757009	0.9605811478101344	1	2
cyclin-dependent kinase inhibitor p21/agonists	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0005349787352844082	0.0010567291843353013	0.04672897196261682	0.9605811478101344	1	2
cyclin-dependent kinase inhibitor p21/agonists	ZHX2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
cyclin-dependent kinase inhibitor p21/agonists	phosphatidylinositol 3-kinases/genetics	0.00023111048486224028	0.000474090432661209	0.04205607476635514	0.9605811478101344	1	2
cyclin-dependent kinase inhibitor p21/agonists	tor serine-threonine kinases/antagonists & inhibitors	0.00025250561210343747	0.0005151993092408466	0.04205607476635514	0.9605811478101344	1	2
cyclin-dependent kinase inhibitor p21/agonists	CDK2	1.2740916099929223e-09	3.968800765346701e-09	0.014018691588785045	0.9605811478101344	1	2
leflunomide/pharmacology	triple negative breast neoplasms/drug therapy	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
leflunomide/pharmacology	neoplasm invasiveness	3.983310559174669e-08	1.1307329883955594e-07	0.02803738317757009	0.9605811478101344	1	2
leflunomide/pharmacology	bone neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
leflunomide/pharmacology	tumor cells cultured	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
leflunomide/pharmacology	tor serine-threonine kinases/genetics	4.571698575261962e-11	1.5428870379209513e-10	0.018691588785046728	0.9605811478101344	1	2
leflunomide/pharmacology	ZHX2	1.8387069644631993e-11	6.294024398771094e-11	0.018691588785046728	0.9605811478101344	1	2
leflunomide/pharmacology	carboxy-lyases/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leflunomide/pharmacology	immunosuppressive agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leflunomide/pharmacology	MAPK1	1.1940993098313868e-05	2.7966328429108155e-05	0.04672897196261682	0.9605811478101344	1	2
leflunomide/pharmacology	mitochondrial dynamics/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leflunomide/pharmacology	phosphatidylinositol 3-kinases/genetics	1.0561129245467704e-05	2.48879625485327e-05	0.04205607476635514	0.9605811478101344	1	2
leflunomide/pharmacology	cell transformation neoplastic/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation viral	host-pathogen interactions	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
gene expression regulation viral	proteasome endopeptidase complex/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation viral	hepatocytes/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation viral	apoferritins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation viral	hepatitis c/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene expression regulation viral	protein interaction maps	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene expression regulation viral	viral nonstructural proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene expression regulation viral	apolipoprotein b-100/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene expression regulation viral	fatty liver/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane proteins/metabolism	t-lymphocytes/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane proteins/metabolism	myeloid-derived suppressor cells/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
membrane proteins/metabolism	neutral ceramidase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane proteins/metabolism	heme oxygenase-1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane proteins/metabolism	colonic neoplasms/drug therapy	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
membrane proteins/metabolism	ASAH2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane proteins/metabolism	HMOX1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
piperidines/metabolism	rna messenger/genetics	1.0143579034505024e-05	2.3965455481436644e-05	0.02803738317757009	0.9605811478101344	1	2
piperidines/metabolism	tumor necrosis factor-alpha/metabolism	0.00025250561210343747	0.0005151993092408466	0.037383177570093455	0.9605811478101344	1	2
piperidines/metabolism	BIRC5	2.332691073636539e-08	6.70113000541217e-08	0.014018691588785045	0.9605811478101344	1	2
piperidines/metabolism	CASP8	0.000335616220874857	0.0006746595949898656	0.03271028037383177	0.9605811478101344	1	2
piperidines/metabolism	u937 cells	6.51304561172239e-07	1.7006114358983332e-06	0.018691588785046728	0.9605811478101344	1	2
piperidines/metabolism	MCL1	0.00018571952850299223	0.00038444692183212586	0.02803738317757009	0.9605811478101344	1	2
piperidines/metabolism	XIAP	6.226627435879095e-09	1.8701087277790802e-08	0.014018691588785045	0.9605811478101344	1	2
piperidines/metabolism	leukemia/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperidines/metabolism	AIFM1	3.37278289741505e-07	8.941098631983529e-07	0.018691588785046728	0.9605811478101344	1	2
piperidines/metabolism	PARP1	0.0035270245753111773	0.006293100091968992	0.05607476635514018	0.9605811478101344	1	2
piperidines/metabolism	TNFRSF10D	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperidines/metabolism	flavonoids/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperidines/metabolism	multiple myeloma/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperidines/metabolism	caspases/metabolism	0.00014922404803296985	0.00031191617472799767	0.03271028037383177	0.9605811478101344	1	2
piperidines/metabolism	poly (adp-ribose) polymerase-1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperidines/metabolism	cytochromes c/metabolism	0.0005161304311359638	0.0010208705253149483	0.04205607476635514	0.9605811478101344	1	2
protective agents/pharmacology	myocardial reperfusion injury/drug therapy	1.241229341530925e-13	4.764384492004497e-13	0.018647711816067742	0.9605811478101344	1	2
protective agents/pharmacology	GSK3B	0.0006539203138513638	0.0012790662774835762	0.05541661182045544	0.9605811478101344	1	2
protective agents/pharmacology	mesenchymal stem cells/cytology	4.271805131850215e-12	1.507921222334831e-11	0.018647711816067742	0.9605811478101344	1	2
protective agents/pharmacology	BCL2	0.004844768432968549	0.008465482200831397	0.02176297661357553	0.8657199677887635	2	2
protective agents/pharmacology	hydrogen peroxide/toxicity	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protective agents/pharmacology	necrosis	2.157919398726449e-10	6.979288089059813e-10	0.018647711816067742	0.9605811478101344	1	2
protective agents/pharmacology	myocytes cardiac/drug effects	1.1072517549504113e-05	2.6029093392842167e-05	0.046290202272826986	0.9605811478101344	1	2
protective agents/pharmacology	potassium channels/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
protective agents/pharmacology	dynamins	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protective agents/pharmacology	quinuclidines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
protective agents/pharmacology	bcl-2-associated x protein/metabolism	5.464098694807351e-05	0.0001197896470350129	0.03711991575621956	0.9605811478101344	1	2
protective agents/pharmacology	ascorbic acid/analogs & derivatives	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protective agents/pharmacology	acetylcysteine/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protective agents/pharmacology	histones/metabolism	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protective agents/pharmacology	cytochromes c/metabolism	0.0033192745475103536	0.0059585869747197755	0.08253257864946689	0.9605811478101344	1	2
protective agents/pharmacology	ABCC9	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
protective agents/pharmacology	AIFM1	1.4380785950063313e-05	3.33579767098365e-05	0.03711991575621956	0.9605811478101344	1	2
protective agents/pharmacology	BAX	9.667544747959944e-06	2.2911966742235928e-05	0.03711991575621956	0.9605811478101344	1	2
protective agents/pharmacology	DNM1L	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
protective agents/pharmacology	H2AX	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
thioredoxin-disulfide reductase/antagonists & inhibitors	thiosemicarbazones/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thioredoxin-disulfide reductase/antagonists & inhibitors	peroxiredoxin iii/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thioredoxin-disulfide reductase/antagonists & inhibitors	pyridines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
thioredoxin-disulfide reductase/antagonists & inhibitors	PRRX1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclosporine/pharmacology	sulfonamides/pharmacology	6.844090960633764e-09	2.0416522459755544e-08	0.027905752270633143	0.9605811478101344	1	2
cyclosporine/pharmacology	rna small interfering/genetics	6.844090960633764e-09	2.0416522459755544e-08	0.027905752270633143	0.9605811478101344	1	2
cyclosporine/pharmacology	curcumin/pharmacology	2.6147717324676023e-10	8.445720357082581e-10	0.027905752270633143	0.9605811478101344	1	2
cyclosporine/pharmacology	myocardial reperfusion injury/metabolism	4.918287999089443e-13	1.8445044021759493e-12	0.018647711816067742	0.9605811478101344	1	2
cyclosporine/pharmacology	cyclophilin d	0.0	0.0	4.387696897898293e-05	0.8657199677887635	2	2
cyclosporine/pharmacology	cardiotonic agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclosporine/pharmacology	oxygen consumption	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclosporine/pharmacology	proto-oncogene proteins c-bcl-2/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclosporine/pharmacology	biphenyl compounds/pharmacology	1.014400341503574e-09	3.1733113974845062e-09	0.018647711816067742	0.9605811478101344	1	2
cyclosporine/pharmacology	nitrophenols/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclosporine/pharmacology	cell death/drug effects	0.00010286491815503229	0.00021798978426395155	0.05541661182045544	0.9605811478101344	1	2
cyclosporine/pharmacology	myocytes cardiac/drug effects	3.1292340773036997e-06	7.742492754616988e-06	0.046290202272826986	0.9605811478101344	1	2
cyclosporine/pharmacology	mitochondria heart/drug effects	1.9701580900033377e-07	5.351490152567894e-07	0.03711991575621956	0.9605811478101344	1	2
cyclosporine/pharmacology	electron transport complex i/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclosporine/pharmacology	cell hypoxia/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclosporine/pharmacology	cell death	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclosporine/pharmacology	PPID	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclosporine/pharmacology	PPIF	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors calcitriol/physiology	cell differentiation/drug effects	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
receptors calcitriol/physiology	CD4	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
receptors calcitriol/physiology	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors calcitriol/physiology	dose-response relationship immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors calcitriol/physiology	growth inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors calcitriol/physiology	th2 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors calcitriol/physiology	l-selectin/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors calcitriol/physiology	interferon-gamma/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors calcitriol/physiology	th1 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors calcitriol/physiology	SELP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors calcitriol/physiology	calcitriol/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors calcitriol/physiology	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna damage/drug effects	caspase 8/metabolism	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
dna damage/drug effects	CASP8	0.0010427713481141465	0.0019929804683790483	0.03271028037383177	0.9605811478101344	1	2
dna damage/drug effects	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0029624131333876313	0.00535064182558618	0.04672897196261682	0.9605811478101344	1	2
dna damage/drug effects	caspase 3/metabolism	9.940125707075254e-05	0.00021089289029021862	0.02803738317757009	0.9605811478101344	1	2
dna damage/drug effects	MCL1	0.0006294795090561189	0.0012353150169710113	0.02803738317757009	0.9605811478101344	1	2
dna damage/drug effects	morpholines/pharmacology	1.983776046765584e-07	5.377218377070026e-07	0.014018691588785045	0.9605811478101344	1	2
dna damage/drug effects	cell death/drug effects	7.930407666079109e-05	0.00017048520692444636	0.02803738317757009	0.9605811478101344	1	2
dna damage/drug effects	biphenyl compounds/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
dna damage/drug effects	aminopyridines/pharmacology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
dna damage/drug effects	sulfonamides/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
dna damage/drug effects	poly(adp-ribose) polymerases/metabolism	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
dna damage/drug effects	piperazines/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
dna damage/drug effects	nitrophenols/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
dna damage/drug effects	glioblastoma/enzymology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
dna damage/drug effects	bcl-2-associated x protein/metabolism	1.360526913485316e-05	3.167571001956098e-05	0.018691588785046728	0.9605811478101344	1	2
dna damage/drug effects	cytochromes c/metabolism	0.0015056804766054865	0.0028289086619682803	0.04205607476635514	0.9605811478101344	1	2
dna damage/drug effects	PTEN	7.335668233077186e-05	0.00015875227051716313	0.02336448598130841	0.9605811478101344	1	2
biphenyl compounds/toxicity	CASP8	0.0010427713481141465	0.0019929804683790483	0.03271028037383177	0.9605811478101344	1	2
biphenyl compounds/toxicity	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0029624131333876313	0.00535064182558618	0.04672897196261682	0.9605811478101344	1	2
biphenyl compounds/toxicity	caspase 3/metabolism	9.940125707075254e-05	0.00021089289029021862	0.02803738317757009	0.9605811478101344	1	2
biphenyl compounds/toxicity	MCL1	0.0006294795090561189	0.0012353150169710113	0.02803738317757009	0.9605811478101344	1	2
biphenyl compounds/toxicity	caspase 8/metabolism	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/toxicity	morpholines/pharmacology	1.983776046765584e-07	5.377218377070026e-07	0.014018691588785045	0.9605811478101344	1	2
biphenyl compounds/toxicity	cell death/drug effects	7.930407666079109e-05	0.00017048520692444636	0.02803738317757009	0.9605811478101344	1	2
biphenyl compounds/toxicity	bcl-2-associated x protein/metabolism	1.360526913485316e-05	3.167571001956098e-05	0.018691588785046728	0.9605811478101344	1	2
biphenyl compounds/toxicity	cytochromes c/metabolism	0.0015056804766054865	0.0028289086619682803	0.04205607476635514	0.9605811478101344	1	2
biphenyl compounds/toxicity	sulfonamides/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
biphenyl compounds/toxicity	PTEN	7.335668233077186e-05	0.00015875227051716313	0.02336448598130841	0.9605811478101344	1	2
biphenyl compounds/toxicity	aminopyridines/pharmacology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
biphenyl compounds/toxicity	poly(adp-ribose) polymerases/metabolism	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
biphenyl compounds/toxicity	piperazines/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
biphenyl compounds/toxicity	nitrophenols/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
biphenyl compounds/toxicity	glioblastoma/enzymology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/physiology	phosphoinositide-3 kinase inhibitors	0.0001371871321772522	0.0002878201437095876	0.07009345794392523	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/physiology	proto-oncogene proteins c-akt/antagonists & inhibitors	4.563453836148312e-06	1.1185662054407782e-05	0.04672897196261682	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/physiology	tor serine-threonine kinases/antagonists & inhibitors	1.3036816781664129e-06	3.327572776130247e-06	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/physiology	CASP9	2.2807573888394828e-06	5.716282699685451e-06	0.04672897196261682	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/physiology	CCL22	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/physiology	PARP1	3.705668535070039e-05	8.268654980389053e-05	0.05607476635514018	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/physiology	PTEN	1.3393322007004826e-09	4.157341455869948e-09	0.02336448598130841	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	erbb receptors/antagonists & inhibitors	6.955092368698956e-08	1.9428085207788495e-07	0.027905752270633143	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	carcinoma non-small-cell lung/drug therapy	0.002644876201650548	0.004812596393000849	0.10925365275766749	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	ZHX2	2.3918581283366436e-06	5.991330153779404e-06	0.03711991575621956	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	sulindac/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	granulosa cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	antineoplastic agents/administration & dosage	1.8387069644631993e-11	6.294024398771094e-11	0.027905752270633143	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	raf kinases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	MAPK1	0.0023368629531065332	0.004278621025584857	0.09148348032117941	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	zearalenone/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	autophagy-related proteins/metabolism	7.971401316808624e-14	3.1145393626262015e-13	0.018647711816067742	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	cell transformation neoplastic/drug effects	9.609091300433192e-12	3.321229738077301e-11	0.018647711816067742	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	BECN1	3.2737088677681214e-06	8.090879174593828e-06	0.046290202272826986	0.9605811478101344	1	2
mitogen-activated protein kinases/metabolism	CASP9	0.0029776217975442387	0.005374589061993891	0.09148348032117941	0.9605811478101344	1	2
aniline compounds/pharmacology	hyaluronic acid/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
aniline compounds/pharmacology	benzylidene compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fluorouracil/therapeutic use	levofloxacin/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fluorouracil/therapeutic use	MAPK1	1.3036816781664129e-06	3.327572776130247e-06	0.04672897196261682	0.9605811478101344	1	2
fluorouracil/therapeutic use	metabolic networks and pathways/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fluorouracil/therapeutic use	organelle biogenesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heme oxygenase-1/genetics	nf-e2-related factor 2/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heme oxygenase-1/genetics	HMOX1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heme oxygenase-1/genetics	NFE2L2	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
heme oxygenase-1/genetics	neuroprotective agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heme oxygenase-1/genetics	amyloid beta-peptides/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heme oxygenase-1/genetics	quassins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heme oxygenase-1/genetics	neurons/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
nitrophenols/administration & dosage	biphenyl compounds/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nitrophenols/administration & dosage	sulfonamides/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nitrophenols/administration & dosage	piperazines/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nitrophenols/administration & dosage	epothilones/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nitrophenols/administration & dosage	PARP1	0.00029652745217612075	0.0006010698966239874	0.05607476635514018	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	antineoplastic agents phytogenic/pharmacology	0.0020359758923705895	0.0037642932054496236	0.021673232895463388	0.8657199677887635	2	2
tor serine-threonine kinases/antagonists & inhibitors	phosphoinositide-3 kinase inhibitors	2.5206503551089554e-12	9.051351633459648e-12	5.854684002208405e-08	0.11552077256850565	7	2
tor serine-threonine kinases/antagonists & inhibitors	proto-oncogene proteins c-akt/antagonists & inhibitors	2.327027459614328e-13	8.833729584982215e-13	1.349938894165808e-07	0.2127419111522651	6	2
tor serine-threonine kinases/antagonists & inhibitors	glucose/deficiency	8.70488068962505e-05	0.0001859560211654424	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	imidazoles/pharmacology	8.097407311336013e-08	2.2550415106774842e-07	0.0015795708832433853	0.8657199677887635	2	2
tor serine-threonine kinases/antagonists & inhibitors	azepines/chemistry	0.0001824454331171843	0.0003784155135811552	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	pyrimidines/chemistry	0.0001824454331171843	0.0003784155135811552	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	sesquiterpenes guaiane	1.1940993098313868e-05	2.7966328429108155e-05	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	cytoprotection/drug effects	8.70488068962505e-05	0.0001859560211654424	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	mesothelioma malignant/drug therapy	2.1270633422276752e-05	4.8553155160405616e-05	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	cyclin-dependent kinase 6/antagonists & inhibitors	0.004141426933179759	0.007290816114879219	0.08253257864946689	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	mitochondrial dynamics/drug effects	0.00044967308686794105	0.000894477825628326	0.08253257864946689	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	antineoplastic agents phytogenic/chemistry	1.1940993098313868e-05	2.7966328429108155e-05	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	chloroquine/pharmacology	0.0036295362031109057	0.006468155044147208	0.08253257864946689	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	chondrosarcoma/drug therapy	1.1940993098313868e-05	2.7966328429108155e-05	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	receptors estrogen/antagonists & inhibitors	0.003158697231605445	0.005679112497956198	0.08253257864946689	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	mitogen-activated protein kinases/antagonists & inhibitors	0.0001824454331171843	0.0003784155135811552	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	CCL22	0.00034075459087046234	0.0006838042431520846	0.08253257864946689	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	CDH1	0.0001824454331171843	0.0003784155135811552	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	CDH2	0.0001824454331171843	0.0003784155135811552	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	CDK4	0.004141426933179759	0.007290816114879219	0.08253257864946689	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	CDKN2A	2.1270633422276752e-05	4.8553155160405616e-05	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	ESRRA	8.70488068962505e-05	0.0001859560211654424	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	MYC	2.1270633422276752e-05	4.8553155160405616e-05	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	phosphoinositide-3 kinase inhibitors/pharmacology	2.1270633422276752e-05	4.8553155160405616e-05	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	antimalarials/pharmacology	0.0023368629531065332	0.004278621025584857	0.08253257864946689	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	8.70488068962505e-05	0.0001859560211654424	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	quinolines/pharmacology	8.70488068962505e-05	0.0001859560211654424	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	phenylurea compounds/pharmacology	3.0037803732119173e-06	7.440439239251359e-06	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	carcinoma squamous cell/drug therapy	1.1940993098313868e-05	2.7966328429108155e-05	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	mouth neoplasms/drug therapy	1.1940993098313868e-05	2.7966328429108155e-05	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	neuroblastoma/drug therapy	0.00012810012533626125	0.0002694477736513917	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	cell membrane permeability/drug effects	0.00012810012533626125	0.0002694477736513917	0.04205607476635514	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	lysosomes/drug effects	0.0004028082663601884	0.0008037937059199416	0.014774701220028882	0.8657199677887635	2	2
tor serine-threonine kinases/antagonists & inhibitors	cyclin-dependent kinase 4/antagonists & inhibitors	0.004141426933179759	0.007290816114879219	0.08253257864946689	0.9605811478101344	1	2
tor serine-threonine kinases/antagonists & inhibitors	pyridines/pharmacology	0.000581706605334853	0.0011444157432339464	0.08253257864946689	0.9605811478101344	1	2
foot/pathology	dinitrofluorobenzene/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
foot/pathology	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
foot/pathology	drug hypersensitivity/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
foot/pathology	nfatc transcription factors/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
foot/pathology	ear/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
foot/pathology	anti-inflammatory agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
foot/pathology	hypersensitivity delayed/chemically induced	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ABCB8	depsides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ABCB8	heart injuries/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ABCB8	CYBB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ABCB8	PINK1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ABCB8	SLC25A28	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ABCB8	cinnamates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ABCB8	sleep apnea obstructive/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ABCB8	drugs chinese herbal/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ABCB8	hypoxia/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tigecycline	paclitaxel/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tigecycline	antineoplastic agents phytogenic/pharmacology	2.228787709945834e-09	6.864130664741689e-09	0.02803738317757009	0.9605811478101344	1	2
tigecycline	peptide elongation factor tu/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tigecycline	dna mitochondrial/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tigecycline	carcinoma renal cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tigecycline	EEF1A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tigecycline	kidney/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDCD1	iron/chemistry	4.952394028201468e-08	1.398979929965227e-07	0.02336448598130841	0.9605811478101344	1	2
PDCD1	nf-e2-related factor 2/genetics	1.6587731900497005e-05	3.833207346631988e-05	0.046290202272826986	0.9605811478101344	1	2
PDCD1	antibodies monoclonal humanized/pharmacology	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
PDCD1	cd36 antigens/antagonists & inhibitors	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
PDCD1	cd8-positive t-lymphocytes/immunology	0.0022360649654099563	0.004109766618652777	0.11249652907369678	0.9605811478101344	1	2
PDCD1	allografts	4.952394028201468e-08	1.398979929965227e-07	0.02336448598130841	0.9605811478101344	1	2
PDCD1	exosomes/metabolism	7.439604488013174e-13	2.765611191227693e-12	0.02336448598130841	0.9605811478101344	1	2
PDCD1	GABPA	4.952394028201468e-08	1.398979929965227e-07	0.02336448598130841	0.9605811478101344	1	2
PDCD1	fatty acids/metabolism	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
PDCD1	PRKAA2	0.002407140969878374	0.004401811736242713	0.09085010295354308	0.9605811478101344	1	2
PDCD1	tumor escape	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
PDCD1	protein kinases/genetics	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
PDCD1	nitrobenzenes/chemistry	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
PDCD1	immune checkpoint inhibitors/chemical synthesis	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
PDCD1	programmed cell death 1 receptor/antagonists & inhibitors	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
PDCD1	liver neoplasms/drug therapy	7.011385258604008e-06	1.6913240938916976e-05	0.046290202272826986	0.9605811478101344	1	2
PDCD1	carbazoles/pharmacology	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
PDCD1	carcinoma squamous cell/immunology	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
PDCD1	b7-h1 antigen/genetics	2.531112663128887e-06	6.315035871524918e-06	0.046290202272826986	0.9605811478101344	1	2
PDCD1	rna small interfering/genetics	0.00021968486658296982	0.00045195595207812996	0.06878335787959994	0.9605811478101344	1	2
PDCD1	t-lymphocytes/cytology	2.531112663128887e-06	6.315035871524918e-06	0.046290202272826986	0.9605811478101344	1	2
PDCD1	mouth neoplasms/immunology	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
PDCD1	maleimides	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
PDCD1	PRKD1	8.077349900048603e-11	2.680858205573861e-10	0.02336448598130841	0.9605811478101344	1	2
PDCD1	BTRC	4.952394028201468e-08	1.398979929965227e-07	0.02336448598130841	0.9605811478101344	1	2
PDCD1	CTLA4	4.952394028201468e-08	1.398979929965227e-07	0.02336448598130841	0.9605811478101344	1	2
PDCD1	NFE2L2	0.0020730681424208086	0.003830945134866649	0.09085010295354308	0.9605811478101344	1	2
PDCD1	CD36	8.992806499463768e-15	3.624079650889731e-14	0.02336448598130841	0.9605811478101344	1	2
ABCC9	myocardial reperfusion injury/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ABCC9	cell line	2.1067664965124244e-05	4.820963955900979e-05	0.06074766355140186	0.9605811478101344	1	2
ABCC9	GSK3B	5.332843400207565e-08	1.503177336841938e-07	0.02803738317757009	0.9605811478101344	1	2
ABCC9	membrane potential mitochondrial/drug effects	0.0016991734374988132	0.0031721740855185296	0.09813084112149532	0.9605811478101344	1	2
ABCC9	myocytes cardiac/drug effects	3.175126828125485e-12	1.1320374564442222e-11	0.02336448598130841	0.9605811478101344	1	2
ABCC9	potassium channels/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ABCC9	quinuclidines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	tumor necrosis factor-alpha/metabolism	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	buthionine sulfoximine/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	antibodies monoclonal/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	cell division/drug effects	3.9129477436006255e-11	1.324622629370591e-10	0.018691588785046728	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	mercaptoethanol/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	interleukins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	cd3 complex/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	CD28	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	CD3E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	IL2	5.513522971511975e-11	1.8460463853590893e-10	0.018691588785046728	0.9605811478101344	1	2
phytohemagglutinins/pharmacology	IL5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
anoikis/drug effects	lung neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
anoikis/drug effects	osteosarcoma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
anoikis/drug effects	bone neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
anoikis/drug effects	CXCL8	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
anoikis/drug effects	CXCR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
AIFM1	melanoma/genetics	0.00012754779744783562	0.0002684140343733778	0.055287464515536164	0.9605811478101344	1	2
AIFM1	proto-oncogene proteins c-bcl-2/genetics	5.855951089484002e-06	1.418345706041341e-05	0.03711991575621956	0.9605811478101344	1	2
AIFM1	BIRC5	0.0014797615977730771	0.002784007484230805	0.055287464515536164	0.9605811478101344	1	2
AIFM1	mesenchymal stem cells/cytology	2.9359124917860413e-06	7.278870866850179e-06	0.03711991575621956	0.9605811478101344	1	2
AIFM1	u937 cells	0.0048682339326305835	0.008502441519854175	0.07319670689438858	0.9605811478101344	1	2
AIFM1	XIAP	0.0009256794632915843	0.0017806125289349898	0.055287464515536164	0.9605811478101344	1	2
AIFM1	hydrogen peroxide/toxicity	1.478060929205327e-08	4.297545478981808e-08	0.018691588785046728	0.9605811478101344	1	2
AIFM1	necrosis	1.8812353098085488e-05	4.327331884262794e-05	0.03711991575621956	0.9605811478101344	1	2
AIFM1	APAF1	5.946021452984951e-12	2.0759759460872875e-11	0.018691588785046728	0.9605811478101344	1	2
AIFM1	BAX	0.0031692476956168836	0.0056966878520268265	0.07319670689438858	0.9605811478101344	1	2
AIFM1	DNM1L	1.478060929205327e-08	4.297545478981808e-08	0.018691588785046728	0.9605811478101344	1	2
AIFM1	pentacyclic triterpenes	2.9359124917860413e-06	7.278870866850179e-06	0.03711991575621956	0.9605811478101344	1	2
AIFM1	H2AX	1.478060929205327e-08	4.297545478981808e-08	0.018691588785046728	0.9605811478101344	1	2
AIFM1	PARP1	0.0016119683485125158	0.0030188293678759834	0.01629997420702796	0.8657199677887635	2	2
AIFM1	PRKCA	5.855951089484002e-06	1.418345706041341e-05	0.03711991575621956	0.9605811478101344	1	2
AIFM1	RTCA	5.946021452984951e-12	2.0759759460872875e-11	0.018691588785046728	0.9605811478101344	1	2
AIFM1	TNFRSF10D	3.37278289741505e-07	8.941098631983529e-07	0.018691588785046728	0.9605811478101344	1	2
AIFM1	flavonoids/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.018691588785046728	0.9605811478101344	1	2
AIFM1	uterine cervical neoplasms/drug therapy	4.189104516050257e-06	1.0322013452154232e-05	0.03711991575621956	0.9605811478101344	1	2
AIFM1	multiple myeloma/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.018691588785046728	0.9605811478101344	1	2
AIFM1	dynamins	1.478060929205327e-08	4.297545478981808e-08	0.018691588785046728	0.9605811478101344	1	2
AIFM1	leukemia/metabolism	3.37278289741505e-07	8.941098631983529e-07	0.018691588785046728	0.9605811478101344	1	2
AIFM1	benzophenanthridines/pharmacology	5.946021452984951e-12	2.0759759460872875e-11	0.018691588785046728	0.9605811478101344	1	2
AIFM1	ascorbic acid/analogs & derivatives	1.478060929205327e-08	4.297545478981808e-08	0.018691588785046728	0.9605811478101344	1	2
AIFM1	acetylcysteine/pharmacology	1.478060929205327e-08	4.297545478981808e-08	0.018691588785046728	0.9605811478101344	1	2
AIFM1	poly (adp-ribose) polymerase-1	3.37278289741505e-07	8.941098631983529e-07	0.018691588785046728	0.9605811478101344	1	2
AIFM1	histones/metabolism	1.478060929205327e-08	4.297545478981808e-08	0.018691588785046728	0.9605811478101344	1	2
AIFM1	bcl-associated death protein/metabolism	5.946021452984951e-12	2.0759759460872875e-11	0.018691588785046728	0.9605811478101344	1	2
AIFM1	cytochromes c/metabolism	0.00012818003458769933	0.0002695901366583607	0.009064629456995965	0.8657199677887635	2	2
cytoskeleton/metabolism	cell movement/drug effects	0.00016503859793592923	0.0003433774660084333	0.09345794392523364	0.9605811478101344	1	2
cytoskeleton/metabolism	neoplasm invasiveness	7.279177260954839e-12	2.5362089167119513e-11	0.02803738317757009	0.9605811478101344	1	2
cytoskeleton/metabolism	phosphoinositide-3 kinase inhibitors	1.5452482721611815e-05	3.57423771554865e-05	0.07009345794392523	0.9605811478101344	1	2
cytoskeleton/metabolism	biological transport	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytoskeleton/metabolism	energy metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
APAF1	PRKCA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
APAF1	RTCA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
APAF1	uterine cervical neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
APAF1	benzophenanthridines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
APAF1	bcl-associated death protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sorafenib/pharmacology	hypoxia-inducible factor 1 alpha subunit/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	amino acid transport system y+/metabolism	1.6653345369377348e-15	6.987116245557217e-15	0.018647711816067742	0.9605811478101344	1	2
sorafenib/pharmacology	hepatic stellate cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	liver cirrhosis/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	collagen type i/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	cell line	0.0037105254359020012	0.006584278858009443	0.11807292352244307	0.9605811478101344	1	2
sorafenib/pharmacology	actins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	FN1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	HIF1A	6.326225783226391e-07	1.653397653728965e-06	0.03711991575621956	0.9605811478101344	1	2
sorafenib/pharmacology	MMRN1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	SLC7A11	3.6574405837264123e-08	1.0407750385906032e-07	0.046290202272826986	0.9605811478101344	1	2
sorafenib/pharmacology	neoplasm invasiveness	5.5506398140336977e-05	0.00012167479282145055	0.05541661182045544	0.9605811478101344	1	2
sorafenib/pharmacology	t-lymphocytes/drug effects	3.1556298685231354e-09	9.644486739838937e-09	0.027905752270633143	0.9605811478101344	1	2
sorafenib/pharmacology	carcinoma hepatocellular/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	potassium channels voltage-gated/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	micrornas/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	immune evasion/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	KCNQ1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sorafenib/pharmacology	KCNQ1OT1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
AREG	ESR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
AREG	letrozole/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
AREG	receptors estrogen/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
AREG	aromatase inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
AREG	CYP19A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
AREG	EGFR	1.2756462552943049e-13	4.887982036275432e-13	0.018691588785046728	0.9605811478101344	1	2
AREG	MAPK1	1.1940993098313868e-05	2.7966328429108155e-05	0.04672897196261682	0.9605811478101344	1	2
AREG	amphiregulin/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	t-lymphocytes/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	neutral ceramidase/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	heme oxygenase-1/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	colonic neoplasms/drug therapy	3.2974283636910684e-08	9.399056310621935e-08	0.027905752270633143	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	ASAH2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	HMOX1	1.2101430968414206e-14	4.8608553469046536e-14	0.018647711816067742	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	benzhydryl compounds/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	lung neoplasms/immunology	2.2922774789435607e-12	8.248756953769811e-12	0.018647711816067742	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	cytokines/blood	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	azocines/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	carcinoma lewis lung/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	ARG1	1.0859091403858656e-12	4.002361204819051e-12	0.018647711816067742	0.9605811478101344	1	2
myeloid-derived suppressor cells/immunology	TCIM	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	antioxidants/pharmacology	1.7878040958763108e-07	4.865757894813097e-07	0.027905752270633143	0.9605811478101344	1	2
ATF4	MCL1	0.0011129153088605959	0.002124647738311405	0.05541661182045544	0.9605811478101344	1	2
ATF4	lung/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	fibroblasts/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	activating transcription factor 4/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	urinary bladder neoplasms/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	oxygen consumption/drug effects	3.585587382559652e-11	1.216980151026404e-10	0.027905752270633143	0.9605811478101344	1	2
ATF4	serine/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	CASP9	0.0034541165284649455	0.006176008532932862	0.09148348032117941	0.9605811478101344	1	2
ATF4	mechanistic target of rapamycin complex 1/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	glycine/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	transforming growth factor beta/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	collagen/biosynthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	stress physiological	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATF4	endoplasmic reticulum stress/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATG12	PRKAA2	1.1102230246251565e-16	4.854858636837654e-16	0.018691588785046728	0.9605811478101344	1	2
ATG12	spermatogenesis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ATG12	CCL22	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATG12	TESC	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ATG12	arsenic/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	sulfonamides/pharmacology	0.0006475204891257524	0.0012672227715466527	0.055287464515536164	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	pyrimidines/pharmacology	0.003963160576982316	0.007002144755293382	0.07319670689438858	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	mesenchymal stem cells/cytology	1.360526913485316e-05	3.167571001956098e-05	0.03711991575621956	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	caspase 8/metabolism	0.0009350718661649271	0.0017982088534848942	0.03711991575621956	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	morpholines/pharmacology	0.002716131057647564	0.004938583008330322	0.055287464515536164	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	imidazoles/pharmacology	0.00019089991251719507	0.0003946517835142163	0.03711991575621956	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	heterografts	5.525480073487188e-10	1.7516288232961253e-09	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	aminopyridines/pharmacology	1.360526913485316e-05	3.167571001956098e-05	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	hydrogen peroxide/toxicity	1.3350204552953215e-07	3.665570485473381e-07	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	poly(adp-ribose) polymerases/metabolism	1.360526913485316e-05	3.167571001956098e-05	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	necrosis	6.91276527382545e-05	0.00015044186038624371	0.03711991575621956	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	piperazines/toxicity	1.360526913485316e-05	3.167571001956098e-05	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	nitrophenols/toxicity	1.360526913485316e-05	3.167571001956098e-05	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	antimalarials/pharmacology	2.4890411328915008e-05	5.6645725534673624e-05	0.03711991575621956	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	glioblastoma/enzymology	1.360526913485316e-05	3.167571001956098e-05	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	autophagy	0.0001308891017559599	0.00027515664716966094	0.03711991575621956	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	dynamins	1.3350204552953215e-07	3.665570485473381e-07	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	neuroblastoma/drug therapy	1.3350204552953215e-07	3.665570485473381e-07	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	cell membrane permeability/drug effects	1.3350204552953215e-07	3.665570485473381e-07	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	cytochromes c/metabolism	0.0004166604755997394	0.0008306836211251519	0.009064629456995965	0.8657199677887635	2	2
bcl-2-associated x protein/metabolism	sulfonamides/toxicity	1.360526913485316e-05	3.167571001956098e-05	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	chloroquine/pharmacology	5.464098694807351e-05	0.0001197896470350129	0.03711991575621956	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	histones/metabolism	1.3350204552953215e-07	3.665570485473381e-07	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	ATG7	0.0007352355217614681	0.0014317676014658938	0.055287464515536164	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	BAK1	5.525480073487188e-10	1.7516288232961253e-09	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	BAX	4.3908209956811106e-08	1.2452897004473516e-07	0.001559737378978988	0.8657199677887635	2	2
bcl-2-associated x protein/metabolism	CD34	5.525480073487188e-10	1.7516288232961253e-09	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	DNM1L	1.3350204552953215e-07	3.665570485473381e-07	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	H2AX	1.3350204552953215e-07	3.665570485473381e-07	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	PIK3CB	5.525480073487188e-10	1.7516288232961253e-09	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	bridged bicyclo compounds heterocyclic/pharmacology	5.525480073487188e-10	1.7516288232961253e-09	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	ascorbic acid/analogs & derivatives	1.3350204552953215e-07	3.665570485473381e-07	0.018691588785046728	0.9605811478101344	1	2
bcl-2-associated x protein/metabolism	acetylcysteine/pharmacology	1.3350204552953215e-07	3.665570485473381e-07	0.018691588785046728	0.9605811478101344	1	2
gene expression	inflammation mediators/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression	nf-e2-related factor 2/biosynthesis	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression	lipopolysaccharides/toxicity	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression	endoplasmic reticulum/drug effects	2.5199984108881246e-05	5.73384158547589e-05	0.055287464515536164	0.9605811478101344	1	2
gene expression	microglia/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression	NFE2L2	0.00028730260487308534	0.0005834436614388677	0.07319670689438858	0.9605811478101344	1	2
gene expression	lysosomal-associated membrane protein 2/genetics	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
gene expression	oxaliplatin	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
gene expression	receptor erbb-2/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression	interleukin-17/biosynthesis	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
gene expression	cyclin d1/genetics	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
gene expression	carcinoma hepatocellular/drug therapy	0.004318096573720398	0.007581254439989436	0.12539913750269532	0.9605811478101344	1	2
gene expression	macrophages/immunology	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
gene expression	biomarkers	5.738583852554768e-08	1.6146541192078551e-07	0.03711991575621956	0.9605811478101344	1	2
gene expression	rna small interfering/genetics	1.4281936911886284e-05	3.31531001298451e-05	0.055287464515536164	0.9605811478101344	1	2
gene expression	inflammation mediators/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression	poly i-c/administration & dosage	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression	receptors interleukin-17/genetics	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
gene expression	organoplatinum compounds/pharmacology	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
gene expression	ERBB2	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression	golgi apparatus/drug effects	8.537504037064991e-12	2.955949890219989e-11	0.018691588785046728	0.9605811478101344	1	2
gene expression	tor serine-threonine kinases/genetics	0.00046387553203119936	0.0009219803236476953	0.07319670689438858	0.9605811478101344	1	2
gene expression	curcumin/analogs & derivatives	8.537504037064991e-12	2.955949890219989e-11	0.018691588785046728	0.9605811478101344	1	2
gene expression	lysosomes/drug effects	0.0012656389571008564	0.002399381575766095	0.09085010295354308	0.9605811478101344	1	2
gene expression	microtubule-associated proteins/genetics	8.537504037064991e-12	2.955949890219989e-11	0.018691588785046728	0.9605811478101344	1	2
gene expression	bcl-2-associated x protein/genetics	8.537504037064991e-12	2.955949890219989e-11	0.018691588785046728	0.9605811478101344	1	2
gene expression	cytochromes c/genetics	8.537504037064991e-12	2.955949890219989e-11	0.018691588785046728	0.9605811478101344	1	2
gene expression	lipoproteins ldl/metabolism	8.537504037064991e-12	2.955949890219989e-11	0.018691588785046728	0.9605811478101344	1	2
gene expression	BAX	0.00046387553203119936	0.0009219803236476953	0.07319670689438858	0.9605811478101344	1	2
ATG7	a549 cells	0.0019314423590830465	0.0035842472126136698	0.08215010393874443	0.9605811478101344	1	2
ATG7	cisplatin/pharmacology	0.0018332059464012396	0.0034119976959526024	0.08215010393874443	0.9605811478101344	1	2
ATG7	drugs chinese herbal/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ATG7	imidazoles/pharmacology	5.394266039404627e-07	1.4151924992478965e-06	0.027905752270633143	0.9605811478101344	1	2
ATG7	BECN1	0.00018940888987306614	0.000391642802581015	0.06878335787959994	0.9605811478101344	1	2
ATG7	antimalarials/pharmacology	1.5950905596362475e-08	4.629269008669209e-08	0.027905752270633143	0.9605811478101344	1	2
ATG7	SQSTM1	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ATG7	autophagy	2.8135184382271916e-07	7.532781363209851e-07	0.027905752270633143	0.9605811478101344	1	2
ATG7	t-2 toxin/toxicity	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ATG7	neuroblastoma/drug therapy	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
ATG7	cell membrane permeability/drug effects	1.7954526754238032e-12	6.504459511624057e-12	0.014018691588785045	0.9605811478101344	1	2
ATG7	lysosomes/drug effects	0.0006366526207366441	0.0012478368727888284	0.06878335787959994	0.9605811478101344	1	2
ATG7	autophagy-related proteins/metabolism	1.7126907669862135e-09	5.295387187002109e-09	0.027905752270633143	0.9605811478101344	1	2
ATG7	chloroquine/pharmacology	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
ATG7	liver/drug effects	5.295763827461997e-13	1.979671089655512e-12	0.027905752270633143	0.9605811478101344	1	2
neutral ceramidase/antagonists & inhibitors	t-lymphocytes/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutral ceramidase/antagonists & inhibitors	heme oxygenase-1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutral ceramidase/antagonists & inhibitors	colonic neoplasms/drug therapy	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
neutral ceramidase/antagonists & inhibitors	ASAH2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutral ceramidase/antagonists & inhibitors	HMOX1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
AURKB	g2 phase cell cycle checkpoints/drug effects	4.0201775242110216e-10	1.2795853046600925e-09	0.014018691588785045	0.9605811478101344	1	2
AURKB	PRKAA2	8.329080758429086e-09	2.4662848853323194e-08	0.018691588785046728	0.9605811478101344	1	2
AURKB	k562 cells	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
AURKB	protein kinase inhibitors/pharmacology	0.0003294132314345388	0.0006636424457847873	0.04672897196261682	0.9605811478101344	1	2
AURKB	benzamides/pharmacology	1.2901231387640877e-06	3.299458875243082e-06	0.02336448598130841	0.9605811478101344	1	2
AURKB	leukemia/drug therapy	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
AURKB	RPL15	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
AURKB	ribosomal protein s6 kinases 70-kda/metabolism	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
AURKB	ribosomal proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
AURKB	aurora kinase b/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
AURKB	pyrazoles/pharmacology	7.66053886991358e-15	3.108771599555579e-14	0.009345794392523364	0.9605811478101344	1	2
stomach neoplasms/drug therapy	caspase 3/metabolism	9.940125707075254e-05	0.00021089289029021862	0.05541661182045544	0.9605811478101344	1	2
stomach neoplasms/drug therapy	nf-kappa b/metabolism	1.0834047752372733e-05	2.5471218260216894e-05	0.046290202272826986	0.9605811478101344	1	2
stomach neoplasms/drug therapy	NFKB1	0.00016138326171488693	0.0003365025680243831	0.0644991443991049	0.9605811478101344	1	2
stomach neoplasms/drug therapy	biological products/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stomach neoplasms/drug therapy	ribosomal protein s6 kinases 70-kda/metabolism	8.205436330399607e-12	2.8445512612051973e-11	0.018647711816067742	0.9605811478101344	1	2
heme oxygenase-1/metabolism	t-lymphocytes/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heme oxygenase-1/metabolism	colonic neoplasms/drug therapy	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
heme oxygenase-1/metabolism	ASAH2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heme oxygenase-1/metabolism	HMOX1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
BAK1	sulfonamides/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
BAK1	pyrimidines/pharmacology	1.0363931934875836e-12	3.832030375652229e-12	0.018691588785046728	0.9605811478101344	1	2
BAK1	u937 cells	8.21016588048451e-11	2.705391381451539e-10	0.018691588785046728	0.9605811478101344	1	2
BAK1	heterografts	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BAK1	BAX	1.1230016916385921e-11	3.875401674322692e-11	0.018691588785046728	0.9605811478101344	1	2
BAK1	CD34	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BAK1	PIK3CB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BAK1	bridged bicyclo compounds heterocyclic/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung neoplasms/genetics	osteosarcoma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung neoplasms/genetics	bone neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung neoplasms/genetics	CXCL8	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
lung neoplasms/genetics	CXCR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
colonic neoplasms/drug therapy	tumor-associated macrophages/drug effects	1.8864353412695323e-09	5.825227787718578e-09	0.027905752270633143	0.9605811478101344	1	2
colonic neoplasms/drug therapy	t-lymphocytes/immunology	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
colonic neoplasms/drug therapy	ASAH2	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
colonic neoplasms/drug therapy	HMOX1	3.6136885706028465e-09	1.0972952155991126e-08	0.027905752270633143	0.9605811478101344	1	2
colonic neoplasms/drug therapy	chemokine cxcl12/metabolism	8.033954999486781e-06	1.919720817477886e-05	0.04166180294604871	0.9605811478101344	1	2
colonic neoplasms/drug therapy	ht29 cells	1.5543122344752192e-15	6.525033538787059e-15	0.014018691588785045	0.9605811478101344	1	2
colonic neoplasms/drug therapy	epoxy compounds/pharmacology	1.5543122344752192e-15	6.525033538787059e-15	0.014018691588785045	0.9605811478101344	1	2
colonic neoplasms/drug therapy	a549 cells	0.0028821284122195756	0.005221459920510863	0.08215010393874443	0.9605811478101344	1	2
colonic neoplasms/drug therapy	hela cells	1.7848166501521767e-05	4.115419107148629e-05	0.04166180294604871	0.9605811478101344	1	2
colonic neoplasms/drug therapy	phenanthrenes/pharmacology	1.5543122344752192e-15	6.525033538787059e-15	0.014018691588785045	0.9605811478101344	1	2
colonic neoplasms/drug therapy	adenocarcinoma/drug therapy	5.133631229115032e-06	1.249986762446474e-05	0.027905752270633143	0.9605811478101344	1	2
colonic neoplasms/drug therapy	nf-kappa b/metabolism	0.0010225856949998002	0.0019572853028349334	0.06878335787959994	0.9605811478101344	1	2
colonic neoplasms/drug therapy	ARG1	5.289347437820169e-08	1.4914890946292245e-07	0.027905752270633143	0.9605811478101344	1	2
colonic neoplasms/drug therapy	CXCL12	0.0030235427645420865	0.005453458022956799	0.09538832359347407	0.9605811478101344	1	2
colonic neoplasms/drug therapy	DDX53	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
colonic neoplasms/drug therapy	MRC1	1.5543122344752192e-15	6.525033538787059e-15	0.014018691588785045	0.9605811478101344	1	2
colonic neoplasms/drug therapy	crotonates/pharmacology	1.972546570527811e-10	6.402282759752272e-10	0.014018691588785045	0.9605811478101344	1	2
colonic neoplasms/drug therapy	sesquiterpenes/pharmacology	1.972546570527811e-10	6.402282759752272e-10	0.014018691588785045	0.9605811478101344	1	2
BAX	endoplasmic reticulum/drug effects	0.00027829089907138727	0.0005660293120595892	0.055287464515536164	0.9605811478101344	1	2
BAX	sulfonamides/pharmacology	0.00018028690241811418	0.00037411441171901944	0.055287464515536164	0.9605811478101344	1	2
BAX	pyrimidines/pharmacology	0.0015286071798684686	0.002871249880877492	0.07319670689438858	0.9605811478101344	1	2
BAX	mesenchymal stem cells/cytology	1.8600621730646694e-06	4.686395930948444e-06	0.03711991575621956	0.9605811478101344	1	2
BAX	u937 cells	0.004048622789790457	0.007142837102448587	0.07319670689438858	0.9605811478101344	1	2
BAX	tor serine-threonine kinases/genetics	0.0025957143669796956	0.004727043062952699	0.07319670689438858	0.9605811478101344	1	2
BAX	heterografts	1.1230016916385921e-11	3.875401674322692e-11	0.018691588785046728	0.9605811478101344	1	2
BAX	hydrogen peroxide/toxicity	7.672186663754132e-09	2.2812727115637374e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	necrosis	1.2773637315999231e-05	2.9837181432688954e-05	0.03711991575621956	0.9605811478101344	1	2
BAX	hydrogen peroxide	1.594815390859594e-10	5.191567951819331e-10	0.018691588785046728	0.9605811478101344	1	2
BAX	microtubule-associated proteins/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	bcl-2-associated x protein/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	CAMK2A	1.594815390859594e-10	5.191567951819331e-10	0.018691588785046728	0.9605811478101344	1	2
BAX	CAMK2B	1.594815390859594e-10	5.191567951819331e-10	0.018691588785046728	0.9605811478101344	1	2
BAX	CASP12	1.594815390859594e-10	5.191567951819331e-10	0.018691588785046728	0.9605811478101344	1	2
BAX	CD34	1.1230016916385921e-11	3.875401674322692e-11	0.018691588785046728	0.9605811478101344	1	2
BAX	DNM1L	7.672186663754132e-09	2.2812727115637374e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	H2AX	7.672186663754132e-09	2.2812727115637374e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	MAPK14	5.284997854237972e-06	1.2864167883665136e-05	0.03711991575621956	0.9605811478101344	1	2
BAX	PIK3CB	1.1230016916385921e-11	3.875401674322692e-11	0.018691588785046728	0.9605811478101344	1	2
BAX	dynamins	7.672186663754132e-09	2.2812727115637374e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	lysosomes/drug effects	0.005621281807727696	0.009727495588790538	0.09085010295354308	0.9605811478101344	1	2
BAX	bridged bicyclo compounds heterocyclic/pharmacology	1.1230016916385921e-11	3.875401674322692e-11	0.018691588785046728	0.9605811478101344	1	2
BAX	ascorbic acid/analogs & derivatives	7.672186663754132e-09	2.2812727115637374e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	cytochromes c/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	golgi apparatus/drug effects	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	curcumin/analogs & derivatives	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	acetylcysteine/pharmacology	7.672186663754132e-09	2.2812727115637374e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	lipoproteins ldl/metabolism	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
BAX	astrocytes/drug effects	1.594815390859594e-10	5.191567951819331e-10	0.018691588785046728	0.9605811478101344	1	2
BAX	histones/metabolism	7.672186663754132e-09	2.2812727115637374e-08	0.018691588785046728	0.9605811478101344	1	2
breast neoplasms/therapy	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
breast neoplasms/therapy	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/therapy	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/therapy	hmgb1 protein/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/therapy	colorectal neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/therapy	KLK3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/therapy	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
breast neoplasms/therapy	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/therapy	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/therapy	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BCR	tumor cells cultured	0.0011396931311093983	0.0021729465716620556	0.08878504672897196	0.9605811478101344	1	2
BCR	enzyme inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
BCR	farnesyltranstransferase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BCR	cytostatic agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BCR	everolimus/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BCR	lymphoma non-hodgkin/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors chimeric antigen/immunology	hek293 cells	2.9976021664879227e-15	1.2339643869814361e-14	0.018691588785046728	0.9605811478101344	1	2
receptors chimeric antigen/immunology	interleukin-10/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors chimeric antigen/immunology	neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors chimeric antigen/immunology	recombinant fusion proteins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors chimeric antigen/immunology	mitochondrial membrane transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BECN1	PRKAA2	0.0019468556078824362	0.003611330341796395	0.09085010295354308	0.9605811478101344	1	2
BECN1	curcumin/pharmacology	3.769483192661571e-05	8.407644454405901e-05	0.06878335787959994	0.9605811478101344	1	2
BECN1	kidney tubules/cytology	2.6134649999676185e-13	9.870105570278529e-13	0.02336448598130841	0.9605811478101344	1	2
BECN1	ureteral obstruction/complications	2.6134649999676185e-13	9.870105570278529e-13	0.02336448598130841	0.9605811478101344	1	2
BECN1	carcinoma hepatocellular/pathology	8.205436330399607e-12	2.8445512612051973e-11	0.02336448598130841	0.9605811478101344	1	2
BECN1	granulosa cells/drug effects	1.6409096303959814e-12	5.956334463445933e-12	0.02336448598130841	0.9605811478101344	1	2
BECN1	t-2 toxin/toxicity	1.6409096303959814e-12	5.956334463445933e-12	0.02336448598130841	0.9605811478101344	1	2
BECN1	fibrosis	2.6134649999676185e-13	9.870105570278529e-13	0.02336448598130841	0.9605811478101344	1	2
BECN1	CASP9	0.00014289127574929061	0.00029941711154916927	0.018291269805799152	0.8657199677887635	2	2
BECN1	MAP1LC3A	2.6134649999676185e-13	9.870105570278529e-13	0.02336448598130841	0.9605811478101344	1	2
BECN1	kidney failure chronic/etiology	2.6134649999676185e-13	9.870105570278529e-13	0.02336448598130841	0.9605811478101344	1	2
BECN1	berberine/analogs & derivatives	8.205436330399607e-12	2.8445512612051973e-11	0.02336448598130841	0.9605811478101344	1	2
BECN1	zearalenone/toxicity	1.6409096303959814e-12	5.956334463445933e-12	0.02336448598130841	0.9605811478101344	1	2
BECN1	nlr family pyrin domain-containing 3 protein/antagonists & inhibitors	2.6134649999676185e-13	9.870105570278529e-13	0.02336448598130841	0.9605811478101344	1	2
BECN1	lysosomes/drug effects	0.005290705352827385	0.009188615330377172	0.11249652907369678	0.9605811478101344	1	2
BECN1	autophagy-related proteins/metabolism	0.0	0.0	0.00043876968978982925	0.8657199677887635	2	2
BECN1	inflammasomes/antagonists & inhibitors	2.6134649999676185e-13	9.870105570278529e-13	0.02336448598130841	0.9605811478101344	1	2
BECN1	phenylpropionates/pharmacology	8.205436330399607e-12	2.8445512612051973e-11	0.02336448598130841	0.9605811478101344	1	2
BECN1	liver/drug effects	2.625674566658631e-09	8.053822043084238e-09	0.046290202272826986	0.9605811478101344	1	2
growth inhibitors/pharmacology	cell differentiation/drug effects	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
growth inhibitors/pharmacology	CD4	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
growth inhibitors/pharmacology	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
growth inhibitors/pharmacology	dose-response relationship immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
growth inhibitors/pharmacology	th2 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
growth inhibitors/pharmacology	l-selectin/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
growth inhibitors/pharmacology	interferon-gamma/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
growth inhibitors/pharmacology	th1 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
growth inhibitors/pharmacology	SELP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
growth inhibitors/pharmacology	calcitriol/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
growth inhibitors/pharmacology	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
energy metabolism	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.17857926374446048	0.9605811478101344	1	2
energy metabolism	neoplasm invasiveness	3.983310559174669e-08	1.1307329883955594e-07	0.05541661182045544	0.9605811478101344	1	2
energy metabolism	phosphoinositide-3 kinase inhibitors	0.0005733062746914319	0.0011294010672262948	0.13557983414505725	0.9605811478101344	1	2
energy metabolism	biological transport	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
energy metabolism	dna/biosynthesis	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
energy metabolism	enterocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
BIRC3	oligopeptides/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
BIRC3	autocrine communication/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BIRC3	necrosis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
BIRC3	dna fragmentation/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
BIRC3	paracrine communication/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BIRC3	MLKL	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BIRC3	tumor necrosis factor-alpha/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
BIRC3	caspases/metabolism	6.6658620179183e-07	1.7392772280599136e-06	0.03271028037383177	0.9605811478101344	1	2
BIRC3	decitabine	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BIRC3	leukemia myeloid acute/enzymology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna messenger/genetics	nf-kappa b	7.831947423930785e-09	2.323762303900228e-08	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	glioblastoma/drug therapy	3.966149089940085e-05	8.832894458080707e-05	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	neovascularization pathologic/drug therapy	0.0005333895384945775	0.0010546294094456502	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	tamoxifen/pharmacology	1.0143579034505024e-05	2.3965455481436644e-05	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	nf-kappa b/genetics	0.00014371247547995125	0.0003010520341455549	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	brain neoplasms/drug therapy	3.966149089940085e-05	8.832894458080707e-05	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	chemokine ccl2/genetics	2.1887613277371543e-08	6.309035135828053e-08	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	sulfonamides/pharmacology	0.0015550934203546474	0.0029180169984663203	0.08215010393874443	0.9605811478101344	1	2
rna messenger/genetics	paracrine communication	2.1887613277371543e-08	6.309035135828053e-08	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	receptors interleukin-8a/antagonists & inhibitors	7.831947423930785e-09	2.323762303900228e-08	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	oligopeptides/pharmacology	6.947266550938469e-05	0.00015113303691671571	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	apoptosis regulatory proteins	2.1887613277371543e-08	6.309035135828053e-08	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	receptors interleukin-8b/antagonists & inhibitors	7.831947423930785e-09	2.323762303900228e-08	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	selective estrogen receptor modulators/pharmacology	1.0143579034505024e-05	2.3965455481436644e-05	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	tumor cells cultured	0.0014100583787457488	0.002657630974062769	0.010095152473770635	0.7135314763244264	3	2
rna messenger/genetics	CXCL1	1.0143579034505024e-05	2.3965455481436644e-05	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	CXCR1	2.9160164422004087e-05	6.588679085635848e-05	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	CXCR2	7.831947423930785e-09	2.323762303900228e-08	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	PCNA	6.947266550938469e-05	0.00015113303691671571	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	XIAP	0.004375835768332781	0.007678346758472037	0.08215010393874443	0.9605811478101344	1	2
rna messenger/genetics	flavonoids/metabolism	1.0143579034505024e-05	2.3965455481436644e-05	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	spleen/drug effects	1.4096945832875463e-10	4.6004952889762907e-10	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	multiple myeloma/metabolism	1.0143579034505024e-05	2.3965455481436644e-05	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	hydroxamic acids/pharmacology	2.4484432259441746e-09	7.522753100002392e-09	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	berberine/pharmacology	8.97557839122376e-05	0.00019155314332562333	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	caspases/metabolism	0.0003372321920995791	0.0006778462367956531	0.012970382291718041	0.8657199677887635	2	2
rna messenger/genetics	breast neoplasms/genetics	2.4484432259441746e-09	7.522753100002392e-09	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	histone deacetylases/metabolism	2.4484432259441746e-09	7.522753100002392e-09	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	cell nucleus/drug effects	5.465211916355628e-08	1.5393075157359337e-07	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	endoplasmic reticulum/metabolism	2.4484432259441746e-09	7.522753100002392e-09	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	antioxidants/metabolism	2.9160164422004087e-05	6.588679085635848e-05	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	benzofurans/pharmacology	2.4484432259441746e-09	7.522753100002392e-09	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	poly (adp-ribose) polymerase-1	1.0143579034505024e-05	2.3965455481436644e-05	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	neoplasm proteins/genetics	1.4096945832875463e-10	4.6004952889762907e-10	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	leukemia/metabolism	1.0143579034505024e-05	2.3965455481436644e-05	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	receptors estrogen/antagonists & inhibitors	0.00014371247547995125	0.0003010520341455549	0.05541661182045544	0.9605811478101344	1	2
rna messenger/genetics	thymus gland/drug effects	1.4096945832875463e-10	4.6004952889762907e-10	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	TNFRSF10D	1.0143579034505024e-05	2.3965455481436644e-05	0.02803738317757009	0.9605811478101344	1	2
rna messenger/genetics	biomarkers tumor/genetics	2.1887613277371543e-08	6.309035135828053e-08	0.02803738317757009	0.9605811478101344	1	2
th2 cells/metabolism	cell differentiation/drug effects	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
th2 cells/metabolism	CD4	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
th2 cells/metabolism	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
th2 cells/metabolism	dose-response relationship immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th2 cells/metabolism	l-selectin/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th2 cells/metabolism	interferon-gamma/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th2 cells/metabolism	th1 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th2 cells/metabolism	SELP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th2 cells/metabolism	calcitriol/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th2 cells/metabolism	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ASAH2	t-lymphocytes/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ASAH2	HMOX1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CALD1	antioxidants/pharmacology	1.2850165376221412e-11	4.427573780511481e-11	0.014018691588785045	0.9605811478101344	1	2
CALD1	endoplasmic reticulum/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
CALD1	gene expression regulation	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
CALD1	SPP1	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
CALD1	tor serine-threonine kinases/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
CALD1	phenylbutyrates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALD1	muscle smooth vascular/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALD1	eukaryotic initiation factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALD1	myocytes smooth muscle/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CALD1	cerebral arteries/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALD1	organophosphorus compounds/pharmacology	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
CALD1	transcription factor chop/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALD1	taurochenodeoxycholic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALD1	HSPA5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALD1	activating transcription factor 4/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CALD1	piperidines/pharmacology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
CALD1	phosphatidylinositol 3-kinases/genetics	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
lactic acid/metabolism	interleukin-10/metabolism	1.6715591133475982e-09	5.170389356213223e-09	0.018647711816067742	0.9605811478101344	1	2
lactic acid/metabolism	gene expression regulation	2.2290638779232097e-08	6.42184769116045e-08	0.018647711816067742	0.9605811478101344	1	2
lactic acid/metabolism	interleukin-6/metabolism	6.72537915212823e-05	0.0001464216051605838	0.046290202272826986	0.9605811478101344	1	2
lactic acid/metabolism	aspirin/administration & dosage	7.66053886991358e-15	3.108771599555579e-14	0.009345794392523364	0.9605811478101344	1	2
lactic acid/metabolism	cyclin b1/metabolism	7.66053886991358e-15	3.108771599555579e-14	0.009345794392523364	0.9605811478101344	1	2
lactic acid/metabolism	HIF1A	1.6093241747561216e-05	3.72127733665684e-05	0.03711991575621956	0.9605811478101344	1	2
lactic acid/metabolism	lymphoma t-cell/drug therapy	7.66053886991358e-15	3.108771599555579e-14	0.009345794392523364	0.9605811478101344	1	2
lactic acid/metabolism	cisplatin/pharmacology	0.00040960392364053355	0.0008169845583885004	0.05541661182045544	0.9605811478101344	1	2
lactic acid/metabolism	glucose/metabolism	0.0	0.0	0.00026326181387389757	0.8657199677887635	2	2
lactic acid/metabolism	interleukin-4/metabolism	7.66053886991358e-15	3.108771599555579e-14	0.009345794392523364	0.9605811478101344	1	2
lactic acid/metabolism	nitric oxide/metabolism	1.0194388222473094e-08	3.0048913306027646e-08	0.018647711816067742	0.9605811478101344	1	2
lactic acid/metabolism	killer cells natural/drug effects	1.8017198843978122e-10	5.858180211060752e-10	0.018647711816067742	0.9605811478101344	1	2
lactic acid/metabolism	adenosine triphosphate/metabolism	1.3988681101473333e-05	3.252029111401139e-05	0.05541661182045544	0.9605811478101344	1	2
lactic acid/metabolism	transforming growth factor beta/metabolism	4.371674359981981e-05	9.688076820673707e-05	0.03711991575621956	0.9605811478101344	1	2
lactic acid/metabolism	BIRC5	6.528633417213214e-06	1.577979714785321e-05	0.027905752270633143	0.9605811478101344	1	2
lactic acid/metabolism	SOCS5	7.66053886991358e-15	3.108771599555579e-14	0.009345794392523364	0.9605811478101344	1	2
lactic acid/metabolism	membrane proteins/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lactic acid/metabolism	carrier proteins/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lactic acid/metabolism	cytokines/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lactic acid/metabolism	IL2	5.5302820489711024e-06	1.3424161468205975e-05	0.03711991575621956	0.9605811478101344	1	2
lactic acid/metabolism	PKM	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/antagonists & inhibitors	sulfonamides/pharmacology	1.765254609153999e-14	7.017730548616547e-14	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/antagonists & inhibitors	rna small interfering/genetics	1.765254609153999e-14	7.017730548616547e-14	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/antagonists & inhibitors	curcumin/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/antagonists & inhibitors	cyclophilin d	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/antagonists & inhibitors	membrane potential mitochondrial/drug effects	0.005711427168056726	0.009871867842686947	0.09813084112149532	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/antagonists & inhibitors	biphenyl compounds/pharmacology	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/antagonists & inhibitors	nitrophenols/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/antagonists & inhibitors	cell death/drug effects	2.415650552922699e-07	6.492778665224878e-07	0.02803738317757009	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	hek293 cells	1.5877318771839732e-05	3.671734049522996e-05	0.055287464515536164	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	caspase 3/metabolism	0.0018743562747002285	0.003481533879072505	0.08215010393874443	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	BCL2	0.0002633655943911073	0.000536959924647229	0.003079666501921066	0.7135314763244264	3	2
proto-oncogene proteins c-bcl-2/metabolism	flavonoids/pharmacology	8.261783901453157e-08	2.3002375484182245e-07	0.027905752270633143	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	neuroprotective agents/pharmacology	1.8864353412695323e-09	5.825227787718578e-09	0.027905752270633143	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	rac1 gtp-binding protein/antagonists & inhibitors	8.881784197001252e-16	3.739270154200565e-15	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	neurons/drug effects	2.3834664919508697e-07	6.414093642686778e-07	0.04166180294604871	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	rna small interfering/administration & dosage	8.881784197001252e-16	3.739270154200565e-15	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	caspases/metabolism	0.005726533008403978	0.009895532200429	0.09538832359347407	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	neoplasm invasiveness/pathology	8.881784197001252e-16	3.739270154200565e-15	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	pc12 cells	5.719856255304023e-09	1.722362615637027e-08	0.027905752270633143	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	kidney neoplasms/drug therapy	8.881784197001252e-16	3.739270154200565e-15	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	OGG1	8.881784197001252e-16	3.739270154200565e-15	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	POLG	8.881784197001252e-16	3.739270154200565e-15	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/metabolism	RAC1	8.881784197001252e-16	3.739270154200565e-15	0.014018691588785045	0.9605811478101344	1	2
CAMK2A	hydrogen peroxide	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CAMK2A	CAMK2B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CAMK2A	CASP12	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CAMK2A	CASP9	3.301742878480951e-05	7.438114538137121e-05	0.04672897196261682	0.9605811478101344	1	2
CAMK2A	MAPK14	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CAMK2A	MAPK3	1.3036816781664129e-06	3.327572776130247e-06	0.037383177570093455	0.9605811478101344	1	2
CAMK2A	astrocytes/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
u937 cells	valproic acid/pharmacology	2.625674566658631e-09	8.053822043084238e-09	0.018691588785046728	0.9605811478101344	1	2
u937 cells	chemokine ccl5/metabolism	2.625674566658631e-09	8.053822043084238e-09	0.018691588785046728	0.9605811478101344	1	2
u937 cells	butyrates/pharmacology	2.625674566658631e-09	8.053822043084238e-09	0.018691588785046728	0.9605811478101344	1	2
u937 cells	interleukin-8/biosynthesis	3.2974283636910684e-08	9.399056310621935e-08	0.018691588785046728	0.9605811478101344	1	2
u937 cells	gene expression/drug effects	1.4425799443884557e-09	4.474047350383552e-09	0.001559737378978988	0.8657199677887635	2	2
u937 cells	heterocyclic compounds 4 or more rings/pharmacology	3.0223626583447682e-05	6.825468799670742e-05	0.03711991575621956	0.9605811478101344	1	2
u937 cells	antineoplastic agents alkylating/pharmacology	3.2974283636910684e-08	9.399056310621935e-08	0.018691588785046728	0.9605811478101344	1	2
u937 cells	sulfonamides/pharmacology	0.00034595022541650255	0.0006940409981786213	0.055287464515536164	0.9605811478101344	1	2
u937 cells	leukocytes mononuclear/drug effects	2.625674566658631e-09	8.053822043084238e-09	0.018691588785046728	0.9605811478101344	1	2
u937 cells	ovarian neoplasms/drug therapy	0.00011081017083902633	0.0002340847606265069	0.03711991575621956	0.9605811478101344	1	2
u937 cells	fibrosarcoma/drug therapy	3.2974283636910684e-08	9.399056310621935e-08	0.018691588785046728	0.9605811478101344	1	2
u937 cells	rho gtp-binding proteins/genetics	3.2974283636910684e-08	9.399056310621935e-08	0.018691588785046728	0.9605811478101344	1	2
u937 cells	neovascularization pathologic/prevention & control	3.2974283636910684e-08	9.399056310621935e-08	0.018691588785046728	0.9605811478101344	1	2
u937 cells	leukemia/drug therapy	7.481000818587713e-05	0.00016173868018064513	0.03711991575621956	0.9605811478101344	1	2
u937 cells	vascular endothelial growth factor a/biosynthesis	3.2974283636910684e-08	9.399056310621935e-08	0.018691588785046728	0.9605811478101344	1	2
u937 cells	caspase 8/metabolism	0.0005161304311359638	0.0010208705253149483	0.03711991575621956	0.9605811478101344	1	2
u937 cells	p38 mitogen-activated protein kinases/metabolism	6.061463760187458e-05	0.0001323068537616207	0.03711991575621956	0.9605811478101344	1	2
u937 cells	cell adhesion/drug effects	0.0028821284122195756	0.005221459920510863	0.07319670689438858	0.9605811478101344	1	2
u937 cells	chemokine ccl2/biosynthesis	3.2974283636910684e-08	9.399056310621935e-08	0.018691588785046728	0.9605811478101344	1	2
u937 cells	pyrimidines/pharmacology	0.0024832858160589444	0.004532407754343345	0.07319670689438858	0.9605811478101344	1	2
u937 cells	trabectedin	3.2974283636910684e-08	9.399056310621935e-08	0.018691588785046728	0.9605811478101344	1	2
u937 cells	BIRC5	0.0019545923744020977	0.003623547689465858	0.055287464515536164	0.9605811478101344	1	2
u937 cells	BRCA1	3.2974283636910684e-08	9.399056310621935e-08	0.018691588785046728	0.9605811478101344	1	2
u937 cells	CASP8	0.00011436723505708901	0.00024120612191875823	0.00535588186581037	0.8657199677887635	2	2
u937 cells	CCL2	5.4981036390344684e-09	1.656493427622738e-08	0.001559737378978988	0.8657199677887635	2	2
u937 cells	CCL5	0.0012483255684894168	0.002368595708610556	0.055287464515536164	0.9605811478101344	1	2
u937 cells	XIAP	0.0012483255684894168	0.002368595708610556	0.055287464515536164	0.9605811478101344	1	2
u937 cells	flavonoids/metabolism	6.51304561172239e-07	1.7006114358983332e-06	0.018691588785046728	0.9605811478101344	1	2
u937 cells	multiple myeloma/metabolism	6.51304561172239e-07	1.7006114358983332e-06	0.018691588785046728	0.9605811478101344	1	2
u937 cells	heterografts	8.21016588048451e-11	2.705391381451539e-10	0.018691588785046728	0.9605811478101344	1	2
u937 cells	bridged bicyclo compounds heterocyclic/pharmacology	8.21016588048451e-11	2.705391381451539e-10	0.018691588785046728	0.9605811478101344	1	2
u937 cells	poly (adp-ribose) polymerase-1	6.51304561172239e-07	1.7006114358983332e-06	0.018691588785046728	0.9605811478101344	1	2
u937 cells	leukemia/metabolism	6.51304561172239e-07	1.7006114358983332e-06	0.018691588785046728	0.9605811478101344	1	2
u937 cells	CD34	8.21016588048451e-11	2.705391381451539e-10	0.018691588785046728	0.9605811478101344	1	2
u937 cells	PIK3CB	8.21016588048451e-11	2.705391381451539e-10	0.018691588785046728	0.9605811478101344	1	2
u937 cells	TNFRSF10D	6.51304561172239e-07	1.7006114358983332e-06	0.018691588785046728	0.9605811478101344	1	2
cytochromes c/metabolism	mesenchymal stem cells/cytology	0.0015056804766054865	0.0028289086619682803	0.08253257864946689	0.9605811478101344	1	2
cytochromes c/metabolism	caspase 3/metabolism	0.0019232779664449806	0.0035696971634126555	0.021673232895463388	0.8657199677887635	2	2
cytochromes c/metabolism	MCL1	4.0233630349550964e-05	8.933243524137962e-05	0.0009776378691598736	0.7135314763244264	3	2
cytochromes c/metabolism	p38 mitogen-activated protein kinases/metabolism	0.005465546182889414	0.009469146804993384	0.08253257864946689	0.9605811478101344	1	2
cytochromes c/metabolism	flavonoids/pharmacology	0.0048682339326305835	0.008502441519854175	0.08253257864946689	0.9605811478101344	1	2
cytochromes c/metabolism	morpholines/pharmacology	1.6173528189167286e-05	3.739057874748457e-05	0.004634401364987668	0.8657199677887635	2	2
cytochromes c/metabolism	multiple myeloma/pathology	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	monoterpenes/pharmacology	6.632486448943098e-09	1.9812093378444308e-08	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	cell death/drug effects	0.0016165391603716328	0.0030271322751718836	0.021673232895463388	0.8657199677887635	2	2
cytochromes c/metabolism	berberine/pharmacology	0.0021217393206759416	0.00391399837200997	0.08253257864946689	0.9605811478101344	1	2
cytochromes c/metabolism	aminopyridines/pharmacology	0.0015056804766054865	0.0028289086619682803	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	hydrogen peroxide/toxicity	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	poly(adp-ribose) polymerases/metabolism	0.0015056804766054865	0.0028289086619682803	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	enzyme inhibitors/pharmacology	0.0033192745475103536	0.0059585869747197755	0.08253257864946689	0.9605811478101344	1	2
cytochromes c/metabolism	endometrial neoplasms/drug therapy	1.0428744410262425e-06	2.682372337347946e-06	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	dna fragmentation/drug effects	0.0033192745475103536	0.0059585869747197755	0.1214816672917065	0.9605811478101344	1	2
cytochromes c/metabolism	necrosis	0.003795571073938131	0.006728692694233973	0.08253257864946689	0.9605811478101344	1	2
cytochromes c/metabolism	piperazines/toxicity	0.0015056804766054865	0.0028289086619682803	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	nitrophenols/toxicity	0.0015056804766054865	0.0028289086619682803	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	carrier proteins/metabolism	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	amyloid beta-peptides/pharmacology	6.632486448943098e-09	1.9812093378444308e-08	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	flavonoids/metabolism	0.0005161304311359638	0.0010208705253149483	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	antineoplastic agents phytogenic/administration & dosage	1.0428744410262425e-06	2.682372337347946e-06	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	glioblastoma/enzymology	0.0015056804766054865	0.0028289086619682803	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	jnk mitogen-activated protein kinases/metabolism	0.0021217393206759416	0.00391399837200997	0.08253257864946689	0.9605811478101344	1	2
cytochromes c/metabolism	tert-butylhydroperoxide/toxicity	5.133631229115032e-06	1.249986762446474e-05	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	multiple myeloma/metabolism	0.0005161304311359638	0.0010208705253149483	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	dynamins	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	protein transport	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	head and neck neoplasms/drug therapy	1.2593558440521235e-07	3.465586326717576e-07	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	free radicals/metabolism	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	ascorbic acid/analogs & derivatives	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	g1 phase cell cycle checkpoints/drug effects	0.0015056804766054865	0.0028289086619682803	0.08253257864946689	0.9605811478101344	1	2
cytochromes c/metabolism	mitochondrial proteins/genetics	1.2593558440521235e-07	3.465586326717576e-07	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	chromones/pharmacology	5.133631229115032e-06	1.249986762446474e-05	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	cyclin-dependent kinases/antagonists & inhibitors	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	acetylcysteine/pharmacology	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	poly (adp-ribose) polymerase-1	0.0005161304311359638	0.0010208705253149483	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	deoxycytidine/analogs & derivatives	1.2593558440521235e-07	3.465586326717576e-07	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	saponins/administration & dosage	1.0428744410262425e-06	2.682372337347946e-06	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	pc12 cells	0.0021217393206759416	0.00391399837200997	0.08253257864946689	0.9605811478101344	1	2
cytochromes c/metabolism	sulfonamides/toxicity	0.0015056804766054865	0.0028289086619682803	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	isocoumarins	3.925533308413165e-07	1.0381451167553493e-06	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	nitriles/metabolism	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	leukemia/metabolism	0.0005161304311359638	0.0010208705253149483	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	resting phase cell cycle/drug effects	1.0428744410262425e-06	2.682372337347946e-06	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	histones/metabolism	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	DNM1L	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	H2AX	0.00011081017083902633	0.0002340847606265069	0.04205607476635514	0.9605811478101344	1	2
cytochromes c/metabolism	TNFRSF10D	0.0005161304311359638	0.0010208705253149483	0.04205607476635514	0.9605811478101344	1	2
CAMK2B	hydrogen peroxide	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CAMK2B	CASP12	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CAMK2B	CASP9	3.301742878480951e-05	7.438114538137121e-05	0.04672897196261682	0.9605811478101344	1	2
CAMK2B	MAPK14	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CAMK2B	MAPK3	1.3036816781664129e-06	3.327572776130247e-06	0.037383177570093455	0.9605811478101344	1	2
CAMK2B	astrocytes/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BTRC	iron/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BTRC	nf-e2-related factor 2/genetics	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
BTRC	cd8-positive t-lymphocytes/immunology	1.36867830402565e-08	3.990032956122905e-08	0.02336448598130841	0.9605811478101344	1	2
BTRC	lung neoplasms/drug therapy	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
BTRC	allografts	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BTRC	CTLA4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BTRC	GABPA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BTRC	GSK3B	1.930989817899853e-05	4.4348399484433295e-05	0.02803738317757009	0.9605811478101344	1	2
BTRC	NFE2L2	1.08218036753982e-08	3.1758169497561496e-08	0.018691588785046728	0.9605811478101344	1	2
BTRC	PRKAA2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
osteosarcoma/genetics	bone neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteosarcoma/genetics	CXCL8	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
osteosarcoma/genetics	CXCR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sulfonamides/pharmacology	nf-kappa b	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
sulfonamides/pharmacology	neovascularization pathologic/drug therapy	4.1519241933407613e-07	1.0959131403660614e-06	0.027905752270633143	0.9605811478101344	1	2
sulfonamides/pharmacology	receptors interleukin-8a/antagonists & inhibitors	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
sulfonamides/pharmacology	rna small interfering/genetics	3.5320302295138717e-06	8.719538965437448e-06	0.04166180294604871	0.9605811478101344	1	2
sulfonamides/pharmacology	receptors interleukin-8b/antagonists & inhibitors	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
sulfonamides/pharmacology	cell adhesion/drug effects	0.00010498705913697393	0.00022242285767771705	0.055287464515536164	0.9605811478101344	1	2
sulfonamides/pharmacology	pyrimidines/pharmacology	8.28094089788678e-05	0.0001775361580285956	0.055287464515536164	0.9605811478101344	1	2
sulfonamides/pharmacology	curcumin/pharmacology	4.1519241933407613e-07	1.0959131403660614e-06	0.04166180294604871	0.9605811478101344	1	2
sulfonamides/pharmacology	CXCL1	1.387981951594952e-10	4.531649055051903e-10	0.027905752270633143	0.9605811478101344	1	2
sulfonamides/pharmacology	CXCR1	1.181569286856643e-09	3.6847580815580287e-09	0.027905752270633143	0.9605811478101344	1	2
sulfonamides/pharmacology	CXCR2	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
sulfonamides/pharmacology	cyclophilin d	6.844090960633764e-09	2.0416522459755544e-08	0.027905752270633143	0.9605811478101344	1	2
sulfonamides/pharmacology	heterografts	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
sulfonamides/pharmacology	biphenyl compounds/pharmacology	1.009497924253644e-06	2.5989502842064855e-06	0.027905752270633143	0.9605811478101344	1	2
sulfonamides/pharmacology	bridged bicyclo compounds heterocyclic/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
sulfonamides/pharmacology	nitrophenols/pharmacology	1.765254609153999e-14	7.017730548616547e-14	0.014018691588785045	0.9605811478101344	1	2
sulfonamides/pharmacology	cell death/drug effects	0.0020191900150675623	0.003734823947333021	0.08215010393874443	0.9605811478101344	1	2
sulfonamides/pharmacology	CD34	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
sulfonamides/pharmacology	PIK3CB	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
ovarian neoplasms/metabolism	cell cycle checkpoints/drug effects	4.712144485718994e-08	1.3323077920124696e-07	0.02803738317757009	0.9605811478101344	1	2
ovarian neoplasms/metabolism	epithelial-mesenchymal transition/drug effects	3.930189507173054e-13	1.4767010609091941e-12	0.014018691588785045	0.9605811478101344	1	2
ovarian neoplasms/metabolism	phenotype	1.9317880628477724e-14	7.674245623363548e-14	0.014018691588785045	0.9605811478101344	1	2
ovarian neoplasms/metabolism	protein kinase inhibitors/pharmacology	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
ovarian neoplasms/metabolism	benzamides/pharmacology	4.051452284770107e-08	1.1493363352368931e-07	0.02336448598130841	0.9605811478101344	1	2
ovarian neoplasms/metabolism	pyrazoles/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CASP12	hydrogen peroxide	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CASP12	CASP9	3.301742878480951e-05	7.438114538137121e-05	0.04672897196261682	0.9605811478101344	1	2
CASP12	MAPK14	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CASP12	MAPK3	1.3036816781664129e-06	3.327572776130247e-06	0.037383177570093455	0.9605811478101344	1	2
CASP12	astrocytes/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	tumor necrosis factor-alpha/metabolism	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	antibodies monoclonal/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	cell division/drug effects	3.9129477436006255e-11	1.324622629370591e-10	0.018691588785046728	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	mercaptoethanol/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	interleukins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	cd3 complex/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	CD28	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	CD3E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	IL2	5.513522971511975e-11	1.8460463853590893e-10	0.018691588785046728	0.9605811478101344	1	2
buthionine sulfoximine/pharmacology	IL5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	endoplasmic reticulum/drug effects	1.8751715004095004e-06	4.721520279490997e-06	0.004634401364987668	0.8657199677887635	2	2
phosphatidylinositol 3-kinases/genetics	proto-oncogene proteins c-bcl-2/genetics	0.002191953486788578	0.00403205326853951	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	antineoplastic agents phytogenic/pharmacology	0.0018879748692423037	0.0035062390428785644	0.021673232895463388	0.8657199677887635	2	2
phosphatidylinositol 3-kinases/genetics	bone neoplasms/drug therapy	0.0008584193001509588	0.0016597762632402297	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	muscle proteins/biosynthesis	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	SPP1	0.004437286496230319	0.0077830781757268165	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	receptors tumor necrosis factor type i/genetics	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	tor serine-threonine kinases/genetics	9.992007221626409e-16	4.201063600732629e-15	1.4830988352012471e-06	0.5304112294886878	4	2
phosphatidylinositol 3-kinases/genetics	ZHX2	6.546840567456247e-05	0.00014276010368042264	0.009064629456995965	0.8657199677887635	2	2
phosphatidylinositol 3-kinases/genetics	antioxidants/metabolism	0.0010606568425614027	0.002026812451446854	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	mitochondria muscle/drug effects	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	carboxy-lyases/genetics	1.0561129245467704e-05	2.48879625485327e-05	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	phenylbutyrates/pharmacology	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	oxidoreductases/metabolism	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	berberine/pharmacology	0.002191953486788578	0.00403205326853951	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	endometrial neoplasms/drug therapy	1.1243992147358384e-06	2.886337627953867e-06	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	sesquiterpenes guaiane	1.0561129245467704e-05	2.48879625485327e-05	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	eukaryotic initiation factor-2/genetics	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	myocytes smooth muscle/cytology	0.0015584255859585339	0.002923025718350808	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	cerebral arteries/cytology	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	cell nucleus/drug effects	1.8935762520433386e-05	4.35526488681948e-05	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	carcinoma squamous cell/drug therapy	1.0561129245467704e-05	2.48879625485327e-05	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	transcription factor chop/genetics	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	taurochenodeoxycholic acid/pharmacology	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	mouth neoplasms/drug therapy	1.0561129245467704e-05	2.48879625485327e-05	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	activating transcription factor 4/genetics	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	mitochondrial dynamics/physiology	1.0561129245467704e-05	2.48879625485327e-05	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	tumor necrosis factor-alpha/pharmacology	0.0034207849472507323	0.006123860548634634	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	saponins/administration & dosage	1.1243992147358384e-06	2.886337627953867e-06	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	antineoplastic agents phytogenic/administration & dosage	1.1243992147358384e-06	2.886337627953867e-06	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	mitogen-activated protein kinases/genetics	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	cell transformation neoplastic/drug effects	0.002972546785324326	0.005366746767346113	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	microtubule-associated proteins/genetics	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	muscle fibers skeletal/drug effects	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	muscle smooth vascular/cytology	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	g1 phase cell cycle checkpoints/drug effects	0.0015584255859585339	0.002923025718350808	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	pentacyclic triterpenes	0.0015584255859585339	0.002923025718350808	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	bcl-2-associated x protein/genetics	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	immunosuppressive agents/pharmacology	1.0561129245467704e-05	2.48879625485327e-05	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	cytochromes c/genetics	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	resting phase cell cycle/drug effects	1.1243992147358384e-06	2.886337627953867e-06	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	lipoproteins ldl/metabolism	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	oncogene protein v-akt/metabolism	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	EIF4E	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	EIF4EBP1	0.0034207849472507323	0.006123860548634634	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	HSPA5	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	RPS6KB1	0.0034207849472507323	0.006123860548634634	0.08253257864946689	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	RPS6KB2	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	TNFRSF1A	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	golgi apparatus/drug effects	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/genetics	curcumin/analogs & derivatives	7.873118414569724e-05	0.00016955119633173794	0.04205607476635514	0.9605811478101344	1	2
CASP9	CASP8	0.00017247763779770775	0.0003580778680003635	0.0023570206333426743	0.7135314763244264	3	2
CASP9	BCL2	9.302275846478913e-05	0.00019831423115757791	7.816078801616797e-05	0.11552077256850565	7	2
CASP9	crotonates/pharmacology	0.00047037084873946533	0.0009341322710329429	0.04672897196261682	0.9605811478101344	1	2
CASP9	plant roots	0.00047037084873946533	0.0009341322710329429	0.04672897196261682	0.9605811478101344	1	2
CASP9	1-phosphatidylinositol 4-kinase/metabolism	0.00047037084873946533	0.0009341322710329429	0.04672897196261682	0.9605811478101344	1	2
CASP9	dna/metabolism	0.00047037084873946533	0.0009341322710329429	0.04672897196261682	0.9605811478101344	1	2
CASP9	urinary bladder neoplasms/metabolism	8.480781446751351e-05	0.00018167923565679537	0.04672897196261682	0.9605811478101344	1	2
CASP9	cell cycle proteins/drug effects	1.0218480160695265e-05	2.4106254074792336e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	g2 phase/drug effects	1.0218480160695265e-05	2.4106254074792336e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	granulosa cells/drug effects	5.069863970974531e-06	1.2393875244710773e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	hydrogen peroxide	3.301742878480951e-05	7.438114538137121e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	membrane potential mitochondrial/drug effects	0.003652789225457198	0.00650591884934152	0.009889961230635923	0.5304112294886878	4	2
CASP9	receptors death domain/drug effects	1.0218480160695265e-05	2.4106254074792336e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	anticarcinogenic agents/isolation & purification	1.0218480160695265e-05	2.4106254074792336e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	zearalenone/toxicity	5.069863970974531e-06	1.2393875244710773e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	isocoumarins	9.097026248960915e-07	2.3510870324357085e-06	0.04672897196261682	0.9605811478101344	1	2
CASP9	sesquiterpenes/pharmacology	0.00047037084873946533	0.0009341322710329429	0.04672897196261682	0.9605811478101344	1	2
CASP9	CCL22	0.00047037084873946533	0.0009341322710329429	0.09148348032117941	0.9605811478101344	1	2
CASP9	MAPK14	0.0034541165284649455	0.006176008532932862	0.09148348032117941	0.9605811478101344	1	2
CASP9	PTEN	0.002293179610604379	0.004211229723022268	0.018291269805799152	0.8657199677887635	2	2
CASP9	TNS1	0.00047037084873946533	0.0009341322710329429	0.04672897196261682	0.9605811478101344	1	2
CASP9	antineoplastic agents phytogenic/chemistry	1.899771066815603e-05	4.366324661852436e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	chondrosarcoma/drug therapy	1.899771066815603e-05	4.366324661852436e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	autophagy-related proteins/metabolism	0.0014959255805809812	0.0028141780887926174	0.09148348032117941	0.9605811478101344	1	2
CASP9	genes cdc/drug effects	1.0218480160695265e-05	2.4106254074792336e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	plant extracts/pharmacology	0.00047037084873946533	0.0009341322710329429	0.04672897196261682	0.9605811478101344	1	2
CASP9	diosgenin/analogs & derivatives	1.0218480160695265e-05	2.4106254074792336e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	phenylpropionates/pharmacology	1.0218480160695265e-05	2.4106254074792336e-05	0.04672897196261682	0.9605811478101344	1	2
CASP9	endoplasmic reticulum stress/drug effects	8.480781446751351e-05	0.00018167923565679537	0.04672897196261682	0.9605811478101344	1	2
CASP9	astrocytes/drug effects	3.301742878480951e-05	7.438114538137121e-05	0.04672897196261682	0.9605811478101344	1	2
sulfonamides/toxicity	CASP8	0.0010427713481141465	0.0019929804683790483	0.03271028037383177	0.9605811478101344	1	2
sulfonamides/toxicity	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0029624131333876313	0.00535064182558618	0.04672897196261682	0.9605811478101344	1	2
sulfonamides/toxicity	caspase 3/metabolism	9.940125707075254e-05	0.00021089289029021862	0.02803738317757009	0.9605811478101344	1	2
sulfonamides/toxicity	MCL1	0.0006294795090561189	0.0012353150169710113	0.02803738317757009	0.9605811478101344	1	2
sulfonamides/toxicity	caspase 8/metabolism	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
sulfonamides/toxicity	morpholines/pharmacology	1.983776046765584e-07	5.377218377070026e-07	0.014018691588785045	0.9605811478101344	1	2
sulfonamides/toxicity	cell death/drug effects	7.930407666079109e-05	0.00017048520692444636	0.02803738317757009	0.9605811478101344	1	2
sulfonamides/toxicity	aminopyridines/pharmacology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
sulfonamides/toxicity	poly(adp-ribose) polymerases/metabolism	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
sulfonamides/toxicity	PTEN	7.335668233077186e-05	0.00015875227051716313	0.02336448598130841	0.9605811478101344	1	2
sulfonamides/toxicity	piperazines/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
sulfonamides/toxicity	nitrophenols/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
sulfonamides/toxicity	glioblastoma/enzymology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
bone neoplasms/genetics	CXCL8	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
bone neoplasms/genetics	CXCR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL22	PRKAA2	3.355178501696088e-08	9.559960662366936e-08	0.03711991575621956	0.9605811478101344	1	2
CCL22	phosphoinositide-3 kinase inhibitors	0.005059275993772427	0.008817241096410916	0.13557983414505725	0.9605811478101344	1	2
CCL22	proto-oncogene proteins c-akt/antagonists & inhibitors	0.0007019029466447391	0.0013702458090688158	0.09148348032117941	0.9605811478101344	1	2
CCL22	spermatogenesis/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL22	PARP1	0.0023608697427153214	0.004318989054711866	0.10925365275766749	0.9605811478101344	1	2
CCL22	PTEN	6.607139012682062e-06	1.595380582100691e-05	0.046290202272826986	0.9605811478101344	1	2
CCL22	TESC	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL22	arsenic/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neoplasm proteins/genetics	carcinoma non-small-cell lung/drug therapy	6.782466204224846e-07	1.7674011921847232e-06	0.05607476635514018	0.9605811478101344	1	2
neoplasm proteins/genetics	cisplatin/pharmacology	1.7214385472641425e-10	5.601280562290409e-10	0.02803738317757009	0.9605811478101344	1	2
neoplasm proteins/genetics	PCNA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neoplasm proteins/genetics	drugs chinese herbal/pharmacology	3.175126828125485e-12	1.1320374564442222e-11	0.03271028037383177	0.9605811478101344	1	2
neoplasm proteins/genetics	thymus gland/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm proteins/genetics	spleen/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CTLA4	iron/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CTLA4	nf-e2-related factor 2/genetics	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
CTLA4	cd8-positive t-lymphocytes/immunology	1.36867830402565e-08	3.990032956122905e-08	0.02336448598130841	0.9605811478101344	1	2
CTLA4	lung neoplasms/drug therapy	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
CTLA4	allografts	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CTLA4	GABPA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CTLA4	GSK3B	1.930989817899853e-05	4.4348399484433295e-05	0.02803738317757009	0.9605811478101344	1	2
CTLA4	NFE2L2	1.08218036753982e-08	3.1758169497561496e-08	0.018691588785046728	0.9605811478101344	1	2
CTLA4	PRKAA2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
clone cells	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
clone cells	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
clone cells	cyclophilin a/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clone cells	tacrolimus binding protein 1a/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clone cells	spiro compounds/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clone cells	enzyme inhibitors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clone cells	imp dehydrogenase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clone cells	CD40LG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clone cells	IL2	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
clone cells	PPIA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amino acid transport system y+/genetics	lipid metabolism/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amino acid transport system y+/genetics	ATM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amino acid transport system y+/genetics	SLC7A11	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
amino acid transport system y+/genetics	cd8-positive t-lymphocytes/immunology	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
amino acid transport system y+/genetics	sulfasalazine/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amino acid transport system y+/genetics	antineoplastic agents immunological/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipid metabolism/drug effects	ATM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipid metabolism/drug effects	SLC7A11	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
lipid metabolism/drug effects	cd8-positive t-lymphocytes/immunology	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
lipid metabolism/drug effects	sulfasalazine/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipid metabolism/drug effects	antineoplastic agents immunological/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD34	pyrimidines/pharmacology	1.0363931934875836e-12	3.832030375652229e-12	0.018691588785046728	0.9605811478101344	1	2
CD34	heterografts	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD34	PIK3CB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD34	bridged bicyclo compounds heterocyclic/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	BCL2	1.564302603385137e-05	3.6179317947587855e-05	1.962364229503536e-06	0.0014672161981045017	12	2
membrane potential mitochondrial/drug effects	morpholines/pharmacology	2.865294056364487e-05	6.486037305413163e-05	0.0008257976708780278	0.7135314763244264	3	2
membrane potential mitochondrial/drug effects	pentacyclic triterpenes/pharmacology	0.0007096482466518728	0.0013832839308797183	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	monoterpenes/pharmacology	0.0001021648951925469	0.0002165687538895562	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	plant extracts/chemistry	0.005711427168056726	0.009871867842686947	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	blood-brain barrier/drug effects	0.0011316140902800642	0.002159223493076145	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	hydroxymethylglutaryl-coa reductase inhibitors/pharmacology	2.962904754433282e-06	7.34083874881953e-06	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	anthraquinones/isolation & purification	0.005711427168056726	0.009871867842686947	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	sesquiterpenes guaiane	0.003335606434196392	0.0059844943169633045	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	neurons/cytology	0.0011316140902800642	0.002159223493076145	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	quinuclidines/pharmacology	0.0016991734374988132	0.0031721740855185296	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	monoamine oxidase/metabolism	0.00021844184500363628	0.00044944063070550324	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	biphenyl compounds/pharmacology	0.0007962397353662443	0.0015470121330062527	0.009214163485586416	0.8657199677887635	2	2
membrane potential mitochondrial/drug effects	nitrophenols/pharmacology	0.005711427168056726	0.009871867842686947	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	cell death/drug effects	0.003158207366720678	0.005679112497956198	0.013546767078293186	0.7135314763244264	3	2
membrane potential mitochondrial/drug effects	hemolysis/drug effects	0.002429378420712003	0.004438426866080398	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	phosphates/pharmacology	0.00021844184500363628	0.00044944063070550324	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	keratinocytes/drug effects	0.0007096482466518728	0.0013832839308797183	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	proto-oncogene proteins c-akt/drug effects	0.002086822641461872	0.0038534560803141836	0.025990895115003187	0.8657199677887635	2	2
membrane potential mitochondrial/drug effects	diet high-fat/adverse effects	2.962904754433282e-06	7.34083874881953e-06	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	antineoplastic agents phytogenic/chemistry	0.003335606434196392	0.0059844943169633045	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	organometallic compounds/metabolism	0.00021844184500363628	0.00044944063070550324	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	iridium/chemistry	0.002429378420712003	0.004438426866080398	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	chondrosarcoma/drug therapy	0.003335606434196392	0.0059844943169633045	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	phenylpropionates/pharmacology	0.002429378420712003	0.004438426866080398	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	voltage-dependent anion channels/genetics	0.005711427168056726	0.009871867842686947	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	carcinoma non-small-cell lung/metabolism	0.0016991734374988132	0.0031721740855185296	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	tor serine-threonine kinases/drug effects	0.0003990913400707674	0.0007966650851860824	0.009214163485586416	0.8657199677887635	2	2
membrane potential mitochondrial/drug effects	EEF1A2	2.962904754433282e-06	7.34083874881953e-06	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	IRF3	0.0007096482466518728	0.0013832839308797183	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	PTPN2	0.00021844184500363628	0.00044944063070550324	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	SPAG17	0.002429378420712003	0.004438426866080398	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	amyloid beta-peptides/pharmacology	0.0001021648951925469	0.0002165687538895562	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	coordination complexes/chemistry	0.002429378420712003	0.004438426866080398	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	potassium channels/metabolism	0.0016991734374988132	0.0031721740855185296	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	mitochondrial adp atp translocases/genetics	0.005711427168056726	0.009871867842686947	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	carcinoma squamous cell/drug therapy	0.003335606434196392	0.0059844943169633045	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	thallium/metabolism	0.00021844184500363628	0.00044944063070550324	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	tert-butylhydroperoxide/toxicity	0.002429378420712003	0.004438426866080398	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	mouth neoplasms/drug therapy	0.003335606434196392	0.0059844943169633045	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	glucose/pharmacology	0.0007096482466518728	0.0013832839308797183	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	sulfides/pharmacology	0.0011316140902800642	0.002159223493076145	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	phosphatidylinositol 3-kinases/drug effects	0.002086822641461872	0.0038534560803141836	0.025990895115003187	0.8657199677887635	2	2
membrane potential mitochondrial/drug effects	chromones/pharmacology	0.002429378420712003	0.004438426866080398	0.09813084112149532	0.9605811478101344	1	2
membrane potential mitochondrial/drug effects	nih 3t3 cells	0.002429378420712003	0.004438426866080398	0.09813084112149532	0.9605811478101344	1	2
pentacyclic triterpenes	melanoma/genetics	8.464442480260459e-10	2.6577047536995528e-09	0.027905752270633143	0.9605811478101344	1	2
pentacyclic triterpenes	proto-oncogene proteins c-bcl-2/genetics	4.798383912429927e-13	1.8004555565223794e-12	0.018647711816067742	0.9605811478101344	1	2
pentacyclic triterpenes	BCL2	0.0020393386082154796	0.0037689302291647017	0.02176297661357553	0.8657199677887635	2	2
pentacyclic triterpenes	breast neoplasms/metabolism	2.66944835125571e-08	7.655566759688592e-08	0.027905752270633143	0.9605811478101344	1	2
pentacyclic triterpenes	EIF4EBP1	4.271805131850215e-12	1.507921222334831e-11	0.018647711816067742	0.9605811478101344	1	2
pentacyclic triterpenes	PARP1	1.011836046060921e-07	2.797361898877892e-07	0.0028958799526128736	0.8657199677887635	2	2
pentacyclic triterpenes	RPS6KB1	4.271805131850215e-12	1.507921222334831e-11	0.018647711816067742	0.9605811478101344	1	2
GABPA	iron/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
GABPA	nf-e2-related factor 2/genetics	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
GABPA	cd8-positive t-lymphocytes/immunology	1.36867830402565e-08	3.990032956122905e-08	0.02336448598130841	0.9605811478101344	1	2
GABPA	lung neoplasms/drug therapy	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
GABPA	allografts	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
GABPA	GSK3B	1.930989817899853e-05	4.4348399484433295e-05	0.02803738317757009	0.9605811478101344	1	2
GABPA	NFE2L2	1.08218036753982e-08	3.1758169497561496e-08	0.018691588785046728	0.9605811478101344	1	2
GABPA	PRKAA2	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
membrane proteins/immunology	carcinoma non-small-cell lung/drug therapy	2.6631302138979684e-05	6.04952554667447e-05	0.05607476635514018	0.9605811478101344	1	2
membrane proteins/immunology	cisplatin/pharmacology	6.321351797566876e-08	1.770042728381439e-07	0.02803738317757009	0.9605811478101344	1	2
membrane proteins/immunology	glucose/metabolism	6.740019653506124e-11	2.2474887072066398e-10	0.018691588785046728	0.9605811478101344	1	2
membrane proteins/immunology	adenosine triphosphate/metabolism	3.6489922194959945e-11	1.2373574354882757e-10	0.02803738317757009	0.9605811478101344	1	2
membrane proteins/immunology	killer cells natural/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
membrane proteins/immunology	carrier proteins/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane proteins/immunology	cytokines/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
membrane proteins/immunology	IL2	4.643840867402105e-12	1.6329729416982715e-11	0.018691588785046728	0.9605811478101344	1	2
membrane proteins/immunology	PKM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
GGT1	tumor-associated macrophages/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
GGT1	triple negative breast neoplasms/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
GGT1	HLF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
GGT1	JAK2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
GGT1	STAT3	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
GGT1	TGFB1	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
kidney neoplasms/drug therapy	cell movement/drug effects	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
kidney neoplasms/drug therapy	caspase 3/metabolism	1.631716847194653e-07	4.4524867632361027e-07	0.02803738317757009	0.9605811478101344	1	2
kidney neoplasms/drug therapy	flavonoids/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
kidney neoplasms/drug therapy	neoplasm invasiveness/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/metabolism	mechanistic target of rapamycin complex 1/antagonists & inhibitors	1.6409096303959814e-12	5.956334463445933e-12	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	cell cycle checkpoints/drug effects	0.002728124300550694	0.0049595716176238204	0.08215010393874443	0.9605811478101344	1	2
breast neoplasms/metabolism	receptors fibroblast growth factor/metabolism	1.6409096303959814e-12	5.956334463445933e-12	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	fibroblast growth factor 2/pharmacology	1.6409096303959814e-12	5.956334463445933e-12	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	EIF4EBP1	2.415650552922699e-07	6.492778665224878e-07	0.027905752270633143	0.9605811478101344	1	2
breast neoplasms/metabolism	ESRRA	5.592304397339376e-12	1.956197482984905e-11	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	RPS6KB1	2.415650552922699e-07	6.492778665224878e-07	0.027905752270633143	0.9605811478101344	1	2
breast neoplasms/metabolism	phosphoinositide-3 kinase inhibitors	0.00041475073474561697	0.0008270257935851824	0.013256225769357815	0.8657199677887635	2	2
breast neoplasms/metabolism	receptors estrogen/metabolism	2.66944835125571e-08	7.655566759688592e-08	0.027905752270633143	0.9605811478101344	1	2
breast neoplasms/metabolism	cyclin d1/metabolism	1.3036816781664129e-06	3.327572776130247e-06	0.027905752270633143	0.9605811478101344	1	2
breast neoplasms/metabolism	neoplasm recurrence local/pathology	1.6409096303959814e-12	5.956334463445933e-12	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	bcl-2-like protein 11/metabolism	1.6409096303959814e-12	5.956334463445933e-12	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	ligands	3.5042941337604105e-07	9.278572962789664e-07	0.027905752270633143	0.9605811478101344	1	2
breast neoplasms/metabolism	FGF2	1.6409096303959814e-12	5.956334463445933e-12	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	PCNA	4.370883921467339e-08	1.239794785803575e-07	0.027905752270633143	0.9605811478101344	1	2
breast neoplasms/metabolism	glucose/deficiency	5.592304397339376e-12	1.956197482984905e-11	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	5.592304397339376e-12	1.956197482984905e-11	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	imidazoles/pharmacology	1.7438755116616633e-06	4.409790948631305e-06	0.027905752270633143	0.9605811478101344	1	2
breast neoplasms/metabolism	cell respiration/drug effects	1.4580143245956911e-05	3.3795521266490534e-05	0.04166180294604871	0.9605811478101344	1	2
breast neoplasms/metabolism	cytoprotection/drug effects	5.592304397339376e-12	1.956197482984905e-11	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	quinolines/pharmacology	5.592304397339376e-12	1.956197482984905e-11	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/metabolism	receptors estrogen/antagonists & inhibitors	1.631716847194653e-07	4.4524867632361027e-07	0.027905752270633143	0.9605811478101344	1	2
CDH1	NFE2L2	5.138143244209914e-09	1.5484661324267384e-08	0.018691588785046728	0.9605811478101344	1	2
CDH1	phosphoinositide-3 kinase inhibitors	0.0033656780815034537	0.0060350089737303304	0.07009345794392523	0.9605811478101344	1	2
CDH1	proto-oncogene proteins c-akt/antagonists & inhibitors	0.00039855525103160705	0.0007956669843122848	0.04672897196261682	0.9605811478101344	1	2
CDH1	azepines/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CDH1	pyrimidines/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CDH1	CDH2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CDH1	mitogen-activated protein kinases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	t-lymphocytes/drug effects	9.341637752235954e-08	2.585868539375999e-07	0.027905752270633143	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	protein kinase inhibitors/pharmacology	3.8616210007447194e-08	1.0973194976726327e-07	0.0019744636040542316	0.8657199677887635	2	2
cyclin-dependent kinase 6/antagonists & inhibitors	breast neoplasms/immunology	2.157919398726449e-10	6.979288089059813e-10	0.018647711816067742	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	CCL5	1.0656399921371573e-06	2.7370958232339287e-06	0.027905752270633143	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	chemokines/metabolism	3.401390280544092e-11	1.1546397675971694e-10	0.018647711816067742	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	CXCL9	4.039733436655979e-09	1.2253135618570785e-08	0.018647711816067742	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	CXCL10	2.7405334346308763e-07	7.346295582582561e-07	0.027905752270633143	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	mesothelioma malignant/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	hypertrophy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	phosphoinositide-3 kinase inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	CDK4	0.0	0.0	4.387696897898293e-05	0.8657199677887635	2	2
cyclin-dependent kinase 6/antagonists & inhibitors	CDKN2A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	MYC	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	TNFRSF4	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	TNFRSF9	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	cyclin-dependent kinase 4/antagonists & inhibitors	0.0	0.0	4.387696897898293e-05	0.8657199677887635	2	2
cyclin-dependent kinase 6/antagonists & inhibitors	pyridines/pharmacology	9.425793479067579e-14	3.6294078698302824e-13	0.018647711816067742	0.9605811478101344	1	2
cyclin-dependent kinase 6/antagonists & inhibitors	receptors chemokine/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
GSK3B	iron/chemistry	1.930989817899853e-05	4.4348399484433295e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	nf-e2-related factor 2/genetics	0.0007779257938639317	0.0015126296766127495	0.05541661182045544	0.9605811478101344	1	2
GSK3B	myocardial reperfusion injury/drug therapy	8.007293963563367e-05	0.00017192016487354672	0.05541661182045544	0.9605811478101344	1	2
GSK3B	allografts	1.930989817899853e-05	4.4348399484433295e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	cell line	7.585360420059306e-05	0.0001638342736495568	0.003185677624312898	0.7135314763244264	3	2
GSK3B	neovascularization pathologic/pathology	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	thiazoles/pharmacology	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	neoplasm proteins/metabolism	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	breast neoplasms/blood supply	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	myeloid cell leukemia sequence 1 protein/metabolism	2.6770707189927023e-06	6.651347217979615e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	tubulin modulators/pharmacology	2.6770707189927023e-06	6.651347217979615e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	lipopolysaccharides/pharmacology	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	myeloid differentiation factor 88/antagonists & inhibitors	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	piperazines	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	plasmids/genetics	0.0007779257938639317	0.0015126296766127495	0.05541661182045544	0.9605811478101344	1	2
GSK3B	stilbenes/pharmacology	2.6770707189927023e-06	6.651347217979615e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	glycogen synthase kinase 3 beta/metabolism	2.936717979906689e-09	8.980410266433103e-09	0.000658154534684744	0.8657199677887635	2	2
GSK3B	CTNNB1	2.6770707189927023e-06	6.651347217979615e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	ITK	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	MMP2	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	MMP9	0.0014382839654139001	0.002708745611125452	0.05541661182045544	0.9605811478101344	1	2
GSK3B	MYD88	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	TRAF6	8.007293963563367e-05	0.00017192016487354672	0.02803738317757009	0.9605811478101344	1	2
GSK3B	muscle proteins/biosynthesis	4.700834836501855e-06	1.1496839320598215e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	potassium channels/metabolism	5.332843400207565e-08	1.503177336841938e-07	0.02803738317757009	0.9605811478101344	1	2
GSK3B	enzyme inhibitors	1.4385896147661725e-06	3.657099484188236e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	glycogen synthase kinase 3/antagonists & inhibitors	1.4385896147661725e-06	3.657099484188236e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	receptors tumor necrosis factor type i/genetics	4.700834836501855e-06	1.1496839320598215e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	mitochondria muscle/drug effects	4.700834836501855e-06	1.1496839320598215e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	tumor necrosis factor-alpha/pharmacology	0.0006539203138513638	0.0012790662774835762	0.05541661182045544	0.9605811478101344	1	2
GSK3B	dna/biosynthesis	2.8725935251161516e-05	6.501893239067951e-05	0.05541661182045544	0.9605811478101344	1	2
GSK3B	oxidoreductases/metabolism	4.700834836501855e-06	1.1496839320598215e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	cardiotonic agents	1.4385896147661725e-06	3.657099484188236e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	quinuclidines/pharmacology	5.332843400207565e-08	1.503177336841938e-07	0.02803738317757009	0.9605811478101344	1	2
GSK3B	mitogen-activated protein kinases/genetics	4.700834836501855e-06	1.1496839320598215e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	cytosol/drug effects	1.4385896147661725e-06	3.657099484188236e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	muscle fibers skeletal/drug effects	4.700834836501855e-06	1.1496839320598215e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	zinc/pharmacology	1.4385896147661725e-06	3.657099484188236e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	myocytes cardiac/drug effects	5.257926119939249e-06	1.2799685888530482e-05	0.0063358268097849415	0.8657199677887635	2	2
GSK3B	myocardial reperfusion injury/prevention & control	1.4385896147661725e-06	3.657099484188236e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	oncogene protein v-akt/metabolism	4.700834836501855e-06	1.1496839320598215e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	EIF4E	4.700834836501855e-06	1.1496839320598215e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	EIF4EBP1	0.0006539203138513638	0.0012790662774835762	0.05541661182045544	0.9605811478101344	1	2
GSK3B	PRKCA	0.0003661012335938185	0.000732734204636575	0.05541661182045544	0.9605811478101344	1	2
GSK3B	PRKCB	1.4385896147661725e-06	3.657099484188236e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	PRKCG	1.4385896147661725e-06	3.657099484188236e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	PRRT2	1.4385896147661725e-06	3.657099484188236e-06	0.02803738317757009	0.9605811478101344	1	2
GSK3B	RPS6KB1	0.0006539203138513638	0.0012790662774835762	0.05541661182045544	0.9605811478101344	1	2
GSK3B	RPS6KB2	4.700834836501855e-06	1.1496839320598215e-05	0.02803738317757009	0.9605811478101344	1	2
GSK3B	TNFRSF1A	4.700834836501855e-06	1.1496839320598215e-05	0.02803738317757009	0.9605811478101344	1	2
burkitt lymphoma/drug therapy	piperidines/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
burkitt lymphoma/drug therapy	cell differentiation/drug effects	7.083156283727021e-11	2.3562074493604914e-10	0.02336448598130841	0.9605811478101344	1	2
burkitt lymphoma/drug therapy	CD4	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
CDH2	NFE2L2	5.138143244209914e-09	1.5484661324267384e-08	0.018691588785046728	0.9605811478101344	1	2
CDH2	phosphoinositide-3 kinase inhibitors	0.0033656780815034537	0.0060350089737303304	0.07009345794392523	0.9605811478101344	1	2
CDH2	proto-oncogene proteins c-akt/antagonists & inhibitors	0.00039855525103160705	0.0007956669843122848	0.04672897196261682	0.9605811478101344	1	2
CDH2	azepines/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CDH2	pyrimidines/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CDH2	mitogen-activated protein kinases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
a549 cells	endothelial cells/metabolism	0.0001667205860131915	0.0003464519774193069	0.05541661182045544	0.9605811478101344	1	2
a549 cells	lymphatic metastasis/genetics	9.390636046546774e-10	2.9393064104807394e-09	0.02803738317757009	0.9605811478101344	1	2
a549 cells	receptors ccr7/genetics	9.390636046546774e-10	2.9393064104807394e-09	0.02803738317757009	0.9605811478101344	1	2
a549 cells	neoplasm recurrence local/genetics	9.390636046546774e-10	2.9393064104807394e-09	0.02803738317757009	0.9605811478101344	1	2
a549 cells	hela cells	0.0023762292356653836	0.004346005988216539	0.08215010393874443	0.9605811478101344	1	2
a549 cells	carcinoma non-small-cell lung/drug therapy	0.0017652395756011519	0.0032941178301188487	0.03823117565875766	0.8657199677887635	2	2
a549 cells	chemokine ccl21/genetics	9.390636046546774e-10	2.9393064104807394e-09	0.02803738317757009	0.9605811478101344	1	2
a549 cells	adenocarcinoma/drug therapy	0.0012141822542055536	0.0023087788133440315	0.05541661182045544	0.9605811478101344	1	2
a549 cells	antineoplastic agents phytogenic/isolation & purification	4.354710387843852e-07	1.1483393688695282e-06	0.0038501128055567616	0.8657199677887635	2	2
a549 cells	CCL21	3.4789498117304696e-05	7.808600778686083e-05	0.05541661182045544	0.9605811478101344	1	2
a549 cells	DDX53	0.0004371614176102989	0.0008701394723726524	0.05541661182045544	0.9605811478101344	1	2
a549 cells	phosphatidylinositol 3-kinases/drug effects	0.002146351246287148	0.003957413637576438	0.08215010393874443	0.9605811478101344	1	2
a549 cells	drugs chinese herbal/chemistry	3.454814989645172e-09	1.0513700606169323e-08	0.02803738317757009	0.9605811478101344	1	2
a549 cells	crotonates/pharmacology	5.3953543135421e-06	1.3103852379926881e-05	0.02803738317757009	0.9605811478101344	1	2
a549 cells	proto-oncogene proteins c-akt/drug effects	0.002146351246287148	0.003957413637576438	0.08215010393874443	0.9605811478101344	1	2
a549 cells	erbb receptors/drug effects	2.9688886460377262e-08	8.498838855860788e-08	0.02803738317757009	0.9605811478101344	1	2
a549 cells	sesquiterpenes/pharmacology	5.3953543135421e-06	1.3103852379926881e-05	0.02803738317757009	0.9605811478101344	1	2
a549 cells	rhizome/chemistry	1.1858723574231789e-06	3.035304589791763e-06	0.02803738317757009	0.9605811478101344	1	2
a549 cells	chloroquine/pharmacology	0.00020629812421091298	0.00042501037587387496	0.05541661182045544	0.9605811478101344	1	2
a549 cells	saponins/isolation & purification	1.1858723574231789e-06	3.035304589791763e-06	0.02803738317757009	0.9605811478101344	1	2
a549 cells	carcinoma non-small-cell lung/metabolism	3.454814989645172e-09	1.0513700606169323e-08	0.02803738317757009	0.9605811478101344	1	2
a549 cells	tor serine-threonine kinases/drug effects	0.0005161304311359638	0.0010208705253149483	0.05541661182045544	0.9605811478101344	1	2
a549 cells	COL4A5	1.1858723574231789e-06	3.035304589791763e-06	0.02803738317757009	0.9605811478101344	1	2
a549 cells	EGFR	0.004427549324985791	0.007766616876226169	0.10825010098314035	0.9605811478101344	1	2
a549 cells	MAPK14	0.00013315331632623995	0.0002794901293184442	0.05541661182045544	0.9605811478101344	1	2
a549 cells	MDM2	2.9688886460377262e-08	8.498838855860788e-08	0.02803738317757009	0.9605811478101344	1	2
a549 cells	METTL7B	2.9688886460377262e-08	8.498838855860788e-08	0.02803738317757009	0.9605811478101344	1	2
a549 cells	SQSTM1	3.454814989645172e-09	1.0513700606169323e-08	0.02803738317757009	0.9605811478101344	1	2
a549 cells	TP73	2.9688886460377262e-08	8.498838855860788e-08	0.02803738317757009	0.9605811478101344	1	2
a549 cells	carcinoma non-small-cell lung/genetics	9.390636046546774e-10	2.9393064104807394e-09	0.02803738317757009	0.9605811478101344	1	2
a549 cells	plant extracts/isolation & purification	0.00036731261271538695	0.0007345585927572655	0.05541661182045544	0.9605811478101344	1	2
HIF1A	hypoxia-inducible factor 1 alpha subunit/metabolism	5.699885008425554e-13	2.128214473594693e-12	0.018691588785046728	0.9605811478101344	1	2
HIF1A	amino acid transport system y+/metabolism	2.548156555759462e-07	6.83975599481186e-07	0.03711991575621956	0.9605811478101344	1	2
HIF1A	melanoma/genetics	5.861997677436559e-05	0.00012821956824615204	0.055287464515536164	0.9605811478101344	1	2
HIF1A	hepatic stellate cells/drug effects	5.699885008425554e-13	2.128214473594693e-12	0.018691588785046728	0.9605811478101344	1	2
HIF1A	liver cirrhosis/drug therapy	5.699885008425554e-13	2.128214473594693e-12	0.018691588785046728	0.9605811478101344	1	2
HIF1A	collagen type i/metabolism	5.699885008425554e-13	2.128214473594693e-12	0.018691588785046728	0.9605811478101344	1	2
HIF1A	actins/metabolism	5.699885008425554e-13	2.128214473594693e-12	0.018691588785046728	0.9605811478101344	1	2
HIF1A	FN1	5.699885008425554e-13	2.128214473594693e-12	0.018691588785046728	0.9605811478101344	1	2
HIF1A	MMRN1	5.699885008425554e-13	2.128214473594693e-12	0.018691588785046728	0.9605811478101344	1	2
HIF1A	SLC7A11	0.0004050279357447062	0.0008080767285584365	0.09085010295354308	0.9605811478101344	1	2
HIF1A	cyclin b1/metabolism	6.563254051350498e-09	1.969333496518451e-08	0.018691588785046728	0.9605811478101344	1	2
HIF1A	interleukin-10/metabolism	7.26351784963164e-06	1.7469841992874266e-05	0.03711991575621956	0.9605811478101344	1	2
HIF1A	neoplasms/metabolism	4.979927581416632e-11	1.6775774379690435e-10	0.018691588785046728	0.9605811478101344	1	2
HIF1A	gene expression regulation	3.20643269862142e-05	7.232268863345786e-05	0.03711991575621956	0.9605811478101344	1	2
HIF1A	epithelial-mesenchymal transition	4.979927581416632e-11	1.6775774379690435e-10	0.018691588785046728	0.9605811478101344	1	2
HIF1A	ceramides/pharmacology	1.4092521308795014e-06	3.5862408796896638e-06	0.03711991575621956	0.9605811478101344	1	2
HIF1A	aspirin/administration & dosage	6.563254051350498e-09	1.969333496518451e-08	0.018691588785046728	0.9605811478101344	1	2
HIF1A	interleukin-6/metabolism	0.0032894624695102292	0.005909400189665244	0.09085010295354308	0.9605811478101344	1	2
HIF1A	interferons/metabolism	4.979927581416632e-11	1.6775774379690435e-10	0.018691588785046728	0.9605811478101344	1	2
HIF1A	janus kinases/metabolism	4.979927581416632e-11	1.6775774379690435e-10	0.018691588785046728	0.9605811478101344	1	2
HIF1A	lymphoma t-cell/drug therapy	6.563254051350498e-09	1.969333496518451e-08	0.018691588785046728	0.9605811478101344	1	2
HIF1A	cytokines/genetics	1.3350875960327357e-11	4.591485153225668e-11	0.018691588785046728	0.9605811478101344	1	2
HIF1A	hypoxia-inducible factor 1 alpha subunit/genetics	4.979927581416632e-11	1.6775774379690435e-10	0.018691588785046728	0.9605811478101344	1	2
HIF1A	glucose/metabolism	0.0015484433619867843	0.002906280688268036	0.07319670689438858	0.9605811478101344	1	2
HIF1A	biomarkers	1.4092521308795014e-06	3.5862408796896638e-06	0.03711991575621956	0.9605811478101344	1	2
HIF1A	interleukin-4/metabolism	6.563254051350498e-09	1.969333496518451e-08	0.018691588785046728	0.9605811478101344	1	2
HIF1A	nitric oxide/metabolism	2.0468055752731473e-05	4.6895946506933754e-05	0.03711991575621956	0.9605811478101344	1	2
HIF1A	ras proteins/metabolism	4.979927581416632e-11	1.6775774379690435e-10	0.018691588785046728	0.9605811478101344	1	2
HIF1A	protein kinase c/genetics	1.3350875960327357e-11	4.591485153225668e-11	0.018691588785046728	0.9605811478101344	1	2
HIF1A	receptors vascular endothelial growth factor/genetics	1.3350875960327357e-11	4.591485153225668e-11	0.018691588785046728	0.9605811478101344	1	2
HIF1A	transforming growth factor beta/metabolism	0.0025586523829360663	0.004666101549956525	0.07319670689438858	0.9605811478101344	1	2
HIF1A	hypoxia/metabolism	4.979927581416632e-11	1.6775774379690435e-10	0.018691588785046728	0.9605811478101344	1	2
HIF1A	vascular endothelial growth factor a/genetics	1.3350875960327357e-11	4.591485153225668e-11	0.018691588785046728	0.9605811478101344	1	2
HIF1A	BIRC5	0.000847366196776056	0.0016385484920644169	0.055287464515536164	0.9605811478101344	1	2
HIF1A	C2	1.36867830402565e-08	3.990032956122905e-08	0.03711991575621956	0.9605811478101344	1	2
HIF1A	FLT1	1.3350875960327357e-11	4.591485153225668e-11	0.018691588785046728	0.9605811478101344	1	2
HIF1A	KDR	1.3350875960327357e-11	4.591485153225668e-11	0.018691588785046728	0.9605811478101344	1	2
HIF1A	SOCS5	6.563254051350498e-09	1.969333496518451e-08	0.018691588785046728	0.9605811478101344	1	2
CDK2	g2 phase cell cycle checkpoints/drug effects	0.00022093315072990727	0.0004542273505495147	0.04166180294604871	0.9605811478101344	1	2
CDK2	cell cycle proteins/metabolism	1.1364735889030086e-06	2.9166534382648742e-06	0.027905752270633143	0.9605811478101344	1	2
CDK2	cisplatin/pharmacology	0.0053196128931922715	0.009236637664915988	0.08215010393874443	0.9605811478101344	1	2
CDK2	ovarian neoplasms/drug therapy	8.540417413271939e-06	2.038089870416925e-05	0.027905752270633143	0.9605811478101344	1	2
CDK2	BCL2	0.0022460044824810232	0.004127690825184762	0.003079666501921066	0.7135314763244264	3	2
CDK2	ZHX2	0.000688492180403788	0.0013445416823332787	0.055287464515536164	0.9605811478101344	1	2
CDK2	isoflavones/pharmacology	2.2231305685238567e-10	7.185981934439817e-10	0.014018691588785045	0.9605811478101344	1	2
CDK2	cell division/drug effects	0.00027928176441338604	0.0005679922831644991	0.055287464515536164	0.9605811478101344	1	2
CDK2	lignans/pharmacology	1.0834047752372733e-05	2.5471218260216894e-05	0.027905752270633143	0.9605811478101344	1	2
CDK2	mitochondria liver/drug effects	0.0006294795090561189	0.0012353150169710113	0.09538832359347407	0.9605811478101344	1	2
CDK2	chemical and drug induced liver injury/pathology	2.145505995088115e-12	7.72438213254454e-12	0.014018691588785045	0.9605811478101344	1	2
CDK2	g1 phase/drug effects	2.145505995088115e-12	7.72438213254454e-12	0.014018691588785045	0.9605811478101344	1	2
CDK2	PARP1	0.00031258288708302384	0.000632509865492521	0.00841444363589401	0.8657199677887635	2	2
CDK2	hydrazones/pharmacology	2.2231305685238567e-10	7.185981934439817e-10	0.014018691588785045	0.9605811478101344	1	2
HLF	tumor-associated macrophages/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
HLF	triple negative breast neoplasms/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
HLF	JAK2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HLF	STAT3	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
HLF	TGFB1	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
biphenyl compounds/pharmacology	neovascularization pathologic/drug therapy	9.484881946519863e-08	2.624531590824171e-07	0.018647711816067742	0.9605811478101344	1	2
biphenyl compounds/pharmacology	rna small interfering/genetics	1.009497924253644e-06	2.5989502842064855e-06	0.027905752270633143	0.9605811478101344	1	2
biphenyl compounds/pharmacology	curcumin/pharmacology	9.484881946519863e-08	2.624531590824171e-07	0.027905752270633143	0.9605811478101344	1	2
biphenyl compounds/pharmacology	extracellular signal-regulated map kinases/drug effects	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	cyclophilin d	1.014400341503574e-09	3.1733113974845062e-09	0.018647711816067742	0.9605811478101344	1	2
biphenyl compounds/pharmacology	nitrophenols/pharmacology	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	cell death/drug effects	0.0011076118552024727	0.0021147061121842845	0.05541661182045544	0.9605811478101344	1	2
biphenyl compounds/pharmacology	lignans/pharmacology	1.8511817145849818e-07	5.037627060376411e-07	0.018647711816067742	0.9605811478101344	1	2
biphenyl compounds/pharmacology	acetylcysteine/metabolism	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	angiogenesis inhibitors/pharmacology	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	nitric oxide synthase/antagonists & inhibitors	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	cell differentiation	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	endothelial cells/drug effects	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	tor serine-threonine kinases/drug effects	6.631623683528431e-08	1.8543315025292944e-07	0.018647711816067742	0.9605811478101344	1	2
biphenyl compounds/pharmacology	MAPK8	0.00036974412504797716	0.0007392870652995194	0.046290202272826986	0.9605811478101344	1	2
biphenyl compounds/pharmacology	p38 mitogen-activated protein kinases/drug effects	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	proto-oncogene proteins c-akt/drug effects	1.6338435868679113e-06	4.1372439879710246e-06	0.027905752270633143	0.9605811478101344	1	2
biphenyl compounds/pharmacology	embryonic stem cells/cytology	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	platelet endothelial cell adhesion molecule-1/biosynthesis	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	phosphatidylinositol 3-kinases/drug effects	1.6338435868679113e-06	4.1372439879710246e-06	0.027905752270633143	0.9605811478101344	1	2
biphenyl compounds/pharmacology	jnk mitogen-activated protein kinases/drug effects	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
biphenyl compounds/pharmacology	caspase 3/biosynthesis	1.3607892590528081e-11	4.6711321163936347e-11	0.009345794392523364	0.9605811478101344	1	2
CDK4	t-lymphocytes/drug effects	9.341637752235954e-08	2.585868539375999e-07	0.027905752270633143	0.9605811478101344	1	2
CDK4	protein kinase inhibitors/pharmacology	3.8616210007447194e-08	1.0973194976726327e-07	0.0019744636040542316	0.8657199677887635	2	2
CDK4	breast neoplasms/immunology	2.157919398726449e-10	6.979288089059813e-10	0.018647711816067742	0.9605811478101344	1	2
CDK4	CCL5	1.0656399921371573e-06	2.7370958232339287e-06	0.027905752270633143	0.9605811478101344	1	2
CDK4	chemokines/metabolism	3.401390280544092e-11	1.1546397675971694e-10	0.018647711816067742	0.9605811478101344	1	2
CDK4	CXCL9	4.039733436655979e-09	1.2253135618570785e-08	0.018647711816067742	0.9605811478101344	1	2
CDK4	pyridines/pharmacology	9.425793479067579e-14	3.6294078698302824e-13	0.018647711816067742	0.9605811478101344	1	2
CDK4	CXCL10	2.7405334346308763e-07	7.346295582582561e-07	0.027905752270633143	0.9605811478101344	1	2
CDK4	mesothelioma malignant/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CDK4	hypertrophy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CDK4	phosphoinositide-3 kinase inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CDK4	CDKN2A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CDK4	MYC	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CDK4	TNFRSF4	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CDK4	TNFRSF9	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CDK4	cyclin-dependent kinase 4/antagonists & inhibitors	0.0	0.0	4.387696897898293e-05	0.8657199677887635	2	2
CDK4	receptors chemokine/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
HMOX1	nf-e2-related factor 2/genetics	6.756817327868703e-13	2.5219960799872885e-12	0.018647711816067742	0.9605811478101344	1	2
HMOX1	t-lymphocytes/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
HMOX1	NFE2L2	2.0956738788768803e-07	5.666595251591545e-07	0.03711991575621956	0.9605811478101344	1	2
HMOX1	neuroprotective agents/pharmacology	4.6629367034256575e-15	1.8989366168660674e-14	0.018647711816067742	0.9605811478101344	1	2
HMOX1	neurons/drug effects	1.496225365826831e-11	5.132842207211758e-11	0.027905752270633143	0.9605811478101344	1	2
HMOX1	amyloid beta-peptides/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
HMOX1	quassins/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	gene expression regulation leukemic/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	t-lymphocytes/drug effects	2.575712587660206e-08	7.393478861181125e-08	0.027905752270633143	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	receptors antigen b-cell/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	plicamycin/analogs & derivatives	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	drug combinations	1.1500711494250027e-10	3.773890266784113e-10	0.018647711816067742	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	doxorubicin/pharmacology	1.0363931934875836e-12	3.832030375652229e-12	0.018647711816067742	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	leukemia lymphocytic chronic b-cell/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	killer cells natural/drug effects	4.8407944319706075e-12	1.6987081909293006e-11	0.018647711816067742	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	antineoplastic agents phytogenic/isolation & purification	4.563453836148312e-06	1.1185662054407782e-05	0.03711991575621956	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	caspase 3/metabolism	0.0002039311921900877	0.0004202126098511265	0.05541661182045544	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	PRF1	1.0363931934875836e-12	3.832030375652229e-12	0.018647711816067742	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	WDTC1	6.270890573478738e-08	1.7570287884618023e-07	0.03711991575621956	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	plant extracts/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	anthraquinones/isolation & purification	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	mitochondrial adp atp translocases/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibiotics antineoplastic/pharmacology	voltage-dependent anion channels/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CDKN2A	protein kinase inhibitors/pharmacology	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
CDKN2A	proto-oncogene proteins c-akt/antagonists & inhibitors	5.697251249958679e-05	0.00012476459630422025	0.04672897196261682	0.9605811478101344	1	2
CDKN2A	pyridines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CDKN2A	mesothelioma malignant/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CDKN2A	phosphoinositide-3 kinase inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CDKN2A	MYC	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CDKN2A	cyclin-dependent kinase 4/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
scorpion venoms/chemistry	carcinoma hepatocellular/drug therapy	1.3067324999838092e-12	4.805009699740331e-12	0.03271028037383177	0.9605811478101344	1	2
scorpion venoms/chemistry	peptides/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
scorpion venoms/chemistry	endocytosis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
scorpion venoms/chemistry	mitochondrial membranes/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
scorpion venoms/chemistry	mitochondria liver/drug effects	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
cell differentiation/drug effects	rna small interfering/metabolism	1.796646799778756e-05	4.14139766246963e-05	0.046290202272826986	0.9605811478101344	1	2
cell differentiation/drug effects	piperidines/chemistry	7.083156283727021e-11	2.3562074493604914e-10	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	ligands	5.155768928943871e-05	0.00011349280485758235	0.046290202272826986	0.9605811478101344	1	2
cell differentiation/drug effects	CD4	2.338018667558117e-12	8.411983613303095e-12	0.0013038910592810965	0.8657199677887635	2	2
cell differentiation/drug effects	dose-response relationship immunologic	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	organophosphorus compounds/chemistry	1.7859732248659554e-08	5.16692529351064e-08	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	pten phosphohydrolase/antagonists & inhibitors	3.9496177328679494e-08	1.1218909014979715e-07	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	organophosphorus compounds/pharmacology	0.00012159104929931885	0.0002561474732420583	0.046290202272826986	0.9605811478101344	1	2
cell differentiation/drug effects	calcitriol/metabolism	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	interleukin-4/antagonists & inhibitors	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	superoxide dismutase/metabolism	1.3276802133588284e-05	3.0966564417788475e-05	0.046290202272826986	0.9605811478101344	1	2
cell differentiation/drug effects	palmitic acid/pharmacology	7.083156283727021e-11	2.3562074493604914e-10	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	neuroblastoma/metabolism	7.083156283727021e-11	2.3562074493604914e-10	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	antimycin a/analogs & derivatives	1.7859732248659554e-08	5.16692529351064e-08	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	insulin antagonists/pharmacology	7.083156283727021e-11	2.3562074493604914e-10	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	ubiquinone/analogs & derivatives	2.1324907325537268e-06	5.352590581892596e-06	0.046290202272826986	0.9605811478101344	1	2
cell differentiation/drug effects	cyclic n-oxides/chemistry	1.7859732248659554e-08	5.16692529351064e-08	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	cell hypoxia	1.796646799778756e-05	4.14139766246963e-05	0.046290202272826986	0.9605811478101344	1	2
cell differentiation/drug effects	autophagy-related protein-1 homolog/metabolism	3.9496177328679494e-08	1.1218909014979715e-07	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	adipose tissue/cytology	1.7859732248659554e-08	5.16692529351064e-08	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	insulin/metabolism	7.083156283727021e-11	2.3562074493604914e-10	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	free radical scavengers/pharmacology	1.7859732248659554e-08	5.16692529351064e-08	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	stem cells/cytology	1.7859732248659554e-08	5.16692529351064e-08	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	l-selectin/biosynthesis	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	interferon-gamma/antagonists & inhibitors	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	th1 cells/metabolism	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	SELP	2.8142801422603725e-09	8.610775544901011e-09	0.02336448598130841	0.9605811478101344	1	2
cell differentiation/drug effects	ULK1	3.9496177328679494e-08	1.1218909014979715e-07	0.02336448598130841	0.9605811478101344	1	2
COL4A5	cell cycle checkpoints/drug effects	8.276241856286504e-07	2.141720427786442e-06	0.02803738317757009	0.9605811478101344	1	2
COL4A5	plant extracts/isolation & purification	7.771561172376096e-16	3.293241989785665e-15	0.009345794392523364	0.9605811478101344	1	2
COL4A5	antineoplastic agents phytogenic/isolation & purification	6.096331439664482e-09	1.8334731357484997e-08	0.018691588785046728	0.9605811478101344	1	2
COL4A5	saponins/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
COL4A5	rhizome/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carrier proteins/immunology	carcinoma non-small-cell lung/drug therapy	2.6631302138979684e-05	6.04952554667447e-05	0.05607476635514018	0.9605811478101344	1	2
carrier proteins/immunology	cisplatin/pharmacology	6.321351797566876e-08	1.770042728381439e-07	0.02803738317757009	0.9605811478101344	1	2
carrier proteins/immunology	glucose/metabolism	6.740019653506124e-11	2.2474887072066398e-10	0.018691588785046728	0.9605811478101344	1	2
carrier proteins/immunology	adenosine triphosphate/metabolism	3.6489922194959945e-11	1.2373574354882757e-10	0.02803738317757009	0.9605811478101344	1	2
carrier proteins/immunology	killer cells natural/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
carrier proteins/immunology	cytokines/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carrier proteins/immunology	IL2	4.643840867402105e-12	1.6329729416982715e-11	0.018691588785046728	0.9605811478101344	1	2
carrier proteins/immunology	PKM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	tumor necrosis factor-alpha/metabolism	0.00025250561210343747	0.0005151993092408466	0.037383177570093455	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	BIRC5	2.332691073636539e-08	6.70113000541217e-08	0.014018691588785045	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	CASP8	0.000335616220874857	0.0006746595949898656	0.03271028037383177	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	MCL1	0.00018571952850299223	0.00038444692183212586	0.02803738317757009	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	XIAP	6.226627435879095e-09	1.8701087277790802e-08	0.014018691588785045	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	flavonoids/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	multiple myeloma/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	caspases/metabolism	0.00014922404803296985	0.00031191617472799767	0.03271028037383177	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	leukemia/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	PARP1	0.0035270245753111773	0.006293100091968992	0.05607476635514018	0.9605811478101344	1	2
poly (adp-ribose) polymerase-1	TNFRSF10D	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nf-e2-related factor 2/genetics	iron/chemistry	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
nf-e2-related factor 2/genetics	lung neoplasms/drug therapy	0.00012810012533626125	0.0002694477736513917	0.046290202272826986	0.9605811478101344	1	2
nf-e2-related factor 2/genetics	NFE2L2	0.0	0.0	0.00026326181387389757	0.8657199677887635	2	2
nf-e2-related factor 2/genetics	PRKAA2	8.41142134544448e-06	2.0083930888494683e-05	0.03711991575621956	0.9605811478101344	1	2
nf-e2-related factor 2/genetics	neuroprotective agents/pharmacology	8.205436330399607e-12	2.8445512612051973e-11	0.018647711816067742	0.9605811478101344	1	2
nf-e2-related factor 2/genetics	neurons/drug effects	4.039733436655979e-09	1.2253135618570785e-08	0.027905752270633143	0.9605811478101344	1	2
nf-e2-related factor 2/genetics	amyloid beta-peptides/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-e2-related factor 2/genetics	quassins/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-e2-related factor 2/genetics	cd8-positive t-lymphocytes/immunology	7.26351784963164e-06	1.7469841992874266e-05	0.046290202272826986	0.9605811478101344	1	2
nf-e2-related factor 2/genetics	allografts	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
JAK2	tumor-associated macrophages/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
JAK2	triple negative breast neoplasms/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
JAK2	STAT3	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
JAK2	TGFB1	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
antineoplastic agents phytogenic/chemistry	phosphoinositide-3 kinase inhibitors	0.0005733062746914319	0.0011294010672262948	0.07009345794392523	0.9605811478101344	1	2
antineoplastic agents phytogenic/chemistry	proto-oncogene proteins c-akt/antagonists & inhibitors	3.379596134700513e-05	7.601850191580994e-05	0.04672897196261682	0.9605811478101344	1	2
antineoplastic agents phytogenic/chemistry	morpholines/pharmacology	7.263079027097774e-13	2.703636103147927e-12	0.014018691588785045	0.9605811478101344	1	2
antineoplastic agents phytogenic/chemistry	chondrosarcoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	cell survival	0.0025059717734812192	0.00457229937617626	0.09148348032117941	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	immunity innate/drug effects	0.0014162765613265904	0.002668666406642908	0.09148348032117941	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	receptors tumor necrosis factor type i/metabolism	2.1244838133149813e-07	5.739568571984893e-07	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	antineoplastic agents phytogenic/pharmacology	0.003860279104721198	0.006836367914758959	0.026746177529959735	0.8657199677887635	2	2
proto-oncogene proteins c-akt/antagonists & inhibitors	nucleotides cyclic/pharmacology	2.1244838133149813e-07	5.739568571984893e-07	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	neoplasms/blood supply	2.1244838133149813e-07	5.739568571984893e-07	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	phosphoinositide-3 kinase inhibitors	5.392253310532169e-11	1.8159218113733507e-10	1.8850717763068333e-07	0.11552077256850565	7	2
proto-oncogene proteins c-akt/antagonists & inhibitors	neoplasms/enzymology	9.10268020487548e-05	0.00019417172325570295	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	lipid droplets/metabolism	9.10268020487548e-05	0.00019417172325570295	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	azepines/chemistry	0.00039855525103160705	0.0007956669843122848	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	phospholipids/metabolism	9.10268020487548e-05	0.00019417172325570295	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	nitrophenols/toxicity	0.0029624131333876313	0.00535064182558618	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	carcinoma squamous cell/drug therapy	3.379596134700513e-05	7.601850191580994e-05	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	piperazines/toxicity	0.0029624131333876313	0.00535064182558618	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	pyridines/pharmacology	0.0011396931311093983	0.0021729465716620556	0.09148348032117941	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	mouth neoplasms/drug therapy	3.379596134700513e-05	7.601850191580994e-05	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	palmitic acid/pharmacology	9.703503700775329e-06	2.298236648347776e-05	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	neuroblastoma/metabolism	9.703503700775329e-06	2.298236648347776e-05	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	insulin antagonists/pharmacology	9.703503700775329e-06	2.298236648347776e-05	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	morpholines/pharmacology	5.7954570162443986e-05	0.00012681444650075078	0.005774374691101998	0.8657199677887635	2	2
proto-oncogene proteins c-akt/antagonists & inhibitors	poly(adp-ribose) polymerases/metabolism	0.0029624131333876313	0.00535064182558618	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	glioblastoma/enzymology	0.0029624131333876313	0.00535064182558618	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	sesquiterpenes guaiane	3.379596134700513e-05	7.601850191580994e-05	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	mesothelioma malignant/drug therapy	5.697251249958679e-05	0.00012476459630422025	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	phosphoinositide-3 kinase inhibitors/pharmacology	5.697251249958679e-05	0.00012476459630422025	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	aminopyridines/pharmacology	0.0029624131333876313	0.00535064182558618	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	phospholipase a2 inhibitors/pharmacology	9.10268020487548e-05	0.00019417172325570295	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	insulin/metabolism	9.703503700775329e-06	2.298236648347776e-05	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	pyrimidines/chemistry	0.00039855525103160705	0.0007956669843122848	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	chondrosarcoma/drug therapy	3.379596134700513e-05	7.601850191580994e-05	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	mitogen-activated protein kinases/antagonists & inhibitors	0.00039855525103160705	0.0007956669843122848	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	MYC	5.697251249958679e-05	0.00012476459630422025	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	PLA2G1B	9.10268020487548e-05	0.00019417172325570295	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-akt/antagonists & inhibitors	PTEN	0.0032981194492135435	0.005924469416348395	0.018291269805799152	0.8657199677887635	2	2
hmgb1 protein/biosynthesis	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
hmgb1 protein/biosynthesis	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hmgb1 protein/biosynthesis	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hmgb1 protein/biosynthesis	colorectal neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hmgb1 protein/biosynthesis	KLK3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hmgb1 protein/biosynthesis	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
hmgb1 protein/biosynthesis	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hmgb1 protein/biosynthesis	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hmgb1 protein/biosynthesis	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAA	astrocytes/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAA	antimycin a/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAA	cell death/drug effects	9.299864525136314e-07	2.396766955583933e-06	0.02803738317757009	0.9605811478101344	1	2
CRYAA	extracellular space/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAA	brain/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CRYAA	alpha-crystallins/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAA	staurosporine/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAA	MAPK3	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
CRYAA	CRYAB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAA	MAPK8	9.200277617527064e-08	2.549619418190507e-07	0.02336448598130841	0.9605811478101344	1	2
cyclophilin a/antagonists & inhibitors	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
cyclophilin a/antagonists & inhibitors	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
cyclophilin a/antagonists & inhibitors	tacrolimus binding protein 1a/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilin a/antagonists & inhibitors	spiro compounds/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilin a/antagonists & inhibitors	enzyme inhibitors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilin a/antagonists & inhibitors	imp dehydrogenase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilin a/antagonists & inhibitors	CD40LG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilin a/antagonists & inhibitors	IL2	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
cyclophilin a/antagonists & inhibitors	PPIA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAB	astrocytes/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAB	antimycin a/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAB	cell death/drug effects	9.299864525136314e-07	2.396766955583933e-06	0.02803738317757009	0.9605811478101344	1	2
CRYAB	extracellular space/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAB	brain/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CRYAB	alpha-crystallins/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAB	staurosporine/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CRYAB	MAPK3	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
CRYAB	MAPK8	9.200277617527064e-08	2.549619418190507e-07	0.02336448598130841	0.9605811478101344	1	2
nitrophenols/pharmacology	rna small interfering/genetics	1.765254609153999e-14	7.017730548616547e-14	0.014018691588785045	0.9605811478101344	1	2
nitrophenols/pharmacology	curcumin/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
nitrophenols/pharmacology	cyclophilin d	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nitrophenols/pharmacology	cell death/drug effects	2.415650552922699e-07	6.492778665224878e-07	0.02803738317757009	0.9605811478101344	1	2
antibodies monoclonal/immunology	tumor necrosis factor-alpha/metabolism	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
antibodies monoclonal/immunology	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibodies monoclonal/immunology	cell division/drug effects	3.9129477436006255e-11	1.324622629370591e-10	0.018691588785046728	0.9605811478101344	1	2
antibodies monoclonal/immunology	mercaptoethanol/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibodies monoclonal/immunology	interleukins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibodies monoclonal/immunology	cd3 complex/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibodies monoclonal/immunology	CD28	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibodies monoclonal/immunology	CD3E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibodies monoclonal/immunology	IL2	5.513522971511975e-11	1.8460463853590893e-10	0.018691588785046728	0.9605811478101344	1	2
antibodies monoclonal/immunology	IL5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gefitinib	carcinoma non-small-cell lung/drug therapy	6.782466204224846e-07	1.7674011921847232e-06	0.05607476635514018	0.9605811478101344	1	2
gefitinib	drugs chinese herbal/pharmacology	3.175126828125485e-12	1.1320374564442222e-11	0.03271028037383177	0.9605811478101344	1	2
gefitinib	MAPK1	4.989061767046721e-07	1.310758267872332e-06	0.04672897196261682	0.9605811478101344	1	2
gefitinib	MAPK3	1.0929630311906635e-08	3.2014944747830144e-08	0.037383177570093455	0.9605811478101344	1	2
gefitinib	EGFR	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gefitinib	MET	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gefitinib	apoptosis	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oleic acid/metabolism	coenzyme a ligases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oleic acid/metabolism	melanoma/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oleic acid/metabolism	ACSL3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oleic acid/metabolism	cell survival	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oleic acid/metabolism	neoplasm metastasis/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oleic acid/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oleic acid/metabolism	lymph/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYBB	depsides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYBB	heart injuries/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYBB	cinnamates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYBB	sleep apnea obstructive/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYBB	drugs chinese herbal/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CYBB	hypoxia/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYBB	PINK1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYBB	SLC25A28	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell death/drug effects	erbb receptors/antagonists & inhibitors	0.0036295362031109057	0.006468155044147208	0.08215010393874443	0.9605811478101344	1	2
cell death/drug effects	rna small interfering/genetics	0.0020191900150675623	0.003734823947333021	0.08215010393874443	0.9605811478101344	1	2
cell death/drug effects	tyrphostins/pharmacology	0.0003091638139606223	0.0006256488086465169	0.05541661182045544	0.9605811478101344	1	2
cell death/drug effects	curcumin/pharmacology	0.0007243323845042005	0.001411033788085228	0.08215010393874443	0.9605811478101344	1	2
cell death/drug effects	astrocytes/physiology	9.299864525136314e-07	2.396766955583933e-06	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	caspase 8/metabolism	0.002749796883666389	0.004997322922113134	0.05541661182045544	0.9605811478101344	1	2
cell death/drug effects	antimycin a/metabolism	9.299864525136314e-07	2.396766955583933e-06	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	morpholines/pharmacology	5.948810599676335e-08	1.6720981145036184e-07	0.001949627583877449	0.8657199677887635	2	2
cell death/drug effects	cyclophilin d	0.00010286491815503229	0.00021798978426395155	0.05541661182045544	0.9605811478101344	1	2
cell death/drug effects	aminopyridines/pharmacology	7.930407666079109e-05	0.00017048520692444636	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	mitophagy/drug effects	6.642900673980989e-10	2.089637238692151e-09	0.0038501128055567616	0.8657199677887635	2	2
cell death/drug effects	glioma/drug therapy	1.5919403573150248e-09	4.9268811058508795e-09	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	extracellular space/drug effects	9.299864525136314e-07	2.396766955583933e-06	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	berberine/pharmacology	0.00013145239114953355	0.00027623544796653794	0.05541661182045544	0.9605811478101344	1	2
cell death/drug effects	EGFR	0.005045234337785032	0.008793464559643034	0.10825010098314035	0.9605811478101344	1	2
cell death/drug effects	mitogen-activated protein kinase 1/antagonists & inhibitors	1.5919403573150248e-09	4.9268811058508795e-09	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	poly(adp-ribose) polymerases/metabolism	7.930407666079109e-05	0.00017048520692444636	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	piperazines/toxicity	7.930407666079109e-05	0.00017048520692444636	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	nitrophenols/toxicity	7.930407666079109e-05	0.00017048520692444636	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	brain/drug effects	2.338776675170351e-05	5.325898381961981e-05	0.05541661182045544	0.9605811478101344	1	2
cell death/drug effects	alpha-crystallins/administration & dosage	9.299864525136314e-07	2.396766955583933e-06	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	glioblastoma/enzymology	7.930407666079109e-05	0.00017048520692444636	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	tert-butylhydroperoxide/toxicity	1.720221642909081e-08	4.9806233464030755e-08	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	staurosporine/toxicity	9.299864525136314e-07	2.396766955583933e-06	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	cell hypoxia	0.00013145239114953355	0.00027623544796653794	0.05541661182045544	0.9605811478101344	1	2
cell death/drug effects	MAPK3	0.0002878800892200939	0.0005845087215327958	0.01707421177850705	0.8657199677887635	2	2
cell death/drug effects	chromones/pharmacology	1.720221642909081e-08	4.9806233464030755e-08	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	quinazolines	1.5919403573150248e-09	4.9268811058508795e-09	0.02803738317757009	0.9605811478101344	1	2
cell death/drug effects	pc12 cells	0.00013145239114953355	0.00027623544796653794	0.05541661182045544	0.9605811478101344	1	2
NFE2L2	inflammation mediators/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
NFE2L2	nf-e2-related factor 2/biosynthesis	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
NFE2L2	iron/chemistry	1.08218036753982e-08	3.1758169497561496e-08	0.018691588785046728	0.9605811478101344	1	2
NFE2L2	lipopolysaccharides/toxicity	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
NFE2L2	cd8-positive t-lymphocytes/immunology	0.0013185536497509753	0.0024947627966797822	0.09085010295354308	0.9605811478101344	1	2
NFE2L2	microglia/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
NFE2L2	allografts	1.08218036753982e-08	3.1758169497561496e-08	0.018691588785046728	0.9605811478101344	1	2
NFE2L2	PRKAA2	0.0014288243052403837	0.002691849806198409	0.07319670689438858	0.9605811478101344	1	2
NFE2L2	neuroprotective agents/pharmacology	8.00197390016244e-07	2.0757993938013727e-06	0.03711991575621956	0.9605811478101344	1	2
NFE2L2	neurons/drug effects	2.2521588208923582e-05	5.13130078361421e-05	0.055287464515536164	0.9605811478101344	1	2
NFE2L2	azepines/chemistry	5.138143244209914e-09	1.5484661324267384e-08	0.018691588785046728	0.9605811478101344	1	2
NFE2L2	amyloid beta-peptides/metabolism	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
NFE2L2	quassins/pharmacology	5.6621374255882984e-14	2.2173855410190196e-13	0.018691588785046728	0.9605811478101344	1	2
NFE2L2	pyrimidines/chemistry	5.138143244209914e-09	1.5484661324267384e-08	0.018691588785046728	0.9605811478101344	1	2
NFE2L2	mitogen-activated protein kinases/antagonists & inhibitors	5.138143244209914e-09	1.5484661324267384e-08	0.018691588785046728	0.9605811478101344	1	2
neoplasms/diagnostic imaging	t-lymphocytes cytotoxic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/diagnostic imaging	ascorbic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
indole alkaloids/administration & dosage	triple negative breast neoplasms/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
indole alkaloids/administration & dosage	antineoplastic agents/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
indole alkaloids/administration & dosage	disulfides/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
indole alkaloids/administration & dosage	PARP1	7.91125735988274e-06	1.8955379512138082e-05	0.05607476635514018	0.9605811478101344	1	2
lymphoma t-cell	cisplatin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphoma t-cell	killer cells natural/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphoma t-cell	asparaginase	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphoma t-cell	SLC7A11	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
CYP19A1	ESR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CYP19A1	letrozole/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYP19A1	receptors estrogen/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYP19A1	aromatase inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYP19A1	MAPK1	1.1940993098313868e-05	2.7966328429108155e-05	0.04672897196261682	0.9605811478101344	1	2
CYP19A1	amphiregulin/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CYP19A1	EGFR	1.2756462552943049e-13	4.887982036275432e-13	0.018691588785046728	0.9605811478101344	1	2
t-lymphocytes cytotoxic/metabolism	ascorbic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigen presentation/drug effects	drug combinations	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antigen presentation/drug effects	antibodies monoclonal/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigen presentation/drug effects	carcinoma non-small-cell lung/drug therapy	6.981901330971318e-05	0.00015178166095962888	0.05607476635514018	0.9605811478101344	1	2
antigen presentation/drug effects	benzamides/pharmacology	1.983776046765584e-07	5.377218377070026e-07	0.02336448598130841	0.9605811478101344	1	2
antigen presentation/drug effects	tumor cells cultured	0.005290705352827385	0.009188615330377172	0.08878504672897196	0.9605811478101344	1	2
antigen presentation/drug effects	histone deacetylases/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigen presentation/drug effects	pyrimidines/pharmacology	1.972546570527811e-10	6.402282759752272e-10	0.018691588785046728	0.9605811478101344	1	2
antigen presentation/drug effects	CIITA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigen presentation/drug effects	FOXP3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigen presentation/drug effects	HDAC9	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
DNM1L	mesenchymal stem cells/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
DNM1L	hydrogen peroxide/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
DNM1L	necrosis	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
DNM1L	dynamins	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
DNM1L	ascorbic acid/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
DNM1L	H2AX	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
DNM1L	acetylcysteine/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
DNM1L	histones/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
urinary bladder neoplasms/pathology	gels/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
urinary bladder neoplasms/pathology	dextrans/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
urinary bladder neoplasms/pathology	adjuvants immunologic/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
urinary bladder neoplasms/pathology	gold/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PRKAA2	iron/chemistry	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
PRKAA2	cd8-positive t-lymphocytes/immunology	0.0015484433619867843	0.002906280688268036	0.09085010295354308	0.9605811478101344	1	2
PRKAA2	allografts	1.720221642909081e-08	4.9806233464030755e-08	0.018691588785046728	0.9605811478101344	1	2
PRKAA2	k562 cells	3.3630246130123e-06	8.306964672607573e-06	0.03711991575621956	0.9605811478101344	1	2
PRKAA2	g2 phase cell cycle checkpoints/drug effects	0.0006205938576925307	0.0012191796644751775	0.055287464515536164	0.9605811478101344	1	2
PRKAA2	leukemia/drug therapy	2.338776675170351e-05	5.325898381961981e-05	0.03711991575621956	0.9605811478101344	1	2
PRKAA2	carcinoma hepatocellular/pathology	4.271805131850215e-12	1.507921222334831e-11	0.018691588785046728	0.9605811478101344	1	2
PRKAA2	lysosomes/drug effects	0.004664810984252532	0.008163326659322156	0.09085010295354308	0.9605811478101344	1	2
PRKAA2	arsenic/toxicity	1.1102230246251565e-16	4.854858636837654e-16	0.018691588785046728	0.9605811478101344	1	2
PRKAA2	aurora kinase b/antagonists & inhibitors	8.329080758429086e-09	2.4662848853323194e-08	0.018691588785046728	0.9605811478101344	1	2
PRKAA2	spermatogenesis/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.018691588785046728	0.9605811478101344	1	2
PRKAA2	ribosomal proteins/genetics	8.329080758429086e-09	2.4662848853323194e-08	0.018691588785046728	0.9605811478101344	1	2
PRKAA2	berberine/analogs & derivatives	4.271805131850215e-12	1.507921222334831e-11	0.018691588785046728	0.9605811478101344	1	2
PRKAA2	ribosomal protein s6 kinases 70-kda/metabolism	8.41142134544448e-06	2.0083930888494683e-05	0.03711991575621956	0.9605811478101344	1	2
PRKAA2	pyrazoles/pharmacology	1.844599756384291e-05	4.25059943862467e-05	0.03711991575621956	0.9605811478101344	1	2
PRKAA2	RPL15	8.329080758429086e-09	2.4662848853323194e-08	0.018691588785046728	0.9605811478101344	1	2
PRKAA2	TESC	1.1102230246251565e-16	4.854858636837654e-16	0.018691588785046728	0.9605811478101344	1	2
iridium/chemistry	coordination complexes/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
iridium/chemistry	hemolysis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
iridium/chemistry	SPAG17	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
iridium/chemistry	nih 3t3 cells	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fusion regulatory protein 1 heavy chain/metabolism	nivolumab/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fusion regulatory protein 1 heavy chain/metabolism	amino acid transport system y+/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fusion regulatory protein 1 heavy chain/metabolism	cysteine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fusion regulatory protein 1 heavy chain/metabolism	melanoma/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
fusion regulatory protein 1 heavy chain/metabolism	SLC3A2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fusion regulatory protein 1 heavy chain/metabolism	SLC7A11	2.220446049250313e-16	9.623824354997229e-16	0.02336448598130841	0.9605811478101344	1	2
fusion regulatory protein 1 heavy chain/metabolism	cd8-positive t-lymphocytes/immunology	8.426592756904938e-14	3.2900569701476906e-13	0.02336448598130841	0.9605811478101344	1	2
l-selectin/biosynthesis	CD4	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
l-selectin/biosynthesis	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
l-selectin/biosynthesis	dose-response relationship immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-selectin/biosynthesis	interferon-gamma/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-selectin/biosynthesis	th1 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-selectin/biosynthesis	SELP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-selectin/biosynthesis	calcitriol/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-selectin/biosynthesis	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mesenchymal stem cells/cytology	triple negative breast neoplasms/drug therapy	3.951110216782183e-09	1.1990926092169797e-08	0.03711991575621956	0.9605811478101344	1	2
mesenchymal stem cells/cytology	doxorubicin/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mesenchymal stem cells/cytology	CXCL8	0.00011482726388178932	0.00024215318164186428	0.0644991443991049	0.9605811478101344	1	2
mesenchymal stem cells/cytology	MSC	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mesenchymal stem cells/cytology	necrosis	8.205436330399607e-12	2.8445512612051973e-11	0.018647711816067742	0.9605811478101344	1	2
mesenchymal stem cells/cytology	hydrogen peroxide/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mesenchymal stem cells/cytology	ascorbic acid/analogs & derivatives	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mesenchymal stem cells/cytology	dynamins	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mesenchymal stem cells/cytology	acetylcysteine/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mesenchymal stem cells/cytology	histones/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mesenchymal stem cells/cytology	H2AX	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hepatic stellate cells/drug effects	amino acid transport system y+/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hepatic stellate cells/drug effects	actins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hepatic stellate cells/drug effects	hypoxia-inducible factor 1 alpha subunit/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hepatic stellate cells/drug effects	FN1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hepatic stellate cells/drug effects	MMRN1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hepatic stellate cells/drug effects	SLC7A11	1.7763568394002505e-15	7.423259210594527e-15	0.02336448598130841	0.9605811478101344	1	2
hepatic stellate cells/drug effects	liver cirrhosis/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hepatic stellate cells/drug effects	collagen type i/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hepatic stellate cells/drug effects	cell line	2.1067664965124244e-05	4.820963955900979e-05	0.06074766355140186	0.9605811478101344	1	2
kidney/cytology	polysaccharides/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney/cytology	complex mixtures/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney/cytology	cisplatin/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
EEF1A1	paclitaxel/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
EEF1A1	antineoplastic agents phytogenic/pharmacology	2.228787709945834e-09	6.864130664741689e-09	0.02803738317757009	0.9605811478101344	1	2
EEF1A1	peptide elongation factor tu/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
EEF1A1	carcinoma renal cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
EEF1A1	dna mitochondrial/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
EEF1A1	kidney/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-gamma/antagonists & inhibitors	CD4	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
interferon-gamma/antagonists & inhibitors	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interferon-gamma/antagonists & inhibitors	dose-response relationship immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-gamma/antagonists & inhibitors	th1 cells/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-gamma/antagonists & inhibitors	SELP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-gamma/antagonists & inhibitors	calcitriol/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-gamma/antagonists & inhibitors	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia myeloid acute/enzymology	oligopeptides/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
leukemia myeloid acute/enzymology	autocrine communication/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia myeloid acute/enzymology	dna fragmentation/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
leukemia myeloid acute/enzymology	necrosis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
leukemia myeloid acute/enzymology	paracrine communication/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia myeloid acute/enzymology	tumor necrosis factor-alpha/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
leukemia myeloid acute/enzymology	caspases/metabolism	6.6658620179183e-07	1.7392772280599136e-06	0.03271028037383177	0.9605811478101344	1	2
leukemia myeloid acute/enzymology	decitabine	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia myeloid acute/enzymology	MLKL	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hyaluronic acid/chemistry	benzylidene compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cisplatin/pharmacology	cell cycle proteins/metabolism	0.00019202393811867946	0.0003969010769326563	0.05541661182045544	0.9605811478101344	1	2
cisplatin/pharmacology	tnf-related apoptosis-inducing ligand/metabolism	0.0002354523302441347	0.0004825481480965497	0.05541661182045544	0.9605811478101344	1	2
cisplatin/pharmacology	janus kinases/antagonists & inhibitors	3.0451243486773194e-06	7.536076062368115e-06	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	paclitaxel/pharmacology	0.00249461225647174	0.004552703503906044	0.08215010393874443	0.9605811478101344	1	2
cisplatin/pharmacology	sirtuin 1/antagonists & inhibitors	3.0451243486773194e-06	7.536076062368115e-06	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	g2 phase cell cycle checkpoints/drug effects	0.004940660590227575	0.008624836476115406	0.08215010393874443	0.9605811478101344	1	2
cisplatin/pharmacology	erbb receptors/antagonists & inhibitors	0.0030107425192709147	0.005432148204982417	0.08215010393874443	0.9605811478101344	1	2
cisplatin/pharmacology	carcinoma non-small-cell lung/drug therapy	1.3689357626356369e-06	3.4876699439092352e-06	0.0024776877650311857	0.7135314763244264	3	2
cisplatin/pharmacology	receptor igf type 1/biosynthesis	3.0451243486773194e-06	7.536076062368115e-06	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	naphthols/pharmacology	3.0451243486773194e-06	7.536076062368115e-06	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	killer cells natural/drug effects	9.71423569883223e-05	0.00020669703598518916	0.05541661182045544	0.9605811478101344	1	2
cisplatin/pharmacology	receptors tnf-related apoptosis-inducing ligand/biosynthesis	3.0451243486773194e-06	7.536076062368115e-06	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	insulin-like growth factor i/metabolism	3.0451243486773194e-06	7.536076062368115e-06	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	tyrphostins/pharmacology	0.0002354523302441347	0.0004825481480965497	0.05541661182045544	0.9605811478101344	1	2
cisplatin/pharmacology	ovarian neoplasms/drug therapy	0.0006622141828784844	0.0012941409594136523	0.05541661182045544	0.9605811478101344	1	2
cisplatin/pharmacology	IGF1R	3.0451243486773194e-06	7.536076062368115e-06	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	NOS2	3.0451243486773194e-06	7.536076062368115e-06	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	PCNA	7.536071625635632e-05	0.00016278564436368611	0.05541661182045544	0.9605811478101344	1	2
cisplatin/pharmacology	SIRT1	0.00040960392364053355	0.0008169845583885004	0.05541661182045544	0.9605811478101344	1	2
cisplatin/pharmacology	spleen/drug effects	1.7214385472641425e-10	5.601280562290409e-10	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	phenylurea compounds/pharmacology	2.913044805374909e-09	8.909253969885698e-09	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	drugs chinese herbal/chemistry	2.913044805374909e-09	8.909253969885698e-09	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	hydrazones/pharmacology	1.0542052585327255e-06	2.7089880582901553e-06	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	mitophagy/drug effects	0.0016415572694056246	0.0030734591266860746	0.10825010098314035	0.9605811478101344	1	2
cisplatin/pharmacology	mitochondrial dynamics/drug effects	7.493829594085177e-06	1.801984457306031e-05	0.05541661182045544	0.9605811478101344	1	2
cisplatin/pharmacology	chloroquine/pharmacology	0.00019202393811867946	0.0003969010769326563	0.05541661182045544	0.9605811478101344	1	2
cisplatin/pharmacology	isoflavones/pharmacology	1.0542052585327255e-06	2.7089880582901553e-06	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	thymus gland/drug effects	1.7214385472641425e-10	5.601280562290409e-10	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	cytokines/immunology	6.321351797566876e-08	1.770042728381439e-07	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	PKM	6.321351797566876e-08	1.770042728381439e-07	0.02803738317757009	0.9605811478101344	1	2
cisplatin/pharmacology	SQSTM1	2.913044805374909e-09	8.909253969885698e-09	0.02803738317757009	0.9605811478101344	1	2
EGFR	erbb receptors/antagonists & inhibitors	6.591595510940795e-05	0.00014357982397275503	0.055287464515536164	0.9605811478101344	1	2
EGFR	BIRC5	0.00024476711127374706	0.0005015450993832318	0.055287464515536164	0.9605811478101344	1	2
EGFR	antineoplastic agents phytogenic/isolation & purification	0.0005979078450407682	0.0011750309445992385	0.07319670689438858	0.9605811478101344	1	2
EGFR	carcinoma non-small-cell lung/drug therapy	1.2567255661011245e-05	2.9370664915621787e-05	0.01629997420702796	0.8657199677887635	2	2
EGFR	tyrphostins/pharmacology	8.654304161082038e-07	2.2390295487389906e-06	0.03711991575621956	0.9605811478101344	1	2
EGFR	glucose/metabolism	0.0004992749085515058	0.0009891286893470752	0.07319670689438858	0.9605811478101344	1	2
EGFR	adenosine triphosphate/metabolism	0.0004128953377312561	0.000823400543261463	0.10825010098314035	0.9605811478101344	1	2
EGFR	drugs chinese herbal/pharmacology	3.474724952212682e-10	1.1127194734405986e-09	0.00535588186581037	0.8657199677887635	2	2
EGFR	ESR1	4.229828293178528e-07	1.116075325610342e-06	0.03711991575621956	0.9605811478101344	1	2
EGFR	letrozole/pharmacology	1.2756462552943049e-13	4.887982036275432e-13	0.018691588785046728	0.9605811478101344	1	2
EGFR	receptors estrogen/physiology	1.2756462552943049e-13	4.887982036275432e-13	0.018691588785046728	0.9605811478101344	1	2
EGFR	aromatase inhibitors/pharmacology	1.2756462552943049e-13	4.887982036275432e-13	0.018691588785046728	0.9605811478101344	1	2
EGFR	mitogen-activated protein kinase 1/antagonists & inhibitors	3.3306690738754696e-16	1.4334294698576293e-15	0.018691588785046728	0.9605811478101344	1	2
EGFR	erbb receptors/drug effects	1.2756462552943049e-13	4.887982036275432e-13	0.018691588785046728	0.9605811478101344	1	2
EGFR	MAPK1	9.662821366718255e-06	2.290323430374157e-05	0.01125813263425861	0.8657199677887635	2	2
EGFR	cell hypoxia	1.9032712395006257e-07	5.172993625309393e-07	0.03711991575621956	0.9605811478101344	1	2
EGFR	amphiregulin/physiology	1.2756462552943049e-13	4.887982036275432e-13	0.018691588785046728	0.9605811478101344	1	2
EGFR	MAPK3	3.675176344364317e-07	9.72635794508996e-07	0.007095639193881167	0.8657199677887635	2	2
EGFR	glioma/drug therapy	3.3306690738754696e-16	1.4334294698576293e-15	0.018691588785046728	0.9605811478101344	1	2
EGFR	apoptosis	2.962904754433282e-06	7.34083874881953e-06	0.055287464515536164	0.9605811478101344	1	2
EGFR	MAPK14	2.869347596190508e-07	7.679458096723515e-07	0.03711991575621956	0.9605811478101344	1	2
EGFR	MDM2	1.2756462552943049e-13	4.887982036275432e-13	0.018691588785046728	0.9605811478101344	1	2
EGFR	MET	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
EGFR	METTL7B	1.2756462552943049e-13	4.887982036275432e-13	0.018691588785046728	0.9605811478101344	1	2
EGFR	TP73	1.2756462552943049e-13	4.887982036275432e-13	0.018691588785046728	0.9605811478101344	1	2
EGFR	quinazolines	3.3306690738754696e-16	1.4334294698576293e-15	0.018691588785046728	0.9605811478101344	1	2
gels/chemistry	dextrans/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gels/chemistry	adjuvants immunologic/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gels/chemistry	gold/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
STAT3	tumor-associated macrophages/drug effects	6.4497296392573844e-12	2.251126153021162e-11	0.027905752270633143	0.9605811478101344	1	2
STAT3	inflammation/metabolism	6.426711829377041e-09	1.9296764594049433e-08	0.027905752270633143	0.9605811478101344	1	2
STAT3	triple negative breast neoplasms/drug therapy	4.1519241933407613e-07	1.0959131403660614e-06	0.055287464515536164	0.9605811478101344	1	2
STAT3	TGFB1	0.0008126624183660835	0.001577390703418911	0.09538832359347407	0.9605811478101344	1	2
STAT3	liver neoplasms/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	antineoplastic agents phytogenic	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	receptor igf type 1/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	gene silencing	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	glioblastoma/drug therapy	6.852673983814839e-11	2.2840174753612935e-10	0.027905752270633143	0.9605811478101344	1	2
STAT3	neoplasm metastasis/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	stat3 transcription factor/metabolism	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
STAT3	receptor protein-tyrosine kinases/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	brain neoplasms/drug therapy	6.852673983814839e-11	2.2840174753612935e-10	0.027905752270633143	0.9605811478101344	1	2
STAT3	interleukin-6/metabolism	7.66053886991358e-15	3.108771599555579e-14	0.0013038910592810965	0.8657199677887635	2	2
STAT3	tumor escape/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	proto-oncogene proteins/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	quercetin/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	tumor necrosis factor-alpha/metabolism	0.0042608211857593226	0.007489045400480033	0.10849863774429329	0.9605811478101344	1	2
STAT3	tumor microenvironment/immunology	1.496225365826831e-11	5.132842207211758e-11	0.027905752270633143	0.9605811478101344	1	2
STAT3	AXL	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	IL6R	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
STAT3	IL6ST	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
endoplasmic reticulum stress/drug effects	antioxidants/pharmacology	3.927413949611491e-12	1.3876862621960603e-11	0.014018691588785045	0.9605811478101344	1	2
endoplasmic reticulum stress/drug effects	MCL1	1.250576779732171e-05	2.9230061316161248e-05	0.02803738317757009	0.9605811478101344	1	2
endoplasmic reticulum stress/drug effects	urinary bladder neoplasms/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drug combinations	antibodies monoclonal/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drug combinations	carcinoma non-small-cell lung/drug therapy	0.005236754305666724	0.009107111447494869	0.10925365275766749	0.9605811478101344	1	2
drug combinations	benzamides/pharmacology	0.00023111048486224028	0.000474090432661209	0.046290202272826986	0.9605811478101344	1	2
drug combinations	doxorubicin/pharmacology	1.5247580975596975e-11	5.2282840645406236e-11	0.018647711816067742	0.9605811478101344	1	2
drug combinations	antineoplastic agents phytogenic/isolation & purification	1.4580143245956911e-05	3.3795521266490534e-05	0.03711991575621956	0.9605811478101344	1	2
drug combinations	histone deacetylases/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drug combinations	pyrimidines/pharmacology	6.09810297691471e-06	1.4748900223235578e-05	0.03711991575621956	0.9605811478101344	1	2
drug combinations	CIITA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drug combinations	FOXP3	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drug combinations	HDAC9	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drug combinations	WDTC1	3.062374598350459e-07	8.184149714476476e-07	0.03711991575621956	0.9605811478101344	1	2
drug combinations	plant extracts/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drug combinations	anthraquinones/isolation & purification	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drug combinations	mitochondrial adp atp translocases/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drug combinations	voltage-dependent anion channels/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
EIF4EBP1	muscle proteins/biosynthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
EIF4EBP1	receptors tumor necrosis factor type i/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
EIF4EBP1	mitogen-activated protein kinases/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
EIF4EBP1	mitochondria muscle/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
EIF4EBP1	muscle fibers skeletal/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
EIF4EBP1	oxidoreductases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
EIF4EBP1	MAPK3	0.0008808255361461015	0.0017019053037375554	0.0735378000087754	0.9605811478101344	1	2
EIF4EBP1	tumor necrosis factor-alpha/pharmacology	1.2249024017307875e-10	4.008110441282339e-10	0.018647711816067742	0.9605811478101344	1	2
EIF4EBP1	EIF4E	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
EIF4EBP1	RPS6KB1	0.0	0.0	4.387696897898293e-05	0.8657199677887635	2	2
EIF4EBP1	RPS6KB2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
EIF4EBP1	TNFRSF1A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
EIF4EBP1	oncogene protein v-akt/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	TGFB1	2.778872919972919e-05	6.296874628937608e-05	0.0644991443991049	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	chemokine cxcl12/metabolism	1.972546570527811e-10	6.402282759752272e-10	0.027905752270633143	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	ht29 cells	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	epoxy compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	phenanthrenes/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	nf-kappa b/metabolism	2.4375466437520643e-06	6.0891715841202705e-06	0.046290202272826986	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	ARG1	1.021405182655144e-14	4.105732263843321e-14	0.018647711816067742	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	CXCL12	1.95626029821927e-05	4.4919419969942165e-05	0.0644991443991049	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	DDX53	1.963318396747127e-12	7.11025690070313e-12	0.018647711816067742	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	MRC1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor-associated macrophages/drug effects	triple negative breast neoplasms/drug therapy	2.980518054584991e-10	9.580764261188203e-10	0.03711991575621956	0.9605811478101344	1	2
ESRRA	protein kinase inhibitors/pharmacology	0.00016570985144803707	0.00034454647347475684	0.04672897196261682	0.9605811478101344	1	2
ESRRA	phosphoinositide-3 kinase inhibitors	0.002079111832937297	0.003839860754950706	0.07009345794392523	0.9605811478101344	1	2
ESRRA	glucose/deficiency	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ESRRA	imidazoles/pharmacology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
ESRRA	cytoprotection/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ESRRA	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ESRRA	quinolines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ESRRA	cell respiration/drug effects	5.295763827461997e-13	1.979671089655512e-12	0.014018691588785045	0.9605811478101344	1	2
ESRRA	receptors estrogen/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
TGFB1	cell movement/drug effects	3.553671490719168e-05	7.970635709804295e-05	0.001652429656873916	0.5304112294886878	4	2
TGFB1	triple negative breast neoplasms/drug therapy	0.0022276188332333025	0.004094584413099445	0.12539913750269532	0.9605811478101344	1	2
TGFB1	neoplasm metastasis/pathology	2.228787709945834e-09	6.864130664741689e-09	0.03271028037383177	0.9605811478101344	1	2
TGFB1	antibiotics antineoplastic/therapeutic use	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
TGFB1	neovascularization pathologic/pathology	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
TGFB1	tumor microenvironment/genetics	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
TGFB1	epithelial-mesenchymal transition/drug effects	2.0755029139785108e-08	5.986484595421011e-08	0.002720786010366554	0.8657199677887635	2	2
TGFB1	cyclams	0.0012340210382624228	0.0023456932366247006	0.09538832359347407	0.9605811478101344	1	2
TGFB1	neovascularization pathologic/immunology	2.311633029439264e-08	6.647565544942857e-08	0.03271028037383177	0.9605811478101344	1	2
TGFB1	thiazoles/pharmacology	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
TGFB1	chemokine cxcl12/metabolism	0.001997504697757946	0.0036965740789128075	0.09538832359347407	0.9605811478101344	1	2
TGFB1	neoplasm proteins/metabolism	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
TGFB1	neovascularization pathologic/metabolism	2.228787709945834e-09	6.864130664741689e-09	0.03271028037383177	0.9605811478101344	1	2
TGFB1	breast neoplasms/blood supply	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
TGFB1	fas receptor/genetics	2.311633029439264e-08	6.647565544942857e-08	0.03271028037383177	0.9605811478101344	1	2
TGFB1	receptors cxcr4/antagonists & inhibitors	0.0012340210382624228	0.0023456932366247006	0.09538832359347407	0.9605811478101344	1	2
TGFB1	transforming growth factor beta1/genetics	0.0	0.0	0.0009214163485586416	0.8657199677887635	2	2
TGFB1	sarcoma/drug therapy	2.311633029439264e-08	6.647565544942857e-08	0.03271028037383177	0.9605811478101344	1	2
TGFB1	paracrine communication/genetics	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
TGFB1	benzylamines	0.0012340210382624228	0.0023456932366247006	0.09538832359347407	0.9605811478101344	1	2
TGFB1	lipopolysaccharides/pharmacology	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
TGFB1	prostatic neoplasms/metabolism	2.228787709945834e-09	6.864130664741689e-09	0.03271028037383177	0.9605811478101344	1	2
TGFB1	cytarabine/pharmacology	6.072542835244832e-08	1.7021030311654978e-07	0.03271028037383177	0.9605811478101344	1	2
TGFB1	myeloid differentiation factor 88/antagonists & inhibitors	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
TGFB1	transforming growth factor beta/antagonists & inhibitors	6.072542835244832e-08	1.7021030311654978e-07	0.03271028037383177	0.9605811478101344	1	2
TGFB1	isoflavones/adverse effects	2.228787709945834e-09	6.864130664741689e-09	0.03271028037383177	0.9605811478101344	1	2
TGFB1	matrix metalloproteinase 9/metabolism	2.228787709945834e-09	6.864130664741689e-09	0.03271028037383177	0.9605811478101344	1	2
TGFB1	hek293 cells	0.005483951482258553	0.009500287756803377	0.12539913750269532	0.9605811478101344	1	2
TGFB1	leukemia myeloid acute/drug therapy	0.004318096573720398	0.007581254439989436	0.12539913750269532	0.9605811478101344	1	2
TGFB1	piperazines	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
TGFB1	doxorubicin/therapeutic use	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
TGFB1	antibodies neutralizing/metabolism	6.072542835244832e-08	1.7021030311654978e-07	0.03271028037383177	0.9605811478101344	1	2
TGFB1	extracellular vesicles/metabolism	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
TGFB1	hypoxia	2.311633029439264e-08	6.647565544942857e-08	0.03271028037383177	0.9605811478101344	1	2
TGFB1	pancreatic neoplasms/drug therapy	2.228787709945834e-09	6.864130664741689e-09	0.03271028037383177	0.9605811478101344	1	2
TGFB1	embryo nonmammalian	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
TGFB1	glycogen synthase kinase 3 beta/metabolism	0.0015852545308657762	0.0029695575103252875	0.0644991443991049	0.9605811478101344	1	2
TGFB1	plant leaves/chemistry	2.311633029439264e-08	6.647565544942857e-08	0.03271028037383177	0.9605811478101344	1	2
TGFB1	human umbilical vein endothelial cells	0.00028984355859373867	0.0005881703432926599	0.09538832359347407	0.9605811478101344	1	2
TGFB1	receptors androgen/metabolism	2.228787709945834e-09	6.864130664741689e-09	0.03271028037383177	0.9605811478101344	1	2
TGFB1	drug resistance neoplasm/genetics	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
TGFB1	fas ligand protein/genetics	2.311633029439264e-08	6.647565544942857e-08	0.03271028037383177	0.9605811478101344	1	2
TGFB1	CDKN1A	2.228787709945834e-09	6.864130664741689e-09	0.03271028037383177	0.9605811478101344	1	2
TGFB1	CXCR4	0.004318096573720398	0.007581254439989436	0.12539913750269532	0.9605811478101344	1	2
TGFB1	ITK	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
TGFB1	MMP2	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
TGFB1	MMP9	1.2106649016629945e-11	4.177267566802144e-11	0.0009214163485586416	0.8657199677887635	2	2
TGFB1	MYD88	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
TGFB1	PRF1	9.231162623679623e-05	0.00019683624132194228	0.0644991443991049	0.9605811478101344	1	2
TGFB1	SMAD2	9.966494296520523e-11	3.274832581962511e-10	0.03271028037383177	0.9605811478101344	1	2
TGFB1	TRAF6	2.778872919972919e-05	6.296874628937608e-05	0.03271028037383177	0.9605811478101344	1	2
AKT1	PIK3CA	1.0481615575486103e-11	3.622236053421906e-11	2.7384805649470102e-33	0.0	70	2
cyclin d1/metabolism	cell cycle checkpoints/drug effects	0.0004249031122725011	0.0008465808620444699	0.05541661182045544	0.9605811478101344	1	2
cyclin d1/metabolism	receptors fibroblast growth factor/metabolism	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	mechanistic target of rapamycin complex 1/antagonists & inhibitors	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	fibroblast growth factor 2/pharmacology	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	neoplasm recurrence local/pathology	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	receptors estrogen/metabolism	8.21016588048451e-11	2.705391381451539e-10	0.018647711816067742	0.9605811478101344	1	2
cyclin d1/metabolism	p38 mitogen-activated protein kinases/metabolism	1.0194388222473094e-08	3.0048913306027646e-08	0.018647711816067742	0.9605811478101344	1	2
cyclin d1/metabolism	bcl-2-like protein 11/metabolism	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	ligands	2.625674566658631e-09	8.053822043084238e-09	0.018647711816067742	0.9605811478101344	1	2
cyclin d1/metabolism	FGF2	2.220446049250313e-16	9.623824354997229e-16	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	MAPK3	0.0018743562747002285	0.003481533879072505	0.0735378000087754	0.9605811478101344	1	2
cyclin d1/metabolism	MCL1	0.003095856903071792	0.005577044938224273	0.05541661182045544	0.9605811478101344	1	2
cyclin d1/metabolism	PCNA	1.594815390859594e-10	5.191567951819331e-10	0.018647711816067742	0.9605811478101344	1	2
cyclin d1/metabolism	multiple myeloma/pathology	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	enzyme inhibitors/pharmacology	1.5919403573150248e-09	4.9268811058508795e-09	0.018647711816067742	0.9605811478101344	1	2
cyclin d1/metabolism	jnk mitogen-activated protein kinases/metabolism	2.980518054584991e-10	9.580764261188203e-10	0.018647711816067742	0.9605811478101344	1	2
cyclin d1/metabolism	flavonoids/pharmacology	6.632486448943098e-09	1.9812093378444308e-08	0.018647711816067742	0.9605811478101344	1	2
cyclin d1/metabolism	free radicals/metabolism	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	carrier proteins/metabolism	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	cyclin-dependent kinases/antagonists & inhibitors	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	protein transport	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	nitriles/metabolism	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/metabolism	piperidines/pharmacology	2.27001811792249e-08	6.53641889303318e-08	0.018647711816067742	0.9605811478101344	1	2
ventricular function left/drug effects	neutrophils/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ventricular function left/drug effects	neutrophil infiltration	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ventricular function left/drug effects	toll-like receptor 4/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ventricular function left/drug effects	myocardium/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ventricular function left/drug effects	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ventricular function left/drug effects	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ventricular function left/drug effects	adaptor proteins vesicular transport/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ventricular function left/drug effects	TICAM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ventricular function left/drug effects	TRIM69	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ventricular function left/drug effects	myocardial reperfusion injury/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neutrophils/immunology	myocardial reperfusion injury/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neutrophils/immunology	neutrophil infiltration	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophils/immunology	toll-like receptor 4/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophils/immunology	myocardium/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophils/immunology	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neutrophils/immunology	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neutrophils/immunology	adaptor proteins vesicular transport/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophils/immunology	TICAM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophils/immunology	TRIM69	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tacrolimus binding protein 1a/metabolism	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
tacrolimus binding protein 1a/metabolism	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
tacrolimus binding protein 1a/metabolism	spiro compounds/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tacrolimus binding protein 1a/metabolism	enzyme inhibitors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tacrolimus binding protein 1a/metabolism	imp dehydrogenase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tacrolimus binding protein 1a/metabolism	CD40LG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tacrolimus binding protein 1a/metabolism	IL2	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
tacrolimus binding protein 1a/metabolism	PPIA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
H2AX	hydrogen peroxide/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
H2AX	necrosis	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
H2AX	dynamins	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
H2AX	ascorbic acid/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
H2AX	acetylcysteine/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
H2AX	histones/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung neoplasms/drug therapy	iron/chemistry	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	allografts	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	pyridines/therapeutic use	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	chalcones/pharmacology	6.585219036736589e-10	2.0717880896399588e-09	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	phenylurea compounds/therapeutic use	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	cell cycle proteins/metabolism	0.00010286491815503229	0.00021798978426395155	0.046290202272826986	0.9605811478101344	1	2
lung neoplasms/drug therapy	sirtuin 1/antagonists & inhibitors	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	janus kinases/antagonists & inhibitors	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	interferon-alpha/metabolism	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	stat3 transcription factor/physiology	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	tnf-related apoptosis-inducing ligand/metabolism	0.00012810012533626125	0.0002694477736513917	0.046290202272826986	0.9605811478101344	1	2
lung neoplasms/drug therapy	clodronic acid/pharmacology	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	ng-nitroarginine methyl ester/pharmacology	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	paclitaxel/pharmacology	0.0016209321813352995	0.003035100869136364	0.06878335787959994	0.9605811478101344	1	2
lung neoplasms/drug therapy	liver neoplasms/drug therapy	6.394809691490089e-05	0.00013950011287026167	0.046290202272826986	0.9605811478101344	1	2
lung neoplasms/drug therapy	erbb receptors/antagonists & inhibitors	0.0019837845797622267	0.0036761205593038803	0.06878335787959994	0.9605811478101344	1	2
lung neoplasms/drug therapy	colorectal neoplasms/immunology	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	b7-h1 antigen/genetics	2.812667174656447e-05	6.368869864108589e-05	0.046290202272826986	0.9605811478101344	1	2
lung neoplasms/drug therapy	receptors ccr5/drug effects	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	receptor igf type 1/biosynthesis	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	naphthols/pharmacology	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	adenocarcinoma/drug therapy	0.0007038336660539768	0.0013726779893107545	0.046290202272826986	0.9605811478101344	1	2
lung neoplasms/drug therapy	maraviroc	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	neoplasm proteins/antagonists & inhibitors	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	receptors tnf-related apoptosis-inducing ligand/biosynthesis	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	insulin-like growth factor i/metabolism	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	chemokine ccl5/antagonists & inhibitors	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	tyrphostins/pharmacology	0.00012810012533626125	0.0002694477736513917	0.046290202272826986	0.9605811478101344	1	2
lung neoplasms/drug therapy	adaptor proteins signal transducing/metabolism	6.585219036736589e-10	2.0717880896399588e-09	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	CCL5	0.0031114927315230023	0.0056047542275015644	0.06878335787959994	0.9605811478101344	1	2
lung neoplasms/drug therapy	CCR5	6.861162231697193e-07	1.7853759575647317e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	CXCL10	0.0017963169899918308	0.0033461639908195237	0.06878335787959994	0.9605811478101344	1	2
lung neoplasms/drug therapy	CXCL9	0.0003305347547476467	0.0006651725331029678	0.046290202272826986	0.9605811478101344	1	2
lung neoplasms/drug therapy	EIF2S1	6.585219036736589e-10	2.0717880896399588e-09	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	IGF1R	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	NOS2	1.1858723574231789e-06	3.035304589791763e-06	0.02336448598130841	0.9605811478101344	1	2
lung neoplasms/drug therapy	SIRT1	0.0002324067354035897	0.0004766608095049624	0.046290202272826986	0.9605811478101344	1	2
lung neoplasms/drug therapy	anti-inflammatory agents/pharmacology	1.0484188629700242e-05	2.472514610200352e-05	0.046290202272826986	0.9605811478101344	1	2
lung neoplasms/drug therapy	pentacyclic triterpenes/pharmacology	3.11347614356805e-11	1.0604962461515275e-10	0.02336448598130841	0.9605811478101344	1	2
macrophages/metabolism	inflammasomes/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	hypertension pulmonary/chemically induced	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	monocrotaline/toxicity	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	endothelial cells/metabolism	5.833880045713613e-10	1.8448850724023771e-09	0.018647711816067742	0.9605811478101344	1	2
macrophages/metabolism	toll-like receptor 4/metabolism	2.718516745048305e-09	8.331645426025164e-09	0.018647711816067742	0.9605811478101344	1	2
macrophages/metabolism	bacterial toxins/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	inflammation/metabolism	2.718516745048305e-09	8.331645426025164e-09	0.018647711816067742	0.9605811478101344	1	2
macrophages/metabolism	nlr family pyrin domain-containing 3 protein/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	lung/blood supply	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	phenylenediamines/pharmacology	3.296304340594247e-10	1.0557367533617368e-09	0.018647711816067742	0.9605811478101344	1	2
macrophages/metabolism	cyclohexylamines/pharmacology	3.296304340594247e-10	1.0557367533617368e-09	0.018647711816067742	0.9605811478101344	1	2
macrophages/metabolism	cell communication/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	antigens cd/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	phenotype	4.7240131872960944e-07	1.2431969772440236e-06	0.027905752270633143	0.9605811478101344	1	2
macrophages/metabolism	endometrial neoplasms/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	estrogen receptor alpha/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	receptors cell surface/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	hek293 cells	2.2268460292407255e-06	5.581798687210041e-06	0.03711991575621956	0.9605811478101344	1	2
macrophages/metabolism	estradiol/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	tumor necrosis factor alpha-induced protein 3/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	hmgb1 protein/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	antigens differentiation myelomonocytic/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
macrophages/metabolism	ESR1	5.833880045713613e-10	1.8448850724023771e-09	0.018647711816067742	0.9605811478101344	1	2
macrophages/metabolism	IL17A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
sulindac/administration & dosage	erbb receptors/antagonists & inhibitors	4.2366110619695974e-13	1.5912913235827203e-12	0.014018691588785045	0.9605811478101344	1	2
sulindac/administration & dosage	carcinoma non-small-cell lung/drug therapy	4.420021589923717e-05	9.793250529056187e-05	0.05607476635514018	0.9605811478101344	1	2
sulindac/administration & dosage	ZHX2	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
sulindac/administration & dosage	antineoplastic agents/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
sulindac/administration & dosage	raf kinases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sulindac/administration & dosage	MAPK1	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
sulindac/administration & dosage	cell transformation neoplastic/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
BCL2	proto-oncogene proteins c-bcl-2/genetics	0.0029695394476696446	0.005361756264206071	0.02176297661357553	0.8657199677887635	2	2
BCL2	caspase 3/metabolism	0.005179795384338215	0.009021857706833425	0.005067514095832102	0.5304112294886878	4	2
BCL2	MCL1	0.0025396522084986106	0.004633367967974958	0.0003021633375022579	0.35414021462530776	5	2
BCL2	berberine/pharmacology	0.0029695394476696446	0.005361756264206071	0.02176297661357553	0.8657199677887635	2	2
BCL2	caspases/metabolism	0.002016717320063033	0.0037308762772906316	0.0009436528626620446	0.35414021462530776	5	2
BCL2	morpholines/pharmacology	0.0025024070011224753	0.004566173099457779	0.003079666501921066	0.7135314763244264	3	2
BCL2	pc12 cells	0.0029695394476696446	0.005361756264206071	0.02176297661357553	0.8657199677887635	2	2
BCL2	PARP1	0.0017881354008018047	0.0033331763034222346	0.000411808019654165	0.11552077256850565	7	2
HCRT	glucose/metabolism	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
HCRT	glucose transporter type 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRT	orexin receptors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRT	orexins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRT	carcinoma hepatocellular/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRT	l-lactate dehydrogenase/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRT	HCRTR1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRT	LDHA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRT	PDHB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRT	PDK1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRT	SLC2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell division/drug effects	gene expression/drug effects	0.0005270664847516482	0.0010423142753434693	0.07319670689438858	0.9605811478101344	1	2
cell division/drug effects	t-lymphocytes/cytology	1.983776046765584e-07	5.377218377070026e-07	0.03711991575621956	0.9605811478101344	1	2
cell division/drug effects	jurkat cells/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	rna messenger/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	g2 phase/drug effects	1.3844481117075702e-13	5.292009703004249e-13	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	chemical and drug induced liver injury/pathology	3.175126828125485e-12	1.1320374564442222e-11	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	diosgenin/analogs & derivatives	1.3844481117075702e-13	5.292009703004249e-13	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	cell cycle proteins/drug effects	1.3844481117075702e-13	5.292009703004249e-13	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	anticarcinogenic agents/isolation & purification	1.3844481117075702e-13	5.292009703004249e-13	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	dna fragmentation/drug effects	1.38042009478756e-06	3.51449217666006e-06	0.055287464515536164	0.9605811478101344	1	2
cell division/drug effects	lignans/pharmacology	1.2728672372785965e-05	2.9738451676929635e-05	0.03711991575621956	0.9605811478101344	1	2
cell division/drug effects	g1 phase/drug effects	3.175126828125485e-12	1.1320374564442222e-11	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	oleic acid/toxicity	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	receptors death domain/drug effects	1.3844481117075702e-13	5.292009703004249e-13	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	mercaptoethanol/pharmacology	3.9129477436006255e-11	1.324622629370591e-10	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	interleukins/metabolism	3.9129477436006255e-11	1.324622629370591e-10	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	arachidonic acid/toxicity	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	cd3 complex/immunology	3.9129477436006255e-11	1.324622629370591e-10	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	mitochondria liver/drug effects	0.0006970924638045606	0.001361095876900722	0.12539913750269532	0.9605811478101344	1	2
cell division/drug effects	CD28	3.9129477436006255e-11	1.324622629370591e-10	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	CD3E	3.9129477436006255e-11	1.324622629370591e-10	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	IL2	8.752998326144734e-13	3.2533059186587842e-12	0.001559737378978988	0.8657199677887635	2	2
cell division/drug effects	IL5	3.9129477436006255e-11	1.324622629370591e-10	0.018691588785046728	0.9605811478101344	1	2
cell division/drug effects	MAPK8	0.003038948212182868	0.005479451274305518	0.09085010295354308	0.9605811478101344	1	2
cell division/drug effects	genes cdc/drug effects	1.3844481117075702e-13	5.292009703004249e-13	0.018691588785046728	0.9605811478101344	1	2
HCRTR1	glucose/metabolism	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
HCRTR1	glucose transporter type 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRTR1	orexin receptors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRTR1	orexins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRTR1	carcinoma hepatocellular/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRTR1	l-lactate dehydrogenase/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRTR1	LDHA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRTR1	PDHB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRTR1	PDK1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HCRTR1	SLC2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bystander effect/genetics	proto-oncogene proteins c-bcl-2/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bystander effect/genetics	minor histocompatibility antigens	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bystander effect/genetics	leukemia lymphocytic chronic b-cell/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bystander effect/genetics	b-lymphocytes/drug effects	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
bystander effect/genetics	dexamethasone/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bystander effect/genetics	gene expression regulation leukemic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bystander effect/genetics	chemokine cxcl12/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bystander effect/genetics	chlorambucil/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bystander effect/genetics	monocytes/drug effects	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
bystander effect/genetics	x-linked inhibitor of apoptosis protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bystander effect/genetics	tumor cells cultured	0.003158697231605445	0.005679112497956198	0.08878504672897196	0.9605811478101344	1	2
bystander effect/genetics	BCL2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bystander effect/genetics	CXCL12	8.390528605239922e-08	2.3337249235313462e-07	0.03271028037383177	0.9605811478101344	1	2
bystander effect/genetics	XIAP	9.435785486289205e-13	3.5005922665607337e-12	0.014018691588785045	0.9605811478101344	1	2
isoflavones/pharmacology	g2 phase cell cycle checkpoints/drug effects	1.594815390859594e-10	5.191567951819331e-10	0.014018691588785045	0.9605811478101344	1	2
isoflavones/pharmacology	cell cycle proteins/metabolism	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
isoflavones/pharmacology	ovarian neoplasms/drug therapy	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
isoflavones/pharmacology	PARP1	0.0011343027438561748	0.002163791910065837	0.05607476635514018	0.9605811478101344	1	2
isoflavones/pharmacology	hydrazones/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	inflammasomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	monocrotaline/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	endothelial cells/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	toll-like receptor 4/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	bacterial toxins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	inflammation/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	nlr family pyrin domain-containing 3 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	lung/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hypertension pulmonary/chemically induced	hmgb1 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemical and drug induced liver injury/pathology	cell line	0.00010933179359395861	0.0002313829319600307	0.06074766355140186	0.9605811478101344	1	2
chemical and drug induced liver injury/pathology	lignans/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemical and drug induced liver injury/pathology	g1 phase/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemical and drug induced liver injury/pathology	mitochondria liver/drug effects	4.979927581416632e-11	1.6775774379690435e-10	0.03271028037383177	0.9605811478101344	1	2
chemical and drug induced liver injury/pathology	PARP1	0.00029652745217612075	0.0006010698966239874	0.05607476635514018	0.9605811478101344	1	2
spiro compounds/metabolism	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
spiro compounds/metabolism	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
spiro compounds/metabolism	enzyme inhibitors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
spiro compounds/metabolism	imp dehydrogenase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
spiro compounds/metabolism	CD40LG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
spiro compounds/metabolism	IL2	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
spiro compounds/metabolism	PPIA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPA5	antioxidants/pharmacology	1.2850165376221412e-11	4.427573780511481e-11	0.014018691588785045	0.9605811478101344	1	2
HSPA5	endoplasmic reticulum/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
HSPA5	gene expression regulation	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
HSPA5	SPP1	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
HSPA5	tor serine-threonine kinases/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
HSPA5	phenylbutyrates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPA5	muscle smooth vascular/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPA5	eukaryotic initiation factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPA5	myocytes smooth muscle/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
HSPA5	cerebral arteries/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPA5	organophosphorus compounds/pharmacology	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
HSPA5	transcription factor chop/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPA5	taurochenodeoxycholic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPA5	activating transcription factor 4/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HSPA5	piperidines/pharmacology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
carcinoma renal cell/drug therapy	paclitaxel/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
carcinoma renal cell/drug therapy	antineoplastic agents phytogenic/pharmacology	2.228787709945834e-09	6.864130664741689e-09	0.02803738317757009	0.9605811478101344	1	2
carcinoma renal cell/drug therapy	peptide elongation factor tu/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma renal cell/drug therapy	dna mitochondrial/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma renal cell/drug therapy	kidney/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
C2	melanoma/genetics	1.247890679678676e-12	4.590172456715957e-12	0.027905752270633143	0.9605811478101344	1	2
C2	host-pathogen interactions	1.1124434706744069e-13	4.2827228289557047e-13	0.046290202272826986	0.9605811478101344	1	2
C2	ceramides/pharmacology	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
C2	cytokines/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
C2	FLT1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
C2	KDR	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
C2	endothelial cells/microbiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
C2	bacterial adhesion	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
C2	intercellular adhesion molecule-1/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
C2	receptors vascular endothelial growth factor/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
C2	fimbriae proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
C2	ICAM1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
C2	vascular endothelial growth factor a/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
C2	protein kinase c/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin b1/metabolism	interleukin-10/metabolism	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
cyclin b1/metabolism	gene expression regulation	6.350475700855895e-14	2.482980816677971e-13	0.009345794392523364	0.9605811478101344	1	2
cyclin b1/metabolism	aspirin/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin b1/metabolism	interleukin-6/metabolism	7.947415625597642e-08	2.213829686837357e-07	0.02336448598130841	0.9605811478101344	1	2
cyclin b1/metabolism	lymphoma t-cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin b1/metabolism	glucose/metabolism	8.329080758429086e-09	2.4662848853323194e-08	0.018691588785046728	0.9605811478101344	1	2
cyclin b1/metabolism	interleukin-4/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin b1/metabolism	nitric oxide/metabolism	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
cyclin b1/metabolism	transforming growth factor beta/metabolism	3.752653865429778e-08	1.0667678239426992e-07	0.018691588785046728	0.9605811478101344	1	2
cyclin b1/metabolism	BIRC5	1.3561035627773776e-09	4.206439413634725e-09	0.014018691588785045	0.9605811478101344	1	2
cyclin b1/metabolism	SOCS5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypertrophy	t-lymphocytes/drug effects	1.3844481117075702e-13	5.292009703004249e-13	0.014018691588785045	0.9605811478101344	1	2
hypertrophy	protein kinase inhibitors/pharmacology	0.00011180421294365583	0.00023589084085949512	0.04672897196261682	0.9605811478101344	1	2
hypertrophy	breast neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hypertrophy	CCL5	1.3098300222225134e-11	4.508841893827007e-11	0.014018691588785045	0.9605811478101344	1	2
hypertrophy	chemokines/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hypertrophy	CXCL9	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
hypertrophy	CXCL10	1.0363931934875836e-12	3.832030375652229e-12	0.014018691588785045	0.9605811478101344	1	2
hypertrophy	TNFRSF4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypertrophy	TNFRSF9	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypertrophy	cyclin-dependent kinase 4/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hypertrophy	receptors chemokine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocrotaline/toxicity	inflammasomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocrotaline/toxicity	endothelial cells/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
monocrotaline/toxicity	toll-like receptor 4/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
monocrotaline/toxicity	bacterial toxins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocrotaline/toxicity	inflammation/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
monocrotaline/toxicity	nlr family pyrin domain-containing 3 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocrotaline/toxicity	lung/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocrotaline/toxicity	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
monocrotaline/toxicity	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
monocrotaline/toxicity	hmgb1 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nerve tissue proteins/metabolism	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
nerve tissue proteins/metabolism	interleukin-1beta/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nerve tissue proteins/metabolism	leukemia myeloid acute/drug therapy	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
nerve tissue proteins/metabolism	mesenchymal stem cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nerve tissue proteins/metabolism	tumor cells cultured	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
nerve tissue proteins/metabolism	cell adhesion/drug effects	9.609091300433192e-12	3.321229738077301e-11	0.018691588785046728	0.9605811478101344	1	2
nerve tissue proteins/metabolism	nf-kappa b/metabolism	1.181569286856643e-09	3.6847580815580287e-09	0.02336448598130841	0.9605811478101344	1	2
nerve tissue proteins/metabolism	CCL2	2.5110025170249628e-11	8.560782974387874e-11	0.018691588785046728	0.9605811478101344	1	2
nerve tissue proteins/metabolism	CCL4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nerve tissue proteins/metabolism	CXCL12	3.443467222474794e-08	9.800124605798924e-08	0.03271028037383177	0.9605811478101344	1	2
nerve tissue proteins/metabolism	NFKB1	1.6902963206888444e-07	4.602649534216085e-07	0.03271028037383177	0.9605811478101344	1	2
IRF3	glucose/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
IRF3	MAPK3	1.0929630311906635e-08	3.2014944747830144e-08	0.037383177570093455	0.9605811478101344	1	2
IRF3	keratinocytes/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents immunological/administration & dosage	cd8-positive t-lymphocytes/immunology	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
antineoplastic agents immunological/administration & dosage	sulfasalazine/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents immunological/administration & dosage	ATM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents immunological/administration & dosage	SLC7A11	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
interleukin-10/metabolism	gene expression regulation	6.096331439664482e-09	1.8334731357484997e-08	0.018647711816067742	0.9605811478101344	1	2
interleukin-10/metabolism	aspirin/administration & dosage	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
interleukin-10/metabolism	neoplasm invasiveness	0.0002893340491763041	0.0005872985745018554	0.05541661182045544	0.9605811478101344	1	2
interleukin-10/metabolism	interleukin-6/metabolism	3.379596134700513e-05	7.601850191580994e-05	0.046290202272826986	0.9605811478101344	1	2
interleukin-10/metabolism	lymphoma t-cell/drug therapy	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
interleukin-10/metabolism	carcinoma non-small-cell lung/drug therapy	0.004631411970105526	0.008108096801404369	0.10925365275766749	0.9605811478101344	1	2
interleukin-10/metabolism	glucose/metabolism	8.41142134544448e-06	2.0083930888494683e-05	0.03711991575621956	0.9605811478101344	1	2
interleukin-10/metabolism	interleukin-4/metabolism	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
interleukin-10/metabolism	nitric oxide/metabolism	2.625674566658631e-09	8.053822043084238e-09	0.018647711816067742	0.9605811478101344	1	2
interleukin-10/metabolism	drugs chinese herbal/pharmacology	5.697251249958679e-05	0.00012476459630422025	0.0644991443991049	0.9605811478101344	1	2
interleukin-10/metabolism	transforming growth factor beta/metabolism	2.1270633422276752e-05	4.8553155160405616e-05	0.03711991575621956	0.9605811478101344	1	2
interleukin-10/metabolism	BIRC5	2.7526414267953214e-06	6.837566266108973e-06	0.027905752270633143	0.9605811478101344	1	2
interleukin-10/metabolism	SOCS5	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
leukemia/metabolism	tumor necrosis factor-alpha/metabolism	0.00025250561210343747	0.0005151993092408466	0.037383177570093455	0.9605811478101344	1	2
leukemia/metabolism	BIRC5	2.332691073636539e-08	6.70113000541217e-08	0.014018691588785045	0.9605811478101344	1	2
leukemia/metabolism	CASP8	0.000335616220874857	0.0006746595949898656	0.03271028037383177	0.9605811478101344	1	2
leukemia/metabolism	MCL1	0.00018571952850299223	0.00038444692183212586	0.02803738317757009	0.9605811478101344	1	2
leukemia/metabolism	XIAP	6.226627435879095e-09	1.8701087277790802e-08	0.014018691588785045	0.9605811478101344	1	2
leukemia/metabolism	flavonoids/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia/metabolism	multiple myeloma/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia/metabolism	PARP1	0.0035270245753111773	0.006293100091968992	0.05607476635514018	0.9605811478101344	1	2
leukemia/metabolism	TNFRSF10D	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia/metabolism	caspases/metabolism	0.00014922404803296985	0.00031191617472799767	0.03271028037383177	0.9605811478101344	1	2
LDHA	glucose/metabolism	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
LDHA	glucose transporter type 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
LDHA	orexin receptors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
LDHA	orexins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
LDHA	carcinoma hepatocellular/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
LDHA	l-lactate dehydrogenase/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
LDHA	PDHB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
LDHA	PDK1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
LDHA	SLC2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	g2 phase cell cycle checkpoints/drug effects	1.3036816781664129e-06	3.327572776130247e-06	0.027905752270633143	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	k562 cells	6.519751405420493e-11	2.177662157047584e-10	0.018647711816067742	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	benzamides/pharmacology	0.00018940888987306614	0.000391642802581015	0.046290202272826986	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	leukemia/drug therapy	2.625674566658631e-09	8.053822043084238e-09	0.018647711816067742	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	nf-kappa b/metabolism	5.697251249958679e-05	0.00012476459630422025	0.046290202272826986	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	pyrazoles/pharmacology	1.6715591133475982e-09	5.170389356213223e-09	0.018647711816067742	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	ribosomal proteins/genetics	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	RPL15	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	NFKB1	0.0005658201448542899	0.0011153511447248442	0.0644991443991049	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	aurora kinase b/antagonists & inhibitors	6.661338147750939e-16	2.8276700708820313e-15	0.009345794392523364	0.9605811478101344	1	2
ribosomal protein s6 kinases 70-kda/metabolism	biological products/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	mechanistic target of rapamycin complex 1/antagonists & inhibitors	2.2737118288151947e-07	6.120229325078429e-07	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	epithelial-mesenchymal transition/drug effects	5.4981036390344684e-09	1.656493427622738e-08	0.001949627583877449	0.8657199677887635	2	2
cell cycle checkpoints/drug effects	fibroblast growth factor 2/pharmacology	2.2737118288151947e-07	6.120229325078429e-07	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	phenotype	0.0020370465275560967	0.0037650097945810057	0.08215010393874443	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	transforming growth factor beta1/genetics	6.09810297691471e-06	1.4748900223235578e-05	0.05541661182045544	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	receptors fibroblast growth factor/metabolism	2.2737118288151947e-07	6.120229325078429e-07	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	plant extracts/isolation & purification	0.00029965026733114186	0.000606786287115817	0.05541661182045544	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	neoplasm recurrence local/pathology	2.2737118288151947e-07	6.120229325078429e-07	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	isoflavones/adverse effects	5.376860068295741e-10	1.7064777714953865e-09	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	receptors estrogen/metabolism	4.86123297633867e-05	0.00010706269569704824	0.05541661182045544	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	pancreatic neoplasms/drug therapy	5.376860068295741e-10	1.7064777714953865e-09	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	bcl-2-like protein 11/metabolism	2.2737118288151947e-07	6.120229325078429e-07	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	ligands	0.0002039311921900877	0.0004202126098511265	0.05541661182045544	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	CDKN1A	5.376860068295741e-10	1.7064777714953865e-09	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	FGF2	2.2737118288151947e-07	6.120229325078429e-07	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	MAPK1	0.0012534531533926474	0.00237791560196189	0.026746177529959735	0.8657199677887635	2	2
cell cycle checkpoints/drug effects	PCNA	6.394809691490089e-05	0.00013950011287026167	0.05541661182045544	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	PI3	3.6323003479776794e-05	8.120559528717489e-05	0.05541661182045544	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	dna neoplasm/metabolism	4.712144485718994e-08	1.3323077920124696e-07	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	cyclohexenes/chemistry	4.712144485718994e-08	1.3323077920124696e-07	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	dioxanes/chemistry	4.712144485718994e-08	1.3323077920124696e-07	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	uterine cervical neoplasms/enzymology	4.712144485718994e-08	1.3323077920124696e-07	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	rhizome/chemistry	8.276241856286504e-07	2.141720427786442e-06	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	saponins/isolation & purification	8.276241856286504e-07	2.141720427786442e-06	0.02803738317757009	0.9605811478101344	1	2
cell cycle checkpoints/drug effects	pyrazoles/pharmacology	0.00035829809211107566	0.0007172468072330666	0.05541661182045544	0.9605811478101344	1	2
MAP1LC3A	curcumin/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
MAP1LC3A	kidney tubules/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MAP1LC3A	ureteral obstruction/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MAP1LC3A	fibrosis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MAP1LC3A	kidney failure chronic/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MAP1LC3A	nlr family pyrin domain-containing 3 protein/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MAP1LC3A	inflammasomes/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd36 antigens/antagonists & inhibitors	antibodies monoclonal humanized/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd36 antigens/antagonists & inhibitors	fatty acids/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd36 antigens/antagonists & inhibitors	CD36	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondrial adp atp translocases/genetics	antineoplastic agents phytogenic/isolation & purification	3.7466474367420233e-10	1.1952840787916093e-09	0.018691588785046728	0.9605811478101344	1	2
mitochondrial adp atp translocases/genetics	doxorubicin/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial adp atp translocases/genetics	plant extracts/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondrial adp atp translocases/genetics	anthraquinones/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondrial adp atp translocases/genetics	voltage-dependent anion channels/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondrial adp atp translocases/genetics	WDTC1	1.5842882561400984e-13	6.04645793169065e-13	0.018691588785046728	0.9605811478101344	1	2
cd11b antigen/metabolism	lymph nodes/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd11b antigen/metabolism	chemokines/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd11b antigen/metabolism	granulocyte colony-stimulating factor/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd11b antigen/metabolism	radiation tolerance/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd11b antigen/metabolism	neutrophils/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd11b antigen/metabolism	CSF3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd11b antigen/metabolism	ITGAM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
uterine cervical neoplasms/drug therapy	antineoplastic agents phytogenic/pharmacology	0.00011921627541833235	0.0002512407226556482	0.05541661182045544	0.9605811478101344	1	2
uterine cervical neoplasms/drug therapy	hela cells	1.8196722684216127e-08	5.263727915791093e-08	0.027905752270633143	0.9605811478101344	1	2
uterine cervical neoplasms/drug therapy	naphthalenes/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
uterine cervical neoplasms/drug therapy	bcl-associated death protein/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
uterine cervical neoplasms/drug therapy	PRKCA	1.0859091403858656e-12	4.002361204819051e-12	0.018647711816067742	0.9605811478101344	1	2
uterine cervical neoplasms/drug therapy	RTCA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
uterine cervical neoplasms/drug therapy	benzophenanthridines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
uterine cervical neoplasms/drug therapy	g1 phase cell cycle checkpoints/drug effects	2.1216362000586741e-13	8.055421894075021e-13	0.018647711816067742	0.9605811478101344	1	2
neutrophil infiltration	myocardial reperfusion injury/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neutrophil infiltration	toll-like receptor 4/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophil infiltration	myocardium/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophil infiltration	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neutrophil infiltration	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neutrophil infiltration	adaptor proteins vesicular transport/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophil infiltration	TICAM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophil infiltration	TRIM69	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MAPK14	BIRC5	1.0040240102648923e-06	2.585461501789342e-06	0.027905752270633143	0.9605811478101344	1	2
MAPK14	antineoplastic agents phytogenic/isolation & purification	4.563453836148312e-06	1.1185662054407782e-05	0.03711991575621956	0.9605811478101344	1	2
MAPK14	carcinoma non-small-cell lung/drug therapy	0.003077677585448413	0.005545201879869789	0.10925365275766749	0.9605811478101344	1	2
MAPK14	drugs chinese herbal/pharmacology	2.6631302138979684e-05	6.04952554667447e-05	0.0644991443991049	0.9605811478101344	1	2
MAPK14	erbb receptors/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MAPK14	hydrogen peroxide	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MAPK14	MAPK3	0.0006144270508697813	0.001207279887494603	0.0735378000087754	0.9605811478101344	1	2
MAPK14	MDM2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MAPK14	METTL7B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MAPK14	TP73	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MAPK14	astrocytes/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibodies monoclonal/pharmacology	histone deacetylases/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibodies monoclonal/pharmacology	pyrimidines/pharmacology	1.972546570527811e-10	6.402282759752272e-10	0.018691588785046728	0.9605811478101344	1	2
antibodies monoclonal/pharmacology	CIITA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibodies monoclonal/pharmacology	FOXP3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibodies monoclonal/pharmacology	HDAC9	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibodies monoclonal/pharmacology	carcinoma non-small-cell lung/drug therapy	6.981901330971318e-05	0.00015178166095962888	0.05607476635514018	0.9605811478101344	1	2
antibodies monoclonal/pharmacology	benzamides/pharmacology	1.983776046765584e-07	5.377218377070026e-07	0.02336448598130841	0.9605811478101344	1	2
antibodies monoclonal/pharmacology	tumor cells cultured	0.005290705352827385	0.009188615330377172	0.08878504672897196	0.9605811478101344	1	2
mutant proteins/metabolism	osteoprotegerin/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutant proteins/metabolism	mutation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutant proteins/metabolism	recombinant proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutant proteins/metabolism	tnf-related apoptosis-inducing ligand/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutant proteins/metabolism	multiple myeloma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutant proteins/metabolism	TNFRSF11B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MAPK8	neovascularization pathologic/drug therapy	0.0002251322773904052	0.0004623862554172011	0.046290202272826986	0.9605811478101344	1	2
MAPK8	extracellular signal-regulated map kinases/drug effects	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	astrocytes/physiology	9.200277617527064e-08	2.549619418190507e-07	0.02336448598130841	0.9605811478101344	1	2
MAPK8	antimycin a/metabolism	9.200277617527064e-08	2.549619418190507e-07	0.02336448598130841	0.9605811478101344	1	2
MAPK8	antioxidants/metabolism	0.0	0.0	0.00043876968978982925	0.8657199677887635	2	2
MAPK8	hepatocytes/metabolism	3.4161414586009187e-07	9.052774865292433e-07	0.046290202272826986	0.9605811478101344	1	2
MAPK8	berberine/pharmacology	3.0584879435746615e-05	6.904222604682516e-05	0.046290202272826986	0.9605811478101344	1	2
MAPK8	extracellular space/drug effects	9.200277617527064e-08	2.549619418190507e-07	0.02336448598130841	0.9605811478101344	1	2
MAPK8	malaria/metabolism	1.247890679678676e-12	4.590172456715957e-12	0.02336448598130841	0.9605811478101344	1	2
MAPK8	cell cycle proteins/drug effects	8.464442480260459e-10	2.6577047536995528e-09	0.02336448598130841	0.9605811478101344	1	2
MAPK8	tor serine-threonine kinases/drug effects	0.00018792661334021687	0.00038897915611388486	0.046290202272826986	0.9605811478101344	1	2
MAPK8	apoferritins/metabolism	3.4161414586009187e-07	9.052774865292433e-07	0.046290202272826986	0.9605811478101344	1	2
MAPK8	p38 mitogen-activated protein kinases/drug effects	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	g2 phase/drug effects	8.464442480260459e-10	2.6577047536995528e-09	0.02336448598130841	0.9605811478101344	1	2
MAPK8	angiogenesis inhibitors/pharmacology	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	brain/drug effects	4.046665105006397e-06	9.974384822267307e-06	0.046290202272826986	0.9605811478101344	1	2
MAPK8	proto-oncogene proteins c-akt/drug effects	0.0009516668167697251	0.0018291648484124224	0.06878335787959994	0.9605811478101344	1	2
MAPK8	cell nucleus/drug effects	7.515323696694054e-09	2.2394628580174417e-08	0.02336448598130841	0.9605811478101344	1	2
MAPK8	receptors death domain/drug effects	8.464442480260459e-10	2.6577047536995528e-09	0.02336448598130841	0.9605811478101344	1	2
MAPK8	lignans/pharmacology	0.0003156281689388196	0.0006386133677859131	0.046290202272826986	0.9605811478101344	1	2
MAPK8	alpha-crystallins/administration & dosage	9.200277617527064e-08	2.549619418190507e-07	0.02336448598130841	0.9605811478101344	1	2
MAPK8	endothelial cells/drug effects	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	embryonic stem cells/cytology	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	anticarcinogenic agents/isolation & purification	8.464442480260459e-10	2.6577047536995528e-09	0.02336448598130841	0.9605811478101344	1	2
MAPK8	jnk mitogen-activated protein kinases/metabolism	3.0584879435746615e-05	6.904222604682516e-05	0.046290202272826986	0.9605811478101344	1	2
MAPK8	staurosporine/toxicity	9.200277617527064e-08	2.549619418190507e-07	0.02336448598130841	0.9605811478101344	1	2
MAPK8	cell differentiation	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	iron overload/metabolism	1.247890679678676e-12	4.590172456715957e-12	0.02336448598130841	0.9605811478101344	1	2
MAPK8	platelet endothelial cell adhesion molecule-1/biosynthesis	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	phosphatidylinositol 3-kinases/drug effects	0.0009516668167697251	0.0018291648484124224	0.06878335787959994	0.9605811478101344	1	2
MAPK8	genes cdc/drug effects	8.464442480260459e-10	2.6577047536995528e-09	0.02336448598130841	0.9605811478101344	1	2
MAPK8	CP	1.247890679678676e-12	4.590172456715957e-12	0.02336448598130841	0.9605811478101344	1	2
MAPK8	host-parasite interactions	1.247890679678676e-12	4.590172456715957e-12	0.02336448598130841	0.9605811478101344	1	2
MAPK8	diosgenin/analogs & derivatives	8.464442480260459e-10	2.6577047536995528e-09	0.02336448598130841	0.9605811478101344	1	2
MAPK8	jnk mitogen-activated protein kinases/drug effects	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	caspase 3/biosynthesis	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	cytoprotection	1.2242470929679783e-05	2.863590060021004e-05	0.046290202272826986	0.9605811478101344	1	2
MAPK8	acetylcysteine/metabolism	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	nitric oxide synthase/antagonists & inhibitors	2.652268324410123e-06	6.593439172014251e-06	0.02336448598130841	0.9605811478101344	1	2
MAPK8	ceruloplasmin/metabolism	1.247890679678676e-12	4.590172456715957e-12	0.02336448598130841	0.9605811478101344	1	2
CD4	oncogene proteins/metabolism	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
CD4	phenotype	5.3953543135421e-06	1.3103852379926881e-05	0.04166180294604871	0.9605811478101344	1	2
CD4	piperidines/chemistry	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
CD4	paclitaxel/pharmacology	6.607139012682062e-06	1.595380582100691e-05	0.04166180294604871	0.9605811478101344	1	2
CD4	antineoplastic agents immunological/pharmacology	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
CD4	breast neoplasms/immunology	3.355178501696088e-08	9.559960662366936e-08	0.027905752270633143	0.9605811478101344	1	2
CD4	th1 cells/drug effects	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
CD4	cancer vaccines/pharmacology	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
CD4	SOCS1	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
CD4	TBX21	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
CD4	dose-response relationship immunologic	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
CD4	calcitriol/metabolism	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
CD4	interleukin-4/antagonists & inhibitors	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
CD4	th1 cells/metabolism	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
CD4	ligands	5.118447821139682e-08	1.445702505258618e-07	0.027905752270633143	0.9605811478101344	1	2
CD4	SELP	1.7763568394002505e-15	7.423259210594527e-15	0.014018691588785045	0.9605811478101344	1	2
endothelial cells/metabolism	inflammasomes/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endothelial cells/metabolism	toll-like receptor 4/metabolism	2.094446838185604e-10	6.793933189394763e-10	0.018647711816067742	0.9605811478101344	1	2
endothelial cells/metabolism	bacterial toxins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endothelial cells/metabolism	inflammation/metabolism	2.094446838185604e-10	6.793933189394763e-10	0.018647711816067742	0.9605811478101344	1	2
endothelial cells/metabolism	nlr family pyrin domain-containing 3 protein/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endothelial cells/metabolism	lung/blood supply	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endothelial cells/metabolism	phenylenediamines/pharmacology	1.9081847213442416e-11	6.5166754548014e-11	0.018647711816067742	0.9605811478101344	1	2
endothelial cells/metabolism	cyclohexylamines/pharmacology	1.9081847213442416e-11	6.5166754548014e-11	0.018647711816067742	0.9605811478101344	1	2
endothelial cells/metabolism	lymphatic metastasis/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endothelial cells/metabolism	receptors ccr7/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endothelial cells/metabolism	carcinoma non-small-cell lung/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endothelial cells/metabolism	neoplasm recurrence local/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endothelial cells/metabolism	chemokine ccl21/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endothelial cells/metabolism	tumor necrosis factor-alpha/metabolism	0.0016675829297913003	0.003114780450359081	0.0735378000087754	0.9605811478101344	1	2
endothelial cells/metabolism	nf-kappa b/metabolism	3.4789498117304696e-05	7.808600778686083e-05	0.046290202272826986	0.9605811478101344	1	2
endothelial cells/metabolism	CCL21	3.930189507173054e-13	1.4767010609091941e-12	0.018647711816067742	0.9605811478101344	1	2
endothelial cells/metabolism	CXCL8	0.00028730260487308534	0.0005834436614388677	0.0644991443991049	0.9605811478101344	1	2
endothelial cells/metabolism	NFKB1	0.00038962000871256564	0.0007784632489437831	0.0644991443991049	0.9605811478101344	1	2
endothelial cells/metabolism	hmgb1 protein/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	melanoma/genetics	2.687248645827367e-09	8.240397516439749e-09	0.027905752270633143	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	minor histocompatibility antigens	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	leukemia lymphocytic chronic b-cell/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	b-lymphocytes/drug effects	1.1483151762803345e-08	3.361844775810492e-08	0.027905752270633143	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	dexamethasone/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	gene expression regulation leukemic	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	chemokine cxcl12/genetics	2.980518054584991e-10	9.580764261188203e-10	0.027905752270633143	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	chlorambucil/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	monocytes/drug effects	1.1483151762803345e-08	3.361844775810492e-08	0.027905752270633143	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	x-linked inhibitor of apoptosis protein/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	BCL2A1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	CXCL12	0.00011330803691222968	0.0002390179485113701	0.0644991443991049	0.9605811478101344	1	2
proto-oncogene proteins c-bcl-2/genetics	XIAP	2.3995120701503225e-07	6.455697635469714e-07	0.027905752270633143	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	ACSL4	0.00015425612723674043	0.0003219461466599444	0.10925365275766749	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	drugs chinese herbal/pharmacology	0.0	0.0	5.0751888037058294e-08	0.2127419111522651	6	2
carcinoma non-small-cell lung/drug therapy	anti-inflammatory agents non-steroidal/pharmacology	1.3424762523861489e-08	3.917273215009239e-08	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	killer cells natural/drug effects	0.002644876201650548	0.004812596393000849	0.10925365275766749	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	histone deacetylases/chemistry	6.981901330971318e-05	0.00015178166095962888	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	CIITA	6.981901330971318e-05	0.00015178166095962888	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	FOXP3	6.981901330971318e-05	0.00015178166095962888	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	HDAC9	6.981901330971318e-05	0.00015178166095962888	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	IREB2	1.3424762523861489e-08	3.917273215009239e-08	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	MAPK1	0.0002911321747229856	0.0005907309210650089	0.013041477345600383	0.7135314763244264	3	2
carcinoma non-small-cell lung/drug therapy	MKI67	1.3424762523861489e-08	3.917273215009239e-08	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	PCNA	0.0022530193887317918	0.00413989261461443	0.10925365275766749	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	sp1 transcription factor/physiology	6.782466204224846e-07	1.7674011921847232e-06	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	spleen/drug effects	6.782466204224846e-07	1.7674011921847232e-06	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	raf kinases/metabolism	4.420021589923717e-05	9.793250529056187e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	antineoplastic agents/administration & dosage	0.004070162479772765	0.007179115388322394	0.15967325731855422	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	drugs chinese herbal/chemistry	3.925344091548766e-06	9.67642962102719e-06	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	gefitinib/pharmacology	6.782466204224846e-07	1.7674011921847232e-06	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	deoxycytidine/administration & dosage	1.8107737531636303e-13	6.887000122434314e-13	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	sp1 transcription factor/metabolism	8.033954999486781e-06	1.919720817477886e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	drugs chinese herbal/administration & dosage	0.00015425612723674043	0.0003219461466599444	0.10925365275766749	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	dna (cytosine-5-)-methyltransferase 1/metabolism	8.033954999486781e-06	1.919720817477886e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	erlotinib hydrochloride/pharmacology	8.033954999486781e-06	1.919720817477886e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	erbb receptors/drug effects	1.5139915970241447e-05	3.505249052944276e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	rna long noncoding/physiology	6.782466204224846e-07	1.7674011921847232e-06	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	cell transformation neoplastic/drug effects	0.0035524822154440194	0.006335959220685143	0.10925365275766749	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	receptors prostaglandin e ep4 subtype/physiology	6.782466204224846e-07	1.7674011921847232e-06	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	chloroquine/pharmacology	0.004070162479772765	0.007179115388322394	0.10925365275766749	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	thymus gland/drug effects	6.782466204224846e-07	1.7674011921847232e-06	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	cytokines/immunology	2.6631302138979684e-05	6.04952554667447e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	proto-oncogene proteins c-met/antagonists & inhibitors	8.033954999486781e-06	1.919720817477886e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	DCR	1.8107737531636303e-13	6.887000122434314e-13	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	DNMT1	8.033954999486781e-06	1.919720817477886e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	HGF	8.033954999486781e-06	1.919720817477886e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	MDM2	1.5139915970241447e-05	3.505249052944276e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	MET	6.782466204224846e-07	1.7674011921847232e-06	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	METTL7B	1.5139915970241447e-05	3.505249052944276e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	PKM	2.6631302138979684e-05	6.04952554667447e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	PTGER4	6.782466204224846e-07	1.7674011921847232e-06	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	SP1	6.024314380681517e-11	2.0164579241728568e-10	0.0028958799526128736	0.8657199677887635	2	2
carcinoma non-small-cell lung/drug therapy	SQSTM1	3.925344091548766e-06	9.67642962102719e-06	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	TP73	1.5139915970241447e-05	3.505249052944276e-05	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	VIP	1.8107737531636303e-13	6.887000122434314e-13	0.05607476635514018	0.9605811478101344	1	2
carcinoma non-small-cell lung/drug therapy	cell proliferation	0.00015425612723674043	0.0003219461466599444	0.10925365275766749	0.9605811478101344	1	2
killer cells natural/metabolism	cisplatin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
killer cells natural/metabolism	asparaginase	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
killer cells natural/metabolism	SLC7A11	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
MLKL	oligopeptides/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MLKL	autocrine communication/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MLKL	necrosis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MLKL	dna fragmentation/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
MLKL	paracrine communication/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MLKL	tumor necrosis factor-alpha/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MLKL	caspases/metabolism	6.6658620179183e-07	1.7392772280599136e-06	0.03271028037383177	0.9605811478101344	1	2
MLKL	decitabine	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glucose/metabolism	gene expression regulation	3.642710610984867e-05	8.138881592115359e-05	0.03711991575621956	0.9605811478101344	1	2
glucose/metabolism	interleukin-6/metabolism	0.00352420294653244	0.0062916296813884404	0.09085010295354308	0.9605811478101344	1	2
glucose/metabolism	aspirin/administration & dosage	8.329080758429086e-09	2.4662848853323194e-08	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	erbb receptors/antagonists & inhibitors	0.0003091638139606223	0.0006256488086465169	0.055287464515536164	0.9605811478101344	1	2
glucose/metabolism	lymphoma t-cell/drug therapy	8.329080758429086e-09	2.4662848853323194e-08	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	interleukin-4/metabolism	8.329080758429086e-09	2.4662848853323194e-08	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	nitric oxide/metabolism	2.338776675170351e-05	5.325898381961981e-05	0.03711991575621956	0.9605811478101344	1	2
glucose/metabolism	killer cells natural/drug effects	2.3918581283366436e-06	5.991330153779404e-06	0.03711991575621956	0.9605811478101344	1	2
glucose/metabolism	adenosine triphosphate/metabolism	1.8105605903429023e-10	5.886057194910102e-10	0.0038501128055567616	0.8657199677887635	2	2
glucose/metabolism	tyrphostins/pharmacology	8.41142134544448e-06	2.0083930888494683e-05	0.03711991575621956	0.9605811478101344	1	2
glucose/metabolism	transforming growth factor beta/metabolism	0.002749796883666389	0.004997322922113134	0.07319670689438858	0.9605811478101344	1	2
glucose/metabolism	BIRC5	0.0009233416052052412	0.001776735530770218	0.055287464515536164	0.9605811478101344	1	2
glucose/metabolism	SOCS5	8.329080758429086e-09	2.4662848853323194e-08	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	glucose transporter type 1/metabolism	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	carcinoma hepatocellular/metabolism	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	orexin receptors/metabolism	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	orexins/pharmacology	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	mitogen-activated protein kinase 1/antagonists & inhibitors	1.241229341530925e-13	4.764384492004497e-13	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	cell hypoxia	2.3918581283366436e-06	5.991330153779404e-06	0.03711991575621956	0.9605811478101344	1	2
glucose/metabolism	quinazolines	1.241229341530925e-13	4.764384492004497e-13	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	glioma/drug therapy	1.241229341530925e-13	4.764384492004497e-13	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	l-lactate dehydrogenase/metabolism	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	cytokines/immunology	6.740019653506124e-11	2.2474887072066398e-10	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	IL2	0.0008396882185267573	0.0016241289448265589	0.07319670689438858	0.9605811478101344	1	2
glucose/metabolism	PDHB	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	PDK1	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	PKM	6.740019653506124e-11	2.2474887072066398e-10	0.018691588785046728	0.9605811478101344	1	2
glucose/metabolism	SLC2A1	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
chondrosarcoma/drug therapy	phosphoinositide-3 kinase inhibitors	0.0005733062746914319	0.0011294010672262948	0.07009345794392523	0.9605811478101344	1	2
chondrosarcoma/drug therapy	morpholines/pharmacology	7.263079027097774e-13	2.703636103147927e-12	0.014018691588785045	0.9605811478101344	1	2
small molecule libraries/pharmacology	necroptosis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
small molecule libraries/pharmacology	ileum/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
small molecule libraries/pharmacology	radiation-protective agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
small molecule libraries/pharmacology	drug interactions	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MYC	protein kinase inhibitors/pharmacology	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
MYC	pyridines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MYC	mesothelioma malignant/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MYC	phosphoinositide-3 kinase inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MYC	cyclin-dependent kinase 4/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
l-lactate dehydrogenase/metabolism	glucose transporter type 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-lactate dehydrogenase/metabolism	orexin receptors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-lactate dehydrogenase/metabolism	orexins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-lactate dehydrogenase/metabolism	carcinoma hepatocellular/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-lactate dehydrogenase/metabolism	PDHB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-lactate dehydrogenase/metabolism	PDK1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
l-lactate dehydrogenase/metabolism	SLC2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
toll-like receptor 4/genetics	myocardium/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
toll-like receptor 4/genetics	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/genetics	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/genetics	adaptor proteins vesicular transport/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
toll-like receptor 4/genetics	TICAM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
toll-like receptor 4/genetics	TRIM69	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
toll-like receptor 4/genetics	myocardial reperfusion injury/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ATM	cd8-positive t-lymphocytes/immunology	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
ATM	sulfasalazine/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ATM	SLC7A11	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
gene expression/drug effects	cell movement/drug effects	4.361220686832645e-05	9.667825628723725e-05	0.002660220255949666	0.7135314763244264	3	2
gene expression/drug effects	antineoplastic agents phytogenic/isolation & purification	0.0014162765613265904	0.002668666406642908	0.07319670689438858	0.9605811478101344	1	2
gene expression/drug effects	caspase 8/metabolism	0.00013315331632623995	0.0002794901293184442	0.03711991575621956	0.9605811478101344	1	2
gene expression/drug effects	p38 mitogen-activated protein kinases/metabolism	1.044588973286853e-05	2.463746008026159e-05	0.03711991575621956	0.9605811478101344	1	2
gene expression/drug effects	cell adhesion/drug effects	0.0010225856949998002	0.0019572853028349334	0.07319670689438858	0.9605811478101344	1	2
gene expression/drug effects	chemokine ccl2/biosynthesis	1.3393322007004826e-09	4.157341455869948e-09	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	trabectedin	1.3393322007004826e-09	4.157341455869948e-09	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	BRCA1	1.3393322007004826e-09	4.157341455869948e-09	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	CCL2	1.3041767665811221e-10	4.264346633483699e-10	0.001559737378978988	0.8657199677887635	2	2
gene expression/drug effects	CCL5	0.0003795874729707327	0.0007588307737835447	0.055287464515536164	0.9605811478101344	1	2
gene expression/drug effects	PI3	3.594389679228982e-07	9.513697916883625e-07	0.03711991575621956	0.9605811478101344	1	2
gene expression/drug effects	SPP1	6.09810297691471e-06	1.4748900223235578e-05	0.03711991575621956	0.9605811478101344	1	2
gene expression/drug effects	jurkat cells/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	rna messenger/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	dna fragmentation/drug effects	3.3630246130123e-06	8.306964672607573e-06	0.055287464515536164	0.9605811478101344	1	2
gene expression/drug effects	oleic acid/toxicity	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	arachidonic acid/toxicity	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	IL2	0.0005842436866995149	0.0011489969498127647	0.07319670689438858	0.9605811478101344	1	2
gene expression/drug effects	chemokine ccl5/metabolism	6.519751405420493e-11	2.177662157047584e-10	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	butyrates/pharmacology	6.519751405420493e-11	2.177662157047584e-10	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	antineoplastic agents alkylating/pharmacology	1.3393322007004826e-09	4.157341455869948e-09	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	valproic acid/pharmacology	6.519751405420493e-11	2.177662157047584e-10	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	interleukin-8/biosynthesis	1.3393322007004826e-09	4.157341455869948e-09	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	osteopontin/genetics	1.9081847213442416e-11	6.5166754548014e-11	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	g2 phase cell cycle checkpoints/drug effects	0.0004249031122725011	0.0008465808620444699	0.055287464515536164	0.9605811478101344	1	2
gene expression/drug effects	heterocyclic compounds 4 or more rings/pharmacology	4.563453836148312e-06	1.1185662054407782e-05	0.03711991575621956	0.9605811478101344	1	2
gene expression/drug effects	diterpenes/isolation & purification	1.9081847213442416e-11	6.5166754548014e-11	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	plant extracts/isolation & purification	8.033954999486781e-06	1.919720817477886e-05	0.03711991575621956	0.9605811478101344	1	2
gene expression/drug effects	leukocytes mononuclear/drug effects	6.519751405420493e-11	2.177662157047584e-10	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	ovarian neoplasms/drug therapy	2.140681395301769e-05	4.8793283783328236e-05	0.03711991575621956	0.9605811478101344	1	2
gene expression/drug effects	fibrosarcoma/drug therapy	1.3393322007004826e-09	4.157341455869948e-09	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	rho gtp-binding proteins/genetics	1.3393322007004826e-09	4.157341455869948e-09	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	neovascularization pathologic/prevention & control	1.3393322007004826e-09	4.157341455869948e-09	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	human umbilical vein endothelial cells/drug effects	1.9081847213442416e-11	6.5166754548014e-11	0.018691588785046728	0.9605811478101344	1	2
gene expression/drug effects	leukemia/drug therapy	1.3416778257835382e-05	3.1283114110485884e-05	0.03711991575621956	0.9605811478101344	1	2
gene expression/drug effects	vascular endothelial growth factor a/biosynthesis	1.3393322007004826e-09	4.157341455869948e-09	0.018691588785046728	0.9605811478101344	1	2
NAMPT	prostatic neoplasms/drug therapy	1.387981951594952e-10	4.531649055051903e-10	0.02336448598130841	0.9605811478101344	1	2
NAMPT	tumor cells cultured	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
NAMPT	SIRT1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NAMPT	naphthoquinones/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
NAMPT	sirtuin 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
necroptosis/drug effects	ileum/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
necroptosis/drug effects	radiation-protective agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
necroptosis/drug effects	drug interactions	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	tamoxifen/pharmacology	1.9317880628477724e-14	7.674245623363548e-14	0.018647711816067742	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	protein kinase inhibitors/pharmacology	0.004664810984252532	0.008163326659322156	0.09148348032117941	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	selective estrogen receptor modulators/pharmacology	1.9317880628477724e-14	7.674245623363548e-14	0.018647711816067742	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	glucose/deficiency	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	histone deacetylases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	imidazoles/pharmacology	1.4788753555095013e-09	4.584679954762864e-09	0.018647711816067742	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	benzofurans/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	breast neoplasms/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	cytoprotection/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	endoplasmic reticulum/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	quinolines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	cell respiration/drug effects	4.051452284770107e-08	1.1493363352368931e-07	0.027905752270633143	0.9605811478101344	1	2
receptors estrogen/antagonists & inhibitors	hydroxamic acids/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antineoplastic agents phytogenic	glioblastoma/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antineoplastic agents phytogenic	stat3 transcription factor/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antineoplastic agents phytogenic	receptor protein-tyrosine kinases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents phytogenic	brain neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antineoplastic agents phytogenic	interleukin-6/metabolism	4.8407944319706075e-12	1.6987081909293006e-11	0.02336448598130841	0.9605811478101344	1	2
antineoplastic agents phytogenic	proto-oncogene proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents phytogenic	quercetin/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents phytogenic	tumor cells cultured	0.0007392287055421054	0.0014384003618208754	0.08878504672897196	0.9605811478101344	1	2
antineoplastic agents phytogenic	AXL	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
OGG1	neuroprotective agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
OGG1	rac1 gtp-binding protein/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
OGG1	neurons/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
OGG1	rna small interfering/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
OGG1	pc12 cells	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
OGG1	POLG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
OGG1	RAC1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
toll-like receptor 4/metabolism	inflammasomes/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/metabolism	bacterial toxins/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/metabolism	inflammation/metabolism	1.0540680550619186e-09	3.2927305862858006e-09	0.018647711816067742	0.9605811478101344	1	2
toll-like receptor 4/metabolism	nlr family pyrin domain-containing 3 protein/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/metabolism	lung/blood supply	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/metabolism	phenylenediamines/pharmacology	1.1500711494250027e-10	3.773890266784113e-10	0.018647711816067742	0.9605811478101344	1	2
toll-like receptor 4/metabolism	cyclohexylamines/pharmacology	1.1500711494250027e-10	3.773890266784113e-10	0.018647711816067742	0.9605811478101344	1	2
toll-like receptor 4/metabolism	acetates/therapeutic use	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/metabolism	interleukin-6/metabolism	4.299934603357869e-05	9.533885572690496e-05	0.046290202272826986	0.9605811478101344	1	2
toll-like receptor 4/metabolism	melanoma/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/metabolism	tyramine/analogs & derivatives	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/metabolism	antineoplastic agents phytogenic/therapeutic use	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/metabolism	paclitaxel/therapeutic use	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
toll-like receptor 4/metabolism	CXCL8	0.000506886801762696	0.0010038480378392095	0.0644991443991049	0.9605811478101344	1	2
toll-like receptor 4/metabolism	XIAP	1.4759829600752283e-06	3.7508612613806633e-06	0.027905752270633143	0.9605811478101344	1	2
toll-like receptor 4/metabolism	hmgb1 protein/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
pyridines/therapeutic use	phenylurea compounds/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	neoplasm invasiveness	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
pyridines/therapeutic use	interferon-alpha/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	stat3 transcription factor/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	clodronic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	ng-nitroarginine methyl ester/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	liver neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pyridines/therapeutic use	colorectal neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	receptors ccr5/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	adenocarcinoma/drug therapy	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
pyridines/therapeutic use	maraviroc	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	neoplasm proteins/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
pyridines/therapeutic use	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyridines/therapeutic use	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
pyridines/therapeutic use	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
PARP1	CASP8	0.001580656145574677	0.0029614468641766213	0.004196605452229575	0.7135314763244264	3	2
PARP1	MCL1	0.0008631200332757105	0.0016687189138603006	0.0024776877650311857	0.7135314763244264	3	2
PARP1	drugs chinese herbal/chemistry	6.895564590614356e-05	0.000150082337703717	0.05607476635514018	0.9605811478101344	1	2
PARP1	biphenyl compounds/administration & dosage	0.00029652745217612075	0.0006010698966239874	0.05607476635514018	0.9605811478101344	1	2
PARP1	sulfonamides/administration & dosage	0.00029652745217612075	0.0006010698966239874	0.05607476635514018	0.9605811478101344	1	2
PARP1	plant roots	0.0023608697427153214	0.004318989054711866	0.05607476635514018	0.9605811478101344	1	2
PARP1	1-phosphatidylinositol 4-kinase/metabolism	0.0023608697427153214	0.004318989054711866	0.05607476635514018	0.9605811478101344	1	2
PARP1	dna/metabolism	0.0023608697427153214	0.004318989054711866	0.05607476635514018	0.9605811478101344	1	2
PARP1	piperazines/administration & dosage	0.00029652745217612075	0.0006010698966239874	0.05607476635514018	0.9605811478101344	1	2
PARP1	flavonoids/metabolism	0.0035270245753111773	0.006293100091968992	0.05607476635514018	0.9605811478101344	1	2
PARP1	naphthalenes/pharmacology	0.00029652745217612075	0.0006010698966239874	0.05607476635514018	0.9605811478101344	1	2
PARP1	disulfides/administration & dosage	7.91125735988274e-06	1.8955379512138082e-05	0.05607476635514018	0.9605811478101344	1	2
PARP1	multiple myeloma/metabolism	0.0035270245753111773	0.006293100091968992	0.05607476635514018	0.9605811478101344	1	2
PARP1	g1 phase/drug effects	0.00029652745217612075	0.0006010698966239874	0.05607476635514018	0.9605811478101344	1	2
PARP1	epothilones/administration & dosage	0.00029652745217612075	0.0006010698966239874	0.05607476635514018	0.9605811478101344	1	2
PARP1	hydrazones/pharmacology	0.0011343027438561748	0.002163791910065837	0.05607476635514018	0.9605811478101344	1	2
PARP1	plant extracts/pharmacology	0.0023608697427153214	0.004318989054711866	0.05607476635514018	0.9605811478101344	1	2
PARP1	PTEN	6.443311990844691e-05	0.00014053036183019464	0.0012799159762966297	0.7135314763244264	3	2
PARP1	SQSTM1	6.895564590614356e-05	0.000150082337703717	0.05607476635514018	0.9605811478101344	1	2
PARP1	TNFRSF10D	0.0035270245753111773	0.006293100091968992	0.05607476635514018	0.9605811478101344	1	2
PARP1	TNS1	0.0023608697427153214	0.004318989054711866	0.05607476635514018	0.9605811478101344	1	2
CXCL8	triple negative breast neoplasms/drug therapy	0.0025655755545276326	0.004675246700241776	0.12539913750269532	0.9605811478101344	1	2
CXCL8	antineoplastic agents alkylating/pharmacology	2.829982222896099e-06	7.021769980915282e-06	0.03271028037383177	0.9605811478101344	1	2
CXCL8	thiazoles/pharmacology	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	neovascularization pathologic/pathology	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	mutation/genetics	2.5567992167907505e-11	8.710183734827328e-11	0.03271028037383177	0.9605811478101344	1	2
CXCL8	breast neoplasms/blood supply	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	epithelial-mesenchymal transition/drug effects	0.00573409467492203	0.009895532200429	0.09538832359347407	0.9605811478101344	1	2
CXCL8	head and neck neoplasms/genetics	2.5567992167907505e-11	8.710183734827328e-11	0.03271028037383177	0.9605811478101344	1	2
CXCL8	lymphatic metastasis/genetics	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
CXCL8	interleukin-8/biosynthesis	2.829982222896099e-06	7.021769980915282e-06	0.03271028037383177	0.9605811478101344	1	2
CXCL8	receptors ccr7/genetics	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
CXCL8	acetates/therapeutic use	9.060780714609251e-08	2.5163382440572464e-07	0.03271028037383177	0.9605811478101344	1	2
CXCL8	neoplasm recurrence local/genetics	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
CXCL8	heterocyclic compounds 4 or more rings/pharmacology	0.00042355659510706634	0.0008441268922462802	0.0644991443991049	0.9605811478101344	1	2
CXCL8	chemokine ccl2/biosynthesis	2.829982222896099e-06	7.021769980915282e-06	0.03271028037383177	0.9605811478101344	1	2
CXCL8	neoplasm proteins/metabolism	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	fibrosarcoma/drug therapy	2.829982222896099e-06	7.021769980915282e-06	0.03271028037383177	0.9605811478101344	1	2
CXCL8	myeloid differentiation factor 88/antagonists & inhibitors	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	caspase 8/genetics	2.5567992167907505e-11	8.710183734827328e-11	0.03271028037383177	0.9605811478101344	1	2
CXCL8	trabectedin	2.829982222896099e-06	7.021769980915282e-06	0.03271028037383177	0.9605811478101344	1	2
CXCL8	hela cells	0.0034513312262458573	0.006172530084058133	0.09538832359347407	0.9605811478101344	1	2
CXCL8	doxorubicin/administration & dosage	2.557620781828973e-12	9.178128743125846e-12	0.03271028037383177	0.9605811478101344	1	2
CXCL8	BRCA1	2.829982222896099e-06	7.021769980915282e-06	0.03271028037383177	0.9605811478101344	1	2
CXCL8	rho gtp-binding proteins/genetics	2.829982222896099e-06	7.021769980915282e-06	0.03271028037383177	0.9605811478101344	1	2
CXCL8	paclitaxel/therapeutic use	9.060780714609251e-08	2.5163382440572464e-07	0.03271028037383177	0.9605811478101344	1	2
CXCL8	melanoma/drug therapy	9.060780714609251e-08	2.5163382440572464e-07	0.03271028037383177	0.9605811478101344	1	2
CXCL8	CXCR1	6.641519666106266e-05	0.0001446101378612591	0.0644991443991049	0.9605811478101344	1	2
CXCL8	ITK	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	MMP2	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	MMP9	0.0008266389137319141	0.0015995905537968442	0.0644991443991049	0.9605811478101344	1	2
CXCL8	MSC	2.557620781828973e-12	9.178128743125846e-12	0.03271028037383177	0.9605811478101344	1	2
CXCL8	MYD88	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	NFKB1	1.1922868581315527e-08	3.4891877685272726e-08	0.0007180836797181683	0.7135314763244264	3	2
CXCL8	TRAF6	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	piperazines	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	lipopolysaccharides/pharmacology	3.560085416054459e-05	7.97285558691404e-05	0.03271028037383177	0.9605811478101344	1	2
CXCL8	neovascularization pathologic/prevention & control	2.829982222896099e-06	7.021769980915282e-06	0.03271028037383177	0.9605811478101344	1	2
CXCL8	tnf-related apoptosis-inducing ligand/pharmacology	2.5567992167907505e-11	8.710183734827328e-11	0.03271028037383177	0.9605811478101344	1	2
CXCL8	carcinoma non-small-cell lung/genetics	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
CXCL8	CASP8	0.001440730063056339	0.0027131206380480158	0.017871301736518	0.8657199677887635	2	2
CXCL8	ovarian neoplasms/drug therapy	0.001104966622113679	0.0021098384068903085	0.0644991443991049	0.9605811478101344	1	2
CXCL8	tyramine/analogs & derivatives	9.060780714609251e-08	2.5163382440572464e-07	0.03271028037383177	0.9605811478101344	1	2
CXCL8	glycogen synthase kinase 3 beta/metabolism	0.0018406431306735582	0.0034220844712952703	0.0644991443991049	0.9605811478101344	1	2
CXCL8	vascular endothelial growth factor a/biosynthesis	2.829982222896099e-06	7.021769980915282e-06	0.03271028037383177	0.9605811478101344	1	2
CXCL8	chemokine ccl21/genetics	3.6136885706028465e-09	1.0972952155991126e-08	0.03271028037383177	0.9605811478101344	1	2
CXCL8	nf-kappa b/metabolism	9.759036387779751e-06	2.3111410770974004e-05	0.00878568916972137	0.8657199677887635	2	2
CXCL8	antineoplastic agents phytogenic/therapeutic use	9.060780714609251e-08	2.5163382440572464e-07	0.03271028037383177	0.9605811478101344	1	2
CXCL8	caspase 8/metabolism	0.0034513312262458573	0.006172530084058133	0.0644991443991049	0.9605811478101344	1	2
CXCL8	CCL21	6.641519666106266e-05	0.0001446101378612591	0.0644991443991049	0.9605811478101344	1	2
CXCL8	CXCL1	2.5199984108881246e-05	5.73384158547589e-05	0.0644991443991049	0.9605811478101344	1	2
voltage-dependent anion channels/genetics	antineoplastic agents phytogenic/isolation & purification	3.7466474367420233e-10	1.1952840787916093e-09	0.018691588785046728	0.9605811478101344	1	2
voltage-dependent anion channels/genetics	doxorubicin/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
voltage-dependent anion channels/genetics	WDTC1	1.5842882561400984e-13	6.04645793169065e-13	0.018691588785046728	0.9605811478101344	1	2
voltage-dependent anion channels/genetics	plant extracts/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
voltage-dependent anion channels/genetics	anthraquinones/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDHB	glucose transporter type 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDHB	orexin receptors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDHB	orexins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDHB	carcinoma hepatocellular/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDHB	PDK1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDHB	SLC2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	estrogens	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	benzopyrans/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	lung neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
specific pathogen-free organisms	immunity innate/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
specific pathogen-free organisms	neoplasms hormone-dependent/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	interleukin-1beta/deficiency	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	estrogen receptor modulators/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	triple negative breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	neutrophil infiltration/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	estrogen receptor beta/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	neutrophils/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	ESR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
specific pathogen-free organisms	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dextrans/chemistry	adjuvants immunologic/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dextrans/chemistry	gold/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDK1	glucose transporter type 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDK1	orexin receptors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDK1	orexins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDK1	carcinoma hepatocellular/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PDK1	SLC2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CXCR1	nf-kappa b	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CXCR1	neovascularization pathologic/drug therapy	3.283429084177669e-11	1.1161431459751656e-10	0.018647711816067742	0.9605811478101344	1	2
CXCR1	receptors interleukin-8b/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CXCR1	CXCR2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CXCR1	receptors interleukin-8a/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CXCR1	cell adhesion/drug effects	3.37278289741505e-07	8.941098631983529e-07	0.03711991575621956	0.9605811478101344	1	2
CXCR1	CXCL1	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
colorectal neoplasms/therapy	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
colorectal neoplasms/therapy	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/therapy	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/therapy	KLK3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/therapy	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
colorectal neoplasms/therapy	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/therapy	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/therapy	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chalcones/pharmacology	cell cycle proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chalcones/pharmacology	antineoplastic agents phytogenic/pharmacology	7.751701947000811e-09	2.301501811573847e-08	0.02803738317757009	0.9605811478101344	1	2
chalcones/pharmacology	b7-h1 antigen/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chalcones/pharmacology	adaptor proteins signal transducing/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chalcones/pharmacology	EIF2S1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PIK3CB	pyrimidines/pharmacology	1.0363931934875836e-12	3.832030375652229e-12	0.018691588785046728	0.9605811478101344	1	2
PIK3CB	heterografts	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PIK3CB	bridged bicyclo compounds heterocyclic/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl5/metabolism	cell movement/drug effects	0.0048237178890900845	0.008429367680007783	0.09345794392523364	0.9605811478101344	1	2
chemokine ccl5/metabolism	butyrates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl5/metabolism	valproic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl5/metabolism	leukocytes mononuclear/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl5/metabolism	leukemia/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokine ccl5/metabolism	p38 mitogen-activated protein kinases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokine ccl5/metabolism	caspase 3/metabolism	3.5042941337604105e-07	9.278572962789664e-07	0.02803738317757009	0.9605811478101344	1	2
chemokine ccl5/metabolism	CCL2	2.853762781640512e-10	9.210915211478555e-10	0.018691588785046728	0.9605811478101344	1	2
chemokine ccl5/metabolism	CCL5	3.764988321108831e-12	1.3309357464134602e-11	0.014018691588785045	0.9605811478101344	1	2
enzyme inhibitors/metabolism	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
enzyme inhibitors/metabolism	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
enzyme inhibitors/metabolism	imp dehydrogenase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
enzyme inhibitors/metabolism	CD40LG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
enzyme inhibitors/metabolism	IL2	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
enzyme inhibitors/metabolism	PPIA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/genetics	ferritins/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/genetics	genetic variation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/genetics	malaria/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/genetics	listeriosis/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/genetics	hemeproteins/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/genetics	transferrin/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/genetics	liver x receptors/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor suppressor protein p53/genetics	TF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PIN1	proto-oncogene proteins c-akt/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
PIN1	hydrogen peroxide/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PIN1	phosphatidylinositol 3-kinases/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
PIN1	cellular senescence/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PIN1	hair cells auditory/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
actins/metabolism	amino acid transport system y+/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
actins/metabolism	liver cirrhosis/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
actins/metabolism	collagen type i/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
actins/metabolism	cell line	2.1067664965124244e-05	4.820963955900979e-05	0.06074766355140186	0.9605811478101344	1	2
actins/metabolism	hypoxia-inducible factor 1 alpha subunit/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
actins/metabolism	FN1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
actins/metabolism	MMRN1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
actins/metabolism	SLC7A11	1.7763568394002505e-15	7.423259210594527e-15	0.02336448598130841	0.9605811478101344	1	2
estrogens	benzopyrans/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogens	lung neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
estrogens	immunity innate/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
estrogens	neoplasms hormone-dependent/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogens	interleukin-1beta/deficiency	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogens	estrogen receptor modulators/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogens	triple negative breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogens	neutrophil infiltration/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogens	estrogen receptor beta/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogens	neutrophils/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogens	ESR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogens	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
astrocytes/drug effects	hydrogen peroxide	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
astrocytes/drug effects	MAPK3	1.3036816781664129e-06	3.327572776130247e-06	0.037383177570093455	0.9605811478101344	1	2
PINK1	depsides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PINK1	heart injuries/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PINK1	cinnamates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PINK1	sleep apnea obstructive/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PINK1	drugs chinese herbal/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PINK1	hypoxia/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PINK1	SLC25A28	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tetrahydrofolate dehydrogenase/genetics	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tetrahydrofolate dehydrogenase/genetics	folic acid antagonists/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tetrahydrofolate dehydrogenase/genetics	cystine/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tetrahydrofolate dehydrogenase/genetics	methotrexate/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tetrahydrofolate dehydrogenase/genetics	vitamin e/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tetrahydrofolate dehydrogenase/genetics	antioxidants/pharmacology	2.481348460037225e-13	9.382399390653529e-13	0.014018691588785045	0.9605811478101344	1	2
tetrahydrofolate dehydrogenase/genetics	biopterin/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PLA2G1B	cell survival	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PLA2G1B	protein kinase inhibitors/pharmacology	7.245952637824349e-05	0.0001573512890364929	0.04672897196261682	0.9605811478101344	1	2
PLA2G1B	phosphoinositide-3 kinase inhibitors	0.0011655363347118364	0.0022206831237233464	0.07009345794392523	0.9605811478101344	1	2
PLA2G1B	benzamides/pharmacology	9.341637752235954e-08	2.585868539375999e-07	0.02336448598130841	0.9605811478101344	1	2
PLA2G1B	pyrimidines/pharmacology	6.519751405420493e-11	2.177662157047584e-10	0.018691588785046728	0.9605811478101344	1	2
PLA2G1B	phospholipids/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PLA2G1B	phospholipase a2 inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PLA2G1B	autophagy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PLA2G1B	cell respiration/drug effects	3.141931159689193e-14	1.2403455364158876e-13	0.014018691588785045	0.9605811478101344	1	2
PLA2G1B	neoplasms/enzymology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PLA2G1B	lipid droplets/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PLA2G1B	apoptosis	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
bcl-associated death protein/metabolism	benzophenanthridines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bcl-associated death protein/metabolism	PRKCA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bcl-associated death protein/metabolism	RTCA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/immunology	adenosine triphosphate/metabolism	3.6489922194959945e-11	1.2373574354882757e-10	0.02803738317757009	0.9605811478101344	1	2
cytokines/immunology	killer cells natural/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytokines/immunology	IL2	4.643840867402105e-12	1.6329729416982715e-11	0.018691588785046728	0.9605811478101344	1	2
cytokines/immunology	PKM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzopyrans/pharmacology	ESR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzopyrans/pharmacology	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
benzopyrans/pharmacology	lung neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
benzopyrans/pharmacology	immunity innate/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
benzopyrans/pharmacology	neoplasms hormone-dependent/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzopyrans/pharmacology	interleukin-1beta/deficiency	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzopyrans/pharmacology	estrogen receptor modulators/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzopyrans/pharmacology	triple negative breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzopyrans/pharmacology	neutrophil infiltration/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzopyrans/pharmacology	estrogen receptor beta/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzopyrans/pharmacology	neutrophils/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oligopeptides/pharmacology	glioblastoma/drug therapy	8.670841822322473e-14	3.383623371656033e-13	0.018647711816067742	0.9605811478101344	1	2
oligopeptides/pharmacology	nf-kappa b/genetics	4.643840867402105e-12	1.6329729416982715e-11	0.018647711816067742	0.9605811478101344	1	2
oligopeptides/pharmacology	brain neoplasms/drug therapy	8.670841822322473e-14	3.383623371656033e-13	0.018647711816067742	0.9605811478101344	1	2
oligopeptides/pharmacology	chemokine ccl2/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oligopeptides/pharmacology	biomarkers tumor/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oligopeptides/pharmacology	paracrine communication	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oligopeptides/pharmacology	apoptosis regulatory proteins	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oligopeptides/pharmacology	CCL2	1.963380338421139e-06	4.9337371440060715e-06	0.03711991575621956	0.9605811478101344	1	2
oligopeptides/pharmacology	NFKB1	0.00020511210721163575	0.0004226064610599145	0.0644991443991049	0.9605811478101344	1	2
oligopeptides/pharmacology	paracrine communication/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oligopeptides/pharmacology	necrosis	1.7066348334537906e-11	5.849197078810691e-11	0.018647711816067742	0.9605811478101344	1	2
oligopeptides/pharmacology	caspases/metabolism	0.0006420702863759731	0.0012583436154682181	0.0644991443991049	0.9605811478101344	1	2
oligopeptides/pharmacology	tumor necrosis factor-alpha/pharmacology	9.058753747126502e-12	3.13445390170504e-11	0.018647711816067742	0.9605811478101344	1	2
oligopeptides/pharmacology	autocrine communication/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oligopeptides/pharmacology	decitabine	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oligopeptides/pharmacology	dna fragmentation/drug effects	9.058753747126502e-12	3.13445390170504e-11	0.027905752270633143	0.9605811478101344	1	2
POLG	neuroprotective agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
POLG	rac1 gtp-binding protein/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
POLG	neurons/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
POLG	rna small interfering/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
POLG	pc12 cells	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
POLG	RAC1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bacterial toxins/metabolism	inflammasomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bacterial toxins/metabolism	inflammation/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
bacterial toxins/metabolism	nlr family pyrin domain-containing 3 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bacterial toxins/metabolism	lung/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bacterial toxins/metabolism	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bacterial toxins/metabolism	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bacterial toxins/metabolism	hmgb1 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fatty liver/metabolism	host-pathogen interactions	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
fatty liver/metabolism	proteasome endopeptidase complex/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fatty liver/metabolism	hepatocytes/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fatty liver/metabolism	apoferritins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fatty liver/metabolism	hepatitis c/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fatty liver/metabolism	protein interaction maps	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fatty liver/metabolism	viral nonstructural proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fatty liver/metabolism	apolipoprotein b-100/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
zoledronic acid	neuroblastoma/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
zoledronic acid	receptors antigen t-cell gamma-delta/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
zoledronic acid	chemokine cxcl10/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
zoledronic acid	neovascularization pathologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
zoledronic acid	t-lymphocyte subsets/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
zoledronic acid	CXCL10	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
pyrazoles/pharmacology	g2 phase cell cycle checkpoints/drug effects	3.2590164190660076e-06	8.061796702296345e-06	0.027905752270633143	0.9605811478101344	1	2
pyrazoles/pharmacology	k562 cells	3.296304340594247e-10	1.0557367533617368e-09	0.018647711816067742	0.9605811478101344	1	2
pyrazoles/pharmacology	epithelial-mesenchymal transition/drug effects	1.8236408904082069e-06	4.6025222472207125e-06	0.027905752270633143	0.9605811478101344	1	2
pyrazoles/pharmacology	phenotype	4.7240131872960944e-07	1.2431969772440236e-06	0.027905752270633143	0.9605811478101344	1	2
pyrazoles/pharmacology	protein kinase inhibitors/pharmacology	1.3263057940804401e-07	3.6484579099046216e-07	0.0019744636040542316	0.8657199677887635	2	2
pyrazoles/pharmacology	benzamides/pharmacology	7.41073868937292e-13	2.7581358309131356e-12	0.00043876968978982925	0.8657199677887635	2	2
pyrazoles/pharmacology	leukemia/drug therapy	1.0194388222473094e-08	3.0048913306027646e-08	0.018647711816067742	0.9605811478101344	1	2
pyrazoles/pharmacology	ribosomal proteins/genetics	7.66053886991358e-15	3.108771599555579e-14	0.009345794392523364	0.9605811478101344	1	2
pyrazoles/pharmacology	aurora kinase b/antagonists & inhibitors	7.66053886991358e-15	3.108771599555579e-14	0.009345794392523364	0.9605811478101344	1	2
pyrazoles/pharmacology	RPL15	7.66053886991358e-15	3.108771599555579e-14	0.009345794392523364	0.9605811478101344	1	2
hek293 cells	cell communication/drug effects	2.5023316752026403e-12	8.987035148211079e-12	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	neovascularization pathologic/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	antigens cd/metabolism	2.5023316752026403e-12	8.987035148211079e-12	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	interleukin-6/metabolism	0.0012155920719849611	0.002311260262428805	0.09085010295354308	0.9605811478101344	1	2
hek293 cells	phenotype	4.0561125722038405e-05	9.005051857008385e-05	0.055287464515536164	0.9605811478101344	1	2
hek293 cells	neoplasm metastasis/pathology	3.3306690738754696e-16	1.4334294698576293e-15	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	prostatic neoplasms/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	receptors cell surface/metabolism	2.5023316752026403e-12	8.987035148211079e-12	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	estrogen receptor alpha/genetics	2.5023316752026403e-12	8.987035148211079e-12	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	matrix metalloproteinase 9/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	endometrial neoplasms/genetics	2.5023316752026403e-12	8.987035148211079e-12	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	estradiol/pharmacology	2.5023316752026403e-12	8.987035148211079e-12	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	tumor necrosis factor alpha-induced protein 3/metabolism	2.5023316752026403e-12	8.987035148211079e-12	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	antigens differentiation myelomonocytic/metabolism	2.5023316752026403e-12	8.987035148211079e-12	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	transforming growth factor beta/metabolism	0.000903634626818417	0.001741333404267317	0.07319670689438858	0.9605811478101344	1	2
hek293 cells	human umbilical vein endothelial cells	6.108080614630751e-07	1.5984683844674041e-06	0.055287464515536164	0.9605811478101344	1	2
hek293 cells	receptors androgen/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	ESR1	4.229828293178528e-07	1.116075325610342e-06	0.03711991575621956	0.9605811478101344	1	2
hek293 cells	IL17A	2.5023316752026403e-12	8.987035148211079e-12	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	MMP9	2.962904754433282e-06	7.34083874881953e-06	0.03711991575621956	0.9605811478101344	1	2
hek293 cells	recombinant fusion proteins/pharmacology	2.9976021664879227e-15	1.2339643869814361e-14	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	mitochondrial membrane transport proteins/genetics	2.9976021664879227e-15	1.2339643869814361e-14	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	interleukin-10/pharmacology	2.9976021664879227e-15	1.2339643869814361e-14	0.018691588785046728	0.9605811478101344	1	2
hek293 cells	neoplasms/immunology	2.9976021664879227e-15	1.2339643869814361e-14	0.018691588785046728	0.9605811478101344	1	2
lipopolysaccharides/toxicity	nf-e2-related factor 2/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipopolysaccharides/toxicity	microglia/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipopolysaccharides/toxicity	inflammation mediators/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nf-kappa b	neovascularization pathologic/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b	receptors interleukin-8a/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nf-kappa b	receptors interleukin-8b/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nf-kappa b	tumor cells cultured	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
nf-kappa b	cell adhesion/drug effects	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
nf-kappa b	CXCL1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b	CXCR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
folic acid antagonists/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
folic acid antagonists/pharmacology	cystine/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
folic acid antagonists/pharmacology	methotrexate/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
folic acid antagonists/pharmacology	vitamin e/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
folic acid antagonists/pharmacology	antioxidants/pharmacology	2.481348460037225e-13	9.382399390653529e-13	0.014018691588785045	0.9605811478101344	1	2
folic acid antagonists/pharmacology	biopterin/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperazines/administration & dosage	biphenyl compounds/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperazines/administration & dosage	sulfonamides/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperazines/administration & dosage	epothilones/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
imp dehydrogenase/antagonists & inhibitors	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
imp dehydrogenase/antagonists & inhibitors	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
imp dehydrogenase/antagonists & inhibitors	CD40LG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
imp dehydrogenase/antagonists & inhibitors	IL2	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
imp dehydrogenase/antagonists & inhibitors	PPIA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PRKCA	cell line	0.005771990481284739	0.009958591918879876	0.11807292352244307	0.9605811478101344	1	2
PRKCA	plasmids/genetics	3.401390280544092e-11	1.1546397675971694e-10	0.018647711816067742	0.9605811478101344	1	2
PRKCA	zinc/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRKCA	enzyme inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRKCA	cardiotonic agents	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRKCA	glycogen synthase kinase 3/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRKCA	myocytes cardiac/drug effects	4.4105279979334e-06	1.0824056244260419e-05	0.046290202272826986	0.9605811478101344	1	2
PRKCA	benzophenanthridines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRKCA	mitochondria heart/drug effects	3.0033297815368343e-07	8.027326345414489e-07	0.03711991575621956	0.9605811478101344	1	2
PRKCA	dna/biosynthesis	2.220446049250313e-16	9.623824354997229e-16	0.018647711816067742	0.9605811478101344	1	2
PRKCA	myocardial reperfusion injury/prevention & control	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRKCA	cytosol/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRKCA	PRKCB	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRKCA	PRKCG	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRKCA	PRRT2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRKCA	RTCA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/pathology	epithelial-mesenchymal transition/drug effects	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
neovascularization pathologic/pathology	thiazoles/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/pathology	neoplasm invasiveness	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
neovascularization pathologic/pathology	neoplasm proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/pathology	breast neoplasms/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/pathology	lipopolysaccharides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/pathology	myeloid differentiation factor 88/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/pathology	piperazines	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/pathology	glycogen synthase kinase 3 beta/metabolism	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/pathology	nf-kappa b/metabolism	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
neovascularization pathologic/pathology	ITK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/pathology	MMP2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/pathology	MMP9	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/pathology	MYD88	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/pathology	NFKB1	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
neovascularization pathologic/pathology	TRAF6	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myocardium/immunology	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardium/immunology	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardium/immunology	adaptor proteins vesicular transport/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myocardium/immunology	TICAM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myocardium/immunology	TRIM69	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myocardium/immunology	myocardial reperfusion injury/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cisplatin/adverse effects	polysaccharides/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cisplatin/adverse effects	complex mixtures/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ileum/drug effects	radiation-protective agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ileum/drug effects	drug interactions	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
butyrates/pharmacology	cell movement/drug effects	0.0048237178890900845	0.008429367680007783	0.09345794392523364	0.9605811478101344	1	2
butyrates/pharmacology	valproic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
butyrates/pharmacology	leukocytes mononuclear/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
butyrates/pharmacology	leukemia/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
butyrates/pharmacology	p38 mitogen-activated protein kinases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
butyrates/pharmacology	caspase 3/metabolism	3.5042941337604105e-07	9.278572962789664e-07	0.02803738317757009	0.9605811478101344	1	2
butyrates/pharmacology	CCL2	2.853762781640512e-10	9.210915211478555e-10	0.018691588785046728	0.9605811478101344	1	2
butyrates/pharmacology	CCL5	3.764988321108831e-12	1.3309357464134602e-11	0.014018691588785045	0.9605811478101344	1	2
radiation-protective agents/pharmacology	drug interactions	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th1 cells/metabolism	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
th1 cells/metabolism	dose-response relationship immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th1 cells/metabolism	calcitriol/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th1 cells/metabolism	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th1 cells/metabolism	SELP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PRRX1	pyridines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PRRX1	thiosemicarbazones/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PRRX1	peroxiredoxin iii/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
serum albumin bovine/chemistry	k562 cells	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
serum albumin bovine/chemistry	galectin 3/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
serum albumin bovine/chemistry	cell proliferation	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
serum albumin bovine/chemistry	alpha 1-antitrypsin/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
serum albumin bovine/chemistry	bone marrow cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
serum albumin bovine/chemistry	leukemia myelogenous chronic bcr-abl positive/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
serum albumin bovine/chemistry	LGALS3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
serum albumin bovine/chemistry	SERPINA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cystine/antagonists & inhibitors	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cystine/antagonists & inhibitors	methotrexate/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cystine/antagonists & inhibitors	vitamin e/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cystine/antagonists & inhibitors	antioxidants/pharmacology	2.481348460037225e-13	9.382399390653529e-13	0.014018691588785045	0.9605811478101344	1	2
cystine/antagonists & inhibitors	biopterin/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adjuvants immunologic/chemistry	gold/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
asparaginase	cisplatin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
asparaginase	SLC7A11	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
PTEN	rna small interfering/metabolism	0.0001221236370820833	0.00025719571596005084	0.046290202272826986	0.9605811478101344	1	2
PTEN	caspase 8/metabolism	0.002621392365332098	0.0047714405077885	0.046290202272826986	0.9605811478101344	1	2
PTEN	CASP8	0.0009998493932872332	0.001917262082379276	0.00878568916972137	0.8657199677887635	2	2
PTEN	MCL1	0.0005606443601331446	0.0011055439452835676	0.0063358268097849415	0.8657199677887635	2	2
PTEN	superoxide dismutase/metabolism	9.536379190955291e-05	0.00020293223472848398	0.046290202272826986	0.9605811478101344	1	2
PTEN	antioxidants/metabolism	4.124634723245979e-05	9.155335384891508e-05	0.046290202272826986	0.9605811478101344	1	2
PTEN	plant roots	6.607139012682062e-06	1.595380582100691e-05	0.02336448598130841	0.9605811478101344	1	2
PTEN	1-phosphatidylinositol 4-kinase/metabolism	6.607139012682062e-06	1.595380582100691e-05	0.02336448598130841	0.9605811478101344	1	2
PTEN	dna/metabolism	6.607139012682062e-06	1.595380582100691e-05	0.02336448598130841	0.9605811478101344	1	2
PTEN	berberine/pharmacology	0.0001221236370820833	0.00025719571596005084	0.046290202272826986	0.9605811478101344	1	2
PTEN	aminopyridines/pharmacology	7.335668233077186e-05	0.00015875227051716313	0.02336448598130841	0.9605811478101344	1	2
PTEN	ubiquinone/analogs & derivatives	2.140681395301769e-05	4.8793283783328236e-05	0.046290202272826986	0.9605811478101344	1	2
PTEN	poly(adp-ribose) polymerases/metabolism	7.335668233077186e-05	0.00015875227051716313	0.02336448598130841	0.9605811478101344	1	2
PTEN	piperazines/toxicity	7.335668233077186e-05	0.00015875227051716313	0.02336448598130841	0.9605811478101344	1	2
PTEN	nitrophenols/toxicity	7.335668233077186e-05	0.00015875227051716313	0.02336448598130841	0.9605811478101344	1	2
PTEN	cell nucleus/drug effects	9.630031228002878e-08	2.6630243134956406e-07	0.02336448598130841	0.9605811478101344	1	2
PTEN	organophosphorus compounds/pharmacology	0.0005842436866995149	0.0011489969498127647	0.046290202272826986	0.9605811478101344	1	2
PTEN	glioblastoma/enzymology	7.335668233077186e-05	0.00015875227051716313	0.02336448598130841	0.9605811478101344	1	2
PTEN	pten phosphohydrolase/antagonists & inhibitors	8.276241856286504e-07	2.141720427786442e-06	0.02336448598130841	0.9605811478101344	1	2
PTEN	caspases/metabolism	0.0004526318393752726	0.0009002820743839432	0.00878568916972137	0.8657199677887635	2	2
PTEN	autophagy-related protein-1 homolog/metabolism	8.276241856286504e-07	2.141720427786442e-06	0.02336448598130841	0.9605811478101344	1	2
PTEN	plant extracts/pharmacology	6.607139012682062e-06	1.595380582100691e-05	0.02336448598130841	0.9605811478101344	1	2
PTEN	TNS1	6.607139012682062e-06	1.595380582100691e-05	0.02336448598130841	0.9605811478101344	1	2
PTEN	ULK1	8.276241856286504e-07	2.141720427786442e-06	0.02336448598130841	0.9605811478101344	1	2
benzhydryl compounds/immunology	lung neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
benzhydryl compounds/immunology	cytokines/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzhydryl compounds/immunology	azocines/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzhydryl compounds/immunology	carcinoma lewis lung/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzhydryl compounds/immunology	ARG1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
benzhydryl compounds/immunology	TCIM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nfatc transcription factors/antagonists & inhibitors	dinitrofluorobenzene/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nfatc transcription factors/antagonists & inhibitors	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nfatc transcription factors/antagonists & inhibitors	drug hypersensitivity/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nfatc transcription factors/antagonists & inhibitors	ear/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nfatc transcription factors/antagonists & inhibitors	anti-inflammatory agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nfatc transcription factors/antagonists & inhibitors	hypersensitivity delayed/chemically induced	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
benzamides/pharmacology	cell survival	3.3210715583043005e-05	7.476310569480622e-05	0.046290202272826986	0.9605811478101344	1	2
benzamides/pharmacology	k562 cells	9.759095198280665e-05	0.00020749135094666547	0.046290202272826986	0.9605811478101344	1	2
benzamides/pharmacology	tnf-related apoptosis-inducing ligand/metabolism	0.00018940888987306614	0.000391642802581015	0.046290202272826986	0.9605811478101344	1	2
benzamides/pharmacology	epithelial-mesenchymal transition/drug effects	0.0033849021607051943	0.006064547605983108	0.06878335787959994	0.9605811478101344	1	2
benzamides/pharmacology	phenotype	0.0019314423590830465	0.0035842472126136698	0.06878335787959994	0.9605811478101344	1	2
benzamides/pharmacology	janus kinases/antagonists & inhibitors	2.17400467983353e-06	5.450586215711811e-06	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	paclitaxel/pharmacology	0.00213812675650904	0.0039432387057725905	0.06878335787959994	0.9605811478101344	1	2
benzamides/pharmacology	sirtuin 1/antagonists & inhibitors	2.17400467983353e-06	5.450586215711811e-06	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	g2 phase cell cycle checkpoints/drug effects	0.004311709748259229	0.00757245312487012	0.06878335787959994	0.9605811478101344	1	2
benzamides/pharmacology	erbb receptors/antagonists & inhibitors	0.002593388005414865	0.004723196658135383	0.06878335787959994	0.9605811478101344	1	2
benzamides/pharmacology	receptor igf type 1/biosynthesis	2.17400467983353e-06	5.450586215711811e-06	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	naphthols/pharmacology	2.17400467983353e-06	5.450586215711811e-06	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	leukemia/drug therapy	0.0003972697744608622	0.0007934599136980786	0.046290202272826986	0.9605811478101344	1	2
benzamides/pharmacology	receptors tnf-related apoptosis-inducing ligand/biosynthesis	2.17400467983353e-06	5.450586215711811e-06	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	insulin-like growth factor i/metabolism	2.17400467983353e-06	5.450586215711811e-06	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	protein kinase inhibitors/pharmacology	2.0046386342009725e-06	5.035118774990093e-06	0.0007084268769477957	0.7135314763244264	3	2
benzamides/pharmacology	histone deacetylases/chemistry	1.983776046765584e-07	5.377218377070026e-07	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	tyrphostins/pharmacology	0.00018940888987306614	0.000391642802581015	0.046290202272826986	0.9605811478101344	1	2
benzamides/pharmacology	pyrimidines/pharmacology	6.888591053133553e-08	1.9256961523962037e-07	0.0025831226577705535	0.8657199677887635	2	2
benzamides/pharmacology	CIITA	1.983776046765584e-07	5.377218377070026e-07	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	FOXP3	1.983776046765584e-07	5.377218377070026e-07	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	HDAC9	1.983776046765584e-07	5.377218377070026e-07	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	IGF1R	2.17400467983353e-06	5.450586215711811e-06	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	NOS2	2.17400467983353e-06	5.450586215711811e-06	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	SIRT1	0.00033448210126574285	0.0006728705628382389	0.046290202272826986	0.9605811478101344	1	2
benzamides/pharmacology	autophagy	0.00033448210126574285	0.0006728705628382389	0.046290202272826986	0.9605811478101344	1	2
benzamides/pharmacology	neoplasms/enzymology	9.341637752235954e-08	2.585868539375999e-07	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	lipid droplets/metabolism	9.341637752235954e-08	2.585868539375999e-07	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	phospholipids/metabolism	9.341637752235954e-08	2.585868539375999e-07	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	cell respiration/drug effects	0.0015584255859585339	0.002923025718350808	0.06878335787959994	0.9605811478101344	1	2
benzamides/pharmacology	apoptosis	0.0003972697744608622	0.0007934599136980786	0.06878335787959994	0.9605811478101344	1	2
benzamides/pharmacology	aurora kinase b/antagonists & inhibitors	1.2901231387640877e-06	3.299458875243082e-06	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	phospholipase a2 inhibitors/pharmacology	9.341637752235954e-08	2.585868539375999e-07	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	ribosomal proteins/genetics	1.2901231387640877e-06	3.299458875243082e-06	0.02336448598130841	0.9605811478101344	1	2
benzamides/pharmacology	RPL15	1.2901231387640877e-06	3.299458875243082e-06	0.02336448598130841	0.9605811478101344	1	2
autophagy-related proteins/metabolism	granulosa cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
autophagy-related proteins/metabolism	liver/drug effects	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
autophagy-related proteins/metabolism	zearalenone/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
autophagy-related proteins/metabolism	t-2 toxin/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SLC7A11	nivolumab/therapeutic use	2.220446049250313e-16	9.623824354997229e-16	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	cisplatin	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	hypoxia-inducible factor 1 alpha subunit/metabolism	1.7763568394002505e-15	7.423259210594527e-15	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	amino acid transport system y+/metabolism	0.0	0.0	0.00043876968978982925	0.8657199677887635	2	2
SLC7A11	melanoma/genetics	8.671025409245914e-06	2.0621159338049175e-05	0.06878335787959994	0.9605811478101344	1	2
SLC7A11	liver cirrhosis/drug therapy	1.7763568394002505e-15	7.423259210594527e-15	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	collagen type i/metabolism	1.7763568394002505e-15	7.423259210594527e-15	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	cd8-positive t-lymphocytes/immunology	1.5345502646368914e-12	5.6016165951513546e-12	0.0042643984729281255	0.8657199677887635	2	2
SLC7A11	sulfasalazine/administration & dosage	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	ACSL4	5.513522971511975e-11	1.8460463853590893e-10	0.046290202272826986	0.9605811478101344	1	2
SLC7A11	cell proliferation	5.513522971511975e-11	1.8460463853590893e-10	0.046290202272826986	0.9605811478101344	1	2
SLC7A11	cysteine/metabolism	2.220446049250313e-16	9.623824354997229e-16	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	anti-inflammatory agents non-steroidal/pharmacology	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	curcumin/pharmacology	3.2152676033847527e-06	7.954468146255277e-06	0.06878335787959994	0.9605811478101344	1	2
SLC7A11	IREB2	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	MKI67	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	MMRN1	1.7763568394002505e-15	7.423259210594527e-15	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	FN1	1.7763568394002505e-15	7.423259210594527e-15	0.02336448598130841	0.9605811478101344	1	2
SLC7A11	SLC3A2	2.220446049250313e-16	9.623824354997229e-16	0.02336448598130841	0.9605811478101344	1	2
inflammation/metabolism	nlr family pyrin domain-containing 3 protein/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
inflammation/metabolism	lung/blood supply	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
inflammation/metabolism	phenylenediamines/pharmacology	1.1500711494250027e-10	3.773890266784113e-10	0.018647711816067742	0.9605811478101344	1	2
inflammation/metabolism	cyclohexylamines/pharmacology	1.1500711494250027e-10	3.773890266784113e-10	0.018647711816067742	0.9605811478101344	1	2
inflammation/metabolism	inflammasomes/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
inflammation/metabolism	liver neoplasms/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/metabolism	receptor igf type 1/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/metabolism	gene silencing	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/metabolism	neoplasm metastasis/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/metabolism	stat3 transcription factor/metabolism	7.1344041785437184e-12	2.48655300867107e-11	0.018647711816067742	0.9605811478101344	1	2
inflammation/metabolism	interleukin-6/metabolism	4.299934603357869e-05	9.533885572690496e-05	0.046290202272826986	0.9605811478101344	1	2
inflammation/metabolism	tumor escape/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/metabolism	tumor necrosis factor-alpha/metabolism	0.002593388005414865	0.004723196658135383	0.0735378000087754	0.9605811478101344	1	2
inflammation/metabolism	tumor microenvironment/immunology	1.337041588556076e-12	4.914820430891025e-12	0.018647711816067742	0.9605811478101344	1	2
inflammation/metabolism	IL6R	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/metabolism	IL6ST	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation/metabolism	hmgb1 protein/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
RAC1	neuroprotective agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RAC1	rac1 gtp-binding protein/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
RAC1	neurons/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
RAC1	rna small interfering/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
RAC1	pc12 cells	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPL15	g2 phase cell cycle checkpoints/drug effects	4.0201775242110216e-10	1.2795853046600925e-09	0.014018691588785045	0.9605811478101344	1	2
RPL15	k562 cells	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPL15	protein kinase inhibitors/pharmacology	0.0003294132314345388	0.0006636424457847873	0.04672897196261682	0.9605811478101344	1	2
RPL15	leukemia/drug therapy	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
RPL15	ribosomal proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
RPL15	aurora kinase b/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondria liver/drug effects	adenosine triphosphate/metabolism	1.3379652941125642e-10	4.3741783518080984e-10	0.012970382291718041	0.8657199677887635	2	2
mitochondria liver/drug effects	peptides/chemistry	4.686422361288578e-10	1.4899241560445649e-09	0.0644991443991049	0.9605811478101344	1	2
mitochondria liver/drug effects	artesunate	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	glycine/analogs & derivatives	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	superoxide dismutase/metabolism	1.4092521308795014e-06	3.5862408796896638e-06	0.0644991443991049	0.9605811478101344	1	2
mitochondria liver/drug effects	endocytosis/drug effects	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	acetaldehyde/pharmacology	6.661338147750939e-16	2.8276700708820313e-15	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	ferrous compounds/administration & dosage	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	oxygen consumption/drug effects	5.417651891548303e-06	1.315510891022654e-05	0.09538832359347407	0.9605811478101344	1	2
mitochondria liver/drug effects	ubiquinone/analogs & derivatives	1.54163859344969e-07	4.219221413651784e-07	0.0644991443991049	0.9605811478101344	1	2
mitochondria liver/drug effects	hydroxymethylglutaryl-coa reductase inhibitors/pharmacology	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	diet high-fat/adverse effects	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	antineoplastic agents/administration & dosage	5.417651891548303e-06	1.315510891022654e-05	0.09538832359347407	0.9605811478101344	1	2
mitochondria liver/drug effects	lignans/pharmacology	3.955015241885462e-05	8.810768521076152e-05	0.0644991443991049	0.9605811478101344	1	2
mitochondria liver/drug effects	phosphates/pharmacology	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	adenosine diphosphate/pharmacology	4.686422361288578e-10	1.4899241560445649e-09	0.0644991443991049	0.9605811478101344	1	2
mitochondria liver/drug effects	thallium/metabolism	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	succinate dehydrogenase/metabolism	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	liver diseases alcoholic/etiology	6.661338147750939e-16	2.8276700708820313e-15	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	CA2	0.0	0.0	0.0009214163485586416	0.8657199677887635	2	2
mitochondria liver/drug effects	EEF1A2	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	PTPN2	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	cell respiration/drug effects	0.00013777087528976661	0.00028901734142614406	0.09538832359347407	0.9605811478101344	1	2
mitochondria liver/drug effects	mitochondrial membranes/drug effects	0.0	0.0	0.0009214163485586416	0.8657199677887635	2	2
mitochondria liver/drug effects	mitochondrial swelling/drug effects	0.0	0.0	0.0009214163485586416	0.8657199677887635	2	2
mitochondria liver/drug effects	g1 phase/drug effects	4.979927581416632e-11	1.6775774379690435e-10	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	organometallic compounds/metabolism	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	electron transport complex iv/metabolism	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	monoamine oxidase/metabolism	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	mitochondrial proton-translocating atpases/metabolism	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	herbicides/toxicity	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	antimycin a/pharmacology	6.661338147750939e-16	2.8276700708820313e-15	0.03271028037383177	0.9605811478101344	1	2
mitochondria liver/drug effects	liver/drug effects	1.227048018748178e-09	3.826043659646419e-09	0.0644991443991049	0.9605811478101344	1	2
mitochondria liver/drug effects	glutathione disulfide/metabolism	6.661338147750939e-16	2.8276700708820313e-15	0.03271028037383177	0.9605811478101344	1	2
RPS6KB1	muscle proteins/biosynthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPS6KB1	receptors tumor necrosis factor type i/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPS6KB1	mitogen-activated protein kinases/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPS6KB1	mitochondria muscle/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPS6KB1	muscle fibers skeletal/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPS6KB1	oxidoreductases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPS6KB1	MAPK3	0.0008808255361461015	0.0017019053037375554	0.0735378000087754	0.9605811478101344	1	2
RPS6KB1	tumor necrosis factor-alpha/pharmacology	1.2249024017307875e-10	4.008110441282339e-10	0.018647711816067742	0.9605811478101344	1	2
RPS6KB1	EIF4E	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPS6KB1	oncogene protein v-akt/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPS6KB1	RPS6KB2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RPS6KB1	TNFRSF1A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	immunity innate/drug effects	2.4646951146678475e-14	9.785989174895859e-14	0.018647711816067742	0.9605811478101344	1	2
lung neoplasms/immunology	neoplasms hormone-dependent/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	cytokines/blood	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	azocines/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	interleukin-1beta/deficiency	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	estrogen receptor modulators/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	triple negative breast neoplasms/therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	neutrophil infiltration/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	carcinoma lewis lung/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	estrogen receptor beta/agonists	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	neutrophils/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	ARG1	4.8407944319706075e-12	1.6987081909293006e-11	0.018647711816067742	0.9605811478101344	1	2
lung neoplasms/immunology	ESR2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung neoplasms/immunology	IL1B	2.2922774789435607e-12	8.248756953769811e-12	0.018647711816067742	0.9605811478101344	1	2
lung neoplasms/immunology	TCIM	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
RTCA	benzophenanthridines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
methotrexate/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
methotrexate/pharmacology	vitamin e/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
methotrexate/pharmacology	antioxidants/pharmacology	2.481348460037225e-13	9.382399390653529e-13	0.014018691588785045	0.9605811478101344	1	2
methotrexate/pharmacology	biopterin/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering/genetics	protein kinases/genetics	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	lysosomal-associated membrane protein 2/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	interleukin-17/biosynthesis	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	cyclin d1/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	tumor escape	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	oxaliplatin	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	carbazoles/pharmacology	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	receptors interleukin-17/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	mouth neoplasms/immunology	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	maleimides	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	organoplatinum compounds/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	curcumin/pharmacology	4.1519241933407613e-07	1.0959131403660614e-06	0.04166180294604871	0.9605811478101344	1	2
rna small interfering/genetics	carcinoma hepatocellular/drug therapy	0.0022276188332333025	0.004094584413099445	0.09538832359347407	0.9605811478101344	1	2
rna small interfering/genetics	PRKD1	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	cyclophilin d	6.844090960633764e-09	2.0416522459755544e-08	0.027905752270633143	0.9605811478101344	1	2
rna small interfering/genetics	macrophages/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	carcinoma squamous cell/immunology	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
rna small interfering/genetics	b7-h1 antigen/genetics	3.951110216782183e-09	1.1990926092169797e-08	0.027905752270633143	0.9605811478101344	1	2
rna small interfering/genetics	biomarkers	6.844090960633764e-09	2.0416522459755544e-08	0.027905752270633143	0.9605811478101344	1	2
receptors tumor necrosis factor type i/metabolism	immunity innate/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors tumor necrosis factor type i/metabolism	nucleotides cyclic/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tumor necrosis factor type i/metabolism	neoplasms/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tumor necrosis factor type i/metabolism	tumor necrosis factor-alpha/metabolism	6.096331439664482e-09	1.8334731357484997e-08	0.037383177570093455	0.9605811478101344	1	2
receptors tumor necrosis factor type i/metabolism	human umbilical vein endothelial cells	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
SLC25A28	depsides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SLC25A28	heart injuries/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SLC25A28	cinnamates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SLC25A28	sleep apnea obstructive/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SLC25A28	drugs chinese herbal/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SLC25A28	hypoxia/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SLC2A1	glucose transporter type 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SLC2A1	orexin receptors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SLC2A1	orexins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SLC2A1	carcinoma hepatocellular/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/antagonists & inhibitors	phosphoinositide-3 kinase inhibitors	0.0015785186546998231	0.002957693490169262	0.07009345794392523	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/antagonists & inhibitors	bcl-2-like protein 11/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/antagonists & inhibitors	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/antagonists & inhibitors	FGF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/antagonists & inhibitors	MAPK3	4.563453836148312e-06	1.1185662054407782e-05	0.037383177570093455	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/antagonists & inhibitors	PCNA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/antagonists & inhibitors	fibroblast growth factor 2/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/antagonists & inhibitors	receptors fibroblast growth factor/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/antagonists & inhibitors	neoplasm recurrence local/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/antagonists & inhibitors	receptors estrogen/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MAPK3	receptors fibroblast growth factor/metabolism	4.563453836148312e-06	1.1185662054407782e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	fibroblast growth factor 2/pharmacology	4.563453836148312e-06	1.1185662054407782e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	receptors estrogen/metabolism	0.0003299736443082013	0.0006641039625474416	0.0735378000087754	0.9605811478101344	1	2
MAPK3	neoplasm recurrence local/pathology	4.563453836148312e-06	1.1185662054407782e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	tyrphostins/pharmacology	0.0010402333012837772	0.0019898545745882976	0.0735378000087754	0.9605811478101344	1	2
MAPK3	drugs chinese herbal/pharmacology	4.250762555102483e-05	9.43339837090081e-05	0.023450931442594587	0.8657199677887635	2	2
MAPK3	ligands	0.0010402333012837772	0.0019898545745882976	0.0735378000087754	0.9605811478101344	1	2
MAPK3	bcl-2-like protein 11/metabolism	4.563453836148312e-06	1.1185662054407782e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	FGF2	4.563453836148312e-06	1.1185662054407782e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	MAPK1	0.005336329702575804	0.009264204510424513	0.04744357798811946	0.8657199677887635	2	2
MAPK3	PCNA	0.00041091819975225263	0.0008195318379138549	0.0735378000087754	0.9605811478101344	1	2
MAPK3	sp1 transcription factor/physiology	1.0929630311906635e-08	3.2014944747830144e-08	0.037383177570093455	0.9605811478101344	1	2
MAPK3	muscle proteins/biosynthesis	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	hydrogen peroxide	1.3036816781664129e-06	3.327572776130247e-06	0.037383177570093455	0.9605811478101344	1	2
MAPK3	antimycin a/metabolism	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	gefitinib/pharmacology	1.0929630311906635e-08	3.2014944747830144e-08	0.037383177570093455	0.9605811478101344	1	2
MAPK3	receptors tumor necrosis factor type i/genetics	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	mitochondria muscle/drug effects	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	alpha-crystallins/administration & dosage	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	glucose/pharmacology	1.0929630311906635e-08	3.2014944747830144e-08	0.037383177570093455	0.9605811478101344	1	2
MAPK3	tumor necrosis factor-alpha/pharmacology	0.0008808255361461015	0.0017019053037375554	0.0735378000087754	0.9605811478101344	1	2
MAPK3	astrocytes/physiology	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	oxidoreductases/metabolism	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	brain/drug effects	0.00011791233277991253	0.0002486353398174743	0.0735378000087754	0.9605811478101344	1	2
MAPK3	apoptosis	0.0018743562747002285	0.003481533879072505	0.10849863774429329	0.9605811478101344	1	2
MAPK3	mitogen-activated protein kinase 1/antagonists & inhibitors	3.720677566043662e-08	1.058360198376089e-07	0.037383177570093455	0.9605811478101344	1	2
MAPK3	staurosporine/toxicity	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	cell hypoxia	0.0005053578131717362	0.0010009099052111427	0.0735378000087754	0.9605811478101344	1	2
MAPK3	mitogen-activated protein kinases/genetics	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	rna long noncoding/physiology	1.0929630311906635e-08	3.2014944747830144e-08	0.037383177570093455	0.9605811478101344	1	2
MAPK3	quinazolines	3.720677566043662e-08	1.058360198376089e-07	0.037383177570093455	0.9605811478101344	1	2
MAPK3	receptors prostaglandin e ep4 subtype/physiology	1.0929630311906635e-08	3.2014944747830144e-08	0.037383177570093455	0.9605811478101344	1	2
MAPK3	muscle fibers skeletal/drug effects	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	keratinocytes/drug effects	1.0929630311906635e-08	3.2014944747830144e-08	0.037383177570093455	0.9605811478101344	1	2
MAPK3	glioma/drug therapy	3.720677566043662e-08	1.058360198376089e-07	0.037383177570093455	0.9605811478101344	1	2
MAPK3	extracellular space/drug effects	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	oncogene protein v-akt/metabolism	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	EIF4E	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	MET	1.0929630311906635e-08	3.2014944747830144e-08	0.037383177570093455	0.9605811478101344	1	2
MAPK3	PTGER4	1.0929630311906635e-08	3.2014944747830144e-08	0.037383177570093455	0.9605811478101344	1	2
MAPK3	RPS6KB2	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
MAPK3	SP1	0.0001564975286577619	0.0003265932334923175	0.0735378000087754	0.9605811478101344	1	2
MAPK3	TNFRSF1A	7.820244053546865e-06	1.8741384879630573e-05	0.037383177570093455	0.9605811478101344	1	2
gene expression regulation	antioxidants/pharmacology	3.4543558768973526e-06	8.528738899645334e-06	0.027905752270633143	0.9605811478101344	1	2
gene expression regulation	endoplasmic reticulum/drug effects	1.1858723574231789e-06	3.035304589791763e-06	0.027905752270633143	0.9605811478101344	1	2
gene expression regulation	aspirin/administration & dosage	6.350475700855895e-14	2.482980816677971e-13	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	interleukin-6/metabolism	0.0001221236370820833	0.00025719571596005084	0.046290202272826986	0.9605811478101344	1	2
gene expression regulation	lymphoma t-cell/drug therapy	6.350475700855895e-14	2.482980816677971e-13	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	interleukin-4/metabolism	6.350475700855895e-14	2.482980816677971e-13	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	nitric oxide/metabolism	3.2974283636910684e-08	9.399056310621935e-08	0.018647711816067742	0.9605811478101344	1	2
gene expression regulation	transforming growth factor beta/metabolism	8.162793669252988e-05	0.00017522468583359933	0.03711991575621956	0.9605811478101344	1	2
gene expression regulation	BIRC5	1.3795897473856122e-05	3.210596870419884e-05	0.027905752270633143	0.9605811478101344	1	2
gene expression regulation	SOCS5	6.350475700855895e-14	2.482980816677971e-13	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	SPP1	9.599393613335394e-09	2.835196656219943e-08	0.018647711816067742	0.9605811478101344	1	2
gene expression regulation	activating transcription factor 4/genetics	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	phenylbutyrates/pharmacology	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	organophosphorus compounds/pharmacology	3.2974283636910684e-08	9.399056310621935e-08	0.018647711816067742	0.9605811478101344	1	2
gene expression regulation	transcription factor chop/genetics	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	tor serine-threonine kinases/genetics	5.238472634128133e-05	0.00011504915294078801	0.03711991575621956	0.9605811478101344	1	2
gene expression regulation	cerebral arteries/cytology	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	eukaryotic initiation factor-2/genetics	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	taurochenodeoxycholic acid/pharmacology	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	myocytes smooth muscle/cytology	2.2231305685238567e-10	7.185981934439817e-10	0.018647711816067742	0.9605811478101344	1	2
gene expression regulation	muscle smooth vascular/cytology	3.9968028886505635e-15	1.6294657930652298e-14	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation	piperidines/pharmacology	4.791069307952256e-08	1.3544492383860922e-07	0.018647711816067742	0.9605811478101344	1	2
flavonolignans/pharmacology	glutathione peroxidase/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
flavonolignans/pharmacology	autophagy-related proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
flavonolignans/pharmacology	precursor cell lymphoblastic leukemia-lymphoma/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SPAG17	coordination complexes/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SPAG17	hemolysis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SPAG17	nih 3t3 cells	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immunity innate/drug effects	neoplasms hormone-dependent/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunity innate/drug effects	nucleotides cyclic/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunity innate/drug effects	interleukin-1beta/deficiency	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunity innate/drug effects	estrogen receptor modulators/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunity innate/drug effects	triple negative breast neoplasms/therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunity innate/drug effects	neoplasms/blood supply	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunity innate/drug effects	neutrophil infiltration/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunity innate/drug effects	tumor necrosis factor-alpha/metabolism	0.0003299736443082013	0.0006641039625474416	0.0735378000087754	0.9605811478101344	1	2
immunity innate/drug effects	estrogen receptor beta/agonists	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunity innate/drug effects	human umbilical vein endothelial cells	1.241229341530925e-13	4.764384492004497e-13	0.027905752270633143	0.9605811478101344	1	2
immunity innate/drug effects	neutrophils/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunity innate/drug effects	ESR2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunity innate/drug effects	IL1B	3.9968028886505635e-15	1.6294657930652298e-14	0.018647711816067742	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	liver neoplasms/metabolism	3.2737088677681214e-06	8.090879174593828e-06	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	neoplasm metastasis/immunology	3.2737088677681214e-06	8.090879174593828e-06	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	tubulin modulators/pharmacology	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	tnf-related apoptosis-inducing ligand/metabolism	0.0022551445239736845	0.004143106946468777	0.0735378000087754	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	stat3 transcription factor/metabolism	0.0006659240867709082	0.0013010451276140882	0.0735378000087754	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	gene silencing	3.2737088677681214e-06	8.090879174593828e-06	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	lymphatic metastasis/genetics	2.7405334346308763e-07	7.346295582582561e-07	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	janus kinases/antagonists & inhibitors	9.940125707075254e-05	0.00021089289029021862	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	tumor escape/immunology	3.2737088677681214e-06	8.090879174593828e-06	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	receptor igf type 1/metabolism	3.2737088677681214e-06	8.090879174593828e-06	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	receptors ccr7/genetics	2.7405334346308763e-07	7.346295582582561e-07	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	sirtuin 1/antagonists & inhibitors	9.940125707075254e-05	0.00021089289029021862	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	tumor microenvironment/immunology	0.00042355659510706634	0.0008441268922462802	0.0735378000087754	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	receptors tnf-related apoptosis-inducing ligand/biosynthesis	9.940125707075254e-05	0.00021089289029021862	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	stilbenes/pharmacology	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	insulin-like growth factor i/metabolism	9.940125707075254e-05	0.00021089289029021862	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	neoplasm recurrence local/genetics	2.7405334346308763e-07	7.346295582582561e-07	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	tyrphostins/pharmacology	0.0022551445239736845	0.004143106946468777	0.0735378000087754	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	transforming growth factor beta/metabolism	5.6233100847791206e-05	0.00012324328106283304	0.007095639193881167	0.8657199677887635	2	2
tumor necrosis factor-alpha/metabolism	human umbilical vein endothelial cells	0.0019468556078824362	0.003611330341796395	0.10849863774429329	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	CCL21	0.0005349787352844082	0.0010567291843353013	0.0735378000087754	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	CTNNB1	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	IGF1R	9.940125707075254e-05	0.00021089289029021862	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	IL6R	3.2737088677681214e-06	8.090879174593828e-06	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	IL6ST	3.2737088677681214e-06	8.090879174593828e-06	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	MCL1	0.004659060138487936	0.008155852158267727	0.01707421177850705	0.8657199677887635	2	2
tumor necrosis factor-alpha/metabolism	NOS2	9.940125707075254e-05	0.00021089289029021862	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	SIRT1	0.003362937346997108	0.006032547606101395	0.0735378000087754	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	flavonoids/metabolism	0.00025250561210343747	0.0005151993092408466	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	multiple myeloma/metabolism	0.00025250561210343747	0.0005151993092408466	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	creatine kinase mb form/metabolism	1.1152948980353017e-05	2.6198616995399886e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	nitric oxide synthase type iii/metabolism	1.1152948980353017e-05	2.6198616995399886e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	myocardial reperfusion injury/metabolism	0.0009928135905789004	0.0019042674245396776	0.0735378000087754	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	myeloid cell leukemia sequence 1 protein/metabolism	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	cytoprotection	0.0006659240867709082	0.0013010451276140882	0.0735378000087754	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	mercaptoethanol/pharmacology	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	interleukins/metabolism	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	cd3 complex/immunology	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	chalcones/administration & dosage	1.1152948980353017e-05	2.6198616995399886e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	CD28	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	CD3E	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	IL5	1.8812353098085488e-05	4.327331884262794e-05	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	TNFRSF10D	0.00025250561210343747	0.0005151993092408466	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	nitric oxide/metabolism	0.003795571073938131	0.006728692694233973	0.0735378000087754	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	nucleotides cyclic/pharmacology	6.096331439664482e-09	1.8334731357484997e-08	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	t-lymphocytes/cytology	0.0008180183275247055	0.0015863900154160179	0.0735378000087754	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	carcinoma non-small-cell lung/genetics	2.7405334346308763e-07	7.346295582582561e-07	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	naphthols/pharmacology	9.940125707075254e-05	0.00021089289029021862	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	receptor igf type 1/biosynthesis	9.940125707075254e-05	0.00021089289029021862	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	neoplasms/blood supply	6.096331439664482e-09	1.8334731357484997e-08	0.037383177570093455	0.9605811478101344	1	2
tumor necrosis factor-alpha/metabolism	chemokine ccl21/genetics	2.7405334346308763e-07	7.346295582582561e-07	0.037383177570093455	0.9605811478101344	1	2
TESC	spermatogenesis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TESC	arsenic/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD40LG	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
CD40LG	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
CD40LG	IL2	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
CD40LG	PPIA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neuroblastoma/immunology	receptors antigen t-cell gamma-delta/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neuroblastoma/immunology	chemokine cxcl10/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neuroblastoma/immunology	neovascularization pathologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neuroblastoma/immunology	t-lymphocyte subsets/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neuroblastoma/immunology	CXCL10	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
vitamin e/pharmacology	antioxidants/pharmacology	2.481348460037225e-13	9.382399390653529e-13	0.014018691588785045	0.9605811478101344	1	2
vitamin e/pharmacology	biopterin/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
vitamin e/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TNFRSF10D	BIRC5	2.332691073636539e-08	6.70113000541217e-08	0.014018691588785045	0.9605811478101344	1	2
TNFRSF10D	CASP8	0.000335616220874857	0.0006746595949898656	0.03271028037383177	0.9605811478101344	1	2
TNFRSF10D	MCL1	0.00018571952850299223	0.00038444692183212586	0.02803738317757009	0.9605811478101344	1	2
TNFRSF10D	XIAP	6.226627435879095e-09	1.8701087277790802e-08	0.014018691588785045	0.9605811478101344	1	2
TNFRSF10D	flavonoids/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TNFRSF10D	multiple myeloma/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TNFRSF10D	caspases/metabolism	0.00014922404803296985	0.00031191617472799767	0.03271028037383177	0.9605811478101344	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	FN1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	MMRN1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	amino acid transport system y+/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	liver cirrhosis/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	collagen type i/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	cell line	2.1067664965124244e-05	4.820963955900979e-05	0.06074766355140186	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	cell movement/drug effects	0.0035668888613312744	0.0063601104419435455	0.023594219167943648	0.8657199677887635	2	2
epithelial-mesenchymal transition/drug effects	thiazoles/pharmacology	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	neoplasm invasiveness	0.0044665755125096185	0.007833828406635279	0.08215010393874443	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	neoplasm proteins/metabolism	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	breast neoplasms/blood supply	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	phenotype	3.4789498117304696e-05	7.808600778686083e-05	0.04166180294604871	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	transforming growth factor beta1/genetics	1.7126907669862135e-09	5.295387187002109e-09	0.027905752270633143	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	lipopolysaccharides/pharmacology	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	myeloid differentiation factor 88/antagonists & inhibitors	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	isoflavones/adverse effects	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	piperazines	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	pancreatic neoplasms/drug therapy	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	glycogen synthase kinase 3 beta/metabolism	1.0834047752372733e-05	2.5471218260216894e-05	0.027905752270633143	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	nf-kappa b/metabolism	0.0015451254639605727	0.002900794127163037	0.06878335787959994	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	CDKN1A	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	ITK	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	MMP2	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	MMP9	2.4375466437520643e-06	6.0891715841202705e-06	0.027905752270633143	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	MYD88	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	TRAF6	6.632486448943098e-09	1.9812093378444308e-08	0.014018691588785045	0.9605811478101344	1	2
epithelial-mesenchymal transition/drug effects	ZHX2	0.0004454742043631388	0.0008864454203789245	0.055287464515536164	0.9605811478101344	1	2
TNFRSF4	t-lymphocytes/drug effects	1.3844481117075702e-13	5.292009703004249e-13	0.014018691588785045	0.9605811478101344	1	2
TNFRSF4	protein kinase inhibitors/pharmacology	0.00011180421294365583	0.00023589084085949512	0.04672897196261682	0.9605811478101344	1	2
TNFRSF4	breast neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
TNFRSF4	CCL5	1.3098300222225134e-11	4.508841893827007e-11	0.014018691588785045	0.9605811478101344	1	2
TNFRSF4	chemokines/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
TNFRSF4	CXCL9	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
TNFRSF4	CXCL10	1.0363931934875836e-12	3.832030375652229e-12	0.014018691588785045	0.9605811478101344	1	2
TNFRSF4	cyclin-dependent kinase 4/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
TNFRSF4	receptors chemokine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TNFRSF4	TNFRSF9	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	recombinant proteins	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	nf-kappa b/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
muscle skeletal/immunology	carcinoma hepatocellular/drug therapy	3.1022891100462857e-07	8.275773780798609e-07	0.03271028037383177	0.9605811478101344	1	2
muscle skeletal/immunology	gene silencing/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	rna small interfering/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	interferon regulatory factor-1/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	interferon-gamma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	interferon regulatory factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	plasmids/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
muscle skeletal/immunology	tumor cells cultured	0.004141426933179759	0.007290816114879219	0.08878504672897196	0.9605811478101344	1	2
muscle skeletal/immunology	proto-oncogene proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	IRF1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	IRF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	MAPK1	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
muscle skeletal/immunology	NFKB1	7.779346631320294e-07	2.018821027864287e-06	0.03271028037383177	0.9605811478101344	1	2
TNFRSF9	t-lymphocytes/drug effects	1.3844481117075702e-13	5.292009703004249e-13	0.014018691588785045	0.9605811478101344	1	2
TNFRSF9	protein kinase inhibitors/pharmacology	0.00011180421294365583	0.00023589084085949512	0.04672897196261682	0.9605811478101344	1	2
TNFRSF9	breast neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
TNFRSF9	CCL5	1.3098300222225134e-11	4.508841893827007e-11	0.014018691588785045	0.9605811478101344	1	2
TNFRSF9	chemokines/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
TNFRSF9	CXCL9	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
TNFRSF9	CXCL10	1.0363931934875836e-12	3.832030375652229e-12	0.014018691588785045	0.9605811478101344	1	2
TNFRSF9	cyclin-dependent kinase 4/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
TNFRSF9	receptors chemokine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lignans/pharmacology	cell line	2.1577347930623603e-06	5.414720773667075e-06	0.0034224035803606685	0.8657199677887635	2	2
lignans/pharmacology	neovascularization pathologic/drug therapy	6.791679374451576e-08	1.8988453822965806e-07	0.018647711816067742	0.9605811478101344	1	2
lignans/pharmacology	extracellular signal-regulated map kinases/drug effects	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	p38 mitogen-activated protein kinases/drug effects	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	proto-oncogene proteins c-akt/drug effects	1.2436006022742419e-06	3.1819549818895767e-06	0.027905752270633143	0.9605811478101344	1	2
lignans/pharmacology	g1 phase/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	acetylcysteine/metabolism	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	angiogenesis inhibitors/pharmacology	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	nitric oxide synthase/antagonists & inhibitors	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	cell differentiation	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	endothelial cells/drug effects	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	tor serine-threonine kinases/drug effects	4.712144485718994e-08	1.3323077920124696e-07	0.018647711816067742	0.9605811478101344	1	2
lignans/pharmacology	embryonic stem cells/cytology	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	platelet endothelial cell adhesion molecule-1/biosynthesis	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	phosphatidylinositol 3-kinases/drug effects	1.2436006022742419e-06	3.1819549818895767e-06	0.027905752270633143	0.9605811478101344	1	2
lignans/pharmacology	jnk mitogen-activated protein kinases/drug effects	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
lignans/pharmacology	caspase 3/biosynthesis	8.043898880316647e-12	2.7938229759486676e-11	0.009345794392523364	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	PTGER4	3.175126828125485e-12	1.1320374564442222e-11	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	SP1	0.0	0.0	0.0009214163485586416	0.8657199677887635	2	2
drugs chinese herbal/pharmacology	TP73	1.181569286856643e-09	3.6847580815580287e-09	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	antineoplastic agents phytogenic/isolation & purification	0.005290705352827385	0.009188615330377172	0.12539913750269532	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	protein kinase inhibitors/pharmacology	0.0007341547076726851	0.0014297891524394806	0.03650184028860656	0.8657199677887635	2	2
drugs chinese herbal/pharmacology	BIRC5	0.002837579581390748	0.005143287948906874	0.09538832359347407	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	MAPK1	0.0004028082663601884	0.0008037937059199416	0.03650184028860656	0.8657199677887635	2	2
drugs chinese herbal/pharmacology	PCNA	1.4883361335149559e-05	3.44874777422362e-05	0.0644991443991049	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	sp1 transcription factor/physiology	3.175126828125485e-12	1.1320374564442222e-11	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	spleen/drug effects	3.175126828125485e-12	1.1320374564442222e-11	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	gefitinib/pharmacology	3.175126828125485e-12	1.1320374564442222e-11	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	sp1 transcription factor/metabolism	3.540051585204651e-10	1.1305193706632698e-09	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	carcinoma non-small-cell lung/blood	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	dna (cytosine-5-)-methyltransferase 1/metabolism	3.540051585204651e-10	1.1305193706632698e-09	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	erlotinib hydrochloride/pharmacology	3.540051585204651e-10	1.1305193706632698e-09	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	apoptosis	0.00013315331632623995	0.0002794901293184442	0.09538832359347407	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	erbb receptors/drug effects	1.181569286856643e-09	3.6847580815580287e-09	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	rna long noncoding/physiology	3.175126828125485e-12	1.1320374564442222e-11	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	receptors prostaglandin e ep4 subtype/physiology	3.175126828125485e-12	1.1320374564442222e-11	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	thrombocytopenia/chemically induced	0.0	0.0	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	thymus gland/drug effects	3.175126828125485e-12	1.1320374564442222e-11	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	proto-oncogene proteins c-met/antagonists & inhibitors	3.540051585204651e-10	1.1305193706632698e-09	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	DNMT1	3.540051585204651e-10	1.1305193706632698e-09	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	HGF	3.540051585204651e-10	1.1305193706632698e-09	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	MDM2	1.181569286856643e-09	3.6847580815580287e-09	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	MET	3.175126828125485e-12	1.1320374564442222e-11	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	METTL7B	1.181569286856643e-09	3.6847580815580287e-09	0.03271028037383177	0.9605811478101344	1	2
drugs chinese herbal/pharmacology	MUC1	0.00010933179359395861	0.0002313829319600307	0.0644991443991049	0.9605811478101344	1	2
TNS1	antineoplastic agents phytogenic/pharmacology	8.836575189352658e-06	2.0978659392144654e-05	0.02803738317757009	0.9605811478101344	1	2
TNS1	CASP8	0.0001886666603145848	0.0003902544822793851	0.03271028037383177	0.9605811478101344	1	2
TNS1	prostatic neoplasms/drug therapy	1.3447498348195808e-07	3.6890686024763117e-07	0.02336448598130841	0.9605811478101344	1	2
TNS1	MCL1	9.985783302068896e-05	0.000211759690529975	0.02803738317757009	0.9605811478101344	1	2
TNS1	plant roots	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TNS1	1-phosphatidylinositol 4-kinase/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TNS1	dna/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TNS1	caspases/metabolism	7.892179161317348e-05	0.0001698289734030108	0.03271028037383177	0.9605811478101344	1	2
TNS1	plant extracts/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thymus gland/drug effects	PCNA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
thymus gland/drug effects	spleen/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl19/immunology	receptors ccr7/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl19/immunology	b-lymphocytes/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
chemokine ccl19/immunology	heterocyclic compounds 4 or more rings/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokine ccl19/immunology	myeloid-derived suppressor cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl19/immunology	monocytes/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
chemokine ccl19/immunology	leukemia lymphocytic chronic b-cell/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl19/immunology	chemokine ccl21/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl19/immunology	tumor cells cultured	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
chemokine ccl19/immunology	CCL19	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl19/immunology	CCL21	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokine ccl19/immunology	CCR7	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PIK3CA	phosphoinositide-3 kinase inhibitors	0.0038246184080465984	0.006779096925847046	7.209845766051693e-05	0.0004890825745798103	13	2
PIK3CA	mitophagy/drug effects	0.004893663856025077	0.008544147980491043	0.01861618615696499	0.5304112294886878	4	2
ULK1	cell line	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
ULK1	rna small interfering/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ULK1	superoxide dismutase/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ULK1	ubiquinone/analogs & derivatives	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ULK1	organophosphorus compounds/pharmacology	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
ULK1	pten phosphohydrolase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ULK1	autophagy-related protein-1 homolog/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
g1 phase/drug effects	cell line	0.00010933179359395861	0.0002313829319600307	0.06074766355140186	0.9605811478101344	1	2
cyclams	cell movement/drug effects	1.5501520311822503e-07	4.2409420503171925e-07	0.0007078265750383096	0.7135314763244264	3	2
cyclams	chemokine cxcl12/metabolism	0.0	0.0	0.00039365091980200724	0.8657199677887635	2	2
cyclams	cytarabine/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cyclams	receptors cxcr4/antagonists & inhibitors	0.0	0.0	6.209005044195697e-07	0.7135314763244264	3	2
cyclams	docetaxel	6.631623683528431e-08	1.8543315025292944e-07	0.027905752270633143	0.9605811478101344	1	2
cyclams	benzylamines	0.0	0.0	6.209005044195697e-07	0.7135314763244264	3	2
cyclams	bone neoplasms/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cyclams	neoplastic stem cells/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cyclams	cytarabine/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cyclams	transforming growth factor beta/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cyclams	chemokine cxcl12/genetics	6.631623683528431e-08	1.8543315025292944e-07	0.04166180294604871	0.9605811478101344	1	2
cyclams	leukemia myeloid acute/drug therapy	0.0	0.0	0.0007848182375863361	0.8657199677887635	2	2
cyclams	prostatic neoplasms/drug therapy	0.0001184325975449596	0.000249660762087319	0.06878335787959994	0.9605811478101344	1	2
cyclams	antibodies neutralizing/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cyclams	tumor microenvironment/immunology	6.967049159811722e-11	2.321086429065108e-10	0.027905752270633143	0.9605811478101344	1	2
cyclams	heterocyclic compounds/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cyclams	hematopoietic stem cells/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cyclams	cell adhesion/drug effects	4.264413928023458e-05	9.457981921845007e-05	0.055287464515536164	0.9605811478101344	1	2
cyclams	CXCL12	0.0	0.0	2.173151765468494e-05	0.7135314763244264	3	2
cyclams	CXCR4	0.0	0.0	2.483602017678279e-06	0.7135314763244264	3	2
proto-oncogene proteins c-met/antagonists & inhibitors	protein kinase inhibitors/pharmacology	1.4380785950063313e-05	3.33579767098365e-05	0.04672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-met/antagonists & inhibitors	dna (cytosine-5-)-methyltransferase 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-met/antagonists & inhibitors	erlotinib hydrochloride/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-met/antagonists & inhibitors	sp1 transcription factor/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-met/antagonists & inhibitors	DNMT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-met/antagonists & inhibitors	HGF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins c-met/antagonists & inhibitors	MUC1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-met/antagonists & inhibitors	SP1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/drug therapy	nf-kappa b/genetics	9.435785486289205e-13	3.5005922665607337e-12	0.018647711816067742	0.9605811478101344	1	2
glioblastoma/drug therapy	stat3 transcription factor/metabolism	1.3655743202889425e-14	5.4772025857250505e-14	0.018647711816067742	0.9605811478101344	1	2
glioblastoma/drug therapy	receptor protein-tyrosine kinases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/drug therapy	brain neoplasms/drug therapy	0.0	0.0	4.387696897898293e-05	0.8657199677887635	2	2
glioblastoma/drug therapy	interleukin-6/metabolism	4.099602150198223e-06	1.0102607377620477e-05	0.046290202272826986	0.9605811478101344	1	2
glioblastoma/drug therapy	biomarkers tumor/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/drug therapy	chemokine ccl2/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/drug therapy	paracrine communication	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/drug therapy	proto-oncogene proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/drug therapy	apoptosis regulatory proteins	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/drug therapy	quercetin/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/drug therapy	tumor cells cultured	1.1631449034044117e-05	2.7302266400788318e-05	0.0075029616954060815	0.8657199677887635	2	2
glioblastoma/drug therapy	AXL	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/drug therapy	CCL2	8.997020867207439e-07	2.3263318409779478e-06	0.03711991575621956	0.9605811478101344	1	2
glioblastoma/drug therapy	NFKB1	0.00012508470989969211	0.0002632557926563967	0.0644991443991049	0.9605811478101344	1	2
tuberculosis/metabolism	host-pathogen interactions	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
tuberculosis/metabolism	iron chelating agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tuberculosis/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
host-pathogen interactions	iron chelating agents/pharmacology	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	cell line	1.1824710239860536e-06	3.0339952445996174e-06	0.030797282136299682	0.8657199677887635	2	2
host-pathogen interactions	phospholipid hydroperoxide glutathione peroxidase/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.046290202272826986	0.9605811478101344	1	2
host-pathogen interactions	proteasome endopeptidase complex/metabolism	1.496225365826831e-11	5.132842207211758e-11	0.046290202272826986	0.9605811478101344	1	2
host-pathogen interactions	hepatitis c/pathology	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	endothelial cells/microbiology	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	ferritins/genetics	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	bacterial adhesion	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	apoferritins/metabolism	3.241851231905457e-14	1.2765911048589306e-13	0.046290202272826986	0.9605811478101344	1	2
host-pathogen interactions	viral nonstructural proteins/genetics	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	protein interaction maps	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	viral structural proteins/metabolism	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	oxidoreductases/genetics	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	homeostasis	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	protein kinases/metabolism	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	intercellular adhesion molecule-1/metabolism	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	hepatocytes/metabolism	3.241851231905457e-14	1.2765911048589306e-13	0.046290202272826986	0.9605811478101344	1	2
host-pathogen interactions	apoptosis	2.27001811792249e-08	6.53641889303318e-08	0.06878335787959994	0.9605811478101344	1	2
host-pathogen interactions	ferritins/metabolism	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	apolipoprotein b-100/antagonists & inhibitors	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	nuclear receptor coactivators/genetics	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	viral proteins/metabolism	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	fimbriae proteins/metabolism	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	ICAM1	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
host-pathogen interactions	NCOA4	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
IL2	b-lymphocytes/drug effects	4.9402176675039655e-05	0.00010876964163483866	0.055287464515536164	0.9605811478101344	1	2
IL2	monocytes/drug effects	4.9402176675039655e-05	0.00010876964163483866	0.055287464515536164	0.9605811478101344	1	2
IL2	t-lymphocytes/cytology	2.464627871789915e-07	6.621997967002687e-07	0.03711991575621956	0.9605811478101344	1	2
IL2	adenosine triphosphate/metabolism	0.0007038336660539768	0.0013726779893107545	0.10825010098314035	0.9605811478101344	1	2
IL2	jurkat cells/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
IL2	killer cells natural/drug effects	5.657314122720081e-07	1.4824395267141947e-06	0.03711991575621956	0.9605811478101344	1	2
IL2	rna messenger/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
IL2	dna fragmentation/drug effects	1.6670598709245255e-06	4.220385352410602e-06	0.055287464515536164	0.9605811478101344	1	2
IL2	cd3 complex/immunology	5.513522971511975e-11	1.8460463853590893e-10	0.018691588785046728	0.9605811478101344	1	2
IL2	oleic acid/toxicity	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
IL2	mercaptoethanol/pharmacology	5.513522971511975e-11	1.8460463853590893e-10	0.018691588785046728	0.9605811478101344	1	2
IL2	CD28	5.513522971511975e-11	1.8460463853590893e-10	0.018691588785046728	0.9605811478101344	1	2
IL2	CD3E	5.513522971511975e-11	1.8460463853590893e-10	0.018691588785046728	0.9605811478101344	1	2
IL2	interleukins/metabolism	5.513522971511975e-11	1.8460463853590893e-10	0.018691588785046728	0.9605811478101344	1	2
IL2	IL5	5.513522971511975e-11	1.8460463853590893e-10	0.018691588785046728	0.9605811478101344	1	2
IL2	PKM	4.643840867402105e-12	1.6329729416982715e-11	0.018691588785046728	0.9605811478101344	1	2
IL2	PPIA	1.0859091403858656e-12	4.002361204819051e-12	0.018691588785046728	0.9605811478101344	1	2
IL2	arachidonic acid/toxicity	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
nlr family pyrin domain-containing 3 protein/metabolism	lung/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nlr family pyrin domain-containing 3 protein/metabolism	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nlr family pyrin domain-containing 3 protein/metabolism	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nlr family pyrin domain-containing 3 protein/metabolism	inflammasomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nlr family pyrin domain-containing 3 protein/metabolism	hmgb1 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
doxorubicin/pharmacology	rna small interfering/metabolism	4.798383912429927e-13	1.8004555565223794e-12	0.018647711816067742	0.9605811478101344	1	2
doxorubicin/pharmacology	integrins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
doxorubicin/pharmacology	cd79 antigens/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
doxorubicin/pharmacology	antineoplastic agents phytogenic/isolation & purification	1.585062934572612e-06	4.019722519146187e-06	0.03711991575621956	0.9605811478101344	1	2
doxorubicin/pharmacology	lymphoma large b-cell diffuse/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
doxorubicin/pharmacology	CD79A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
doxorubicin/pharmacology	CD79B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
doxorubicin/pharmacology	SYK	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
doxorubicin/pharmacology	WDTC1	1.478060929205327e-08	4.297545478981808e-08	0.03711991575621956	0.9605811478101344	1	2
doxorubicin/pharmacology	plant extracts/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
doxorubicin/pharmacology	anthraquinones/isolation & purification	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
doxorubicin/pharmacology	src-family kinases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors antigen b-cell/antagonists & inhibitors	PRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors antigen b-cell/antagonists & inhibitors	t-lymphocytes/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
receptors antigen b-cell/antagonists & inhibitors	plicamycin/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors antigen b-cell/antagonists & inhibitors	gene expression regulation leukemic/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors antigen b-cell/antagonists & inhibitors	leukemia lymphocytic chronic b-cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors antigen b-cell/antagonists & inhibitors	killer cells natural/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors antigen b-cell/antagonists & inhibitors	tumor cells cultured	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
receptors antigen b-cell/antagonists & inhibitors	caspase 3/metabolism	2.66944835125571e-08	7.655566759688592e-08	0.02803738317757009	0.9605811478101344	1	2
neovascularization pathologic/immunology	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
neovascularization pathologic/immunology	fas receptor/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/immunology	sarcoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/immunology	hypoxia	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/immunology	plant leaves/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/immunology	fas ligand protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/immunology	PRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
thiazoles/pharmacology	neoplasm invasiveness	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
thiazoles/pharmacology	neoplasm proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thiazoles/pharmacology	breast neoplasms/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thiazoles/pharmacology	lipopolysaccharides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thiazoles/pharmacology	myeloid differentiation factor 88/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thiazoles/pharmacology	piperazines	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thiazoles/pharmacology	glycogen synthase kinase 3 beta/metabolism	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
thiazoles/pharmacology	nf-kappa b/metabolism	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
thiazoles/pharmacology	ITK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thiazoles/pharmacology	MMP2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thiazoles/pharmacology	MMP9	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
thiazoles/pharmacology	MYD88	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thiazoles/pharmacology	NFKB1	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
thiazoles/pharmacology	TRAF6	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung/blood supply	inflammasomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung/blood supply	phenylenediamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung/blood supply	cyclohexylamines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lung/blood supply	hmgb1 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ceramides/pharmacology	melanoma/genetics	1.5344746584489144e-09	4.75503826696861e-09	0.027905752270633143	0.9605811478101344	1	2
ceramides/pharmacology	cd8-positive t-lymphocytes/immunology	1.4092521308795014e-06	3.5862408796896638e-06	0.046290202272826986	0.9605811478101344	1	2
ceramides/pharmacology	carcinoma hepatocellular/drug therapy	0.00011921627541833235	0.0002512407226556482	0.0644991443991049	0.9605811478101344	1	2
ceramides/pharmacology	cell line transformed	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ceramides/pharmacology	cytokines/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ceramides/pharmacology	protein kinase c/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ceramides/pharmacology	receptors vascular endothelial growth factor/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ceramides/pharmacology	vascular endothelial growth factor a/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ceramides/pharmacology	CSF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ceramides/pharmacology	CSF2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ceramides/pharmacology	FLT1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ceramides/pharmacology	KDR	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ceramides/pharmacology	antigens polyomavirus transforming/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	neoplasm invasiveness	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	interferon-alpha/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	stat3 transcription factor/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	clodronic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	ng-nitroarginine methyl ester/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	liver neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	colorectal neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	receptors ccr5/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	adenocarcinoma/drug therapy	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	maraviroc	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	neoplasm proteins/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
phenylurea compounds/therapeutic use	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
listeriosis/etiology	ferritins/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
listeriosis/etiology	hemeproteins/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
listeriosis/etiology	transferrin/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
listeriosis/etiology	liver x receptors/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
listeriosis/etiology	TF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
listeriosis/etiology	genetic variation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
listeriosis/etiology	malaria/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophilin d	curcumin/pharmacology	2.6147717324676023e-10	8.445720357082581e-10	0.027905752270633143	0.9605811478101344	1	2
cyclophilin d	myocardial reperfusion injury/metabolism	4.918287999089443e-13	1.8445044021759493e-12	0.018647711816067742	0.9605811478101344	1	2
cyclophilin d	cardiotonic agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclophilin d	oxygen consumption	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclophilin d	myocytes cardiac/drug effects	3.1292340773036997e-06	7.742492754616988e-06	0.046290202272826986	0.9605811478101344	1	2
cyclophilin d	mitochondria heart/drug effects	1.9701580900033377e-07	5.351490152567894e-07	0.03711991575621956	0.9605811478101344	1	2
cyclophilin d	electron transport complex i/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclophilin d	cell hypoxia/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclophilin d	cell death	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclophilin d	PPID	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclophilin d	PPIF	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
killer cells natural/drug effects	gene expression regulation leukemic/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
killer cells natural/drug effects	t-lymphocytes/drug effects	1.5950905596362475e-08	4.629269008669209e-08	0.027905752270633143	0.9605811478101344	1	2
killer cells natural/drug effects	plicamycin/analogs & derivatives	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
killer cells natural/drug effects	leukemia lymphocytic chronic b-cell/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
killer cells natural/drug effects	adenosine triphosphate/metabolism	1.7179468846384438e-06	4.347215989040331e-06	0.05541661182045544	0.9605811478101344	1	2
killer cells natural/drug effects	caspase 3/metabolism	0.00016270533715601054	0.00033919509016790096	0.05541661182045544	0.9605811478101344	1	2
killer cells natural/drug effects	PRF1	4.798383912429927e-13	1.8004555565223794e-12	0.018647711816067742	0.9605811478101344	1	2
killer cells natural/drug effects	PKM	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
microglia/drug effects	nf-e2-related factor 2/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
microglia/drug effects	inflammation mediators/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	fibrosarcoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	rho gtp-binding proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	neovascularization pathologic/prevention & control	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	vascular endothelial growth factor a/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	caspase 8/metabolism	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	cell adhesion/drug effects	2.2819819367470018e-09	7.0161954736296045e-09	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	chemokine ccl2/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	trabectedin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	BRCA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	CASP8	6.575019124388515e-05	0.00014324705697086758	0.03271028037383177	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	CCL2	4.814946774622797e-09	1.4524551441631335e-08	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	interleukin-8/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	heterocyclic compounds 4 or more rings/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
antineoplastic agents alkylating/pharmacology	ovarian neoplasms/drug therapy	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
granulosa cells/drug effects	zearalenone/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antioxidants/pharmacology	biopterin/analogs & derivatives	2.481348460037225e-13	9.382399390653529e-13	0.014018691588785045	0.9605811478101344	1	2
antioxidants/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	2.481348460037225e-13	9.382399390653529e-13	0.014018691588785045	0.9605811478101344	1	2
antioxidants/pharmacology	SPP1	7.867758154977977e-07	2.041524441578845e-06	0.027905752270633143	0.9605811478101344	1	2
antioxidants/pharmacology	activating transcription factor 4/genetics	1.2850165376221412e-11	4.427573780511481e-11	0.014018691588785045	0.9605811478101344	1	2
antioxidants/pharmacology	phenylbutyrates/pharmacology	1.2850165376221412e-11	4.427573780511481e-11	0.014018691588785045	0.9605811478101344	1	2
antioxidants/pharmacology	organophosphorus compounds/pharmacology	1.992378137138928e-06	5.004893832475685e-06	0.027905752270633143	0.9605811478101344	1	2
antioxidants/pharmacology	transcription factor chop/genetics	1.2850165376221412e-11	4.427573780511481e-11	0.014018691588785045	0.9605811478101344	1	2
antioxidants/pharmacology	urinary bladder neoplasms/metabolism	3.927413949611491e-12	1.3876862621960603e-11	0.014018691588785045	0.9605811478101344	1	2
antioxidants/pharmacology	tor serine-threonine kinases/genetics	0.0005215779470576498	0.001031552796620655	0.055287464515536164	0.9605811478101344	1	2
antioxidants/pharmacology	cerebral arteries/cytology	1.2850165376221412e-11	4.427573780511481e-11	0.014018691588785045	0.9605811478101344	1	2
antioxidants/pharmacology	eukaryotic initiation factor-2/genetics	1.2850165376221412e-11	4.427573780511481e-11	0.014018691588785045	0.9605811478101344	1	2
antioxidants/pharmacology	taurochenodeoxycholic acid/pharmacology	1.2850165376221412e-11	4.427573780511481e-11	0.014018691588785045	0.9605811478101344	1	2
antioxidants/pharmacology	myocytes smooth muscle/cytology	4.6343591852959776e-08	1.313177629063176e-07	0.027905752270633143	0.9605811478101344	1	2
antioxidants/pharmacology	endoplasmic reticulum/drug effects	2.9688111218173496e-05	6.706592993220177e-05	0.04166180294604871	0.9605811478101344	1	2
antioxidants/pharmacology	muscle smooth vascular/cytology	1.2850165376221412e-11	4.427573780511481e-11	0.014018691588785045	0.9605811478101344	1	2
antioxidants/pharmacology	piperidines/pharmacology	2.639939188142648e-06	6.570939175905296e-06	0.027905752270633143	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	receptors fibroblast growth factor/metabolism	0.0015785186546998231	0.002957693490169262	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	fibroblast growth factor 2/pharmacology	0.0015785186546998231	0.002957693490169262	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	pyrimidines/pharmacology	0.0018081906316250729	0.0033665754978947477	0.02543061333281605	0.8657199677887635	2	2
phosphoinositide-3 kinase inhibitors	bcl-2-like protein 11/metabolism	0.0015785186546998231	0.002957693490169262	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	FGF2	0.0015785186546998231	0.002957693490169262	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	autophagy	1.9540235604686984e-05	4.487273352902183e-05	0.004607081742793208	0.8657199677887635	2	2
phosphoinositide-3 kinase inhibitors	glucose/deficiency	0.002079111832937297	0.003839860754950706	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	neoplasms/enzymology	0.0011655363347118364	0.0022206831237233464	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	lipid droplets/metabolism	0.0011655363347118364	0.0022206831237233464	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	azepines/chemistry	0.0033656780815034537	0.0060350089737303304	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	biological transport	1.5452482721611815e-05	3.57423771554865e-05	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	0.002079111832937297	0.003839860754950706	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	phenylurea compounds/pharmacology	0.00023501543991510943	0.0004817423223548097	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	imidazoles/pharmacology	3.2328513919543944e-05	7.290365908746087e-05	0.004607081742793208	0.8657199677887635	2	2
phosphoinositide-3 kinase inhibitors	drug antagonism	3.6012106237715e-05	8.051870178776395e-05	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	phospholipids/metabolism	0.0011655363347118364	0.0022206831237233464	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	creatine kinase mb form/metabolism	0.0011655363347118364	0.0022206831237233464	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	carcinoma squamous cell/drug therapy	0.0005733062746914319	0.0011294010672262948	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	nitric oxide synthase type iii/metabolism	0.0011655363347118364	0.0022206831237233464	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	mouth neoplasms/drug therapy	0.0005733062746914319	0.0011294010672262948	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	phagosomes/metabolism	3.6012106237715e-05	8.051870178776395e-05	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	cell respiration/drug effects	0.00019456010397544965	0.00040187944280032923	0.013256225769357815	0.8657199677887635	2	2
phosphoinositide-3 kinase inhibitors	palmitic acid/pharmacology	0.00023501543991510943	0.0004817423223548097	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	neuroblastoma/metabolism	0.00023501543991510943	0.0004817423223548097	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	homeostasis/drug effects	3.6012106237715e-05	8.051870178776395e-05	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	insulin antagonists/pharmacology	0.00023501543991510943	0.0004817423223548097	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	morpholines/pharmacology	0.0010985303427488713	0.00209773055577058	0.013256225769357815	0.8657199677887635	2	2
phosphoinositide-3 kinase inhibitors	neuroblastoma/drug therapy	0.0026732333724176494	0.00486138645620788	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	cell membrane permeability/drug effects	0.0026732333724176494	0.00486138645620788	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	sesquiterpenes guaiane	0.0005733062746914319	0.0011294010672262948	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	mitogen-activated protein kinase 1/antagonists & inhibitors	0.0001371871321772522	0.0002878201437095876	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	cytoprotection/drug effects	0.002079111832937297	0.003839860754950706	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	quinolines/pharmacology	0.002079111832937297	0.003839860754950706	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	malaria/drug therapy	3.6012106237715e-05	8.051870178776395e-05	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	quinazolines	0.0001371871321772522	0.0002878201437095876	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	phospholipase a2 inhibitors/pharmacology	0.0011655363347118364	0.0022206831237233464	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	antimalarials/pharmacology	2.124656325097618e-06	5.334140589359176e-06	0.004607081742793208	0.8657199677887635	2	2
phosphoinositide-3 kinase inhibitors	insulin/metabolism	0.00023501543991510943	0.0004817423223548097	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	pyrimidines/chemistry	0.0033656780815034537	0.0060350089737303304	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	glioma/drug therapy	0.0001371871321772522	0.0002878201437095876	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	mitogen-activated protein kinases/antagonists & inhibitors	0.0033656780815034537	0.0060350089737303304	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	chalcones/administration & dosage	0.0011655363347118364	0.0022206831237233464	0.07009345794392523	0.9605811478101344	1	2
phosphoinositide-3 kinase inhibitors	neoplasm recurrence local/pathology	0.0015785186546998231	0.002957693490169262	0.07009345794392523	0.9605811478101344	1	2
aspirin/administration & dosage	interleukin-6/metabolism	7.947415625597642e-08	2.213829686837357e-07	0.02336448598130841	0.9605811478101344	1	2
aspirin/administration & dosage	lymphoma t-cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
aspirin/administration & dosage	interleukin-4/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
aspirin/administration & dosage	nitric oxide/metabolism	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
aspirin/administration & dosage	transforming growth factor beta/metabolism	3.752653865429778e-08	1.0667678239426992e-07	0.018691588785046728	0.9605811478101344	1	2
aspirin/administration & dosage	BIRC5	1.3561035627773776e-09	4.206439413634725e-09	0.014018691588785045	0.9605811478101344	1	2
aspirin/administration & dosage	SOCS5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PPIA	b-lymphocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
PPIA	monocytes/drug effects	5.551115123125783e-16	2.3645862873778448e-15	0.014018691588785045	0.9605811478101344	1	2
neoplasms hormone-dependent/immunology	interleukin-1beta/deficiency	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms hormone-dependent/immunology	estrogen receptor modulators/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms hormone-dependent/immunology	triple negative breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms hormone-dependent/immunology	neutrophil infiltration/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms hormone-dependent/immunology	estrogen receptor beta/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms hormone-dependent/immunology	neutrophils/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms hormone-dependent/immunology	ESR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms hormone-dependent/immunology	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biopterin/analogs & derivatives	phospholipid hydroperoxide glutathione peroxidase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylenediamines/pharmacology	cyclohexylamines/pharmacology	0.0	0.0	4.387696897898293e-05	0.8657199677887635	2	2
phenylenediamines/pharmacology	adaptor proteins vesicular transport/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phenylenediamines/pharmacology	TICAM1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phenylenediamines/pharmacology	TRIM69	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phenylenediamines/pharmacology	inflammasomes/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phenylenediamines/pharmacology	myocardial reperfusion injury/drug therapy	2.4646951146678475e-14	9.785989174895859e-14	0.018647711816067742	0.9605811478101344	1	2
phenylenediamines/pharmacology	hmgb1 protein/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
valproic acid/pharmacology	cell movement/drug effects	0.0048237178890900845	0.008429367680007783	0.09345794392523364	0.9605811478101344	1	2
valproic acid/pharmacology	leukocytes mononuclear/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
valproic acid/pharmacology	leukemia/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
valproic acid/pharmacology	p38 mitogen-activated protein kinases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
valproic acid/pharmacology	caspase 3/metabolism	3.5042941337604105e-07	9.278572962789664e-07	0.02803738317757009	0.9605811478101344	1	2
valproic acid/pharmacology	CCL2	2.853762781640512e-10	9.210915211478555e-10	0.018691588785046728	0.9605811478101344	1	2
valproic acid/pharmacology	CCL5	3.764988321108831e-12	1.3309357464134602e-11	0.014018691588785045	0.9605811478101344	1	2
hemeproteins/toxicity	ferritins/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemeproteins/toxicity	transferrin/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemeproteins/toxicity	liver x receptors/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemeproteins/toxicity	TF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemeproteins/toxicity	genetic variation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hemeproteins/toxicity	malaria/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins	nf-kappa b/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
recombinant proteins	carcinoma hepatocellular/drug therapy	3.1022891100462857e-07	8.275773780798609e-07	0.03271028037383177	0.9605811478101344	1	2
recombinant proteins	gene silencing/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins	rna small interfering/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins	interferon regulatory factor-1/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins	interferon-gamma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins	interferon regulatory factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins	plasmids/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
recombinant proteins	tumor cells cultured	0.004141426933179759	0.007290816114879219	0.08878504672897196	0.9605811478101344	1	2
recombinant proteins	proto-oncogene proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins	IRF1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins	IRF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins	MAPK1	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
recombinant proteins	NFKB1	7.779346631320294e-07	2.018821027864287e-06	0.03271028037383177	0.9605811478101344	1	2
liver/drug effects	artesunate	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver/drug effects	ferrous compounds/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver/drug effects	antineoplastic agents/administration & dosage	0.0	0.0	0.027905752270633143	0.9605811478101344	1	2
liver/drug effects	t-2 toxin/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
KLK3	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
KLK3	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
KLK3	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
KLK3	MUC1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
KLK3	NPEPPS	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
KLK3	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
KLK3	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
k562 cells	galectin 3/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
k562 cells	g2 phase cell cycle checkpoints/drug effects	4.4710874202991135e-07	1.1787460892353803e-06	0.027905752270633143	0.9605811478101344	1	2
k562 cells	cell proliferation	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
k562 cells	alpha 1-antitrypsin/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
k562 cells	bone marrow cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
k562 cells	leukemia/drug therapy	5.376860068295741e-10	1.7064777714953865e-09	0.018647711816067742	0.9605811478101344	1	2
k562 cells	leukemia myelogenous chronic bcr-abl positive/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
k562 cells	protein kinase inhibitors/pharmacology	0.004070162479772765	0.007179115388322394	0.09148348032117941	0.9605811478101344	1	2
k562 cells	LGALS3	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
k562 cells	SERPINA1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
k562 cells	aurora kinase b/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
k562 cells	ribosomal proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
inflammation mediators/antagonists & inhibitors	nf-e2-related factor 2/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors antigen t-cell gamma-delta/metabolism	chemokine cxcl10/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors antigen t-cell gamma-delta/metabolism	neovascularization pathologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors antigen t-cell gamma-delta/metabolism	t-lymphocyte subsets/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors antigen t-cell gamma-delta/metabolism	CXCL10	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
adenosine triphosphate/metabolism	cell line	0.00028739851330628063	0.0005835846768628547	0.044603084392293074	0.8657199677887635	2	2
adenosine triphosphate/metabolism	hydrogen peroxide/antagonists & inhibitors	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	pyruvic acid/metabolism	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	autocrine communication	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	erbb receptors/antagonists & inhibitors	0.00025250561210343747	0.0005151993092408466	0.08215010393874443	0.9605811478101344	1	2
adenosine triphosphate/metabolism	peptides/chemistry	3.540051585204651e-10	1.1305193706632698e-09	0.05541661182045544	0.9605811478101344	1	2
adenosine triphosphate/metabolism	cell survival/physiology	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	antioxidants/chemistry	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	tyrphostins/pharmacology	6.247304675577325e-06	1.5103133057799219e-05	0.05541661182045544	0.9605811478101344	1	2
adenosine triphosphate/metabolism	biological factors/chemistry	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	WDTC1	0.00019239971282947188	0.0003974542179765948	0.10825010098314035	0.9605811478101344	1	2
adenosine triphosphate/metabolism	hydroxymethylglutaryl-coa reductase inhibitors/pharmacology	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	adenosine triphosphatases/antagonists & inhibitors	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	isoantigens/immunology	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	superoxide dismutase/metabolism	1.1858723574231789e-06	3.035304589791763e-06	0.05541661182045544	0.9605811478101344	1	2
adenosine triphosphate/metabolism	cell respiration/drug effects	0.0001231941431495409	0.0002594006750225459	0.08215010393874443	0.9605811478101344	1	2
adenosine triphosphate/metabolism	acetaldehyde/pharmacology	4.440892098500626e-16	1.9067729111536865e-15	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	ubiquinone/analogs & derivatives	1.2593558440521235e-07	3.465586326717576e-07	0.05541661182045544	0.9605811478101344	1	2
adenosine triphosphate/metabolism	mitogen-activated protein kinase 1/antagonists & inhibitors	5.6621374255882984e-14	2.2173855410190196e-13	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	antimycin a/pharmacology	4.440892098500626e-16	1.9067729111536865e-15	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	cell hypoxia	1.7179468846384438e-06	4.347215989040331e-06	0.05541661182045544	0.9605811478101344	1	2
adenosine triphosphate/metabolism	quinazolines	5.6621374255882984e-14	2.2173855410190196e-13	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	glioma/drug therapy	5.6621374255882984e-14	2.2173855410190196e-13	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	diet high-fat/adverse effects	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	glutathione disulfide/metabolism	4.440892098500626e-16	1.9067729111536865e-15	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	liver diseases alcoholic/etiology	4.440892098500626e-16	1.9067729111536865e-15	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	EEF1A2	0.0	0.0	0.02803738317757009	0.9605811478101344	1	2
adenosine triphosphate/metabolism	PKM	3.6489922194959945e-11	1.2373574354882757e-10	0.02803738317757009	0.9605811478101344	1	2
SELP	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SELP	dose-response relationship immunologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SELP	calcitriol/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SELP	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nivolumab/therapeutic use	melanoma/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
nivolumab/therapeutic use	amino acid transport system y+/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nivolumab/therapeutic use	cd8-positive t-lymphocytes/immunology	8.426592756904938e-14	3.2900569701476906e-13	0.02336448598130841	0.9605811478101344	1	2
nivolumab/therapeutic use	cysteine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nivolumab/therapeutic use	SLC3A2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
melanoma/genetics	amino acid transport system y+/metabolism	1.1142342604131272e-10	3.6595615929671724e-10	0.027905752270633143	0.9605811478101344	1	2
melanoma/genetics	cd8-positive t-lymphocytes/immunology	5.861997677436559e-05	0.00012821956824615204	0.06878335787959994	0.9605811478101344	1	2
melanoma/genetics	cysteine/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
melanoma/genetics	SLC3A2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
melanoma/genetics	cytokines/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
melanoma/genetics	protein kinase c/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
melanoma/genetics	receptors vascular endothelial growth factor/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
melanoma/genetics	vascular endothelial growth factor a/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
melanoma/genetics	FLT1	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
melanoma/genetics	KDR	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
necrosis	caspases/metabolism	0.0015385039170436876	0.0028888549108311385	0.0644991443991049	0.9605811478101344	1	2
necrosis	tumor necrosis factor-alpha/pharmacology	2.157919398726449e-10	6.979288089059813e-10	0.018647711816067742	0.9605811478101344	1	2
necrosis	hydrogen peroxide/toxicity	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
necrosis	ascorbic acid/analogs & derivatives	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
necrosis	autocrine communication/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
necrosis	decitabine	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
necrosis	dynamins	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
necrosis	acetylcysteine/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
necrosis	dna fragmentation/drug effects	2.157919398726449e-10	6.979288089059813e-10	0.027905752270633143	0.9605811478101344	1	2
necrosis	paracrine communication/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
necrosis	histones/metabolism	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
chemokine cxcl12/metabolism	cell movement/drug effects	0.0011138057233034404	0.0021261635140601086	0.023594219167943648	0.8657199677887635	2	2
chemokine cxcl12/metabolism	receptors cxcr4/antagonists & inhibitors	0.0	0.0	0.00039365091980200724	0.8657199677887635	2	2
chemokine cxcl12/metabolism	ht29 cells	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/metabolism	docetaxel	2.2737118288151947e-07	6.120229325078429e-07	0.027905752270633143	0.9605811478101344	1	2
chemokine cxcl12/metabolism	epoxy compounds/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/metabolism	benzylamines	0.0	0.0	0.00039365091980200724	0.8657199677887635	2	2
chemokine cxcl12/metabolism	bone neoplasms/metabolism	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/metabolism	cytarabine/pharmacology	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/metabolism	transforming growth factor beta/antagonists & inhibitors	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/metabolism	leukemia myeloid acute/drug therapy	1.1645568596674316e-05	2.7329589826447614e-05	0.055287464515536164	0.9605811478101344	1	2
chemokine cxcl12/metabolism	prostatic neoplasms/drug therapy	0.0002285341201130331	0.00046919827546812123	0.06878335787959994	0.9605811478101344	1	2
chemokine cxcl12/metabolism	phenanthrenes/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/metabolism	antibodies neutralizing/metabolism	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/metabolism	heterocyclic compounds/pharmacology	2.220446049250313e-16	9.623824354997229e-16	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/metabolism	cell adhesion/drug effects	8.891606009264752e-05	0.00018981615926827	0.055287464515536164	0.9605811478101344	1	2
chemokine cxcl12/metabolism	nf-kappa b/metabolism	0.0004887564791243859	0.0009688997349158837	0.06878335787959994	0.9605811478101344	1	2
chemokine cxcl12/metabolism	ARG1	8.160347397812018e-09	2.4208737813100024e-08	0.027905752270633143	0.9605811478101344	1	2
chemokine cxcl12/metabolism	CXCL12	0.0	0.0	2.173151765468494e-05	0.7135314763244264	3	2
chemokine cxcl12/metabolism	CXCR4	0.0	0.0	0.0007848182375863361	0.8657199677887635	2	2
chemokine cxcl12/metabolism	DDX53	1.60878124821906e-07	4.3942528444913075e-07	0.027905752270633143	0.9605811478101344	1	2
chemokine cxcl12/metabolism	MRC1	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
MUC1	docetaxel	1.0194388222473094e-08	3.0048913306027646e-08	0.018647711816067742	0.9605811478101344	1	2
MUC1	dendritic cells/immunology	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
MUC1	dna (cytosine-5-)-methyltransferase 1/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MUC1	erlotinib hydrochloride/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MUC1	prostate-specific antigen/immunology	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
MUC1	sp1 transcription factor/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MUC1	DNMT1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MUC1	HGF	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MUC1	NPEPPS	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
MUC1	PROM1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
MUC1	PSAT1	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
MUC1	SP1	4.7413184489641935e-12	1.6669843591574318e-11	0.018647711816067742	0.9605811478101344	1	2
transferrin/metabolism	ferritins/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transferrin/metabolism	genetic variation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transferrin/metabolism	malaria/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transferrin/metabolism	liver x receptors/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transferrin/metabolism	TF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
organophosphorus compounds/chemistry	antimycin a/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
organophosphorus compounds/chemistry	cyclic n-oxides/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
organophosphorus compounds/chemistry	cell hypoxia	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
organophosphorus compounds/chemistry	adipose tissue/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
organophosphorus compounds/chemistry	free radical scavengers/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
organophosphorus compounds/chemistry	stem cells/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nf-kappa b/genetics	brain neoplasms/drug therapy	9.435785486289205e-13	3.5005922665607337e-12	0.018647711816067742	0.9605811478101344	1	2
nf-kappa b/genetics	biomarkers tumor/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	chemokine ccl2/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	paracrine communication	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	carcinoma hepatocellular/drug therapy	0.00023632792072836306	0.0004842976109507342	0.0644991443991049	0.9605811478101344	1	2
nf-kappa b/genetics	gene silencing/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	rna small interfering/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	interferon regulatory factor-1/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	apoptosis regulatory proteins	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	interferon-gamma/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	interferon regulatory factor-2/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	plasmids/genetics	1.20579102258489e-10	3.9473319177359547e-10	0.018647711816067742	0.9605811478101344	1	2
nf-kappa b/genetics	tumor cells cultured	5.6233100847791206e-05	0.00012324328106283304	0.0075029616954060815	0.8657199677887635	2	2
nf-kappa b/genetics	proto-oncogene proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	CCL2	5.3953543135421e-06	1.3103852379926881e-05	0.03711991575621956	0.9605811478101344	1	2
nf-kappa b/genetics	IRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	IRF2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nf-kappa b/genetics	MAPK1	0.003158697231605445	0.005679112497956198	0.09148348032117941	0.9605811478101344	1	2
nf-kappa b/genetics	NFKB1	1.3241630014704242e-12	4.8682917886309674e-12	0.0009214163485586416	0.8657199677887635	2	2
minor histocompatibility antigens	leukemia lymphocytic chronic b-cell/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minor histocompatibility antigens	b-lymphocytes/drug effects	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
minor histocompatibility antigens	dexamethasone/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minor histocompatibility antigens	gene expression regulation leukemic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minor histocompatibility antigens	chemokine cxcl12/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
minor histocompatibility antigens	chlorambucil/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minor histocompatibility antigens	monocytes/drug effects	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
minor histocompatibility antigens	x-linked inhibitor of apoptosis protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minor histocompatibility antigens	tumor cells cultured	0.003158697231605445	0.005679112497956198	0.08878504672897196	0.9605811478101344	1	2
minor histocompatibility antigens	BCL2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
minor histocompatibility antigens	CXCL12	8.390528605239922e-08	2.3337249235313462e-07	0.03271028037383177	0.9605811478101344	1	2
minor histocompatibility antigens	XIAP	9.435785486289205e-13	3.5005922665607337e-12	0.014018691588785045	0.9605811478101344	1	2
cyclohexylamines/pharmacology	adaptor proteins vesicular transport/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclohexylamines/pharmacology	TICAM1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclohexylamines/pharmacology	TRIM69	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclohexylamines/pharmacology	inflammasomes/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclohexylamines/pharmacology	myocardial reperfusion injury/drug therapy	2.4646951146678475e-14	9.785989174895859e-14	0.018647711816067742	0.9605811478101344	1	2
cyclohexylamines/pharmacology	hmgb1 protein/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
NPEPPS	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
NPEPPS	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
NPEPPS	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
NPEPPS	PROM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
NPEPPS	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	osteopontin/genetics	1.20579102258489e-10	3.9473319177359547e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	g2 phase cell cycle checkpoints/drug effects	0.0007392287055421054	0.0014384003618208754	0.055287464515536164	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	diterpenes/isolation & purification	1.20579102258489e-10	3.9473319177359547e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	BIRC5	0.0010891859401410686	0.002080066834840215	0.055287464515536164	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	PI3	1.0656399921371573e-06	2.7370958232339287e-06	0.03711991575621956	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	SPP1	1.4580143245956911e-05	3.3795521266490534e-05	0.03711991575621956	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	WDTC1	0.0002893340491763041	0.0005872985745018554	0.07319670689438858	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	plant extracts/chemistry	3.7466474367420233e-10	1.1952840787916093e-09	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	anthraquinones/isolation & purification	3.7466474367420233e-10	1.1952840787916093e-09	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	erbb receptors/drug effects	3.401390280544092e-11	1.1546397675971694e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	rhizome/chemistry	6.096331439664482e-09	1.8334731357484997e-08	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	saponins/isolation & purification	6.096331439664482e-09	1.8334731357484997e-08	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	MDM2	3.401390280544092e-11	1.1546397675971694e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	METTL7B	3.401390280544092e-11	1.1546397675971694e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	TP73	3.401390280544092e-11	1.1546397675971694e-10	0.018691588785046728	0.9605811478101344	1	2
antineoplastic agents phytogenic/isolation & purification	plant extracts/isolation & purification	0.0	0.0	0.00026326181387389757	0.8657199677887635	2	2
antineoplastic agents phytogenic/isolation & purification	human umbilical vein endothelial cells/drug effects	1.20579102258489e-10	3.9473319177359547e-10	0.018691588785046728	0.9605811478101344	1	2
osteoprotegerin/genetics	mutation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteoprotegerin/genetics	recombinant proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteoprotegerin/genetics	tnf-related apoptosis-inducing ligand/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteoprotegerin/genetics	multiple myeloma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteoprotegerin/genetics	TNFRSF11B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
melanoma/blood	coenzyme a ligases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
melanoma/blood	cell survival	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
melanoma/blood	ACSL3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
melanoma/blood	neoplasm metastasis/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
melanoma/blood	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
melanoma/blood	lymph/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stat3 transcription factor/metabolism	liver neoplasms/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/metabolism	neoplasm metastasis/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/metabolism	gene silencing	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/metabolism	receptor protein-tyrosine kinases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/metabolism	brain neoplasms/drug therapy	1.3655743202889425e-14	5.4772025857250505e-14	0.018647711816067742	0.9605811478101344	1	2
stat3 transcription factor/metabolism	interleukin-6/metabolism	0.0	0.0	0.00043876968978982925	0.8657199677887635	2	2
stat3 transcription factor/metabolism	tumor escape/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/metabolism	proto-oncogene proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/metabolism	quercetin/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/metabolism	tumor microenvironment/immunology	1.6653345369377348e-15	6.987116245557217e-15	0.018647711816067742	0.9605811478101344	1	2
stat3 transcription factor/metabolism	AXL	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/metabolism	IL6R	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/metabolism	IL6ST	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/metabolism	receptor igf type 1/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fatty acids/metabolism	antibodies monoclonal humanized/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fatty acids/metabolism	CD36	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	b-lymphocytes/drug effects	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	dexamethasone/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	gene expression regulation leukemic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	chemokine cxcl12/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	chlorambucil/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	monocytes/drug effects	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	x-linked inhibitor of apoptosis protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	tumor cells cultured	0.003158697231605445	0.005679112497956198	0.08878504672897196	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	BCL2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	CXCL12	8.390528605239922e-08	2.3337249235313462e-07	0.03271028037383177	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/genetics	XIAP	9.435785486289205e-13	3.5005922665607337e-12	0.014018691588785045	0.9605811478101344	1	2
DNMT1	protein kinase inhibitors/pharmacology	1.4380785950063313e-05	3.33579767098365e-05	0.04672897196261682	0.9605811478101344	1	2
DNMT1	dna (cytosine-5-)-methyltransferase 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
DNMT1	erlotinib hydrochloride/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
DNMT1	sp1 transcription factor/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
DNMT1	HGF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
DNMT1	SP1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endothelial cells/microbiology	bacterial adhesion	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endothelial cells/microbiology	intercellular adhesion molecule-1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endothelial cells/microbiology	fimbriae proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endothelial cells/microbiology	ICAM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell cycle proteins/metabolism	g2 phase cell cycle checkpoints/drug effects	9.299864525136314e-07	2.396766955583933e-06	0.027905752270633143	0.9605811478101344	1	2
cell cycle proteins/metabolism	antineoplastic agents phytogenic/pharmacology	0.00028984355859373867	0.0005881703432926599	0.05541661182045544	0.9605811478101344	1	2
cell cycle proteins/metabolism	ovarian neoplasms/drug therapy	3.779043855622888e-09	1.1473472724975686e-08	0.018647711816067742	0.9605811478101344	1	2
cell cycle proteins/metabolism	b7-h1 antigen/genetics	4.271805131850215e-12	1.507921222334831e-11	0.018647711816067742	0.9605811478101344	1	2
cell cycle proteins/metabolism	adaptor proteins signal transducing/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell cycle proteins/metabolism	EIF2S1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell cycle proteins/metabolism	hydrazones/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
lymph nodes/drug effects	chemokines/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lymph nodes/drug effects	granulocyte colony-stimulating factor/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymph nodes/drug effects	radiation tolerance/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymph nodes/drug effects	neutrophils/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymph nodes/drug effects	CSF3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymph nodes/drug effects	ITGAM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm invasiveness	cell movement/drug effects	2.5732674098999375e-05	5.85323427767191e-05	0.0007542676550763924	0.5304112294886878	4	2
neoplasm invasiveness	triple negative breast neoplasms/drug therapy	0.0019199350996133013	0.0035643928154491466	0.10825010098314035	0.9605811478101344	1	2
neoplasm invasiveness	neoplasm proteins/metabolism	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	breast neoplasms/blood supply	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	t-lymphocytes/drug effects	0.00213812675650904	0.0039432387057725905	0.08215010393874443	0.9605811478101344	1	2
neoplasm invasiveness	interferon-alpha/metabolism	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	stat3 transcription factor/physiology	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	clodronic acid/pharmacology	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	ng-nitroarginine methyl ester/pharmacology	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	liver neoplasms/drug therapy	0.00015425612723674043	0.0003219461466599444	0.05541661182045544	0.9605811478101344	1	2
neoplasm invasiveness	carcinoma hepatocellular/genetics	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	lipopolysaccharides/pharmacology	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	potassium channels voltage-gated/metabolism	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	myeloid differentiation factor 88/antagonists & inhibitors	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	colorectal neoplasms/immunology	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	receptors ccr5/drug effects	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	piperazines	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	adenocarcinoma/drug therapy	0.0013546484695101668	0.0025577879126282574	0.05541661182045544	0.9605811478101344	1	2
neoplasm invasiveness	maraviroc	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	neoplasm proteins/antagonists & inhibitors	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	micrornas/genetics	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	immune evasion/drug effects	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	glycogen synthase kinase 3 beta/metabolism	0.0013546484695101668	0.0025577879126282574	0.05541661182045544	0.9605811478101344	1	2
neoplasm invasiveness	tumor cells cultured	0.001851039274745836	0.003441122591028347	0.010095152473770635	0.7135314763244264	3	2
neoplasm invasiveness	bone neoplasms/drug therapy	3.0044275784346652e-05	6.78635582925187e-05	0.05541661182045544	0.9605811478101344	1	2
neoplasm invasiveness	chemokine ccl5/antagonists & inhibitors	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	CCL5	0.005218843234083725	0.00907667867989887	0.08215010393874443	0.9605811478101344	1	2
neoplasm invasiveness	CCR5	2.554966810675019e-06	6.365906683440256e-06	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	CXCL10	0.0031692476956168836	0.0056966878520268265	0.08215010393874443	0.9605811478101344	1	2
neoplasm invasiveness	CXCL9	0.0006828003702413765	0.0013336625233063314	0.05541661182045544	0.9605811478101344	1	2
neoplasm invasiveness	ITK	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	KCNQ1	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	KCNQ1OT1	1.478060929205327e-08	4.297545478981808e-08	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	MMP2	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	MMP9	0.0005842436866995149	0.0011489969498127647	0.05541661182045544	0.9605811478101344	1	2
neoplasm invasiveness	MYD88	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	TRAF6	2.140681395301769e-05	4.8793283783328236e-05	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	biological transport	7.279177260954839e-12	2.5362089167119513e-11	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	carboxy-lyases/genetics	3.983310559174669e-08	1.1307329883955594e-07	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	mitochondrial dynamics/physiology	3.983310559174669e-08	1.1307329883955594e-07	0.02803738317757009	0.9605811478101344	1	2
neoplasm invasiveness	cell transformation neoplastic/drug effects	0.00019239971282947188	0.0003974542179765948	0.05541661182045544	0.9605811478101344	1	2
neoplasm invasiveness	immunosuppressive agents/pharmacology	3.983310559174669e-08	1.1307329883955594e-07	0.02803738317757009	0.9605811478101344	1	2
interleukin-8/biosynthesis	heterocyclic compounds 4 or more rings/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
interleukin-8/biosynthesis	ovarian neoplasms/drug therapy	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
interleukin-8/biosynthesis	fibrosarcoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-8/biosynthesis	rho gtp-binding proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-8/biosynthesis	neovascularization pathologic/prevention & control	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-8/biosynthesis	vascular endothelial growth factor a/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-8/biosynthesis	caspase 8/metabolism	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
interleukin-8/biosynthesis	cell adhesion/drug effects	2.2819819367470018e-09	7.0161954736296045e-09	0.018691588785046728	0.9605811478101344	1	2
interleukin-8/biosynthesis	chemokine ccl2/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-8/biosynthesis	trabectedin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-8/biosynthesis	BRCA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-8/biosynthesis	CASP8	6.575019124388515e-05	0.00014324705697086758	0.03271028037383177	0.9605811478101344	1	2
interleukin-8/biosynthesis	CCL2	4.814946774622797e-09	1.4524551441631335e-08	0.018691588785046728	0.9605811478101344	1	2
tumor cells cultured	gene expression regulation leukemic/drug effects	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	interleukin-1beta/metabolism	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	b-lymphocytes/drug effects	0.0010252351652214609	0.001962015877337277	0.021305579908653116	0.8657199677887635	2	2
tumor cells cultured	brain neoplasms/drug therapy	1.1631449034044117e-05	2.7302266400788318e-05	0.0075029616954060815	0.8657199677887635	2	2
tumor cells cultured	chemokine ccl2/genetics	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	myeloid-derived suppressor cells/drug effects	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	quercetin/pharmacology	0.0007392287055421054	0.0014384003618208754	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	biomarkers tumor/genetics	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	receptors ccr7/immunology	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	plicamycin/analogs & derivatives	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	chemokine ccl21/immunology	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	receptor protein-tyrosine kinases/metabolism	0.0007392287055421054	0.0014384003618208754	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	apoptosis regulatory proteins	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	leukemia lymphocytic chronic b-cell/blood	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	interferon-gamma/genetics	0.004141426933179759	0.007290816114879219	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	interferon regulatory factor-2/genetics	0.004141426933179759	0.007290816114879219	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	paracrine communication	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	rna small interfering/pharmacology	0.004141426933179759	0.007290816114879219	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	gene silencing/drug effects	0.004141426933179759	0.007290816114879219	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	dexamethasone/pharmacology	0.003158697231605445	0.005679112497956198	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	gene expression regulation leukemic	0.003158697231605445	0.005679112497956198	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	receptors interleukin-8b/antagonists & inhibitors	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	proto-oncogene proteins/metabolism	0.0007392287055421054	0.0014384003618208754	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	monocytes/drug effects	0.0010252351652214609	0.001962015877337277	0.021305579908653116	0.8657199677887635	2	2
tumor cells cultured	chlorambucil/pharmacology	0.003158697231605445	0.005679112497956198	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	receptors interleukin-8a/antagonists & inhibitors	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	mesenchymal stem cells/drug effects	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	interferon regulatory factor-1/genetics	0.004141426933179759	0.007290816114879219	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	histone deacetylases/chemistry	0.005290705352827385	0.009188615330377172	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	proto-oncogene proteins/genetics	0.004141426933179759	0.007290816114879219	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	AXL	0.0007392287055421054	0.0014384003618208754	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	BCL2A1	0.003158697231605445	0.005679112497956198	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	CCL19	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	CCL4	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	CCR7	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	CIITA	0.005290705352827385	0.009188615330377172	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	CXCR2	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	FOXP3	0.005290705352827385	0.009188615330377172	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	HDAC9	0.005290705352827385	0.009188615330377172	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	IRF1	0.004141426933179759	0.007290816114879219	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	IRF2	0.004141426933179759	0.007290816114879219	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	NFKB1	0.0035689922692765386	0.006363346397623252	0.01666296211191502	0.7135314763244264	3	2
tumor cells cultured	leukemia lymphocytic chronic b-cell/drug therapy	0.0016675829297913003	0.003114780450359081	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	carboxy-lyases/genetics	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	cytostatic agents/pharmacology	0.0011396931311093983	0.0021729465716620556	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	carcinoma squamous cell/drug therapy	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	enzyme inhibitors/pharmacology	7.329572627901015e-05	0.00015875227051716313	0.0075029616954060815	0.8657199677887635	2	2
tumor cells cultured	mouth neoplasms/drug therapy	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	lymphoma non-hodgkin/drug therapy	0.0011396931311093983	0.0021729465716620556	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	naphthoquinones/chemistry	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	cell nucleus/drug effects	0.003158697231605445	0.005679112497956198	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	everolimus/pharmacology	0.0011396931311093983	0.0021729465716620556	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	sesquiterpenes guaiane	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	sirtuin 1/metabolism	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	mitochondrial dynamics/physiology	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	farnesyltranstransferase/antagonists & inhibitors	0.0011396931311093983	0.0021729465716620556	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	immunosuppressive agents/pharmacology	0.0023368629531065332	0.004278621025584857	0.08878504672897196	0.9605811478101344	1	2
tumor cells cultured	x-linked inhibitor of apoptosis protein/genetics	0.003158697231605445	0.005679112497956198	0.08878504672897196	0.9605811478101344	1	2
neoplasm proteins/metabolism	breast neoplasms/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm proteins/metabolism	lipopolysaccharides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm proteins/metabolism	myeloid differentiation factor 88/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm proteins/metabolism	piperazines	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm proteins/metabolism	glycogen synthase kinase 3 beta/metabolism	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
neoplasm proteins/metabolism	nf-kappa b/metabolism	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
neoplasm proteins/metabolism	ITK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm proteins/metabolism	MMP2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm proteins/metabolism	MMP9	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
neoplasm proteins/metabolism	MYD88	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm proteins/metabolism	NFKB1	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
neoplasm proteins/metabolism	TRAF6	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HGF	protein kinase inhibitors/pharmacology	1.4380785950063313e-05	3.33579767098365e-05	0.04672897196261682	0.9605811478101344	1	2
HGF	dna (cytosine-5-)-methyltransferase 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HGF	erlotinib hydrochloride/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HGF	sp1 transcription factor/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
HGF	SP1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cysteine/metabolism	amino acid transport system y+/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cysteine/metabolism	cd8-positive t-lymphocytes/immunology	8.426592756904938e-14	3.2900569701476906e-13	0.02336448598130841	0.9605811478101344	1	2
cysteine/metabolism	SLC3A2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PROM1	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
PROM1	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PROM1	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PROM1	PSAT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/blood supply	lipopolysaccharides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/blood supply	myeloid differentiation factor 88/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/blood supply	piperazines	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/blood supply	glycogen synthase kinase 3 beta/metabolism	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
breast neoplasms/blood supply	nf-kappa b/metabolism	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
breast neoplasms/blood supply	ITK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/blood supply	MMP2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/blood supply	MMP9	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
breast neoplasms/blood supply	MYD88	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/blood supply	NFKB1	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
breast neoplasms/blood supply	TRAF6	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver x receptors/agonists	ferritins/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver x receptors/agonists	genetic variation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver x receptors/agonists	malaria/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver x receptors/agonists	TF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PSAT1	docetaxel	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
PSAT1	dendritic cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PSAT1	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
galectin 3/genetics	cell proliferation	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
galectin 3/genetics	alpha 1-antitrypsin/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
galectin 3/genetics	bone marrow cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
galectin 3/genetics	leukemia myelogenous chronic bcr-abl positive/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
galectin 3/genetics	LGALS3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
galectin 3/genetics	SERPINA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimycin a/metabolism	alpha-crystallins/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimycin a/metabolism	astrocytes/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimycin a/metabolism	brain/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antimycin a/metabolism	staurosporine/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimycin a/metabolism	extracellular space/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caspase 8/metabolism	heterocyclic compounds 4 or more rings/pharmacology	1.631716847194653e-07	4.4524867632361027e-07	0.018647711816067742	0.9605811478101344	1	2
caspase 8/metabolism	fibrosarcoma/drug therapy	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	rho gtp-binding proteins/genetics	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	neovascularization pathologic/prevention & control	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	ovarian neoplasms/drug therapy	1.1858723574231789e-06	3.035304589791763e-06	0.018647711816067742	0.9605811478101344	1	2
caspase 8/metabolism	vascular endothelial growth factor a/biosynthesis	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	cell adhesion/drug effects	0.0001667205860131915	0.0003464519774193069	0.03711991575621956	0.9605811478101344	1	2
caspase 8/metabolism	chemokine ccl2/biosynthesis	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	trabectedin	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	caspase 3/metabolism	0.003158697231605445	0.005679112497956198	0.05541661182045544	0.9605811478101344	1	2
caspase 8/metabolism	BRCA1	4.643840867402105e-12	1.6329729416982715e-11	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	CASP8	7.5524831189e-07	1.962719799687732e-06	0.0009214163485586416	0.8657199677887635	2	2
caspase 8/metabolism	CCL2	0.0002285341201130331	0.00046919827546812123	0.03711991575621956	0.9605811478101344	1	2
caspase 8/metabolism	nitrophenols/toxicity	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	piperazines/toxicity	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	morpholines/pharmacology	7.157089921661086e-05	0.00015555946233515735	0.027905752270633143	0.9605811478101344	1	2
caspase 8/metabolism	poly(adp-ribose) polymerases/metabolism	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	glioblastoma/enzymology	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
caspase 8/metabolism	aminopyridines/pharmacology	1.08218036753982e-08	3.1758169497561496e-08	0.009345794392523364	0.9605811478101344	1	2
adaptor proteins vesicular transport/genetics	myocardial reperfusion injury/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adaptor proteins vesicular transport/genetics	TICAM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adaptor proteins vesicular transport/genetics	TRIM69	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr7/immunology	b-lymphocytes/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
receptors ccr7/immunology	heterocyclic compounds 4 or more rings/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors ccr7/immunology	myeloid-derived suppressor cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr7/immunology	monocytes/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
receptors ccr7/immunology	leukemia lymphocytic chronic b-cell/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr7/immunology	chemokine ccl21/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr7/immunology	CCL19	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr7/immunology	CCL21	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors ccr7/immunology	CCR7	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	cell survival	0.002169074537427762	0.003993633018889962	0.09148348032117941	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	epithelial-mesenchymal transition	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	janus kinases/metabolism	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	neoplasms/metabolism	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	interferons/metabolism	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	hypoxia/metabolism	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	breast neoplasms/immunology	0.005308761667742301	0.009218522269070037	0.09148348032117941	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	sp1 transcription factor/physiology	1.38042009478756e-06	3.51449217666006e-06	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	glucose/deficiency	0.00016570985144803707	0.00034454647347475684	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	neoplasms/enzymology	7.245952637824349e-05	0.0001573512890364929	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	lipid droplets/metabolism	7.245952637824349e-05	0.0001573512890364929	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	0.00016570985144803707	0.00034454647347475684	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	gefitinib/pharmacology	1.38042009478756e-06	3.51449217666006e-06	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	phospholipids/metabolism	7.245952637824349e-05	0.0001573512890364929	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	creatine kinase mb form/metabolism	7.245952637824349e-05	0.0001573512890364929	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	pyridines/pharmacology	0.0009672575947450301	0.0018557340279271165	0.09148348032117941	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	nitric oxide synthase type iii/metabolism	7.245952637824349e-05	0.0001573512890364929	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	cell respiration/drug effects	3.6721567080455486e-06	9.062425688268217e-06	0.005774374691101998	0.8657199677887635	2	2
protein kinase inhibitors/pharmacology	sp1 transcription factor/metabolism	1.4380785950063313e-05	3.33579767098365e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	myocardial reperfusion injury/metabolism	0.0030261069175234745	0.005457190030881529	0.09148348032117941	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	dna (cytosine-5-)-methyltransferase 1/metabolism	1.4380785950063313e-05	3.33579767098365e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	cyclin-dependent kinase 4/antagonists & inhibitors	3.8616210007447194e-08	1.0973194976726327e-07	0.0019744636040542316	0.8657199677887635	2	2
protein kinase inhibitors/pharmacology	mesothelioma malignant/drug therapy	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	erlotinib hydrochloride/pharmacology	1.4380785950063313e-05	3.33579767098365e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	phosphoinositide-3 kinase inhibitors/pharmacology	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	cytoprotection/drug effects	0.00016570985144803707	0.00034454647347475684	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	quinolines/pharmacology	0.00016570985144803707	0.00034454647347475684	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	cytoprotection	0.002169074537427762	0.003993633018889962	0.09148348032117941	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	rna long noncoding/physiology	1.38042009478756e-06	3.51449217666006e-06	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	aurora kinase b/antagonists & inhibitors	0.0003294132314345388	0.0006636424457847873	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	receptors chemokine/metabolism	0.00011180421294365583	0.00023589084085949512	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	phospholipase a2 inhibitors/pharmacology	7.245952637824349e-05	0.0001573512890364929	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	ribosomal proteins/genetics	0.0003294132314345388	0.0006636424457847873	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	receptors prostaglandin e ep4 subtype/physiology	1.38042009478756e-06	3.51449217666006e-06	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	chalcones/administration & dosage	7.245952637824349e-05	0.0001573512890364929	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	PTGER4	1.38042009478756e-06	3.51449217666006e-06	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	SP1	2.1084545220872997e-10	6.838365004851542e-10	0.0019744636040542316	0.8657199677887635	2	2
protein kinase inhibitors/pharmacology	ras proteins/metabolism	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	chemokines/metabolism	0.00352420294653244	0.0062916296813884404	0.09148348032117941	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	hypoxia-inducible factor 1 alpha subunit/genetics	4.481045854376475e-05	9.915505720322413e-05	0.04672897196261682	0.9605811478101344	1	2
protein kinase inhibitors/pharmacology	biomarkers	0.0030261069175234745	0.005457190030881529	0.09148348032117941	0.9605811478101344	1	2
ACSL3	coenzyme a ligases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ACSL3	cell survival	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ACSL3	neoplasm metastasis/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ACSL3	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ACSL3	lymph/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ACSL4	endoplasmic reticulum/drug effects	4.643840867402105e-12	1.6329729416982715e-11	0.027905752270633143	0.9605811478101344	1	2
ACSL4	AIFM2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ACSL4	ATL1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ACSL4	S100A4	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ACSL4	cell proliferation	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
ACSL4	anti-inflammatory agents non-steroidal/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ACSL4	curcumin/pharmacology	8.43769498715119e-15	3.412847167064932e-14	0.027905752270633143	0.9605811478101344	1	2
ACSL4	IREB2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ACSL4	MKI67	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	receptors interleukin-8a/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	receptors interleukin-8b/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	cell adhesion/drug effects	2.2521588208923582e-05	5.13130078361421e-05	0.03711991575621956	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	CXCL1	2.6139090891774686e-12	9.361836841810401e-12	0.018647711816067742	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	CXCR2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	phosphatidylinositol 3-kinases/drug effects	6.940633325847045e-07	1.805416276171256e-06	0.027905752270633143	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	extracellular signal-regulated map kinases/drug effects	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	platelet endothelial cell adhesion molecule-1/biosynthesis	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	proto-oncogene proteins c-akt/drug effects	6.940633325847045e-07	1.805416276171256e-06	0.027905752270633143	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	embryonic stem cells/cytology	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	jnk mitogen-activated protein kinases/drug effects	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	p38 mitogen-activated protein kinases/drug effects	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	caspase 3/biosynthesis	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	acetylcysteine/metabolism	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	angiogenesis inhibitors/pharmacology	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	nitric oxide synthase/antagonists & inhibitors	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	cell differentiation	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	endothelial cells/drug effects	2.6139090891774686e-12	9.361836841810401e-12	0.009345794392523364	0.9605811478101344	1	2
neovascularization pathologic/drug therapy	tor serine-threonine kinases/drug effects	2.27001811792249e-08	6.53641889303318e-08	0.018647711816067742	0.9605811478101344	1	2
AIFM2	endoplasmic reticulum/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
AIFM2	ATL1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
AIFM2	S100A4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MET	MAPK1	4.989061767046721e-07	1.310758267872332e-06	0.04672897196261682	0.9605811478101344	1	2
MET	apoptosis	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
amino acid transport system y+/metabolism	collagen type i/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
amino acid transport system y+/metabolism	cd8-positive t-lymphocytes/immunology	2.548156555759462e-07	6.83975599481186e-07	0.046290202272826986	0.9605811478101344	1	2
amino acid transport system y+/metabolism	FN1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
amino acid transport system y+/metabolism	MMRN1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
amino acid transport system y+/metabolism	SLC3A2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
amino acid transport system y+/metabolism	liver cirrhosis/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
amino acid transport system y+/metabolism	cell line	0.0026331175783703697	0.004791991445968626	0.11807292352244307	0.9605811478101344	1	2
coenzyme a ligases/metabolism	neoplasm metastasis/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
coenzyme a ligases/metabolism	cell survival	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
coenzyme a ligases/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
coenzyme a ligases/metabolism	lymph/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm metastasis/drug therapy	cell survival	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neoplasm metastasis/drug therapy	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neoplasm metastasis/drug therapy	lymph/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutation	recombinant proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutation	tnf-related apoptosis-inducing ligand/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutation	multiple myeloma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutation	TNFRSF11B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ATL1	endoplasmic reticulum/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
ATL1	S100A4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
histone deacetylases/chemistry	pyrimidines/pharmacology	1.972546570527811e-10	6.402282759752272e-10	0.018691588785046728	0.9605811478101344	1	2
histone deacetylases/chemistry	CIITA	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
histone deacetylases/chemistry	FOXP3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
histone deacetylases/chemistry	HDAC9	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fas receptor/genetics	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
fas receptor/genetics	sarcoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fas receptor/genetics	hypoxia	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fas receptor/genetics	plant leaves/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fas receptor/genetics	fas ligand protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fas receptor/genetics	PRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptor protein-tyrosine kinases/metabolism	brain neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptor protein-tyrosine kinases/metabolism	interleukin-6/metabolism	4.8407944319706075e-12	1.6987081909293006e-11	0.02336448598130841	0.9605811478101344	1	2
receptor protein-tyrosine kinases/metabolism	proto-oncogene proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor protein-tyrosine kinases/metabolism	quercetin/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor protein-tyrosine kinases/metabolism	AXL	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bacterial adhesion	intercellular adhesion molecule-1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bacterial adhesion	fimbriae proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bacterial adhesion	ICAM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocytes/drug effects	plicamycin/analogs & derivatives	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
t-lymphocytes/drug effects	gene expression regulation leukemic/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
t-lymphocytes/drug effects	carcinoma hepatocellular/genetics	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
t-lymphocytes/drug effects	chemokines/metabolism	1.5950905596362475e-08	4.629269008669209e-08	0.027905752270633143	0.9605811478101344	1	2
t-lymphocytes/drug effects	potassium channels voltage-gated/metabolism	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
t-lymphocytes/drug effects	breast neoplasms/immunology	6.220781134658182e-08	1.743210249834057e-07	0.027905752270633143	0.9605811478101344	1	2
t-lymphocytes/drug effects	leukemia lymphocytic chronic b-cell/drug therapy	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
t-lymphocytes/drug effects	micrornas/genetics	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
t-lymphocytes/drug effects	immune evasion/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
t-lymphocytes/drug effects	caspase 3/metabolism	0.002593388005414865	0.004723196658135383	0.08215010393874443	0.9605811478101344	1	2
t-lymphocytes/drug effects	CCL5	3.3210715583043005e-05	7.476310569480622e-05	0.04166180294604871	0.9605811478101344	1	2
t-lymphocytes/drug effects	CXCL10	1.2155711399119973e-05	2.8435981424699963e-05	0.04166180294604871	0.9605811478101344	1	2
t-lymphocytes/drug effects	CXCL9	5.394266039404627e-07	1.4151924992478965e-06	0.027905752270633143	0.9605811478101344	1	2
t-lymphocytes/drug effects	KCNQ1	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
t-lymphocytes/drug effects	KCNQ1OT1	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
t-lymphocytes/drug effects	PRF1	5.59903934327366e-09	1.6864428885313885e-08	0.027905752270633143	0.9605811478101344	1	2
t-lymphocytes/drug effects	cyclin-dependent kinase 4/antagonists & inhibitors	9.341637752235954e-08	2.585868539375999e-07	0.027905752270633143	0.9605811478101344	1	2
t-lymphocytes/drug effects	receptors chemokine/metabolism	1.3844481117075702e-13	5.292009703004249e-13	0.014018691588785045	0.9605811478101344	1	2
cytokines/blood	azocines/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/blood	carcinoma lewis lung/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/blood	ARG1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytokines/blood	TCIM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD36	antibodies monoclonal humanized/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	leukocytes mononuclear/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	leukemia/drug therapy	1.0194388222473094e-08	3.0048913306027646e-08	0.018647711816067742	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	caspase 3/metabolism	0.0006312673934151247	0.0012386031405194151	0.05541661182045544	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	CCL2	2.1067664965124244e-05	4.820963955900979e-05	0.03711991575621956	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	CCL5	2.7020662509702476e-06	6.712693712832904e-06	0.027905752270633143	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	MCL1	0.002730526982987369	0.004963530292761606	0.05541661182045544	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	multiple myeloma/pathology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	enzyme inhibitors/pharmacology	1.0014790108314742e-09	3.133779340166384e-09	0.018647711816067742	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	jnk mitogen-activated protein kinases/metabolism	1.8017198843978122e-10	5.858180211060752e-10	0.018647711816067742	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	flavonoids/pharmacology	4.316326407405313e-09	1.3081287234429188e-08	0.018647711816067742	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	free radicals/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	carrier proteins/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	cyclin-dependent kinases/antagonists & inhibitors	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	protein transport	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	nitriles/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/metabolism	piperidines/pharmacology	1.5210269710408397e-08	4.4213055580103406e-08	0.018647711816067742	0.9605811478101344	1	2
interferon-alpha/metabolism	stat3 transcription factor/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-alpha/metabolism	clodronic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-alpha/metabolism	ng-nitroarginine methyl ester/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-alpha/metabolism	liver neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interferon-alpha/metabolism	colorectal neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-alpha/metabolism	receptors ccr5/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-alpha/metabolism	adenocarcinoma/drug therapy	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
interferon-alpha/metabolism	maraviroc	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-alpha/metabolism	neoplasm proteins/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-alpha/metabolism	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-alpha/metabolism	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
interferon-alpha/metabolism	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-alpha/metabolism	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
interferon-alpha/metabolism	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	iron/chemistry	1.36867830402565e-08	3.990032956122905e-08	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	sulfasalazine/administration & dosage	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	SLC3A2	8.426592756904938e-14	3.2900569701476906e-13	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	antigens polyomavirus transforming/genetics	3.041566998263079e-12	1.0874082889201291e-11	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	t-lymphocytes regulatory/immunology	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	neoplasms/pathology	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	allografts	1.36867830402565e-08	3.990032956122905e-08	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	cell line transformed	3.041566998263079e-12	1.0874082889201291e-11	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	indoleamine-pyrrole 23-dioxygenase/antagonists & inhibitors	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	enzyme inhibitors/chemistry	0.0	0.0	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	CSF1	3.041566998263079e-12	1.0874082889201291e-11	0.02336448598130841	0.9605811478101344	1	2
cd8-positive t-lymphocytes/immunology	CSF2	3.041566998263079e-12	1.0874082889201291e-11	0.02336448598130841	0.9605811478101344	1	2
FN1	liver cirrhosis/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
FN1	collagen type i/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
FN1	cell line	2.1067664965124244e-05	4.820963955900979e-05	0.06074766355140186	0.9605811478101344	1	2
FN1	MMRN1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteopontin/genetics	cell movement/drug effects	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
osteopontin/genetics	g2 phase cell cycle checkpoints/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
osteopontin/genetics	diterpenes/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteopontin/genetics	plant extracts/isolation & purification	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
osteopontin/genetics	human umbilical vein endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteopontin/genetics	PI3	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
osteopontin/genetics	SPP1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell survival	pyrimidines/pharmacology	3.594389679228982e-07	9.513697916883625e-07	0.03711991575621956	0.9605811478101344	1	2
cell survival	autophagy	2.3352098033058155e-11	7.973781282838256e-11	0.018647711816067742	0.9605811478101344	1	2
cell survival	neoplasms/enzymology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell survival	lipid droplets/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell survival	phospholipids/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell survival	cell respiration/drug effects	3.1556298685231354e-09	9.644486739838937e-09	0.027905752270633143	0.9605811478101344	1	2
cell survival	apoptosis	4.0513481458503975e-11	1.370842908528385e-10	0.027905752270633143	0.9605811478101344	1	2
cell survival	phospholipase a2 inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell survival	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
cell survival	lymph/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptor erbb-2/antagonists & inhibitors	inflammation mediators/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor erbb-2/antagonists & inhibitors	poly i-c/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor erbb-2/antagonists & inhibitors	ERBB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine cxcl10/metabolism	neovascularization pathologic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine cxcl10/metabolism	t-lymphocyte subsets/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine cxcl10/metabolism	CXCL10	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
plicamycin/analogs & derivatives	gene expression regulation leukemic/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
plicamycin/analogs & derivatives	leukemia lymphocytic chronic b-cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
plicamycin/analogs & derivatives	caspase 3/metabolism	2.66944835125571e-08	7.655566759688592e-08	0.02803738317757009	0.9605811478101344	1	2
plicamycin/analogs & derivatives	PRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mercaptoethanol/pharmacology	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mercaptoethanol/pharmacology	interleukins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mercaptoethanol/pharmacology	cd3 complex/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mercaptoethanol/pharmacology	CD28	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mercaptoethanol/pharmacology	CD3E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mercaptoethanol/pharmacology	IL5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stat3 transcription factor/physiology	clodronic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stat3 transcription factor/physiology	ng-nitroarginine methyl ester/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stat3 transcription factor/physiology	liver neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/physiology	colorectal neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stat3 transcription factor/physiology	receptors ccr5/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stat3 transcription factor/physiology	adenocarcinoma/drug therapy	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
stat3 transcription factor/physiology	maraviroc	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stat3 transcription factor/physiology	neoplasm proteins/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stat3 transcription factor/physiology	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stat3 transcription factor/physiology	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
stat3 transcription factor/physiology	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stat3 transcription factor/physiology	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
stat3 transcription factor/physiology	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
pyrimidines/pharmacology	CIITA	1.972546570527811e-10	6.402282759752272e-10	0.018691588785046728	0.9605811478101344	1	2
pyrimidines/pharmacology	FOXP3	1.972546570527811e-10	6.402282759752272e-10	0.018691588785046728	0.9605811478101344	1	2
pyrimidines/pharmacology	HDAC9	1.972546570527811e-10	6.402282759752272e-10	0.018691588785046728	0.9605811478101344	1	2
pyrimidines/pharmacology	autophagy	1.044588973286853e-05	2.463746008026159e-05	0.03711991575621956	0.9605811478101344	1	2
pyrimidines/pharmacology	neoplasms/enzymology	6.519751405420493e-11	2.177662157047584e-10	0.018691588785046728	0.9605811478101344	1	2
pyrimidines/pharmacology	lipid droplets/metabolism	6.519751405420493e-11	2.177662157047584e-10	0.018691588785046728	0.9605811478101344	1	2
pyrimidines/pharmacology	phenylurea compounds/pharmacology	1.8107737531636303e-13	6.887000122434314e-13	0.018691588785046728	0.9605811478101344	1	2
pyrimidines/pharmacology	phospholipids/metabolism	6.519751405420493e-11	2.177662157047584e-10	0.018691588785046728	0.9605811478101344	1	2
pyrimidines/pharmacology	lysosomes/drug effects	0.0035524822154440194	0.006335959220685143	0.09085010295354308	0.9605811478101344	1	2
pyrimidines/pharmacology	heterografts	1.0363931934875836e-12	3.832030375652229e-12	0.018691588785046728	0.9605811478101344	1	2
pyrimidines/pharmacology	cell respiration/drug effects	9.759095198280665e-05	0.00020749135094666547	0.055287464515536164	0.9605811478101344	1	2
pyrimidines/pharmacology	apoptosis	1.3416778257835382e-05	3.1283114110485884e-05	0.055287464515536164	0.9605811478101344	1	2
pyrimidines/pharmacology	bridged bicyclo compounds heterocyclic/pharmacology	1.0363931934875836e-12	3.832030375652229e-12	0.018691588785046728	0.9605811478101344	1	2
pyrimidines/pharmacology	phospholipase a2 inhibitors/pharmacology	6.519751405420493e-11	2.177662157047584e-10	0.018691588785046728	0.9605811478101344	1	2
pyrimidines/pharmacology	mitophagy/drug effects	8.28094089788678e-05	0.0001775361580285956	0.07319670689438858	0.9605811478101344	1	2
pyrimidines/pharmacology	mitochondrial dynamics/drug effects	2.575712587660206e-08	7.393478861181125e-08	0.03711991575621956	0.9605811478101344	1	2
mutation/genetics	head and neck neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutation/genetics	caspase 8/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutation/genetics	hela cells	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
mutation/genetics	tnf-related apoptosis-inducing ligand/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mutation/genetics	CASP8	1.194367449386391e-08	3.492032028122417e-08	0.03271028037383177	0.9605811478101344	1	2
mutation/genetics	CXCL1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mutation/genetics	NFKB1	6.62905286219484e-11	2.212829031122965e-10	0.03271028037383177	0.9605811478101344	1	2
curcumin/pharmacology	anti-inflammatory agents non-steroidal/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
curcumin/pharmacology	IREB2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
curcumin/pharmacology	MKI67	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
curcumin/pharmacology	kidney tubules/cytology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
curcumin/pharmacology	kidney failure chronic/etiology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
curcumin/pharmacology	fibrosis	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
curcumin/pharmacology	ureteral obstruction/complications	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
curcumin/pharmacology	inflammasomes/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
curcumin/pharmacology	nlr family pyrin domain-containing 3 protein/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
curcumin/pharmacology	cell proliferation	8.43769498715119e-15	3.412847167064932e-14	0.027905752270633143	0.9605811478101344	1	2
brain neoplasms/drug therapy	interleukin-6/metabolism	4.099602150198223e-06	1.0102607377620477e-05	0.046290202272826986	0.9605811478101344	1	2
brain neoplasms/drug therapy	biomarkers tumor/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain neoplasms/drug therapy	chemokine ccl2/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain neoplasms/drug therapy	paracrine communication	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain neoplasms/drug therapy	proto-oncogene proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain neoplasms/drug therapy	apoptosis regulatory proteins	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain neoplasms/drug therapy	quercetin/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain neoplasms/drug therapy	AXL	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain neoplasms/drug therapy	CCL2	8.997020867207439e-07	2.3263318409779478e-06	0.03711991575621956	0.9605811478101344	1	2
brain neoplasms/drug therapy	NFKB1	0.00012508470989969211	0.0002632557926563967	0.0644991443991049	0.9605811478101344	1	2
PTGER4	sp1 transcription factor/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PTGER4	rna long noncoding/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PTGER4	MAPK1	4.989061767046721e-07	1.310758267872332e-06	0.04672897196261682	0.9605811478101344	1	2
PTGER4	receptors prostaglandin e ep4 subtype/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PTGER4	gefitinib/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PTGER4	SP1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apoferritins/metabolism	proteasome endopeptidase complex/metabolism	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
apoferritins/metabolism	viral nonstructural proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apoferritins/metabolism	protein interaction maps	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apoferritins/metabolism	jnk mitogen-activated protein kinases/metabolism	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
apoferritins/metabolism	host-parasite interactions	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apoferritins/metabolism	hepatocytes/metabolism	0.0	0.0	4.387696897898293e-05	0.8657199677887635	2	2
apoferritins/metabolism	antioxidants/metabolism	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
apoferritins/metabolism	cytoprotection	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
apoferritins/metabolism	apolipoprotein b-100/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apoferritins/metabolism	hepatitis c/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apoferritins/metabolism	iron overload/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apoferritins/metabolism	malaria/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apoferritins/metabolism	ceruloplasmin/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
apoferritins/metabolism	CP	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fibroblast growth factor 2/pharmacology	receptors fibroblast growth factor/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibroblast growth factor 2/pharmacology	neoplasm recurrence local/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibroblast growth factor 2/pharmacology	receptors estrogen/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fibroblast growth factor 2/pharmacology	bcl-2-like protein 11/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibroblast growth factor 2/pharmacology	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fibroblast growth factor 2/pharmacology	FGF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibroblast growth factor 2/pharmacology	PCNA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MMRN1	liver cirrhosis/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MMRN1	collagen type i/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MMRN1	cell line	2.1067664965124244e-05	4.820963955900979e-05	0.06074766355140186	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	cell movement/drug effects	1.5501520311822503e-07	4.2409420503171925e-07	0.0007078265750383096	0.7135314763244264	3	2
receptors cxcr4/antagonists & inhibitors	cytarabine/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	docetaxel	6.631623683528431e-08	1.8543315025292944e-07	0.027905752270633143	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	benzylamines	0.0	0.0	6.209005044195697e-07	0.7135314763244264	3	2
receptors cxcr4/antagonists & inhibitors	bone neoplasms/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	neoplastic stem cells/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	cytarabine/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	transforming growth factor beta/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	chemokine cxcl12/genetics	6.631623683528431e-08	1.8543315025292944e-07	0.04166180294604871	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	leukemia myeloid acute/drug therapy	0.0	0.0	0.0007848182375863361	0.8657199677887635	2	2
receptors cxcr4/antagonists & inhibitors	prostatic neoplasms/drug therapy	0.0001184325975449596	0.000249660762087319	0.06878335787959994	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	antibodies neutralizing/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	tumor microenvironment/immunology	6.967049159811722e-11	2.321086429065108e-10	0.027905752270633143	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	heterocyclic compounds/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	hematopoietic stem cells/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	cell adhesion/drug effects	4.264413928023458e-05	9.457981921845007e-05	0.055287464515536164	0.9605811478101344	1	2
receptors cxcr4/antagonists & inhibitors	CXCL12	0.0	0.0	2.173151765468494e-05	0.7135314763244264	3	2
receptors cxcr4/antagonists & inhibitors	CXCR4	0.0	0.0	2.483602017678279e-06	0.7135314763244264	3	2
interleukin-6/metabolism	liver neoplasms/metabolism	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	neoplasm metastasis/immunology	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	neovascularization pathologic/metabolism	4.8407944319706075e-12	1.6987081909293006e-11	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	tumor escape/immunology	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	melanoma/drug therapy	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	proto-oncogene proteins/metabolism	4.8407944319706075e-12	1.6987081909293006e-11	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	lymphoma t-cell/drug therapy	7.947415625597642e-08	2.213829686837357e-07	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	prostatic neoplasms/metabolism	4.8407944319706075e-12	1.6987081909293006e-11	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	interleukin-4/metabolism	7.947415625597642e-08	2.213829686837357e-07	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	nitric oxide/metabolism	8.28094089788678e-05	0.0001775361580285956	0.046290202272826986	0.9605811478101344	1	2
interleukin-6/metabolism	matrix metalloproteinase 9/metabolism	4.8407944319706075e-12	1.6987081909293006e-11	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	quercetin/pharmacology	4.8407944319706075e-12	1.6987081909293006e-11	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	tumor microenvironment/immunology	1.8692622000271442e-06	4.7090371327923305e-06	0.046290202272826986	0.9605811478101344	1	2
interleukin-6/metabolism	transforming growth factor beta/metabolism	2.7085016562899966e-08	7.766555406149284e-08	0.0025831226577705535	0.8657199677887635	2	2
interleukin-6/metabolism	human umbilical vein endothelial cells	2.6227374333220865e-05	5.9651449277785604e-05	0.06878335787959994	0.9605811478101344	1	2
interleukin-6/metabolism	tyramine/analogs & derivatives	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	antineoplastic agents phytogenic/therapeutic use	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	receptors androgen/metabolism	4.8407944319706075e-12	1.6987081909293006e-11	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	paclitaxel/therapeutic use	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	AXL	4.8407944319706075e-12	1.6987081909293006e-11	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	BIRC5	0.0020871879353784317	0.003853807855223488	0.06878335787959994	0.9605811478101344	1	2
interleukin-6/metabolism	IL6R	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	IL6ST	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	MMP9	8.28094089788678e-05	0.0001775361580285956	0.046290202272826986	0.9605811478101344	1	2
interleukin-6/metabolism	SOCS5	7.947415625597642e-08	2.213829686837357e-07	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	XIAP	0.001339528980152771	0.0025331447769455606	0.06878335787959994	0.9605811478101344	1	2
interleukin-6/metabolism	gene silencing	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	receptor igf type 1/metabolism	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	neoplasm metastasis/pathology	4.8407944319706075e-12	1.6987081909293006e-11	0.02336448598130841	0.9605811478101344	1	2
interleukin-6/metabolism	acetates/therapeutic use	3.7999681179456957e-10	1.210193515303578e-09	0.02336448598130841	0.9605811478101344	1	2
SP1	sp1 transcription factor/physiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SP1	dna (cytosine-5-)-methyltransferase 1/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SP1	erlotinib hydrochloride/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SP1	rna long noncoding/physiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SP1	MAPK1	0.0009245100227380787	0.0017786733840601363	0.09148348032117941	0.9605811478101344	1	2
SP1	receptors prostaglandin e ep4 subtype/physiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SP1	gefitinib/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SP1	sp1 transcription factor/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
caspase 3/metabolism	gene expression regulation leukemic/drug effects	2.66944835125571e-08	7.655566759688592e-08	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	leukocytes mononuclear/drug effects	3.5042941337604105e-07	9.278572962789664e-07	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	leukemia/drug therapy	0.0007392287055421054	0.0014384003618208754	0.05541661182045544	0.9605811478101344	1	2
caspase 3/metabolism	PRF1	9.940125707075254e-05	0.00021089289029021862	0.05541661182045544	0.9605811478101344	1	2
caspase 3/metabolism	mitochondrial proteins/genetics	1.20579102258489e-10	3.9473319177359547e-10	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	nitrophenols/toxicity	9.940125707075254e-05	0.00021089289029021862	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	piperazines/toxicity	9.940125707075254e-05	0.00021089289029021862	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	head and neck neoplasms/drug therapy	1.20579102258489e-10	3.9473319177359547e-10	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	poly(adp-ribose) polymerases/metabolism	9.940125707075254e-05	0.00021089289029021862	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	glioblastoma/enzymology	9.940125707075254e-05	0.00021089289029021862	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	flavonoids/pharmacology	0.0005349787352844082	0.0010567291843353013	0.05541661182045544	0.9605811478101344	1	2
caspase 3/metabolism	neoplasm invasiveness/pathology	1.631716847194653e-07	4.4524867632361027e-07	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	deoxycytidine/analogs & derivatives	1.20579102258489e-10	3.9473319177359547e-10	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	aminopyridines/pharmacology	9.940125707075254e-05	0.00021089289029021862	0.02803738317757009	0.9605811478101344	1	2
caspase 3/metabolism	leukemia lymphocytic chronic b-cell/drug therapy	2.66944835125571e-08	7.655566759688592e-08	0.02803738317757009	0.9605811478101344	1	2
S100A4	endoplasmic reticulum/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
g2 phase cell cycle checkpoints/drug effects	ribosomal proteins/genetics	4.0201775242110216e-10	1.2795853046600925e-09	0.014018691588785045	0.9605811478101344	1	2
g2 phase cell cycle checkpoints/drug effects	diterpenes/isolation & purification	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
g2 phase cell cycle checkpoints/drug effects	plant extracts/isolation & purification	2.4375466437520643e-06	6.0891715841202705e-06	0.027905752270633143	0.9605811478101344	1	2
g2 phase cell cycle checkpoints/drug effects	ovarian neoplasms/drug therapy	7.206855936026102e-06	1.733734420922024e-05	0.027905752270633143	0.9605811478101344	1	2
g2 phase cell cycle checkpoints/drug effects	human umbilical vein endothelial cells/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
g2 phase cell cycle checkpoints/drug effects	leukemia/drug therapy	4.298636627986241e-06	1.0570638007343368e-05	0.027905752270633143	0.9605811478101344	1	2
g2 phase cell cycle checkpoints/drug effects	PI3	7.824615122498102e-08	2.181000179783036e-07	0.027905752270633143	0.9605811478101344	1	2
g2 phase cell cycle checkpoints/drug effects	SPP1	1.7967192348367078e-06	4.538733465820318e-06	0.027905752270633143	0.9605811478101344	1	2
g2 phase cell cycle checkpoints/drug effects	hydrazones/pharmacology	1.594815390859594e-10	5.191567951819331e-10	0.014018691588785045	0.9605811478101344	1	2
g2 phase cell cycle checkpoints/drug effects	aurora kinase b/antagonists & inhibitors	4.0201775242110216e-10	1.2795853046600925e-09	0.014018691588785045	0.9605811478101344	1	2
interleukin-1beta/metabolism	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
interleukin-1beta/metabolism	leukemia myeloid acute/drug therapy	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
interleukin-1beta/metabolism	mesenchymal stem cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-1beta/metabolism	cell adhesion/drug effects	9.609091300433192e-12	3.321229738077301e-11	0.018691588785046728	0.9605811478101344	1	2
interleukin-1beta/metabolism	nf-kappa b/metabolism	1.181569286856643e-09	3.6847580815580287e-09	0.02336448598130841	0.9605811478101344	1	2
interleukin-1beta/metabolism	CCL2	2.5110025170249628e-11	8.560782974387874e-11	0.018691588785046728	0.9605811478101344	1	2
interleukin-1beta/metabolism	CCL4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-1beta/metabolism	CXCL12	3.443467222474794e-08	9.800124605798924e-08	0.03271028037383177	0.9605811478101344	1	2
interleukin-1beta/metabolism	NFKB1	1.6902963206888444e-07	4.602649534216085e-07	0.03271028037383177	0.9605811478101344	1	2
transforming growth factor beta1/genetics	antibiotics antineoplastic/therapeutic use	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transforming growth factor beta1/genetics	paracrine communication/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transforming growth factor beta1/genetics	isoflavones/adverse effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transforming growth factor beta1/genetics	doxorubicin/therapeutic use	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transforming growth factor beta1/genetics	extracellular vesicles/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transforming growth factor beta1/genetics	pancreatic neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transforming growth factor beta1/genetics	embryo nonmammalian	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transforming growth factor beta1/genetics	drug resistance neoplasm/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transforming growth factor beta1/genetics	CDKN1A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transforming growth factor beta1/genetics	MAPK1	0.00044967308686794105	0.000894477825628326	0.09148348032117941	0.9605811478101344	1	2
transforming growth factor beta1/genetics	SMAD2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transforming growth factor beta1/genetics	ZHX2	6.220781134658182e-08	1.743210249834057e-07	0.03711991575621956	0.9605811478101344	1	2
transforming growth factor beta1/genetics	tumor microenvironment/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b-lymphocytes/drug effects	heterocyclic compounds 4 or more rings/pharmacology	6.955092368698956e-08	1.9428085207788495e-07	0.027905752270633143	0.9605811478101344	1	2
b-lymphocytes/drug effects	dexamethasone/pharmacology	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
b-lymphocytes/drug effects	gene expression regulation leukemic	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
b-lymphocytes/drug effects	chemokine cxcl12/genetics	3.0033297815368343e-07	8.027326345414489e-07	0.04166180294604871	0.9605811478101344	1	2
b-lymphocytes/drug effects	myeloid-derived suppressor cells/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
b-lymphocytes/drug effects	chlorambucil/pharmacology	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
b-lymphocytes/drug effects	monocytes/drug effects	0.0	0.0	6.209005044195697e-07	0.7135314763244264	3	2
b-lymphocytes/drug effects	leukemia lymphocytic chronic b-cell/blood	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
b-lymphocytes/drug effects	x-linked inhibitor of apoptosis protein/genetics	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
b-lymphocytes/drug effects	chemokine ccl21/immunology	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
b-lymphocytes/drug effects	BCL2A1	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
b-lymphocytes/drug effects	CCL19	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
b-lymphocytes/drug effects	CCL21	1.181569286856643e-09	3.6847580815580287e-09	0.027905752270633143	0.9605811478101344	1	2
b-lymphocytes/drug effects	CCR7	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
b-lymphocytes/drug effects	CXCL12	0.0018239373399110415	0.003395033387113435	0.09538832359347407	0.9605811478101344	1	2
b-lymphocytes/drug effects	XIAP	2.7620974430098144e-05	6.267235198464587e-05	0.04166180294604871	0.9605811478101344	1	2
TF	ferritins/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TF	genetic variation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TF	malaria/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
copper/chemistry	peroxidase/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
copper/chemistry	tellurium/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
copper/chemistry	immunosuppressive agents/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
copper/chemistry	hydrogen peroxide/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
TICAM1	myocardial reperfusion injury/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
TICAM1	TRIM69	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ht29 cells	epoxy compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ht29 cells	phenanthrenes/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ht29 cells	nf-kappa b/metabolism	3.540051585204651e-10	1.1305193706632698e-09	0.02336448598130841	0.9605811478101344	1	2
ht29 cells	ARG1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ht29 cells	CXCL12	1.2665093418462448e-08	3.7000129811880225e-08	0.03271028037383177	0.9605811478101344	1	2
ht29 cells	DDX53	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ht29 cells	MRC1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BIRC5	SOCS5	1.3561035627773776e-09	4.206439413634725e-09	0.014018691588785045	0.9605811478101344	1	2
BIRC5	XIAP	0.0002763169510785479	0.0005621181156467821	0.04166180294604871	0.9605811478101344	1	2
BIRC5	flavonoids/metabolism	2.332691073636539e-08	6.70113000541217e-08	0.014018691588785045	0.9605811478101344	1	2
BIRC5	multiple myeloma/metabolism	2.332691073636539e-08	6.70113000541217e-08	0.014018691588785045	0.9605811478101344	1	2
BIRC5	erbb receptors/drug effects	1.6042722705833512e-12	5.852249341797109e-12	0.014018691588785045	0.9605811478101344	1	2
BIRC5	nitric oxide/metabolism	8.475718828671042e-06	2.0230881101498228e-05	0.027905752270633143	0.9605811478101344	1	2
BIRC5	MDM2	1.6042722705833512e-12	5.852249341797109e-12	0.014018691588785045	0.9605811478101344	1	2
BIRC5	METTL7B	1.6042722705833512e-12	5.852249341797109e-12	0.014018691588785045	0.9605811478101344	1	2
BIRC5	TP73	1.6042722705833512e-12	5.852249341797109e-12	0.014018691588785045	0.9605811478101344	1	2
BIRC5	transforming growth factor beta/metabolism	0.0015903189896189218	0.0029787913586881306	0.055287464515536164	0.9605811478101344	1	2
BIRC5	lymphoma t-cell/drug therapy	1.3561035627773776e-09	4.206439413634725e-09	0.014018691588785045	0.9605811478101344	1	2
BIRC5	interleukin-4/metabolism	1.3561035627773776e-09	4.206439413634725e-09	0.014018691588785045	0.9605811478101344	1	2
TRIM69	myocardial reperfusion injury/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
head and neck neoplasms/genetics	caspase 8/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
head and neck neoplasms/genetics	hela cells	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
head and neck neoplasms/genetics	tnf-related apoptosis-inducing ligand/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
head and neck neoplasms/genetics	CASP8	1.194367449386391e-08	3.492032028122417e-08	0.03271028037383177	0.9605811478101344	1	2
head and neck neoplasms/genetics	CXCL1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
head and neck neoplasms/genetics	NFKB1	6.62905286219484e-11	2.212829031122965e-10	0.03271028037383177	0.9605811478101344	1	2
CASP8	heterocyclic compounds 4 or more rings/pharmacology	0.002774005480236208	0.005030537327541365	0.0644991443991049	0.9605811478101344	1	2
CASP8	chemokine ccl2/biosynthesis	6.575019124388515e-05	0.00014324705697086758	0.03271028037383177	0.9605811478101344	1	2
CASP8	fibrosarcoma/drug therapy	6.575019124388515e-05	0.00014324705697086758	0.03271028037383177	0.9605811478101344	1	2
CASP8	caspase 8/genetics	1.194367449386391e-08	3.492032028122417e-08	0.03271028037383177	0.9605811478101344	1	2
CASP8	trabectedin	6.575019124388515e-05	0.00014324705697086758	0.03271028037383177	0.9605811478101344	1	2
CASP8	hela cells	7.5524831189e-07	1.962719799687732e-06	0.002720786010366554	0.8657199677887635	2	2
CASP8	BRCA1	6.575019124388515e-05	0.00014324705697086758	0.03271028037383177	0.9605811478101344	1	2
CASP8	rho gtp-binding proteins/genetics	6.575019124388515e-05	0.00014324705697086758	0.03271028037383177	0.9605811478101344	1	2
CASP8	neovascularization pathologic/prevention & control	6.575019124388515e-05	0.00014324705697086758	0.03271028037383177	0.9605811478101344	1	2
CASP8	tnf-related apoptosis-inducing ligand/pharmacology	1.194367449386391e-08	3.492032028122417e-08	0.03271028037383177	0.9605811478101344	1	2
CASP8	CXCL1	0.000335616220874857	0.0006746595949898656	0.0644991443991049	0.9605811478101344	1	2
CASP8	DDX53	0.004079415120180285	0.007194859976780652	0.0644991443991049	0.9605811478101344	1	2
CASP8	ovarian neoplasms/drug therapy	0.005703882993700171	0.009866563019386581	0.0644991443991049	0.9605811478101344	1	2
CASP8	MCL1	2.013423624436239e-05	4.6135901134452504e-05	0.00041630292572802344	0.7135314763244264	3	2
CASP8	flavonoids/metabolism	0.000335616220874857	0.0006746595949898656	0.03271028037383177	0.9605811478101344	1	2
CASP8	multiple myeloma/metabolism	0.000335616220874857	0.0006746595949898656	0.03271028037383177	0.9605811478101344	1	2
CASP8	1-phosphatidylinositol 4-kinase/metabolism	0.0001886666603145848	0.0003902544822793851	0.03271028037383177	0.9605811478101344	1	2
CASP8	caspases/metabolism	1.4514800703135933e-05	3.366175722128338e-05	0.0007180836797181683	0.7135314763244264	3	2
CASP8	crotonates/pharmacology	0.0001886666603145848	0.0003902544822793851	0.03271028037383177	0.9605811478101344	1	2
CASP8	plant roots	0.0001886666603145848	0.0003902544822793851	0.03271028037383177	0.9605811478101344	1	2
CASP8	nitrophenols/toxicity	0.0010427713481141465	0.0019929804683790483	0.03271028037383177	0.9605811478101344	1	2
CASP8	g2 phase/drug effects	2.531112663128887e-06	6.315035871524918e-06	0.03271028037383177	0.9605811478101344	1	2
CASP8	piperazines/toxicity	0.0010427713481141465	0.0019929804683790483	0.03271028037383177	0.9605811478101344	1	2
CASP8	plant extracts/pharmacology	0.0001886666603145848	0.0003902544822793851	0.03271028037383177	0.9605811478101344	1	2
CASP8	receptors death domain/drug effects	2.531112663128887e-06	6.315035871524918e-06	0.03271028037383177	0.9605811478101344	1	2
CASP8	poly(adp-ribose) polymerases/metabolism	0.0010427713481141465	0.0019929804683790483	0.03271028037383177	0.9605811478101344	1	2
CASP8	genes cdc/drug effects	2.531112663128887e-06	6.315035871524918e-06	0.03271028037383177	0.9605811478101344	1	2
CASP8	glioblastoma/enzymology	0.0010427713481141465	0.0019929804683790483	0.03271028037383177	0.9605811478101344	1	2
CASP8	dna/metabolism	0.0001886666603145848	0.0003902544822793851	0.03271028037383177	0.9605811478101344	1	2
CASP8	diosgenin/analogs & derivatives	2.531112663128887e-06	6.315035871524918e-06	0.03271028037383177	0.9605811478101344	1	2
CASP8	cell cycle proteins/drug effects	2.531112663128887e-06	6.315035871524918e-06	0.03271028037383177	0.9605811478101344	1	2
CASP8	anticarcinogenic agents/isolation & purification	2.531112663128887e-06	6.315035871524918e-06	0.03271028037383177	0.9605811478101344	1	2
CASP8	sesquiterpenes/pharmacology	0.0001886666603145848	0.0003902544822793851	0.03271028037383177	0.9605811478101344	1	2
CASP8	aminopyridines/pharmacology	0.0010427713481141465	0.0019929804683790483	0.03271028037383177	0.9605811478101344	1	2
CASP8	vascular endothelial growth factor a/biosynthesis	6.575019124388515e-05	0.00014324705697086758	0.03271028037383177	0.9605811478101344	1	2
sarcoma/drug therapy	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
sarcoma/drug therapy	hypoxia	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sarcoma/drug therapy	plant leaves/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sarcoma/drug therapy	fas ligand protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sarcoma/drug therapy	PRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
azocines/immunology	carcinoma lewis lung/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
azocines/immunology	ARG1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
azocines/immunology	TCIM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors fibroblast growth factor/metabolism	neoplasm recurrence local/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors fibroblast growth factor/metabolism	receptors estrogen/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors fibroblast growth factor/metabolism	bcl-2-like protein 11/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors fibroblast growth factor/metabolism	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors fibroblast growth factor/metabolism	FGF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors fibroblast growth factor/metabolism	PCNA	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biomarkers tumor/genetics	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
biomarkers tumor/genetics	chemokine ccl2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
biomarkers tumor/genetics	paracrine communication	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
biomarkers tumor/genetics	apoptosis regulatory proteins	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
biomarkers tumor/genetics	CCL2	2.5110025170249628e-11	8.560782974387874e-11	0.018691588785046728	0.9605811478101344	1	2
biomarkers tumor/genetics	NFKB1	1.6902963206888444e-07	4.602649534216085e-07	0.03271028037383177	0.9605811478101344	1	2
gtp phosphohydrolases/genetics	leucine/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gtp phosphohydrolases/genetics	myocytes cardiac/drug effects	3.3306690738754696e-16	1.4334294698576293e-15	0.02336448598130841	0.9605811478101344	1	2
gtp phosphohydrolases/genetics	mitochondria heart/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
gtp phosphohydrolases/genetics	organelle biogenesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
gtp phosphohydrolases/genetics	myocardial reperfusion injury/enzymology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gtp phosphohydrolases/genetics	mitochondrial dynamics/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
gene expression regulation leukemic/drug effects	leukemia lymphocytic chronic b-cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene expression regulation leukemic/drug effects	PRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
clodronic acid/pharmacology	ng-nitroarginine methyl ester/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clodronic acid/pharmacology	liver neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
clodronic acid/pharmacology	colorectal neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clodronic acid/pharmacology	receptors ccr5/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clodronic acid/pharmacology	adenocarcinoma/drug therapy	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
clodronic acid/pharmacology	maraviroc	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clodronic acid/pharmacology	neoplasm proteins/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clodronic acid/pharmacology	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clodronic acid/pharmacology	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
clodronic acid/pharmacology	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
clodronic acid/pharmacology	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
clodronic acid/pharmacology	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
CIITA	FOXP3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CIITA	HDAC9	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl2/genetics	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
chemokine ccl2/genetics	paracrine communication	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl2/genetics	apoptosis regulatory proteins	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl2/genetics	CCL2	2.5110025170249628e-11	8.560782974387874e-11	0.018691588785046728	0.9605811478101344	1	2
chemokine ccl2/genetics	NFKB1	1.6902963206888444e-07	4.602649534216085e-07	0.03271028037383177	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	ovarian neoplasms/drug therapy	6.096331439664482e-09	1.8334731357484997e-08	0.018647711816067742	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	fibrosarcoma/drug therapy	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	rho gtp-binding proteins/genetics	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	neovascularization pathologic/prevention & control	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	myeloid-derived suppressor cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	monocytes/drug effects	6.955092368698956e-08	1.9428085207788495e-07	0.027905752270633143	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	leukemia lymphocytic chronic b-cell/blood	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	vascular endothelial growth factor a/biosynthesis	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	chemokine ccl21/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	cell adhesion/drug effects	6.247304675577325e-06	1.5103133057799219e-05	0.03711991575621956	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	chemokine ccl2/biosynthesis	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	trabectedin	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	BRCA1	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	CCL19	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	CCL2	9.703503700775329e-06	2.298236648347776e-05	0.03711991575621956	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	CCL21	1.6409096303959814e-12	5.956334463445933e-12	0.018647711816067742	0.9605811478101344	1	2
heterocyclic compounds 4 or more rings/pharmacology	CCR7	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
alpha-crystallins/administration & dosage	astrocytes/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
alpha-crystallins/administration & dosage	brain/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
alpha-crystallins/administration & dosage	staurosporine/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
alpha-crystallins/administration & dosage	extracellular space/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glucose/pharmacology	keratinocytes/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nucleotides cyclic/pharmacology	neoplasms/blood supply	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nucleotides cyclic/pharmacology	human umbilical vein endothelial cells	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
astrocytes/physiology	extracellular space/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
astrocytes/physiology	brain/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
astrocytes/physiology	staurosporine/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydrogen peroxide/toxicity	ascorbic acid/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydrogen peroxide/toxicity	dynamins	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydrogen peroxide/toxicity	acetylcysteine/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydrogen peroxide/toxicity	histones/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukins/metabolism	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interleukins/metabolism	cd3 complex/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukins/metabolism	CD28	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukins/metabolism	CD3E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukins/metabolism	IL5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
epoxy compounds/pharmacology	phenanthrenes/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
epoxy compounds/pharmacology	nf-kappa b/metabolism	3.540051585204651e-10	1.1305193706632698e-09	0.02336448598130841	0.9605811478101344	1	2
epoxy compounds/pharmacology	ARG1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
epoxy compounds/pharmacology	CXCL12	1.2665093418462448e-08	3.7000129811880225e-08	0.03271028037383177	0.9605811478101344	1	2
epoxy compounds/pharmacology	DDX53	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
epoxy compounds/pharmacology	MRC1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-1beta/deficiency	estrogen receptor modulators/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-1beta/deficiency	triple negative breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-1beta/deficiency	neutrophil infiltration/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-1beta/deficiency	estrogen receptor beta/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-1beta/deficiency	neutrophils/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-1beta/deficiency	ESR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-1beta/deficiency	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antigens polyomavirus transforming/genetics	carcinoma hepatocellular/drug therapy	2.311633029439264e-08	6.647565544942857e-08	0.03271028037383177	0.9605811478101344	1	2
antigens polyomavirus transforming/genetics	cell line transformed	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigens polyomavirus transforming/genetics	CSF1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigens polyomavirus transforming/genetics	CSF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	liver neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	colorectal neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	receptors ccr5/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	adenocarcinoma/drug therapy	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	maraviroc	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	neoplasm proteins/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
ng-nitroarginine methyl ester/pharmacology	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
ascorbic acid/analogs & derivatives	dynamins	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ascorbic acid/analogs & derivatives	acetylcysteine/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ascorbic acid/analogs & derivatives	histones/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
FOXP3	HDAC9	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diterpenes/isolation & purification	cell movement/drug effects	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
diterpenes/isolation & purification	plant extracts/isolation & purification	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
diterpenes/isolation & purification	human umbilical vein endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diterpenes/isolation & purification	PI3	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
diterpenes/isolation & purification	SPP1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
estrogen receptor modulators/pharmacology	triple negative breast neoplasms/therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor modulators/pharmacology	neutrophil infiltration/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor modulators/pharmacology	estrogen receptor beta/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor modulators/pharmacology	neutrophils/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor modulators/pharmacology	ESR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor modulators/pharmacology	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dexamethasone/pharmacology	gene expression regulation leukemic	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dexamethasone/pharmacology	chemokine cxcl12/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
dexamethasone/pharmacology	chlorambucil/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dexamethasone/pharmacology	monocytes/drug effects	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
dexamethasone/pharmacology	x-linked inhibitor of apoptosis protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dexamethasone/pharmacology	BCL2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dexamethasone/pharmacology	CXCL12	8.390528605239922e-08	2.3337249235313462e-07	0.03271028037383177	0.9605811478101344	1	2
dexamethasone/pharmacology	XIAP	9.435785486289205e-13	3.5005922665607337e-12	0.014018691588785045	0.9605811478101344	1	2
liver neoplasms/drug therapy	immune checkpoint inhibitors/chemical synthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver neoplasms/drug therapy	nitrobenzenes/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver neoplasms/drug therapy	programmed cell death 1 receptor/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver neoplasms/drug therapy	colorectal neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver neoplasms/drug therapy	receptors ccr5/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver neoplasms/drug therapy	t-lymphocytes/cytology	1.0363931934875836e-12	3.832030375652229e-12	0.018647711816067742	0.9605811478101344	1	2
liver neoplasms/drug therapy	adenocarcinoma/drug therapy	6.632486448943098e-09	1.9812093378444308e-08	0.018647711816067742	0.9605811478101344	1	2
liver neoplasms/drug therapy	maraviroc	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver neoplasms/drug therapy	neoplasm proteins/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver neoplasms/drug therapy	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver neoplasms/drug therapy	CCL5	3.594389679228982e-07	9.513697916883625e-07	0.027905752270633143	0.9605811478101344	1	2
liver neoplasms/drug therapy	CCR5	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver neoplasms/drug therapy	CXCL10	8.261783901453157e-08	2.3002375484182245e-07	0.027905752270633143	0.9605811478101344	1	2
liver neoplasms/drug therapy	CXCL9	8.575536947219575e-10	2.6922033121500384e-09	0.018647711816067742	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	paclitaxel/pharmacology	0.0033165574239023554	0.005956619263782921	0.08215010393874443	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	hela cells	0.0030184185630593996	0.005444954897574702	0.08215010393874443	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	b7-h1 antigen/genetics	9.231162623679623e-05	0.00019683624132194228	0.05541661182045544	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	adaptor proteins signal transducing/metabolism	7.751701947000811e-09	2.301501811573847e-08	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	EIF2S1	7.751701947000811e-09	2.301501811573847e-08	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	1-phosphatidylinositol 4-kinase/metabolism	8.836575189352658e-06	2.0978659392144654e-05	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	plant roots	8.836575189352658e-06	2.0978659392144654e-05	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	dna mitochondrial/genetics	2.228787709945834e-09	6.864130664741689e-09	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	carcinoma squamous cell/drug therapy	6.072542835244832e-08	1.7021030311654978e-07	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	mouth neoplasms/drug therapy	6.072542835244832e-08	1.7021030311654978e-07	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	plant extracts/pharmacology	8.836575189352658e-06	2.0978659392144654e-05	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	dna/metabolism	8.836575189352658e-06	2.0978659392144654e-05	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	sesquiterpenes guaiane	6.072542835244832e-08	1.7021030311654978e-07	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	kidney/drug effects	2.228787709945834e-09	6.864130664741689e-09	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	peptide elongation factor tu/genetics	2.228787709945834e-09	6.864130664741689e-09	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	naphthalenes/pharmacology	1.4351140087409675e-07	3.9350072956996457e-07	0.02803738317757009	0.9605811478101344	1	2
antineoplastic agents phytogenic/pharmacology	g1 phase cell cycle checkpoints/drug effects	9.231162623679623e-05	0.00019683624132194228	0.05541661182045544	0.9605811478101344	1	2
benzylamines	cell movement/drug effects	1.5501520311822503e-07	4.2409420503171925e-07	0.0007078265750383096	0.7135314763244264	3	2
benzylamines	cytarabine/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
benzylamines	docetaxel	6.631623683528431e-08	1.8543315025292944e-07	0.027905752270633143	0.9605811478101344	1	2
benzylamines	bone neoplasms/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
benzylamines	neoplastic stem cells/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
benzylamines	cytarabine/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
benzylamines	transforming growth factor beta/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
benzylamines	chemokine cxcl12/genetics	6.631623683528431e-08	1.8543315025292944e-07	0.04166180294604871	0.9605811478101344	1	2
benzylamines	leukemia myeloid acute/drug therapy	0.0	0.0	0.0007848182375863361	0.8657199677887635	2	2
benzylamines	prostatic neoplasms/drug therapy	0.0001184325975449596	0.000249660762087319	0.06878335787959994	0.9605811478101344	1	2
benzylamines	antibodies neutralizing/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
benzylamines	tumor microenvironment/immunology	6.967049159811722e-11	2.321086429065108e-10	0.027905752270633143	0.9605811478101344	1	2
benzylamines	heterocyclic compounds/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
benzylamines	hematopoietic stem cells/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
benzylamines	cell adhesion/drug effects	4.264413928023458e-05	9.457981921845007e-05	0.055287464515536164	0.9605811478101344	1	2
benzylamines	CXCL12	0.0	0.0	2.173151765468494e-05	0.7135314763244264	3	2
benzylamines	CXCR4	0.0	0.0	2.483602017678279e-06	0.7135314763244264	3	2
carcinoma hepatocellular/genetics	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
carcinoma hepatocellular/genetics	potassium channels voltage-gated/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma hepatocellular/genetics	micrornas/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma hepatocellular/genetics	immune evasion/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma hepatocellular/genetics	KCNQ1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma hepatocellular/genetics	KCNQ1OT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd3 complex/immunology	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cd3 complex/immunology	CD28	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd3 complex/immunology	CD3E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd3 complex/immunology	IL5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	MCL1	0.0009303674639992154	0.0017894741207585016	0.05541661182045544	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	multiple myeloma/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	enzyme inhibitors/pharmacology	1.8387069644631993e-11	6.294024398771094e-11	0.018647711816067742	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	host-parasite interactions	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	hepatocytes/metabolism	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	antioxidants/metabolism	7.971401316808624e-14	3.1145393626262015e-13	0.018647711816067742	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	flavonoids/pharmacology	1.06237907360196e-10	3.490289646070036e-10	0.018647711816067742	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	free radicals/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	cytoprotection	2.0128343436454088e-13	7.647591178475611e-13	0.018647711816067742	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	carrier proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	cyclin-dependent kinases/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	iron overload/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	protein transport	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	malaria/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	nitriles/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	piperidines/pharmacology	4.817741761087291e-10	1.530790752968044e-09	0.018647711816067742	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	ceruloplasmin/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/metabolism	CP	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MAPK1	interferon-gamma/genetics	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	interferon regulatory factor-2/genetics	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	rna small interfering/pharmacology	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	proto-oncogene proteins/genetics	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	gene silencing/drug effects	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	plasmids/genetics	0.004141426933179759	0.007290816114879219	0.09148348032117941	0.9605811478101344	1	2
MAPK1	bone neoplasms/drug therapy	0.0009245100227380787	0.0017786733840601363	0.09148348032117941	0.9605811478101344	1	2
MAPK1	pancreatic neoplasms/drug therapy	1.3036816781664129e-06	3.327572776130247e-06	0.04672897196261682	0.9605811478101344	1	2
MAPK1	isoflavones/adverse effects	1.3036816781664129e-06	3.327572776130247e-06	0.04672897196261682	0.9605811478101344	1	2
MAPK1	IRF2	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	interferon regulatory factor-1/genetics	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	ESR1	0.003158697231605445	0.005679112497956198	0.09148348032117941	0.9605811478101344	1	2
MAPK1	CDKN1A	1.3036816781664129e-06	3.327572776130247e-06	0.04672897196261682	0.9605811478101344	1	2
MAPK1	ZHX2	1.5184076218588416e-09	4.7059110552071605e-09	0.00029061674794538726	0.7135314763244264	3	2
MAPK1	sp1 transcription factor/physiology	4.989061767046721e-07	1.310758267872332e-06	0.04672897196261682	0.9605811478101344	1	2
MAPK1	amphiregulin/physiology	1.1940993098313868e-05	2.7966328429108155e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	extracellular signal-regulated map kinases/drug effects	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	dna neoplasm/metabolism	2.1270633422276752e-05	4.8553155160405616e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	platelet endothelial cell adhesion molecule-1/biosynthesis	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	raf kinases/metabolism	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	metabolic networks and pathways/drug effects	1.3036816781664129e-06	3.327572776130247e-06	0.04672897196261682	0.9605811478101344	1	2
MAPK1	carboxy-lyases/genetics	1.1940993098313868e-05	2.7966328429108155e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	antineoplastic agents/administration & dosage	0.0036295362031109057	0.006468155044147208	0.13433803313621812	0.9605811478101344	1	2
MAPK1	gefitinib/pharmacology	4.989061767046721e-07	1.310758267872332e-06	0.04672897196261682	0.9605811478101344	1	2
MAPK1	levofloxacin/pharmacology	1.3036816781664129e-06	3.327572776130247e-06	0.04672897196261682	0.9605811478101344	1	2
MAPK1	receptors estrogen/physiology	1.1940993098313868e-05	2.7966328429108155e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	embryonic stem cells/cytology	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	jnk mitogen-activated protein kinases/drug effects	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	p38 mitogen-activated protein kinases/drug effects	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	cyclohexenes/chemistry	2.1270633422276752e-05	4.8553155160405616e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	letrozole/pharmacology	1.1940993098313868e-05	2.7966328429108155e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	dioxanes/chemistry	2.1270633422276752e-05	4.8553155160405616e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	mitochondrial dynamics/physiology	1.1940993098313868e-05	2.7966328429108155e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	caspase 3/biosynthesis	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	rna long noncoding/physiology	4.989061767046721e-07	1.310758267872332e-06	0.04672897196261682	0.9605811478101344	1	2
MAPK1	cell transformation neoplastic/drug effects	3.5466395376104742e-09	1.0791651742373136e-08	0.0019744636040542316	0.8657199677887635	2	2
MAPK1	receptors prostaglandin e ep4 subtype/physiology	4.989061767046721e-07	1.310758267872332e-06	0.04672897196261682	0.9605811478101344	1	2
MAPK1	uterine cervical neoplasms/enzymology	2.1270633422276752e-05	4.8553155160405616e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	acetylcysteine/metabolism	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	angiogenesis inhibitors/pharmacology	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	nitric oxide synthase/antagonists & inhibitors	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	aromatase inhibitors/pharmacology	1.1940993098313868e-05	2.7966328429108155e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	organelle biogenesis	0.00034075459087046234	0.0006838042431520846	0.09148348032117941	0.9605811478101344	1	2
MAPK1	cell differentiation	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	immunosuppressive agents/pharmacology	1.1940993098313868e-05	2.7966328429108155e-05	0.04672897196261682	0.9605811478101344	1	2
MAPK1	endothelial cells/drug effects	0.000581706605334853	0.0011444157432339464	0.04672897196261682	0.9605811478101344	1	2
MAPK1	IRF1	3.5703317128876755e-05	7.986068134903872e-05	0.04672897196261682	0.9605811478101344	1	2
paracrine communication	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
paracrine communication	apoptosis regulatory proteins	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
paracrine communication	CCL2	2.5110025170249628e-11	8.560782974387874e-11	0.018691588785046728	0.9605811478101344	1	2
paracrine communication	NFKB1	1.6902963206888444e-07	4.602649534216085e-07	0.03271028037383177	0.9605811478101344	1	2
lysosomal-associated membrane protein 2/genetics	oxaliplatin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lysosomal-associated membrane protein 2/genetics	interleukin-17/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lysosomal-associated membrane protein 2/genetics	cyclin d1/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lysosomal-associated membrane protein 2/genetics	carcinoma hepatocellular/drug therapy	7.751701947000811e-09	2.301501811573847e-08	0.03271028037383177	0.9605811478101344	1	2
lysosomal-associated membrane protein 2/genetics	macrophages/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lysosomal-associated membrane protein 2/genetics	biomarkers	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
lysosomal-associated membrane protein 2/genetics	receptors interleukin-17/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lysosomal-associated membrane protein 2/genetics	organoplatinum compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MCL1	tubulin modulators/pharmacology	1.250576779732171e-05	2.9230061316161248e-05	0.02803738317757009	0.9605811478101344	1	2
MCL1	myeloid cell leukemia sequence 1 protein/metabolism	1.250576779732171e-05	2.9230061316161248e-05	0.02803738317757009	0.9605811478101344	1	2
MCL1	stilbenes/pharmacology	1.250576779732171e-05	2.9230061316161248e-05	0.02803738317757009	0.9605811478101344	1	2
MCL1	caspases/metabolism	0.0031435760532831925	0.005661621044174794	0.012970382291718041	0.8657199677887635	2	2
MCL1	plant roots	9.985783302068896e-05	0.000211759690529975	0.02803738317757009	0.9605811478101344	1	2
MCL1	nitrophenols/toxicity	0.0006294795090561189	0.0012353150169710113	0.02803738317757009	0.9605811478101344	1	2
MCL1	urinary bladder neoplasms/metabolism	1.250576779732171e-05	2.9230061316161248e-05	0.02803738317757009	0.9605811478101344	1	2
MCL1	piperazines/toxicity	0.0006294795090561189	0.0012353150169710113	0.02803738317757009	0.9605811478101344	1	2
MCL1	enzyme inhibitors/pharmacology	0.0015484433619867843	0.002906280688268036	0.05541661182045544	0.9605811478101344	1	2
MCL1	plant extracts/pharmacology	9.985783302068896e-05	0.000211759690529975	0.02803738317757009	0.9605811478101344	1	2
MCL1	poly(adp-ribose) polymerases/metabolism	0.0006294795090561189	0.0012353150169710113	0.02803738317757009	0.9605811478101344	1	2
MCL1	glioblastoma/enzymology	0.0006294795090561189	0.0012353150169710113	0.02803738317757009	0.9605811478101344	1	2
MCL1	dna/metabolism	9.985783302068896e-05	0.000211759690529975	0.02803738317757009	0.9605811478101344	1	2
MCL1	flavonoids/pharmacology	0.002393861586014956	0.004377891526912554	0.05541661182045544	0.9605811478101344	1	2
MCL1	free radicals/metabolism	3.20643269862142e-05	7.232268863345786e-05	0.02803738317757009	0.9605811478101344	1	2
MCL1	carrier proteins/metabolism	3.20643269862142e-05	7.232268863345786e-05	0.02803738317757009	0.9605811478101344	1	2
MCL1	cyclin-dependent kinases/antagonists & inhibitors	3.20643269862142e-05	7.232268863345786e-05	0.02803738317757009	0.9605811478101344	1	2
MCL1	aminopyridines/pharmacology	0.0006294795090561189	0.0012353150169710113	0.02803738317757009	0.9605811478101344	1	2
MCL1	protein transport	3.20643269862142e-05	7.232268863345786e-05	0.02803738317757009	0.9605811478101344	1	2
MCL1	nitriles/metabolism	3.20643269862142e-05	7.232268863345786e-05	0.02803738317757009	0.9605811478101344	1	2
MCL1	piperidines/pharmacology	0.0034904524840041473	0.00623238551727595	0.05541661182045544	0.9605811478101344	1	2
MCL1	CTNNB1	1.250576779732171e-05	2.9230061316161248e-05	0.02803738317757009	0.9605811478101344	1	2
MCL1	flavonoids/metabolism	0.00018571952850299223	0.00038444692183212586	0.02803738317757009	0.9605811478101344	1	2
MCL1	multiple myeloma/metabolism	0.00018571952850299223	0.00038444692183212586	0.02803738317757009	0.9605811478101344	1	2
MCL1	1-phosphatidylinositol 4-kinase/metabolism	9.985783302068896e-05	0.000211759690529975	0.02803738317757009	0.9605811478101344	1	2
MCL1	multiple myeloma/pathology	3.20643269862142e-05	7.232268863345786e-05	0.02803738317757009	0.9605811478101344	1	2
plant extracts/isolation & purification	rhizome/chemistry	7.771561172376096e-16	3.293241989785665e-15	0.009345794392523364	0.9605811478101344	1	2
plant extracts/isolation & purification	saponins/isolation & purification	7.771561172376096e-16	3.293241989785665e-15	0.009345794392523364	0.9605811478101344	1	2
plant extracts/isolation & purification	human umbilical vein endothelial cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plant extracts/isolation & purification	PI3	1.3098300222225134e-11	4.508841893827007e-11	0.018647711816067742	0.9605811478101344	1	2
plant extracts/isolation & purification	SPP1	1.7126907669862135e-09	5.295387187002109e-09	0.018647711816067742	0.9605811478101344	1	2
oxaliplatin	interleukin-17/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxaliplatin	cyclin d1/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxaliplatin	carcinoma hepatocellular/drug therapy	7.751701947000811e-09	2.301501811573847e-08	0.03271028037383177	0.9605811478101344	1	2
oxaliplatin	macrophages/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxaliplatin	biomarkers	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
oxaliplatin	receptors interleukin-17/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxaliplatin	organoplatinum compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukocytes mononuclear/drug effects	cell movement/drug effects	0.0048237178890900845	0.008429367680007783	0.09345794392523364	0.9605811478101344	1	2
leukocytes mononuclear/drug effects	leukemia/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
leukocytes mononuclear/drug effects	CCL2	2.853762781640512e-10	9.210915211478555e-10	0.018691588785046728	0.9605811478101344	1	2
leukocytes mononuclear/drug effects	CCL5	3.764988321108831e-12	1.3309357464134602e-11	0.014018691588785045	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	nitric oxide/metabolism	1.594815390859594e-10	5.191567951819331e-10	0.018647711816067742	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	cardiotonic agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	oxygen consumption	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	cytoprotection	8.670841822322473e-14	3.383623371656033e-13	0.018647711816067742	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	myocytes cardiac/drug effects	0.0	0.0	0.00043876968978982925	0.8657199677887635	2	2
myocardial reperfusion injury/metabolism	mitochondria heart/drug effects	0.0	0.0	0.00026326181387389757	0.8657199677887635	2	2
myocardial reperfusion injury/metabolism	electron transport complex i/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	cell hypoxia/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	cell death	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	chalcones/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	PPID	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	PPIF	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	nitric oxide synthase type iii/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/metabolism	creatine kinase mb form/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins/metabolism	quercetin/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins/metabolism	AXL	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PCNA	receptors estrogen/metabolism	2.1216362000586741e-13	8.055421894075021e-13	0.018647711816067742	0.9605811478101344	1	2
PCNA	neoplasm recurrence local/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PCNA	ligands	1.7066348334537906e-11	5.849197078810691e-11	0.018647711816067742	0.9605811478101344	1	2
PCNA	bcl-2-like protein 11/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PCNA	FGF2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
PCNA	spleen/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ovarian neoplasms/drug therapy	fibrosarcoma/drug therapy	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
ovarian neoplasms/drug therapy	rho gtp-binding proteins/genetics	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
ovarian neoplasms/drug therapy	neovascularization pathologic/prevention & control	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
ovarian neoplasms/drug therapy	vascular endothelial growth factor a/biosynthesis	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
ovarian neoplasms/drug therapy	cell adhesion/drug effects	2.812667174656447e-05	6.368869864108589e-05	0.03711991575621956	0.9605811478101344	1	2
ovarian neoplasms/drug therapy	chemokine ccl2/biosynthesis	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
ovarian neoplasms/drug therapy	trabectedin	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
ovarian neoplasms/drug therapy	BRCA1	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
ovarian neoplasms/drug therapy	CCL2	4.124634723245979e-05	9.155335384891508e-05	0.03711991575621956	0.9605811478101344	1	2
ovarian neoplasms/drug therapy	hydrazones/pharmacology	1.709743457922741e-14	6.820413200702116e-14	0.009345794392523364	0.9605811478101344	1	2
triple negative breast neoplasms/therapy	neutrophil infiltration/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
triple negative breast neoplasms/therapy	estrogen receptor beta/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
triple negative breast neoplasms/therapy	neutrophils/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
triple negative breast neoplasms/therapy	ESR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
triple negative breast neoplasms/therapy	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antimycin a/analogs & derivatives	cyclic n-oxides/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimycin a/analogs & derivatives	cell hypoxia	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antimycin a/analogs & derivatives	adipose tissue/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimycin a/analogs & derivatives	free radical scavengers/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimycin a/analogs & derivatives	stem cells/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	interleukin-17/biosynthesis	7.751701947000811e-09	2.301501811573847e-08	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	tubulin modulators/pharmacology	6.216338571674029e-07	1.6258343158750772e-06	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	cyclin d1/genetics	7.751701947000811e-09	2.301501811573847e-08	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	myeloid cell leukemia sequence 1 protein/metabolism	6.216338571674029e-07	1.6258343158750772e-06	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	macrophages/immunology	7.751701947000811e-09	2.301501811573847e-08	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	cell line transformed	2.311633029439264e-08	6.647565544942857e-08	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	gene silencing/drug effects	3.1022891100462857e-07	8.275773780798609e-07	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	rna small interfering/pharmacology	3.1022891100462857e-07	8.275773780798609e-07	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	biomarkers	0.00011921627541833235	0.0002512407226556482	0.0644991443991049	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	interferon regulatory factor-1/genetics	3.1022891100462857e-07	8.275773780798609e-07	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	interferon-gamma/genetics	3.1022891100462857e-07	8.275773780798609e-07	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	interferon regulatory factor-2/genetics	3.1022891100462857e-07	8.275773780798609e-07	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	plasmids/genetics	0.00035179075315983077	0.000705501412194647	0.0644991443991049	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	receptors interleukin-17/genetics	7.751701947000811e-09	2.301501811573847e-08	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	peptides/chemistry	6.216338571674029e-07	1.6258343158750772e-06	0.0644991443991049	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	stilbenes/pharmacology	6.216338571674029e-07	1.6258343158750772e-06	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	glycogen synthase kinase 3 beta/metabolism	0.0015852545308657762	0.0029695575103252875	0.0644991443991049	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	organoplatinum compounds/pharmacology	7.751701947000811e-09	2.301501811573847e-08	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	proto-oncogene proteins/genetics	3.1022891100462857e-07	8.275773780798609e-07	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	CSF1	2.311633029439264e-08	6.647565544942857e-08	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	CSF2	2.311633029439264e-08	6.647565544942857e-08	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	CTNNB1	6.216338571674029e-07	1.6258343158750772e-06	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	IRF1	3.1022891100462857e-07	8.275773780798609e-07	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	IRF2	3.1022891100462857e-07	8.275773780798609e-07	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	endocytosis/drug effects	1.3067324999838092e-12	4.805009699740331e-12	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	mitochondrial membranes/drug effects	1.167139594193678e-06	2.9950062584709276e-06	0.0644991443991049	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	berberine/pharmacology	0.00015172431761112382	0.00031681198548063813	0.0644991443991049	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	phenylurea compounds/pharmacology	7.751701947000811e-09	2.301501811573847e-08	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	cell nucleus/drug effects	1.4351140087409675e-07	3.9350072956996457e-07	0.03271028037383177	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	antioxidants/metabolism	5.266270046766497e-05	0.00011564812947321487	0.0644991443991049	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	mitophagy/drug effects	0.0022276188332333025	0.004094584413099445	0.12539913750269532	0.9605811478101344	1	2
carcinoma hepatocellular/drug therapy	mitochondrial dynamics/drug effects	1.3323328819980773e-05	3.107179541177661e-05	0.0644991443991049	0.9605811478101344	1	2
golgi apparatus/drug effects	endoplasmic reticulum/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
golgi apparatus/drug effects	cell line	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
golgi apparatus/drug effects	tor serine-threonine kinases/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
golgi apparatus/drug effects	curcumin/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
golgi apparatus/drug effects	lysosomes/drug effects	4.712144485718994e-08	1.3323077920124696e-07	0.02336448598130841	0.9605811478101344	1	2
golgi apparatus/drug effects	microtubule-associated proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
golgi apparatus/drug effects	bcl-2-associated x protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
golgi apparatus/drug effects	cytochromes c/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
golgi apparatus/drug effects	lipoproteins ldl/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipopolysaccharides/pharmacology	myeloid differentiation factor 88/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipopolysaccharides/pharmacology	piperazines	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipopolysaccharides/pharmacology	glycogen synthase kinase 3 beta/metabolism	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
lipopolysaccharides/pharmacology	nf-kappa b/metabolism	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
lipopolysaccharides/pharmacology	ITK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipopolysaccharides/pharmacology	MMP2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipopolysaccharides/pharmacology	MMP9	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
lipopolysaccharides/pharmacology	MYD88	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipopolysaccharides/pharmacology	NFKB1	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
lipopolysaccharides/pharmacology	TRAF6	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents/pharmacology	oxygen consumption	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents/pharmacology	myocytes cardiac/drug effects	5.295763827461997e-13	1.979671089655512e-12	0.02336448598130841	0.9605811478101344	1	2
cardiotonic agents/pharmacology	mitochondria heart/drug effects	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
cardiotonic agents/pharmacology	electron transport complex i/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents/pharmacology	cell hypoxia/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents/pharmacology	cell death	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents/pharmacology	PPID	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents/pharmacology	PPIF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/blood supply	human umbilical vein endothelial cells	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
leucine/pharmacology	myocytes cardiac/drug effects	3.3306690738754696e-16	1.4334294698576293e-15	0.02336448598130841	0.9605811478101344	1	2
leucine/pharmacology	mitochondria heart/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
leucine/pharmacology	organelle biogenesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
leucine/pharmacology	myocardial reperfusion injury/enzymology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leucine/pharmacology	mitochondrial dynamics/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
WDTC1	antineoplastic agents/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	tnf-related apoptosis-inducing ligand/metabolism	2.1244838133149813e-07	5.739568571984893e-07	0.03711991575621956	0.9605811478101344	1	2
WDTC1	receptors tnf-related apoptosis-inducing ligand/agonists	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	CFLAR	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	recombinant fusion proteins/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	uncoupling agents/pharmacology	3.341771304121721e-14	1.3157031020227804e-13	0.03711991575621956	0.9605811478101344	1	2
WDTC1	biological transport/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	mitochondrial adp atp translocases/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	leukemia t-cell/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	BIRC2	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	TNFRSF12A	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	plant extracts/chemistry	1.5842882561400984e-13	6.04645793169065e-13	0.018691588785046728	0.9605811478101344	1	2
WDTC1	anthraquinones/isolation & purification	1.5842882561400984e-13	6.04645793169065e-13	0.018691588785046728	0.9605811478101344	1	2
WDTC1	adenosine triphosphatases/antagonists & inhibitors	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	isoantigens/immunology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	nucleotidyltransferases/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	palmitates/metabolism	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	adenosine diphosphate/pharmacology	6.438183319801283e-13	2.4034721611069876e-12	0.03711991575621956	0.9605811478101344	1	2
WDTC1	carbonyl cyanide p-trifluoromethoxyphenylhydrazone/pharmacology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
WDTC1	oxygen consumption/drug effects	1.4454715613343438e-07	3.9624216069003624e-07	0.055287464515536164	0.9605811478101344	1	2
XIAP	acetates/therapeutic use	2.0128343436454088e-13	7.647591178475611e-13	0.014018691588785045	0.9605811478101344	1	2
XIAP	CXCL12	0.0049997590413601856	0.008723169054673527	0.09538832359347407	0.9605811478101344	1	2
XIAP	paclitaxel/therapeutic use	2.0128343436454088e-13	7.647591178475611e-13	0.014018691588785045	0.9605811478101344	1	2
XIAP	melanoma/drug therapy	2.0128343436454088e-13	7.647591178475611e-13	0.014018691588785045	0.9605811478101344	1	2
XIAP	gene expression regulation leukemic	9.435785486289205e-13	3.5005922665607337e-12	0.014018691588785045	0.9605811478101344	1	2
XIAP	chemokine cxcl12/genetics	3.5793269266282124e-06	8.834322184965725e-06	0.04166180294604871	0.9605811478101344	1	2
XIAP	monocytes/drug effects	2.7620974430098144e-05	6.267235198464587e-05	0.04166180294604871	0.9605811478101344	1	2
XIAP	chlorambucil/pharmacology	9.435785486289205e-13	3.5005922665607337e-12	0.014018691588785045	0.9605811478101344	1	2
XIAP	tyramine/analogs & derivatives	2.0128343436454088e-13	7.647591178475611e-13	0.014018691588785045	0.9605811478101344	1	2
XIAP	flavonoids/metabolism	6.226627435879095e-09	1.8701087277790802e-08	0.014018691588785045	0.9605811478101344	1	2
XIAP	multiple myeloma/metabolism	6.226627435879095e-09	1.8701087277790802e-08	0.014018691588785045	0.9605811478101344	1	2
XIAP	antineoplastic agents phytogenic/therapeutic use	2.0128343436454088e-13	7.647591178475611e-13	0.014018691588785045	0.9605811478101344	1	2
XIAP	BCL2A1	9.435785486289205e-13	3.5005922665607337e-12	0.014018691588785045	0.9605811478101344	1	2
XIAP	x-linked inhibitor of apoptosis protein/genetics	9.435785486289205e-13	3.5005922665607337e-12	0.014018691588785045	0.9605811478101344	1	2
intercellular adhesion molecule-1/metabolism	fimbriae proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
intercellular adhesion molecule-1/metabolism	ICAM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid cell leukemia sequence 1 protein/metabolism	tubulin modulators/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid cell leukemia sequence 1 protein/metabolism	stilbenes/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid cell leukemia sequence 1 protein/metabolism	glycogen synthase kinase 3 beta/metabolism	1.3211653993039363e-14	5.301975741509499e-14	0.009345794392523364	0.9605811478101344	1	2
myeloid cell leukemia sequence 1 protein/metabolism	transforming growth factor beta/metabolism	3.454814989645172e-09	1.0513700606169323e-08	0.018691588785046728	0.9605811478101344	1	2
myeloid cell leukemia sequence 1 protein/metabolism	CTNNB1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tubulin modulators/pharmacology	stilbenes/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tubulin modulators/pharmacology	glycogen synthase kinase 3 beta/metabolism	1.3211653993039363e-14	5.301975741509499e-14	0.009345794392523364	0.9605811478101344	1	2
tubulin modulators/pharmacology	transforming growth factor beta/metabolism	3.454814989645172e-09	1.0513700606169323e-08	0.018691588785046728	0.9605811478101344	1	2
tubulin modulators/pharmacology	CTNNB1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphoma t-cell/drug therapy	interleukin-4/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphoma t-cell/drug therapy	nitric oxide/metabolism	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
lymphoma t-cell/drug therapy	transforming growth factor beta/metabolism	3.752653865429778e-08	1.0667678239426992e-07	0.018691588785046728	0.9605811478101344	1	2
lymphoma t-cell/drug therapy	SOCS5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
brain/drug effects	staurosporine/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain/drug effects	uncoupling agents/pharmacology	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
brain/drug effects	extracellular space/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain/drug effects	cyclic amp response element-binding protein/biosynthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain/drug effects	24-dinitrophenol/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
flavonoids/metabolism	multiple myeloma/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
flavonoids/metabolism	caspases/metabolism	0.00014922404803296985	0.00031191617472799767	0.03271028037383177	0.9605811478101344	1	2
autophagy	neoplasms/enzymology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
autophagy	lipid droplets/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
autophagy	imidazoles/pharmacology	1.5210269710408397e-08	4.4213055580103406e-08	0.018647711816067742	0.9605811478101344	1	2
autophagy	phospholipids/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
autophagy	lysosomes/drug effects	0.00010933179359395861	0.0002313829319600307	0.046290202272826986	0.9605811478101344	1	2
autophagy	cell respiration/drug effects	2.8135184382271916e-07	7.532781363209851e-07	0.027905752270633143	0.9605811478101344	1	2
autophagy	neuroblastoma/drug therapy	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
autophagy	cell membrane permeability/drug effects	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
autophagy	apoptosis	1.0194388222473094e-08	3.0048913306027646e-08	0.027905752270633143	0.9605811478101344	1	2
autophagy	phospholipase a2 inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
autophagy	antimalarials/pharmacology	1.8017198843978122e-10	5.858180211060752e-10	0.018647711816067742	0.9605811478101344	1	2
autophagy	chloroquine/pharmacology	1.0014790108314742e-09	3.133779340166384e-09	0.018647711816067742	0.9605811478101344	1	2
caspase 8/genetics	hela cells	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
caspase 8/genetics	tnf-related apoptosis-inducing ligand/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caspase 8/genetics	CXCL1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
caspase 8/genetics	NFKB1	6.62905286219484e-11	2.212829031122965e-10	0.03271028037383177	0.9605811478101344	1	2
gene silencing/drug effects	rna small interfering/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene silencing/drug effects	interferon regulatory factor-1/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene silencing/drug effects	interferon-gamma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene silencing/drug effects	interferon regulatory factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene silencing/drug effects	plasmids/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
gene silencing/drug effects	proto-oncogene proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene silencing/drug effects	IRF1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene silencing/drug effects	IRF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene silencing/drug effects	NFKB1	7.779346631320294e-07	2.018821027864287e-06	0.03271028037383177	0.9605811478101344	1	2
interleukin-17/biosynthesis	cyclin d1/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-17/biosynthesis	macrophages/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-17/biosynthesis	biomarkers	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interleukin-17/biosynthesis	receptors interleukin-17/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-17/biosynthesis	organoplatinum compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sp1 transcription factor/physiology	rna long noncoding/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sp1 transcription factor/physiology	receptors prostaglandin e ep4 subtype/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sp1 transcription factor/physiology	gefitinib/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
host-parasite interactions	hepatocytes/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
host-parasite interactions	antioxidants/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
host-parasite interactions	cytoprotection	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
host-parasite interactions	iron overload/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
host-parasite interactions	malaria/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
host-parasite interactions	ceruloplasmin/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
host-parasite interactions	CP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenotype	cell communication/drug effects	9.425793479067579e-14	3.6294078698302824e-13	0.014018691588785045	0.9605811478101344	1	2
phenotype	antigens cd/metabolism	9.425793479067579e-14	3.6294078698302824e-13	0.014018691588785045	0.9605811478101344	1	2
phenotype	oncogene proteins/metabolism	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
phenotype	antineoplastic agents immunological/pharmacology	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
phenotype	paclitaxel/pharmacology	1.4883361335149559e-05	3.44874777422362e-05	0.04166180294604871	0.9605811478101344	1	2
phenotype	endometrial neoplasms/genetics	9.425793479067579e-14	3.6294078698302824e-13	0.014018691588785045	0.9605811478101344	1	2
phenotype	estrogen receptor alpha/genetics	9.425793479067579e-14	3.6294078698302824e-13	0.014018691588785045	0.9605811478101344	1	2
phenotype	receptors cell surface/metabolism	9.425793479067579e-14	3.6294078698302824e-13	0.014018691588785045	0.9605811478101344	1	2
phenotype	estradiol/pharmacology	9.425793479067579e-14	3.6294078698302824e-13	0.014018691588785045	0.9605811478101344	1	2
phenotype	tumor necrosis factor alpha-induced protein 3/metabolism	9.425793479067579e-14	3.6294078698302824e-13	0.014018691588785045	0.9605811478101344	1	2
phenotype	breast neoplasms/immunology	1.102566139499217e-07	3.0455247110597264e-07	0.027905752270633143	0.9605811478101344	1	2
phenotype	antigens differentiation myelomonocytic/metabolism	9.425793479067579e-14	3.6294078698302824e-13	0.014018691588785045	0.9605811478101344	1	2
phenotype	th1 cells/drug effects	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
phenotype	cancer vaccines/pharmacology	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
phenotype	ESR1	7.29222757733794e-08	2.034405081932771e-07	0.027905752270633143	0.9605811478101344	1	2
phenotype	IL17A	9.425793479067579e-14	3.6294078698302824e-13	0.014018691588785045	0.9605811478101344	1	2
phenotype	SOCS1	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
phenotype	TBX21	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
receptors interleukin-8a/antagonists & inhibitors	receptors interleukin-8b/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-8a/antagonists & inhibitors	cell adhesion/drug effects	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
receptors interleukin-8a/antagonists & inhibitors	CXCL1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors interleukin-8a/antagonists & inhibitors	CXCR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monoterpenes/pharmacology	amyloid beta-peptides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monoterpenes/pharmacology	dna fragmentation/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
hydroxymethylglutaryl-coa reductase inhibitors/pharmacology	ubiquinone/analogs & derivatives	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hydroxymethylglutaryl-coa reductase inhibitors/pharmacology	diet high-fat/adverse effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydroxymethylglutaryl-coa reductase inhibitors/pharmacology	EEF1A2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/genetics	protein kinase c/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/genetics	receptors vascular endothelial growth factor/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/genetics	vascular endothelial growth factor a/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/genetics	FLT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytokines/genetics	KDR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hepatocytes/metabolism	proteasome endopeptidase complex/metabolism	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
hepatocytes/metabolism	antioxidants/metabolism	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
hepatocytes/metabolism	cytoprotection	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
hepatocytes/metabolism	apolipoprotein b-100/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hepatocytes/metabolism	iron overload/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hepatocytes/metabolism	malaria/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hepatocytes/metabolism	ceruloplasmin/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hepatocytes/metabolism	CP	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hepatocytes/metabolism	hepatitis c/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hepatocytes/metabolism	protein interaction maps	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hepatocytes/metabolism	viral nonstructural proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
paracrine communication/drug effects	caspases/metabolism	6.6658620179183e-07	1.7392772280599136e-06	0.03271028037383177	0.9605811478101344	1	2
paracrine communication/drug effects	tumor necrosis factor-alpha/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
paracrine communication/drug effects	autocrine communication/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
paracrine communication/drug effects	decitabine	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
paracrine communication/drug effects	dna fragmentation/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
CD28	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CD28	CD3E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD28	IL5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neurons/cytology	sulfides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neurons/cytology	blood-brain barrier/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokines/metabolism	granulocyte colony-stimulating factor/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokines/metabolism	breast neoplasms/immunology	1.8387069644631993e-11	6.294024398771094e-11	0.018647711816067742	0.9605811478101344	1	2
chemokines/metabolism	radiation tolerance/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokines/metabolism	neutrophils/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokines/metabolism	CCL5	2.3995120701503225e-07	6.455697635469714e-07	0.027905752270633143	0.9605811478101344	1	2
chemokines/metabolism	CSF3	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokines/metabolism	CXCL10	5.289347437820169e-08	1.4914890946292245e-07	0.027905752270633143	0.9605811478101344	1	2
chemokines/metabolism	CXCL9	4.817741761087291e-10	1.530790752968044e-09	0.018647711816067742	0.9605811478101344	1	2
chemokines/metabolism	ITGAM	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokines/metabolism	cyclin-dependent kinase 4/antagonists & inhibitors	3.401390280544092e-11	1.1546397675971694e-10	0.018647711816067742	0.9605811478101344	1	2
chemokines/metabolism	receptors chemokine/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/genetics	macrophages/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin d1/genetics	biomarkers	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin d1/genetics	receptors interleukin-17/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin d1/genetics	organoplatinum compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic	t-lymphocyte subsets/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic	CXCL10	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
CD3E	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CD3E	IL5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytarabine/pharmacology	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
cytarabine/pharmacology	transforming growth factor beta/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytarabine/pharmacology	leukemia myeloid acute/drug therapy	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
cytarabine/pharmacology	antibodies neutralizing/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytarabine/pharmacology	CXCL12	3.443467222474794e-08	9.800124605798924e-08	0.03271028037383177	0.9605811478101344	1	2
cytarabine/pharmacology	CXCR4	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
sulfonamides/administration & dosage	epothilones/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sulfonamides/administration & dosage	biphenyl compounds/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophil infiltration/drug effects	estrogen receptor beta/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophil infiltration/drug effects	neutrophils/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophil infiltration/drug effects	ESR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophil infiltration/drug effects	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fibrosarcoma/drug therapy	rho gtp-binding proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibrosarcoma/drug therapy	neovascularization pathologic/prevention & control	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibrosarcoma/drug therapy	vascular endothelial growth factor a/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibrosarcoma/drug therapy	cell adhesion/drug effects	2.2819819367470018e-09	7.0161954736296045e-09	0.018691588785046728	0.9605811478101344	1	2
fibrosarcoma/drug therapy	chemokine ccl2/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibrosarcoma/drug therapy	trabectedin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibrosarcoma/drug therapy	BRCA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibrosarcoma/drug therapy	CCL2	4.814946774622797e-09	1.4524551441631335e-08	0.018691588785046728	0.9605811478101344	1	2
rho gtp-binding proteins/genetics	neovascularization pathologic/prevention & control	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rho gtp-binding proteins/genetics	vascular endothelial growth factor a/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rho gtp-binding proteins/genetics	cell adhesion/drug effects	2.2819819367470018e-09	7.0161954736296045e-09	0.018691588785046728	0.9605811478101344	1	2
rho gtp-binding proteins/genetics	chemokine ccl2/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rho gtp-binding proteins/genetics	trabectedin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rho gtp-binding proteins/genetics	BRCA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rho gtp-binding proteins/genetics	CCL2	4.814946774622797e-09	1.4524551441631335e-08	0.018691588785046728	0.9605811478101344	1	2
antioxidants/metabolism	tor serine-threonine kinases/genetics	8.276241856286504e-07	2.141720427786442e-06	0.03711991575621956	0.9605811478101344	1	2
antioxidants/metabolism	cytoprotection	4.9960036108132044e-15	2.0341992171968518e-14	0.018647711816067742	0.9605811478101344	1	2
antioxidants/metabolism	iron overload/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antioxidants/metabolism	malaria/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antioxidants/metabolism	ceruloplasmin/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antioxidants/metabolism	CP	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antioxidants/metabolism	berberine/pharmacology	7.971401316808624e-14	3.1145393626262015e-13	0.018647711816067742	0.9605811478101344	1	2
antioxidants/metabolism	cell nucleus/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antioxidants/metabolism	caspases/metabolism	0.00033222227641316326	0.0006685075066493952	0.0644991443991049	0.9605811478101344	1	2
gene expression regulation leukemic	chemokine cxcl12/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
gene expression regulation leukemic	chlorambucil/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene expression regulation leukemic	monocytes/drug effects	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
gene expression regulation leukemic	x-linked inhibitor of apoptosis protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene expression regulation leukemic	BCL2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene expression regulation leukemic	CXCL12	8.390528605239922e-08	2.3337249235313462e-07	0.03271028037383177	0.9605811478101344	1	2
docetaxel	bone neoplasms/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
docetaxel	prostatic neoplasms/drug therapy	5.435487294180863e-05	0.00011924539687771112	0.046290202272826986	0.9605811478101344	1	2
docetaxel	heterocyclic compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
docetaxel	cell adhesion/drug effects	1.7848166501521767e-05	4.115419107148629e-05	0.03711991575621956	0.9605811478101344	1	2
docetaxel	CXCL12	0.0005494341001327507	0.0010850880544363032	0.0644991443991049	0.9605811478101344	1	2
docetaxel	CXCR4	1.617445133716977e-06	4.096660575323597e-06	0.03711991575621956	0.9605811478101344	1	2
docetaxel	dendritic cells/immunology	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
docetaxel	prostate-specific antigen/immunology	1.8107737531636303e-13	6.887000122434314e-13	0.009345794392523364	0.9605811478101344	1	2
multiple myeloma/metabolism	caspases/metabolism	0.00014922404803296985	0.00031191617472799767	0.03271028037383177	0.9605811478101344	1	2
potassium channels voltage-gated/metabolism	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
potassium channels voltage-gated/metabolism	micrornas/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
potassium channels voltage-gated/metabolism	immune evasion/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
potassium channels voltage-gated/metabolism	KCNQ1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
potassium channels voltage-gated/metabolism	KCNQ1OT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell proliferation	SERPINA1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell proliferation	alpha 1-antitrypsin/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell proliferation	bone marrow cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell proliferation	anti-inflammatory agents non-steroidal/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell proliferation	leukemia myelogenous chronic bcr-abl positive/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell proliferation	IREB2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell proliferation	LGALS3	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell proliferation	MKI67	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
artesunate	antineoplastic agents/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
artesunate	ferrous compounds/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid differentiation factor 88/antagonists & inhibitors	piperazines	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid differentiation factor 88/antagonists & inhibitors	glycogen synthase kinase 3 beta/metabolism	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
myeloid differentiation factor 88/antagonists & inhibitors	nf-kappa b/metabolism	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
myeloid differentiation factor 88/antagonists & inhibitors	ITK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid differentiation factor 88/antagonists & inhibitors	MMP2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid differentiation factor 88/antagonists & inhibitors	MMP9	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
myeloid differentiation factor 88/antagonists & inhibitors	MYD88	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid differentiation factor 88/antagonists & inhibitors	NFKB1	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
myeloid differentiation factor 88/antagonists & inhibitors	TRAF6	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	endoplasmic reticulum/drug effects	3.6781688805831436e-13	1.385077155919678e-12	0.0007848182375863361	0.8657199677887635	2	2
tor serine-threonine kinases/genetics	triple negative breast neoplasms/drug therapy	0.00018028690241811418	0.00037411441171901944	0.07319670689438858	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	bone neoplasms/drug therapy	5.298349585736162e-07	1.3910218107443546e-06	0.03711991575621956	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	SPP1	1.6643422604656344e-05	3.845673669958741e-05	0.03711991575621956	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	taurochenodeoxycholic acid/pharmacology	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	cell nucleus/drug effects	1.594815390859594e-10	5.191567951819331e-10	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	myocytes smooth muscle/cytology	1.8600621730646694e-06	4.686395930948444e-06	0.03711991575621956	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	mitochondrial dynamics/physiology	4.571698575261962e-11	1.5428870379209513e-10	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	cell transformation neoplastic/drug effects	7.206855936026102e-06	1.733734420922024e-05	0.03711991575621956	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	microtubule-associated proteins/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	muscle smooth vascular/cytology	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	bcl-2-associated x protein/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	ZHX2	0.0020932584079262906	0.0038630753643558095	0.07319670689438858	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	immunosuppressive agents/pharmacology	4.571698575261962e-11	1.5428870379209513e-10	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	piperidines/pharmacology	4.2526251766927814e-05	9.434683024323047e-05	0.03711991575621956	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	cytochromes c/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	lipoproteins ldl/metabolism	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	carboxy-lyases/genetics	4.571698575261962e-11	1.5428870379209513e-10	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	phenylbutyrates/pharmacology	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	berberine/pharmacology	3.807053167936836e-06	9.389027768084044e-06	0.03711991575621956	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	organophosphorus compounds/pharmacology	3.4190642285381045e-05	7.68044096900745e-05	0.03711991575621956	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	transcription factor chop/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	activating transcription factor 4/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	cerebral arteries/cytology	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	curcumin/analogs & derivatives	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	eukaryotic initiation factor-2/genetics	3.3397795640155437e-09	1.017767240185414e-08	0.018691588785046728	0.9605811478101344	1	2
tor serine-threonine kinases/genetics	lysosomes/drug effects	0.005621281807727696	0.009727495588790538	0.09085010295354308	0.9605811478101344	1	2
rna small interfering/pharmacology	interferon regulatory factor-1/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering/pharmacology	interferon-gamma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering/pharmacology	interferon regulatory factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering/pharmacology	plasmids/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rna small interfering/pharmacology	proto-oncogene proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering/pharmacology	IRF1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering/pharmacology	IRF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering/pharmacology	NFKB1	7.779346631320294e-07	2.018821027864287e-06	0.03271028037383177	0.9605811478101344	1	2
plant extracts/chemistry	anthraquinones/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxygen consumption	myocytes cardiac/drug effects	5.295763827461997e-13	1.979671089655512e-12	0.02336448598130841	0.9605811478101344	1	2
oxygen consumption	mitochondria heart/drug effects	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
oxygen consumption	electron transport complex i/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxygen consumption	cell hypoxia/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxygen consumption	cell death	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxygen consumption	PPID	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxygen consumption	PPIF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
peroxidase/chemistry	tellurium/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
peroxidase/chemistry	immunosuppressive agents/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
peroxidase/chemistry	hydrogen peroxide/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transforming growth factor beta/antagonists & inhibitors	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
transforming growth factor beta/antagonists & inhibitors	leukemia myeloid acute/drug therapy	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/antagonists & inhibitors	antibodies neutralizing/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transforming growth factor beta/antagonists & inhibitors	CXCL12	3.443467222474794e-08	9.800124605798924e-08	0.03271028037383177	0.9605811478101344	1	2
transforming growth factor beta/antagonists & inhibitors	CXCR4	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
hela cells	adenocarcinoma/drug therapy	3.3932426944938143e-06	8.378789890043635e-06	0.027905752270633143	0.9605811478101344	1	2
hela cells	tnf-related apoptosis-inducing ligand/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
hela cells	CXCL1	4.5583425922757215e-10	1.4496226377397246e-09	0.027905752270633143	0.9605811478101344	1	2
hela cells	DDX53	4.7240131872960944e-07	1.2431969772440236e-06	0.027905752270633143	0.9605811478101344	1	2
hela cells	NFKB1	0.004254485858506296	0.007478506275081466	0.09538832359347407	0.9605811478101344	1	2
hela cells	crotonates/pharmacology	9.049661020554822e-11	2.9797928043786246e-10	0.014018691588785045	0.9605811478101344	1	2
hela cells	naphthalenes/pharmacology	1.9317880628477724e-14	7.674245623363548e-14	0.014018691588785045	0.9605811478101344	1	2
hela cells	sesquiterpenes/pharmacology	9.049661020554822e-11	2.9797928043786246e-10	0.014018691588785045	0.9605811478101344	1	2
hela cells	g1 phase cell cycle checkpoints/drug effects	1.08218036753982e-08	3.1758169497561496e-08	0.027905752270633143	0.9605811478101344	1	2
curcumin/analogs & derivatives	endoplasmic reticulum/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
curcumin/analogs & derivatives	cell line	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
curcumin/analogs & derivatives	lysosomes/drug effects	4.712144485718994e-08	1.3323077920124696e-07	0.02336448598130841	0.9605811478101344	1	2
curcumin/analogs & derivatives	microtubule-associated proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
curcumin/analogs & derivatives	bcl-2-associated x protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
curcumin/analogs & derivatives	cytochromes c/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
curcumin/analogs & derivatives	lipoproteins ldl/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm recurrence local/pathology	receptors estrogen/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neoplasm recurrence local/pathology	bcl-2-like protein 11/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm recurrence local/pathology	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neoplasm recurrence local/pathology	FGF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
IL5	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
thallium/metabolism	mitochondrial membranes/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
thallium/metabolism	mitochondrial swelling/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
thallium/metabolism	monoamine oxidase/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thallium/metabolism	oxygen consumption/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
thallium/metabolism	phosphates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thallium/metabolism	organometallic compounds/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
thallium/metabolism	CA2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
thallium/metabolism	PTPN2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sulfides/pharmacology	blood-brain barrier/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
granulocyte colony-stimulating factor/pharmacology	radiation tolerance/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
granulocyte colony-stimulating factor/pharmacology	neutrophils/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
granulocyte colony-stimulating factor/pharmacology	CSF3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
granulocyte colony-stimulating factor/pharmacology	ITGAM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/immunology	receptors ccr5/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/immunology	adenocarcinoma/drug therapy	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
colorectal neoplasms/immunology	maraviroc	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/immunology	neoplasm proteins/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/immunology	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/immunology	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
colorectal neoplasms/immunology	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
colorectal neoplasms/immunology	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
colorectal neoplasms/immunology	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
lysosomes/drug effects	endoplasmic reticulum/drug effects	0.0008137316370441239	0.0015782156169553874	0.06878335787959994	0.9605811478101344	1	2
lysosomes/drug effects	imidazoles/pharmacology	0.0001607252703398343	0.0003351622775421041	0.046290202272826986	0.9605811478101344	1	2
lysosomes/drug effects	berberine/pharmacology	2.0075977058109373e-05	4.6011969041288514e-05	0.046290202272826986	0.9605811478101344	1	2
lysosomes/drug effects	carcinoma hepatocellular/pathology	3.540051585204651e-10	1.1305193706632698e-09	0.02336448598130841	0.9605811478101344	1	2
lysosomes/drug effects	phenylurea compounds/pharmacology	9.049661020554822e-11	2.9797928043786246e-10	0.02336448598130841	0.9605811478101344	1	2
lysosomes/drug effects	chromones/pharmacology	3.540051585204651e-10	1.1305193706632698e-09	0.02336448598130841	0.9605811478101344	1	2
lysosomes/drug effects	morpholines/pharmacology	0.0024160201691011407	0.004417682259772927	0.06878335787959994	0.9605811478101344	1	2
lysosomes/drug effects	tert-butylhydroperoxide/toxicity	3.540051585204651e-10	1.1305193706632698e-09	0.02336448598130841	0.9605811478101344	1	2
lysosomes/drug effects	neuroblastoma/drug therapy	9.630031228002878e-08	2.6630243134956406e-07	0.02336448598130841	0.9605811478101344	1	2
lysosomes/drug effects	cell membrane permeability/drug effects	9.630031228002878e-08	2.6630243134956406e-07	0.02336448598130841	0.9605811478101344	1	2
lysosomes/drug effects	pc12 cells	2.0075977058109373e-05	4.6011969041288514e-05	0.046290202272826986	0.9605811478101344	1	2
lysosomes/drug effects	microtubule-associated proteins/genetics	4.712144485718994e-08	1.3323077920124696e-07	0.02336448598130841	0.9605811478101344	1	2
lysosomes/drug effects	antimalarials/pharmacology	2.0075977058109373e-05	4.6011969041288514e-05	0.046290202272826986	0.9605811478101344	1	2
lysosomes/drug effects	berberine/analogs & derivatives	3.540051585204651e-10	1.1305193706632698e-09	0.02336448598130841	0.9605811478101344	1	2
lysosomes/drug effects	mitophagy/drug effects	5.224154442373674e-12	1.8329433027602605e-11	0.0025831226577705535	0.8657199677887635	2	2
lysosomes/drug effects	bcl-2-associated x protein/genetics	4.712144485718994e-08	1.3323077920124696e-07	0.02336448598130841	0.9605811478101344	1	2
lysosomes/drug effects	mitochondrial dynamics/drug effects	9.770295995581435e-07	2.5162420991774264e-06	0.046290202272826986	0.9605811478101344	1	2
lysosomes/drug effects	chloroquine/pharmacology	4.481045854376475e-05	9.915505720322413e-05	0.046290202272826986	0.9605811478101344	1	2
lysosomes/drug effects	cytochromes c/genetics	4.712144485718994e-08	1.3323077920124696e-07	0.02336448598130841	0.9605811478101344	1	2
lysosomes/drug effects	lipoproteins ldl/metabolism	4.712144485718994e-08	1.3323077920124696e-07	0.02336448598130841	0.9605811478101344	1	2
isoflavones/adverse effects	cell movement/drug effects	0.0009047857165859208	0.001741333404267317	0.09345794392523364	0.9605811478101344	1	2
isoflavones/adverse effects	pancreatic neoplasms/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
isoflavones/adverse effects	CDKN1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
isoflavones/adverse effects	ZHX2	1.241229341530925e-13	4.764384492004497e-13	0.018691588785046728	0.9605811478101344	1	2
b7-h1 antigen/genetics	protein kinases/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b7-h1 antigen/genetics	tumor escape	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b7-h1 antigen/genetics	carbazoles/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b7-h1 antigen/genetics	carcinoma squamous cell/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b7-h1 antigen/genetics	mouth neoplasms/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b7-h1 antigen/genetics	maleimides	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b7-h1 antigen/genetics	adaptor proteins signal transducing/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b7-h1 antigen/genetics	EIF2S1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
b7-h1 antigen/genetics	PRKD1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interleukin-4/metabolism	nitric oxide/metabolism	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
interleukin-4/metabolism	transforming growth factor beta/metabolism	3.752653865429778e-08	1.0667678239426992e-07	0.018691588785046728	0.9605811478101344	1	2
interleukin-4/metabolism	SOCS5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant fusion proteins/pharmacology	mitochondrial membrane transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant fusion proteins/pharmacology	interleukin-10/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant fusion proteins/pharmacology	neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bone neoplasms/metabolism	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
bone neoplasms/metabolism	prostatic neoplasms/drug therapy	1.387981951594952e-10	4.531649055051903e-10	0.02336448598130841	0.9605811478101344	1	2
bone neoplasms/metabolism	heterocyclic compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bone neoplasms/metabolism	cell adhesion/drug effects	9.609091300433192e-12	3.321229738077301e-11	0.018691588785046728	0.9605811478101344	1	2
bone neoplasms/metabolism	CXCL12	3.443467222474794e-08	9.800124605798924e-08	0.03271028037383177	0.9605811478101344	1	2
bone neoplasms/metabolism	CXCR4	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
metabolic networks and pathways/drug effects	levofloxacin/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
metabolic networks and pathways/drug effects	organelle biogenesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nitric oxide/metabolism	transforming growth factor beta/metabolism	5.435487294180863e-05	0.00011924539687771112	0.03711991575621956	0.9605811478101344	1	2
nitric oxide/metabolism	SOCS5	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
nitric oxide/metabolism	creatine kinase mb form/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nitric oxide/metabolism	nitric oxide synthase type iii/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nitric oxide/metabolism	cytoprotection	4.0513481458503975e-11	1.370842908528385e-10	0.018647711816067742	0.9605811478101344	1	2
nitric oxide/metabolism	myocytes cardiac/drug effects	3.855916164230422e-05	8.598689146247835e-05	0.046290202272826986	0.9605811478101344	1	2
nitric oxide/metabolism	mitochondria heart/drug effects	4.298636627986241e-06	1.0570638007343368e-05	0.03711991575621956	0.9605811478101344	1	2
nitric oxide/metabolism	chalcones/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
staurosporine/toxicity	extracellular space/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dynamins	acetylcysteine/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dynamins	histones/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine cxcl12/genetics	cytarabine/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/genetics	cyclophosphamide/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/genetics	leukemia myeloid acute/drug therapy	0.0	0.0	0.0007848182375863361	0.8657199677887635	2	2
chemokine cxcl12/genetics	receptors cxcr4/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/genetics	chlorambucil/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/genetics	monocytes/drug effects	3.0033297815368343e-07	8.027326345414489e-07	0.04166180294604871	0.9605811478101344	1	2
chemokine cxcl12/genetics	tumor microenvironment/immunology	8.537504037064991e-12	2.955949890219989e-11	0.027905752270633143	0.9605811478101344	1	2
chemokine cxcl12/genetics	x-linked inhibitor of apoptosis protein/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/genetics	hematopoietic stem cells/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/genetics	human umbilical vein endothelial cells	1.5919403573150248e-09	4.9268811058508795e-09	0.04166180294604871	0.9605811478101344	1	2
chemokine cxcl12/genetics	BCL2A1	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/genetics	CXCL12	0.0	0.0	2.173151765468494e-05	0.7135314763244264	3	2
chemokine cxcl12/genetics	CXCR4	0.0	0.0	0.0007848182375863361	0.8657199677887635	2	2
chemokine cxcl12/genetics	EPHB2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/genetics	neoplastic stem cells/immunology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
chemokine cxcl12/genetics	cell movement/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
antineoplastic agents/administration & dosage	triple negative breast neoplasms/drug therapy	4.595889480096815e-08	1.302779265327521e-07	0.055287464515536164	0.9605811478101344	1	2
antineoplastic agents/administration & dosage	erbb receptors/antagonists & inhibitors	2.415650552922699e-07	6.492778665224878e-07	0.04166180294604871	0.9605811478101344	1	2
antineoplastic agents/administration & dosage	ZHX2	6.2977002734943e-06	1.5223297404890069e-05	0.055287464515536164	0.9605811478101344	1	2
antineoplastic agents/administration & dosage	raf kinases/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
antineoplastic agents/administration & dosage	ferrous compounds/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
antineoplastic agents/administration & dosage	cell transformation neoplastic/drug effects	6.740019653506124e-11	2.2474887072066398e-10	0.027905752270633143	0.9605811478101344	1	2
antineoplastic agents/administration & dosage	disulfides/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
interferon regulatory factor-1/genetics	interferon-gamma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon regulatory factor-1/genetics	interferon regulatory factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon regulatory factor-1/genetics	plasmids/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interferon regulatory factor-1/genetics	proto-oncogene proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon regulatory factor-1/genetics	IRF1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon regulatory factor-1/genetics	IRF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon regulatory factor-1/genetics	NFKB1	7.779346631320294e-07	2.018821027864287e-06	0.03271028037383177	0.9605811478101344	1	2
macrophages/immunology	biomarkers	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
macrophages/immunology	receptors interleukin-17/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
macrophages/immunology	organoplatinum compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocyte subsets/cytology	CXCL10	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
alpha 1-antitrypsin/chemistry	bone marrow cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
alpha 1-antitrypsin/chemistry	leukemia myelogenous chronic bcr-abl positive/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
alpha 1-antitrypsin/chemistry	LGALS3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
alpha 1-antitrypsin/chemistry	SERPINA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondrial membranes/drug effects	peptides/chemistry	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
mitochondrial membranes/drug effects	endocytosis/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial membranes/drug effects	mitochondrial swelling/drug effects	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
mitochondrial membranes/drug effects	monoamine oxidase/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial membranes/drug effects	oxygen consumption/drug effects	0.0	0.0	0.027905752270633143	0.9605811478101344	1	2
mitochondrial membranes/drug effects	phosphates/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial membranes/drug effects	organometallic compounds/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial membranes/drug effects	CA2	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
mitochondrial membranes/drug effects	PTPN2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell line transformed	CSF1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell line transformed	CSF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclic n-oxides/chemistry	adipose tissue/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclic n-oxides/chemistry	free radical scavengers/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclic n-oxides/chemistry	stem cells/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclic n-oxides/chemistry	cell hypoxia	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors ccr5/drug effects	adenocarcinoma/drug therapy	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
receptors ccr5/drug effects	maraviroc	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr5/drug effects	neoplasm proteins/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr5/drug effects	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr5/drug effects	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
receptors ccr5/drug effects	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr5/drug effects	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
receptors ccr5/drug effects	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
anti-inflammatory agents non-steroidal/pharmacology	IREB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
anti-inflammatory agents non-steroidal/pharmacology	MKI67	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/prevention & control	vascular endothelial growth factor a/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/prevention & control	cell adhesion/drug effects	2.2819819367470018e-09	7.0161954736296045e-09	0.018691588785046728	0.9605811478101344	1	2
neovascularization pathologic/prevention & control	chemokine ccl2/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/prevention & control	trabectedin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/prevention & control	BRCA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/prevention & control	CCL2	4.814946774622797e-09	1.4524551441631335e-08	0.018691588785046728	0.9605811478101344	1	2
thiosemicarbazones/pharmacology	pyridines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
thiosemicarbazones/pharmacology	peroxiredoxin iii/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
multiple myeloma/pathology	enzyme inhibitors/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
multiple myeloma/pathology	flavonoids/pharmacology	7.771561172376096e-16	3.293241989785665e-15	0.009345794392523364	0.9605811478101344	1	2
multiple myeloma/pathology	free radicals/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
multiple myeloma/pathology	carrier proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
multiple myeloma/pathology	cyclin-dependent kinases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
multiple myeloma/pathology	protein transport	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
multiple myeloma/pathology	nitriles/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
multiple myeloma/pathology	piperidines/pharmacology	8.43769498715119e-15	3.412847167064932e-14	0.009345794392523364	0.9605811478101344	1	2
human umbilical vein endothelial cells/drug effects	cell movement/drug effects	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
human umbilical vein endothelial cells/drug effects	PI3	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
human umbilical vein endothelial cells/drug effects	SPP1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myeloid-derived suppressor cells/drug effects	CCL19	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid-derived suppressor cells/drug effects	CCL21	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myeloid-derived suppressor cells/drug effects	CCR7	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid-derived suppressor cells/drug effects	monocytes/drug effects	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
myeloid-derived suppressor cells/drug effects	leukemia lymphocytic chronic b-cell/blood	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myeloid-derived suppressor cells/drug effects	chemokine ccl21/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
apoptosis regulatory proteins	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
apoptosis regulatory proteins	CCL2	2.5110025170249628e-11	8.560782974387874e-11	0.018691588785046728	0.9605811478101344	1	2
apoptosis regulatory proteins	NFKB1	1.6902963206888444e-07	4.602649534216085e-07	0.03271028037383177	0.9605811478101344	1	2
cell hypoxia	erbb receptors/antagonists & inhibitors	6.955092368698956e-08	1.9428085207788495e-07	0.027905752270633143	0.9605811478101344	1	2
cell hypoxia	tyrphostins/pharmacology	3.401390280544092e-11	1.1546397675971694e-10	0.018647711816067742	0.9605811478101344	1	2
cell hypoxia	mitogen-activated protein kinase 1/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell hypoxia	adipose tissue/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell hypoxia	quinazolines	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell hypoxia	free radical scavengers/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell hypoxia	glioma/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell hypoxia	stem cells/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interferon-gamma/genetics	interferon regulatory factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-gamma/genetics	plasmids/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interferon-gamma/genetics	proto-oncogene proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-gamma/genetics	IRF1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-gamma/genetics	IRF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon-gamma/genetics	NFKB1	7.779346631320294e-07	2.018821027864287e-06	0.03271028037383177	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	cell movement/drug effects	4.628383749816223e-06	1.1341031886635707e-05	0.002660220255949666	0.7135314763244264	3	2
leukemia myeloid acute/drug therapy	cytarabine/administration & dosage	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	cyclophosphamide/administration & dosage	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	receptors cxcr4/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	mesenchymal stem cells/drug effects	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	antibodies neutralizing/metabolism	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	tumor microenvironment/immunology	6.772899574514213e-09	2.0220567341758885e-08	0.03711991575621956	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	hematopoietic stem cells/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	cell adhesion/drug effects	0.00028730260487308534	0.0005834436614388677	0.07319670689438858	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	human umbilical vein endothelial cells	3.082276387456062e-07	8.232347642717294e-07	0.055287464515536164	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	nf-kappa b/metabolism	0.0012656389571008564	0.002399381575766095	0.09085010295354308	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	CCL2	0.00038583550967108415	0.000771111431945981	0.07319670689438858	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	CCL4	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	CXCL12	0.0	0.0	4.1197189866701315e-07	0.5304112294886878	4	2
leukemia myeloid acute/drug therapy	CXCR4	0.0	0.0	9.899096193684516e-06	0.7135314763244264	3	2
leukemia myeloid acute/drug therapy	EPHB2	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	neoplastic stem cells/immunology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
leukemia myeloid acute/drug therapy	cell movement/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
caspases/metabolism	adenocarcinoma/drug therapy	0.005204540509032296	0.009063958068178836	0.0644991443991049	0.9605811478101344	1	2
caspases/metabolism	DDX53	0.0023543067423027475	0.004309843495042425	0.0644991443991049	0.9605811478101344	1	2
caspases/metabolism	1-phosphatidylinositol 4-kinase/metabolism	7.892179161317348e-05	0.0001698289734030108	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	berberine/pharmacology	0.0007800009282057374	0.0015165309052098852	0.0644991443991049	0.9605811478101344	1	2
caspases/metabolism	dna neoplasm/metabolism	2.8825420285150116e-06	7.148159559633222e-06	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	crotonates/pharmacology	7.892179161317348e-05	0.0001698289734030108	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	plant roots	7.892179161317348e-05	0.0001698289734030108	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	tumor necrosis factor-alpha/pharmacology	0.0013155754058667979	0.002489341447695774	0.0644991443991049	0.9605811478101344	1	2
caspases/metabolism	plant extracts/pharmacology	7.892179161317348e-05	0.0001698289734030108	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	autocrine communication/drug effects	6.6658620179183e-07	1.7392772280599136e-06	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	decitabine	6.6658620179183e-07	1.7392772280599136e-06	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	cell nucleus/drug effects	2.8825420285150116e-06	7.148159559633222e-06	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	cyclohexenes/chemistry	2.8825420285150116e-06	7.148159559633222e-06	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	dna/metabolism	7.892179161317348e-05	0.0001698289734030108	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	dioxanes/chemistry	2.8825420285150116e-06	7.148159559633222e-06	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	dna fragmentation/drug effects	0.0013155754058667979	0.002489341447695774	0.09538832359347407	0.9605811478101344	1	2
caspases/metabolism	sesquiterpenes/pharmacology	7.892179161317348e-05	0.0001698289734030108	0.03271028037383177	0.9605811478101344	1	2
caspases/metabolism	uterine cervical neoplasms/enzymology	2.8825420285150116e-06	7.148159559633222e-06	0.03271028037383177	0.9605811478101344	1	2
mitochondrial proteins/genetics	head and neck neoplasms/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondrial proteins/genetics	deoxycytidine/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drugs chinese herbal/chemistry	chloroquine/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drugs chinese herbal/chemistry	SQSTM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
imidazoles/pharmacology	glucose/deficiency	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
imidazoles/pharmacology	cell respiration/drug effects	5.394266039404627e-07	1.4151924992478965e-06	0.027905752270633143	0.9605811478101344	1	2
imidazoles/pharmacology	neuroblastoma/drug therapy	8.43769498715119e-15	3.412847167064932e-14	0.009345794392523364	0.9605811478101344	1	2
imidazoles/pharmacology	cell membrane permeability/drug effects	8.43769498715119e-15	3.412847167064932e-14	0.009345794392523364	0.9605811478101344	1	2
imidazoles/pharmacology	cytoprotection/drug effects	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
imidazoles/pharmacology	quinolines/pharmacology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
imidazoles/pharmacology	antimalarials/pharmacology	4.817741761087291e-10	1.530790752968044e-09	0.018647711816067742	0.9605811478101344	1	2
imidazoles/pharmacology	chloroquine/pharmacology	2.477217875274107e-09	7.60692196574422e-09	0.018647711816067742	0.9605811478101344	1	2
imidazoles/pharmacology	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
drug antagonism	phagosomes/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drug antagonism	homeostasis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drug antagonism	malaria/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drug antagonism	antimalarials/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chlorambucil/pharmacology	monocytes/drug effects	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
chlorambucil/pharmacology	x-linked inhibitor of apoptosis protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chlorambucil/pharmacology	BCL2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chlorambucil/pharmacology	CXCL12	8.390528605239922e-08	2.3337249235313462e-07	0.03271028037383177	0.9605811478101344	1	2
cytostatic agents/pharmacology	enzyme inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytostatic agents/pharmacology	lymphoma non-hodgkin/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytostatic agents/pharmacology	everolimus/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytostatic agents/pharmacology	farnesyltranstransferase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
biomarkers	epithelial-mesenchymal transition	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biomarkers	janus kinases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biomarkers	neoplasms/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biomarkers	interferons/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biomarkers	hypoxia-inducible factor 1 alpha subunit/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biomarkers	ras proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biomarkers	receptors interleukin-17/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biomarkers	organoplatinum compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
biomarkers	hypoxia/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bone marrow cells/drug effects	leukemia myelogenous chronic bcr-abl positive/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bone marrow cells/drug effects	LGALS3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bone marrow cells/drug effects	SERPINA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gefitinib/pharmacology	rna long noncoding/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gefitinib/pharmacology	receptors prostaglandin e ep4 subtype/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
quercetin/pharmacology	AXL	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adipose tissue/cytology	free radical scavengers/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adipose tissue/cytology	stem cells/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperazines	glycogen synthase kinase 3 beta/metabolism	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
piperazines	nf-kappa b/metabolism	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
piperazines	ITK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperazines	MMP2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperazines	MMP9	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
piperazines	MYD88	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperazines	NFKB1	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
piperazines	TRAF6	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nitrophenols/toxicity	piperazines/toxicity	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
nitrophenols/toxicity	morpholines/pharmacology	1.983776046765584e-07	5.377218377070026e-07	0.014018691588785045	0.9605811478101344	1	2
nitrophenols/toxicity	poly(adp-ribose) polymerases/metabolism	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
nitrophenols/toxicity	glioblastoma/enzymology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
nitrophenols/toxicity	aminopyridines/pharmacology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
acetylcysteine/pharmacology	histones/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytoprotection	nitric oxide synthase type iii/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoprotection	creatine kinase mb form/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoprotection	myocytes cardiac/drug effects	1.4759829600752283e-06	3.7508612613806633e-06	0.046290202272826986	0.9605811478101344	1	2
cytoprotection	mitochondria heart/drug effects	7.824615122498102e-08	2.181000179783036e-07	0.03711991575621956	0.9605811478101344	1	2
cytoprotection	iron overload/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoprotection	malaria/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoprotection	chalcones/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoprotection	ceruloplasmin/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytoprotection	CP	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
succinate dehydrogenase/metabolism	glycine/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
succinate dehydrogenase/metabolism	adenosine diphosphate/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
succinate dehydrogenase/metabolism	mitochondrial swelling/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
succinate dehydrogenase/metabolism	electron transport complex iv/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
succinate dehydrogenase/metabolism	herbicides/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
succinate dehydrogenase/metabolism	mitochondrial proton-translocating atpases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
succinate dehydrogenase/metabolism	CA2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interferon regulatory factor-2/genetics	plasmids/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
interferon regulatory factor-2/genetics	proto-oncogene proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon regulatory factor-2/genetics	IRF1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon regulatory factor-2/genetics	IRF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferon regulatory factor-2/genetics	NFKB1	7.779346631320294e-07	2.018821027864287e-06	0.03271028037383177	0.9605811478101344	1	2
epothilones/administration & dosage	biphenyl compounds/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocytes/drug effects	leukemia lymphocytic chronic b-cell/blood	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
monocytes/drug effects	x-linked inhibitor of apoptosis protein/genetics	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
monocytes/drug effects	chemokine ccl21/immunology	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
monocytes/drug effects	BCL2A1	3.3306690738754696e-15	1.3654628438231006e-14	0.014018691588785045	0.9605811478101344	1	2
monocytes/drug effects	CCL19	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
monocytes/drug effects	CCL21	1.181569286856643e-09	3.6847580815580287e-09	0.027905752270633143	0.9605811478101344	1	2
monocytes/drug effects	CCR7	1.1102230246251565e-16	4.854858636837654e-16	0.014018691588785045	0.9605811478101344	1	2
monocytes/drug effects	CXCL12	0.0018239373399110415	0.003395033387113435	0.09538832359347407	0.9605811478101344	1	2
phenanthrenes/pharmacology	nf-kappa b/metabolism	3.540051585204651e-10	1.1305193706632698e-09	0.02336448598130841	0.9605811478101344	1	2
phenanthrenes/pharmacology	ARG1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phenanthrenes/pharmacology	CXCL12	1.2665093418462448e-08	3.7000129811880225e-08	0.03271028037383177	0.9605811478101344	1	2
phenanthrenes/pharmacology	DDX53	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phenanthrenes/pharmacology	MRC1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	heterocyclic compounds/pharmacology	1.387981951594952e-10	4.531649055051903e-10	0.02336448598130841	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	cell adhesion/drug effects	0.0023762292356653836	0.004346005988216539	0.09085010295354308	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	CXCR4	0.000653003327605095	0.0012777260709120638	0.09085010295354308	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	PI3	2.33575571040312e-06	5.852794852025002e-06	0.046290202272826986	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	SIRT1	4.371674359981981e-05	9.688076820673707e-05	0.046290202272826986	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	1-phosphatidylinositol 4-kinase/metabolism	1.3447498348195808e-07	3.6890686024763117e-07	0.02336448598130841	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	plant roots	1.3447498348195808e-07	3.6890686024763117e-07	0.02336448598130841	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	plant extracts/pharmacology	1.3447498348195808e-07	3.6890686024763117e-07	0.02336448598130841	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	naphthoquinones/chemistry	1.387981951594952e-10	4.531649055051903e-10	0.02336448598130841	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	dna/metabolism	1.3447498348195808e-07	3.6890686024763117e-07	0.02336448598130841	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	sirtuin 1/metabolism	1.387981951594952e-10	4.531649055051903e-10	0.02336448598130841	0.9605811478101344	1	2
prostatic neoplasms/drug therapy	mitophagy/drug effects	0.0002651666335166114	0.0005405819635482431	0.09085010295354308	0.9605811478101344	1	2
glycine/analogs & derivatives	adenosine diphosphate/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glycine/analogs & derivatives	mitochondrial swelling/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glycine/analogs & derivatives	electron transport complex iv/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycine/analogs & derivatives	herbicides/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycine/analogs & derivatives	mitochondrial proton-translocating atpases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycine/analogs & derivatives	CA2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/blood	chemokine ccl21/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/blood	CCL19	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/blood	CCL21	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/blood	CCR7	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
doxorubicin/administration & dosage	triple negative breast neoplasms/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
doxorubicin/administration & dosage	MSC	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
radiation tolerance/drug effects	neutrophils/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
radiation tolerance/drug effects	CSF3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
radiation tolerance/drug effects	ITGAM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
deoxycytidine/administration & dosage	drugs chinese herbal/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
deoxycytidine/administration & dosage	DCR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
deoxycytidine/administration & dosage	VIP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tellurium/chemistry	immunosuppressive agents/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tellurium/chemistry	hydrogen peroxide/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
inflammation mediators/metabolism	poly i-c/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
inflammation mediators/metabolism	ERBB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mesenchymal stem cells/drug effects	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
mesenchymal stem cells/drug effects	cell adhesion/drug effects	9.609091300433192e-12	3.321229738077301e-11	0.018691588785046728	0.9605811478101344	1	2
mesenchymal stem cells/drug effects	nf-kappa b/metabolism	1.181569286856643e-09	3.6847580815580287e-09	0.02336448598130841	0.9605811478101344	1	2
mesenchymal stem cells/drug effects	CCL2	2.5110025170249628e-11	8.560782974387874e-11	0.018691588785046728	0.9605811478101344	1	2
mesenchymal stem cells/drug effects	CCL4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mesenchymal stem cells/drug effects	CXCL12	3.443467222474794e-08	9.800124605798924e-08	0.03271028037383177	0.9605811478101344	1	2
mesenchymal stem cells/drug effects	NFKB1	1.6902963206888444e-07	4.602649534216085e-07	0.03271028037383177	0.9605811478101344	1	2
superoxide dismutase/metabolism	cell line	0.00502421532032693	0.008757522284968625	0.11807292352244307	0.9605811478101344	1	2
superoxide dismutase/metabolism	rna small interfering/metabolism	1.0859091403858656e-12	4.002361204819051e-12	0.018647711816067742	0.9605811478101344	1	2
superoxide dismutase/metabolism	cell respiration/drug effects	9.599393613335394e-09	2.835196656219943e-08	0.027905752270633143	0.9605811478101344	1	2
superoxide dismutase/metabolism	acetaldehyde/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
superoxide dismutase/metabolism	ubiquinone/analogs & derivatives	3.9968028886505635e-15	1.6294657930652298e-14	0.018647711816067742	0.9605811478101344	1	2
superoxide dismutase/metabolism	antimycin a/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
superoxide dismutase/metabolism	autophagy-related protein-1 homolog/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
superoxide dismutase/metabolism	glutathione disulfide/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
superoxide dismutase/metabolism	liver diseases alcoholic/etiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
superoxide dismutase/metabolism	organophosphorus compounds/pharmacology	1.594815390859594e-10	5.191567951819331e-10	0.018647711816067742	0.9605811478101344	1	2
superoxide dismutase/metabolism	pten phosphohydrolase/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/metabolism	tamoxifen/pharmacology	4.440892098500626e-16	1.9067729111536865e-15	0.018647711816067742	0.9605811478101344	1	2
receptors estrogen/metabolism	osteoprotegerin/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/metabolism	selective estrogen receptor modulators/pharmacology	4.440892098500626e-16	1.9067729111536865e-15	0.018647711816067742	0.9605811478101344	1	2
receptors estrogen/metabolism	bone neoplasms/drug therapy	4.6629367034256575e-15	1.8989366168660674e-14	0.018647711816067742	0.9605811478101344	1	2
receptors estrogen/metabolism	bone density conservation agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/metabolism	bcl-2-like protein 11/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/metabolism	ligands	8.205436330399607e-12	2.8445512612051973e-11	0.018647711816067742	0.9605811478101344	1	2
receptors estrogen/metabolism	FGF2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/metabolism	TNFSF11	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/metabolism	rank ligand/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors estrogen/metabolism	osteoclasts/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	proto-oncogene proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	IRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	IRF2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	NFKB1	0.0005658201448542899	0.0011153511447248442	0.0644991443991049	0.9605811478101344	1	2
plasmids/genetics	enzyme inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	glycogen synthase kinase 3/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	dna/biosynthesis	9.658940314238862e-15	3.8840108708433053e-14	0.018647711816067742	0.9605811478101344	1	2
plasmids/genetics	cardiotonic agents	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	cytosol/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	zinc/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	myocytes cardiac/drug effects	1.4580143245956911e-05	3.3795521266490534e-05	0.046290202272826986	0.9605811478101344	1	2
plasmids/genetics	mitochondria heart/drug effects	1.3036816781664129e-06	3.327572776130247e-06	0.03711991575621956	0.9605811478101344	1	2
plasmids/genetics	myocardial reperfusion injury/prevention & control	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	PRKCB	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	PRKCG	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plasmids/genetics	PRRT2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
leukemia/drug therapy	CCL2	2.6631302138979684e-05	6.04952554667447e-05	0.03711991575621956	0.9605811478101344	1	2
leukemia/drug therapy	CCL5	3.5793269266282124e-06	8.834322184965725e-06	0.027905752270633143	0.9605811478101344	1	2
leukemia/drug therapy	aurora kinase b/antagonists & inhibitors	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
leukemia/drug therapy	ribosomal proteins/genetics	1.5987211554602254e-14	6.390247287089747e-14	0.009345794392523364	0.9605811478101344	1	2
vascular endothelial growth factor a/biosynthesis	cell adhesion/drug effects	2.2819819367470018e-09	7.0161954736296045e-09	0.018691588785046728	0.9605811478101344	1	2
vascular endothelial growth factor a/biosynthesis	chemokine ccl2/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
vascular endothelial growth factor a/biosynthesis	trabectedin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
vascular endothelial growth factor a/biosynthesis	BRCA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
vascular endothelial growth factor a/biosynthesis	CCL2	4.814946774622797e-09	1.4524551441631335e-08	0.018691588785046728	0.9605811478101344	1	2
leukemia lymphocytic chronic b-cell/drug therapy	PRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antibodies neutralizing/metabolism	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
antibodies neutralizing/metabolism	CXCL12	3.443467222474794e-08	9.800124605798924e-08	0.03271028037383177	0.9605811478101344	1	2
antibodies neutralizing/metabolism	CXCR4	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
nucleotidyltransferases/metabolism	palmitates/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nucleotidyltransferases/metabolism	adenosine diphosphate/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nucleotidyltransferases/metabolism	carbonyl cyanide p-trifluoromethoxyphenylhydrazone/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nucleotidyltransferases/metabolism	oxygen consumption/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
nucleotidyltransferases/metabolism	uncoupling agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nucleotidyltransferases/metabolism	biological transport/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nucleotidyltransferases/metabolism	mitochondrial adp atp translocases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenocarcinoma/drug therapy	maraviroc	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
adenocarcinoma/drug therapy	neoplasm proteins/antagonists & inhibitors	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
adenocarcinoma/drug therapy	chemokine ccl5/antagonists & inhibitors	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
adenocarcinoma/drug therapy	CCL5	1.5191652836921143e-05	3.516858061197369e-05	0.027905752270633143	0.9605811478101344	1	2
adenocarcinoma/drug therapy	CCR5	7.090994458280875e-13	2.6409163144624447e-12	0.009345794392523364	0.9605811478101344	1	2
adenocarcinoma/drug therapy	CXCL10	5.133631229115032e-06	1.249986762446474e-05	0.027905752270633143	0.9605811478101344	1	2
adenocarcinoma/drug therapy	CXCL9	1.7753559933275653e-07	4.83247517788718e-07	0.018647711816067742	0.9605811478101344	1	2
adenocarcinoma/drug therapy	DDX53	8.78729425890512e-08	2.4425398867919834e-07	0.018647711816067742	0.9605811478101344	1	2
adenocarcinoma/drug therapy	crotonates/pharmacology	5.946021452984951e-12	2.0759759460872875e-11	0.009345794392523364	0.9605811478101344	1	2
adenocarcinoma/drug therapy	sesquiterpenes/pharmacology	5.946021452984951e-12	2.0759759460872875e-11	0.009345794392523364	0.9605811478101344	1	2
levofloxacin/pharmacology	organelle biogenesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
palmitates/metabolism	adenosine diphosphate/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
palmitates/metabolism	carbonyl cyanide p-trifluoromethoxyphenylhydrazone/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
palmitates/metabolism	oxygen consumption/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
palmitates/metabolism	uncoupling agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
palmitates/metabolism	biological transport/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
palmitates/metabolism	mitochondrial adp atp translocases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
piperazines/toxicity	morpholines/pharmacology	1.983776046765584e-07	5.377218377070026e-07	0.014018691588785045	0.9605811478101344	1	2
piperazines/toxicity	poly(adp-ribose) polymerases/metabolism	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
piperazines/toxicity	glioblastoma/enzymology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
piperazines/toxicity	aminopyridines/pharmacology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
hypoxia	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
hypoxia	plant leaves/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia	fas ligand protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia	PRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
immunosuppressive agents/chemistry	hydrogen peroxide/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
x-linked inhibitor of apoptosis protein/genetics	BCL2A1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
x-linked inhibitor of apoptosis protein/genetics	CXCL12	8.390528605239922e-08	2.3337249235313462e-07	0.03271028037383177	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	muscle proteins/biosynthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	mitochondria muscle/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	autocrine communication/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	oxidoreductases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	decitabine	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	mitogen-activated protein kinases/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	dna fragmentation/drug effects	1.2249024017307875e-10	4.008110441282339e-10	0.027905752270633143	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	muscle fibers skeletal/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	oncogene protein v-akt/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	EIF4E	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	RPS6KB2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	TNFRSF1A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor necrosis factor-alpha/pharmacology	receptors tumor necrosis factor type i/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pancreatic neoplasms/drug therapy	cell movement/drug effects	0.0009047857165859208	0.001741333404267317	0.09345794392523364	0.9605811478101344	1	2
pancreatic neoplasms/drug therapy	CDKN1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pancreatic neoplasms/drug therapy	ZHX2	1.241229341530925e-13	4.764384492004497e-13	0.018691588785046728	0.9605811478101344	1	2
poly i-c/administration & dosage	ERBB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia myelogenous chronic bcr-abl positive/genetics	LGALS3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia myelogenous chronic bcr-abl positive/genetics	SERPINA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myocytes cardiac/drug effects	myocardial reperfusion injury/drug therapy	3.925533308413165e-07	1.0381451167553493e-06	0.046290202272826986	0.9605811478101344	1	2
myocytes cardiac/drug effects	cell line	0.0005422943399908675	0.0010710835445775012	0.030797282136299682	0.8657199677887635	2	2
myocytes cardiac/drug effects	zinc/pharmacology	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	enzyme inhibitors	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	cardiotonic agents	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	glycogen synthase kinase 3/antagonists & inhibitors	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	mitochondria heart/drug effects	0.0	0.0	5.885312838100187e-08	0.5304112294886878	4	2
myocytes cardiac/drug effects	potassium channels/metabolism	3.175126828125485e-12	1.1320374564442222e-11	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	nitric oxide synthase type iii/metabolism	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	organelle biogenesis	7.643512212052173e-08	2.1315982450205703e-07	0.046290202272826986	0.9605811478101344	1	2
myocytes cardiac/drug effects	electron transport complex i/antagonists & inhibitors	5.295763827461997e-13	1.979671089655512e-12	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	cell hypoxia/drug effects	5.295763827461997e-13	1.979671089655512e-12	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	myocardial reperfusion injury/enzymology	3.3306690738754696e-16	1.4334294698576293e-15	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	mitochondrial dynamics/drug effects	1.3743073712380038e-07	3.769216186224096e-07	0.046290202272826986	0.9605811478101344	1	2
myocytes cardiac/drug effects	myocardial reperfusion injury/prevention & control	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	cell death	5.295763827461997e-13	1.979671089655512e-12	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	chalcones/administration & dosage	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	creatine kinase mb form/metabolism	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	PPID	5.295763827461997e-13	1.979671089655512e-12	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	PPIF	5.295763827461997e-13	1.979671089655512e-12	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	PRKCB	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	PRKCG	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	PRRT2	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	quinuclidines/pharmacology	3.175126828125485e-12	1.1320374564442222e-11	0.02336448598130841	0.9605811478101344	1	2
myocytes cardiac/drug effects	dna/biosynthesis	7.643512212052173e-08	2.1315982450205703e-07	0.046290202272826986	0.9605811478101344	1	2
myocytes cardiac/drug effects	cytosol/drug effects	6.325615586888489e-10	1.9955240014267763e-09	0.02336448598130841	0.9605811478101344	1	2
receptors interleukin-17/genetics	organoplatinum compounds/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinase c/genetics	receptors vascular endothelial growth factor/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinase c/genetics	vascular endothelial growth factor a/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinase c/genetics	FLT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinase c/genetics	KDR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-8b/antagonists & inhibitors	cell adhesion/drug effects	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
receptors interleukin-8b/antagonists & inhibitors	CXCL1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors interleukin-8b/antagonists & inhibitors	CXCR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amyloid beta-peptides/pharmacology	dna fragmentation/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
mitochondria heart/drug effects	zinc/pharmacology	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	enzyme inhibitors	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	cardiotonic agents	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	glycogen synthase kinase 3/antagonists & inhibitors	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	nitric oxide synthase type iii/metabolism	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	creatine kinase mb form/metabolism	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	organelle biogenesis	2.051229297528323e-09	6.331443868389258e-09	0.03711991575621956	0.9605811478101344	1	2
mitochondria heart/drug effects	electron transport complex i/antagonists & inhibitors	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	cell hypoxia/drug effects	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	myocardial reperfusion injury/enzymology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	mitochondrial dynamics/drug effects	4.2223107232786106e-09	1.2798117518125765e-08	0.03711991575621956	0.9605811478101344	1	2
mitochondria heart/drug effects	myocardial reperfusion injury/prevention & control	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	cell death	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	chalcones/administration & dosage	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	PPID	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	PPIF	8.881784197001252e-16	3.739270154200565e-15	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	PRKCB	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	PRKCG	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	PRRT2	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
mitochondria heart/drug effects	dna/biosynthesis	2.051229297528323e-09	6.331443868389258e-09	0.03711991575621956	0.9605811478101344	1	2
mitochondria heart/drug effects	cytosol/drug effects	5.592304397339376e-12	1.956197482984905e-11	0.018691588785046728	0.9605811478101344	1	2
pyridines/pharmacology	peroxiredoxin iii/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pyridines/pharmacology	cyclin-dependent kinase 4/antagonists & inhibitors	9.425793479067579e-14	3.6294078698302824e-13	0.018647711816067742	0.9605811478101344	1	2
pyridines/pharmacology	mesothelioma malignant/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pyridines/pharmacology	phosphoinositide-3 kinase inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
recombinant proteins/metabolism	tnf-related apoptosis-inducing ligand/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins/metabolism	multiple myeloma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant proteins/metabolism	TNFRSF11B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stilbenes/pharmacology	glycogen synthase kinase 3 beta/metabolism	1.3211653993039363e-14	5.301975741509499e-14	0.009345794392523364	0.9605811478101344	1	2
stilbenes/pharmacology	transforming growth factor beta/metabolism	3.454814989645172e-09	1.0513700606169323e-08	0.018691588785046728	0.9605811478101344	1	2
stilbenes/pharmacology	CTNNB1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
IREB2	MKI67	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
maraviroc	neoplasm proteins/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
maraviroc	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
maraviroc	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
maraviroc	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
maraviroc	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
maraviroc	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
enzyme inhibitors/pharmacology	lymphoma non-hodgkin/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
enzyme inhibitors/pharmacology	everolimus/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
enzyme inhibitors/pharmacology	flavonoids/pharmacology	6.157706566867205e-10	1.9461742314548185e-09	0.018647711816067742	0.9605811478101344	1	2
enzyme inhibitors/pharmacology	free radicals/metabolism	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
enzyme inhibitors/pharmacology	carrier proteins/metabolism	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
enzyme inhibitors/pharmacology	cyclin-dependent kinases/antagonists & inhibitors	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
enzyme inhibitors/pharmacology	protein transport	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
enzyme inhibitors/pharmacology	farnesyltranstransferase/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
enzyme inhibitors/pharmacology	nitriles/metabolism	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
enzyme inhibitors/pharmacology	piperidines/pharmacology	2.477217875274107e-09	7.60692196574422e-09	0.018647711816067742	0.9605811478101344	1	2
ferritins/blood	genetic variation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ferritins/blood	malaria/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3 beta/metabolism	transforming growth factor beta/metabolism	0.0001667205860131915	0.0003464519774193069	0.03711991575621956	0.9605811478101344	1	2
glycogen synthase kinase 3 beta/metabolism	nf-kappa b/metabolism	0.00036731261271538695	0.0007345585927572655	0.046290202272826986	0.9605811478101344	1	2
glycogen synthase kinase 3 beta/metabolism	CTNNB1	1.3211653993039363e-14	5.301975741509499e-14	0.009345794392523364	0.9605811478101344	1	2
glycogen synthase kinase 3 beta/metabolism	ITK	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
glycogen synthase kinase 3 beta/metabolism	MMP2	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
glycogen synthase kinase 3 beta/metabolism	MMP9	1.2593558440521235e-07	3.465586326717576e-07	0.018647711816067742	0.9605811478101344	1	2
glycogen synthase kinase 3 beta/metabolism	MYD88	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
glycogen synthase kinase 3 beta/metabolism	NFKB1	0.0023238349829961535	0.004262200624332351	0.0644991443991049	0.9605811478101344	1	2
glycogen synthase kinase 3 beta/metabolism	TRAF6	8.21016588048451e-11	2.705391381451539e-10	0.009345794392523364	0.9605811478101344	1	2
neoplasm proteins/antagonists & inhibitors	chemokine ccl5/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm proteins/antagonists & inhibitors	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
neoplasm proteins/antagonists & inhibitors	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm proteins/antagonists & inhibitors	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
neoplasm proteins/antagonists & inhibitors	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
adenosine diphosphate/pharmacology	mitochondrial swelling/drug effects	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
adenosine diphosphate/pharmacology	electron transport complex iv/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenosine diphosphate/pharmacology	carbonyl cyanide p-trifluoromethoxyphenylhydrazone/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenosine diphosphate/pharmacology	oxygen consumption/drug effects	0.0	0.0	0.027905752270633143	0.9605811478101344	1	2
adenosine diphosphate/pharmacology	uncoupling agents/pharmacology	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
adenosine diphosphate/pharmacology	biological transport/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenosine diphosphate/pharmacology	herbicides/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenosine diphosphate/pharmacology	mitochondrial adp atp translocases/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenosine diphosphate/pharmacology	mitochondrial proton-translocating atpases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
adenosine diphosphate/pharmacology	CA2	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
micrornas/genetics	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
micrornas/genetics	immune evasion/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
micrornas/genetics	KCNQ1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
micrornas/genetics	KCNQ1OT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heterocyclic compounds/pharmacology	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
heterocyclic compounds/pharmacology	cell adhesion/drug effects	9.609091300433192e-12	3.321229738077301e-11	0.018691588785046728	0.9605811478101344	1	2
heterocyclic compounds/pharmacology	CXCL12	3.443467222474794e-08	9.800124605798924e-08	0.03271028037383177	0.9605811478101344	1	2
heterocyclic compounds/pharmacology	CXCR4	2.964295475749168e-14	1.1714785203319173e-13	0.018691588785046728	0.9605811478101344	1	2
iron overload/metabolism	malaria/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
iron overload/metabolism	ceruloplasmin/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
iron overload/metabolism	CP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/genetics	TNFRSF11B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/genetics	multiple myeloma/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondrial membrane transport proteins/genetics	interleukin-10/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondrial membrane transport proteins/genetics	neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
free radical scavengers/pharmacology	stem cells/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor beta/agonists	neutrophils/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor beta/agonists	ESR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor beta/agonists	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phagosomes/metabolism	homeostasis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phagosomes/metabolism	malaria/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phagosomes/metabolism	antimalarials/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neutrophils/metabolism	CSF3	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophils/metabolism	ITGAM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl21/immunology	CCL19	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl21/immunology	CCL21	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokine ccl21/immunology	CCR7	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
organelle biogenesis	myocardial reperfusion injury/enzymology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
organelle biogenesis	mitochondrial dynamics/drug effects	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
immune evasion/drug effects	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
immune evasion/drug effects	KCNQ1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immune evasion/drug effects	KCNQ1OT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell respiration/drug effects	glucose/deficiency	5.295763827461997e-13	1.979671089655512e-12	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	phospholipids/metabolism	3.141931159689193e-14	1.2403455364158876e-13	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	5.295763827461997e-13	1.979671089655512e-12	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	acetaldehyde/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	apoptosis	3.925533308413165e-07	1.0381451167553493e-06	0.04166180294604871	0.9605811478101344	1	2
cell respiration/drug effects	antimycin a/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	cytoprotection/drug effects	5.295763827461997e-13	1.979671089655512e-12	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	quinolines/pharmacology	5.295763827461997e-13	1.979671089655512e-12	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	phospholipase a2 inhibitors/pharmacology	3.141931159689193e-14	1.2403455364158876e-13	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	glutathione disulfide/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	liver diseases alcoholic/etiology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	neoplasms/enzymology	3.141931159689193e-14	1.2403455364158876e-13	0.014018691588785045	0.9605811478101344	1	2
cell respiration/drug effects	lipid droplets/metabolism	3.141931159689193e-14	1.2403455364158876e-13	0.014018691588785045	0.9605811478101344	1	2
cell adhesion/drug effects	cell movement/drug effects	5.898792460035107e-05	0.00012901158234188479	0.002660220255949666	0.7135314763244264	3	2
cell adhesion/drug effects	chemokine ccl2/biosynthesis	2.2819819367470018e-09	7.0161954736296045e-09	0.018691588785046728	0.9605811478101344	1	2
cell adhesion/drug effects	nf-kappa b/metabolism	0.004085590664280603	0.007203446858541282	0.09085010295354308	0.9605811478101344	1	2
cell adhesion/drug effects	trabectedin	2.2819819367470018e-09	7.0161954736296045e-09	0.018691588785046728	0.9605811478101344	1	2
cell adhesion/drug effects	BRCA1	2.2819819367470018e-09	7.0161954736296045e-09	0.018691588785046728	0.9605811478101344	1	2
cell adhesion/drug effects	CCL2	2.4306012758046336e-10	7.854301176746381e-10	0.001559737378978988	0.8657199677887635	2	2
cell adhesion/drug effects	CCL4	9.609091300433192e-12	3.321229738077301e-11	0.018691588785046728	0.9605811478101344	1	2
cell adhesion/drug effects	CXCL1	7.29222757733794e-08	2.034405081932771e-07	0.03711991575621956	0.9605811478101344	1	2
cell adhesion/drug effects	CXCL12	2.2410965960784068e-07	6.039073301190016e-07	0.00535588186581037	0.8657199677887635	2	2
cell adhesion/drug effects	CXCR2	2.145505995088115e-12	7.72438213254454e-12	0.018691588785046728	0.9605811478101344	1	2
cell adhesion/drug effects	CXCR4	0.00028730260487308534	0.0005834436614388677	0.07319670689438858	0.9605811478101344	1	2
carcinoma lewis lung/immunology	ARG1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
carcinoma lewis lung/immunology	TCIM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
head and neck neoplasms/drug therapy	deoxycytidine/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
electron transport complex i/antagonists & inhibitors	cell hypoxia/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
electron transport complex i/antagonists & inhibitors	cell death	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
electron transport complex i/antagonists & inhibitors	PPID	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
electron transport complex i/antagonists & inhibitors	PPIF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transforming growth factor beta/metabolism	neovascularization pathologic/metabolism	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	tnf-related apoptosis-inducing ligand/metabolism	2.1270633422276752e-05	4.8553155160405616e-05	0.03711991575621956	0.9605811478101344	1	2
transforming growth factor beta/metabolism	janus kinases/antagonists & inhibitors	7.29222757733794e-08	2.034405081932771e-07	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	neoplasm metastasis/pathology	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	prostatic neoplasms/metabolism	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	paclitaxel/pharmacology	0.00045602481600359734	0.0009067035028629555	0.055287464515536164	0.9605811478101344	1	2
transforming growth factor beta/metabolism	sirtuin 1/antagonists & inhibitors	7.29222757733794e-08	2.034405081932771e-07	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	erbb receptors/antagonists & inhibitors	0.000581706605334853	0.0011444157432339464	0.055287464515536164	0.9605811478101344	1	2
transforming growth factor beta/metabolism	insulin-like growth factor i/metabolism	7.29222757733794e-08	2.034405081932771e-07	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	human umbilical vein endothelial cells	1.6311526357615236e-05	3.770565455364864e-05	0.055287464515536164	0.9605811478101344	1	2
transforming growth factor beta/metabolism	receptors androgen/metabolism	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	CTNNB1	3.454814989645172e-09	1.0513700606169323e-08	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	IGF1R	7.29222757733794e-08	2.034405081932771e-07	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	MMP9	5.435487294180863e-05	0.00011924539687771112	0.03711991575621956	0.9605811478101344	1	2
transforming growth factor beta/metabolism	NOS2	7.29222757733794e-08	2.034405081932771e-07	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	SIRT1	4.371674359981981e-05	9.688076820673707e-05	0.03711991575621956	0.9605811478101344	1	2
transforming growth factor beta/metabolism	SOCS5	3.752653865429778e-08	1.0667678239426992e-07	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	matrix metalloproteinase 9/metabolism	1.431965657161527e-12	5.228014374747035e-12	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	tyrphostins/pharmacology	2.1270633422276752e-05	4.8553155160405616e-05	0.03711991575621956	0.9605811478101344	1	2
transforming growth factor beta/metabolism	naphthols/pharmacology	7.29222757733794e-08	2.034405081932771e-07	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	receptor igf type 1/biosynthesis	7.29222757733794e-08	2.034405081932771e-07	0.018691588785046728	0.9605811478101344	1	2
transforming growth factor beta/metabolism	receptors tnf-related apoptosis-inducing ligand/biosynthesis	7.29222757733794e-08	2.034405081932771e-07	0.018691588785046728	0.9605811478101344	1	2
sp1 transcription factor/metabolism	dna (cytosine-5-)-methyltransferase 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sp1 transcription factor/metabolism	erlotinib hydrochloride/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell hypoxia/drug effects	cell death	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell hypoxia/drug effects	PPID	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell hypoxia/drug effects	PPIF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors vascular endothelial growth factor/genetics	vascular endothelial growth factor a/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors vascular endothelial growth factor/genetics	FLT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors vascular endothelial growth factor/genetics	KDR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
autocrine communication/drug effects	decitabine	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
autocrine communication/drug effects	dna fragmentation/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/pharmacology	CXCL1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/pharmacology	NFKB1	6.62905286219484e-11	2.212829031122965e-10	0.03271028037383177	0.9605811478101344	1	2
nf-kappa b/metabolism	lymphatic metastasis/genetics	1.9081847213442416e-11	6.5166754548014e-11	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	receptors ccr7/genetics	1.9081847213442416e-11	6.5166754548014e-11	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	neoplasm recurrence local/genetics	1.9081847213442416e-11	6.5166754548014e-11	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	carcinoma non-small-cell lung/genetics	1.9081847213442416e-11	6.5166754548014e-11	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	chemokine ccl21/genetics	1.9081847213442416e-11	6.5166754548014e-11	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	ARG1	2.0075977058109373e-05	4.6011969041288514e-05	0.046290202272826986	0.9605811478101344	1	2
nf-kappa b/metabolism	CCL2	0.004971895893240763	0.00867524221701269	0.09085010295354308	0.9605811478101344	1	2
nf-kappa b/metabolism	CCL21	5.3953543135421e-06	1.3103852379926881e-05	0.046290202272826986	0.9605811478101344	1	2
nf-kappa b/metabolism	CCL4	1.181569286856643e-09	3.6847580815580287e-09	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	CXCL12	4.671784832543935e-06	1.143975033184459e-05	0.00878568916972137	0.8657199677887635	2	2
nf-kappa b/metabolism	DDX53	0.00010933179359395861	0.0002313829319600307	0.046290202272826986	0.9605811478101344	1	2
nf-kappa b/metabolism	ITK	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	MMP2	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	MMP9	0.00013315331632623995	0.0002794901293184442	0.046290202272826986	0.9605811478101344	1	2
nf-kappa b/metabolism	MRC1	3.540051585204651e-10	1.1305193706632698e-09	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	MYD88	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	NFKB1	0.0	0.0	2.0363182419826644e-06	0.5304112294886878	4	2
nf-kappa b/metabolism	TRAF6	2.4375466437520643e-06	6.0891715841202705e-06	0.02336448598130841	0.9605811478101344	1	2
nf-kappa b/metabolism	biological products/pharmacology	9.049661020554822e-11	2.9797928043786246e-10	0.02336448598130841	0.9605811478101344	1	2
homeostasis/drug effects	malaria/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
homeostasis/drug effects	antimalarials/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
multiple myeloma/genetics	TNFRSF11B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myocardial reperfusion injury/enzymology	mitochondrial dynamics/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
carcinoma non-small-cell lung/blood	thrombocytopenia/chemically induced	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphoma non-hodgkin/drug therapy	everolimus/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphoma non-hodgkin/drug therapy	farnesyltranstransferase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drugs chinese herbal/administration & dosage	depsides/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drugs chinese herbal/administration & dosage	sleep apnea obstructive/complications	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drugs chinese herbal/administration & dosage	hypoxia/complications	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drugs chinese herbal/administration & dosage	heart injuries/etiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drugs chinese herbal/administration & dosage	cinnamates/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drugs chinese herbal/administration & dosage	DCR	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
drugs chinese herbal/administration & dosage	VIP	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neutrophils/drug effects	ESR2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neutrophils/drug effects	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
chemokine ccl5/antagonists & inhibitors	CCL5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
chemokine ccl5/antagonists & inhibitors	CCR5	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl5/antagonists & inhibitors	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
chemokine ccl5/antagonists & inhibitors	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
dna (cytosine-5-)-methyltransferase 1/metabolism	erlotinib hydrochloride/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
plant leaves/chemistry	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
plant leaves/chemistry	fas ligand protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
plant leaves/chemistry	PRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL2	cell movement/drug effects	8.950910923566369e-08	2.4877055848076556e-07	5.7028681401190826e-05	0.5304112294886878	4	2
CCL2	chemokine ccl2/biosynthesis	4.814946774622797e-09	1.4524551441631335e-08	0.018691588785046728	0.9605811478101344	1	2
CCL2	trabectedin	4.814946774622797e-09	1.4524551441631335e-08	0.018691588785046728	0.9605811478101344	1	2
CCL2	BRCA1	4.814946774622797e-09	1.4524551441631335e-08	0.018691588785046728	0.9605811478101344	1	2
CCL2	CCL4	2.5110025170249628e-11	8.560782974387874e-11	0.018691588785046728	0.9605811478101344	1	2
CCL2	CCL5	0.0006100488854396957	0.0011987841199798941	0.055287464515536164	0.9605811478101344	1	2
CCL2	NFKB1	1.7423216069900604e-06	4.406872409190875e-06	0.00535588186581037	0.8657199677887635	2	2
mitochondrial swelling/drug effects	electron transport complex iv/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial swelling/drug effects	monoamine oxidase/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial swelling/drug effects	oxygen consumption/drug effects	0.0	0.0	0.027905752270633143	0.9605811478101344	1	2
mitochondrial swelling/drug effects	phosphates/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial swelling/drug effects	herbicides/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial swelling/drug effects	organometallic compounds/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial swelling/drug effects	mitochondrial proton-translocating atpases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial swelling/drug effects	CA2	0.0	0.0	4.387696897898293e-05	0.8657199677887635	2	2
mitochondrial swelling/drug effects	PTPN2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL4	cell movement/drug effects	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
CCL4	CXCL12	3.443467222474794e-08	9.800124605798924e-08	0.03271028037383177	0.9605811478101344	1	2
CCL4	NFKB1	1.6902963206888444e-07	4.602649534216085e-07	0.03271028037383177	0.9605811478101344	1	2
microtubule-associated proteins/genetics	endoplasmic reticulum/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
microtubule-associated proteins/genetics	cell line	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
microtubule-associated proteins/genetics	bcl-2-associated x protein/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
microtubule-associated proteins/genetics	cytochromes c/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
microtubule-associated proteins/genetics	lipoproteins ldl/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adaptor proteins signal transducing/metabolism	EIF2S1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CSF1	CSF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
human umbilical vein endothelial cells	neovascularization pathologic/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
human umbilical vein endothelial cells	neoplasm metastasis/pathology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
human umbilical vein endothelial cells	prostatic neoplasms/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
human umbilical vein endothelial cells	cyclophosphamide/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
human umbilical vein endothelial cells	matrix metalloproteinase 9/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
human umbilical vein endothelial cells	receptors cxcr4/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
human umbilical vein endothelial cells	receptors androgen/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
human umbilical vein endothelial cells	CXCL12	0.00022135041722104454	0.00045495795645470214	0.09538832359347407	0.9605811478101344	1	2
human umbilical vein endothelial cells	CXCR4	3.082276387456062e-07	8.232347642717294e-07	0.055287464515536164	0.9605811478101344	1	2
human umbilical vein endothelial cells	EPHB2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
human umbilical vein endothelial cells	MMP9	1.5919403573150248e-09	4.9268811058508795e-09	0.027905752270633143	0.9605811478101344	1	2
human umbilical vein endothelial cells	cell movement/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
mitochondrial dynamics/drug effects	phenylurea compounds/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mitochondrial dynamics/drug effects	mitophagy/drug effects	6.098743732252387e-11	2.0410610474909025e-10	0.03711991575621956	0.9605811478101344	1	2
CXCL1	CXCR2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CXCL1	NFKB1	3.7587875762357115e-05	8.384636633027617e-05	0.0644991443991049	0.9605811478101344	1	2
CXCL12	cell movement/drug effects	2.3016894201921545e-05	5.243609044884958e-05	0.001652429656873916	0.5304112294886878	4	2
CXCL12	cytarabine/administration & dosage	4.493805327854261e-11	1.5184585420464482e-10	0.03271028037383177	0.9605811478101344	1	2
CXCL12	cyclophosphamide/administration & dosage	4.493805327854261e-11	1.5184585420464482e-10	0.03271028037383177	0.9605811478101344	1	2
CXCL12	MRC1	1.2665093418462448e-08	3.7000129811880225e-08	0.03271028037383177	0.9605811478101344	1	2
CXCL12	tumor microenvironment/immunology	2.7537399954979946e-05	6.250201711008831e-05	0.0644991443991049	0.9605811478101344	1	2
CXCL12	hematopoietic stem cells/drug effects	4.493805327854261e-11	1.5184585420464482e-10	0.03271028037383177	0.9605811478101344	1	2
CXCL12	receptors cxcr4/genetics	4.493805327854261e-11	1.5184585420464482e-10	0.03271028037383177	0.9605811478101344	1	2
CXCL12	ARG1	0.00011330803691222968	0.0002390179485113701	0.0644991443991049	0.9605811478101344	1	2
CXCL12	neoplastic stem cells/immunology	4.493805327854261e-11	1.5184585420464482e-10	0.03271028037383177	0.9605811478101344	1	2
CXCL12	cell movement/genetics	4.493805327854261e-11	1.5184585420464482e-10	0.03271028037383177	0.9605811478101344	1	2
CXCL12	BCL2A1	8.390528605239922e-08	2.3337249235313462e-07	0.03271028037383177	0.9605811478101344	1	2
CXCL12	CXCR4	0.0	0.0	4.1197189866701315e-07	0.5304112294886878	4	2
CXCL12	DDX53	0.0004660334170053515	0.0009261857560964475	0.0644991443991049	0.9605811478101344	1	2
CXCL12	EPHB2	4.493805327854261e-11	1.5184585420464482e-10	0.03271028037383177	0.9605811478101344	1	2
chemokine ccl2/biosynthesis	BRCA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chemokine ccl2/biosynthesis	trabectedin	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CXCR4	cell movement/drug effects	4.628383749816223e-06	1.1341031886635707e-05	0.002660220255949666	0.7135314763244264	3	2
CXCR4	cytarabine/administration & dosage	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
CXCR4	cyclophosphamide/administration & dosage	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
CXCR4	tumor microenvironment/immunology	6.772899574514213e-09	2.0220567341758885e-08	0.03711991575621956	0.9605811478101344	1	2
CXCR4	hematopoietic stem cells/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
CXCR4	receptors cxcr4/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
CXCR4	neoplastic stem cells/immunology	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
CXCR4	cell movement/genetics	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
CXCR4	EPHB2	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
decitabine	dna fragmentation/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
DDX53	ARG1	1.8017198843978122e-10	5.858180211060752e-10	0.018647711816067742	0.9605811478101344	1	2
DDX53	MRC1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
DDX53	crotonates/pharmacology	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
DDX53	sesquiterpenes/pharmacology	9.170442183403793e-14	3.5385003370613725e-13	0.009345794392523364	0.9605811478101344	1	2
interleukin-10/pharmacology	neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
morpholines/pharmacology	poly(adp-ribose) polymerases/metabolism	1.983776046765584e-07	5.377218377070026e-07	0.014018691588785045	0.9605811478101344	1	2
morpholines/pharmacology	tert-butylhydroperoxide/toxicity	1.3844481117075702e-13	5.292009703004249e-13	0.014018691588785045	0.9605811478101344	1	2
morpholines/pharmacology	glioblastoma/enzymology	1.983776046765584e-07	5.377218377070026e-07	0.014018691588785045	0.9605811478101344	1	2
morpholines/pharmacology	pc12 cells	4.610132509075271e-07	1.2149677451600714e-06	0.027905752270633143	0.9605811478101344	1	2
morpholines/pharmacology	aminopyridines/pharmacology	1.983776046765584e-07	5.377218377070026e-07	0.014018691588785045	0.9605811478101344	1	2
morpholines/pharmacology	mitophagy/drug effects	4.299934603357869e-05	9.533885572690496e-05	0.055287464515536164	0.9605811478101344	1	2
morpholines/pharmacology	berberine/pharmacology	4.610132509075271e-07	1.2149677451600714e-06	0.027905752270633143	0.9605811478101344	1	2
morpholines/pharmacology	chromones/pharmacology	1.3844481117075702e-13	5.292009703004249e-13	0.014018691588785045	0.9605811478101344	1	2
bcl-2-like protein 11/metabolism	ligands	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bcl-2-like protein 11/metabolism	FGF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
poly(adp-ribose) polymerases/metabolism	glioblastoma/enzymology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
poly(adp-ribose) polymerases/metabolism	aminopyridines/pharmacology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
ESR2	IL1B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
trabectedin	BRCA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
erbb receptors/drug effects	MDM2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
erbb receptors/drug effects	METTL7B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
erbb receptors/drug effects	TP73	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
malaria/metabolism	ceruloplasmin/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
malaria/metabolism	CP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neuroblastoma/drug therapy	cell membrane permeability/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neuroblastoma/drug therapy	antimalarials/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neuroblastoma/drug therapy	chloroquine/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
IL1B	drug hypersensitivity/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
IL1B	dinitrofluorobenzene/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
IL1B	anti-inflammatory agents/pharmacology	1.2101430968414206e-14	4.8608553469046536e-14	0.018647711816067742	0.9605811478101344	1	2
IL1B	hypersensitivity delayed/chemically induced	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
IL1B	ear/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
vascular endothelial growth factor a/genetics	FLT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
vascular endothelial growth factor a/genetics	KDR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ligands	FGF2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ligands	dose-response relationship immunologic	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ligands	calcitriol/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ligands	interleukin-4/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fas ligand protein/genetics	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
fas ligand protein/genetics	PRF1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
acetaldehyde/pharmacology	antimycin a/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetaldehyde/pharmacology	glutathione disulfide/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetaldehyde/pharmacology	liver diseases alcoholic/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins/genetics	IRF1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins/genetics	IRF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proto-oncogene proteins/genetics	NFKB1	7.779346631320294e-07	2.018821027864287e-06	0.03271028037383177	0.9605811478101344	1	2
ubiquinone/analogs & derivatives	cell line	0.002179454742623821	0.004011069963720367	0.11807292352244307	0.9605811478101344	1	2
ubiquinone/analogs & derivatives	rna small interfering/metabolism	1.021405182655144e-14	4.105732263843321e-14	0.018647711816067742	0.9605811478101344	1	2
ubiquinone/analogs & derivatives	autophagy-related protein-1 homolog/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ubiquinone/analogs & derivatives	diet high-fat/adverse effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ubiquinone/analogs & derivatives	EEF1A2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ubiquinone/analogs & derivatives	organophosphorus compounds/pharmacology	3.608668919241609e-12	1.2766998127637835e-11	0.018647711816067742	0.9605811478101344	1	2
ubiquinone/analogs & derivatives	pten phosphohydrolase/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ARG1	MRC1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ARG1	TCIM	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glioblastoma/enzymology	aminopyridines/pharmacology	8.915090887740007e-14	3.450841360479137e-13	0.004672897196261682	0.9605811478101344	1	2
everolimus/pharmacology	farnesyltranstransferase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
NFKB1	cell movement/drug effects	0.004380456958591905	0.007685843945808875	0.0193118796039811	0.7135314763244264	3	2
NFKB1	lymphatic metastasis/genetics	7.672186663754132e-09	2.2812727115637374e-08	0.03271028037383177	0.9605811478101344	1	2
NFKB1	receptors ccr7/genetics	7.672186663754132e-09	2.2812727115637374e-08	0.03271028037383177	0.9605811478101344	1	2
NFKB1	neoplasm recurrence local/genetics	7.672186663754132e-09	2.2812727115637374e-08	0.03271028037383177	0.9605811478101344	1	2
NFKB1	carcinoma non-small-cell lung/genetics	7.672186663754132e-09	2.2812727115637374e-08	0.03271028037383177	0.9605811478101344	1	2
NFKB1	IRF2	7.779346631320294e-07	2.018821027864287e-06	0.03271028037383177	0.9605811478101344	1	2
NFKB1	chemokine ccl21/genetics	7.672186663754132e-09	2.2812727115637374e-08	0.03271028037383177	0.9605811478101344	1	2
NFKB1	ITK	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
NFKB1	MMP2	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
NFKB1	CCL21	9.536379190955291e-05	0.00020293223472848398	0.0644991443991049	0.9605811478101344	1	2
NFKB1	MMP9	0.001076153824293935	0.002055891128847819	0.0644991443991049	0.9605811478101344	1	2
NFKB1	MYD88	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
NFKB1	TRAF6	5.238472634128133e-05	0.00011504915294078801	0.03271028037383177	0.9605811478101344	1	2
NFKB1	biological products/pharmacology	2.4626201189370533e-08	7.071613490795019e-08	0.03271028037383177	0.9605811478101344	1	2
NFKB1	IRF1	7.779346631320294e-07	2.018821027864287e-06	0.03271028037383177	0.9605811478101344	1	2
cell membrane permeability/drug effects	antimalarials/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell membrane permeability/drug effects	chloroquine/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
PI3	cell movement/drug effects	1.6551720180446594e-05	3.825286441703213e-05	0.008336624106006756	0.8657199677887635	2	2
PI3	SPP1	7.1344041785437184e-12	2.48655300867107e-11	0.018647711816067742	0.9605811478101344	1	2
electron transport complex iv/metabolism	herbicides/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
electron transport complex iv/metabolism	mitochondrial proton-translocating atpases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
electron transport complex iv/metabolism	CA2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL19	CCL21	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL19	CCR7	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
azepines/chemistry	pyrimidines/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
azepines/chemistry	mitogen-activated protein kinases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CCL21	lymphatic metastasis/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL21	receptors ccr7/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL21	neoplasm recurrence local/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL21	carcinoma non-small-cell lung/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL21	chemokine ccl21/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL21	CCR7	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
CCL5	breast neoplasms/immunology	7.561999765259841e-07	1.9649613532639835e-06	0.027905752270633143	0.9605811478101344	1	2
CCL5	CCR5	2.895462758445433e-10	9.322307666209828e-10	0.014018691588785045	0.9605811478101344	1	2
CCL5	CXCL10	1.4432899320127035e-15	6.06704602879239e-15	0.00039365091980200724	0.8657199677887635	2	2
CCL5	CXCL9	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
CCL5	cyclin-dependent kinase 4/antagonists & inhibitors	1.0656399921371573e-06	2.7370958232339287e-06	0.027905752270633143	0.9605811478101344	1	2
CCL5	receptors chemokine/metabolism	1.3098300222225134e-11	4.508841893827007e-11	0.014018691588785045	0.9605811478101344	1	2
CCR5	CXCL10	3.1692204416344794e-11	1.0774860801412028e-10	0.014018691588785045	0.9605811478101344	1	2
CCR5	CXCL9	3.241851231905457e-14	1.2765911048589306e-13	0.009345794392523364	0.9605811478101344	1	2
apoptosis	viral structural proteins/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
apoptosis	homeostasis	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
apoptosis	phospholipids/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
apoptosis	oxidoreductases/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
apoptosis	neoplasms/enzymology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
apoptosis	ferritins/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
apoptosis	lipid droplets/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
apoptosis	phospholipase a2 inhibitors/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
apoptosis	nuclear receptor coactivators/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
apoptosis	NCOA4	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
cell death	PPID	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell death	PPIF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bcl-2-associated x protein/genetics	endoplasmic reticulum/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
bcl-2-associated x protein/genetics	cell line	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
bcl-2-associated x protein/genetics	cytochromes c/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bcl-2-associated x protein/genetics	lipoproteins ldl/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glucose/deficiency	peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glucose/deficiency	cytoprotection/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glucose/deficiency	quinolines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
flavonoids/pharmacology	free radicals/metabolism	7.771561172376096e-16	3.293241989785665e-15	0.009345794392523364	0.9605811478101344	1	2
flavonoids/pharmacology	neoplasm invasiveness/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
flavonoids/pharmacology	carrier proteins/metabolism	7.771561172376096e-16	3.293241989785665e-15	0.009345794392523364	0.9605811478101344	1	2
flavonoids/pharmacology	cyclin-dependent kinases/antagonists & inhibitors	7.771561172376096e-16	3.293241989785665e-15	0.009345794392523364	0.9605811478101344	1	2
flavonoids/pharmacology	protein transport	7.771561172376096e-16	3.293241989785665e-15	0.009345794392523364	0.9605811478101344	1	2
flavonoids/pharmacology	nitriles/metabolism	7.771561172376096e-16	3.293241989785665e-15	0.009345794392523364	0.9605811478101344	1	2
flavonoids/pharmacology	piperidines/pharmacology	9.992527361113446e-09	2.9509140538150182e-08	0.018647711816067742	0.9605811478101344	1	2
CDKN1A	cell movement/drug effects	0.0009047857165859208	0.001741333404267317	0.09345794392523364	0.9605811478101344	1	2
CDKN1A	ZHX2	1.241229341530925e-13	4.764384492004497e-13	0.018691588785046728	0.9605811478101344	1	2
neoplasms/enzymology	lipid droplets/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/enzymology	phospholipids/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/enzymology	phospholipase a2 inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipid droplets/metabolism	phospholipids/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipid droplets/metabolism	phospholipase a2 inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dendritic cells/immunology	prostate-specific antigen/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CSF3	ITGAM	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	extracellular signal-regulated map kinases/drug effects	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	platelet endothelial cell adhesion molecule-1/biosynthesis	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	proto-oncogene proteins c-akt/drug effects	0.0	0.0	6.209005044195697e-07	0.7135314763244264	3	2
phosphatidylinositol 3-kinases/drug effects	cellular senescence/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	embryonic stem cells/cytology	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	jnk mitogen-activated protein kinases/drug effects	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	p38 mitogen-activated protein kinases/drug effects	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	hair cells auditory/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	caspase 3/biosynthesis	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	acetylcysteine/metabolism	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	angiogenesis inhibitors/pharmacology	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	nitric oxide synthase/antagonists & inhibitors	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	hydrogen peroxide/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	cell differentiation	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	endothelial cells/drug effects	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	carcinoma non-small-cell lung/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
phosphatidylinositol 3-kinases/drug effects	tor serine-threonine kinases/drug effects	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
CXCL10	breast neoplasms/immunology	1.8770705223492e-07	5.103039565567838e-07	0.027905752270633143	0.9605811478101344	1	2
CXCL10	CXCL9	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
CXCL10	cyclin-dependent kinase 4/antagonists & inhibitors	2.7405334346308763e-07	7.346295582582561e-07	0.027905752270633143	0.9605811478101344	1	2
CXCL10	receptors chemokine/metabolism	1.0363931934875836e-12	3.832030375652229e-12	0.014018691588785045	0.9605811478101344	1	2
free radicals/metabolism	carrier proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
free radicals/metabolism	cyclin-dependent kinases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
free radicals/metabolism	protein transport	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
free radicals/metabolism	nitriles/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
free radicals/metabolism	piperidines/pharmacology	8.43769498715119e-15	3.412847167064932e-14	0.009345794392523364	0.9605811478101344	1	2
CXCL9	breast neoplasms/immunology	2.477217875274107e-09	7.60692196574422e-09	0.018647711816067742	0.9605811478101344	1	2
CXCL9	cyclin-dependent kinase 4/antagonists & inhibitors	4.039733436655979e-09	1.2253135618570785e-08	0.018647711816067742	0.9605811478101344	1	2
CXCL9	receptors chemokine/metabolism	3.3306690738754696e-16	1.4334294698576293e-15	0.009345794392523364	0.9605811478101344	1	2
antimycin a/pharmacology	glutathione disulfide/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antimycin a/pharmacology	liver diseases alcoholic/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytochromes c/genetics	endoplasmic reticulum/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
cytochromes c/genetics	cell line	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cytochromes c/genetics	lipoproteins ldl/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma hepatocellular/pathology	berberine/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ceruloplasmin/metabolism	CP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lipoproteins ldl/metabolism	endoplasmic reticulum/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
lipoproteins ldl/metabolism	cell line	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
fimbriae proteins/metabolism	ICAM1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	cytoprotection/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
peroxisome proliferator-activated receptor gamma coactivator 1-alpha/metabolism	quinolines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
FLT1	KDR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylurea compounds/pharmacology	mitophagy/drug effects	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
malaria/drug therapy	antimalarials/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
carbonyl cyanide p-trifluoromethoxyphenylhydrazone/pharmacology	oxygen consumption/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
carbonyl cyanide p-trifluoromethoxyphenylhydrazone/pharmacology	uncoupling agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
carbonyl cyanide p-trifluoromethoxyphenylhydrazone/pharmacology	biological transport/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carbonyl cyanide p-trifluoromethoxyphenylhydrazone/pharmacology	mitochondrial adp atp translocases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
IRF1	IRF2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monoamine oxidase/metabolism	oxygen consumption/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
monoamine oxidase/metabolism	phosphates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monoamine oxidase/metabolism	organometallic compounds/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monoamine oxidase/metabolism	CA2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
monoamine oxidase/metabolism	PTPN2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ITK	MMP2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ITK	MMP9	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
ITK	MYD88	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ITK	TRAF6	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
crotonates/pharmacology	sesquiterpenes/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
KCNQ1	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
KCNQ1	KCNQ1OT1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phospholipids/metabolism	phospholipase a2 inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
KCNQ1OT1	cell movement/drug effects	0.0019935783502662563	0.003690547058494578	0.09345794392523364	0.9605811478101344	1	2
oxygen consumption/drug effects	activating transcription factor 4/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	mechanistic target of rapamycin complex 1/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	transforming growth factor beta/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	uncoupling agents/pharmacology	0.0	0.0	0.027905752270633143	0.9605811478101344	1	2
oxygen consumption/drug effects	phosphates/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	biological transport/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	mitochondrial adp atp translocases/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	organometallic compounds/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	CA2	0.0	0.0	0.027905752270633143	0.9605811478101344	1	2
oxygen consumption/drug effects	PTPN2	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	serine/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	glycine/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	collagen/biosynthesis	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	lung/cytology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	stress physiological	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
oxygen consumption/drug effects	fibroblasts/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
LGALS3	SERPINA1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna fragmentation/drug effects	jurkat cells/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
dna fragmentation/drug effects	rna messenger/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
dna fragmentation/drug effects	oleic acid/toxicity	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
dna fragmentation/drug effects	arachidonic acid/toxicity	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
iron/chemistry	allografts	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell movement/drug effects	receptor cross-talk/drug effects	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	cytarabine/administration & dosage	0.00031889726529688023	0.0006431619927978059	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	receptors interleukin-10/genetics	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	interleukin-10/genetics	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	neoplastic stem cells/immunology	0.00031889726529688023	0.0006431619927978059	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	receptors ccr10/genetics	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	bortezomib/pharmacology	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	chemokine ccl27/metabolism	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	hematopoietic stem cells/drug effects	0.00031889726529688023	0.0006431619927978059	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	biological transport	0.00016503859793592923	0.0003433774660084333	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	carcinoma squamous cell/drug therapy	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	mouth neoplasms/drug therapy	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	sesquiterpenes guaiane	0.0027667287480445113	0.005018579632816569	0.09345794392523364	0.9605811478101344	1	2
cell movement/drug effects	neoplasm invasiveness/pathology	0.0037076139699631083	0.006579642048434209	0.09345794392523364	0.9605811478101344	1	2
carrier proteins/metabolism	cyclin-dependent kinases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carrier proteins/metabolism	protein transport	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carrier proteins/metabolism	nitriles/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carrier proteins/metabolism	piperidines/pharmacology	8.43769498715119e-15	3.412847167064932e-14	0.009345794392523364	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	cellular senescence/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	embryonic stem cells/cytology	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	jnk mitogen-activated protein kinases/drug effects	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	p38 mitogen-activated protein kinases/drug effects	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	hair cells auditory/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	caspase 3/biosynthesis	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	acetylcysteine/metabolism	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	angiogenesis inhibitors/pharmacology	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	nitric oxide synthase/antagonists & inhibitors	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	hydrogen peroxide/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	cell differentiation	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	endothelial cells/drug effects	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	carcinoma non-small-cell lung/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	tor serine-threonine kinases/drug effects	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
proto-oncogene proteins c-akt/drug effects	platelet endothelial cell adhesion molecule-1/biosynthesis	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
proto-oncogene proteins c-akt/drug effects	extracellular signal-regulated map kinases/drug effects	3.1123414956368833e-10	9.972519298910334e-10	0.014018691588785045	0.9605811478101344	1	2
rna long noncoding/physiology	receptors prostaglandin e ep4 subtype/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MMP2	MMP9	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
MMP2	MYD88	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MMP2	TRAF6	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MMP9	neovascularization pathologic/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MMP9	neoplasm metastasis/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MMP9	prostatic neoplasms/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MMP9	matrix metalloproteinase 9/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MMP9	receptors androgen/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MMP9	MYD88	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
MMP9	TRAF6	3.608668919241609e-12	1.2766998127637835e-11	0.009345794392523364	0.9605811478101344	1	2
MSC	triple negative breast neoplasms/drug therapy	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
MYD88	TRAF6	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin-dependent kinases/antagonists & inhibitors	protein transport	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin-dependent kinases/antagonists & inhibitors	nitriles/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin-dependent kinases/antagonists & inhibitors	piperidines/pharmacology	8.43769498715119e-15	3.412847167064932e-14	0.009345794392523364	0.9605811478101344	1	2
antimalarials/pharmacology	chloroquine/pharmacology	1.8387069644631993e-11	6.294024398771094e-11	0.018647711816067742	0.9605811478101344	1	2
SPP1	endoplasmic reticulum/drug effects	2.3675133753453537e-07	6.371940295363081e-07	0.027905752270633143	0.9605811478101344	1	2
SPP1	activating transcription factor 4/genetics	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
SPP1	phenylbutyrates/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
SPP1	organophosphorus compounds/pharmacology	4.2223107232786106e-09	1.2798117518125765e-08	0.018647711816067742	0.9605811478101344	1	2
SPP1	transcription factor chop/genetics	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
SPP1	cerebral arteries/cytology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
SPP1	eukaryotic initiation factor-2/genetics	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
SPP1	taurochenodeoxycholic acid/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
SPP1	myocytes smooth muscle/cytology	1.5247580975596975e-11	5.2282840645406236e-11	0.018647711816067742	0.9605811478101344	1	2
SPP1	muscle smooth vascular/cytology	1.1102230246251565e-16	4.854858636837654e-16	0.009345794392523364	0.9605811478101344	1	2
SPP1	piperidines/pharmacology	6.426711829377041e-09	1.9296764594049433e-08	0.018647711816067742	0.9605811478101344	1	2
nih 3t3 cells	coordination complexes/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nih 3t3 cells	hemolysis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
uncoupling agents/pharmacology	24-dinitrophenol/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
uncoupling agents/pharmacology	biological transport/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
uncoupling agents/pharmacology	mitochondrial adp atp translocases/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
uncoupling agents/pharmacology	cyclic amp response element-binding protein/biosynthesis	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ZHX2	triple negative breast neoplasms/drug therapy	0.00013145239114953355	0.00027623544796653794	0.07319670689438858	0.9605811478101344	1	2
ZHX2	erbb receptors/antagonists & inhibitors	0.0003091638139606223	0.0006256488086465169	0.055287464515536164	0.9605811478101344	1	2
ZHX2	bone neoplasms/drug therapy	3.082276387456062e-07	8.232347642717294e-07	0.03711991575621956	0.9605811478101344	1	2
ZHX2	raf kinases/metabolism	2.157919398726449e-10	6.979288089059813e-10	0.018691588785046728	0.9605811478101344	1	2
ZHX2	carboxy-lyases/genetics	1.8387069644631993e-11	6.294024398771094e-11	0.018691588785046728	0.9605811478101344	1	2
ZHX2	mitochondrial dynamics/physiology	1.8387069644631993e-11	6.294024398771094e-11	0.018691588785046728	0.9605811478101344	1	2
ZHX2	cell transformation neoplastic/drug effects	0.0	0.0	0.00026326181387389757	0.8657199677887635	2	2
ZHX2	immunosuppressive agents/pharmacology	1.8387069644631993e-11	6.294024398771094e-11	0.018691588785046728	0.9605811478101344	1	2
phosphates/pharmacology	organometallic compounds/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phosphates/pharmacology	CA2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phosphates/pharmacology	PTPN2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
coordination complexes/chemistry	hemolysis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
biological transport/drug effects	mitochondrial adp atp translocases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PPID	PPIF	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
herbicides/toxicity	mitochondrial proton-translocating atpases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
herbicides/toxicity	CA2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
MDM2	METTL7B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
MDM2	TP73	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
METTL7B	TP73	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell line	myocardial reperfusion injury/drug therapy	0.002179454742623821	0.004011069963720367	0.11807292352244307	0.9605811478101344	1	2
cell line	liver cirrhosis/drug therapy	2.1067664965124244e-05	4.820963955900979e-05	0.06074766355140186	0.9605811478101344	1	2
cell line	collagen type i/metabolism	2.1067664965124244e-05	4.820963955900979e-05	0.06074766355140186	0.9605811478101344	1	2
cell line	rna small interfering/metabolism	0.005771990481284739	0.009958591918879876	0.11807292352244307	0.9605811478101344	1	2
cell line	hydrogen peroxide/antagonists & inhibitors	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	autocrine communication	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	pyruvic acid/metabolism	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	peptides/chemistry	0.0002506687066090585	0.0005127800745329859	0.11807292352244307	0.9605811478101344	1	2
cell line	cell survival/physiology	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	antioxidants/chemistry	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	biological factors/chemistry	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	muscle proteins/biosynthesis	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	extracellular signal-regulated map kinases/drug effects	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	potassium channels/metabolism	2.1067664965124244e-05	4.820963955900979e-05	0.06074766355140186	0.9605811478101344	1	2
cell line	platelet endothelial cell adhesion molecule-1/biosynthesis	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	ferritins/genetics	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	enzyme inhibitors	0.00016909702180767372	0.0003510924886350495	0.06074766355140186	0.9605811478101344	1	2
cell line	glycogen synthase kinase 3/antagonists & inhibitors	0.00016909702180767372	0.0003510924886350495	0.06074766355140186	0.9605811478101344	1	2
cell line	adenosine triphosphatases/antagonists & inhibitors	6.03680407773588e-07	1.5807536378375377e-06	0.06074766355140186	0.9605811478101344	1	2
cell line	pten phosphohydrolase/antagonists & inhibitors	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	receptors tumor necrosis factor type i/genetics	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	isoantigens/immunology	6.03680407773588e-07	1.5807536378375377e-06	0.06074766355140186	0.9605811478101344	1	2
cell line	mitochondria muscle/drug effects	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	embryonic stem cells/cytology	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	jnk mitogen-activated protein kinases/drug effects	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	viral structural proteins/metabolism	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	oxidoreductases/genetics	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	homeostasis	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	p38 mitogen-activated protein kinases/drug effects	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	protein kinases/metabolism	1.0802914118812623e-11	3.7315157526489224e-11	0.06074766355140186	0.9605811478101344	1	2
cell line	dna/biosynthesis	0.0011329578723839884	0.002161600482028572	0.11807292352244307	0.9605811478101344	1	2
cell line	oxidoreductases/metabolism	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	cardiotonic agents	0.00016909702180767372	0.0003510924886350495	0.06074766355140186	0.9605811478101344	1	2
cell line	autophagy-related protein-1 homolog/metabolism	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	caspase 3/biosynthesis	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	ferritins/metabolism	1.0802914118812623e-11	3.7315157526489224e-11	0.06074766355140186	0.9605811478101344	1	2
cell line	quinuclidines/pharmacology	2.1067664965124244e-05	4.820963955900979e-05	0.06074766355140186	0.9605811478101344	1	2
cell line	mitogen-activated protein kinases/genetics	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	acetylcysteine/metabolism	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	cytosol/drug effects	0.00016909702180767372	0.0003510924886350495	0.06074766355140186	0.9605811478101344	1	2
cell line	muscle fibers skeletal/drug effects	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	zinc/pharmacology	0.00016909702180767372	0.0003510924886350495	0.06074766355140186	0.9605811478101344	1	2
cell line	angiogenesis inhibitors/pharmacology	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	nitric oxide synthase/antagonists & inhibitors	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	nuclear receptor coactivators/genetics	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	cell differentiation	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	viral proteins/metabolism	1.0802914118812623e-11	3.7315157526489224e-11	0.06074766355140186	0.9605811478101344	1	2
cell line	endothelial cells/drug effects	0.0017798780064963715	0.0033183451959438526	0.06074766355140186	0.9605811478101344	1	2
cell line	myocardial reperfusion injury/prevention & control	0.00016909702180767372	0.0003510924886350495	0.06074766355140186	0.9605811478101344	1	2
cell line	oncogene protein v-akt/metabolism	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	EIF4E	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	NCOA4	1.60878124821906e-07	4.3942528444913075e-07	0.06074766355140186	0.9605811478101344	1	2
cell line	PRKCB	0.00016909702180767372	0.0003510924886350495	0.06074766355140186	0.9605811478101344	1	2
cell line	PRKCG	0.00016909702180767372	0.0003510924886350495	0.06074766355140186	0.9605811478101344	1	2
cell line	PRRT2	0.00016909702180767372	0.0003510924886350495	0.06074766355140186	0.9605811478101344	1	2
cell line	RPS6KB2	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
cell line	TNFRSF1A	0.00035829809211107566	0.0007172468072330666	0.06074766355140186	0.9605811478101344	1	2
protein transport	nitriles/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein transport	piperidines/pharmacology	8.43769498715119e-15	3.412847167064932e-14	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/drug therapy	potassium channels/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocardial reperfusion injury/drug therapy	quinuclidines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pyrimidines/chemistry	mitogen-activated protein kinases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytoprotection/drug effects	quinolines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diet high-fat/adverse effects	EEF1A2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
organometallic compounds/metabolism	CA2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
organometallic compounds/metabolism	PTPN2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
triple negative breast neoplasms/drug therapy	bone neoplasms/drug therapy	6.075266956173664e-10	1.9206694271539568e-09	0.03711991575621956	0.9605811478101344	1	2
triple negative breast neoplasms/drug therapy	disulfides/administration & dosage	0.0	0.0	0.018691588785046728	0.9605811478101344	1	2
triple negative breast neoplasms/drug therapy	carboxy-lyases/genetics	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
triple negative breast neoplasms/drug therapy	mitochondrial dynamics/physiology	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
triple negative breast neoplasms/drug therapy	cell transformation neoplastic/drug effects	2.9688886460377262e-08	8.498838855860788e-08	0.03711991575621956	0.9605811478101344	1	2
triple negative breast neoplasms/drug therapy	immunosuppressive agents/pharmacology	5.551115123125783e-16	2.3645862873778448e-15	0.018691588785046728	0.9605811478101344	1	2
chloroquine/pharmacology	SQSTM1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
aurora kinase b/antagonists & inhibitors	ribosomal proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutathione disulfide/metabolism	liver diseases alcoholic/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitophagy/drug effects	berberine/pharmacology	1.1483151762803345e-08	3.361844775810492e-08	0.03711991575621956	0.9605811478101344	1	2
mitophagy/drug effects	tert-butylhydroperoxide/toxicity	1.1102230246251565e-16	4.854858636837654e-16	0.018691588785046728	0.9605811478101344	1	2
mitophagy/drug effects	neurons/drug effects	4.1519241933407613e-07	1.0959131403660614e-06	0.055287464515536164	0.9605811478101344	1	2
mitophagy/drug effects	chromones/pharmacology	1.1102230246251565e-16	4.854858636837654e-16	0.018691588785046728	0.9605811478101344	1	2
mitophagy/drug effects	pc12 cells	1.1483151762803345e-08	3.361844775810492e-08	0.03711991575621956	0.9605811478101344	1	2
nitriles/metabolism	piperidines/pharmacology	8.43769498715119e-15	3.412847167064932e-14	0.009345794392523364	0.9605811478101344	1	2
piperidines/pharmacology	endoplasmic reticulum/drug effects	8.848760142399215e-07	2.288801778737892e-06	0.027905752270633143	0.9605811478101344	1	2
piperidines/pharmacology	phenylbutyrates/pharmacology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
piperidines/pharmacology	muscle smooth vascular/cytology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
piperidines/pharmacology	eukaryotic initiation factor-2/genetics	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
piperidines/pharmacology	myocytes smooth muscle/cytology	1.3665724107880806e-10	4.4657163944057507e-10	0.018647711816067742	0.9605811478101344	1	2
piperidines/pharmacology	cerebral arteries/cytology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
piperidines/pharmacology	organophosphorus compounds/pharmacology	2.27001811792249e-08	6.53641889303318e-08	0.018647711816067742	0.9605811478101344	1	2
piperidines/pharmacology	transcription factor chop/genetics	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
piperidines/pharmacology	taurochenodeoxycholic acid/pharmacology	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
piperidines/pharmacology	activating transcription factor 4/genetics	1.887379141862766e-15	7.82786593675513e-15	0.009345794392523364	0.9605811478101344	1	2
mitochondrial proton-translocating atpases/metabolism	CA2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
glutathione peroxidase/metabolism	precursor cell lymphoblastic leukemia-lymphoma/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glutathione peroxidase/metabolism	autophagy-related proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
precursor cell lymphoblastic leukemia-lymphoma/metabolism	autophagy-related proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CA2	PTPN2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
carcinoma non-small-cell lung/metabolism	tor serine-threonine kinases/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	extracellular signal-regulated map kinases/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	p38 mitogen-activated protein kinases/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	angiogenesis inhibitors/pharmacology	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	endothelial cells/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	embryonic stem cells/cytology	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	cell differentiation	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	platelet endothelial cell adhesion molecule-1/biosynthesis	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	jnk mitogen-activated protein kinases/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	caspase 3/biosynthesis	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	acetylcysteine/metabolism	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
tor serine-threonine kinases/drug effects	nitric oxide synthase/antagonists & inhibitors	1.431965657161527e-12	5.228014374747035e-12	0.009345794392523364	0.9605811478101344	1	2
DCR	VIP	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/metabolism	epithelial-mesenchymal transition	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/metabolism	interferons/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/metabolism	janus kinases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/metabolism	hypoxia-inducible factor 1 alpha subunit/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/metabolism	ras proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/metabolism	hypoxia/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering/metabolism	src-family kinases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rna small interfering/metabolism	integrins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rna small interfering/metabolism	cd79 antigens/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rna small interfering/metabolism	lymphoma large b-cell diffuse/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rna small interfering/metabolism	CD79A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rna small interfering/metabolism	CD79B	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rna small interfering/metabolism	SYK	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rna small interfering/metabolism	pten phosphohydrolase/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rna small interfering/metabolism	organophosphorus compounds/pharmacology	2.980518054584991e-10	9.580764261188203e-10	0.018647711816067742	0.9605811478101344	1	2
rna small interfering/metabolism	autophagy-related protein-1 homolog/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
epithelial-mesenchymal transition	interferons/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
epithelial-mesenchymal transition	janus kinases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
epithelial-mesenchymal transition	hypoxia-inducible factor 1 alpha subunit/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
epithelial-mesenchymal transition	ras proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
epithelial-mesenchymal transition	hypoxia/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor escape	protein kinases/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor escape	carbazoles/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor escape	carcinoma squamous cell/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor escape	mouth neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor escape	maleimides	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor escape	PRKD1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinases/genetics	carbazoles/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinases/genetics	carcinoma squamous cell/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinases/genetics	mouth neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinases/genetics	maleimides	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinases/genetics	PRKD1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferons/metabolism	janus kinases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferons/metabolism	hypoxia-inducible factor 1 alpha subunit/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferons/metabolism	ras proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interferons/metabolism	hypoxia/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
collagen type i/metabolism	liver cirrhosis/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
janus kinases/metabolism	hypoxia-inducible factor 1 alpha subunit/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
janus kinases/metabolism	ras proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
janus kinases/metabolism	hypoxia/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm metastasis/pathology	neovascularization pathologic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm metastasis/pathology	prostatic neoplasms/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm metastasis/pathology	matrix metalloproteinase 9/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm metastasis/pathology	receptors androgen/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver neoplasms/metabolism	receptor igf type 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver neoplasms/metabolism	gene silencing	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver neoplasms/metabolism	neoplasm metastasis/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver neoplasms/metabolism	tumor escape/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver neoplasms/metabolism	tumor microenvironment/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
liver neoplasms/metabolism	IL6R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
liver neoplasms/metabolism	IL6ST	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor cross-talk/drug effects	proteasome endopeptidase complex/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptor cross-talk/drug effects	receptors interleukin-10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor cross-talk/drug effects	interleukin-10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor cross-talk/drug effects	receptors ccr10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor cross-talk/drug effects	bortezomib/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor cross-talk/drug effects	chemokine ccl27/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetates/therapeutic use	melanoma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetates/therapeutic use	tyramine/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetates/therapeutic use	antineoplastic agents phytogenic/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetates/therapeutic use	paclitaxel/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphatic metastasis/genetics	receptors ccr7/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphatic metastasis/genetics	carcinoma non-small-cell lung/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphatic metastasis/genetics	neoplasm recurrence local/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphatic metastasis/genetics	chemokine ccl21/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents/metabolism	tnf-related apoptosis-inducing ligand/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antineoplastic agents/metabolism	receptors tnf-related apoptosis-inducing ligand/agonists	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents/metabolism	recombinant fusion proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents/metabolism	leukemia t-cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents/metabolism	BIRC2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents/metabolism	CFLAR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents/metabolism	TNFRSF12A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibiotics antineoplastic/therapeutic use	tumor microenvironment/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibiotics antineoplastic/therapeutic use	paracrine communication/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibiotics antineoplastic/therapeutic use	doxorubicin/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibiotics antineoplastic/therapeutic use	extracellular vesicles/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibiotics antineoplastic/therapeutic use	embryo nonmammalian	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibiotics antineoplastic/therapeutic use	drug resistance neoplasm/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antibiotics antineoplastic/therapeutic use	SMAD2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/metabolism	gene silencing	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/metabolism	neoplasm metastasis/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/metabolism	tumor escape/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/metabolism	tumor microenvironment/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptor igf type 1/metabolism	IL6R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/metabolism	IL6ST	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	janus kinases/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	tnf-related apoptosis-inducing ligand/metabolism	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	paclitaxel/pharmacology	5.513522971511975e-11	1.8460463853590893e-10	0.014018691588785045	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	erbb receptors/antagonists & inhibitors	1.20579102258489e-10	3.9473319177359547e-10	0.014018691588785045	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	receptor igf type 1/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	naphthols/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	receptors tnf-related apoptosis-inducing ligand/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	insulin-like growth factor i/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	tyrphostins/pharmacology	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	IGF1R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	NOS2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sirtuin 1/antagonists & inhibitors	SIRT1	2.786659791809143e-14	1.1048422062544142e-13	0.009345794392523364	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	tnf-related apoptosis-inducing ligand/metabolism	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	paclitaxel/pharmacology	5.513522971511975e-11	1.8460463853590893e-10	0.014018691588785045	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	erbb receptors/antagonists & inhibitors	1.20579102258489e-10	3.9473319177359547e-10	0.014018691588785045	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	receptor igf type 1/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	naphthols/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	receptors tnf-related apoptosis-inducing ligand/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	insulin-like growth factor i/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	tyrphostins/pharmacology	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	IGF1R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	NOS2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
janus kinases/antagonists & inhibitors	SIRT1	2.786659791809143e-14	1.1048422062544142e-13	0.009345794392523364	0.9605811478101344	1	2
carbazoles/pharmacology	carcinoma squamous cell/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carbazoles/pharmacology	mouth neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carbazoles/pharmacology	maleimides	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carbazoles/pharmacology	PRKD1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia-inducible factor 1 alpha subunit/genetics	ras proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia-inducible factor 1 alpha subunit/genetics	hypoxia/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell communication/drug effects	antigens cd/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell communication/drug effects	endometrial neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell communication/drug effects	estrogen receptor alpha/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell communication/drug effects	receptors cell surface/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell communication/drug effects	estradiol/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell communication/drug effects	tumor necrosis factor alpha-induced protein 3/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell communication/drug effects	antigens differentiation myelomonocytic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell communication/drug effects	ESR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell communication/drug effects	IL17A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	receptors tnf-related apoptosis-inducing ligand/agonists	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	paclitaxel/pharmacology	2.1244838133149813e-07	5.739568571984893e-07	0.027905752270633143	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	erbb receptors/antagonists & inhibitors	3.5042941337604105e-07	9.278572962789664e-07	0.027905752270633143	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	recombinant fusion proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	receptor igf type 1/biosynthesis	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	naphthols/pharmacology	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	leukemia t-cell/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	receptors tnf-related apoptosis-inducing ligand/biosynthesis	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	insulin-like growth factor i/metabolism	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	tyrphostins/pharmacology	3.7466474367420233e-10	1.1952840787916093e-09	0.018647711816067742	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	BIRC2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	CFLAR	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	IGF1R	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	NOS2	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	SIRT1	1.6715591133475982e-09	5.170389356213223e-09	0.018647711816067742	0.9605811478101344	1	2
tnf-related apoptosis-inducing ligand/metabolism	TNFRSF12A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
gene silencing	neoplasm metastasis/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene silencing	tumor escape/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene silencing	tumor microenvironment/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
gene silencing	IL6R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
gene silencing	IL6ST	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor microenvironment/genetics	paracrine communication/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor microenvironment/genetics	doxorubicin/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor microenvironment/genetics	extracellular vesicles/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor microenvironment/genetics	embryo nonmammalian	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor microenvironment/genetics	drug resistance neoplasm/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor microenvironment/genetics	SMAD2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma squamous cell/immunology	mouth neoplasms/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma squamous cell/immunology	maleimides	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma squamous cell/immunology	PRKD1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
paclitaxel/pharmacology	oncogene proteins/metabolism	5.88418203051333e-15	2.3931829073742463e-14	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	erbb receptors/antagonists & inhibitors	2.5434173791749615e-05	5.7865304278247397e-05	0.04166180294604871	0.9605811478101344	1	2
paclitaxel/pharmacology	receptor igf type 1/biosynthesis	5.513522971511975e-11	1.8460463853590893e-10	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	naphthols/pharmacology	5.513522971511975e-11	1.8460463853590893e-10	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	breast neoplasms/immunology	1.4454715613343438e-07	3.9624216069003624e-07	0.027905752270633143	0.9605811478101344	1	2
paclitaxel/pharmacology	receptors tnf-related apoptosis-inducing ligand/biosynthesis	5.513522971511975e-11	1.8460463853590893e-10	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	insulin-like growth factor i/metabolism	5.513522971511975e-11	1.8460463853590893e-10	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	tyrphostins/pharmacology	2.1244838133149813e-07	5.739568571984893e-07	0.027905752270633143	0.9605811478101344	1	2
paclitaxel/pharmacology	th1 cells/drug effects	5.88418203051333e-15	2.3931829073742463e-14	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	cancer vaccines/pharmacology	5.88418203051333e-15	2.3931829073742463e-14	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	IGF1R	5.513522971511975e-11	1.8460463853590893e-10	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	NOS2	5.513522971511975e-11	1.8460463853590893e-10	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	SIRT1	6.03680407773588e-07	1.5807536378375377e-06	0.027905752270633143	0.9605811478101344	1	2
paclitaxel/pharmacology	SOCS1	5.88418203051333e-15	2.3931829073742463e-14	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	TBX21	5.88418203051333e-15	2.3931829073742463e-14	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	dna mitochondrial/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	kidney/drug effects	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	peptide elongation factor tu/genetics	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
paclitaxel/pharmacology	antineoplastic agents immunological/pharmacology	5.88418203051333e-15	2.3931829073742463e-14	0.014018691588785045	0.9605811478101344	1	2
receptors ccr7/genetics	carcinoma non-small-cell lung/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr7/genetics	neoplasm recurrence local/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr7/genetics	chemokine ccl21/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ras proteins/metabolism	hypoxia/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	receptor igf type 1/biosynthesis	1.20579102258489e-10	3.9473319177359547e-10	0.014018691588785045	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	naphthols/pharmacology	1.20579102258489e-10	3.9473319177359547e-10	0.014018691588785045	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	receptors tnf-related apoptosis-inducing ligand/biosynthesis	1.20579102258489e-10	3.9473319177359547e-10	0.014018691588785045	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	insulin-like growth factor i/metabolism	1.20579102258489e-10	3.9473319177359547e-10	0.014018691588785045	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	tyrphostins/pharmacology	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
erbb receptors/antagonists & inhibitors	IGF1R	1.20579102258489e-10	3.9473319177359547e-10	0.014018691588785045	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	NOS2	1.20579102258489e-10	3.9473319177359547e-10	0.014018691588785045	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	SIRT1	9.611297673295383e-07	2.4767401951942096e-06	0.027905752270633143	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	raf kinases/metabolism	4.2366110619695974e-13	1.5912913235827203e-12	0.014018691588785045	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	mitogen-activated protein kinase 1/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	cell transformation neoplastic/drug effects	1.631716847194653e-07	4.4524867632361027e-07	0.027905752270633143	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	quinazolines	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
erbb receptors/antagonists & inhibitors	glioma/drug therapy	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
breast neoplasms/immunology	oncogene proteins/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
breast neoplasms/immunology	antineoplastic agents immunological/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
breast neoplasms/immunology	th1 cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
breast neoplasms/immunology	cancer vaccines/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
breast neoplasms/immunology	SOCS1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
breast neoplasms/immunology	TBX21	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
breast neoplasms/immunology	cyclin-dependent kinase 4/antagonists & inhibitors	2.157919398726449e-10	6.979288089059813e-10	0.018647711816067742	0.9605811478101344	1	2
breast neoplasms/immunology	receptors chemokine/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
melanoma/drug therapy	tyramine/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
melanoma/drug therapy	antineoplastic agents phytogenic/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
melanoma/drug therapy	paclitaxel/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm metastasis/immunology	tumor escape/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm metastasis/immunology	tumor microenvironment/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neoplasm metastasis/immunology	IL6R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasm metastasis/immunology	IL6ST	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigens cd/metabolism	endometrial neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigens cd/metabolism	estrogen receptor alpha/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigens cd/metabolism	receptors cell surface/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigens cd/metabolism	estradiol/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigens cd/metabolism	tumor necrosis factor alpha-induced protein 3/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigens cd/metabolism	antigens differentiation myelomonocytic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigens cd/metabolism	ESR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
antigens cd/metabolism	IL17A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nitrobenzenes/chemistry	immune checkpoint inhibitors/chemical synthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nitrobenzenes/chemistry	programmed cell death 1 receptor/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nitrobenzenes/chemistry	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytarabine/administration & dosage	neoplastic stem cells/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytarabine/administration & dosage	tumor microenvironment/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cytarabine/administration & dosage	hematopoietic stem cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
proteasome endopeptidase complex/metabolism	receptors interleukin-10/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome endopeptidase complex/metabolism	interleukin-10/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome endopeptidase complex/metabolism	receptors ccr10/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome endopeptidase complex/metabolism	bortezomib/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome endopeptidase complex/metabolism	chemokine ccl27/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome endopeptidase complex/metabolism	hepatitis c/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome endopeptidase complex/metabolism	viral nonstructural proteins/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome endopeptidase complex/metabolism	protein interaction maps	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
proteasome endopeptidase complex/metabolism	apolipoprotein b-100/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
mouth neoplasms/immunology	maleimides	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mouth neoplasms/immunology	PRKD1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/metabolism	prostatic neoplasms/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/metabolism	matrix metalloproteinase 9/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neovascularization pathologic/metabolism	receptors androgen/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immune checkpoint inhibitors/chemical synthesis	programmed cell death 1 receptor/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
immune checkpoint inhibitors/chemical synthesis	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
maleimides	PRKD1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/biosynthesis	naphthols/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/biosynthesis	receptors tnf-related apoptosis-inducing ligand/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/biosynthesis	insulin-like growth factor i/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/biosynthesis	tyrphostins/pharmacology	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
receptor igf type 1/biosynthesis	IGF1R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/biosynthesis	NOS2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptor igf type 1/biosynthesis	SIRT1	2.786659791809143e-14	1.1048422062544142e-13	0.009345794392523364	0.9605811478101344	1	2
naphthols/pharmacology	receptors tnf-related apoptosis-inducing ligand/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
naphthols/pharmacology	insulin-like growth factor i/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
naphthols/pharmacology	tyrphostins/pharmacology	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
naphthols/pharmacology	IGF1R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
naphthols/pharmacology	NOS2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
naphthols/pharmacology	SIRT1	2.786659791809143e-14	1.1048422062544142e-13	0.009345794392523364	0.9605811478101344	1	2
tamoxifen/pharmacology	rank ligand/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tamoxifen/pharmacology	osteoclasts/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tamoxifen/pharmacology	osteoprotegerin/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tamoxifen/pharmacology	selective estrogen receptor modulators/pharmacology	0.0	0.0	4.387696897898293e-05	0.8657199677887635	2	2
tamoxifen/pharmacology	bone neoplasms/drug therapy	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
tamoxifen/pharmacology	bone density conservation agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tamoxifen/pharmacology	TNFSF11	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tamoxifen/pharmacology	hydroxamic acids/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tamoxifen/pharmacology	breast neoplasms/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tamoxifen/pharmacology	histone deacetylases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tamoxifen/pharmacology	endoplasmic reticulum/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tamoxifen/pharmacology	benzofurans/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
t-lymphocytes regulatory/immunology	neoplasms/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocytes regulatory/immunology	indoleamine-pyrrole 23-dioxygenase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
t-lymphocytes regulatory/immunology	enzyme inhibitors/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tnf-related apoptosis-inducing ligand/biosynthesis	insulin-like growth factor i/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tnf-related apoptosis-inducing ligand/biosynthesis	tyrphostins/pharmacology	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
receptors tnf-related apoptosis-inducing ligand/biosynthesis	IGF1R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tnf-related apoptosis-inducing ligand/biosynthesis	NOS2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tnf-related apoptosis-inducing ligand/biosynthesis	SIRT1	2.786659791809143e-14	1.1048422062544142e-13	0.009345794392523364	0.9605811478101344	1	2
insulin-like growth factor i/metabolism	tyrphostins/pharmacology	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
insulin-like growth factor i/metabolism	IGF1R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
insulin-like growth factor i/metabolism	NOS2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
insulin-like growth factor i/metabolism	SIRT1	2.786659791809143e-14	1.1048422062544142e-13	0.009345794392523364	0.9605811478101344	1	2
oncogene proteins/metabolism	antineoplastic agents immunological/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oncogene proteins/metabolism	th1 cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oncogene proteins/metabolism	cancer vaccines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oncogene proteins/metabolism	SOCS1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oncogene proteins/metabolism	TBX21	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tyrphostins/pharmacology	IGF1R	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
tyrphostins/pharmacology	NOS2	2.6645352591003757e-15	1.0984980065939618e-14	0.009345794392523364	0.9605811478101344	1	2
tyrphostins/pharmacology	SIRT1	1.6715591133475982e-09	5.170389356213223e-09	0.018647711816067742	0.9605811478101344	1	2
tyrphostins/pharmacology	mitogen-activated protein kinase 1/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tyrphostins/pharmacology	quinazolines	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tyrphostins/pharmacology	glioma/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neoplasms/pathology	indoleamine-pyrrole 23-dioxygenase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplasms/pathology	enzyme inhibitors/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tyramine/analogs & derivatives	antineoplastic agents phytogenic/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tyramine/analogs & derivatives	paclitaxel/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents phytogenic/therapeutic use	paclitaxel/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SIRT1	IGF1R	2.786659791809143e-14	1.1048422062544142e-13	0.009345794392523364	0.9605811478101344	1	2
SIRT1	naphthoquinones/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SIRT1	sirtuin 1/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
SIRT1	NOS2	2.786659791809143e-14	1.1048422062544142e-13	0.009345794392523364	0.9605811478101344	1	2
receptors tnf-related apoptosis-inducing ligand/agonists	recombinant fusion proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tnf-related apoptosis-inducing ligand/agonists	leukemia t-cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tnf-related apoptosis-inducing ligand/agonists	BIRC2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tnf-related apoptosis-inducing ligand/agonists	CFLAR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tnf-related apoptosis-inducing ligand/agonists	TNFRSF12A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neuroprotective agents/pharmacology	neurons/drug effects	0.0	0.0	0.00013163090693694878	0.8657199677887635	2	2
neuroprotective agents/pharmacology	amyloid beta-peptides/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neuroprotective agents/pharmacology	quassins/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neuroprotective agents/pharmacology	rna small interfering/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neuroprotective agents/pharmacology	pc12 cells	4.798383912429927e-13	1.8004555565223794e-12	0.018647711816067742	0.9605811478101344	1	2
neuroprotective agents/pharmacology	rac1 gtp-binding protein/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neurons/drug effects	amyloid beta-peptides/metabolism	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
neurons/drug effects	quassins/pharmacology	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
neurons/drug effects	rna small interfering/administration & dosage	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
neurons/drug effects	pc12 cells	4.817741761087291e-10	1.530790752968044e-09	0.027905752270633143	0.9605811478101344	1	2
neurons/drug effects	rac1 gtp-binding protein/antagonists & inhibitors	0.0	0.0	0.014018691588785045	0.9605811478101344	1	2
antineoplastic agents immunological/pharmacology	th1 cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents immunological/pharmacology	cancer vaccines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents immunological/pharmacology	SOCS1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents immunological/pharmacology	TBX21	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rank ligand/antagonists & inhibitors	osteoclasts/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rank ligand/antagonists & inhibitors	osteoprotegerin/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rank ligand/antagonists & inhibitors	selective estrogen receptor modulators/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rank ligand/antagonists & inhibitors	bone neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rank ligand/antagonists & inhibitors	bone density conservation agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rank ligand/antagonists & inhibitors	TNFSF11	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
programmed cell death 1 receptor/antagonists & inhibitors	t-lymphocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor escape/immunology	tumor microenvironment/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor escape/immunology	IL6R	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor escape/immunology	IL6ST	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophosphamide/administration & dosage	cell movement/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophosphamide/administration & dosage	receptors cxcr4/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclophosphamide/administration & dosage	EPHB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
paracrine communication/genetics	doxorubicin/therapeutic use	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
paracrine communication/genetics	extracellular vesicles/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
paracrine communication/genetics	embryo nonmammalian	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
paracrine communication/genetics	drug resistance neoplasm/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
paracrine communication/genetics	SMAD2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna neoplasm/metabolism	cyclohexenes/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna neoplasm/metabolism	dioxanes/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna neoplasm/metabolism	uterine cervical neoplasms/enzymology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endometrial neoplasms/genetics	estrogen receptor alpha/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endometrial neoplasms/genetics	receptors cell surface/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endometrial neoplasms/genetics	estradiol/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endometrial neoplasms/genetics	tumor necrosis factor alpha-induced protein 3/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endometrial neoplasms/genetics	antigens differentiation myelomonocytic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endometrial neoplasms/genetics	ESR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
endometrial neoplasms/genetics	IL17A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
IGF1R	NOS2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glucose transporter type 1/metabolism	carcinoma hepatocellular/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glucose transporter type 1/metabolism	orexin receptors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glucose transporter type 1/metabolism	orexins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma hepatocellular/metabolism	orexin receptors/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma hepatocellular/metabolism	orexins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-10/genetics	bortezomib/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-10/genetics	chemokine ccl27/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-10/genetics	interleukin-10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors interleukin-10/genetics	receptors ccr10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pten phosphohydrolase/antagonists & inhibitors	organophosphorus compounds/pharmacology	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
pten phosphohydrolase/antagonists & inhibitors	autophagy-related protein-1 homolog/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma non-small-cell lung/genetics	neoplasm recurrence local/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma non-small-cell lung/genetics	chemokine ccl21/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amyloid beta-peptides/metabolism	quassins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
organophosphorus compounds/pharmacology	endoplasmic reticulum/drug effects	6.51304561172239e-07	1.7006114358983332e-06	0.027905752270633143	0.9605811478101344	1	2
organophosphorus compounds/pharmacology	phenylbutyrates/pharmacology	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
organophosphorus compounds/pharmacology	transcription factor chop/genetics	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
organophosphorus compounds/pharmacology	cerebral arteries/cytology	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
organophosphorus compounds/pharmacology	eukaryotic initiation factor-2/genetics	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
organophosphorus compounds/pharmacology	taurochenodeoxycholic acid/pharmacology	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
organophosphorus compounds/pharmacology	myocytes smooth muscle/cytology	8.21016588048451e-11	2.705391381451539e-10	0.018647711816067742	0.9605811478101344	1	2
organophosphorus compounds/pharmacology	autophagy-related protein-1 homolog/metabolism	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
organophosphorus compounds/pharmacology	muscle smooth vascular/cytology	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
organophosphorus compounds/pharmacology	activating transcription factor 4/genetics	8.881784197001252e-16	3.739270154200565e-15	0.009345794392523364	0.9605811478101344	1	2
estrogen receptor alpha/genetics	receptors cell surface/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor alpha/genetics	estradiol/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor alpha/genetics	tumor necrosis factor alpha-induced protein 3/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor alpha/genetics	antigens differentiation myelomonocytic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estrogen receptor alpha/genetics	ESR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
estrogen receptor alpha/genetics	IL17A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
creatine kinase mb form/metabolism	nitric oxide synthase type iii/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
creatine kinase mb form/metabolism	chalcones/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell movement/genetics	receptors cxcr4/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell movement/genetics	EPHB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
anti-inflammatory agents/pharmacology	drug hypersensitivity/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-inflammatory agents/pharmacology	hypersensitivity delayed/chemically induced	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-inflammatory agents/pharmacology	ear/pathology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-inflammatory agents/pharmacology	pentacyclic triterpenes/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
anti-inflammatory agents/pharmacology	dinitrofluorobenzene/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
polysaccharides/chemistry	complex mixtures/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteoclasts/drug effects	osteoprotegerin/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteoclasts/drug effects	selective estrogen receptor modulators/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
osteoclasts/drug effects	bone neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
osteoclasts/drug effects	bone density conservation agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteoclasts/drug effects	TNFSF11	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors cell surface/metabolism	estradiol/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors cell surface/metabolism	tumor necrosis factor alpha-induced protein 3/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors cell surface/metabolism	antigens differentiation myelomonocytic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors cell surface/metabolism	ESR1	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
receptors cell surface/metabolism	IL17A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/genetics	endoplasmic reticulum/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
activating transcription factor 4/genetics	phenylbutyrates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/genetics	transcription factor chop/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/genetics	cerebral arteries/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/genetics	eukaryotic initiation factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/genetics	taurochenodeoxycholic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/genetics	myocytes smooth muscle/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
activating transcription factor 4/genetics	muscle smooth vascular/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/metabolism	matrix metalloproteinase 9/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
prostatic neoplasms/metabolism	receptors androgen/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-10/genetics	receptors ccr10/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-10/genetics	bortezomib/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
interleukin-10/genetics	chemokine ccl27/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ESR1	antigens differentiation myelomonocytic/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ESR1	estradiol/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ESR1	IL17A	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ESR1	amphiregulin/physiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ESR1	tumor necrosis factor alpha-induced protein 3/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ESR1	receptors estrogen/physiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ESR1	letrozole/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
ESR1	aromatase inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
nitric oxide synthase type iii/metabolism	chalcones/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neoplastic stem cells/immunology	tumor microenvironment/immunology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
neoplastic stem cells/immunology	hematopoietic stem cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylbutyrates/pharmacology	endoplasmic reticulum/drug effects	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
phenylbutyrates/pharmacology	transcription factor chop/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylbutyrates/pharmacology	cerebral arteries/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylbutyrates/pharmacology	eukaryotic initiation factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylbutyrates/pharmacology	taurochenodeoxycholic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phenylbutyrates/pharmacology	myocytes smooth muscle/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
phenylbutyrates/pharmacology	muscle smooth vascular/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
palmitic acid/pharmacology	neuroblastoma/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
palmitic acid/pharmacology	insulin antagonists/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
palmitic acid/pharmacology	insulin/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neuroblastoma/metabolism	insulin antagonists/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
neuroblastoma/metabolism	insulin/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endoplasmic reticulum/drug effects	transcription factor chop/genetics	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
endoplasmic reticulum/drug effects	cerebral arteries/cytology	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
endoplasmic reticulum/drug effects	eukaryotic initiation factor-2/genetics	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
endoplasmic reticulum/drug effects	taurochenodeoxycholic acid/pharmacology	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
endoplasmic reticulum/drug effects	myocytes smooth muscle/cytology	1.08218036753982e-08	3.1758169497561496e-08	0.027905752270633143	0.9605811478101344	1	2
endoplasmic reticulum/drug effects	muscle smooth vascular/cytology	1.431965657161527e-12	5.228014374747035e-12	0.014018691588785045	0.9605811478101344	1	2
neoplasm recurrence local/genetics	chemokine ccl21/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
orexin receptors/metabolism	orexins/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
naphthoquinones/chemistry	sirtuin 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna small interfering/administration & dosage	pc12 cells	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rna small interfering/administration & dosage	rac1 gtp-binding protein/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
insulin antagonists/pharmacology	insulin/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factor chop/genetics	cerebral arteries/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factor chop/genetics	eukaryotic initiation factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factor chop/genetics	taurochenodeoxycholic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
transcription factor chop/genetics	myocytes smooth muscle/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
transcription factor chop/genetics	muscle smooth vascular/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr10/genetics	bortezomib/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors ccr10/genetics	chemokine ccl27/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclin-dependent kinase 4/antagonists & inhibitors	mesothelioma malignant/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin-dependent kinase 4/antagonists & inhibitors	phosphoinositide-3 kinase inhibitors/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclin-dependent kinase 4/antagonists & inhibitors	receptors chemokine/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cyclohexenes/chemistry	dioxanes/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cyclohexenes/chemistry	uterine cervical neoplasms/enzymology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cerebral arteries/cytology	eukaryotic initiation factor-2/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cerebral arteries/cytology	taurochenodeoxycholic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cerebral arteries/cytology	myocytes smooth muscle/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cerebral arteries/cytology	muscle smooth vascular/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
matrix metalloproteinase 9/metabolism	receptors androgen/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia/complications	sleep apnea obstructive/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia/complications	depsides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia/complications	heart injuries/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypoxia/complications	cinnamates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
src-family kinases/metabolism	integrins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
src-family kinases/metabolism	cd79 antigens/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
src-family kinases/metabolism	lymphoma large b-cell diffuse/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
src-family kinases/metabolism	CD79A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
src-family kinases/metabolism	CD79B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
src-family kinases/metabolism	SYK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
eukaryotic initiation factor-2/genetics	taurochenodeoxycholic acid/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
eukaryotic initiation factor-2/genetics	myocytes smooth muscle/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
eukaryotic initiation factor-2/genetics	muscle smooth vascular/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocrotaline	pulmonary arterial hypertension/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocrotaline	myocytes smooth muscle/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
monocrotaline	pulmonary artery/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
monocrotaline	pyruvates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dioxanes/chemistry	uterine cervical neoplasms/enzymology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sleep apnea obstructive/complications	depsides/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sleep apnea obstructive/complications	heart injuries/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
sleep apnea obstructive/complications	cinnamates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amphiregulin/physiology	receptors estrogen/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amphiregulin/physiology	letrozole/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
amphiregulin/physiology	aromatase inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pulmonary arterial hypertension/drug therapy	myocytes smooth muscle/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pulmonary arterial hypertension/drug therapy	pulmonary artery/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pulmonary arterial hypertension/drug therapy	pyruvates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myocytes smooth muscle/cytology	pulmonary artery/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocytes smooth muscle/cytology	pyruvates/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocytes smooth muscle/cytology	muscle smooth vascular/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
myocytes smooth muscle/cytology	taurochenodeoxycholic acid/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
estradiol/pharmacology	tumor necrosis factor alpha-induced protein 3/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estradiol/pharmacology	antigens differentiation myelomonocytic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
estradiol/pharmacology	IL17A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular signal-regulated map kinases/drug effects	p38 mitogen-activated protein kinases/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular signal-regulated map kinases/drug effects	caspase 3/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular signal-regulated map kinases/drug effects	acetylcysteine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular signal-regulated map kinases/drug effects	angiogenesis inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular signal-regulated map kinases/drug effects	nitric oxide synthase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular signal-regulated map kinases/drug effects	cell differentiation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular signal-regulated map kinases/drug effects	endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular signal-regulated map kinases/drug effects	platelet endothelial cell adhesion molecule-1/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular signal-regulated map kinases/drug effects	embryonic stem cells/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular signal-regulated map kinases/drug effects	jnk mitogen-activated protein kinases/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor necrosis factor alpha-induced protein 3/metabolism	antigens differentiation myelomonocytic/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor necrosis factor alpha-induced protein 3/metabolism	IL17A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pc12 cells	berberine/pharmacology	2.3432367157738554e-12	8.428007032525606e-12	0.018647711816067742	0.9605811478101344	1	2
pc12 cells	tert-butylhydroperoxide/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pc12 cells	chromones/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pc12 cells	rac1 gtp-binding protein/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
recombinant fusion proteins/metabolism	leukemia t-cell/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant fusion proteins/metabolism	BIRC2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant fusion proteins/metabolism	CFLAR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
recombinant fusion proteins/metabolism	TNFRSF12A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors cxcr4/genetics	EPHB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
taurochenodeoxycholic acid/pharmacology	muscle smooth vascular/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
platelet endothelial cell adhesion molecule-1/biosynthesis	embryonic stem cells/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
platelet endothelial cell adhesion molecule-1/biosynthesis	jnk mitogen-activated protein kinases/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
platelet endothelial cell adhesion molecule-1/biosynthesis	p38 mitogen-activated protein kinases/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
platelet endothelial cell adhesion molecule-1/biosynthesis	caspase 3/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
platelet endothelial cell adhesion molecule-1/biosynthesis	acetylcysteine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
platelet endothelial cell adhesion molecule-1/biosynthesis	angiogenesis inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
platelet endothelial cell adhesion molecule-1/biosynthesis	nitric oxide synthase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
platelet endothelial cell adhesion molecule-1/biosynthesis	cell differentiation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
platelet endothelial cell adhesion molecule-1/biosynthesis	endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
depsides/pharmacology	heart injuries/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
depsides/pharmacology	cinnamates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
doxorubicin/therapeutic use	extracellular vesicles/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
doxorubicin/therapeutic use	embryo nonmammalian	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
doxorubicin/therapeutic use	drug resistance neoplasm/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
doxorubicin/therapeutic use	SMAD2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
inflammasomes/metabolism	hmgb1 protein/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
naphthalenes/pharmacology	g1 phase cell cycle checkpoints/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
leukemia t-cell/drug therapy	BIRC2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia t-cell/drug therapy	CFLAR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
leukemia t-cell/drug therapy	TNFRSF12A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
integrins/metabolism	cd79 antigens/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
integrins/metabolism	lymphoma large b-cell diffuse/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
integrins/metabolism	CD79A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
integrins/metabolism	CD79B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
integrins/metabolism	SYK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pulmonary artery/cytology	pyruvates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
tumor microenvironment/immunology	hematopoietic stem cells/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor microenvironment/immunology	IL6R	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
tumor microenvironment/immunology	IL6ST	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
extracellular vesicles/metabolism	embryo nonmammalian	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular vesicles/metabolism	drug resistance neoplasm/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
extracellular vesicles/metabolism	SMAD2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bortezomib/pharmacology	chemokine ccl27/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteoprotegerin/pharmacology	selective estrogen receptor modulators/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
osteoprotegerin/pharmacology	bone neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
osteoprotegerin/pharmacology	bone density conservation agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
osteoprotegerin/pharmacology	TNFSF11	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
g2 phase/drug effects	receptors death domain/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
g2 phase/drug effects	genes cdc/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
g2 phase/drug effects	diosgenin/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
g2 phase/drug effects	cell cycle proteins/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
g2 phase/drug effects	anticarcinogenic agents/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma squamous cell/drug therapy	mouth neoplasms/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carcinoma squamous cell/drug therapy	sesquiterpenes guaiane	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd79 antigens/antagonists & inhibitors	lymphoma large b-cell diffuse/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd79 antigens/antagonists & inhibitors	CD79A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd79 antigens/antagonists & inhibitors	CD79B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cd79 antigens/antagonists & inhibitors	SYK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
g1 phase cell cycle checkpoints/drug effects	endometrial neoplasms/drug therapy	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
g1 phase cell cycle checkpoints/drug effects	antineoplastic agents phytogenic/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
g1 phase cell cycle checkpoints/drug effects	resting phase cell cycle/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
g1 phase cell cycle checkpoints/drug effects	saponins/administration & dosage	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
selective estrogen receptor modulators/pharmacology	bone neoplasms/drug therapy	0.0	0.0	0.018647711816067742	0.9605811478101344	1	2
selective estrogen receptor modulators/pharmacology	bone density conservation agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
selective estrogen receptor modulators/pharmacology	TNFSF11	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
selective estrogen receptor modulators/pharmacology	hydroxamic acids/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
selective estrogen receptor modulators/pharmacology	breast neoplasms/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
selective estrogen receptor modulators/pharmacology	histone deacetylases/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
selective estrogen receptor modulators/pharmacology	endoplasmic reticulum/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
selective estrogen receptor modulators/pharmacology	benzofurans/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
rhizome/chemistry	saponins/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors estrogen/physiology	letrozole/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors estrogen/physiology	aromatase inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
embryo nonmammalian	drug resistance neoplasm/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
embryo nonmammalian	SMAD2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
embryonic stem cells/cytology	jnk mitogen-activated protein kinases/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
embryonic stem cells/cytology	p38 mitogen-activated protein kinases/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
embryonic stem cells/cytology	caspase 3/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
embryonic stem cells/cytology	acetylcysteine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
embryonic stem cells/cytology	angiogenesis inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
embryonic stem cells/cytology	nitric oxide synthase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
embryonic stem cells/cytology	cell differentiation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
embryonic stem cells/cytology	endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
indoleamine-pyrrole 23-dioxygenase/antagonists & inhibitors	enzyme inhibitors/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/drug effects	p38 mitogen-activated protein kinases/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/drug effects	caspase 3/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/drug effects	acetylcysteine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/drug effects	angiogenesis inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/drug effects	nitric oxide synthase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/drug effects	cell differentiation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jnk mitogen-activated protein kinases/drug effects	endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mouth neoplasms/drug therapy	sesquiterpenes guaiane	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
bone neoplasms/drug therapy	bone density conservation agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bone neoplasms/drug therapy	TNFSF11	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bone neoplasms/drug therapy	carboxy-lyases/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bone neoplasms/drug therapy	mitochondrial dynamics/physiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bone neoplasms/drug therapy	cell transformation neoplastic/drug effects	1.5420997812043424e-13	5.891564022871832e-13	0.018647711816067742	0.9605811478101344	1	2
bone neoplasms/drug therapy	immunosuppressive agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
bone density conservation agents/pharmacology	TNFSF11	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antigens differentiation myelomonocytic/metabolism	IL17A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors death domain/drug effects	genes cdc/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors death domain/drug effects	diosgenin/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors death domain/drug effects	cell cycle proteins/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors death domain/drug effects	anticarcinogenic agents/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphoma large b-cell diffuse/metabolism	CD79A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphoma large b-cell diffuse/metabolism	CD79B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lymphoma large b-cell diffuse/metabolism	SYK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/drug effects	caspase 3/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/drug effects	acetylcysteine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/drug effects	angiogenesis inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/drug effects	nitric oxide synthase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/drug effects	cell differentiation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
p38 mitogen-activated protein kinases/drug effects	endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th1 cells/drug effects	cancer vaccines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th1 cells/drug effects	SOCS1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
th1 cells/drug effects	TBX21	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drug resistance neoplasm/genetics	SMAD2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna/biosynthesis	enzyme inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dna/biosynthesis	glycogen synthase kinase 3/antagonists & inhibitors	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dna/biosynthesis	cardiotonic agents	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dna/biosynthesis	cytosol/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dna/biosynthesis	zinc/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dna/biosynthesis	enterocytes/cytology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dna/biosynthesis	myocardial reperfusion injury/prevention & control	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dna/biosynthesis	PRKCB	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dna/biosynthesis	PRKCG	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
dna/biosynthesis	PRRT2	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cancer vaccines/pharmacology	SOCS1	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cancer vaccines/pharmacology	TBX21	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
genes cdc/drug effects	diosgenin/analogs & derivatives	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
genes cdc/drug effects	cell cycle proteins/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
genes cdc/drug effects	anticarcinogenic agents/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BIRC2	CFLAR	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
BIRC2	TNFRSF12A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
letrozole/pharmacology	aromatase inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD79A	CD79B	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD79A	SYK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CD79B	SYK	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
CFLAR	TNFRSF12A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diosgenin/analogs & derivatives	cell cycle proteins/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
diosgenin/analogs & derivatives	anticarcinogenic agents/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caspase 3/biosynthesis	acetylcysteine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caspase 3/biosynthesis	angiogenesis inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caspase 3/biosynthesis	nitric oxide synthase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caspase 3/biosynthesis	cell differentiation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
caspase 3/biosynthesis	endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell cycle proteins/drug effects	anticarcinogenic agents/isolation & purification	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
IL6R	IL6ST	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
SOCS1	TBX21	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetylcysteine/metabolism	angiogenesis inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetylcysteine/metabolism	nitric oxide synthase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetylcysteine/metabolism	cell differentiation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
acetylcysteine/metabolism	endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
angiogenesis inhibitors/pharmacology	nitric oxide synthase/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
angiogenesis inhibitors/pharmacology	cell differentiation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
angiogenesis inhibitors/pharmacology	endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nitric oxide synthase/antagonists & inhibitors	cell differentiation	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nitric oxide synthase/antagonists & inhibitors	endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heart injuries/etiology	cinnamates/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydroxamic acids/pharmacology	breast neoplasms/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydroxamic acids/pharmacology	histone deacetylases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydroxamic acids/pharmacology	endoplasmic reticulum/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydroxamic acids/pharmacology	benzofurans/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
1-phosphatidylinositol 4-kinase/metabolism	plant roots	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
1-phosphatidylinositol 4-kinase/metabolism	plant extracts/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
1-phosphatidylinositol 4-kinase/metabolism	dna/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
potassium channels/metabolism	quinuclidines/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
raf kinases/metabolism	cell transformation neoplastic/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell differentiation	endothelial cells/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
berberine/pharmacology	chromones/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
berberine/pharmacology	cell nucleus/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
berberine/pharmacology	tert-butylhydroperoxide/toxicity	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
plant roots	plant extracts/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
plant roots	dna/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney tubules/cytology	ureteral obstruction/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney tubules/cytology	inflammasomes/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney tubules/cytology	nlr family pyrin domain-containing 3 protein/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney tubules/cytology	kidney failure chronic/etiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney tubules/cytology	fibrosis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/genetics	histone deacetylases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/genetics	endoplasmic reticulum/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
breast neoplasms/genetics	benzofurans/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
plant extracts/pharmacology	dna/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
genetic variation	malaria/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
heterografts	bridged bicyclo compounds heterocyclic/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
histone deacetylases/metabolism	endoplasmic reticulum/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
histone deacetylases/metabolism	benzofurans/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jurkat cells/drug effects	rna messenger/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jurkat cells/drug effects	oleic acid/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
jurkat cells/drug effects	arachidonic acid/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endometrial neoplasms/drug therapy	saponins/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endometrial neoplasms/drug therapy	antineoplastic agents phytogenic/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endometrial neoplasms/drug therapy	resting phase cell cycle/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney failure chronic/etiology	fibrosis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney failure chronic/etiology	ureteral obstruction/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney failure chronic/etiology	inflammasomes/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney failure chronic/etiology	nlr family pyrin domain-containing 3 protein/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna messenger/metabolism	oleic acid/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
rna messenger/metabolism	arachidonic acid/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
endoplasmic reticulum/metabolism	benzofurans/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
arsenic/toxicity	spermatogenesis/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibrosis	ureteral obstruction/complications	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibrosis	inflammasomes/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibrosis	nlr family pyrin domain-containing 3 protein/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ureteral obstruction/complications	inflammasomes/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ureteral obstruction/complications	nlr family pyrin domain-containing 3 protein/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
inflammasomes/antagonists & inhibitors	nlr family pyrin domain-containing 3 protein/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
saponins/administration & dosage	antineoplastic agents phytogenic/administration & dosage	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
saponins/administration & dosage	resting phase cell cycle/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antineoplastic agents phytogenic/administration & dosage	resting phase cell cycle/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell transformation neoplastic/drug effects	carboxy-lyases/genetics	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell transformation neoplastic/drug effects	mitochondrial dynamics/physiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell transformation neoplastic/drug effects	immunosuppressive agents/pharmacology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
brain neoplasms/genetics	cation transport proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oleic acid/toxicity	arachidonic acid/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle proteins/biosynthesis	oxidoreductases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle proteins/biosynthesis	mitogen-activated protein kinases/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle proteins/biosynthesis	muscle fibers skeletal/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle proteins/biosynthesis	oncogene protein v-akt/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle proteins/biosynthesis	EIF4E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle proteins/biosynthesis	RPS6KB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle proteins/biosynthesis	TNFRSF1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle proteins/biosynthesis	receptors tumor necrosis factor type i/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle proteins/biosynthesis	mitochondria muscle/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
enzyme inhibitors	glycogen synthase kinase 3/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
enzyme inhibitors	cardiotonic agents	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
enzyme inhibitors	cytosol/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
enzyme inhibitors	zinc/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
enzyme inhibitors	myocardial reperfusion injury/prevention & control	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
enzyme inhibitors	PRKCB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
enzyme inhibitors	PRKCG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
enzyme inhibitors	PRRT2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/antagonists & inhibitors	cardiotonic agents	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/antagonists & inhibitors	cytosol/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/antagonists & inhibitors	zinc/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/antagonists & inhibitors	myocardial reperfusion injury/prevention & control	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/antagonists & inhibitors	PRKCB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/antagonists & inhibitors	PRKCG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycogen synthase kinase 3/antagonists & inhibitors	PRRT2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tumor necrosis factor type i/genetics	mitogen-activated protein kinases/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tumor necrosis factor type i/genetics	muscle fibers skeletal/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tumor necrosis factor type i/genetics	oncogene protein v-akt/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tumor necrosis factor type i/genetics	EIF4E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tumor necrosis factor type i/genetics	RPS6KB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tumor necrosis factor type i/genetics	TNFRSF1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tumor necrosis factor type i/genetics	mitochondria muscle/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
receptors tumor necrosis factor type i/genetics	oxidoreductases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carboxy-lyases/genetics	mitochondrial dynamics/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
carboxy-lyases/genetics	immunosuppressive agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondria muscle/drug effects	oxidoreductases/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondria muscle/drug effects	mitogen-activated protein kinases/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondria muscle/drug effects	muscle fibers skeletal/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondria muscle/drug effects	oncogene protein v-akt/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondria muscle/drug effects	EIF4E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondria muscle/drug effects	RPS6KB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondria muscle/drug effects	TNFRSF1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drug hypersensitivity/drug therapy	dinitrofluorobenzene/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drug hypersensitivity/drug therapy	hypersensitivity delayed/chemically induced	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
drug hypersensitivity/drug therapy	ear/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dinitrofluorobenzene/pharmacology	hypersensitivity delayed/chemically induced	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dinitrofluorobenzene/pharmacology	ear/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidoreductases/metabolism	mitogen-activated protein kinases/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidoreductases/metabolism	muscle fibers skeletal/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidoreductases/metabolism	oncogene protein v-akt/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidoreductases/metabolism	EIF4E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidoreductases/metabolism	RPS6KB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidoreductases/metabolism	TNFRSF1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitochondrial dynamics/physiology	immunosuppressive agents/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hypersensitivity delayed/chemically induced	ear/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents	cytosol/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents	zinc/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents	myocardial reperfusion injury/prevention & control	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents	PRKCB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents	PRKCG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cardiotonic agents	PRRT2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitogen-activated protein kinases/genetics	EIF4E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitogen-activated protein kinases/genetics	RPS6KB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitogen-activated protein kinases/genetics	TNFRSF1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitogen-activated protein kinases/genetics	muscle fibers skeletal/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitogen-activated protein kinases/genetics	oncogene protein v-akt/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytosol/drug effects	zinc/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytosol/drug effects	myocardial reperfusion injury/prevention & control	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytosol/drug effects	PRKCB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytosol/drug effects	PRKCG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cytosol/drug effects	PRRT2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle fibers skeletal/drug effects	EIF4E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle fibers skeletal/drug effects	RPS6KB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle fibers skeletal/drug effects	TNFRSF1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
muscle fibers skeletal/drug effects	oncogene protein v-akt/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
zinc/pharmacology	myocardial reperfusion injury/prevention & control	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
zinc/pharmacology	PRKCB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
zinc/pharmacology	PRKCG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
zinc/pharmacology	PRRT2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myocardial reperfusion injury/prevention & control	PRKCB	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myocardial reperfusion injury/prevention & control	PRKCG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
myocardial reperfusion injury/prevention & control	PRRT2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oncogene protein v-akt/metabolism	EIF4E	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oncogene protein v-akt/metabolism	RPS6KB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oncogene protein v-akt/metabolism	TNFRSF1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
EIF4E	RPS6KB2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
EIF4E	TNFRSF1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PRKCB	PRKCG	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PRKCB	PRRT2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
PRKCG	PRRT2	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
RPS6KB2	TNFRSF1A	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydrogen peroxide/antagonists & inhibitors	autocrine communication	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydrogen peroxide/antagonists & inhibitors	pyruvic acid/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydrogen peroxide/antagonists & inhibitors	peptides/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
hydrogen peroxide/antagonists & inhibitors	cell survival/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydrogen peroxide/antagonists & inhibitors	antioxidants/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hydrogen peroxide/antagonists & inhibitors	biological factors/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
autocrine communication	pyruvic acid/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
autocrine communication	peptides/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
autocrine communication	cell survival/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
autocrine communication	antioxidants/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
autocrine communication	biological factors/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyruvic acid/metabolism	peptides/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
pyruvic acid/metabolism	cell survival/physiology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyruvic acid/metabolism	antioxidants/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
pyruvic acid/metabolism	biological factors/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mesothelioma malignant/drug therapy	phosphoinositide-3 kinase inhibitors/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
iron chelating agents/pharmacology	phospholipid hydroperoxide glutathione peroxidase/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
peptides/chemistry	cell survival/physiology	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
peptides/chemistry	antioxidants/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
peptides/chemistry	biological factors/chemistry	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
peptides/chemistry	endocytosis/drug effects	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
cell survival/physiology	antioxidants/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cell survival/physiology	biological factors/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
antioxidants/chemistry	biological factors/chemistry	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
chromones/pharmacology	tert-butylhydroperoxide/toxicity	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
viral structural proteins/metabolism	oxidoreductases/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
viral structural proteins/metabolism	homeostasis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
viral structural proteins/metabolism	nuclear receptor coactivators/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
viral structural proteins/metabolism	NCOA4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
viral structural proteins/metabolism	ferritins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dose-response relationship immunologic	calcitriol/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dose-response relationship immunologic	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidoreductases/genetics	homeostasis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidoreductases/genetics	nuclear receptor coactivators/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidoreductases/genetics	NCOA4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
oxidoreductases/genetics	ferritins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
homeostasis	nuclear receptor coactivators/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
homeostasis	NCOA4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
homeostasis	ferritins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinases/metabolism	ferritins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
protein kinases/metabolism	viral proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/metabolism	lung/cytology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/metabolism	stress physiological	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/metabolism	fibroblasts/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/metabolism	glycine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/metabolism	collagen/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/metabolism	serine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/metabolism	mechanistic target of rapamycin complex 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
activating transcription factor 4/metabolism	transforming growth factor beta/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
calcitriol/metabolism	interleukin-4/antagonists & inhibitors	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
24-dinitrophenol/pharmacology	cyclic amp response element-binding protein/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
ferritins/metabolism	viral proteins/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
apolipoprotein b-100/antagonists & inhibitors	hepatitis c/pathology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
apolipoprotein b-100/antagonists & inhibitors	protein interaction maps	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
apolipoprotein b-100/antagonists & inhibitors	viral nonstructural proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung/cytology	stress physiological	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung/cytology	fibroblasts/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung/cytology	glycine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung/cytology	collagen/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung/cytology	serine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung/cytology	mechanistic target of rapamycin complex 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
lung/cytology	transforming growth factor beta/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cellular senescence/drug effects	hair cells auditory/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
cellular senescence/drug effects	hydrogen peroxide/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna mitochondrial/genetics	kidney/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
dna mitochondrial/genetics	peptide elongation factor tu/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nuclear receptor coactivators/genetics	NCOA4	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
nuclear receptor coactivators/genetics	ferritins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stress physiological	fibroblasts/drug effects	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stress physiological	glycine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stress physiological	collagen/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stress physiological	serine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stress physiological	mechanistic target of rapamycin complex 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
stress physiological	transforming growth factor beta/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
phospholipid hydroperoxide glutathione peroxidase/metabolism	lymph/metabolism	0.0	0.0	0.009345794392523364	0.9605811478101344	1	2
fibroblasts/drug effects	glycine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibroblasts/drug effects	collagen/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibroblasts/drug effects	serine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibroblasts/drug effects	mechanistic target of rapamycin complex 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
fibroblasts/drug effects	transforming growth factor beta/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hair cells auditory/drug effects	hydrogen peroxide/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycine/metabolism	collagen/biosynthesis	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycine/metabolism	serine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycine/metabolism	mechanistic target of rapamycin complex 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
glycine/metabolism	transforming growth factor beta/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
NCOA4	ferritins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
collagen/biosynthesis	serine/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
collagen/biosynthesis	mechanistic target of rapamycin complex 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
collagen/biosynthesis	transforming growth factor beta/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitogen-activated protein kinase 1/antagonists & inhibitors	quinazolines	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mitogen-activated protein kinase 1/antagonists & inhibitors	glioma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hepatitis c/pathology	viral nonstructural proteins/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
hepatitis c/pathology	protein interaction maps	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
serine/metabolism	mechanistic target of rapamycin complex 1/metabolism	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
serine/metabolism	transforming growth factor beta/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
kidney/drug effects	peptide elongation factor tu/genetics	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
quinazolines	glioma/drug therapy	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
viral nonstructural proteins/genetics	protein interaction maps	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
mechanistic target of rapamycin complex 1/metabolism	transforming growth factor beta/pharmacology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
adenosine triphosphatases/antagonists & inhibitors	isoantigens/immunology	0.0	0.0	0.004672897196261682	0.9605811478101344	1	2
